<!-- saved from url=(0080)https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance"
    xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL"
    xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26"
    xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31"
    xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024"
    xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024"
    xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024"
    xmlns:srt="http://fasb.org/srt/2024" xmlns:dhai="http://dih.com/20240930">

<head>
    <meta http-equiv="Content-Type" content="text/html; charset=windows-1252">
    <title></title>
    <meta http-equiv="Content-Type" content="text/html">
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_DHAI_dih.com_20240930 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20240401_20240930 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityRegistrantName_DIH HOLDING US, INC. -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DDocumentType_424B4 -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001883788 -->
<!-- Field: Set; Name: xdx; ID: xdx_07E_XDX_Z%2D%2D\2025 OPERATIONS\EDGAR\01 JANUARY\DIH Holding US Inc\01%2D07%2D2025\Form S%2D1A\Draft\Production\forms%2D1.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_07F_SO_Z%2D%2D\2025 OPERATIONS\EDGAR\01 JANUARY\DIH Holding US Inc\01%2D07%2D2025\Form S%2D1A\Draft\Production\forms%2D1.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_061_Integer_0_Integer -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_TradingDays_0_TradingDays -->
<!-- Field: Set; Name: xdx; ID: xdx_068_NotePayable_0_NotePayable -->

<body style="font: 10pt Times New Roman, Times, Serif">
    <div style="display: none">
        <ix:header>
            <ix:hidden>
                <ix:nonnumeric contextref="From2024-04-01to2024-09-30" id="Fact000003" name="dei:AmendmentFlag">false
                </ix:nonnumeric>
                <ix:nonnumeric contextref="From2024-04-01to2024-09-30" id="Fact000004" name="dei:EntityRegistrantName">
                    DIH HOLDING US, INC.</ix:nonnumeric>
                <ix:nonnumeric contextref="From2024-04-01to2024-09-30" id="Fact000005" name="dei:DocumentType">424B4
                </ix:nonnumeric>
                <ix:nonnumeric contextref="From2024-04-01to2024-09-30" id="Fact000006" name="dei:EntityCentralIndexKey">
                    0001883788</ix:nonnumeric>
                <ix:nonfraction name="us-gaap:CommitmentsAndContingencies" contextref="AsOf2024-03-31"
                    id="xdx2ixbrl0126" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:CommitmentsAndContingencies" contextref="AsOf2023-03-31"
                    id="xdx2ixbrl0127" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:PreferredStockValue" contextref="AsOf2024-03-31" id="xdx2ixbrl0132"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:PreferredStockValue" contextref="AsOf2023-03-31" id="xdx2ixbrl0133"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="DHAI:NoncashBusinessCombinationExpense" contextref="From2022-04-012023-03-31"
                    id="xdx2ixbrl0291" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="DHAI:ChangeInManufacturingWarrantyObligationEstimate"
                    contextref="From2022-04-012023-03-31" id="xdx2ixbrl0312" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="DHAI:ProceedsFromReverseRecapitalization" contextref="From2022-04-012023-03-31"
                    id="xdx2ixbrl0375" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:RestrictedCash" contextref="AsOf2024-03-31" id="xdx2ixbrl0404"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:RestrictedCash" contextref="AsOf2023-03-31" id="xdx2ixbrl0405"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:IncomeTaxesPaidNet" contextref="From2023-04-012024-03-31"
                    id="xdx2ixbrl0416" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"
                    contextref="From2023-04-012024-03-31" id="xdx2ixbrl0422" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1"
                    contextref="From2022-04-012023-03-31" id="xdx2ixbrl0426" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0436" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0437"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2022-04-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                    id="xdx2ixbrl0439" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0442" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0443"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0444"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="DHAI:StockIssuedDuringPeriodValueNetTransactionsWithParent"
                    contextref="From2022-04-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0448" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="DHAI:StockIssuedDuringPeriodValueNetTransactionsWithParent"
                    contextref="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0450"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="DHAI:StockIssuedDuringPeriodValueNetTransactionsWithParent"
                    contextref="From2022-04-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                    id="xdx2ixbrl0451" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2023-04-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0470" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2023-04-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0471"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2023-04-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                    id="xdx2ixbrl0473" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="DHAI:IssuanceOfCommonStockUponReverseRecapitalization"
                    contextref="From2023-04-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0478"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="DHAI:IssuanceOfCommonStockUponReverseRecapitalization"
                    contextref="From2023-04-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                    id="xdx2ixbrl0479" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2023-04-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0484" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2023-04-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0485"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2023-04-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0486"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease"
                    contextref="From2022-04-012023-03-31" id="xdx2ixbrl0622" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonnumeric contextref="AsOf2024-03-31_us-gaap_LeaseholdImprovementsMember" id="xdx2ixbrl0674"
                    name="us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration">
                    http://fasb.org/us-gaap/2024#LeaseholdImprovementsMember</ix:nonnumeric>
                <ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                    contextref="From2022-04-012023-03-31_custom_EarnoutSharesMember" id="xdx2ixbrl0854" unitref="Shares"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                    contextref="From2022-04-012023-03-31_custom_PublicWarrantsMember" id="xdx2ixbrl0857"
                    unitref="Shares" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                    contextref="From2022-04-012023-03-31_custom_PrivatePlacementWarrantMember" id="xdx2ixbrl0860"
                    unitref="Shares" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                    contextref="From2022-04-012023-03-31" id="xdx2ixbrl0863" unitref="Shares" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization"
                    contextref="AsOf2024-03-31" id="xdx2ixbrl0925" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization"
                    contextref="AsOf2023-03-31" id="xdx2ixbrl0931" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization"
                    contextref="AsOf2024-03-31" id="xdx2ixbrl0937" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization"
                    contextref="AsOf2023-03-31" id="xdx2ixbrl0943" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"
                    contextref="AsOf2024-03-31" id="xdx2ixbrl0955" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"
                    contextref="AsOf2024-03-31" id="xdx2ixbrl1217" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"
                    contextref="AsOf2023-03-31" id="xdx2ixbrl1218" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member"
                    id="xdx2ixbrl1281" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel3Member"
                    id="xdx2ixbrl1283" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member"
                    id="xdx2ixbrl1289" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_us-gaap_FairValueInputsLevel3Member"
                    id="xdx2ixbrl1291" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember_us-gaap_FairValueInputsLevel2Member"
                    id="xdx2ixbrl1297" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember_us-gaap_FairValueInputsLevel3Member"
                    id="xdx2ixbrl1299" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember_us-gaap_FairValueInputsLevel1Member"
                    id="xdx2ixbrl1303" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember_us-gaap_FairValueInputsLevel3Member"
                    id="xdx2ixbrl1307" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember_us-gaap_FairValueInputsLevel1Member"
                    id="xdx2ixbrl1311" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember_us-gaap_FairValueInputsLevel3Member"
                    id="xdx2ixbrl1315" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_FairValueInputsLevel3Member"
                    id="xdx2ixbrl1323" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member"
                    id="xdx2ixbrl1329" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel3Member"
                    id="xdx2ixbrl1331" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member"
                    id="xdx2ixbrl1337" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_us-gaap_FairValueInputsLevel3Member"
                    id="xdx2ixbrl1339" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember_us-gaap_FairValueInputsLevel2Member"
                    id="xdx2ixbrl1345" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember_us-gaap_FairValueInputsLevel3Member"
                    id="xdx2ixbrl1347" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember_us-gaap_FairValueInputsLevel1Member"
                    id="xdx2ixbrl1351" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember_us-gaap_FairValueInputsLevel3Member"
                    id="xdx2ixbrl1355" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember_us-gaap_FairValueInputsLevel1Member"
                    id="xdx2ixbrl1359" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember_us-gaap_FairValueInputsLevel3Member"
                    id="xdx2ixbrl1363" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                    contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_FairValueInputsLevel3Member"
                    id="xdx2ixbrl1371" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit"
                    contextref="From2023-04-012024-03-31" id="xdx2ixbrl1409" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit"
                    contextref="From2022-04-012023-03-31" id="xdx2ixbrl1410" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextref="From2023-04-012024-03-31"
                    id="xdx2ixbrl1412" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextref="From2022-04-012023-03-31"
                    id="xdx2ixbrl1413" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit"
                    contextref="From2023-04-012024-03-31" id="xdx2ixbrl1421" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit"
                    contextref="From2022-04-012023-03-31" id="xdx2ixbrl1422" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="DHAI:NonCurrentStateAndLocalTaxExpenseBenefit"
                    contextref="From2023-04-012024-03-31" id="xdx2ixbrl1433" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="DHAI:NonCurrentStateAndLocalTaxExpenseBenefit"
                    contextref="From2022-04-012023-03-31" id="xdx2ixbrl1434" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="DHAI:NonCurrentForeignTaxExpenseBenefit" contextref="From2022-04-012023-03-31"
                    id="xdx2ixbrl1440" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefits" contextref="AsOf2023-03-31" id="xdx2ixbrl1540"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefits" contextref="AsOf2022-03-31" id="xdx2ixbrl1542"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"
                    contextref="From2023-04-012024-03-31" id="xdx2ixbrl1544" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"
                    contextref="From2022-04-012023-03-31" id="xdx2ixbrl1546" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"
                    contextref="From2022-04-012023-03-31" id="xdx2ixbrl1550" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefits" contextref="AsOf2023-03-31" id="xdx2ixbrl1554"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:ShortTermLeaseCost" contextref="From2022-04-012023-03-31"
                    id="xdx2ixbrl1594" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="DHAI:OtherNoncashChangesToRouAssetsDueToReassessmentOfLeaseTerm"
                    contextref="From2022-04-012023-03-31" id="xdx2ixbrl1608" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"
                    contextref="AsOf2024-03-31" id="xdx2ixbrl1634" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction
                    name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                    contextref="From2022-04-012023-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                    id="xdx2ixbrl1654" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction
                    name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                    contextref="From2023-04-012024-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                    id="xdx2ixbrl1678" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonnumeric
                    contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember"
                    id="xdx2ixbrl1722" name="us-gaap:WarrantsAndRightsOutstandingTerm">P5Y</ix:nonnumeric>
                <ix:nonfraction name="us-gaap:RestrictedCash" contextref="AsOf2024-03-31" id="xdx2ixbrl1734"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:ConvertibleDebtCurrent" contextref="AsOf2024-03-31" id="xdx2ixbrl1801"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:ConvertibleDebtNoncurrent" contextref="AsOf2024-03-31" id="xdx2ixbrl1817"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:CommitmentsAndContingencies" contextref="AsOf2024-09-30"
                    id="xdx2ixbrl1837" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:CommitmentsAndContingencies" contextref="AsOf2024-03-31"
                    id="xdx2ixbrl1838" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:PreferredStockValue" contextref="AsOf2024-09-30" id="xdx2ixbrl1843"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:PreferredStockValue" contextref="AsOf2024-03-31" id="xdx2ixbrl1844"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2049" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2050"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                    id="xdx2ixbrl2052" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2055" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2056"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2057"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2077" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2078"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                    id="xdx2ixbrl2080" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2083" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2084"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2085"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2024-04-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2105" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2024-04-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2106"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2024-04-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                    id="xdx2ixbrl2108" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"
                    contextref="From2024-04-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2111" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"
                    contextref="From2024-04-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2113"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"
                    contextref="From2024-04-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                    id="xdx2ixbrl2114" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2024-04-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2117" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2024-04-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2118"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2024-04-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2119"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2023-04-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2147" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2023-04-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2148"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:NetIncomeLoss"
                    contextref="From2023-04-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                    id="xdx2ixbrl2150" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2023-04-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2153" unitref="USD"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2023-04-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2154"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                    contextref="From2023-04-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2155"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="DHAI:ChangeInFairValueOfConvertibleDebtAndWarrantLiability"
                    contextref="From2023-04-012023-09-30" id="xdx2ixbrl2201" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:OtherNoncashExpense" contextref="From2024-04-01to2024-09-30"
                    id="xdx2ixbrl2209" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="DHAI:ProceedsFromIssuanceOfConvertibleNoteNetOfIssuanceCosts"
                    contextref="From2023-04-012023-09-30" id="xdx2ixbrl2273" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:RestrictedCash" contextref="AsOf2023-09-30" id="xdx2ixbrl2300"
                    unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:IncomeTaxesPaidNet" contextref="From2023-04-012023-09-30"
                    id="xdx2ixbrl2312" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"
                    contextref="From2023-04-012023-09-30" id="xdx2ixbrl2318" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                    contextref="From2023-04-012023-09-30_custom_EarnoutSharesMember" id="xdx2ixbrl2578" unitref="Shares"
                    xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                    contextref="From2023-04-012023-09-30_custom_PublicWarrantsMember" id="xdx2ixbrl2581"
                    unitref="Shares" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                    contextref="From2023-04-012023-09-30_custom_PrivatePlacementWarrantMember" id="xdx2ixbrl2584"
                    unitref="Shares" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                    contextref="From2023-04-012023-09-30_us-gaap_ConvertibleDebtSecuritiesMember" id="xdx2ixbrl2587"
                    unitref="Shares" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                    contextref="From2023-04-012023-09-30_custom_WarrantsIssuedWithConvertibleDebtMember"
                    id="xdx2ixbrl2590" unitref="Shares" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                    contextref="From2023-04-012023-09-30" id="xdx2ixbrl2593" unitref="Shares" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization"
                    contextref="AsOf2024-03-31" id="xdx2ixbrl2665" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization"
                    contextref="AsOf2024-09-30" id="xdx2ixbrl2671" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization"
                    contextref="AsOf2024-03-31" id="xdx2ixbrl2677" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonnumeric
                    contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember"
                    id="xdx2ixbrl2798" name="us-gaap:WarrantsAndRightsOutstandingTerm">P5Y</ix:nonnumeric>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"
                    contextref="From2023-07-012023-09-30" id="xdx2ixbrl2907" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"
                    contextref="From2023-04-012023-09-30" id="xdx2ixbrl2909" unitref="USD" xs:nil="true">
                </ix:nonfraction>
                <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"
                    contextref="AsOf2024-09-30" id="xdx2ixbrl3020" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction
                    name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                    contextref="From2024-07-012024-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                    id="xdx2ixbrl3044" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction
                    name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                    contextref="From2023-07-012023-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                    id="xdx2ixbrl3064" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction
                    name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
                    contextref="From2024-04-012024-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                    id="xdx2ixbrl3080" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction
                    name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                    contextref="From2024-04-012024-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                    id="xdx2ixbrl3088" unitref="USD" xs:nil="true"></ix:nonfraction>
                <ix:nonfraction
                    name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                    contextref="From2023-04-012023-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                    id="xdx2ixbrl3112" unitref="USD" xs:nil="true"></ix:nonfraction>
            </ix:hidden>
            <ix:references>
                <link:schemaref xlink:href="dhai-20240930.xsd" xlink:type="simple">
                </link:schemaref>
            </ix:references>
            <ix:resources>
                <xbrli:context id="From2024-04-01to2024-09-30">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_RelatedPartyMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                us-gaap:RelatedPartyMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_RelatedPartyMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                us-gaap:RelatedPartyMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_us-gaap_RelatedPartyMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                us-gaap:RelatedPartyMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2022-03-31">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2022-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-09-30">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2022-03-31_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2022-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2022-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2022-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2022-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-06-30">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-06-30">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-09-30_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-02-072024-02-07_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-02-07</xbrli:startdate>
                        <xbrli:enddate>2024-02-07</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-02-07_custom_DihUsCorporationMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DihUsCorporationMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-02-07</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-02-07_custom_HocomaMedicalGmbhMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:HocomaMedicalGmbhMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-02-07</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-02-072024-02-07_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonClassAMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-02-07</xbrli:startdate>
                        <xbrli:enddate>2024-02-07</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-02-07_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonClassAMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-02-07</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-02-07_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-02-07</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-02-262023-02-26_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember_custom_StockholdersMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonClassAMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">DHAI:StockholdersMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-02-26</xbrli:startdate>
                        <xbrli:enddate>2023-02-26</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-02-26_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonClassAMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-02-26</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-02-262023-02-26_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonClassAMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-02-26</xbrli:startdate>
                        <xbrli:enddate>2023-02-26</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-02-26_custom_CommonClassAOneMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                DHAI:CommonClassAOneMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-02-26</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-02-262023-02-26_custom_CommonClassAOneMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                DHAI:CommonClassAOneMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-02-26</xbrli:startdate>
                        <xbrli:enddate>2023-02-26</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-02-26_custom_CommonClassATwoMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                DHAI:CommonClassATwoMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-02-26</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-02-262023-02-26_custom_CommonClassATwoMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                DHAI:CommonClassATwoMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-02-26</xbrli:startdate>
                        <xbrli:enddate>2023-02-26</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-02-26_custom_CommonClassAThreeMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                DHAI:CommonClassAThreeMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-02-26</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-02-262023-02-26_custom_CommonClassAThreeMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                DHAI:CommonClassAThreeMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-02-26</xbrli:startdate>
                        <xbrli:enddate>2023-02-26</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-02-082024-02-08_us-gaap_CommonClassAMember_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonClassAMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SubscriptionAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">DHAI:OrbiMedMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-02-08</xbrli:startdate>
                        <xbrli:enddate>2024-02-08</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-02-08_us-gaap_CommonClassAMember_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonClassAMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SubscriptionAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">DHAI:OrbiMedMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-02-08</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-02-08_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SubscriptionAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">DHAI:OrbiMedMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-02-08</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-02-07_custom_LegacyDihMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:LegacyDihMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-02-07</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-02-07_custom_DihNevadaMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">DHAI:DihNevadaMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-02-07</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SecuritiesPurchaseAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">
                                DHAI:OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-06</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_DIHHongKongMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">DHAI:DIHHongKongMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-04-012024-03-31_custom_MajorCustomersMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">DHAI:MajorCustomersMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">
                                us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">
                                us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-04-012024-03-31_custom_MajorCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">DHAI:MajorCustomersMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">
                                us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">
                                DHAI:TradeAndAccountsReceivableMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-04-012024-03-31_custom_NoCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">DHAI:NoCustomersMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">
                                us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">
                                DHAI:TradeAndAccountsReceivableMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2022-04-012023-03-31_custom_OneCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">DHAI:OneCustomersMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">
                                us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">
                                DHAI:TradeAndAccountsReceivableMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-04-012024-03-31_custom_NoCustomersMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">DHAI:NoCustomersMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">
                                us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">
                                us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2022-04-012023-03-31_custom_OneCustomersMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">DHAI:OneCustomersMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">
                                us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">
                                us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_SoftwareMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                DHAI:SoftwareMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_PatentAndTechnologyMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">
                                DHAI:PatentAndTechnologyMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_PublicWarrantsMember_us-gaap_IPOMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">
                                DHAI:PublicWarrantsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_PrivatePlacementWarrantMember_us-gaap_IPOMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">
                                DHAI:PrivatePlacementWarrantMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_PrivatePlacementWarrantMember_us-gaap_CommonClassAMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">
                                DHAI:PrivatePlacementWarrantMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonClassAMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_PublicWarrantsMember_us-gaap_CommonClassAMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">
                                DHAI:PublicWarrantsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonClassAMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-10-012022-10-31_custom_SafeGaitAcquisitionMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:SafeGaitAcquisitionMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-10-01</xbrli:startdate>
                        <xbrli:enddate>2022-10-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-06-30_custom_SafeGaitAcquisitionMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:SafeGaitAcquisitionMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-06-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_SafeGaitAcquisitionMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:SafeGaitAcquisitionMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-02-07_custom_DihNevadaMember22260578">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:DihNevadaMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-02-07</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_custom_DIHHongKongMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">DHAI:DIHHongKongMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-04-012024-09-30_custom_MajorCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">DHAI:MajorCustomersMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">
                                us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">
                                DHAI:TradeAndAccountsReceivableMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-04-012024-09-30_custom_NoCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">DHAI:NoCustomersMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">
                                us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">
                                DHAI:TradeAndAccountsReceivableMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-07-012024-09-30_custom_NoCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">DHAI:NoCustomersMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">
                                us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">
                                DHAI:TradeAndAccountsReceivableMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-07-012023-09-30_custom_OneCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_RevenuesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">DHAI:OneCustomersMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">
                                us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">
                                DHAI:RevenuesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-04-012023-09-30_custom_OneCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_RevenuesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">DHAI:OneCustomersMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">
                                us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">
                                DHAI:RevenuesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_ComputerEquipmentMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:ComputerEquipmentMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:MachineryAndEquipmentMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:MachineryAndEquipmentMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_VehiclesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:VehiclesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:FurnitureAndFixturesMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:FurnitureAndFixturesMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_LeaseholdImprovementsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:LeaseholdImprovementsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_custom_DevicesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">DHAI:DevicesMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_custom_DevicesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">DHAI:DevicesMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_us-gaap_ServiceMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_us-gaap_ServiceMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_custom_OtherMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">DHAI:OtherMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_custom_OtherMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">DHAI:OtherMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_custom_DevicesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">DHAI:DevicesMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_custom_DevicesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">DHAI:DevicesMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_custom_DevicesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">DHAI:DevicesMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_custom_DevicesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">DHAI:DevicesMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_us-gaap_ServiceMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_us-gaap_ServiceMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_us-gaap_ServiceMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_us-gaap_ServiceMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_custom_OtherMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">DHAI:OtherMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_custom_OtherMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">DHAI:OtherMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_custom_OtherMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">DHAI:OtherMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_custom_OtherMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">DHAI:OtherMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_us-gaap_TransferredAtPointInTimeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">
                                us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_us-gaap_TransferredAtPointInTimeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">
                                us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_us-gaap_TransferredAtPointInTimeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">
                                us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_us-gaap_TransferredAtPointInTimeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">
                                us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_us-gaap_TransferredOverTimeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">
                                us-gaap:TransferredOverTimeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_us-gaap_TransferredOverTimeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">
                                us-gaap:TransferredOverTimeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_us-gaap_TransferredOverTimeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">
                                us-gaap:TransferredOverTimeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_us-gaap_TransferredOverTimeMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">
                                us-gaap:TransferredOverTimeMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-09-30_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_us-gaap_EMEAMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_us-gaap_EMEAMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_srt_AmericasMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AmericasMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_srt_AmericasMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AmericasMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_srt_AsiaPacificMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_srt_AsiaPacificMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_us-gaap_EMEAMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_us-gaap_EMEAMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_us-gaap_EMEAMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_us-gaap_EMEAMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_srt_AmericasMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AmericasMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_srt_AmericasMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AmericasMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_srt_AmericasMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AmericasMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_srt_AmericasMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AmericasMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_srt_AsiaPacificMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_srt_AsiaPacificMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_srt_AsiaPacificMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_srt_AsiaPacificMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_country_US">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_country_US">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_country_RU">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:RU
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_country_US">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_country_US">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_country_RU">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:RU
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_custom_OtherMember22262187">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">DHAI:OtherMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_custom_OtherMember22262187">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">DHAI:OtherMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_custom_OtherMember22262187">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">DHAI:OtherMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_custom_OtherMember22262203">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">DHAI:OtherMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_EMEAMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_EMEAMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_srt_AmericasMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AmericasMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_srt_AmericasMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AmericasMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_srt_AsiaPacificMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_srt_AsiaPacificMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_us-gaap_EMEAMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_srt_AmericasMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AmericasMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_srt_AsiaPacificMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-06-06_us-gaap_ConvertibleDebtMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ShortTermDebtTypeAxis">
                                us-gaap:ConvertibleDebtMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-06</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-06-062024-06-06_us-gaap_ConvertibleDebtMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ShortTermDebtTypeAxis">
                                us-gaap:ConvertibleDebtMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-06-06</xbrli:startdate>
                        <xbrli:enddate>2024-06-06</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-06-30_us-gaap_ConvertibleDebtMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ShortTermDebtTypeAxis">
                                us-gaap:ConvertibleDebtMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_custom_EarnoutSharesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:EarnoutSharesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_custom_EarnoutSharesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:EarnoutSharesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_custom_PublicWarrantsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:PublicWarrantsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_custom_PublicWarrantsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:PublicWarrantsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_custom_PrivatePlacementWarrantMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:PrivatePlacementWarrantMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_custom_PrivatePlacementWarrantMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:PrivatePlacementWarrantMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_custom_EarnoutSharesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:EarnoutSharesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_custom_EarnoutSharesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:EarnoutSharesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_custom_PublicWarrantsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:PublicWarrantsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_custom_PublicWarrantsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:PublicWarrantsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_custom_PrivatePlacementWarrantMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:PrivatePlacementWarrantMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_custom_PrivatePlacementWarrantMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:PrivatePlacementWarrantMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_us-gaap_ConvertibleDebtSecuritiesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_us-gaap_ConvertibleDebtSecuritiesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_custom_WarrantsIssuedWithConvertibleDebtMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:WarrantsIssuedWithConvertibleDebtMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_custom_WarrantsIssuedWithConvertibleDebtMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember
                                dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
                                DHAI:WarrantsIssuedWithConvertibleDebtMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_ComputerEquipmentMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:ComputerEquipmentMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_MachineryAndEquipmentMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:MachineryAndEquipmentMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_MachineryAndEquipmentMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:MachineryAndEquipmentMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_LeaseholdImprovementsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:LeaseholdImprovementsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_FurnitureAndFixturesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:FurnitureAndFixturesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_FurnitureAndFixturesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:FurnitureAndFixturesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_VehiclesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:VehiclesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_DemonstrationUnitsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                DHAI:DemonstrationUnitsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_custom_DemonstrationUnitsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                DHAI:DemonstrationUnitsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_us-gaap_ComputerEquipmentMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:ComputerEquipmentMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:MachineryAndEquipmentMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_us-gaap_LeaseholdImprovementsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:LeaseholdImprovementsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_us-gaap_FurnitureAndFixturesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:FurnitureAndFixturesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_us-gaap_VehiclesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                us-gaap:VehiclesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_custom_DemonstrationUnitsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
                                DHAI:DemonstrationUnitsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_WarrantMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:WarrantMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_WarrantMember_us-gaap_CommonStockMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:WarrantMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-04-012024-03-31_custom_RedemptionOfWarrantsMember_us-gaap_CommonStockMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">
                                DHAI:RedemptionOfWarrantsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="DHAI:ShareRedemptionTriggerPriceAxis">
                                DHAI:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_custom_RedemptionOfWarrantsMember_us-gaap_CommonStockMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">
                                DHAI:RedemptionOfWarrantsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="DHAI:ShareRedemptionTriggerPriceAxis">
                                DHAI:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_PrivatePlacementWarrantsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">
                                DHAI:PrivatePlacementWarrantsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_custom_PrivatePlacementWarrantsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">
                                DHAI:PrivatePlacementWarrantsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_custom_DihCaymanAndDihHongKongMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:DihCaymanAndDihHongKongMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_custom_MotekGroupMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:MotekGroupMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_custom_DihCaymanAndDihHongKongMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:DihCaymanAndDihHongKongMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_custom_MotekGroupMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:MotekGroupMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_DIHHongKongMember22266921">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:DIHHongKongMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_custom_DIHHongKongMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:DIHHongKongMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_MotekGroupMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:MotekGroupMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_custom_MotekGroupMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:MotekGroupMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_custom_DIHHongKongMember22266953">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:DIHHongKongMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_custom_MotekGroupMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:MotekGroupMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2021-07-012021-07-01_custom_HocomaAgMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2021-07-01</xbrli:startdate>
                        <xbrli:enddate>2021-07-01</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2021-07-012021-07-01_custom_SharePurchaseAgreementMember_custom_DihNevadaMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SharePurchaseAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:DihNevadaMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2021-07-01</xbrli:startdate>
                        <xbrli:enddate>2021-07-01</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2021-07-01_custom_SharePurchaseAgreementMember_custom_DihNevadaMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SharePurchaseAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:DihNevadaMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2021-07-01</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2021-07-012021-07-01_custom_HocomaAgMember_custom_ContributionAgreementMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:ContributionAgreementMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2021-07-01</xbrli:startdate>
                        <xbrli:enddate>2021-07-01</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2021-07-012021-07-01_custom_ContributionAgreementMember_custom_HocomaMedicalGmbhMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:ContributionAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaMedicalGmbhMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2021-07-01</xbrli:startdate>
                        <xbrli:enddate>2021-07-01</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2021-07-012021-07-01_custom_ContributionAgreementMember_custom_DihUsCorporationMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:ContributionAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:DihUsCorporationMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2021-07-01</xbrli:startdate>
                        <xbrli:enddate>2021-07-01</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2021-07-012021-07-01_custom_DIHHoldingUSIncMember_custom_TransferOfMembershipInterestsAgreementMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:TransferOfMembershipInterestsAgreementMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2021-07-01</xbrli:startdate>
                        <xbrli:enddate>2021-07-01</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2021-07-01_custom_TransferOfMembershipInterestsAgreementMember_custom_DIHHoldingUSIncMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:TransferOfMembershipInterestsAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:DIHHoldingUSIncMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2021-07-01</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2021-07-12_custom_BusinessAssetShareAndIpPurchaseAgreementMember_custom_HocomaAgMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:BusinessAssetShareAndIpPurchaseAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2021-07-12</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2021-07-122021-07-12_custom_BusinessAssetShareAndIpPurchaseAgreementMember_custom_HocomaAgMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:BusinessAssetShareAndIpPurchaseAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2021-07-12</xbrli:startdate>
                        <xbrli:enddate>2021-07-12</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012024-03-31_custom_HocomaAgMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_custom_HocomaAgMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_HocomaAgMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_custom_HocomaAgMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2022-04-012023-03-31_custom_MotekGroupMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:MotekGroupMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_custom_RelatedPartyOneMember_custom_HocomaAgMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
                                DHAI:RelatedPartyOneMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_custom_RelatedPartyTwoMember_custom_HocomaAgMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
                                DHAI:RelatedPartyTwoMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_custom_RelatedPartyThreeMember_custom_HocomaAgMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
                                DHAI:RelatedPartyThreeMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_custom_HocomaAgMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-09-30_custom_HocomaAgMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:HocomaAgMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-07-012024-09-30_custom_MotekGroupMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:MotekGroupMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-07-012023-09-30_custom_MotekGroupMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:MotekGroupMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2023-04-012023-09-30_custom_MotekGroupMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
                                DHAI:MotekGroupMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_EquitySecuritiesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByAssetClassAxis">
                                us-gaap:EquitySecuritiesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_EquitySecuritiesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByAssetClassAxis">
                                us-gaap:EquitySecuritiesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_us-gaap_DebtSecuritiesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByAssetClassAxis">
                                us-gaap:DebtSecuritiesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_DebtSecuritiesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByAssetClassAxis">
                                us-gaap:DebtSecuritiesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-03-31_custom_CashAndCashEquivalentsAndHedgeFundsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByAssetClassAxis">
                                DHAI:CashAndCashEquivalentsAndHedgeFundsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_custom_CashAndCashEquivalentsAndHedgeFundsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByAssetClassAxis">
                                DHAI:CashAndCashEquivalentsAndHedgeFundsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel3Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_us-gaap_FairValueInputsLevel3Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember_us-gaap_FairValueInputsLevel1Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember_us-gaap_FairValueInputsLevel2Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember_us-gaap_FairValueInputsLevel3Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember_us-gaap_FairValueInputsLevel1Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember_us-gaap_FairValueInputsLevel2Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember_us-gaap_FairValueInputsLevel3Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember_us-gaap_FairValueInputsLevel1Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                DHAI:DefinedBenefitPlanNonTraditionalAssetsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember_us-gaap_FairValueInputsLevel2Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                DHAI:DefinedBenefitPlanNonTraditionalAssetsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember_us-gaap_FairValueInputsLevel3Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                DHAI:DefinedBenefitPlanNonTraditionalAssetsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                DHAI:DefinedBenefitPlanNonTraditionalAssetsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_FairValueInputsLevel1Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_FairValueInputsLevel2Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_FairValueInputsLevel3Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel3Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_us-gaap_FairValueInputsLevel3Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember_us-gaap_FairValueInputsLevel1Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember_us-gaap_FairValueInputsLevel2Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember_us-gaap_FairValueInputsLevel3Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember_us-gaap_FairValueInputsLevel1Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember_us-gaap_FairValueInputsLevel2Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember_us-gaap_FairValueInputsLevel3Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember_us-gaap_FairValueInputsLevel1Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                DHAI:DefinedBenefitPlanNonTraditionalAssetsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember_us-gaap_FairValueInputsLevel2Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                DHAI:DefinedBenefitPlanNonTraditionalAssetsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember_us-gaap_FairValueInputsLevel3Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                DHAI:DefinedBenefitPlanNonTraditionalAssetsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">
                                DHAI:DefinedBenefitPlanNonTraditionalAssetsMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_FairValueInputsLevel1Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_FairValueInputsLevel2Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_FairValueInputsLevel3Member">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">
                                us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">
                                us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2022-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2022-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2022-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2022-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2022-04-012023-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2022-04-012023-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2022-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-04-012024-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-04-012024-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-03-31</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-03-31</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-06-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-07-012024-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-07-012024-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-07-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-06-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-06-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-07-012023-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-07-012023-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-07-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2023-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2023-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-04-012024-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-04-012024-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-04-012023-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2023-04-012023-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
                            </xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2023-04-01</xbrli:startdate>
                        <xbrli:enddate>2023-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SecuritiesPurchaseAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">
                                DHAI:OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:SubsequentEventTypeAxis">
                                us-gaap:SubsequentEventMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-06</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-06-062024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SecuritiesPurchaseAgreementMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">
                                DHAI:OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:SubsequentEventTypeAxis">
                                us-gaap:SubsequentEventMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-06-06</xbrli:startdate>
                        <xbrli:enddate>2024-06-06</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-06-062024-06-06_us-gaap_CommonStockMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">
                                DHAI:OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:SubsequentEventTypeAxis">
                                us-gaap:SubsequentEventMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SecuritiesPurchaseAgreementMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-06-06</xbrli:startdate>
                        <xbrli:enddate>2024-06-06</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-06-06_us-gaap_CommonStockMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">
                                DHAI:OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:SubsequentEventTypeAxis">
                                us-gaap:SubsequentEventMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SecuritiesPurchaseAgreementMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-06</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-06-062024-06-06_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_custom_SecuritiesPurchaseAgreementMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">
                                DHAI:OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SecuritiesPurchaseAgreementMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-06-06</xbrli:startdate>
                        <xbrli:enddate>2024-06-06</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-06-062024-06-06_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">
                                DHAI:OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SecuritiesPurchaseAgreementMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-06-06</xbrli:startdate>
                        <xbrli:enddate>2024-06-06</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-06-06_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">
                                DHAI:OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">
                                us-gaap:CommonStockMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:TypeOfArrangementAxis">
                                DHAI:SecuritiesPurchaseAgreementMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-06</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="From2024-06-062024-06-06_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_ConvertibleDebtMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">
                                DHAI:OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember
                            </xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:ShortTermDebtTypeAxis">
                                us-gaap:ConvertibleDebtMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-06-06</xbrli:startdate>
                        <xbrli:enddate>2024-06-06</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-09-30_custom_PublicWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">
                                DHAI:PublicWarrantsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:MeasurementInputTypeAxis">
                                us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-09-30_custom_PublicWarrantsMember_us-gaap_MeasurementInputCreditSpreadMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">
                                DHAI:PublicWarrantsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:MeasurementInputTypeAxis">
                                us-gaap:MeasurementInputCreditSpreadMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context
                    id="AsOf2024-09-30_custom_PublicWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:ClassOfWarrantOrRightAxis">
                                DHAI:PublicWarrantsMember</xbrldi:explicitmember>
                            <xbrldi:explicitmember dimension="us-gaap:MeasurementInputTypeAxis">
                                us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-09-30</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="AsOf2024-06-06">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:instant>2024-06-06</xbrli:instant>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:context id="From2024-04-012024-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
                    <xbrli:entity>
                        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001883788</xbrli:identifier>
                        <xbrli:segment>
                            <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
                                us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitmember>
                        </xbrli:segment>
                    </xbrli:entity>
                    <xbrli:period>
                        <xbrli:startdate>2024-04-01</xbrli:startdate>
                        <xbrli:enddate>2024-09-30</xbrli:enddate>
                    </xbrli:period>
                </xbrli:context>
                <xbrli:unit id="USD">
                    <xbrli:measure>iso4217:USD</xbrli:measure>
                </xbrli:unit>
                <xbrli:unit id="Shares">
                    <xbrli:measure>xbrli:shares</xbrli:measure>
                </xbrli:unit>
                <xbrli:unit id="USDPShares">
                    <xbrli:divide>
                        <xbrli:unitnumerator>
                            <xbrli:measure>iso4217:USD</xbrli:measure>
                        </xbrli:unitnumerator>
                        <xbrli:unitdenominator>
                            <xbrli:measure>xbrli:shares</xbrli:measure>
                        </xbrli:unitdenominator>
                    </xbrli:divide>
                </xbrli:unit>
                <xbrli:unit id="Pure">
                    <xbrli:measure>xbrli:pure</xbrli:measure>
                </xbrli:unit>
                <xbrli:unit id="Integer">
                    <xbrli:measure>DHAI:Integer</xbrli:measure>
                </xbrli:unit>
                <xbrli:unit id="TradingDays">
                    <xbrli:measure>DHAI:TradingDays</xbrli:measure>
                </xbrli:unit>
                <xbrli:unit id="NotePayable">
                    <xbrli:measure>DHAI:NotePayable</xbrli:measure>
                </xbrli:unit>
                <ix:relationship fromrefs="Fact000434" torefs="Footnote000505">
                    <ix:relationship fromrefs="Fact000460" torefs="Footnote000505">
                        <ix:relationship fromrefs="Fact000468" torefs="Footnote000505">
                            <ix:relationship fromrefs="Fact000482" torefs="Footnote000505">
                                <ix:relationship fromrefs="Fact000496" torefs="Footnote000505">
                                    <ix:relationship fromrefs="Fact000504" torefs="Footnote000505">
                                        <ix:relationship fromrefs="Fact002075" torefs="Footnote002174">
                                            <ix:relationship fromrefs="Fact002095" torefs="Footnote002174">
                                                <ix:relationship fromrefs="Fact002137" torefs="Footnote002174">
                                                    <ix:relationship fromrefs="Fact002145" torefs="Footnote002174">
                                                        <ix:relationship fromrefs="Fact002165" torefs="Footnote002174">
                                                            <ix:relationship fromrefs="Fact002173"
                                                                torefs="Footnote002174">
                                                            </ix:relationship>
                                                        </ix:relationship>
                                                    </ix:relationship>
                                                </ix:relationship>
                                            </ix:relationship>
                                        </ix:relationship>
                                    </ix:relationship>
                                </ix:relationship>
                            </ix:relationship>
                        </ix:relationship>
                    </ix:relationship>
                </ix:relationship>
            </ix:resources>
        </ix:header>
    </div>


    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        &nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: right"><b>Filed
            pursuant to Rule
            424(b)(4)</b></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: right">
        <b>Registration Statement
            No. 333-283853</b></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            HOLDING US, INC.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,937,100
        </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, each consisting of One
            Share of Class A Common
            Stock and One Class A Warrant to purchase One Share of Class A Common Stock</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,937,100
        </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of Class A Common Stock
            Underlying the Class
            A Warrants</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are offering on a reasonable best efforts basis 5,937,100 units (�Units�), each consisting of one share of
            Class A
            common stock, par value $0.0001 per share (�common stock� or �Common Stock� or �Class A Common Stock�),
            and one warrant (the �Class A warrant�) to purchase one share of common stock at a public offering price of
            $0.7832
            per Unit, for gross proceeds of $4.6 million. The Units have no stand-alone rights and will not be certified
            or issued as
            stand-alone securities. The common stock (as defined below) and Class A warrants are immediately separable
            and
            will be issued separately in this offering. Each Class A warrant will be immediately exercisable for one
            share of common stock at an
            exercise price of $0.7832 per share (100% of the public offering price per Unit) and will expire on the
            fifth anniversary
            of the original issuance date.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            Common Stock is listed on the Nasdaq Global Market (�Nasdaq�) under the symbol �DHAI.� On January 30,
            2025, the last reported sales price per share of our Common Stock was $0.7832.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            securities will be offered at a fixed price and are expected to be issued in a single closing. We expect
            this offering to be completed
            not later than one business day following the commencement of sales in this offering (after the effective
            date of the registration statement
            of which this prospectus forms a part) and we will deliver all securities to be issued in connection with
            this offering delivery versus
            payment or receipt versus payment, as the case may be, upon receipt of investor funds received by us.
            Accordingly, neither we nor the
            placement agent have made any arrangements to place investor funds in an escrow account or trust account
            since the placement agent will
            not receive investor funds in connection with the sale of the securities offered hereunder.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="width: 100%">&nbsp;</td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have engaged Maxim Group LLC (the �placement agent� or �Maxim�) to act as our exclusive placement agent in
            connection
            with this offering. The placement agent has agreed to use its reasonable best efforts to arrange for the
            sale of the securities offered
            by this prospectus. The placement agent is not purchasing or selling any of the securities we are offering
            and the placement agent is
            not required to arrange the purchase or sale of any specific number of securities or dollar amount. We have
            agreed to pay to the placement
            agent the placement agent fees set forth in the table below, which assumes that we sell all of the
            securities offered by this prospectus.
            There is no arrangement for funds to be received in escrow, trust or similar arrangement. There is no
            minimum offering requirement as
            a condition of closing of this offering. We may sell fewer than all of the Units offered hereby, which may
            significantly reduce the amount
            of proceeds received by us. Because there is no escrow account and no minimum number of securities or amount
            of proceeds, investors could
            be in a position where they have invested in us, but we have not raised sufficient proceeds in this offering
            to adequately fund the intended
            uses of the proceeds as described in this prospectus. See �<i>Risk Factors</i>� for more information
            regarding risks related
            to this offering. We will bear all costs associated with the offering. See �<i>Plan of Distribution</i>� for
            more information
            regarding these arrangements.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
            is no established trading market for the Class A warrants and we do not expect an active trading market to
            develop. We do not intend to list the Class A warrants on any securities exchange or other trading market.
            Without an active trading market, the liquidity of these securities will be limited.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are an �emerging growth company,� as defined under the federal securities laws and, as such, we have elected
            to comply with
            certain reduced public company reporting requirements for this prospectus and future filings. See �Risk
            Factors - We are an emerging
            growth company and a �smaller reporting company� and the reduced reporting requirements applicable to such
            companies may
            make our Common Stock less attractive to investors.�</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
            in our securities is speculative and involves a high degree of risk. You should carefully consider the risk
            factors beginning on page
            9 of this prospectus before purchasing our securities.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
            the Securities and Exchange Commission nor any state securities commission has approved or disapproved of
            these securities or determined
            if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per Unit<sup></sup></span>
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 60%; text-align: justify">Public offering price</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">0.7832</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">4,649,936.72</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement agent
                        fees<sup>(1)</sup></span></td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">0.0429</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">254,909.67</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: justify">Proceeds to us, before expenses</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">0.7403</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">4,395,207.05</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">
        &nbsp;</p>

    <!-- Field: Rule-Page -->
    <div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%">
        <div style="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</div>
    </div><!-- Field: /Rule-Page -->

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
        </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have agreed to pay the
            placement agent a cash
            fee equal to 7.0% of the aggregate gross proceeds raised in this offering (or 3.5% of the public offering
            price of the Units for any
            investors we introduce to the placement agent), and to reimburse the placement agent for certain of its
            offering-related expenses. See
            �Plan of Distribution� for a description of the compensation to be received by the placement agent.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery
            of the securities hereby is expected to be made on or about February 3, 2025, subject to the satisfaction of
            customary closing
            conditions.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sole
            Placement Agent</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 18pt">Maxim
            Group LLC</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            date of this prospectus is January 31, 2025.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="width: 100%">&nbsp;</td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
            OF CONTENTS</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#nd_001">ABOUT
                            THIS PROSPECTUS</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#nd_002">CAUTIONARY
                            NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#nd_003">PROSPECTUS
                            SUMMARY</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#nd_004">THE
                            OFFERING</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#nd_005">RISK
                            FACTORS</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#nd_006">MARKET
                            AND INDUSTRY DATA</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#nd_007">USE
                            OF PROCEEDS</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#nd_008">CAPITALIZATION</a></span>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#nd_009">DILUTION</a></span>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#nd_010">MARKET
                            INFORMATION FOR SECURITIES AND DIVIDEND POLICY</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#nd_011">MANAGEMENT�S
                            DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#D_001">BUSINESS</a></span>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#D_002">MANAGEMENT</a></span>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#D_003">EXECUTIVE
                            AND DIRECTOR COMPENSATION</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#D_004">CERTAIN
                            RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#D_005">PRINCIPAL
                            SECURITYHOLDERS</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a
                        href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#D_006">PLAN
                        OF DISTRIBUTION</a></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">74</td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#D_007">DESCRIPTION
                            OF SECURITIES</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#D_008">LEGAL
                            MATTERS</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#D_009">EXPERTS</a></span>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#D_010">CHANGES
                            IN REGISTRANT�S CERTIFYING ACCOUNTANT</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#SSS_001">WHERE
                            YOU CAN FIND MORE INFORMATION</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#aab_008">INDEX
                            TO CONSOLIDATED FINANCIAL STATEMENTS</a></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">F-<span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
            </tr>
        </tbody>
    </table>
    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>




    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_001"></span>ABOUT
            THIS PROSPECTUS</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
            should rely only on the information contained in this prospectus and in any free writing prospectus. We have
            not and the placement agent
            has not authorized anyone to provide you with information different from that contained in this prospectus.
            We are offering to sell,
            and seeking offers to buy, our securities only in jurisdictions where offers and sales are permitted. The
            information in this prospectus
            is accurate only as of the date of this prospectus is accurate only as of the date of the document
            incorporated by reference, regardless
            of the time of delivery of this prospectus or any sale of our securities.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
            we nor the placement agent have done anything that would permit this offering or possession or distribution
            of this prospectus in any
            jurisdiction where action for that purpose is required, other than in the United States. Persons outside the
            United States who come into
            possession of this prospectus must inform themselves about, and observe any restrictions relating to, the
            offering of our securities
            and the distribution of this prospectus outside of the United States.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            own or have rights to trademarks or trade names that we use in connection with the operation of our
            business, including our corporate
            names, logos and website names. In addition, we own or have the rights to copyrights, trade secrets and
            other proprietary rights that
            protect the content of our products. This prospectus may also contain trademarks, service marks and trade
            names of other companies, which
            are the property of their respective owners. Our use or display of third parties� trademarks, service marks,
            trade names or products
            in this prospectus is not intended to, and should not be read to, imply a relationship with or endorsement
            or sponsorship of us. Solely
            for convenience, some of the copyrights, trade names and trademarks referred to in this prospectus are
            listed without their �, �
            and <sup>TM</sup> symbols, but we will assert, to the fullest extent under applicable law, our rights to our
            copyrights, trade names
            and trademarks. All other trademarks are the property of their respective owners.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_002"></span>CAUTIONARY
            NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
            statements contained in this registration statement may constitute �forward-looking statements� for purposes
            of federal securities
            laws. Such statements can be identified by the fact that they do not relate strictly to historical or
            current facts. Forward-looking
            statements appear in a number of places in this registration statement including, without limitation, in the
            sections of this registration
            statement titled �<i>Business</i>� and �<i>Management�s Discussion and Analysis of Financial Condition and
                Results
                of Operations</i>.� In addition, any statements that refer to projections, forecasts or other
            characterizations of future events
            or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking
            statements are typically identified
            by words such as �plan,� �believe,� �expect,� �anticipate,� �contemplate,�
            �intend,� �outlook,� �estimate,� �forecast,� �project,� �continue,�
            �could,� �may,� �might,� �possible,� �potential,� �predict,�
            �should,� �will,� �would� and other similar words and expressions (including the negative of any
            of the foregoing), but the absence of these words does not mean that a statement is not
            forward-looking.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
            forward-looking statements are based on information available as of the date of this registration statement
            and our management�s
            current expectations, forecasts and assumptions, and involve a number of judgments, known and unknown risks
            and uncertainties and other
            factors, many of which are outside the control of the Company and our directors, officers and affiliates.
            There can be no assurance that
            future developments will be those that have been anticipated. Accordingly, forward-looking statements should
            not be relied upon as representing
            our views as of any subsequent date.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
            forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause
            actual results or performance
            to be materially different from those expressed or implied by these forward-looking statements. These risks
            and uncertainties include,
            but are not limited to, those factors described in �<i>Risk Factors,</i>� our periodic filings with the SEC
            and the following:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unexpected
                        technical and marketing difficulties inherent in major research and product development
                        efforts;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                        ability to remain a market innovator, to create new market opportunities, and/or to expand into
                        new markets;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                        potential need for changes in our long-term strategy in response to future developments;</span>
                </td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">our ability to attract and
                    retain skilled employees;</td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                        ability to raise sufficient capital to support our operations and fund our growth
                        initiatives;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">unexpected changes in
                    significant operating expenses, including components and raw materials;</td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">any disruptions or threatened
                    disruptions to our relations with our resellers, suppliers, customers and employees, including
                    shortages in components for our products;</td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                        in the supply, demand and/or prices for our products;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                        complexities and uncertainty of obtaining and conducting international business, including
                        export compliance and other reporting
                        and compliance requirements;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                        impact of potential security and cyber threats or the risk of unauthorized access to our, our
                        customers� and/or our suppliers�
                        information and systems;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                        in the regulatory environment and the consequences to our financial position, business and
                        reputation that could result from failing
                        to comply with such regulatory requirements;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                        ability to continue to successfully integrate acquired companies into our operations, including
                        the ability to timely and sufficiently
                        integrate international operations into our ongoing business and compliance programs;</span>
                </td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                        to develop new products or integrate new technology into current products;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unfavorable
                        results in legal proceedings to which we may be subject;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                        to establish and maintain effective internal control over financial reporting; and</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                        economic and business conditions in the United States and elsewhere in the world, including the
                        impact of inflation.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>



    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
            should refer to �<i>Risk Factors</i>� on page 9 of this registration statement for a discussion of important
            factors that
            may cause our actual results to differ materially from those expressed or implied by our forward-looking
            statements. As a result of the
            risks, uncertainties and assumptions described under �<i>Risk Factors</i>� and elsewhere, we cannot assure
            you that the forward-looking
            statements in this registration statement will prove to be accurate. Furthermore, if our forward-looking
            statements prove to be inaccurate,
            the inaccuracy may be material. In light of the significant uncertainties in these forward-looking
            statements, you should not regard
            these statements as a representation or warranty by us or any other person that we will achieve our
            objectives and plans in any specified
            time frame or at all.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
            should not rely upon forward-looking statements as predictions of future events. Although we believe that
            the expectations reflected
            in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of
            activity, performance, or events
            and circumstances reflected in the forward-looking statements will be achieved or occur. We undertake no
            obligation to update publicly
            any forward-looking statements for any reason after the date of this registration statement to conform these
            statements to new information,
            actual results or changes in our expectations, except as required by law.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            forward-looking statements contained in this registration statement are based on our current expectations
            and beliefs concerning future
            developments and their potential effects on us. There can be no assurance that future developments affecting
            us will be those that we
            have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which
            are beyond our control) or
            other assumptions that may cause actual results or performance to be materially different from those
            expressed or implied by these forward-looking
            statements. These risks and uncertainties include, but are not limited to, those factors described under the
            heading �Risk Factors.�
            Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove
            incorrect, actual results may
            vary in material respects from those projected in these forward-looking statements. We undertake no
            obligation to update or revise any
            forward-looking statements, whether as a result of new information, future events or otherwise, except as
            may be required under applicable
            securities laws.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <div style="border: Black 1pt solid; padding-right: 0.1in; padding-left: 0.1in">

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="nd_003"></span>PROSPECTUS
                SUMMARY</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                summary highlights selected information that is presented in greater detail elsewhere in this
                registration statement. Because it is only
                a summary, it does not contain all of the information you should consider before investing in our
                securities and it is qualified in its
                entirety by, and should be read in conjunction with, the more detailed information included elsewhere in
                this registration statement.
                Before you decide whether to purchase our securities, you should read this entire prospectus carefully,
                including the sections of this
                registration statement titled �<i>Risk Factors</i>� and �<i>Management�s Discussion and Analysis of
                    Financial
                    Condition and Results of Operations</i>�. You should also carefully read the information in this
                registration statement, including
                our financial statements, and the exhibits to the registration statement of which this prospectus is a
                part.</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
                Holding US, Inc. <span style="background-color: white">and its consolidated subsidiaries (�DIH�)
                </span>is a global provider
                of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an
                interactive manner to enable
                clinical research and intensive functional rehabilitation and training in patients with walking
                impairments, reduced balance and/or impaired
                arm and hand functions. We strive to serve the rehabilitation market by providing a broad array of
                devices and services focused on the
                customer and patient recovery. DIH stands for our vision to �Deliver Inspiration &amp; Health� to
                improve the daily lives
                of millions of people with disabilities and functional impairments.</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
                offers innovative, robotic-enabled rehabilitation devices in an interactive environment. These solutions
                allow for intensive rehabilitation
                across the spectrum of patient specific levels of care, while also tracking patients� progress and
                providing a network of collaboration
                and encouragement. DIH is dedicated to restoring mobility and enhancing human performance through a
                broad array of devices that can enable
                the transformation of rehabilitation care at our customers. Our revenue is concentrated in Europe,
                Middle East and Africa (�EMEA�)
                and Americas, with the remaining revenue in Asia Pacific (�APAC�).</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
                    Combination</b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                February 7, 2024, Aurora Technology Acquisition Corp. a Cayman Island exempted company which migrated
                and domesticated as a Delaware
                corporation (�ATAK�), Aurora Technology Merger Sub, a Nevada corporation and a direct, wholly-owned
                subsidiary of ATAK (�Merger
                Sub�) and DIH Holding US Inc., a Nevada corporation (�Legacy DIH�) consummated a business combination
                pursuant to a
                business agreement dated as of February 26, 2023 (as amended, supplemented or otherwise modified from
                time to time, the �Business
                Combination Agreement,� and the transactions contemplated thereby, the �Business Combination�) following
                the receipt
                of the required approval by ATAK�s and Legacy DIH�s shareholders and the fulfillment or waiver of other
                customary closing
                conditions. In connection with the closing of the Business Combination (the �Closing�), ATAK migrated
                and changed its domestication
                to become a Delaware corporation and changed its name to �DIH Holding US, Inc.� The Amended and Restated
                Certificate of Incorporation
                of DIH authorizes one class of common stock as Class A Common Stock.</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                connection with the Closing of the Business Combination and in accordance with the terms of the Business
                Combination Agreement, ATAK
                agreed to waive the closing condition that the Reorganization be completed prior to Closing. The Company
                agreed to use its best efforts
                to complete the Reorganization as defined in the Business Combination Agreement as soon as possible
                thereafter. The Reorganization has
                not been completed as of the date of this prospectus.</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
                Growth Company</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                are an �emerging growth company,� as defined in Section 2(a) of the Securities Act, as modified by the
                Jumpstart Our Business
                Startups Act of 2012 (the �JOBS Act�). As an emerging growth company, we are eligible to take advantage
                of certain exemptions
                from various reporting requirements that are applicable to other public companies that are not emerging
                growth companies, including,
                but not limited to, not being required to comply with the auditor attestation requirements of Section
                404 of the Sarbanes-Oxley Act of
                2002, as amended (the �Sarbanes-Oxley Act�), reduced disclosure obligations regarding executive
                compensation in our periodic
                reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote
                on executive compensation and
                stockholder approval of any golden parachute payments not previously approved.</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            &nbsp;</p>

    </div>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <div style="border: Black 1pt solid; padding-right: 0.1in; padding-left: 0.1in">

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
                Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with
                new or revised financial accounting
                standards until private companies (that is, those that have not had a Securities Act registration
                statement declared effective or do
                not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the
                �Exchange Act�) are
                required to comply with the new or revised financial accounting standards. The JOBS Act provides that a
                company can elect to opt out
                of the extended transition period and comply with the requirements that apply to non-emerging growth
                companies but any such election
                to opt out is irrevocable. As a result, changes in rules of U.S. generally accepted accounting
                principles or their interpretation, the
                adoption of new guidance or the application of existing guidance to changes in our business could
                significantly affect our business,
                financial condition and results of operations. In addition, we are in the process of evaluating the
                benefits of relying on the other
                exemptions and reduced reporting requirements provided by the JOBS Act, as more fully described in the
                section of this registration statement
                titled �<i>Management�s Discussion and Analysis of Financial Condition and Results of Operations �
                    Emerging Growth
                    Company</i>.�</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                will remain an emerging growth company until the earlier of: (i) the last day of the fiscal year (a)
                following the fifth anniversary
                of the closing of the ATAK initial public offering (the �IPO�), (b) in which we have total annual gross
                revenues of at least
                $1.235 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market
                value of our common equity that
                is held by non-affiliates equals or exceeds $700 million as of the last business day of our most
                recently completed second fiscal quarter;
                and (ii) the date on which we have issued more than $1.0 billion in non-convertible debt securities
                during the prior three-year period.
                References herein to �emerging growth company� have the meaning associated with it in the JOBS
                Act.</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
                Risk Factors</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
                Related to this Offering and Ownership of our Securities</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="vertical-align: top">
                    <td style="width: 0.25in">&nbsp;</td>
                    <td style="font: 12pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font-size: 10pt"><b>&#9679;</b></span></td>
                    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-size: 10pt"><b><i>This is a reasonable
                                    best efforts offering, with no minimum amount of securities required to be sold, and
                                    we may sell fewer than all of the securities
                                    offered hereby.</i></b></span></td>
                </tr>
            </tbody>
        </table>
        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investors
                                    in this offering will experience immediate and substantial dilution in the book
                                    value of
                                    their investment.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
                                    management will have broad discretion over the use of the proceeds we receive in
                                    this offering
                                    and might not apply the proceeds in ways that increase the value of your
                                    investment.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    may seek to raise additional funds, finance acquisitions or develop strategic
                                    relationships
                                    by issuing securities that would dilute your ownership. Depending on the terms
                                    available
                                    to us, if these activities result in significant dilution, it may negatively impact
                                    the trading
                                    price of our common stock.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
                                    Class A warrants are speculative in nature and there is not expected
                                    to be an active trading market for the warrants.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Holders
                                    of the Class A warrants will have no rights as a common stockholder
                                    until they acquire our common stock.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>This
                                    offering may cause the trading price of our common stock to decrease.</i></b></span>
                    </td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
                                    our shares of common stock become subject to the penny stock rules, it would become
                                    more
                                    difficult to trade our shares.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            &nbsp;</p>

    </div>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <div style="border: Black 1pt solid; padding-right: 0.1in; padding-left: 0.1in">

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Purchasers
                                    who purchase our securities in this offering pursuant to a securities purchase
                                    agreement
                                    may have rights not available to purchasers that purchase without the benefit of a
                                    securities
                                    purchase agreement.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
                Related to Our Business and Our Industry</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    have not fully completed our planned corporate reorganization.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    are substantially dependent on the commercial success of our current key product
                                    lines.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    rely on sales from certain key products and markets, any disruptions to those
                                    products or
                                    markets due to change of market environment, regulatory requirements, or personal
                                    and sales
                                    practices, could generate adverse effects to our sales and business
                                    performance.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Global,
                                    regional, and local economic weakness and uncertainty could adversely affect our
                                    demand for
                                    our products and services and our business and financial performance.</i></b></span>
                    </td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>War,
                                    geopolitical factors, and foreign exchange fluctuations could adversely affect the
                                    performance
                                    of our business.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Geopolitical
                                    risks associated with the ongoing conflict in Israel and Palestine could result in
                                    increased
                                    market volatility and uncertainty, which could negatively impact our business,
                                    financial
                                    condition, and results of operations.</i></b></span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">
                            <b><i>Management has determined there is substantial
                                    doubt regarding its ability to continue as a going concern.</i></b></p>
                    </td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    may not have sufficient funds to meet certain future operating needs or capital
                                    requirements,
                                    which could impair our efforts to develop and commercialize existing and new
                                    products, and
                                    as a result, we may in the future consider one or more capital-raising transactions,
                                    including
                                    future equity or debt financings, strategic transactions, or borrowings which may
                                    also dilute
                                    our stockholders.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
                                    market for robotics and VR-enabled smart rehabilitation systems are in the early
                                    growth stage,
                                    and important assumptions about the potential market for our current and future
                                    products
                                    may not be realized.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Currently,
                                    most of our products are purchased by customers as capital equipment, funded by our
                                    customers�
                                    own capital budgets, government grants, or charitable organizations� donations.
                                    There
                                    is a risk that such grants or donations may not be secured timely or at all or
                                    capital budgets
                                    reduced, which could adversely impact our sales forecasts.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
                                    we are unable to train customers on the safe and appropriate use of our products, we
                                    may
                                    be unable to achieve our expected growth.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
                                    customers misuse our products, we may become subject to prohibitions on the sale or
                                    marketing
                                    of our products, significant fines, penalties, sanctions, or product liability
                                    claims, and
                                    our image and reputation within the industry and marketplace could be
                                    harmed.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
                                    we are unable to educate clinicians on the safe, effective and appropriate use of
                                    our products,
                                    we may experience increased claims of product liability and may be unable to achieve
                                    our
                                    expected growth.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
                                    an emerging leader in a fragmented industry, we need time and efforts to develop
                                    talent,
                                    expertise, competencies, process and infrastructure; if we lose key employees or
                                    fail to
                                    replicate and leverage our sales, marketing, and training infrastructure, our growth
                                    would
                                    suffer adverse effects.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
                                    health benefits of our products have not yet been substantiated by long-term large
                                    randomized
                                    clinical data, which could limit sales of such products.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
                                    success depends largely upon consumer satisfaction with the effectiveness of our
                                    products.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            &nbsp;</p>

    </div>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <div style="border: Black 1pt solid; padding-right: 0.1in; padding-left: 0.1in">

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>For
                                    certain of our products, we rely on sole source third parties to manufacture and
                                    supply certain
                                    raw materials.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
                                    these manufacturers are unable to supply these raw materials or products in a timely
                                    manner,
                                    or at all, we may be unable to meet customer demand, which would have a material
                                    adverse
                                    effect on our business.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    utilize independent distributors who are free to market other products that compete
                                    with
                                    our products for sales.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Due
                                    to the nature of market fragmentation, our product and solution offerings may not
                                    always
                                    deliver the targeted sales amount, or may take longer than expected to establish
                                    itself in
                                    customers minds, and accepted by mainstream.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    may enter into collaborations, in-licensing arrangements, joint ventures, strategic
                                    alliances,
                                    business acquisitions or partnerships with third parties that may not result in the
                                    development
                                    of commercially viable products, the generation of significant future revenue, or
                                    consistent
                                    realization of deal economics.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    may not successfully integrate newly acquired product lines into our business
                                    operations
                                    or realize the benefits of our partnerships with other companies, acquisitions of
                                    complementary
                                    products or technologies or other strategic alternatives.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    may pursue acquisitions, which involve a number of risks, and if we are unable to
                                    address
                                    and resolve these risks successfully, such acquisitions could harm our
                                    business.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    may have difficulty managing our growth which could limit our ability to increase
                                    sales and
                                    cash flow.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
                Related to Government Regulation</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    are subject to extensive and dynamic medical device regulation, which may impede or
                                    hinder
                                    the approval or sale of our products and, in some cases, may ultimately result in an
                                    inability
                                    to obtain approval of certain products or may result in the recall or seizure of
                                    previously
                                    approved products.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
                                    we fail to obtain regulatory approvals in the United States or foreign jurisdictions
                                    for
                                    our products, or any future products, we will be unable to market our products in
                                    those jurisdictions.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Due
                                    to the fact that more than 95% of our revenue comes from health-regulated medical
                                    device
                                    products, if we do not obtain or maintain necessary regulatory clearances or
                                    approvals, or
                                    if clearances or approvals for future medical products or modifications to existing
                                    medical
                                    products are delayed or not issued, our commercial operations and sales targets
                                    would be
                                    adversely affected.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    may be subject to adverse medical device reporting obligations, voluntary corrective
                                    actions
                                    or agency enforcement actions.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Legislative
                                    or regulatory healthcare reforms in the United States and other countries may make
                                    it more
                                    difficult and costly for us to obtain regulatory clearance or approval of any future
                                    product
                                    candidates and to produce, market, and distribute our products after clearance or
                                    approval
                                    is obtained.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>United
                                    States and foreign privacy and data protection laws and regulations may impose
                                    additional
                                    liabilities on us.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            &nbsp;</p>

    </div>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <div style="border: Black 1pt solid; padding-right: 0.1in; padding-left: 0.1in">

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
                                    in law or regulation could make it more difficult and costly for DIH and its
                                    subsidiaries
                                    to manufacture, market and distribute its products or obtain or maintain regulatory
                                    approval
                                    of new or modified products.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    may fail to comply with regulations of the United States and foreign regulatory
                                    agencies
                                    which could delay, or prevent entirely, and the commercialization of our
                                    products.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>In
                                    some instances, in our advertising and promotion, we may make claims regarding our
                                    product
                                    as compared to competing products, which may subject us to heightened regulatory
                                    scrutiny,
                                    enforcement risk, and litigation risks.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
                                    we fail to obtain or maintain the necessary ISO 13485 certification or the
                                    certification
                                    according to (EU) 2017/745 (MDR), our commercial operations in the EU and some other
                                    countries
                                    will be harmed.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Modifications
                                    to our products may require re-registration, new 510(k) clearances or premarket
                                    approvals,
                                    or may require us to renew existing registrations in non-European Union
                                    countries.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
                                    innovative development of our products may lead to the application of new laws,
                                    regulations,
                                    standards, etc. not considered until now.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Any
                                    negative publicity concerning our products could harm our business and reputation
                                    and negatively
                                    impact our financial results.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>United
                                    States or European healthcare reform measures and other potential legislative
                                    initiatives
                                    could adversely affect our business.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
                Related to Our Intellectual Property and Information Technology</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    depend on computer and information systems we do not own or control and failures in
                                    our systems
                                    or a cybersecurity attack or breach of our IT systems or technology could
                                    significantly disrupt
                                    our business operations or result in sensitive information being compromised which
                                    would
                                    adversely affect our reputation and/or results of operations.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
                                    success depends in part on our ability to obtain and maintain protection for the
                                    intellectual
                                    property relating to or incorporated into our products.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    are not able to protect our intellectual property rights in all
                                    countries.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    may be subject to patent infringement claims, especially for products acquired
                                    through acquisitions,
                                    which could result in substantial costs and liability and prevent us from
                                    commercializing
                                    such acquired products.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    may be subject to damages resulting from claims that our employees or we have
                                    wrongfully
                                    used or disclosed alleged trade secrets of their former employers.</i></b></span>
                    </td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
                Related to Ownership of Common Stock</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Future
                                    sales of a substantial number of shares of Common Stock by us or our large
                                    stockholders,
                                    certain of whom may have registration rights, or dilutive exercises of a substantial
                                    number
                                    of warrants by our warrant holders could adversely affect the market price of our
                                    Common
                                    Stock.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Future
                                    grants of shares of Common Stock under our equity incentive plan to our employees,
                                    non-employee
                                    directors and consultants, or sales by these individuals in the public market, could
                                    result
                                    in substantial dilution, thus decreasing the value of your investment in Common
                                    Stock. In
                                    addition, stockholders will experience dilution upon the exercise of outstanding
                                    warrants.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            &nbsp;</p>

    </div>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <div style="border: Black 1pt solid; padding-right: 0.1in; padding-left: 0.1in">

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
                                    securities or industry analysts do not publish research or reports about DIH�s
                                    business,
                                    or if they issue an adverse opinion regarding its stock, its stock price and trading
                                    volume
                                    could decline.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    are an emerging growth company and a �smaller reporting company� and the reduced
                                    reporting requirements applicable to such companies may make our Common Stock less
                                    attractive
                                    to investors.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
                                    price of our Common Stock may be volatile, and you may lose all or part of your
                                    investment.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
                Risks</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exchange
                                    rate fluctuations between the U.S. dollar, the Euro and the Swiss Franc may
                                    negatively affect
                                    our revenue and earnings.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    are subject to certain regulatory regimes that may affect the way that we conduct
                                    business
                                    internationally, and our failure to comply with applicable laws and regulations
                                    could materially
                                    adversely affect our reputation and result in penalties and increased
                                    costs.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
                                    there are significant disruptions in our information technology systems, our
                                    business, financial
                                    condition and operating results could be adversely affected.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
                                    we fail to properly manage our anticipated growth, our business could
                                    suffer.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    are highly dependent on the knowledge and skills of our global leadership team, and
                                    if we
                                    are not successful in attracting and retaining highly qualified personnel, we may
                                    not be
                                    able to successfully implement our business strategy.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>DIH�s
                                    management team has limited experience managing a public company.</i></b></span>
                    </td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: italic bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                            style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
                                    have identified material weaknesses in our internal control over financial
                                    reporting. These
                                    material weaknesses could continue to adversely affect our ability to report our
                                    results
                                    of operations and financial condition accurately and in a timely
                                    manner.</i></b></span></td>
                </tr>
            </tbody>
        </table>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
                Information</span></p>

        <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                were incorporated under the name �Aurora Technology Acquisition Corp.� on August 6, 2021 as a Cayman
                Islands exempted company
                for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization
                or similar business combination
                with one or more businesses or entities. On February 6, 2024, we changed our jurisdiction of
                incorporation by deregistering as a Cayman
                Islands exempted company and continuing and domesticating as a corporation incorporated under the laws
                of the State of Delaware. On February
                7, 2024, we changed our name to �DIH Holding US, Inc.�</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                principal executive offices are located at 77 Accord Park Drive, Suite D-1, Norwell, MA 02061 and our
                telephone number is 877-944-2200.
                Our website address is <i>www.dih.com</i>. Any information contained on, or that can be accessed
                through, our website is not incorporated
                by reference into, nor is it in any way part of this registration statement and should not be relied
                upon in connection with making any
                decision with respect to an investment in our securities. We are required to file annual, quarterly and
                current reports, proxy statements
                and other information with the SEC. You may obtain any of the documents filed by us with the SEC at no
                cost from the SEC�s website
                at <i><span style="text-decoration: underline">http://www.sec.gov</span>.</i></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            &nbsp;</p>

    </div>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

    <div style="border: Black 1pt solid; padding-right: 0.1in; padding-left: 0.1in">

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="nd_004"></span>THE
                    OFFERING</b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

        <table cellspacing="0" cellpadding="0"
            style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuer:</i></span>
                    </td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
                            Holding US, Inc.</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Securities
                                offered by us:</i></span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,937,100
                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units,
                                each Unit consisting of one share of our Class A Common Stock and one Class A warrant to
                                purchase one share of our common stock. Each Class A warrant will have an exercise price
                                of $0.7832 per share (100% of the public offering price of one Unit), is exercisable
                                immediately and will expire on the fifth anniversary of the original issuance
                                date.</span></p>
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                Units will not be certificated or issued in stand-alone form. The shares of our common
                                stock and the Class A
                                warrants comprising the Units are immediately separable upon issuance and will be issued
                                separately in this offering.</span></p>
                    </td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Number
                                of shares of Common Stock being offered by us:</i></span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,937,100
                        </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of
                            Common Stock (assuming no exercise of the Class A warrants
                            issued in this offering).</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Number
                                of Class A warrants being offered by us:</i></span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,937,100
                        </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class A
                            warrants to purchase 5,937,100
                            shares of Common Stock.</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Public
                            </i></span><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>offering
                                price:</i></span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.7832
                        </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
                            Unit.</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
                                    stock outstanding immediately prior to this offering:</i></span></p>
                    </td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,080,368
                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                (exclusive of shares that may be issued upon the exercise of warrants and options
                                outstanding as of the date hereof or shares that
                                may be issued pursuant to the Company�s Equity Incentive Plan or in connection with the
                                Company�s convertible debentures
                                or Business Combination Agreement). See �<i>Capitalization</i>.�</span></p>
                    </td>
                </tr>
            </tbody>
        </table>

        <p style="margin: 0">&nbsp;</p>

    </div>

    <p style="margin: 0">&nbsp;</p>

    <p style="margin: 0"></p>

    <!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="margin: 0">&nbsp;</p>

    <div style="border: Black 1pt solid; padding-right: 0.1in; padding-left: 0.1in">

        <p style="margin: 0">&nbsp;</p>

        <table cellspacing="0" cellpadding="0"
            style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 28%"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
                                stock to be outstanding immediately after this offering:</i></span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 70%">41,017,468
                        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                            (excludes 6,000,000 shares of common stock issuable in connection with the earn-out
                            provisions set forth in the Business Combination
                            Agreement and no exercise of the Class A warrants issued in this offering)</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use
                                of proceeds:</i></span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">We estimate that the net
                        proceeds from our sale
                        of Units in this offering will be approximately $3.9 million, after deducting the placement
                        agent fees and estimated offering
                        expenses payable by us. We currently intend to use the net proceeds from this offering for
                        working capital, capital expenditures
                        relating to growing our business, and general corporate purposes. See �<i>Use of Proceeds</i>.�
                    </td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Description
                                of warrants:</i></span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                Class A warrants will have an exercise price per share of 100% of the public offering
                                price
                                per Unit, will be exercisable immediately and will expire on the fifth anniversary of
                                the
                                original issuance date. Each Class A warrant is exercisable for one share of common
                                stock,
                                subject to adjustment in the event of stock dividends, stock splits, stock combinations,
                                reclassifications, reorganizations or similar events affecting our common stock as
                                described
                                herein.</span></p>
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                holder of Class A warrants will be prohibited from exercising its warrant for shares of
                                our common stock if, as a result of such
                                exercise, the holder, together with its affiliates, would own more than 4.99% of the
                                total number of shares of our common stock then
                                issued and outstanding. However, any holder may increase such percentage to any other
                                percentage not in excess of 9.99%. The terms
                                of the Class A warrants will be governed by a Warrant Agency Agreement, dated as of the
                                closing date of this offering, between us
                                and Continental Stock Transfer &amp; Trust Company as the warrant agent (the �Warrant
                                Agent�).</span></p>
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                offering also relates to the offering of the shares of common stock issuable upon the
                                exercise of the Class A warrants. For more
                                information regarding the Class A warrants, you should carefully read the section titled
                                �<i>Description of Securities �
                                    Warrants</i>� in this prospectus.</span></p>
                    </td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Placement
                                    agent compensation:</i></span></p>
                    </td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                            the closing of this offering, we will pay Maxim a cash transaction fee equal to 7.0% of the
                            aggregate gross cash proceeds to us from
                            the sale of the securities in the offering (or 3.5% of the public offering price of the
                            Units for any investors we introduce to the
                            placement agent). In addition, we will reimburse Maxim for certain out-of-pocket expenses
                            related to the offering. See �<i>Plan
                                of Distribution</i>.�</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reasonable
                                best efforts offering:</i></span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                            have agreed to offer and sell the securities offered hereby directly to the purchasers. We
                            have retained Maxim to act as our exclusive
                            placement agent to use its reasonable best efforts to solicit offers to purchase the
                            securities offered by this prospectus. The placement
                            agent is not required to buy or sell any specific number or dollar amount of the securities
                            offered hereby. See �<i>Plan of
                                Distribution</i>� beginning on page 74 of this prospectus.</span></td>
                </tr>

                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 28%"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lock-Up</i></span>
                    </td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 70%">
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                have agreed to use our best efforts to cause our officers, directors and holders of 5%
                                of
                                more of our common stock not to sell, offer, agree to sell, contract to sell,
                                hypothecate,
                                pledge, grant any option to purchase, make any short sale of, or otherwise dispose of or
                                hedge, directly or indirectly, any shares of our capital stock or any securities
                                convertible
                                into or exercisable or exchangeable for a period of up to six months from the close of
                                this
                                offering, without the prior written consent of the placement agent.</span></p>
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>
                        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">
                            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
                                the section of this prospectus entitled �Plan of Distribution� for additional
                                information.</span></p>
                    </td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nasdaq
                                trading symbol:</i></span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                            Common Stock is listed on the Nasdaq Global Market under the symbol �DHAI.� We do not intend
                            to list the Class A warrants offered hereunder on any stock exchange.</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transfer
                                agent, warrant agent and registrar:</i></span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                            transfer agent and registrar for our common stock and the warrant agent for the warrants is
                            Continental Stock Transfer &amp; Trust
                            Company.</span></td>
                </tr>

                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risk
                                factors:</i></span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                            securities offered by this prospectus are speculative and involve a high degree of risk.
                            Investors purchasing securities should not
                            purchase the securities unless they can afford the loss of their entire investment. See
                            �<i>Risk Factors</i>� beginning
                            on page 9.</span></td>
                </tr>
            </tbody>
        </table>
        <p
            style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    </div>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

    <!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_005"></span>RISK
            FACTORS</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investing
                in our securities involves a high degree of risk. Before making an investment decision, you should
                consider carefully the following risk
                factors, as well as the other information set forth in this registration statement, including matters
                addressed in the section of this
                registration statement titled �Cautionary Note Regarding Forward-Looking Statements�. If any of these
                risks actually occur,
                it may materially harm our business, financial condition, liquidity and results of operations. As a
                result, the market price of our securities
                could decline, and you could lose all or part of your investment. Additionally, the risks and
                uncertainties described in this registration
                statement, any prospectus supplement, any post-effective amendment or in any document incorporated by
                reference herein or therein are
                not the only risks and uncertainties that we face. We may face additional risks and uncertainties that
                are not presently known to us,
                or that we currently deem immaterial. The following discussions should be read in conjunction with our
                financial statements and the notes
                to the financial statements included therein.</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
            Related to this Offering and Ownership of our Securities</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>This is a reasonable best
                efforts offering,
                with no minimum amount of securities required to be sold, and we may sell fewer than all of the
                securities offered hereby.</i></b></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&nbsp;</i></b></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        The placement agent has agreed to use its reasonable best efforts to
        solicit offers to purchase the Units in this offering. The placement agent has no obligation to buy any of the
        securities from us or
        to arrange for the purchase or sale of any specific number or dollar amount of the securities. There is no
        required minimum number of
        securities that must be sold as a condition to complete this offering. As there is no minimum offering amount
        required as a condition
        to the closing of this offering, the actual offering amount, placement agent fees and proceeds to us are not
        presently determinable and
        may be substantially less than the maximum amounts set forth in this prospectus. We may sell fewer than all of
        the securities offered
        hereby, which would significantly reduce the amount of proceeds received by us, and investors in this offering
        will not receive a refund
        in the event that we do not sell all of the Units offered in this offering. The success of this offering will
        impact our ability to use
        the proceeds to execute our business plans. We may have insufficient capital to implement our business plans,
        potentially resulting in
        greater operating losses or dilution unless we are able to raise capital from alternative sources.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
            in this offering will experience immediate and substantial dilution in the book value of their
            investment.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            public offering price will be substantially higher than the net tangible book value per share of our
            outstanding shares of common stock.
            As a result, investors in this offering will incur immediate dilution of $(1.59) per share based on the
            public offering price
            of $0.7832 per Unit. Investors in this offering will pay a price per Unit that substantially exceeds the
            book value of our assets
            after subtracting our liabilities. See �<i>Dilution</i>� for a more complete description of how the value of
            your investment
            will be diluted upon the completion of this offering.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            management will have broad discretion over the use of the proceeds we receive in this offering and might not
            apply the proceeds in ways
            that increase the value of your investment.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            management will have broad discretion over the use of our net proceeds from this offering, and you will be
            relying on the judgment of
            our management regarding the application of these proceeds. Our management might not apply our net proceeds
            in ways that ultimately increase
            the value of your investment. We expect to use the net proceeds from this offering for working capital,
            capital expenditures relating
            to growing our business, and general corporate purposes. Our management might not be able to yield a
            significant return, if any, on any
            investment of these net proceeds. You will not have the opportunity to influence our decisions on how to use
            our net proceeds from this
            offering.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may seek to raise additional funds, finance acquisitions or develop strategic relationships by issuing
            securities that would dilute your
            ownership. Depending on the terms available to us, if these activities result in significant dilution, it
            may negatively impact the trading
            price of our common stock.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
            additional financing that we secure may require the granting of rights, preferences or privileges senior to,
            or <i>pari passu </i>with,
            those of our common stock. Any issuances by us of equity securities may be at or below the prevailing market
            price of our common stock
            and in any event may have a dilutive impact on your ownership interest, which could cause the market price
            of our common stock to decline.
            We may also raise additional funds through the incurrence of debt or the issuance or sale of other
            securities or instruments senior to
            our shares of common stock, which may be highly dilutive. The holders of any securities or instruments we
            may issue may have rights superior
            to the rights of our common stockholders. If we experience dilution from the issuance of additional
            securities and we grant superior
            rights to new securities over holders of our common stock, it may negatively impact the trading price of our
            common stock and you may
            lose all or part of your investment.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Class A warrants are speculative in nature and there is not expected to be an active trading market for the
            warrants.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Class A warrants offered in this offering do not confer any rights of common stock ownership on their
            holders,
            such as voting rights or the right to receive dividends, but rather merely represent the right to acquire
            shares of our common stock
            at a fixed price for a limited period of time. Specifically, commencing on the date of issuance, holders of
            the Class A warrants may
            exercise their right to acquire the common stock and pay an exercise price of $0.7832 per share (100% of the
            public offering price
            of a Unit), prior to five years from the date of issuance, after which date any unexercised warrants will
            expire and have no further
            value. In addition, there is no established trading market for the Class A warrants and we do not expect an
            active trading market to develop. Without an active trading market, the liquidity of the
            Class A warrants will be limited.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
            of the Class A warrants will have no rights as a common stockholder until they acquire our common
            stock.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
            holders of the Class A warrants acquire shares of our common stock upon exercise of the Class A warrants,
            the holders will have no rights with respect to shares of our common stock issuable upon exercise of the
            Class A warrants. Upon exercise of the Class A warrants, the holder will be entitled to exercise the rights
            of a common stockholder as to the security exercised only as to matters for which the record date occurs
            after the exercise.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
            of the Class A warrants could discourage an acquisition of us by a third party.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
            provisions of the Class A warrants could make it more difficult or expensive for a third party to acquire
            us. The Class A warrants prohibit
            us from engaging in certain transactions constituting �fundamental transactions� unless, among other things,
            the surviving
            entity assumes our obligations under the Class A warrants. These and other provisions of the warrants
            offered by this prospectus could
            prevent or deter a third party from acquiring us even where the acquisition could be beneficial to
            you.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
            possible �short squeeze� due to a sudden increase in demand of our shares of common stock that largely
            exceeds supply may
            lead to price volatility in our shares of Common Stock.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
            this offering, investors may purchase our shares of common stock to hedge existing exposure in our shares of
            common stock or to speculate
            on the price of our shares of common stock. Speculation on the price of our shares of common stock may
            involve long and short exposures.
            To the extent aggregate short exposure exceeds the number of shares of our common stock available for
            purchase in the open market, investors
            with short exposure may have to pay a premium to repurchase our shares of common stock for delivery to
            lenders of our shares of common
            stock. Those repurchases may in turn, dramatically increase the price of our shares of common stock until
            investors with short exposure
            are able to purchase additional common shares to cover their short position. This is often referred to as a
            �short squeeze.�
            A short squeeze could lead to volatile price movements in our shares of common stock that are not directly
            correlated to the performance
            or prospects of our company and once investors purchase the shares of common stock necessary to cover their
            short position the price
            of our common stock may decline.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
            active, liquid and orderly trading market for our Common Stock may not develop, the price of our stock may
            be volatile, and you could
            lose all or part of your investment.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
            though our Common Stock is currently listed on Nasdaq, we cannot predict the extent to which investor
            interest in our company will lead
            to the development of an active trading market in our securities or how liquid that market might become. If
            such a market does not develop
            or is not sustained, it may be difficult for you to sell your shares of Common Stock at the time you wish to
            sell them, at a price that
            is attractive to you, or at all. There could be extreme fluctuations in the price of our Common Stock if
            there are a limited number of
            shares in our public float.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            trading price of our Common Stock is highly volatile and could be subject to wide fluctuations in response
            to various factors, some
            of which are beyond our control. Our stock price could be subject to wide fluctuations in response to a
            variety of factors, which include:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                        we achieve our anticipated corporate objectives;</span></td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
                        or anticipated fluctuations in our quarterly or annual operating results;</span></td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                        in our financial or operational estimates;</span></td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                        ability to implement our operational plans;</span></td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                        in the economic performance or market valuations of companies similar to ours; and</span></td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                        economic or political conditions in the United States or elsewhere.</span></td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            addition, broad market and industry factors may seriously affect the market price of companies� stock,
            including ours, regardless
            of actual operating performance. These fluctuations may be even more pronounced in the trading market for
            our stock shortly following
            this offering. In addition, in the past, following periods of volatility in the overall market and the
            market price of a particular company�s
            securities, securities class action litigation has often been instituted against these companies. This
            litigation, if instituted against
            us, could result in substantial costs and a diversion of our management�s attention and resources.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
            offering may cause the trading price of our Common Stock to decrease.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            number of shares of Common Stock underlying the securities we propose to issue and ultimately will issue if
            this offering is completed
            may result in an immediate decrease in the trading price of our Common Stock. This decrease may continue
            after the completion of this
            offering.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            our shares of Common Stock become subject to the penny stock rules, it would become more difficult to trade
            our shares.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks.
            Penny stocks are generally
            equity securities with a price of less than $5.00, other than securities registered on certain national
            securities exchanges or authorized
            for quotation on certain automated quotation systems, provided that current price and volume information
            with respect to transactions
            in such securities is provided by the exchange or system. If we do not retain a listing on Nasdaq and if the
            price of our common stock
            is less than $5.00, our common stock will be deemed a penny stock. The penny stock rules require a
            broker-dealer, before a transaction
            in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document
            containing specified information.
            In addition, the penny stock rules require that before effecting any transaction in a penny stock not
            otherwise exempt from those rules,
            a broker-dealer must make a special written determination that the penny stock is a suitable investment for
            the purchaser and receive
            (i) the purchaser�s written acknowledgment of the receipt of a risk disclosure statement; (ii) a written
            agreement to transactions
            involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. These
            disclosure requirements may have
            the effect of reducing the trading activity in the secondary market for our common stock, and therefore
            stockholders may have difficulty
            selling their shares.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            we were to dissolve, the holders of our securities may lose all or substantial amounts of their
            investments.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            we were to dissolve as a corporation, as part of ceasing to do business or otherwise, we will be required to
            pay all amounts owed to
            any creditors before distributing any assets to holders of our capital stock. There is a risk that in the
            event of such a dissolution,
            there will be insufficient funds to repay amounts owed to holders of any of our indebtedness and
            insufficient assets to distribute to
            our capital stockholders, in which case investors could lose their entire investment.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            securities or industry analysts do not publish or cease publishing research or reports about us, our
            business or our market, or if they
            change their recommendations regarding our securities adversely, our stock price and trading volume could
            decline.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            trading market for our common stock is influenced by the research and reports that industry or securities
            analysts may publish about
            us, our business, our market or our competitors. If any of the analysts who may cover us change their
            recommendation regarding our common
            stock adversely, or provide more favorable relative recommendations about our competitors, our stock price
            would likely decline. If any
            analyst who may cover us were to cease coverage of our company or fail to regularly publish reports on us,
            we could lose visibility in
            the financial markets, which in turn could cause our stock price or trading volume to decline.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            making your investment decision, you should understand that we and the placement agent have not authorized
            any other party to provide
            you with information concerning us or this offering.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
            should carefully evaluate all of the information in this prospectus before investing in our company. We may
            receive media coverage regarding
            our company, including coverage that is not directly attributable to statements made by our officers, that
            incorrectly reports on statements
            made by our officers or employees, or that is misleading as a result of omitting information provided by us,
            our officers or employees.
            We and the placement agent have not authorized any other party to provide you with information concerning us
            or this offering, and you
            should not rely on unauthorized information in making an investment decision.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchasers
            who purchase our securities in this offering pursuant to a securities purchase agreement may have rights not
            available to purchasers
            that purchase without the benefit of a securities purchase agreement.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            addition to rights and remedies available to all purchasers in this offering under federal securities and
            state law, the purchasers that
            enter into a securities purchase agreement will also be able to bring claims for breach of contract against
            us. The ability to pursue
            a claim for breach of contract provides those investors with the means to enforce the covenants uniquely
            available to them under the
            securities purchase agreement including timely delivery of shares and indemnification for breach of
            contract.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
            Related to Our Business and Our Industry</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have not fully completed our planned corporate reorganization.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            connection with the Business Combination, we had anticipated completing a corporate reorganization in which,
            among other changes, Motekforce
            Link BV and its subsidiaries and Hocoma AG were to become wholly owned subsidiaries of DIH Holding US, Inc.
            The parties were unable to
            complete this corporate reorganization prior to the Business Combination and, as previously disclosed, the
            parties opted to close the
            Business Combination and waive the condition to close that this reorganization be completed. These entities
            are owned by DIH Technology,
            Inc., our largest stockholder.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            products produced by Motek remain a key part of our product line and we operate with Motek pursuant to the
            terms of an exclusive contract
            which obligates Motek to provide these products to us. While we do not believe this arrangement currently
            has a material adverse effect
            on our results of operations, there can be no assurance that Motek will not begin to sell its products to
            our competitors which would
            have an adverse impact on us.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
            can be no assurance that the complete reorganization will be completed.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are substantially dependent on the commercial success of our current key product lines.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            success is substantially dependent on our ability to continue to generate and grow revenue from the sales of
            our current key product
            lines, LokoMat, Erigo, Armeo, C-Mill and CAREN/Grail, which represent approximately 90% of our revenue for
            the year ended March 31,
            2024. Our success will depend on many factors including, but not limited to, our ability to:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">develop
                        and execute our sales and marketing strategies and maintain and manage the necessary sales,
                        marketing and other capabilities and
                        infrastructure that are required to successfully commercialize our products;</span></td>
            </tr>
        </tbody>
    </table>

    <p style="margin: 0">&nbsp;</p>

    <p style="margin: 0"></p>

    <!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="margin: 0">&nbsp;</p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">achieve,
                        maintain and grow market acceptance of, and demand for our current products;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establish
                        or demonstrate in the medical community the safety and efficacy of our rehabilitation products
                        and their potential advantages over
                        in comparison to, existing competing products and devices and products currently in
                        development;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">offer
                        our products at competitive prices as compared to alternative options, and our ability to
                        achieve a suitable profit margin from the
                        sales of our products;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">comply
                        with applicable legal and regulatory requirements, including medical device compliance;</span>
                </td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintain
                        our distribution and supply arrangements with third parties; and</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enforce
                        our intellectual property rights related to current and future products, if any.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            we do not achieve one or more of these factors, many of which are beyond our control, in a timely manner or
            at all, we may not be able
            to continue to generate and grow revenue from the sales of our current products, which may materially impact
            the success of our business.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            rely on sales from certain key products and markets, any disruptions to those products or markets due to
            change of market environment,
            regulatory requirements, or personal and sales practices, could generate adverse effects to our sales and
            business performance.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
            of our key product lines, LokoMat accounts for more than 45% of our revenue for the year ended March 31,
            2024; our other key products,
            Erigo, Armeo, C-Mill and CAREN/Grail collectively account for 45% of our revenues for the year ended March
            31, 2024. In addition,
            approximately 80% of our revenue is concentrated in the EMEA and Americas, with the remaining portion in
            Asia Pacific (�APAC�)
            for the year ended March 31, 2024. Any disruptions to those key products and/or markets due to changes in
            market conditions, regulatory
            requirements, or personal and sales practices, could generate adverse effects to our sales and business
            performance.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global,
            regional, and local economic weakness and uncertainty could adversely affect our demand for our products and
            services and our business
            and financial performance.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            business and financial performance depends on worldwide economic conditions and the demand for our products
            and services in the markets
            in which we compete. Ongoing economic weakness, including an economic slowdown or recession, uncertainty in
            markets throughout the world
            and other adverse economic conditions, including inflation, changes in monetary policy and increased
            interest rates, may result in decreased
            demand for our products and services and increased expenses and difficulty in managing inventory levels and
            accurately forecasting revenue,
            gross margin, cash flows and expenses.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prolonged
            or more severe economic weakness and uncertainty could also cause our expenses to vary materially from our
            expectations. Any financial
            turmoil affecting the banking system and financial markets or any significant financial services institution
            failures could negatively
            impact our treasury operations, as the financial condition of such parties may deteriorate rapidly and
            without notice.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">War,
            geopolitical factors, and foreign exchange fluctuations could adversely affect the performance of our
            business.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
            to our significant presence in Europe, and emerging needs from South East Asia and the Middle East, war or
            geopolitical instability in
            those regions could adversely affect demand and supply chain disruptions from those regions; and foreign
            exchange, especially the Euro�s
            depreciation versus the US dollar, would adversely depress our US dollar-denominated revenue and
            profitability. We believe that an increasing
            percentage of our future revenue will come from international sales as we continue to expand our operations
            and develop opportunities
            in additional territories. International sales are subject to a number of additional risks,
            including:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
                        in staffing and managing our foreign operations;</span></td>
            </tr>
        </tbody>
    </table>

    <p style="margin: 0">&nbsp;</p>

    <p style="margin: 0"></p>

    <!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="margin: 0">&nbsp;</p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
                        in penetrating markets in which our competitors� products are more established;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
                        protection for intellectual property rights in some countries;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">export
                        restrictions, trade regulations and foreign tax laws;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuating
                        foreign currency exchange rates;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
                        and maintaining foreign certification and compliance with other regulatory requirements;</span>
                </td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">customs
                        clearance and shipping delays; and</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">political
                        and economic instability.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            one or more of these risks were realized, we could be required to dedicate significant resources to remedy
            the situation, and if we are
            unsuccessful at finding a solution, our revenue may decline.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Geopolitical
            risks associated with the ongoing conflicts in Ukraine and in the Middle East have resulted in increased
            market volatility and uncertainty,
            which could negatively impact our business, financial condition, and results of operations.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            credit and financial markets have experienced extreme volatility and disruptions due to the current conflict
            between Ukraine and Russia
            and the conflicts in the Middle East. The conflict is expected to have further global economic consequences,
            including but not limited
            to the possibility of severely diminished liquidity and credit availability, declines in consumer
            confidence, declines in economic growth,
            increases in inflation rates and uncertainty about economic and political stability. In addition, the United
            States and other countries
            have imposed sanctions on Russia which increases the risk that Russia, as a retaliatory action, may launch
            cyberattacks against the United
            States, its government, infrastructure and businesses.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            uncertain nature, scope, magnitude, and duration of these hostilities could have an adverse impact on
            macroeconomic and other factors
            that affect our business and supply chain. Any disruption in our supply chain could reduce our revenue and
            adversely impact our financial
            results. Such a disruption could occur as a result of any number of events, including, but not limited to,
            military conflicts, geopolitical
            developments, war or terrorism, including the ongoing conflicts in Ukraine and in the Middle East, regional
            or global pandemics, and
            disruptions in utility and other services. Any inability to obtain adequate deliveries or any other
            circumstance that would require us
            to seek alternative sources of supply or to manufacture, assemble, and test such components internally could
            significantly delay our
            ability to ship our products, which could damage relationships with current and prospective customers and
            could harm our reputation and
            brand and could adversely affect our business, financial condition, and results of operations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
            of the foregoing consequences, including those we cannot yet predict, may cause our business, financial
            condition, results of operations
            and the price of our Common Stock to be adversely affected.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Management
                    has determined there is substantial doubt regarding its ability to continue as a going
                    concern.</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
            Accounting Standards Codification (�ASC�) 205-40, <i>Going Concern</i>, the Company is required each
            reporting period,
            to evaluate whether there is substantial doubt regarding its ability to continue as a going concern. As of
            September 30, 2024,
            DIH�s cash and cash equivalents amounted to $1.8 million compared to $3.2 million at March 31, 2024. DIH�s
            operating
            losses began in fiscal 2020 and conti<span style="background-color: white">nued through the </span>six
            months ended September 30,
            2024. DIH�s historical operating losses resulted in an accumulated deficit of $(35.8) million as of
            September 30, 2024.
            Operating losses were mainly driven by decreased sales during the COVID-19 pandemic due to social distancing
            measures that affected
            demand for rehabilitation services, increased expenditures in connection with its implementation of a new
            financial system (Oracle)
            and increased compliance costs associated with the EU MDR. Additionally, DIH had elevated costs related to
            its efforts of adopting
            to public company standards. During the six months ended September 30, 2024, DIH had negative cash flows
            from operating activities
            of $(1.5) million and an operating income of $1.1 million and negative working capital as of September 30,
            2024. The above
            conditions raise substantial doubt about the Company�s ability to continue as a going concern within one
            year after the date
            of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. See the section titled
            �Management�s Discussion and Analysis of Financial
            Condition and Results of Operations�Liquidity and Capital Resources.�</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may not have sufficient funds to meet certain future operating needs or capital requirements, which could
            impair our efforts to develop
            and commercialize existing and new products, and as a result, we may in the future consider one or more
            capital-raising transactions,
            including future equity or debt financings, strategic transactions, or borrowings which may also dilute our
            stockholders.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may need to raise additional capital to fund our growth, working capital and strategic expansion. Given the
            turbulent global environment
            and volatile capital market, we may not be able to secure such financing in a timely manner and with
            favorable terms. Any such capital
            raise involving the sale of equity securities would result in dilution to our shareholders. If we cannot
            raise the required funds, or
            cannot raise them on terms acceptable to us or investors, we may be forced to curtail substantially our
            current operations and scale
            down our growth plan.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            market for robotics and VR-enabled smart rehabilitation systems are in the early growth stage, and important
            assumptions about the potential
            market for our current and future products may not be realized.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
            the market for robotics and VR-enabled �smart� rehabilitation systems has enjoyed increasing recognition
            from our customers,
            to date, the market is small. Significant market development efforts are still required to cross in order
            for us to enjoy accelerating
            growth. As such, it is difficult to predict the future size and rate of growth of the market; and we cannot
            assure you that our estimate
            regarding our current products is achievable or that our estimate regarding future products profile will
            remain the same. If our estimates
            of our current or future addressable market are incorrect, our business may not develop as we expect, and
            the price of our securities
            may suffer.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
            most of our products are purchased by customers as capital equipment, funded by our customers� own capital
            budgets, government
            grants, or charitable organizations� donations. There is a risk that such grants or donations may not be
            secured timely or at all
            or capital budgets reduced, which could adversely impact our sales forecasts.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
            we have seen significant interest in our products to support our growth plan, due to limited sales and
            clinician application personnel
            that are instrumental to our efforts to convert such interest into sales orders, at any quarter we can only
            focus on a fraction of the
            total sales opportunities. Accordingly, if there are delays or disruptions to potential customers� budgeting
            processes due to customers�
            internal capital budget limitations, delays in funding of government grants or charitable organizations�
            donations, our sales opportunities
            may not be realized.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            the future, we may develop operational leasing or vendor-enabled financing to expand our growth beyond
            capital budget limitations, as
            part of our efforts to enrich and expanding our business models. There can be no assurance that we will have
            adequate working capital
            to do so after this offering.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            we are unable to train customers on the safe and appropriate use of our products, we may be unable to
            achieve our expected growth.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
            is critical to the success of our commercialization efforts to train a sufficient number of customers and
            provide them with adequate
            instruction in the safe and appropriate use of our products. This training process may take longer than
            expected and may therefore affect
            our ability to increase sales. Following completion of training, we rely on the trained customers to
            advocate the benefits of our products
            in the marketplace. Convincing our customers to dedicate the time and energy necessary for adequate training
            is challenging, and we cannot
            assure you that we will be successful in these efforts. If we cannot attract potential new customers to our
            education and training programs,
            we may be unable to achieve our expected growth. If our customers are not properly trained, they may misuse
            or ineffectively use our
            products. This may also result in, among other things, unsatisfactory patient outcomes, patient injury,
            negative publicity or lawsuits
            against us, any of which could have an adverse effect on our business and reputation.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            customers misuse our products, we may become subject to prohibitions on the sale or marketing of our
            products, significant fines, penalties,
            sanctions, or product liability claims, and our image and reputation within the industry and marketplace
            could be harmed.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            customers may also misuse our devices, or our future products or use improper techniques, potentially
            leading to adverse results, side
            effects or injury, which may lead to product liability claims. If our current or future products are misused
            or used with improper techniques
            or are determined to cause or contribute to consumer harm, we may become subject to costly litigation by our
            customers or their patients.
            Product liability claims could divert management�s attention from our core business, be expensive to defend,
            result in sizable
            damage awards against us that may not be covered by insurance and subject us to negative publicity resulting
            in reduced sales of our
            products. Furthermore, the use of our current or future products for indications other than those cleared by
            the FDA may not effectively
            treat such conditions, which could harm our reputation in the marketplace among physicians and consumers.
            Any of these events could harm
            our business and results of operations and cause our stock price to decline.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            we are unable to educate clinicians on the safe, effective and appropriate use of our products, we may
            experience increased claims of
            product liability and may be unable to achieve our expected growth.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
            of our products require the use of specialized techniques and/or product-specific knowledge. It is critical
            to the success of our business
            to broadly educate clinicians who use or desire to use our products in order to provide them with adequate
            instructions in the appropriate
            use of our products. It is also important that we educate our other customers and patients on the risks
            associated with our products.
            Failure to provide adequate training and education could result in, among other things, unsatisfactory
            patient outcomes, patient injury,
            negative publicity or increased product liability claims or lawsuits against us, any of which could have a
            material and adverse effect
            on our business and reputation. We make extensive educational resources available to clinicians and our
            other customers in an effort
            to ensure that they have access to current treatment methodologies, are aware of the advantages and risks of
            our products, and are educated
            regarding the safe and appropriate use of our products. However, there can be no assurance that these
            resources will successfully prevent
            all negative events and if we fail to educate clinicians, our other customers and patients, they may make
            decisions or form conclusions
            regarding our products without full knowledge of the risks and benefits or may view our products negatively.
            In addition, claims against
            us may occur even if such claims are without merit and/or no product defect is present, due to, for example,
            improper surgical techniques,
            inappropriate use of our products, or other lack of awareness regarding the safe and effective use of our
            products. Any of these events
            could harm our business and results of operations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
            an emerging leader in a fragmented industry, we need time and efforts to develop talent, expertise,
            competencies, process and infrastructure;
            if we lose key employees or fail to replicate and leverage our sales, marketing, and training
            infrastructure, our growth would suffer
            adverse effects.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
            key element of our long-term business strategy is the continued leveraging of our sales, marketing, clinical
            training and services infrastructure,
            through the training, retention, and motivation of skilled sales, marketing, clinical applications training,
            and services representatives
            with industry experience and knowledge. In order to continue growing our business efficiently, we need
            coordinate the development of
            our sales, marketing, clinical training and services infrastructure with the timing of market expansion, new
            product launch, regulatory
            approvals, limited resources consideration and other factors in various geographies. Managing and
            maintaining our sales and marketing
            infrastructure is expensive and time consuming, and an inability to leverage such an organization
            effectively, or in coordination with
            regulatory or other developments, could inhibit potential sales and the penetration and adoption of our
            products into both existing and
            new markets.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newly
            hired sales representatives require training and take time to achieve full productivity. If we fail to train
            new hires adequately, or
            if we experience high turnover in our sales force in the future, we cannot be certain that new hires will
            become as productive as may
            be necessary to maintain or increase our sales. In addition, if we are not able to retain existing and
            recruit new trainers to our clinical
            staff, we may not be able to successfully train customers on the use of our sophisticated products, which
            could inhibit new sales and
            harm our reputation. If we are unable to expand our sales, marketing, and training capabilities, we may not
            be able to effectively commercialize
            our products, or enhance the strength of our brand, which could have a material adverse effect on our
            operating results.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            health benefits of our products have not yet been substantiated by long-term large randomized clinical data,
            which could limit sales
            of such products.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
            there have been numerous published research studies supporting the benefits of our products and users of our
            products have reported encouraging
            health benefits of our products, currently there is no large scale, randomized clinical trial establishing
            the long-term health benefits
            of our or competitors� products due to the relatively small size of the applicable user population, and the
            fragmented application
            practice that we are still in the early stage to change through consolidation and integration. While many of
            the top rehabilitation hospitals
            have purchased some of our products, many potential conservative customers and healthcare providers may be
            slower to adopt or recommend
            our products.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            success depends largely upon consumer satisfaction with the effectiveness of our products.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            order to generate repeat and referral business, consumers must be satisfied with the effectiveness of our
            products. If consumers are
            not satisfied with the benefits of our products, our reputation and future sales could suffer.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
            certain of our products, we rely on sole source third parties to manufacture and supply certain raw
            materials. If these manufacturers
            are unable to supply these raw materials or products in a timely manner, or at all, we may be unable to meet
            customer demand, which would
            have a material adverse effect on our business.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            currently depend on sole source, third party manufacturers, to manufacture and supply certain raw materials
            and products. We cannot assure
            you that these manufacturers will be able to provide these raw materials, and products in quantities that
            are sufficient to meet demand
            in a timely manner, or at all, which could result in decreased revenues and loss of market share. There may
            be delays in the manufacturing
            process over which we have no control, including shortages of raw materials, labor disputes, backlogs and
            failure to meet FDA standards.
            We are aware that certain of our sole source manufacturers also rely on sole source suppliers with respect
            to materials used in our products.
            We rely on our third-party manufacturers to maintain their manufacturing facilities in compliance with
            applicable international, FDA
            and other federal, state and/or local regulations including health, safety and environmental standards. If
            they fail to maintain compliance
            with critical regulations, they could be ordered to suspend, curtail or cease operations, which would have a
            material adverse impact
            on our business. Increases in the prices we pay our manufacturers, interruptions in our supply of raw
            materials or products, or lapses
            in quality, such as failures to meet our specifications and other regulatory requirements, could materially
            adversely affect our business.
            Any manufacturing defect or error discovered after our products have been produced and distributed could
            result in significant consequences,
            including costly recall procedures and damage to our reputation. Our ability to replace an existing
            manufacturer may be difficult, because
            the number of potential manufacturers is limited. If we do undertake to negotiate terms of supply with
            another manufacturer or other
            manufacturers, our relationships with our existing manufacturers could be harmed. Any interruption in the
            supply of raw materials or
            products, or the inability to obtain these raw materials or products from alternate sources in a timely
            manner, could impair our ability
            to meet the demands of our customers, which would have a material adverse effect on our business.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            utilize independent distributors who are free to market other products that compete with our products for
            sales.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
            we have proportionally more influence on the independent distributors we are using to cover majority of the
            global markets due to our
            limited direct sales force, considering the fact that the rehabilitation technology market is very
            fragmented, we generally do not sign
            mutual exclusive distribution agreement with distributors. Consequently, our distribution partners could
            indirectly compete against our
            interests by promoting alternative technologies to prospective customers in lieu of ours. We believe that as
            we assemble more and integrated
            offering through our consolidation and integration strategy, the influence and motivation we may impose on
            our distribution partners
            to dedicate on selling and promoting our products and solution shall increase and such kind of competition
            risk would be better addressed.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
            ensure credibility and enforce the effective genesis of our distributor management, we may terminate a
            distributor who has not demonstrated
            its best efforts and/or interests in selling and promoting our products and solutions, albeit such
            termination may adversely affect our
            sales performance in the market covered by such distributor.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
            to the nature of market fragmentation, our product and solution offerings may not always deliver the
            targeted sales amount, or may take
            longer than expected to establish itself in customers minds, and accepted by mainstream.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            fragmented market reflects both opportunity for consolidation and challenges of overcoming customers�
            mindsets used to using alternative
            approaches as well as fragmented clinical practices. Change and acceptance of new idea and solution normally
            happens over time and in
            multiple wave-shaped phases instead of a straight line progression. Consequently, our new innovative product
            and solution offerings may
            not deliver the targeted sales amount or face uncertain time periods for customers to accept due to various
            dynamic factors that may
            influence the perceptions and consensus formation among prospective customers. Consequently, such judgments
            and self-reinforcing efforts
            may cause the actual results to deviate from our planned results for a sustained period, which may have
            adverse effect on our performance.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances, business
            acquisitions or partnerships
            with third parties that may not result in the development of commercially viable products, the generation of
            significant future revenue,
            or consistent realization of deal economics.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            the ordinary course of our business, we may enter into collaborations, in-licensing arrangements, joint
            ventures, strategic alliances,
            business acquisitions, partnerships or other arrangements to develop our products and to pursue new
            geographic or product markets. Proposing,
            negotiating, and implementing collaborations, in-licensing arrangements, joint ventures, strategic
            alliances, or partnerships may be
            a lengthy and complex process.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may not identify, secure, or complete any such transactions or arrangements in a timely manner, on a
            cost-effective basis, on acceptable
            terms or at all. We have limited institutional knowledge and experience with respect to these business
            development activities, and we
            may also not realize the anticipated benefits from some of those transactions or arrangements.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
            as we pursue these arrangements and choose to pursue other collaborations, in-licensing arrangements, joint
            ventures, strategic alliances,
            or partnerships in the future, we may not be in a position to exercise sole decision-making authority
            regarding the transaction or arrangement.
            This could create the potential risk of creating impasses on decisions, and our collaborators may have
            economic or business interests
            or goals that are, or that may become, inconsistent with our business interests or goals. It is possible
            that conflicts may arise with
            our collaborators. Our collaborators or any future collaborators may act in their self-interest, which may
            be adverse to our best interest,
            and they may breach their obligations to us. Disputes between us and our collaborators or any future
            collaborators may result in litigation
            or arbitration which would increase our expenses and divert the attention of our management. Further, these
            transactions and arrangements
            are contractual in nature and may be terminated or dissolved under the terms of the applicable agreements.
            Our collaborators or any future
            collaborators may allege that we have breached our agreement with them, and accordingly seek to terminate
            such agreement, which could
            adversely affect our competitive business position and harm our business prospects.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
            due to the fragmentation nature and the fact that most acquisition targets are at sub-optimal immature
            organization stage with less than
            $10 million in revenue, the risk of integrating such organizations and products can also be higher than
            acquisitions and consolidations
            in a mature industry. Consequently, there are risks that some of those acquisitions may fail to deliver the
            expected deal economics and
            could have adverse effect on our financial condition and business results.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may not successfully integrate newly acquired product lines into our business operations or realize the
            benefits of our partnerships
            with other companies, acquisitions of complementary products or technologies or other strategic
            alternatives.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically
            we have acquired or gained the rights to our product lines through acquisitions and other strategic
            alternatives. As a result of these
            acquisitions, we have undergone substantial changes to our business and product offerings in a short period
            of time. Additionally, in
            the future, we may consider other opportunities to partner with or acquire other businesses, products or
            technologies that may enhance
            our product platform or technology, expand the breadth of our markets or customer base or advance our
            business strategies.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
            we have previously been successful in integrating such products and technologies into our business and
            operations, there can be no assurances
            that we will continue to do so in the future. If we fail to successfully integrate collaborations, assets,
            products or technologies,
            or if we fail to successfully exploit acquired product or distribution rights, our business could be harmed.
            Furthermore, we may have
            to incur debt or issue equity securities in connection with proposed collaborations or to pay for any
            product acquisitions or investments,
            the issuance of which could be dilutive to our existing shareholders. Identifying, contemplating,
            negotiating or completing a collaboration
            or product acquisition and integrating an acquired product or technology could significantly divert
            management and employee time and
            resources.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
            integrating new product lines with that of our own is a complex, costly and time-consuming process, which
            requires significant management
            attention and resources. The integration process may disrupt our existing operations and, if implemented
            ineffectively, would preclude
            realization of the full benefits that are expected. Our failure to meet the challenges involved in
            successfully integrating our acquisitions
            in order to realize the anticipated benefits may cause an interruption of, or a loss of momentum in, our
            operating activities and could
            adversely affect our results of operations. Potential difficulties, costs, and delays we may encounter as
            part of the integration process
            may include:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">distracting
                        management from day-to-day operations;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                        inability to achieve synergies as planned;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
                        associated with the assumption of contingent or other liabilities;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
                        effects on existing business relationships with suppliers or customers;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inheriting
                        and uncovering previously unknown issues, problems and costs from the acquired product
                        lines;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">uncertainties
                        associated with entering new markets in which we have limited or no experience;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
                        legal and accounting costs relating to the product line or compliance with regulatory
                        matters;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                        between our expenditures to acquire new products, technologies or businesses and generating net
                        sales from those acquired products,
                        technologies or businesses; and</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
                        difficulties in managing our business due to increased personnel, increased data and information
                        to analyze, and the potential addition
                        of international locations.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
            one or all of these factors may increase operating costs or lower anticipated financial performance. Many of
            these factors are also outside
            of our control. In addition, even if new product lines or businesses are integrated successfully, we may not
            realize the full benefits
            of the acquisition, including the synergies, cost savings or sales or growth opportunities that we expect or
            within the anticipated time
            frame. Additional unanticipated costs may be incurred in the integration of product lines or businesses. All
            of these factors could decrease
            or delay the expected accretive effect of the transaction, and negatively impact the price of our common
            stock. The failure to integrate
            any acquired product line or business successfully would have a material adverse effect on our business,
            financial condition and results
            of operations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may pursue acquisitions, which involve a number of risks, and if we are unable to address and resolve these
            risks successfully, such
            acquisitions could harm our business.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may in the future acquire businesses, products or technologies to expand our offerings and capabilities,
            user base and business. We have
            evaluated, and expect to continue to evaluate, a wide array of potential strategic transactions; however, we
            have limited experience
            completing or integrating acquisitions. Any acquisition could be material to our financial condition and
            results of operations and any
            anticipated benefits from an acquisition may never materialize. In addition, the process of integrating
            acquired businesses, products
            or technologies may create unforeseen operating difficulties and expenditures. Acquisitions in international
            markets would involve additional
            risks, including those related to integration of operations across different cultures and languages,
            currency risks and the particular
            economic, political and regulatory risks associated with specific countries.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            process of integrating an acquired business, product or technology can create unforeseen operating
            difficulties, expenditures and other
            challenges such as:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially
                        increased regulatory and compliance requirements;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">implementation
                        or remediation of controls, procedures and policies at the acquired company;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">diversion
                        of management time and focus from operation of its then-existing business to acquisition
                        integration challenges;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">coordination
                        of product, sales, marketing and program and systems management functions;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">transition
                        of the acquired company�s users and providers onto our systems;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">retention
                        of employees from the acquired company;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">integration
                        of employees from the acquired company into our organization;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">integration
                        of the acquired company�s accounting, information management, human resources and other
                        administrative systems and operations
                        into our systems and operations;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">liability
                        for activities of the acquired company prior to the acquisition, including violations of law,
                        commercial disputes and tax and other
                        known and unknown liabilities; and</span></td>
            </tr>
        </tbody>
    </table>

    <p style="margin: 0">&nbsp;</p>

    <p style="margin: 0"></p>

    <!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="margin: 0">&nbsp;</p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation
                        or other claims in connection with the acquired company, including claims brought by terminated
                        employees, providers, former stockholders
                        or other third parties.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may not be able to address these risks successfully, or at all, without incurring significant costs, delays
            or other operational problems
            and if we were unable to address such risks successfully our business could be harmed.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may have difficulty managing our growth which could limit our ability to increase sales and cash
            flow.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            anticipate experiencing significant growth in our operations and the number of our employees if our current
            and future products are successful.
            This growth will place significant demands on our management, as well as our financial and operational
            resources. In order to achieve
            our business objectives, we will need to grow our business. Continued growth would increase the challenges
            involved in:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">implementing
                        appropriate operational and financial systems;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expanding
                        our sales and marketing infrastructure and capabilities;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ensuring
                        compliance with applicable FDA, and other regulatory requirements;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">providing
                        adequate training and supervision to maintain high quality standards; and</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">preserving
                        our culture and values.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            growth will require us to continually develop and improve our operational, financial and other internal
            controls. If we cannot scale
            and manage our business appropriately, we will not realize our projected growth and our financial results
            could be adversely affected.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
            Related to Government Regulation</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are subject to extensive and dynamic medical device regulation, which may impede or hinder the approval or
            sale of our products and,
            in some cases, may ultimately result in an inability to obtain approval of certain products or may result in
            the recall or seizure of
            previously approved products.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            products, marketing, sales and development activities and manufacturing processes are subject to extensive
            and rigorous regulation by
            various regulatory agencies and governing bodies. Under the US Food, Drug and Cosmetic Act, medical devices
            must receive FDA clearance
            or approval or an exemption from such clearance or approval before they can be commercially marketed in the
            United States. In the European
            Union, we are required to comply with applicable medical device directives (including the Medical Devices
            Directive and the European
            Medical Device Regulation) and obtain CE Mark (European Conformity) certification in order to market medical
            devices. In addition, exported
            devices are subject to the regulatory requirements of each country to which the device is exported. Many
            countries require that product
            approvals be renewed or recertified on a regular basis, generally every four to five years. The renewal or
            recertification process requires
            that we evaluate any device changes and any new regulations or standards relevant to the device and conduct
            appropriate testing to document
            continued compliance. Where renewal or recertification applications are required, they may need to be
            renewed and/or approved in order
            to continue selling our products in those countries. There can be no assurance that we will receive the
            required approvals for new products
            or modifications to existing products on a timely basis or that any approval will not be subsequently
            withdrawn or conditioned upon extensive
            post-market study requirements.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            European Union regulatory bodies finalized a new Medical Device Regulation (�MDR�) in 2017, which replaced
            the existing directives
            and provided three years for transition and compliance. The MDR changes several aspects of the existing
            regulatory framework, such as
            updating clinical data requirements and introducing new ones, such as Unique Device Identification. We and
            those who will oversee compliance
            to the new MDR face uncertainties as the MDR is rolled out and enforced by the Commission and EEA Competent
            Authorities, creating risks
            in several areas, including the CE Marking process and data transparency, in the upcoming years.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulations
            regarding the development, manufacture and sale of medical devices are evolving and subject to future
            change. We cannot predict what
            impact, if any, those changes might have on our business. Failure to comply with regulatory requirements
            could have a material adverse
            effect on our business, financial condition and results of operations. Later discovery of previously unknown
            problems with a product
            or manufacturer could result in fines, delays or suspensions of regulatory clearances or approvals, seizures
            or recalls of products,
            physician advisories or other field actions, operating restrictions and/or criminal prosecution. We may also
            initiate field actions as
            a result of a failure to strictly comply with our internal quality policies. The failure to receive product
            approval clearance on a timely
            basis, suspensions of regulatory clearances, seizures or recalls of products, physician advisories or other
            field actions, or the withdrawal
            of product approval by regulatory authorities could have a material adverse effect on our business,
            financial condition or results of
            operations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            we fail to obtain regulatory approvals in the United States or foreign jurisdictions for our products, or
            any future products, we will
            be unable to market our products in those jurisdictions.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            addition to regulations in the United States, we are subject to a variety of foreign regulations governing
            manufacturing, clinical trials,
            commercial sales and distribution of our future products. Whether or not we obtain FDA approval for a
            product, we must obtain approval
            of the product by the comparable regulatory authorities of foreign countries before commencing clinical
            trials or marketing in those
            countries. The approval procedures vary among countries and can involve additional clinical testing, or the
            time required to obtain approval
            may differ from that required to obtain FDA approval. Clinical trials conducted in one country may not be
            accepted by regulatory authorities
            in other countries. Approval by the FDA does not ensure approval by regulatory authorities in other
            countries, and approval by one or
            more foreign regulatory authorities does not ensure approval by regulatory authorities in other foreign
            countries or by the FDA. The
            foreign regulatory approval process may include all of the risks associated with obtaining FDA
            approval.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
            to the fact that more than 95% of our revenue comes from health-regulated medical device products, if we do
            not obtain or maintain necessary
            regulatory clearances or approvals, or if clearances or approvals for future medical products or
            modifications to existing medical products
            are delayed or not issued, our commercial operations and sales targets would be adversely affected.</span>
    </p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            operate under highly regulated global health markets and must register and maintain effectiveness and
            compliance of such registration,
            with each of our medical devices with every markets� relevant authority either directly or through our agent
            or distributors. Any
            missing or failure to comply with such registrations may disrupt any sales activities in that particular
            market, and result in adverse
            effects.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may be subject to adverse medical device reporting obligations, voluntary corrective actions or agency
            enforcement actions.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            FDA and similar foreign governmental authorities have the authority to require the recall of commercialized
            products in the event of
            material deficiencies or defects in design or manufacture of a product or in the event that a product poses
            an unacceptable risk to health.
            The FDA�s authority to require a recall must be based on an FDA finding that there is reasonable probability
            that the device would
            cause serious injury or death. Manufacturers may also, under their own initiative, recall a product if any
            material deficiency in a device
            is found or withdraw a product to improve device performance or for other reasons. The FDA requires that
            certain classifications of recalls
            be reported to the FDA within 10 working days after the recall is initiated. A government-mandated or
            voluntary recall by us or one of
            our distributors could occur as a result of a perceived or actual unacceptable risk to health, component
            failures, malfunctions, manufacturing
            errors, design or labelling defects or other deficiencies and issues. Regulatory agencies in other countries
            have similar authority to
            recall devices because of material deficiencies or defects in design or manufacture that could endanger
            health. Any recall would divert
            management attention and financial resources and could cause the price of our stock to decline, expose us to
            product liability or other
            claims and harm our reputation with customers. Such events could impair our ability to produce our products
            in a cost-effective and timely
            manner in order to meet customer demands. Companies are required to maintain certain records of recalls,
            even if they are not reportable
            to the FDA or similar foreign governmental authorities. We may initiate voluntary recalls involving our
            products in the future that we
            determine do not require notification of the FDA or foreign governmental authorities. If the FDA or foreign
            governmental authorities
            disagree with our determinations, they could require us to report those actions as recalls. A future recall
            announcement could harm our
            reputation with customers and negatively affect our sales. In addition, the FDA or a foreign governmental
            authority could take enforcement
            action for failing to report the recalls when they were conducted.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            addition, under the FDA�s medical device reporting regulations, we are required to report to the FDA any
            incident in which our
            product may have caused or contributed to a death or serious injury or in which our product malfunctioned
            and, if the malfunction were
            to recur, would likely cause or contribute to death or serious injury. Repeated product malfunctions may
            result in a voluntary or involuntary
            product recall. We are also required to follow detailed record-keeping requirements for all self-initiated
            medical device corrections
            and removals, and to report such corrective and removal actions to the FDA if they are carried out in
            response to a risk to health and
            have not otherwise been reported under the medical device reporting regulations. Depending on the corrective
            action we take to address
            a product�s deficiencies or defects, the FDA may require, or we may decide, that we need to obtain new
            approvals or clearances
            for the device before marketing or distributing the corrected device. Seeking such approvals or clearances
            may delay our ability to replace
            the recalled devices in a timely manner. Moreover, if we do not adequately address problems associated with
            our devices, we may face
            additional regulatory enforcement action, including FDA warning letters, product seizure, injunctions,
            administrative penalties, or civil
            or criminal fines. We may also be required to bear other costs or take other actions that may have a
            negative impact on our sales as
            well as face significant adverse publicity or regulatory consequences, which could harm our business,
            including our ability to market
            our products in the future.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
            adverse event involving our products, whether in the United States or abroad, could result in future
            voluntary corrective actions, such
            as recalls or customer notifications, or agency action, such as inspection, mandatory recall or other
            enforcement action. Any corrective
            action, whether voluntary or involuntary, will likely oblige us to defend ourselves in resulting lawsuits,
            and will require the dedication
            of our time and capital, distract management from operating our business and may harm our reputation and
            financial results.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legislative
            or regulatory healthcare reforms in the United States and other countries may make it more difficult and
            costly for us to obtain regulatory
            clearance or approval of any future product candidates and to produce, market, and distribute our products
            after clearance or approval
            is obtained.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
            political, economic and regulatory influences are subjecting the health care industry to fundamental
            changes. Both the federal and state
            governments in the United States and foreign governments continue to propose and pass new legislation and
            regulations designed to contain
            or reduce the cost of health care, improve quality of care, and expand access to healthcare, among other
            purposes. Such legislation and
            regulations may result in decreased reimbursement for medical devices and/or the procedures in which they
            are used, which may further
            exacerbate industry-wide pressure to reduce the prices charged for medical devices. This could harm our
            ability to market and generate
            sales from our products.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            addition, regulations and guidance are often revised or reinterpreted by governmental agencies, including
            the FDA, CMS, and the Department
            of Health and Human Services Office of the Inspector General (�OIG�) and others, in ways that may
            significantly affect our
            business and our products. Any new regulations, revisions or reinterpretations of existing regulations may
            impose additional costs or
            lengthen review times of our products.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            the future there may continue to be additional proposals relating to the reform of the United States.
            healthcare system. Certain of these
            proposals could limit the prices we are able to charge for our products or the amount of reimbursement
            available for our products, and
            could limit the acceptance and availability of our products, any of which could have a material adverse
            effect on our business, results
            of operations and financial condition.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
            States and foreign privacy and data protection laws and regulations may impose additional liabilities on
            us.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
            we do not store patient data at our premises or DIH-managed data center, United States, federal and state
            privacy and data security laws
            and regulations regulate how we and our partners collect, use and share certain information. In addition to
            the Health Insurance Portability
            and Accountability Act (�HIPAA�), certain state laws govern the privacy and security of health information
            in certain circumstances,
            some of which are more stringent than HIPAA and many of which differ from each other in significant ways and
            may not have the same effect,
            thus complicating compliance efforts. Failure to comply with these laws, where applicable, can result in the
            imposition of significant
            civil and/or criminal penalties and private litigation. For example, the California Consumer Privacy Act, or
            CCPA, went into effect January
            1, 2020. The CCPA, among other things, creates new data privacy obligations for covered companies and
            provides new privacy rights to
            California residents, including the right to opt out of certain disclosures of their information. The CCPA
            also creates a private right
            of action with statutory damages for certain data breaches, thereby potentially increasing risks associated
            with a data breach. The CCPA
            was recently amended by the California Privacy Rights Act or CPRA, expanding certain consumer rights such as
            the right to know. It remains
            unclear what, if any, additional modifications will be made to these laws by the California legislature or
            how these laws will be interpreted
            and enforced. The California Attorney General has issued clarifying regulations and initiating enforcement
            activity. The potential effects
            of the CCPA and CPRA are significant and may cause us to incur substantial costs and expenses to comply. The
            CCPA has prompted a wave
            of proposals for new federal and state privacy legislation, some of which may be more stringent than the
            CCPA, that, if passed, could
            increase our potential liability, increase our compliance costs, and adversely affect our business.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may also be subject to or affected by foreign laws and regulations, including regulatory guidance, governing
            the collection, use, disclosure,
            security, transfer, and storage of personal data, such as information that we collect about customers and
            patients in connection with
            our operations abroad. The global legislative and regulatory landscape for privacy and data protection
            continues to evolve, and implementation
            standards and enforcement practices are likely to remain uncertain for the foreseeable future. This
            evolution may create uncertainty
            in our business, result in liability, or impose additional costs on us. The cost of compliance with these
            laws, regulations and standards
            is high and is likely to increase in the future.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
            example, the European Union implemented the General Data Protection Regulation (�GDPR�) a broad data
            protection framework
            that expands the scope of European Union data protection law to include certain non-European Union entities
            that process the personal
            data of European Union residents, including clinical trial data. The GDPR increases our compliance burden
            with respect to data protection,
            including by mandating potentially burdensome documentation requirements and granting certain rights to
            individuals to control how we
            collect, use, disclose, retain and protect information about them. The processing of sensitive personal
            data, such as information about
            health conditions, leads to heightened compliance burdens under the GDPR and is a topic of active interest
            among European Union regulators.
            In addition, the GDPR provides for breach reporting requirements, more robust regulatory enforcement and
            fines of up to the greater of
            20 million euros or 4% of annual global revenue. The GDPR increases our responsibility and liability in
            relation to personal data that
            we process, and we may be required to put in place additional mechanisms to ensure compliance with the GDPR,
            which could divert management�s
            attention and increase our cost of doing business.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
            data security breach or other privacy violation that compromises the confidentiality, integrity or
            availability of the personal information
            of our customers, clinical trials participants, collaborators or employees could harm our reputation, compel
            us to comply with United
            States or international breach notification laws, subject us to mandatory corrective action, and otherwise
            subject us to liability under
            United States or foreign laws and regulations. Data breaches or other security incidents could also
            compromise our trade secrets or other
            intellectual property. If we are unable to prevent such data security breaches and security incidents or
            implement satisfactory remedial
            measures, our operations could be disrupted, and we may suffer reputational harm, financial loss or other
            regulatory penalties. In addition,
            such events can be difficult to detect, and any delay in identifying them may lead to increased harm.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finally,
            it is possible that these privacy laws may be interpreted and applied in a manner that is inconsistent with
            our practices. Any failure
            or perceived failure by us to comply with federal, state, or foreign laws or self-regulatory organization�s
            rules or regulations
            could result in an expense or liability to us.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
            in law or regulation could make it more difficult and costly for DIH and its subsidiaries to manufacture,
            market and distribute its products
            or obtain or maintain regulatory approval of new or modified products.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            experience with the transition to the EU MDR showed how complex, time-consuming and expensive a change in
            Medical Device Legislation
            can be. Progression on innovations and new products could be significantly delayed during the work on
            compliance with new legislations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may fail to comply with regulations of the United States and foreign regulatory agencies which could delay,
            or prevent entirely, and
            the commercialization of our products.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
            the non-invasive and lower risk nature of rehabilitation products, similar to other rehabilitation
            technology providers, most of our
            products are in FDA risk class 1 and this class is not subject to mandatory scrutiny by the U.S.
            authorities. There is the possibility
            that, in the future, the FDA may not agree with our classification. We might have to register if
            disagreement arises, and consequently
            we would have to stop distributing the device in the U.S. Under such a scenario, possible alternatives
            registration pathways might be
            510(k)s or PMAs, which amount to an increase in the registration time from six months to multiple years and
            result in significant suspension
            of our sales activity for products in question in the US.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            some instances, in our advertising and promotion, we may make claims regarding our product as compared to
            competing products, which may
            subject us to heightened regulatory scrutiny, enforcement risk, and litigation risks.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            FDA applies a heightened level of scrutiny to comparative claims when applying its statutory standards for
            advertising and promotion,
            including with regard to its requirement that promotional labelling be truthful and not misleading. There is
            potential for differing
            interpretations of whether certain communications are consistent with a product�s FDA-required labelling,
            and FDA will evaluate
            communications on a fact-specific basis.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            addition, making comparative claims may draw attention from our competitors. Where a company makes a claim
            in advertising or promotion
            that its product is superior to the product of a competitor (or that the competitor�s product is inferior),
            this creates a risk
            of a lawsuit by the competitor under federal and state false advertising or unfair and deceptive trade
            practices law, and possibly also
            state libel law. Such a suit may seek injunctive relief against further advertising, a court order directing
            corrective advertising,
            and compensatory and punitive damages where permitted by law.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
            such lawsuit or threat of lawsuit against us will likely oblige us to defend ourselves in court, and will
            require the dedication of our
            time and capital, distract management from operating our business and may harm our reputation and financial
            results. If any such lawsuit
            against us is successful, we would suffer additional losses of time and capital in taking any required
            corrective action and would suffer
            harm to our reputation, all of which would have an adverse effect on our business.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            we fail to obtain or maintain the necessary ISO 13485 certification or the certification according to (EU)
            2017/745 (MDR), our commercial
            operations in the EU and some other countries will be harmed.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
            the certifications according to ISO 13485 and (EU) 2017/745 constitute the legal basis for any commercial
            activity in the European Union
            and many other countries, these certifications and maintenance of such certifications is a vital task for
            us. Failure to certify will
            lead to a disruption of device sales not only in the European Union, but also in the United States and many
            other countries, as these
            usually consider a certification a prerequisite for any device registrations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            majority of our products are classified as medical devices and are regulated by the FDA, the European Union
            and other governmental authorities
            both inside and outside of the United States. These agencies enforce laws and regulations that govern the
            development, testing, manufacturing,
            labeling, advertising, marketing and distribution, and market surveillance of our medical products. Our
            failure to comply with these
            complex laws and regulations could have a material adverse effect on our business, results of operations,
            financial condition and cash
            flows. Even after regulatory clearance or approval has been granted, a cleared or approved product and its
            manufacturer are subject to
            extensive regulatory requirements relating to manufacturing, labeling, packaging, adverse event reporting,
            storage, advertising and promotion
            for the product. If we fail to comply with the regulatory requirements of the FDA or other non-U.S.
            regulatory authorities, or if previously
            unknown problems with our products or manufacturing processes are discovered, we could be subject to
            administrative or judicially imposed
            sanctions, including restrictions on the products, manufacturers or manufacturing process; adverse
            inspectional observations (Form 483),
            warning letters, non-warning letters incorporating inspectional observations; civil or criminal penalties or
            fines; injunctions; product
            seizures, detentions or import bans; voluntary or mandatory product recalls and publicity requirements;
            suspension or withdrawal of regulatory
            clearances or approvals; total or partial suspension of production; imposition of restrictions on
            operations, including costly new manufacturing
            requirements; refusal to clear or approve pending applications or premarket notifications; and import and
            export.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Modifications
            to our products may require re-registration, new 510(k) clearances or premarket approvals, or may require us
            to renew existing registrations
            in non-European Union countries.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product
            modifications consisting either of changes to hardware or software or in expanding or restricting
            indications or contraindications can
            have an impact on the validity of our registrations. Thus, a product modification may lead to regulatory
            change projects, which will
            consume time and resources. A delay in marketing activities for the respective products may result. Many of
            these changes are beyond
            our control, as they are initiated by suppliers of components. Often those changes cannot be predicted, as
            their announcement happens
            on short notice, thus increasing the risk of business disruption.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            innovative development of our products may lead to the application of new laws, regulations, standards, etc.
            not considered until now.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developing
            our products further in the direction of increasingly independent acting devices might bring those products
            into the scope of standards
            or regulations for robotic devices or artificial intelligence, or other similar areas. As this requires
            further competencies, resources
            and time, a potential delay or disruption of our commercial activities could result.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
            negative publicity concerning our products could harm our business and reputation and negatively impact our
            financial results.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            reactions of potential patients, physicians, the news media, legislative and regulatory bodies and others to
            information about complications
            or alleged complications of our products could result in negative publicity and could materially reduce
            market acceptance of our products.
            These reactions, or any investigations and potential resulting negative publicity, may have a material
            adverse effect on our business
            and reputation and negatively impact our financial condition, results of operations or the market price of
            our common stock. In addition,
            significant negative publicity could result in an increased number of product liability claims against
            us.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
            States or European healthcare reform measures and other potential legislative initiatives could adversely
            affect our business.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Europe
            and the United States are our major markets, and any major healthcare reform that may change the health
            industry landscape or reimbursement
            environment, may have a significant impact on our sales performance and growth projects in the affected
            markets.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
            political changes in the United States or in Europe could result in significant changes in, and uncertainty
            with respect to, legislation,
            regulation, global trade, and government policy that could substantially impact our business and the medical
            device industry generally.
            The FDA and European Union Commission�s policies may also change, and additional government regulations may
            be issued that could
            prevent, limit, or delay regulatory approval of our future products, or impose more stringent product
            labeling and post-marketing testing
            and other requirements.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
            Related to Our Intellectual Property and Information Technology</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            depend on computer and information systems we do not own or control and failures in our systems or a
            cybersecurity attack or breach of
            our IT systems or technology could significantly disrupt our business operations or result in sensitive
            information being compromised
            which would adversely affect our reputation and/or results of operations.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have entered into agreements with third parties for hardware, software, telecommunications, and other
            information technology services
            in connection with the operation of our business. It is possible we or a third party that we rely on could
            incur interruptions from a
            loss of communications, hardware or software failures, a cybersecurity attack or a breach of our IT systems
            or technology, computer viruses
            or malware. Though most of those information systems and platforms are provided by well-established
            multinational firms like Oracle and
            Microsoft, any interruptions to our arrangements with third parties, to our computing and communications
            infrastructure, or to our information
            systems or any of those operated by a third party that we rely on could significantly disrupt our business
            operations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            the current environment, there are numerous and evolving risks to cybersecurity and privacy, including
            criminal hackers, hacktivists,
            state-sponsored intrusions, industrial espionage, employee malfeasance and human or technological error. A
            cyberattack of our systems
            or networks that impairs our information technology systems could disrupt our business operations and result
            in loss of service to customers,
            including technical support for our robotics and VR-enabled devices.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            success depends in part on our ability to obtain and maintain protection for the intellectual property
            relating to or incorporated into
            our products.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            success depends in part on our ability to obtain and maintain protection for the intellectual property
            relating to or incorporated into
            our products. We seek to protect our intellectual property through a combination of patents, trademarks,
            confidentiality, and assignment
            agreements with our employees and certain of our contractors, as well as confidentiality agreements with
            certain of our consultants,
            scientific advisors, and other vendors and contractors. In addition, we rely on trade secrets law to protect
            our proprietary software
            and product candidates/products in development.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            patent position of robotic and VR-enabled inventions can be highly uncertain and involves many new and
            evolving complex legal, factual,
            and technical issues. Patent laws and interpretations of those laws are subject to change and any such
            changes may diminish the value
            of our patents or narrow the scope of our right to exclude others. In addition, we may fail to apply for or
            be unable to obtain patents
            necessary to protect our technology or products from copycats or fail to enforce our patents due to lack of
            information about the exact
            use of technology or processes by third parties. Also, we cannot be sure that any patents will be granted in
            a timely manner or at all
            with respect to any of our patent pending applications or that any patents that are granted will be adequate
            to exclude others for any
            significant period of time or at all. Given the foregoing and in order to continue reducing operational
            expenses in the future, we may
            invest fewer resources in filing and prosecuting new patents and on maintaining and enforcing various
            patents, especially in regions
            where we currently do not focus our market growth strategy.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation
            to establish or challenge the validity of patents, or to defend against or assert against others
            infringement, unauthorized use, enforceability,
            or invalidity, can be lengthy and expensive and may result in our patents being invalidated or interpreted
            narrowly and restricting our
            ability to be granted new patents related to our pending patent applications. Even if we prevail, litigation
            may be time consuming, force
            us to incur significant costs, and could divert management�s attention from managing our business while any
            damages or other remedies
            awarded to us may not be valuable.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            addition, we seek to protect our trade secrets, know-how, and confidential information that is not
            patentable by entering into confidentiality
            and assignment agreements with our employees and certain of our contractors and confidentiality agreements
            with certain of our consultants,
            scientific advisors, and other vendors and contractors. However, we may fail to enter into the necessary
            agreements, and even if entered
            into, these agreements may be breached or otherwise fail to prevent disclosure, third-party infringement, or
            misappropriation of our
            proprietary information, may be limited as to their term and may not provide an adequate remedy in the event
            of unauthorized disclosure
            or use of proprietary information. Enforcing a claim that a third party illegally obtained or is using our
            trade secrets without authorization
            may be expensive and time consuming, and the outcome is unpredictable. Some of our employees or consultants
            may own certain technology
            which they license to us for a set term. If these technologies are material to our business after the term
            of the license, our inability
            to use them could adversely affect our business and profitability.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are not able to protect our intellectual property rights in all countries.</span></p>

    <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing,
            prosecuting, maintaining, and defending patents on each of our products in all countries throughout the
            world would be prohibitively
            expensive, and thus our intellectual property rights outside the United States and Europe are limited. In
            addition, the laws of some
            foreign countries, especially developing countries, such as China, do not protect intellectual property
            rights to the same extent as
            federal and state laws in the United States. It may not be possible to effectively enforce intellectual
            property rights in some countries
            at all or to the same extent as in the United States and other countries. Consequently, we are unable to
            prevent third parties from using
            our inventions in all countries, or from selling or importing products made using our inventions in the
            jurisdictions in which we do
            not have (or are unable to effectively enforce) patent protection. Copycats may use our technologies in
            jurisdictions where we have not
            obtained patent protection to develop, market or otherwise commercialize their own products, and we may be
            unable to prevent those copycats
            from importing those infringing products into territories where we have patent protection, but enforcement
            may not be as strong as in
            the United States. These products may compete with our products and our patents and other intellectual
            property rights may not be effective
            or sufficient to prevent them from competing in those jurisdictions.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may be subject to patent infringement claims, especially for products acquired through acquisitions, which
            could result in substantial
            costs and liability and prevent us from commercializing such acquired products.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            medical device industry is characterized by competing intellectual property, given the existence of large
            number of patents, the rapid
            rate of new patent issuances, and the complexities of the technology involved; and patent infringement
            assessments require costly due
            diligence and extensive resources to cope with the complexity to assess infringement risks in a complex
            world of regulations and intellectual
            property filings. As a result, we may choose not to conduct extensive and expensive intellectual property
            due diligence, especially for
            small deal value; as a consequence, we might be vulnerable to certain unknown intellectual property
            infringement claims, especially related
            to products we acquired from others. Determining whether a product infringes a patent involves complex legal
            and factual issues and the
            outcome of patent litigation is often uncertain. Even though we have conducted research of issued patents,
            no assurance can be given
            that patents containing claims covering our products, technology or methods do not exist, have not been
            filed or could not be filed or
            issued. In addition, because patent applications can take years to issue and because publication schedules
            for pending applications vary
            by jurisdiction, there may be applications now pending of which we are unaware, and which may result in
            issued patents that our current
            or future products infringe.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Infringement
            actions and other intellectual property claims brought against us, whether with or without merit, may cause
            us to incur meaningful costs
            and could place a significant strain on our financial resources, divert the attention of management, and
            harm our reputation.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            may be subject to damages resulting from claims that our employees or we have wrongfully used or disclosed
            alleged trade secrets of their
            former employers.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
            of our employees were previously employed at other medical device companies, including our competitors or
            potential competitors, and
            we may hire employees in the future that are so employed. We could in the future be subject to claims that
            these employees, or we, have
            inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former
            employers. If we fail in
            defending against such claims, a court could order us to pay substantial damages and prohibit us from using
            technologies or features
            that are found to incorporate or be derived from the trade secrets or other proprietary information of the
            former employers. If any of
            these technologies or features that are important to our products, this could prevent us from selling those
            products and could have a
            material adverse effect on our business. Even if we are successful in defending against these claims, such
            litigation could result in
            substantial costs and divert the attention of management.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
            Related to Ownership of Common Stock</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
            sales of a substantial number of shares of Common Stock by us or our large stockholders, certain of whom may
            have registration rights,
            or dilutive exercises of a substantial number of warrants by our warrant holders could adversely affect the
            market price of our Common
            Stock.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
            by us or our stockholders of a substantial number of shares of Common Stock in the public market following
            this offering, or the perception
            that these sales might occur, could cause the market price of the Common Stock to decline or could impair
            our ability to raise capital
            through a future sale of our equity securities. Additionally, dilutive exercises of a substantial number of
            warrants by our warrant-holders,
            or the perception that such exercises may occur, could put downward price on the market price of our Common
            Stock.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
            grants of shares of Common Stock under our equity incentive plan to our employees, non-employee directors
            and consultants, or sales by
            these individuals in the public market, could result in substantial dilution, thus decreasing the value of
            your investment in Common
            Stock. In addition, stockholders will experience dilution upon the exercise of outstanding warrants.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
            approved an equity incentive plan which provides for the issuance of up to 4,300,000 additional shares of
            Common Stock.
            Additionally, shares of granted or issued under our equity incentive plans will, subject to vesting
            provisions and Rule 144 volume
            limitations applicable to our �affiliates,� be available for sale in the open market immediately upon
            registration.
            Further, as of September 30, 2024, there were 13,665,000 shares of Common Stock underlying issued and
            outstanding warrants and
            660,000 shares of Common Stock underlying a convertible debenture as of September 30, 2024 based on the
            then-applicable conversion
            price of $5.00 (such conversion price will decrease and the number of shares issuable in connection with the
            conversion will
            increase as a result of this offering), which if exercised, could decrease the net tangible book value of
            our Common Stock and cause
            dilution to our existing stockholders. In addition, the Company may issue shares of its Common Stock in lieu
            of monthly cash
            redemption payments. Sales of a substantial number of the above-mentioned shares of Common Stock in the
            public market could result
            in a significant decrease in the market price of the Common Stock and have a material adverse effect on your
            investment.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            securities or industry analysts do not publish research or reports about DIH�s business, or if they issue an
            adverse opinion regarding
            its stock, its stock price and trading volume could decline.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            trading market for Common Stock is influenced by the research and reports that industry or securities
            analysts publish about DIH or its
            business. DIH does not currently have and may never obtain research coverage by securities and industry
            analysts. Since DIH became public
            through a merger, securities analysts of major brokerage firms may not provide coverage of DIH since there
            is no incentive to brokerage
            firms to recommend the purchase of its common stock. If no or few securities or industry analysts commence
            coverage of DIH, the trading
            price for its stock would be negatively impacted. In the event DIH obtains securities or industry analyst
            coverage, if any of the analysts
            who cover it issues an adverse opinion regarding DIH, its business model, its intellectual property or its
            stock performance, or if its
            clinical trials and operating results fail to meet the expectations of analysts, its stock price would
            likely decline. If one or more
            of these analysts cease coverage of DIH or fail to publish reports on it regularly, DIH could lose
            visibility in the financial markets,
            which in turn could cause its stock price or trading volume to decline.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are an emerging growth company and a �smaller reporting company� and the reduced reporting requirements
            applicable to such
            companies may make our Common Stock less attractive to investors.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            is an emerging growth company, as defined in the JOBS Act. For as long as DIH continues to be an emerging
            growth company, it may take
            advantage of exemptions from various reporting requirements that are applicable to other public companies
            that are not emerging growth
            companies, including not being required to comply with the auditor attestation requirements of Section 404
            of the Sarbanes-Oxley Act,
            reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements
            and exemptions from the
            requirements of holding nonbinding advisory stockholder votes on executive compensation and stockholder
            approval of any golden parachute
            payments not previously approved. DIH cannot predict if investors will find its common stock less attractive
            because DIH may rely on
            these exemptions. If some investors find Common Stock less attractive as a result, there may be a less
            active trading market for Common
            Stock and its stock price may be more volatile.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a)
            following February 9, 2027 (the fifth
            anniversary of the closing of ATAK�s IPO), (b) in which it has total annual gross revenue of at least $1.235
            billion, or (c) in
            which it is deemed to be a large accelerated filer, which requires the market value of its common stock that
            is held by non-affiliates
            to equal or exceed $700 million as of the last business day of the second fiscal quarter of such year, and
            (2) the date on which DIH
            has issued more than $1 billion in non-convertible debt during the prior three-year period.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
            the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until
            such time as those standards
            apply to private companies. DIH has opted to continue to take advantage of the benefits of the extended
            transition period, although it
            may decide to early adopt such new or revised accounting standards to the extent permitted by such
            standards. This may make it difficult
            or impossible to compare DIH�s financial results with the financial results of another public company that
            is either not an emerging
            growth company or is an emerging growth company that has chosen not to take advantage of the extended
            transition period exemptions because
            of the potential differences in accounting standards used.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
            DIH is a �smaller reporting company� as defined in Item 10(f) of Regulation S-K, which allows us to take
            advantage of certain
            scaled disclosure requirements available specifically to smaller reporting companies. For example, we may
            continue to use reduced compensation
            disclosure obligations, and we will not be obligated to follow the auditor attestation requirements of
            Section 404 of the Sarbanes-Oxley
            Act. We will remain a smaller reporting company until the last day of the fiscal year in which we have at
            least $100 million in revenue
            and at least $700 million in aggregate market value of our shares held by non-affiliated persons and
            entities (known as �public
            float�), or, alternatively, if our revenue exceeds $100 million, until the last day of the fiscal year in
            which our public float
            was at least $250.0 million (in each case, with respect to public float, as measured as of the last business
            day of the second quarter
            of such fiscal year). For the year ended March 31, 2024, DIH recorded revenue of approximately $64
            million.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            cannot predict or otherwise determine if investors will find our securities less attractive as a result of
            our reliance on exemptions
            as a smaller reporting company and/or �non-accelerated filer.� If some investors find our securities less
            attractive as a
            result, there may be a less active trading market for our Common Stock and the price of our Common Stock may
            be more volatile.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            price of our Common Stock may be volatile, and you may lose all or part of your investment.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            market price of our Common Stock is volatile and may fluctuate substantially as a result of many factors. In
            addition, because the warrants
            are exercisable into shares of our Common Stock, volatility, or a reduction in the market price of our
            Common Stock could have an adverse
            effect on the trading price of the warrants. Factors which may cause fluctuations in the price of our Common
            Stock include, but are not
            limited to:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
                        or anticipated fluctuations in our growth rate or results of operations or those of our
                        competitors;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">customer
                        acceptance of our products;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                        by us or our competitors of new products or services, commercial relationships, acquisitions, or
                        expansion plans;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                        by us or our competitors of other material developments;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                        involvement in litigation;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                        in government regulation applicable to us and our products;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales,
                        or the anticipation of sales, of our Common Stock, warrants and debt securities by us, or sales
                        of our Common Stock by our insiders
                        or other shareholders, including upon expiration of contractual lock-up agreements;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
                        with respect to intellectual property rights;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">competition
                        from existing or new technologies and products;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                        in key personnel;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                        trading volume of the Common Stock;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                        in the estimation of the future size and growth rate of our markets;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                        in our quarterly or annual forecasts with respect to operating results and financial
                        conditions;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                        economic and market conditions; and</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Announcements
                        regarding business acquisitions.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            addition, the stock markets have experienced extreme price and volume fluctuations. Broad market and
            industry factors may materially
            harm the market price of our Common Stock, regardless of our operating performance. Technical factors in the
            public trading market for
            Common Stock may produce price movements that may or may not comport with macroeconomic, industry or
            DIH-specific fundamentals, including,
            without limitation, the sentiment of retail investors (including as may be expressed on financial trading
            and other social media sites),
            the amount and status of short interest in our securities, access to margin debt, trading in options and
            other derivatives on our Common
            Stock and any related hedging or other technical trading factors. In the past, following periods of
            volatility in the market price of
            a company�s securities, securities class action litigation has often been instituted against that company.
            If we become involved
            in any similar litigation, we could incur substantial costs and our management�s attention and resources
            could be diverted.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
            Risks</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
            rate fluctuations between the U.S. dollar, the Euro and the Swiss Franc may negatively affect our revenue
            and earnings.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            U.S. dollar is our functional and reporting currency. However, more than 50% of our sales orders come from
            Europe in euros; and we pay
            a significant portion of our expenses in euro and Swiss Francs; and we expect this to continue. As a result,
            we are exposed to exchange
            rate risks that may materially and adversely affect our financial results. Accordingly, any depreciation of
            the euro relative to the
            U.S. dollar would adversely impact our revenue, and any appreciation of Swiss Franc against U.S. dollar will
            adversely impact net loss
            or net income, if any.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            operations also could be adversely affected if we are unable to effectively hedge against currency
            fluctuations in the future.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are subject to certain regulatory regimes that may affect the way that we conduct business internationally,
            and our failure to comply
            with applicable laws and regulations could materially adversely affect our reputation and result in
            penalties and increased costs.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are subject to a complex system of laws and regulations related to international trade, including economic
            sanctions and export control
            laws and regulations. We also depend on our distributors and agents for compliance and adherence to local
            laws and regulations in the
            markets in which they operate. Significant political or regulatory developments in the jurisdictions in
            which we sell our products, such
            as those stemming from the presidential administration in the United States or the U.K.�s exit from the E.U.
            (known as �Brexit�),
            are difficult to predict and may have a material adverse effect on us. For example, in the United States,
            the Trump administration-imposed
            tariffs on imports from China, Mexico, Canada, and other countries, and expressed support for greater
            restrictions on free trade and
            increase tariffs on goods imported into the United States. Changes in U.S. political, regulatory, and
            economic conditions or in its policies
            governing international trade and foreign manufacturing and investment in the United States could adversely
            affect our sales in the United
            States.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are also subject to the U.S. Foreign Corrupt Practices Act and may be subject to similar worldwide
            anti-bribery laws that generally prohibit
            companies and their intermediaries from making improper payments to government officials for the purpose of
            obtaining or retaining business.
            Despite our compliance and training programs, we cannot be certain that our procedures will be sufficient to
            ensure consistent compliance
            with all applicable international trade and anti-corruption laws, or that our employees or channel partners
            will strictly follow all
            policies and requirements to which we subject them. Any alleged or actual violations of these laws may
            subject us to government scrutiny,
            investigation, debarment, and civil and criminal penalties, which may have an adverse effect on our results
            of operations, financial
            condition and reputation.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            there are significant disruptions in our information technology systems, our business, financial condition
            and operating results could
            be adversely affected.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            efficient operation of our business depends on our information technology systems like Oracle�s ERP and
            Microsoft 360 Office Platforms.
            We rely on our information technology systems to effectively manage sales and marketing data, accounting and
            financial functions, inventory
            management, product development tasks, research and development data, customer service and technical support
            functions. Our information
            technology systems are vulnerable to damage or interruption from earthquakes, fires, floods and other
            natural disasters, terrorist attacks,
            attacks by computer viruses or hackers, power losses, and computer system or data network failures. In
            addition, our data management
            application is hosted by a third-party service provider whose security and information technology systems
            are subject to similar risks,
            and our products� systems contain software which could be subject to computer virus or hacker attacks or
            other failures.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            failure of our or our service providers� information technology systems or our products� software to perform
            as we anticipate
            or our failure to effectively implement new information technology systems could disrupt our entire
            operation or adversely affect our
            software products and could result in decreased sales, increased overhead costs, and product shortages, all
            of which could have a material
            adverse effect on our reputation, business, financial condition, and operating results.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            we fail to properly manage our anticipated growth, our business could suffer.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            growth and product expansion has placed, and we expect that it will continue to place, a significant strain
            on our management team and
            on our financial resources. Failure to manage our growth effectively could cause us to misallocate
            management or financial resources,
            and result in losses or weaknesses in our infrastructure, which could materially adversely affect our
            business. Additionally, our anticipated
            growth will increase the demands placed on our suppliers, resulting in an increased need for us to manage
            our suppliers and monitor for
            quality assurance. Any failure by us to manage our growth effectively could have an adverse effect on our
            ability to achieve our business
            objectives.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are highly dependent on the knowledge and skills of our global leadership team, and if we are not successful
            in attracting and retaining
            highly qualified personnel, we may not be able to successfully implement our business strategy.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            ability to continue to lead in this fragmented industry depends upon our ability to attract, develop and
            retain highly qualified managerial,
            scientific, sales and medical personnel. We are highly dependent on our global leadership team and have
            benefited substantially from
            the leadership and performance of our global leadership team. The loss of the services of any of our
            executive officers and other key
            global leadership team member, and our inability to find suitable replacements could result in delays in
            product development and harm
            the smooth operation of our business.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH�s
            management team has limited experience managing a public company.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Members
            of our management team have limited experience managing a publicly traded company, interacting with public
            company investors, and complying
            with the increasingly complex laws pertaining to public companies as DIH only became subject to the
            requirements upon completion of the
            Business Combination in February 2024. As a public company, we are subject to significant regulatory
            oversight and reporting obligations
            under the federal securities laws and the continuous scrutiny of securities analysts and investors. These
            new obligations and constituents
            require significant attention from our senior management and could divert their attention away from the
            day-to-day management of our
            business, which could harm our business, results of operations, and financial condition.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have identified material weaknesses in our internal control over financial reporting. These material
            weaknesses could continue to adversely
            affect our ability to report our results of operations and financial condition accurately and in a timely
            manner.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            management is responsible for establishing and maintaining adequate internal control over financial
            reporting designed to provide reasonable
            assurance regarding the reliability of financial reporting and the preparation of financial statements for
            external purposes in accordance
            with GAAP. Our management is likewise required to evaluate the effectiveness of our internal controls and to
            disclose any changes and
            material weaknesses identified through such evaluation in those internal controls. A material weakness is a
            deficiency, or a combination
            of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility
            that a material misstatement
            of our annual or interim financial statements will not be prevented or detected on a timely basis.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            identified a material weakness in our internal control over financial reporting with respect to our
            accounting personnel. Specifically,
            the Company concluded that it had limited accounting personnel and other resources with which to address its
            internal control over financial
            reporting in accordance with requirements applicable to public companies. Historically, the Company has not
            retained a sufficient number
            of professionals with an appropriate level of accounting knowledge, training and experience to appropriately
            analyze, record and disclose
            accounting matters under U. S. GAAP.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
            failure to maintain such internal control could adversely impact our ability to report our financial
            position and results from operations
            on a timely and accurate basis. If our financial statements are not accurate, investors may not have a
            complete understanding of our
            operations. Likewise, if our financial statements are not filed on a timely basis, we could be subject to
            sanctions or investigations
            by Nasdaq or any other exchange on which our Common Stock are listed, the SEC or other regulatory
            authorities. In either case, there
            could result a material adverse effect on our business. Ineffective internal controls could also cause
            investors to lose confidence in
            our reported financial information, which could have a negative effect on the trading price of the Common
            Stock.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_006"></span>MARKET
            AND INDUSTRY DATA</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
            information contained in this registration statement relates to or is based on studies, publications,
            surveys and other data obtained
            from third-party sources and our own internal estimates and research. While we believe these third-party
            sources to be reliable as of
            the date of this registration statement, we have not independently verified the market and industry data
            contained in this registration
            statement or the underlying assumptions relied on therein. Finally, while we believe our own internal
            research is reliable, such research
            has not been verified by any independent source. Notwithstanding the foregoing, we are liable for the
            information provided in this registration
            statement. The industry in which we operate is subject to a high degree of uncertainty and risk due to a
            variety of factors, including
            those described in the section of this registration statement titled �<i>Risk Factors</i>�. These and other
            factors could
            cause results to differ materially from those expressed in the estimates made by the independent parties and
            by us.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_007"></span>USE
            OF PROCEEDS</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            estimate that the net proceeds from this offering will be approximately $3.9 million, after deducting
            placement agent fees and estimated offering expenses payable by us. </span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            currently intend to use the net proceeds of this offering as follows:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0" border="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
        <tbody>
            <tr style="vertical-align: top">
                <td style="width: 1in">&nbsp;</td>
                <td style="text-align: justify; width: 0.5in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital expenditures
                        relating
                        to growing our business; and</span></td>
            </tr>

            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remainder as working
                        capital and for general corporate
                        purposes</span></td>
            </tr>

        </tbody>
    </table>


    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            actual allocation of proceeds realized from this offering will depend upon our operating revenue, cash
            position, our working capital
            requirements. We cannot currently allocate specific percentages of the net proceeds to us from this offering
            that we may use for these
            purposes. Therefore, as of the date of this prospectus, we cannot specify with certainty all of the
            particular uses for the net proceeds
            to be received upon the completion of this offering. Accordingly, we will have discretion in the application
            of the net proceeds, and
            investors will be relying on our judgment regarding the application of the proceeds of this offering.
            Pending our use of the net proceeds
            from this offering, we intend to invest the net proceeds in a variety of capital preservation investments,
            including short-term, investment-grade,
            interest-bearing instruments and U.S. government securities.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                id="nd_008"></span>CAPITALIZATION</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            following table sets forth our capitalization as of September 30, 2024 as follows:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0" border="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
        <tbody>
            <tr style="vertical-align: top">
                <td style="width: 1in">&nbsp;</td>
                <td style="text-align: justify; width: 0.5in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on an actual basis;
                        and</span></td>
            </tr>

            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on an as adjusted basis to
                        reflect the issuance and sale by us of 5,937,100 Units in this offering at the public offering
                        price of $0.7832 per Unit, after deducting placement agent fees and estimated offering expenses
                        payable by us and the receipt
                        by us of the proceeds of such sale and assuming no exercise of any outstanding warrants to
                        purchase shares of Common Stock.</span></td>
            </tr>
        </tbody>
    </table>


    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            information below is illustrative only. Our capitalization following the closing of this offering will
            change based on the actual public
            offering price and other terms of this offering determined at pricing. You should read this table in
            conjunction with �<i>Management�s
                Discussion and Analysis of Financial Condition and Results of Operations</i>� and the financial
            statements and related notes included
            in the Form 10-K for the year ended March 31, 2024 the Form 10-Q for the quarterly period ended September
            30, 2024 and subsequent reports
            filed pursuant to the Exchange Act.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of
                    September 30, 2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Unaudited,
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Unaudited,
                    As</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: justify">
                    (In thousands)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Actual
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 60%; text-align: justify; padding-bottom: 2.5pt">Cash</td>
                <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">1,759</td>
                <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td>
                <td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">5,667</td>
                <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: justify; padding-bottom: 1pt">Total assets</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">38,194</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">42,102</p>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: justify; padding-bottom: 1pt">Total Labilities</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">72,589</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">72,589</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: justify; padding-bottom: 1pt">Stockholders� Equity</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt">Common stock, $0.0001 par value&#894; 100,000,000
                    shares authorized&#894; 34,544,935 shares issued and outstanding at September 30, 2024</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">3</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">4</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: justify; padding-bottom: 1pt">Preferred stock, $0.00001 par value&#894;
                    10,000,000 shares authorized; no shares issued and outstanding at September 30, 2024</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">�</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">�</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">Additional paid in capital</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">3,323</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">7,230</p>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">Accumulated Deficit</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">(35,756</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">(35,756</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">Accumulated Other Comprehensive
                    Income (Loss)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(1,965</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(1,965</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">Total stockholders� (deficit)
                    equity</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(34,395</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(30,487</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: justify; padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 20pt; text-align: justify; padding-bottom: 2.5pt">Total capitalization</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">38,194</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">42,102</p>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            number of shares of our common stock outstanding set forth in the table above excludes, as of September 30,
            2024:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0" border="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
        <tbody>
            <tr style="vertical-align: top">
                <td style="width: 0.5in">&nbsp;</td>
                <td style="text-align: justify; width: 0.5in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,335,000 shares
                        of our common stock issuable upon the exercise of the Public Warrants issued in the IPO and the
                        Private Placement Warrants issued in
                        a private placement in connection with the IPO;</span></td>
            </tr>

            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,300,000 shares of common
                        stock available for issuance under
                        our DIH Holding US, Inc. Equity Incentive Plan;</span></td>
            </tr>

            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,000 shares of common
                        stock issuable in connection with
                        warrants outstanding as of September 30, 2024;</span></td>
            </tr>

            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">660,000 shares
                        of common stock issuable in connection with a convertible debenture as of September 30, 2024
                        based on the then-applicable conversion price of $5.00 (such conversion price will decrease
                        and the number of shares issuable in connection with the conversion will increase as a result of
                        this offering);</span></td>
            </tr>

            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&#9679;</td>
                <td style="text-align: justify">shares of common stock that may be issued, at our option, in lieu of
                    cash redemption payments on the convertible
                    debenture;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000,000 shares of common
                        stock issuable in connection with
                        the earn-out provisions set forth in the Business Combination Agreement; and</span></td>
            </tr>

            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,937,100</span><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                        shares of common stock issuable upon the exercise of the warrants to be issued in this
                        offering.</span></td>
            </tr>
        </tbody>
    </table>


    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_009"></span>DILUTION</span>
    </p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            you invest in our Units in this offering, your investment will be immediately and substantially diluted to
            the extent of the difference
            between the public offering price per share of our common stock that is part of the Unit and the as adjusted
            net tangible book value
            per share of our common stock after giving effect to the offering.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            net tangible book value (deficit) as of September 30, 2024 was $(36.8) million, or approximately $(1.06) per
            share. Net tangible
            book value per share represents our total tangible assets less total liabilities, divided by the number of
            shares of common stock outstanding.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
            adjusted net tangible book value dilution per share of common stock to new investors represents the
            difference between the amount per
            share of common stock that is part of the Unit paid by investors in the offering and the net tangible book
            value per share of common
            stock immediately after completion of the offering. After giving effect to the offering and our sale of the
            Units in the offering at
            the public offering price of $0.7832 per Unit, and after deduction of placement agent fees from gross
            proceeds raised in
            the offering and estimated offering expenses payable by us, our as adjusted net tangible book value as of
            September 30, 2024 would have
            been $(32.9) million, or $(0.81) per share of common stock. This represents an immediate increase in net
            tangible book value
            of $0.25 per share of common stock to existing stockholders and an immediate dilution in net tangible book
            value of $(1.59)
            per share of common stock to investors of the offering, as illustrated in the following table, based on
            shares outstanding as of
            September 30, 2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            information below is illustrative only. The dilution caused by this offering will change based on the actual
            public offering price and
            other terms of this offering determined at pricing. You should read this table in conjunction with
            �<i>Management�s Discussion
                and Analysis of Financial Condition and Results of Operations</i>� and the financial statements and
            related notes included in the
            Form 10-K for our fiscal year ended March 31, 2024, our Form 10-Q for the fiscal quarter ended September 30,
            2024 and subsequent Exchange
            Act reports.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 60%; text-align: left; padding-bottom: 1pt">Offering price per share of common stock
                    (attributing no value
                    to warrants)</td>
                <td style="width: 2%; padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; width: 1%; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; width: 16%; text-align: right">&nbsp;</td>
                <td style="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="width: 2%; padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; width: 1%; text-align: left">$</td>
                <td style="padding-bottom: 1pt; width: 16%; text-align: right">0.7832</td>
                <td style="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual net tangible book
                        value per share of common stock before this offering<sup>(1)</sup></span></td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">$</td>
                <td style="padding-bottom: 1pt; text-align: right">(1.06</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase (decrease) in net
                        tangible book value per share attributable to new investors<sup>(2)</sup></span></td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">$</td>
                <td style="padding-bottom: 1pt; text-align: right">0.25</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net tangible book value per
                        share after this offering<sup>(3)</sup></span></td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(0.81</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt">Immediate dilution in net tangible book value per
                    share to new investors</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(1.59</td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <!-- Field: Rule-Page -->
    <div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%">
        <div style="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</div>
    </div><!-- Field: /Rule-Page -->

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determined
                        by dividing (i) net tangible book value (total assets less intangible assets) less total
                        liabilities by (ii) the total number of
                        shares of common stock issued and outstanding prior to the offering.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                        the difference between (i) as adjusted net tangible book value per share after this offering and
                        (ii) net tangible book value per
                        share as of September 30, 2024.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determined
                        by dividing (i) as adjusted net tangible book value, which is our net tangible book value plus
                        the cash proceeds of this offering,
                        after deducting the estimated offering expenses payable by us, by (ii) the total number of
                        shares of common stock to be outstanding
                        following this offering.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            information discussed above is illustrative only and will adjust based on the actual public offering price,
            the actual number of Units
            that we offer in this offering, and other terms of this offering determined at the time of pricing.
            In addition, we may choose to raise additional capital due to market conditions or strategic considerations.
            To the extent that additional
            capital is raised through the sale of equity or convertible debt securities, the issuance of these
            securities could result in further
            dilution to our stockholders.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            number of shares of our common stock outstanding set forth in the table above excludes, as of September 30,
            2024:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0" border="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
        <tbody>
            <tr style="vertical-align: top">
                <td style="width: 0.5in">&nbsp;</td>
                <td style="text-align: justify; width: 0.5in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify">13,335,000 shares of our common stock issuable upon the exercise of the
                    Public Warrants issued in
                    the IPO and the Private Placement Warrants issued in a private placement in connection with the IPO;
                </td>
            </tr>

            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,300,000 shares of common
                        stock available for issuance under
                        our DIH Holding US, Inc. Equity Incentive Plan;</span></td>
            </tr>

            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,000 shares of common
                        stock issuable in connection with
                        warrants outstanding as of September 30, 2024;</span></td>
            </tr>

            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify">660,000 shares of common stock issuable in connection with a convertible
                    debenture as of September 30, 2024 based on the then-applicable conversion price of $5.00 (such
                    conversion price will decrease
                    and the number of shares issuable in connection with the conversion will increase as a result of
                    this offering);</td>
            </tr>

            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&#9679;</td>
                <td style="text-align: justify">shares of common stock that may be issued, at our option, in lieu of
                    cash redemption payments on the convertible
                    debenture;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000,000 shares of common
                        stock issuable in connection with
                        the earn-out provisions set forth in the Business Combination Agreement; and</span></td>
            </tr>

            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top">
                <td>&nbsp;</td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,937,100</span><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                        shares of our common stock issuable upon the exercise of the warrants to be issued in this
                        offering.</span></td>
            </tr>
        </tbody>
    </table>


    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_010"></span>MARKET
            INFORMATION FOR SECURITIES AND DIVIDEND POLICY</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
            Information</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            Class A Common Stock is listed on the Nasdaq Global Market under the symbol �DHAI� and our Public Warrants
            are listed on
            the Nasdaq Capital Market under the symbol �DHAIW.�</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
            of Record</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
            of January 30, 2025, there <span style="background-color: white">were 120 holders of record of our Class A
                Common Stock.</span></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
            Policy</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have not paid any cash dividends on shares of our Class A Common Stock to date and do not intend to pay cash
            dividends. The payment of
            cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements
            and general financial condition.
            The payment of any dividends will be within the discretion of our board of directors. It is the present
            intention of our board of directors
            to retain all earnings, if any, for use in our business operations and, accordingly, our board of directors
            does not anticipate declaring
            any dividends in the foreseeable future.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
            Authorized for Issuance under Equity Compensation Plans</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            DIH Holding US, Inc. Equity Incentive Plan provides for the issuance of up to 4,300,000 additional shares of
            Common Stock. Additionally,
            shares of Common Stock granted or issued under our equity incentive plans will, subject to vesting
            provisions, lock-up restrictions,
            and Rule 144 volume limitations applicable to our �affiliates,� be available for sale in the open market
            immediately upon
            registration.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_011"></span>MANAGEMENT�S
            DISCUSSION AND ANALYSIS OF FINANCIAL</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDITION
                AND RESULTS OF OPERATIONS</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            following discussion and analysis of our financial condition and results of operations should be read
            together with the consolidated
            financial statements and related notes thereto included elsewhere in this registration statement. In
            addition to historical information,
            this discussion and analysis contains forward-looking statements that involve risks, uncertainties and
            assumptions. Our actual results
            may differ materially from these forward-looking statements as a result of certain factors. We discuss
            factors that we believe could
            cause or contribute to these differences below and elsewhere in this registration statement, including those
            set forth in the sections
            of this registration statement titled �Risk Factors� and �Cautionary Note Regarding Forward-Looking
            Statements.�</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
                fiscal year ends on March 31. �Fiscal 2024� and �fiscal 2023� refer to the year ended March 31, 2024 and
                2023,
                respectively.</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            is a global solution provider in blending innovative robotic and VR technologies with clinical integration
            and insights. DIH has a focused
            portfolio of rehabilitation solutions, which includes both technology and products designed for the
            hospital, clinic, and research markets.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            fiscal 2024, DIH generated revenue of $64.5 million compared to $54.1 million in fiscal 2023.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH�s
            net loss for fiscal 2024 was $8.4 million, compared to $1.0 million in fiscal 2023. The net loss increased
            $7.4 million which was primarily
            driven by total transaction costs of $7.1 million to close the Business Combination with ATAK, which
            included a non-cash financial advisory
            fee of $3.5 million paid with 700,000 shares of Common Stock. The increase in net loss was also driven by an
            increase in the cost of
            goods sold, which was largely due to higher device sales volume, direct cost inflation, and an increase in
            the inventory reserve for
            slow moving parts, as well as elevated costs related to professional service and IT costs related to audit,
            legal and other professional
            services to close the business combination discussed in more detail below. The increase in costs and
            expenses is offset by an increase
            in revenue as the Company is emerging from the COVID-19 pandemic period that depressed global sales volume
            due to social distancing measures,
            and the current year was free of additional non-recurring expenditures for the European Union Medical Device
            Regulation (EU MDR) and
            other large scale projects.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            the six months ended September 30, 2024, DIH generated revenue of $35.1 million compared to $26.1 million in
            the six months ended September
            30, 2023.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH�s
            net loss for the six months ended September 30, 2024 was $0.5 million, compared to $5.4 million in the six
            months ended September 30,
            2023. The $4.9 million improvement was primarily driven by the $8.2 million increase in gross profit,
            primarily due to the increase in
            sales volume in EMEA and Americas. The net loss improvement was partially offset by elevated professional
            service costs and other costs
            incurred to enhance our infrastructure and operations as a public company following the recent business
            combination as well as increased
            personnel costs during the six months ended September 30, 2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
                Developments</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
                    Combination</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
            February 7, 2024, ATAK, Aurora Technology Merger Sub (�Merger Sub�) and DIH Nevada consummated a previously
            announced business
            combination pursuant to the Business Combination Agreement dated as of February 26, 2023 following the
            receipt of the required approval
            by ATAK�s and DIH Nevada�s shareholders and the fulfillment or waiver of other customary closing conditions.
            ATAK agreed
            to waive the closing condition that the Reorganization be completed prior to Closing. As a result, at the
            Closing of the Business Combination,
            the Company includes Hocoma Medical that holds assets transferred from Hocoma AG as well as other commercial
            entities controlled by the
            Company. Whereas, Hocoma AG and Motekforce Link BV and its subsidiaries were excluded. The Company agreed to
            use its best efforts to
            complete the intended Reorganization to transfer Hocoma AG and Motek to the Company as soon as possible
            thereafter.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            the interim, DIH continues its historical relationship with Motek as an exclusive distributor of the
            advanced human movement research
            and rehabilitation products and services designed to support efficient functional movement therapy within
            specified territories. DIH
            also intends to continue making periodic payments on notes payable to Hocoma AG, which arose from Hocoma AG
            transferring assets to the
            Company.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
            closing of the Business Combination, the Company received cash held in trust account of $899 thousand. In
            connection with the Closing
            of the Business Combination, ATAK migrated and changed its domestication to become a Delaware corporation
            and changed its name to �DIH
            Holding US, Inc.� Legacy DIH stockholders received shares of Common Stock of DIH.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            historical financial results presented in the registration statements were prepared on a combined basis
            including Legacy DIH, Hocoma
            AG and Motek Group pursuant to the Business Combination Agreement for the intended Reorganization. In this
            Annual Report on Form 10-K,
            the Company has recast historical financial statements on a consolidated basis including operations from
            Legacy DIH excluding Hocoma
            AG and the Motek Group that remained with DIH Hong Kong. The Business Combination was accounted for as a
            reverse recapitalization, in
            accordance with GAAP. Under this method of accounting, ATAK was treated as the �acquired� company for
            financial reporting
            purposes. Accordingly, the Business Combination was treated as the equivalent of DIH Nevada issuing stock
            for the net assets of ATAK,
            accompanied by a recapitalization. The net assets of ATAK were stated at historical cost, with no goodwill
            or other intangible assets
            recorded. Operations prior to the Business Combination were those of Legacy DIH and its subsidiaries,
            excluding Hocoma AG and Motek Group.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
            a consequence of the Business Combination, the Company became the successor to an SEC-registered company,
            which requires DIH to hire
            additional personnel and implement procedures and processes to address public company regulatory
            requirements and customary practices.
            DIH expects to incur additional annual expenses as a public company for, among other things, directors� and
            officers� liability
            insurance, director fees and additional internal and external accounting and legal and administrative
            resources, including increased
            audit and legal fees.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Issuance
                    of Convertible Debt</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
            June 6, 2024, the Company entered into a Securities Purchase Agreement, issuing $3.3 million in principal
            amount of 8% Original Issue
            Discount Senior Secured Convertible Debentures (�Debentures�), resulting in net proceeds of approximately
            $2.5 million after
            estimated expenses and $300 thousand initially deposited into a bank account pending fulfillment of certain
            conditions. The Debentures,
            maturing on December 7, 2025, are convertible into 660,000 shares of Common Stock at a $5.00 per share
            conversion price, and are secured
            by substantially all of the Company�s domestic assets, with guarantees from domestic subsidiaries. In
            connection with the issuance
            of the Debentures, the Company also issued warrants to purchase 330,000 shares of Common Stock at $5.00 per
            share. For further details,
            see Note 12 to the <i>condensed consolidated financial statements</i>.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
                Factors Affecting the DIH�s Operating Results</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            believes that its future success and financial performance depend on a number of factors that present
            significant opportunities for its
            business, but also pose risks and challenges, including those discussed below and in the Section of this
            this registration statement
            entitled �Risk Factors.�</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Supply
                Chain and Inflation</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            global supply chain and logistics challenges continue to impact DIH and the industry. As a result of these
            challenges, DIH has experienced
            cost increases for freight and logistics, raw materials and purchased components as well as increased
            manufacturing conversion costs.
            These supply chain disruptions have not materially affected DIH�s business outlook and goals or its
            operating results, including
            its sales, revenue, or liquidity or capital resources and DIH has not implemented any mitigation efforts to
            date as a result. However,
            DIH cannot predict the impact to it of any future or prolonged supply chain disruptions or any mitigation
            efforts it may take going forward.
            For example as a result of these supply chain disruptions, DIH may be required to extend the overall
            shipment and installation timeline.
            In addition, DIH may consider additional or alternative third-party manufacturers and logistics providers,
            suppliers, vendors or distributors.
            Such mitigation efforts may result in cost increases and any attempts to offset such increases with price
            increases may result in reduced
            sales, increased customer dissatisfaction, or otherwise harm DIH�s reputation. Further, if DIH were to elect
            to transition or add
            manufacturers or logistics providers, suppliers, vendors or distributors, it may result in temporary or
            additional delays in shipments
            of products or risks related to consistent product quality or reliability. This in turn may limit DIH�s
            ability to fulfill customer
            sales orders and DIH may be unable to satisfy all of the demand for its products. DIH may in the future also
            purchase components further
            in advance, which in return can result in less capital being allocated to other activities such as marketing
            and other business needs.
            DIH cannot quantify the impact of such disruptions at this time or predict the impact of any mitigation
            efforts DIH may take in response
            to supply chain disruptions on its business, financial condition, and results of operations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Input
            cost inflation historically has not been a material factor to our gross margin; however, beginning at the
            end of fiscal 2022 DIH began
            to experience increases in raw material and components costs due to inflation effects, which are expected to
            continue to remain at elevated
            levels for at least the near term.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
                Currency Fluctuations</i></span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH�s
            business operates in three different functional currencies (Euro, Swiss Franc, Singapore Dollar). DIH�s
            reporting currency is the
            U.S. Dollar. DIH�s results are affected by fluctuations in currency exchange rates that give rise to
            translational exchange rate
            risks. The extent of such fluctuations is determined in part by global economic conditions and
            macro-economic trends. Movements in exchange
            rates have a direct impact on DIH�s reported revenues. Generally, the impact on operating income or loss
            associated with exchange
            rate changes on reported revenues is partially offset from exchange rate impacts on operating expenses
            denominated in the same functional
            currencies. As foreign currency exchange rates change, translation of the statements of operations of DIH�s
            international businesses
            into U.S. dollars may affect year-over-year comparability of DIH�s operating results.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>EU
                MDR Implementation Costs</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
            in law or regulation could make it more difficult and costly for DIH and its subsidiaries to manufacture,
            market and distribute its products
            or obtain or maintain regulatory approval of new or modified products. DIH�s experience with the transition
            to the EU MDR, which
            it began in 2019, showed how complex, time-consuming and expensive a change in Medical Device Legislation
            can be. The EU MDR replaced
            the existing European Medical Devices Directive (MDD) and Active Implantable Medical Device Directive
            (AIMDD) regulatory frameworks,
            and manufacturers of medical devices were required to comply with EU MDR beginning in May 2021 for new
            product registrations and by May
            2024 for medical devices which have a valid CE Certificate to the prior Directives (issued before May 2021).
            Updates to the legislative
            text of the EU MDR were adopted by the European Parliament and are currently being reviewed for adoption by
            the Council of the European
            Union, including an extension of the transitional period to 2027 for class IIb and III and 2028 for class I
            and IIa medical devices which
            have a valid CE Certificate to the prior Directives (issued before May 2021).</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Macroeconomic
                Uncertainties on Future Operations</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH�s
            operations are exposed to and impacted by various global macroeconomic factors. DIH faces continuing market
            and operating challenges
            across the globe due to, among other factors, impact of the conflicts in Ukraine and the Middle East,
            conditions related to the COVID-19
            pandemic, supply chain disruption, higher interest rates and inflationary pressures. Continued evolution of
            these conditions could lead
            to economic slowdowns.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
                of Presentation</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
            to <i>Note 2</i> of the <i>Notes to Annual Consolidated Financial Statements</i> for a discussion of the
            underlying basis used to prepare
            the consolidated financial statements.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Components
                of Results of Operations</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            generates revenue from the sale of medical rehabilitation devices and technology. DIH�s primary customers
            include healthcare systems,
            clinics, third-party healthcare providers, distributors, and other institutions, including governmental
            healthcare programs and group
            purchasing organizations. Shipping and handling costs charged to customers are included in net sales. DIH
            expects revenue to increase
            sequentially in future periods as it expects the demand for its products to expand in represented
            markets.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

    <!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
                    of Sales</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
            of sales primarily consists of direct materials, supplies, in-bound freight and labor-related costs,
            including salaries and benefits
            for our manufacturing personnel, technical support team, our professional consulting personnel and our
            training teams. Cost of sales
            also includes allocated overhead costs, including facilities costs, depreciation of manufacturing-related
            equipment and facilities and
            other direct costs. DIH expects cost of sales to increase in absolute dollars in future periods as it
            expects orders for its products
            to continue to grow and expects cost of sales per unit to decrease as leverage improves behind expected
            growth.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Selling,
                    General and Administrative Expense</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling,
            general and administrative expense primarily consists of personnel related expenses for DIH�s corporate,
            executive, finance and
            other administrative functions, expenses for outside professional services, including legal, audit and
            advisory services as well as expenses
            for facilities, depreciation, amortization, and marketing costs. Personnel-related expenses consist of
            salaries and benefits.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            expects selling, general and administrative expenses to increase for the foreseeable future as it scales
            headcount, expands hiring of
            engineers and designers, continues to invest in development of technology in order to drive the growth of
            the business, and as a result
            of operating as a public company, including compliance with the rules and regulations of the SEC, legal,
            audit, additional insurance
            expenses, investor relations activities and other administrative and professional services.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
                    and Development</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
            and development primarily consists of research, engineering, and technical activities to develop a new
            product or service or make significant
            improvement to an existing product or manufacturing process. Research and development costs also include
            pre-approval regulatory and
            clinical trial expenses.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            expects research and development costs to increase as it continues to invest in product design and
            technology to drive the growth of
            the business.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest
                    Expense</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
            expense primarily consists of interest expense associated with related party notes payable and bank
            charges.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
                    Income (Expense), Net</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
            income (expense), net primarily consists of the non-service components of net periodic defined benefit plan
            income (costs) and certain
            non-recurring costs in connection with the Business Combination.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
                    Tax Expense</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            income tax provision (benefit) consists of an estimate for U.S. federal, state and foreign income taxes
            based on enacted rates, as adjusted
            for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities
            and changes in the tax law.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
                of Operations for the Fiscal Years Ended March 31, 2024 and 2023</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended
                    March 31,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="border-bottom: Black 1pt solid; font-weight: bold">(in thousands, except percentages)</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$ Change
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% Change
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 36%">Revenue</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 12%; text-align: right">64,473</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 12%; text-align: right">54,059</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 12%; text-align: right">10,414</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 12%; text-align: right">19.3</td>
                <td style="width: 1%; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-bottom: 1pt">Costs of sales</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">34,702</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">23,474</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">11,228</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">47.8</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Gross Profit</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">29,771</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">30,585</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(814</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(2.7</td>
                <td style="text-align: left">)%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Operating expenses:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Selling, general and administrative expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">25,776</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">22,957</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">2,819</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">12.3</td>
                <td style="text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Research and development</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">6,609</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">6,919</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(310</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(4.5</td>
                <td style="padding-bottom: 1pt; text-align: left">)%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt">Total operating expenses</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">32,385</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">29,876</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">2,509</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">8.4</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Operating loss</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(2,614</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">709</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(3,323</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(468.7</td>
                <td style="text-align: left">)%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Other income (expense):</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Interest expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(693</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(277</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(416</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">150.2</td>
                <td style="text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Other income (expense), net</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(3,890</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">572</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(4,462</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(780.1</td>
                <td style="text-align: left">)%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Total other income (expense)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(4,583</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">295</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(4,878</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(1653.6</td>
                <td style="padding-bottom: 1pt; text-align: left">)%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Profit (loss) before income taxes</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(7,197</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">1,004</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(8,201</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(816.8</td>
                <td style="text-align: left">)%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">1,246</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">2,018</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(772</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(38.3</td>
                <td style="padding-bottom: 1pt; text-align: left">)%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(8,443</td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(1,014</td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(7,429</td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">732.6</td>
                <td style="padding-bottom: 2.5pt; text-align: left">%</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            following table presents net revenue by major source for the year ended March 31, 2024 and 2023:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended
                    March 31,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="border-bottom: Black 1pt solid; font-weight: bold">(in thousands, except percentages)</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$ Change
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% Change
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 36%">Devices</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 12%; text-align: right">51,125</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 12%; text-align: right">43,452</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 12%; text-align: right">7,673</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 12%; text-align: right">17.7</td>
                <td style="width: 1%; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>Services</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">11,105</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">9,292</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">1,813</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">19.5</td>
                <td style="text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-bottom: 1pt">Other</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">2,243</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">1,315</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">928</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">70.6</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">64,473</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">54,059</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">10,414</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">19.3</td>
                <td style="padding-bottom: 2.5pt; text-align: left">%</td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
            for the year ended March 31, 2024 increased by $10.4 million, or 19.3%, to $64.5 million from $54.1 million
            for the year ended March
            31, 2023. The overall increase was primarily due to an increase in devices sold of $7.7 million, or 17.7%.
            The increase in devices revenue
            was driven by higher sales volume in Europe, the Americas and Asia. Services revenue represented an increase
            of $1.8 million, up 19.5%
            compared to the prior period. Other revenues represented an increase of $0.9 million, up 70.6% compared to
            the prior period.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
            in foreign currency exchange rates had a favorable impact on our net sales for the year ended March 31,
            2024, resulting in an increase
            of approximately $1.7 million. This was mainly driven by fluctuations in Euro valuations throughout the
            period.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
                    of Sales</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
            of sales for the year ended March 31, 2024 increased by $11.2 million, or 47.8%, to $34.7 million from $23.5
            million for the year ended
            March 31, 2023. The cost of goods for device sales increased by $7.3 million, which directly correlated to
            the increase in device sales
            with an incremental cost of $4.4 million for the additional volume and inflationary cost increases on direct
            costs of goods of approximately
            $2.2 million. The additional increase in cost of sales is mainly driven by an increase of $0.6 million in
            inventory reserve for slow
            moving parts and increased overhead and services parts costs of $3.9 million. The impact due to foreign
            currency translation losses resulted
            in an increase of approximately $0.1 million.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 45; Options: NewSection; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Selling,
                    General and Administrative Expense</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling,
            general and administrative expense for the year ended March 31, 2024 increased by $2.8 million, or 12.3%, to
            $25.7 million from $23.0
            million for the year ended March 31, 2023. The increase was primarily due to an increase in professional
            service costs of $1.5 million
            related to audit, legal and other professional services in preparation for the Business Combination and
            becoming a publicly listed company,
            and investment in finance capacity in preparation for public company reporting obligations. The increase was
            also attributable to personnel
            related expense primarily due to an $1 million increase in pension expense resulting from changes in market
            yields. The increase was
            partially offset by a decrease in credit loss provisions.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
                    and Development</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
            and development costs for the year ended March 31, 2024 decreased by $0.3 million, or 4.5%, to $6.6 million
            from $6.9 million for the
            year ended March 31, 2023. The decrease was primarily due to a decrease in the research and development
            material purchase and external
            consulting of $0.2 million and charges pertaining to the Gorbel acquisition of $0.4 million, that are not
            recurring in the current period.
            The decrease was offset by an increase in personnel expenses of $0.3 million.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest
                    Expense</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
            expense for the year ended March 31, 2024 increased by $416 thousand, or 150.2% in relates to interests on
            Related Party Notes and an
            increase in temporary bank charge.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
                    Income (Expense), Net</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
            income (expense), net for the year ended March 31, 2024 was $3.9 million of expense compared to $0.6 million
            of income for the year ended
            March 31, 2023. The change was primarily driven by a $3.5 million financial advisory fee paid with 700,000
            shares of Common Stock in
            connection with closing of the Business Combination as well as realized foreign exchange losses during the
            period.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
                    Tax Expense</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
            tax expense for the year ended March 31, 2024 decreased by $0.8 million to $1.2 million. The change was
            primarily driven by changes in
            the net results of the underlying subsidiaries across jurisdictions. The tax expense for March 31, 2024 and
            March 31, 2023 is driven
            by pre-tax book income in certain jurisdictions while the benefit from pre-tax losses in other jurisdiction
            may not be realizable.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 46; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
                of Operations for the Three and Six Months Ended September 30, 2024 and 2023</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td style="font-weight: bold; text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three
                    months ended <br> September 30,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six months
                    ended September 30,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="border-bottom: Black 1pt solid; font-weight: bold">(in thousands, except percentages)</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    <p style="margin-top: 0; margin-bottom: 0">$</p>
                    <p style="margin-top: 0; margin-bottom: 0">Change</p>
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    <p style="margin-top: 0; margin-bottom: 0">%</p>
                    <p style="margin-top: 0; margin-bottom: 0">Change</p>
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    <p style="margin-top: 0; margin-bottom: 0">$</p>
                    <p style="margin-top: 0; margin-bottom: 0">Change</p>
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    <p style="margin-top: 0; margin-bottom: 0">%</p>
                    <p style="margin-top: 0; margin-bottom: 0">Change</p>
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 28%">Revenue</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 5%; text-align: right">18,162</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 5%; text-align: right">13,060</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 5%; text-align: right">5,102</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 5%; text-align: right">39.1</td>
                <td style="width: 1%; text-align: left">%</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 5%; text-align: right">35,122</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 5%; text-align: right">26,105</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 5%; text-align: right">9,017</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 5%; text-align: right">34.5</td>
                <td style="width: 1%; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-bottom: 1pt">Cost of sales</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">8,605</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">7,652</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">953</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">12.5</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">16,110</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">15,300</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">810</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">5.3</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Gross profit</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">9,557</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">5,408</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">4,149</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">76.7</td>
                <td style="text-align: left">%</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">19,012</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">10,805</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">8,207</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">76.0</td>
                <td style="text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Operating expenses:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Selling, general, and administrative expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">5,758</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">6,372</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(614</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(9.6</td>
                <td style="text-align: left">)%</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">14,368</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">12,209</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">2,159</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">17.7</td>
                <td style="text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Research and development</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">1,911</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">1,584</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">327</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">20.6</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">3,555</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">3,022</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">533</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">17.6</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt">Total operating expenses</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">7,669</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">7,956</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(287</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(3.6</td>
                <td style="padding-bottom: 1pt; text-align: left">)%</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">17,923</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">15,231</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">2,692</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">17.7</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Operating income (loss)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">1,888</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(2,548</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">4,436</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">174.1</td>
                <td style="text-align: left">%</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">1,089</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(4,426</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">5,515</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">124.6</td>
                <td style="text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Other income (expense):</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Interest expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(26</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(155</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">129</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">83.2</td>
                <td style="text-align: left">%</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(161</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(275</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">114</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">41.5</td>
                <td style="text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other income (expense), net</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(1,761</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">271</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(2,032</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(749.8</td>
                <td style="padding-bottom: 1pt; text-align: left">)%</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(414</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(418</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">4</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">1.0</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Total other income (expense)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(1,787</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">116</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(1,903</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(1640.5</td>
                <td style="padding-bottom: 1pt; text-align: left">)%</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(575</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(693</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">118</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">17.0</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Income (loss) before income taxes</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">101</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(2,432</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">2,533</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">104.2</td>
                <td style="text-align: left">%</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">514</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(5,119</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">5,633</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">110.0</td>
                <td style="text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">335</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">52</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">283</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">544.2</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">1,058</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">278</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">780</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">280.6</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(234</td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(2,484</td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">2,250</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">90.6</td>
                <td style="padding-bottom: 2.5pt; text-align: left">%</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(544</td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(5,397</td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">4,853</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">89.9</td>
                <td style="padding-bottom: 2.5pt; text-align: left">%</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            following table presents net revenue by major source for the three and six months ended September 30, 2024
            and 2023:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td style="font-weight: bold; text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three
                    months ended September 30,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six months
                    ended September 30,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="border-bottom: Black 1pt solid; font-weight: bold">(in thousands, except percentages)</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    <p style="margin-top: 0; margin-bottom: 0">$</p>
                    <p style="margin-top: 0; margin-bottom: 0">Change</p>
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    <p style="margin-top: 0; margin-bottom: 0">%</p>
                    <p style="margin-top: 0; margin-bottom: 0">Change</p>
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    <p style="margin-top: 0; margin-bottom: 0">$</p>
                    <p style="margin-top: 0; margin-bottom: 0">Change</p>
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    <p style="margin-top: 0; margin-bottom: 0">%</p>
                    <p style="margin-top: 0; margin-bottom: 0">Change</p>
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 28%">Devices</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 5%; text-align: right">15,045</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 5%; text-align: right">10,112</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 5%; text-align: right">4,933</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 5%; text-align: right">48.8</td>
                <td style="width: 1%; text-align: left">%</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 5%; text-align: right">28,573</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 5%; text-align: right">20,555</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 5%; text-align: right">8,018</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 5%; text-align: right">39.0</td>
                <td style="width: 1%; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>Services</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">2,695</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">2,710</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(15</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(0.6</td>
                <td style="text-align: left">)%</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">5,995</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">5,085</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">910</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">17.9</td>
                <td style="text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-bottom: 1pt">Other</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">422</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">238</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">184</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">77.3</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">554</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">465</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">89</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">19.1</td>
                <td style="padding-bottom: 1pt; text-align: left">%</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">18,162</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">13,060</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">5,102</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">39.1</td>
                <td style="padding-bottom: 2.5pt; text-align: left">%</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">35,122</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">26,105</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">9,017</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">34.5</td>
                <td style="padding-bottom: 2.5pt; text-align: left">%</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
            for the three months ended September 30, 2024 increased by $5.1 million, or 39.1%, to $18.2 million from
            $13.1 million for the three
            months ended September 30, 2023. The overall increase was primarily due to an increase in devices sold of
            $4.9 million, or 48.8% year
            over year. The increase in devices revenue was primarily driven by higher sales volume in EMEA. Services
            revenue was consistent compared
            to the prior period. Other revenue increased by $0.2 million to $0.4 million for the three months ended
            September 30, 2024 compared to
            $0.2 million for the three months ended September 30, 2023. Total revenue in the EMEA and in the Americas
            increased by $4.5 million and
            $0.7 million, respectively, to $10.7 million and $4.6 million for the three months ended September 30, 2024
            compared to $6.2 million
            and $3.8 million for the three months ended September 30, 2023. The increase was partially offset by a
            decrease in sales in the APAC
            of $0.1 million.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 47; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
            for the six months ended September 30, 2024 increased by $9.0 million, or 34.5%, to $35.1 million from $26.1
            million for the six months
            ended September 30, 2023. The overall increase was primarily due to an increase in devices sold of $8.0
            million, or 39.0% year over year.
            The increase in devices revenue was primarily driven by higher sales volume in EMEA and Americas. Services
            revenue represented an increase
            of $0.9 million, up 17.9% compared to the prior period related to extended warranty in connection with
            increase in device revenue. Other
            revenues was consistent compared to the prior period. Total revenue in the EMEA and in the Americas
            increased by $8.9 million and $2.3
            million, respectively, to $21.7 million and $9.1 million for the six months ended September 30, 2024
            compared to $12.9 million and $6.8
            million for the six months ended September 30, 2023. The increase was partially offset by a decrease in
            sales in the APAC of $2.2 million.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
            impact due to foreign currency translation is immaterial for the three and six months ended September 30,
            2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
                    of Sales</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Cost
            of sales for the</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">three
            months ended September 30, 2024
            increased by $0.9 million, or 12.5%, to $8.6 million from $7.7 million for the three months ended September
            30, 2023. The cost of sales
            for device sales increased by $1.3 million for the three months ended September 30, 2024 compared to the
            three months ended September
            30, 2023. The cost of sales increase correlated to the increase in device sales in the three months ended
            September 30, 2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
            of sales for the six months ended September 30, 2024 increased by $0.8 million, or 5.3%, to $16.1 million
            from $15.3 million for the
            six months ended September 30, 2023. The cost of sales for device sales increased by $0.9 million for the
            six months ended September
            30, 2024 compared to the six months ended September 30, 2023. The cost of sales increased by $1.6 million
            correlated to an increase in
            device sales. An inventory reserve and provisions of approximately $0.7 million was recognized in the six
            months ended September 30,
            2023, while the impact from inventory reserve and provisions was insignificant in the six months ended
            September 30, 2024, which partially
            offset the increase in cost of sales due to volume. The cost of services was consistent compared to the
            prior period.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company implemented a 10% price increase in fiscal year 2024 for sales orders received after the
            implementation date, which resulted
            in improvement in gross margin realized in the three and six months ended September 30, 2024 compared to the
            three and six months ended
            September 30, 2023.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            impact due to foreign currency translation resulted in an immaterial change for the three and six months
            ended September 30, 2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Selling,
                    General and Administrative Expense</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Selling,
            general and administrative expense for the </span><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">three months
            ended September 30, 2024 decreased by $0.6 million, or 9.6%, to $5.8 million from $6.4 million for the three
            months ended September 30,
            2023. The decrease was driven by a $0.5 million decrease in professional service fee during the three months
            ended September 30, 2024
            because professional expenses incurred during <span style="background-color: white">three months ended
                September 30, 2023 related to
                the Business Combination were not recurring</span>.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Selling,
            general and administrative expense for the six months ended September 30, 2024 increased by $2.2 million, or
            17.7%, to $14.4 million
            from $12.2 million for the </span><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">six months ended September
            30, 2023. The increase was driven by a $0.9 million increase in personnel expenses related to compensation,
            bonus and benefits, a $0.7
            million increase in professional service costs related to audit, legal and other professional services and
            overhead expenses associated
            with operating as a public company. In addition, the provision for credit losses decreased by $0.4 million
            during the six months ended
            September 30, 2024 and decreased by $1.0 million during the six months ended September 30, 2023<span
                style="background-color: white">,
                resulting in a $0.6 million increase in total expense.</span></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Research
                    and Development</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Research
            and development costs for the </span><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">three months ended September
            30, 2024 increased by $0.3 million, or 20.6%, to $1.9 million from $1.6 million for the three months ended
            September 30, 2023. The increase
            was primarily attributable to a $0.2 million increase in the amortization expense related to capitalized
            software that was ready for
            its intended use during the three months ended September 30, 2024 and a $0.1 million increase in employee
            compensation.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 48; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
            and development costs for the six months ended September 30, 2024 increased by $0.5 million, or 17.6%, to
            $3.6 million from $3.0 million
            for the six months ended September 30, 2023. The increase was primarily attributable to a $0.3 million
            increase in employee compensation
            and bonus, along with a $0.2 million increase in the amortization expense related to capitalized software
            that was ready for its intended
            use during <span style="background-color: white">the three months ended September 30, 2024.</span></span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest
                    Expense</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
            expense for three and six months ended September 30, 2024 and 2023 were consistent to interest on Related
            Party Notes and bank
            charges.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
                    Income (Expense), Net</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
            income (expense), net for the three months ended September 30, 2024 was $1.8 million of expense, compared to
            $0.3 million of income for
            the three months ended September 30, 2023. The change was primarily driven by the fluctuation in the
            exchange rate between the Swiss
            Franc and both the U.S. dollar and euro in the three months ended September 30, 2024, along with a $0.4
            million expense due to change
            in the fair value of the convertible note and warrant.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
            income (expense), net for the six months ended September 30, 2024 was consistent to that for the six months
            ended September 30, 2023
            primarily due to $0.4 million increase in expense due to change in the fair value of the convertible note
            and warrant offset by $0.4
            million decrease in loss due to transactions in foreign currencies.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
                    Tax Expense</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
            tax expense for the three months ended September 30, 2024 increased by $0.3 million to $0.3 million compared
            to $0 million in the three
            months ended September 30, 2023. Income tax expense for the six months ended September 30, 2024 increased by
            $0.8 million to $1.1 million
            compared to $0.3 million in the six months ended September 30, 2023. The change was primarily driven by
            changes in the net results of
            the underlying subsidiaries across jurisdictions. The tax expense for the three and six months ended
            September 30, 2024 and 2023 is driven
            by pre-tax book income in certain jurisdictions while the benefit from pre-tax losses in other jurisdiction
            may not be realizable.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
                and Capital Resources</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
            of September 30, 2024 and March 31 2024, DIH�s cash and cash equivalents amounted to $1.8 million and $3.2
            million, respectively.
            In addition, DIH received $300 thousands from the convertible debt financing deposited into a bank account
            as restricted cash which was
            released in October 2024 in addition to the cash and cash equivalents as of September 30, 2024. DIH�s
            operating losses began in
            fiscal 2020 and conti<span style="background-color: white">nued through the </span>six months ended
            September 30, 2024. DIH�s historical
            operating losses resulted in an accumulated deficit of $(35.8) million as of September 30, 2024. Operating
            losses were mainly driven
            by decreased sales during the COVID-19 pandemic due to social distancing measures that affected demand for
            rehabilitation services, increased
            expenditures in connection with its implementation of a new financial system (Oracle) and increased
            compliance costs associated with
            the EU MDR. Additionally, DIH had elevated costs related to its efforts of adopting to public company
            standards. During the six months
            ended September 30, 2024, DIH had negative cash flows from operating activities of $(1.5) million and an
            operating income of $1.1 million
            and negative working capital as of September 30, 2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            connection with the transfer of Hocoma AG�s business and assets to DIH, we incurred three related party
            notes payable to Hocoma
            AG as further discussed in <i>Note 13</i> of the <i>Notes to Annual Condensed Consolidated Financial
                Statements.</i> The three Related
            Party Notes amounting to $10.47 million, $7.80 million and $1.57 million reflect transferring the assets,
            equity ownership in subsidiaries
            and IP rights it held to Legacy DIH. Each of the Related Party Notes Payable is due on June 30, 2026 with
            interest rate of 1.25%. The
            Company has made periodic payment on Related Party Notes payable with proceeds from its operations. The
            remaining balance on the Related
            Party Notes payable is $9.4 million and $11.5 million as of September 30, 2024 and March 31, 2024,
            respectively.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 49; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            June 2024, we issued a 8% Original Issue Discount Senior Secured Convertible Debentures, resulting in net
            proceeds of approximately $2.8
            million after offering expenses. The first redemption payment was made in cash on November 1, 2024. For
            additional details, including
            the terms and conditions of these Debentures and associated warrants, please refer to Note 12 to the
            condensed consolidated financial
            statements.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            above conditions raise substantial doubt about the Company�s ability to continue as a going concern within
            one year after the
            date of the filing of the Quarterly Report for the quarter ended September 30, 2024. Our revenue has
            increased by 34.5%, from $26.1 million to $35.1 million for the six months ended September 30,
            2024 and 2023, respectively. We anticipate sources of liquidity to include cash on hand and cash flow from
            operations. We continue
            to explore financing alternatives in debt or equity to fund our ongoing operations and to fulfill current
            obligations. We continue
            to take steps to streamline its organization and cost structure as well as improve future revenue
            growth.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH�s
            other material contractual operating cash commitments at September 30, 2024 relate to leases and employee
            benefit plans. DIH�s
            employee benefit plans are discussed further in <i>Note 14 </i>of the <i>Notes to Annual Consolidated
                Financial Statements. </i>DIH�s
            long-term lease obligations and future payments are discussed further in <i>Note 17</i> of the <i>Notes to
                Annual Consolidated Financial
                Statements</i>.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash
                Flows</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            following table summarizes DIH�s cash flow activities for the periods presented:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended
                    March 31,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="border-bottom: Black 1pt solid; font-weight: bold">(in thousands)</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 60%; text-align: left">Net cash (used in) / provided by operating activities</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">5,192</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">5,501</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Net cash (used in) / provided by investing activities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(202</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(145</td>
                <td style="text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Net cash (used in) / provided by financing activities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(4,945</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(4,053</td>
                <td style="text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Effect of currency translation on cash, cash
                    equivalents and restricted cash</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">5</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(61</td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt">Net increase (decrease) in cash, cash equivalents
                    and restricted cash</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">50</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">1,242</td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net
                Cash Provided by / (Used in) Operating Activities</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
            cash provided by operating activities for the year ended March 31, 2024 was in line with that for the year
            ended March 31, 2023 primarily
            driven by:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Decrease
            in net loss of $7.4 million. The primary driver was $3.5 million noncash fee recorded in other expense paid
            to Maxim in equity in connection
            with closing of the Business Combination. The decrease was also driven by operating loss of $2.6 million for
            the year ended March 31,
            2024 compared to $0.7 million operating income for the year ended March 31, 2023. The change in operating
            loss is primarily due to increase
            in professional service costs in preparation for the business combination.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
            increase of $6.1 million in non-cash charges pertains to a $3.5 million charge due to Maxim success fee paid
            in equity and a $2.3 million
            increase in change in inventory reserve as well a $1.0 million increase in foreign exchange gain / (losses),
            which is attributable to
            the change in Euro during the last part of fiscal year 2023 and the slight rebound and stabilization during
            fiscal year 2024. The increases
            in non-cash charges were offset by a decrease in allowance for doubtful accounts of $1.7 million.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
            decrease of $2.3 million relating to changes in working capital was driven by increase in spend for
            inventory purchase of $3.8 million
            as the Company was preparing for FY25 production and aligning with customer schedules for order fulfillment.
            The decrease was also driven
            by a decrease in deferred revenue resulted from the difference in timing of payments received from our
            customers related to service contracts.
            In addition, during the period, the Company began paying accrued expenses related to costs in connection
            with Company becoming a publicly
            listed.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 50; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
            decrease in working capital was partially offset by increase of $2.2 million in advanced payments from
            customer for the year ended March
            31, 2024 compared to the year ended March 31, 2023 primarily due to the timing of the order received. Many
            customers prepay a portion
            of each order, which supports the operations of the company in the production of the goods. We also observed
            a total increase of $5.2
            million in accounts receivable and accounts payable as we are managing our working capital. Working capital
            was impacted by favorable
            changes in due from and due to related parties balances driven by the Company�s purchase from the Motek
            Group and change in balance
            from Hocoma AG.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net
                Cash (Used in) / Provided by Investing Activities</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
            cash used in investing activities is consistent between the year ended March 31, 2024 compared to that for
            the year ended March 31, 2023.
            The cash used in investing activities primarily includes purchase of property and equipment. DIH expects to
            fund future cash flows used
            in investing activities with cash flow generated by operations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net
                Cash (Used in) / Provided by Financing Activities</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
            cash used in financing activities increased by $0.8 million to $4.9 million for the year ended March 31,
            2024 compared to $4.1 million
            for the year ended March 31, 2023. The increase was primarily due to increase of $1.8 million in payments on
            related party notes payable
            resulting from the asset transfer from Hocoma AG to the Company offset by proceeds received upon closing of
            the Business Combination.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash
                Flows</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            following table summarizes DIH�s cash flow activities for the periods presented:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td style="font-weight: bold; text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six months
                    ended September 30,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="border-bottom: Black 1pt solid; font-weight: bold">(in thousands)</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 60%; text-align: left">Net cash provided by / (used in) operating activities</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">(1,534</td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">1,763</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Net cash used in investing activities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(423</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(73</td>
                <td style="text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Net cash provided by / (used in) financing activities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">756</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(3,744</td>
                <td style="text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Effect of currency translation on cash and cash
                    equivalents</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">35</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">15</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt">Net decrease in cash and cash equivalents</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(1,166</td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(2,039</td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net
                Cash used in Operating Activities</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Net
            cash used in operating activities increased by $3.3 million to $(1.5) million for the six months ended
            September 30, 2024 compared to
            $1.8 million for the six months ended September 30, 2023 primarily driven by:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Decrease
                        of net loss of $4.9 million. The primary driver was increased gross profit of $8.2 million due
                        to increased sales volume and gross
                        margin offset by increased operating expenses of $2.7 million.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-cash
                        charges were decreased by $0.1 million for the six months ended September 30, 2024 and 2023.
                        Non-cash charges decreased by $0.8 million
                        because an inventory reserve and provisions of approximately $0.7 million were recognized in the
                        six months ended September 30, 2023,
                        while the impact from inventory reserve and provisions was insignificant in the six months ended
                        September 30, 2024. The non-cash
                        charges also decreased by $0.4 million due to 0.0 foreign exchange gain in the six months ended
                        September 30, 2024 as compared to
                        a foreign exchange loss of $0.4 million in the six months ended September 2023, which is
                        primarily attributable to the fluctuation
                        in the exchange rate between Swiss Franc and both U.S. dollar and euro. The decreases in
                        non-cash charges were offset by a $0.4 million
                        increase of change in fair value of convertible note and warrant during the six months ended
                        September 30, 2024. The decreases in
                        non-cash charges were also offset by a decrease in provision for credit losses of $0.4 million
                        during the when comparing the six
                        months ended September 30, 2024 to the six months ended September 30, 2023.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 51; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                        decrease of $8.0 million relating to changes in working capital was driven by a decrease of $4.3
                        million in advanced payments from
                        customer for the six months ended September 30, 2024 compared to the six months ended September
                        30, 2023 primarily due to the timing
                        of the orders received. The decrease is also due to a total decrease of $3.8 million in accounts
                        receivable and accounts payable,
                        along with a $2.0 million net decrease in due from related parties and due to related parties
                        driven by the Company�s purchases
                        from the Motek Group and change in balance from Hocoma AG.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
            decrease in working capital was partially offset by an increase of $1.1 million increase in employee
            compensation accrued and an increase
            of $0.9 million in accrued expense and other liabilities.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investing
                Activities</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
            cash used in investing activities increased by $0.4 million for the six months ended September 30, 2024. The
            cash used in investing activities
            primarily includes purchase of property and equipment. DIH expects to fund future cash flows used in
            investing activities with cash flow
            generated by operations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financing
                Activities</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
            cash (used in)/provided by financing activities increased by $4.5 million to $0.8 million for the six months
            ended September 30, 2024
            compared to $(3.7) million for the six months ended September 30, 2023. The increase was primarily due to
            the $2.8 million proceeds from
            the convertible debt financing net of transaction fee and a $1.7 million decrease in payments on related
            party notes payable resulting
            from the asset transfer from Hocoma AG.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
                Accounting Policies and Estimates</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH�s
            financial statements are based on the selection and application of significant accounting policies, which
            require management to make
            significant estimates and assumptions. Management believes that the following are some of the more critical
            judgment areas in the application
            of accounting policies that currently affect DIH�s financial condition and results of operations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
                    Recognition</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
            are recognized as the performance obligations to deliver products or services are satisfied and are recorded
            based on the amount of consideration
            DIH expects to receive in exchange for satisfying the performance obligations. DIH�s sales are recognized
            primarily when it transfers
            control to the customer, which can be on the date of shipment of the product, the date of receipt of the
            product by the customer or upon
            completion of any required product installation service depending on the terms of the sales contracts and
            product shipping terms. The
            sales amount of warranties are deferred and recognized as revenue on a straight-line basis over the warranty
            period.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            provide a variety of products and services to our customers. Most of our contracts consist of a single,
            distinct performance obligation
            or promise to transfer goods or services to a customer. For contracts that include multiple performance
            obligations, we allocate the
            total transaction price to each performance obligation using our best estimate of the standalone selling
            price of each identified performance
            obligation.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
            revenue primarily represents service contracts and equipment maintenance, for which consideration is
            received in advance of when service
            for the device or equipment is provided, and a smaller component of product shipments where a residual
            installation service is to be
            completed. Revenue related to services contracts and equipment maintenance is recognized over the service
            period as time elapses. Revenues
            related to products containing an installation clause, are recognized once the item is confirmed
            installed.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employee
                    Benefit Plans</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            has defined contribution plans or benefit pension plans covering substantially all of its employees. We
            recognize a liability for the
            underfunded status of the single employer defined benefit plans. Actuarial gains or losses and prior service
            costs or credits are recorded
            within other comprehensive income (loss). The determination of our obligation and related expense for our
            sponsored pensions is dependent,
            in part, on management�s selection of certain actuarial assumptions in calculating these amounts.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 52; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            actuarial assumptions used for the defined benefit plans are based on the economic conditions prevailing in
            the jurisdiction in which
            they are offered. Changes in the defined benefit obligation are most sensitive to changes in the discount
            rate. The discount rate is
            based on the yield of high-quality corporate bonds quoted in an active market in the currency of the
            respective plan. A decrease in the
            discount curve increases the defined benefit obligation. DIH regularly reviews the actuarial assumptions
            used in calculating the defined
            benefit obligation to determine their continuing relevance. We utilized weighted discount rates of 1.50% and
            2.10% for our pension plan
            expenses for fiscal 2024 and fiscal 2023, respectively.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sensitivity
            to changes in the discount rate used in the calculation of our pension plan liabilities is illustrated below
            (dollars in millions).</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <table cellpadding="0" cellspacing="0"
        style="font: 12pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: center; padding-bottom: 1pt">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&nbsp;
                </td>
                <td
                    style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">
                    &nbsp;</td>
                <td
                    style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">
                    <p
                        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">
                        <b>Percentage</b></p>
                    <p
                        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">
                        <b>Point Change</b></p>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&nbsp;
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&nbsp;
                </td>
                <td
                    style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">
                    &nbsp;</td>
                <td
                    style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">
                    <p style="margin-top: 0; margin-bottom: 0"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<b>Projected</b></span>
                    </p>
                    <p style="margin-top: 0; margin-bottom: 0"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Benefit</b></span>
                    </p>
                    <p style="margin-top: 0; margin-bottom: 0"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Obligation (Decrease)
                                Increase</b></span></p>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&nbsp;
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">&nbsp;
                </td>
                <td
                    style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">
                    &nbsp;</td>
                <td
                    style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">
                    <p style="margin-top: 0; margin-bottom: 0"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<b>Service</b></span>
                    </p>
                    <p style="margin-top: 0; margin-bottom: 0"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost</b></span></p>
                    <p style="margin-top: 0; margin-bottom: 0"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Decrease)
                                Increase</b> &nbsp;</span></p>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&nbsp;
                </td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Discount rate</td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+/-1.00%</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (1.6) / 2.1</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (0.2) / 0.2 &nbsp;</span>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
                    Taxes</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            accounts for income taxes in accordance with Accounting Standards Codification Topic 740, Income Taxes
            (Topic 740). Deferred tax assets
            and liabilities are recognized for the future tax consequences attributable to differences between financial
            statement carrying amounts
            of existing assets and liabilities and their respective tax bases and operating loss and other loss
            carryforwards. Deferred tax assets
            and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in
            which those temporary differences
            are expected to be recovered or settled. DIH reviews its deferred income tax asset valuation allowances on a
            quarterly basis or whenever
            events or changes in circumstances indicate that a review is required. In determining the requirement for a
            valuation allowance, the
            historical and projected financial results of the legal entity or combined group recording the net deferred
            income tax asset is considered,
            along with any positive or negative evidence including tax law changes. Since future financial results and
            tax law may differ from previous
            estimates, periodic adjustments to DIH�s valuation allowances may be necessary. DIH has generated operating
            losses in each of the
            years presented.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            is subject to income taxes in the U.S. and numerous foreign jurisdictions These tax laws and regulations are
            complex and significant
            judgment is required in determining DIH�s worldwide provision for income taxes and recording the related
            deferred tax assets and
            liabilities.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            the ordinary course of DIH�s business, there are transactions and calculations where the ultimate tax
            determination is uncertain.
            Accruals for unrecognized tax benefits are provided for in accordance with the requirements of Topic 740. An
            unrecognized tax benefit
            represents the difference between the recognition of benefits related to items for income tax reporting
            purposes and financial reporting
            purposes. DIH�s tax returns are subject to regular review and audit by US and non-US tax authorities.
            Although the outcome of tax
            audits is always uncertain, DIH believes that it has appropriate support for the positions taken on its tax
            returns and that its annual
            tax provision includes amounts sufficient to pay any assessments. Nonetheless, the amounts ultimately paid,
            if any, upon resolution of
            the issues raised by the taxing authorities may differ materially from the amounts accrued for each year and
            would be the obligation
            of Parent. DIH accrues interest and penalties related to uncertain tax positions as a component of income
            tax expense.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
            to Note 15 of the Notes to Annual Consolidated Financial Statements for further discussion regarding DIH�s
            income taxes.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 53; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
                Accounting Standards Not Yet Adopted</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
            the summary of recent accounting pronouncements, see Note 2 - Summary of Significant Accounting Policies to
            our condensed consolidated
            financial statements included elsewhere in this prospectus.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
                Growth Company Status</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company is an �emerging growth company,� as defined in Section 2(a) of the Securities Act, as modified by
            the JOBS Act, and
            it may take advantage of certain exemptions from various reporting requirements that are applicable to other
            public companies that are
            not emerging growth companies including, but not limited to, not being required to comply with the
            independent registered public accounting
            firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations
            regarding executive compensation
            in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding
            advisory vote on executive
            compensation and shareholder approval of any golden parachute payments not previously approved.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
            Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new
            or revised financial accounting
            standards until private companies (that is, those that have not had a Securities Act registration statement
            declared effective or do
            not have a class of securities registered under the Exchange Act) are required to comply with the new or
            revised financial accounting
            standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
            comply with the requirements
            that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has
            elected not to opt out of
            such extended transition period which means that when a standard is issued or revised and it has different
            application dates for public
            or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at
            the time private companies
            adopt the new or revised standard. This may make comparison of the Company�s financial statements with
            another public company which
            is either not an emerging growth company or an emerging growth company which has opted out of using the
            extended transition period difficult
            or impossible because of the potential differences in accounting standards used.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                id="D_001"></span>BUSINESS</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overview</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            Holding US, Inc., a Delaware corporation, and its consolidated subsidiaries are referred to in this
            registration statement as �we,�
            �our,� �us,� the �Company,� or �DIH.� DIH is a global provider of advanced robotic devices
            used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable
            clinical research and intensive
            functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired
            arm and hand functions.
            We strive to serve the rehabilitation market by providing a broad array of devices and services focused on
            the customer and patient recovery.
            DIH stands for our vision to �Deliver Inspiration &amp; Health� to improve the daily lives of millions of
            people with disabilities
            and functional impairments.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            offers innovative, robotic-enabled rehabilitation devices in an interactive environment. These solutions
            allow for intensive rehabilitation
            across the spectrum of patient specific levels of care, while also tracking patients� progress and providing
            a network of collaboration
            and encouragement. DIH is dedicated to restoring mobility and enhancing human performance through a broad
            array of devices that can enable
            the transformation of rehabilitation care at our customers. Our revenue is concentrated in the EMEA and
            Americas, with the remaining
            revenue in the APAC.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
            History</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            Technology Ltd. (�DIH Cayman�) was founded in 2014 by Chief Executive Officer and Chairman, Jason Chen, with
            the belief that
            synergies could be created by integrating the niche players in the rehabilitation therapy and research
            markets to build a global leading
            growth platform. As part of this strategy, in April 2015, DIH Hong Kong, a wholly owned subsidiary of DIH
            Cayman, acquired Motek ForceLink
            B.V. and its subsidiaries (together �Motek� or �Motek Group�), a Netherlands-based technology leader in
            sophisticated
            VR-enabled movement platforms that set the standards for human movement research and treatment; and in
            September 2016 acquired Hocoma
            AG (�Hocoma�), a Switzerland-based global market leader in the development, manufacturing and marketing of
            robotic and sensor-based
            devices for functional movement therapy.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 54; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequently,
            DIH Hong Kong organized Motek ForceLink and Hocoma under a global management framework, with the purpose of
            building a scalable global
            business blending the technical, product and market strengths of those two firms to create a scalable and
            fully aligned global growth
            and operational bases that can be leveraged for rapid growth.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
            to the reverse recapitalization with Aurora Technology Acquisition Corp. (�ATAK�) and the reorganization,
            DIH Cayman owned
            100% of DIH Hong Kong and DIH Hong Kong owned 100% of various operating entities including the manufacturing
            entities Hocoma AG and Motek
            Group. Hocoma AG was the sole owner of five commercial selling entities located in the United States, Chile,
            Slovenia, Germany, and Singapore.
            The commercial entities had exclusive rights to distribute the goods produced by Hocoma AG and Motek Group.
            While the business under
            DIH Cayman historically functioned together, they maintained largely independent management teams and did
            not rely on corporate or other
            support functions from DIH Cayman.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
            October 6, 2020, Hocoma AG created a new wholly owned subsidiary, DIH US Corp, a Delaware entity. The
            purpose of DIH US Corp was to own
            100% of the commercial selling entities. On May 31, 2021, Hocoma AG completed the share transfer of
            commercial entities to DIH US Corp.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
            June 2, 2021, DIH Cayman formed a wholly owned subsidiary, DIH Holding US Inc., a Nevada Corporation
            (�Legacy DIH� or �DIH
            Nevada�). This entity was established to serve as a US-based holding company, to which assets could be
            transferred, setting the
            foundation for the future of the Company, which would eventually engage in the Business Combination with
            ATAK.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
            June 21, 2021, Hocoma AG formed another wholly owned subsidiary, Hocoma Medical GmbH. The purpose of Hocoma
            Medical GmbH was to transfer
            the net assets of Hocoma AG, excluding intellectual property and non-transferable debt, and then sell the
            entity and its assets to DIH
            Nevada, for inclusion in the foundation of the future Company.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
            July 1, 2021, DIH Cayman completed a series of reorganization steps to transfer DIH US Corp and its
            subsidiaries from Hocoma AG to DIH
            Nevada, effectively creating the Company. Hocoma AG entered into the following transactions:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hocoma
                        AG sold 100% of its share ownership of DIH US Corp to DIH Nevada, for $7.8 million.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hocoma
                        AG sold its net assets, excluding third-party debt and intellectual property, to Hocoma Medical
                        GmbH for a $10.5 million intercompany
                        note between Hocoma AG and Hocoma Medical GmbH.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hocoma
                        AG sold its intellectual property to DIH Technology Inc. (a wholly owned subsidiary of DIH US
                        Corp) for $1.6 million.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hocoma
                        AG then sold the share ownership of Hocoma Medical GmbH to DIH Nevada for $10.5 million.</span>
                </td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
            on July 1, 2021, the former shareholders of Hocoma AG applied for and were granted an ex-parte preliminary
            injunctions by a Swiss district
            court. The injunctions prohibited Hocoma AG to transfer any business or assets to Hocoma Medical, and as
            well as the sale of Hocoma Medical
            from DIH Hong Kong to the Company. Consequently, Hocoma AG and its shareholders challenged these preliminary
            injunctions through their
            Swiss counsels at Homburger. On January 12, 2024, the court revoked the preliminary injunctions granted on
            July 1, 2021. Therefore, the
            injunctions no longer have any legal effect on the contribution of the business/assets of Hocoma AG to
            Hocoma Medical and the transfer
            of the ownership of Hocoma Medical GmbH to the Company. Hocoma Medical GmbH, including the business/assets
            transferred by Hocoma AG,
            became a wholly-owned subsidiary of DIH Nevada as of July 1, 2021.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            Cayman intended to transfer Hocoma AG (remaining assets and liabilities) and Motek Group to DIH Nevada
            pursuant to the Business Combination
            Agreement. However, DIH Cayman was subject to a lien in Hong Kong related to DIH China, a company formed in
            the People�s Republic
            of China (�DIH China�) and a wholly owned subsidiary of DIH Hong Kong. The lien was filed on July 17, 2021
            on the
            immediate parent company of Hocoma AG and Motek Group and prevented the transfer of Hocoma AG and Motek
            Group. This matter is currently
            under review by local authorities and DIH Cayman is working to facilitate the completion of the intended
            transfer.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 55; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
            the Company�s businesses have historically functioned together with the other businesses controlled by DIH
            Cayman, the Company�s
            businesses are largely isolated and not co-dependent on corporate or other support functions. DIH Hong Kong
            is a wholly-owned subsidiary
            of DIH Cayman and the Company was a wholly-owned subsidiary of DIH Cayman prior to closing of the Business
            Combination.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            October 2022, DIH Nevada acquired the SafeGait 360 and SafeGait Active smart mobility trainer systems from
            Gorbel, an innovative United
            States-based developer and manufacturer of smart material handling and fall protection equipment. The
            SafeGait acquisition was accounted
            for as an asset acquisition based on an evaluation of the U.S. GAAP guidance for business
            combinations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization
            structure immediately prior to the Business Combination</span></p>

    <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
            before closing of the Business Combination, DIH Nevada was a wholly owned subsidiary of DIH Cayman. DIH
            Nevada held 100% ownership of
            DIH US Corp, which in turn owned the commercial entities. Additionally, DIH Nevada held 100% ownership of
            Hocoma Medical GmbH, which
            contained the net assets transferred from Hocoma AG.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            maintained exclusive distributor agreements with Motek Group for its advanced human movement research and
            rehabilitation products and
            services designed to support efficient functional movement therapy within specified territories. Under the
            distribution agreements, Motek
            supplied the products and services to the Company at the prices detailed in the agreement, with the Company
            entitled to a distributor
            margin.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
            Combination</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
            February 7, 2024 (the �Closing Date�), Aurora Technology Acquisition Corp. a Cayman Island exempted company
            which migrated
            and domesticated as a Delaware corporation (�ATAK�), Aurora Technology Merger Sub, a Nevada corporation and
            a direct, wholly-owned
            subsidiary of ATAK (�Merger Sub�) and DIH Nevada consummated a previously announced business combination
            pursuant to a business
            agreement dated as of February 26, 2023 (as amended, supplemented or otherwise modified from time to time,
            the �Business Combination
            Agreement,� and the transactions contemplated thereby, the �Business Combination�) following the receipt of
            the required
            approval by ATAK�s and DIH Nevada�s shareholders and the fulfillment or waiver of other customary closing
            conditions. In
            connection with the Closing, ATAK migrated and changed its domestication to become a Delaware corporation
            and changed its name to �DIH
            Holding US, Inc.� The Amended and Restated Certificate of Incorporation of DIH authorizes one class of
            common stock as Class A
            Common Stock (�Common Stock�).</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            historical financial results presented in the registration statements were prepared on a combined basis
            including Legacy DIH, Hocoma
            AG and Motek Group pursuant to the Business Combination Agreement for the intended Reorganization (as such
            term is defined in the Business
            Combination Agreement). Due to the lien on DIH Hong Kong related to DIH China, the Reorganization could not
            be completed as defined by
            the Business Combination Agreement, meaning that Motek Group and Hocoma AG ownership could not be
            transferred to the Company prior to
            the Closing.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            connection with the Closing of the Business Combination and in accordance with the terms of the Business
            Combination Agreement, ATAK
            agreed to waive the closing condition that the Reorganization be completed prior to Closing. The Company
            agreed to use its best efforts
            to complete the Reorganization as defined in the Business Combination Agreement as soon as possible
            thereafter. The Reorganization has
            not been completed as of the filing date of this registration statement. In this registration statement, the
            Company has recast historical
            financial statements on a consolidated basis including only operations from Legacy DIH. Hocoma AG and the
            Motek Group remained with DIH
            Hong Kong and are excluded from the consolidation of the Company.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 56; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
            Closing of the Business Combination with ATAK, the Company owns 100% of DIH US Corp, which in turn owns the
            commercial entities. Additionally,
            the Company owns 100% ownership of Hocoma Medical GmbH, which contains the net assets transferred from
            Hocoma AG. The Company maintains
            an exclusive distribution agreement with Motek Group as of the date of this registration statement. DIH
            Cayman owns approximately 34.7%
            shares of common stock of the Company, including earn-out shares held in escrow account. Jason Chen, the
            Company�s Chief Executive
            Officer and Chairman of the Board of Directors does not own any shares of DIH directly but may be deemed to
            have indirect ownership of
            DIH through his ownership ,of approximately 42% of the outstanding shares of DIH Cayman.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company�s organizational chart as of the date of this registration statement is as follows:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img
                src="./prospectus_files/form424b3_001.jpg" alt="" style="width: 650px">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry
            and Market Overview</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
            Opportunity</span></p>

    <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            market for robotic devices for rehabilitation and human performance enhancement is rapidly growing. As
            populations age and the consequent
            demand for healthcare services increases, we expect there will be a growing need for innovative solutions
            that can help individuals recover
            from injuries and optimize their physical abilities. Additionally, there is a growing interest in the use of
            technology to enhance human
            performance, whether in sports or in everyday life.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH�s
            target market is composed of three major sub-markets:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
                        Research Facilities (�ARFs�): which include advanced human performance labs or
                        rehabilitation/biomedical research centers
                        at universities and academic hospitals);</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inpatient
                        rehabilitation facilities (�IRFs�) which include free standing rehabilitation hospitals and
                        rehabilitation units in acute
                        care hospitals);</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outpatient
                        rehabilitation facilities (�ORFs�) which include outpatient rehabilitation clinics, skilled
                        nursing or long-term care
                        facilities). We are currently focused on the North American and European markets to accelerate
                        market penetration, while seeking
                        early-stage opportunities in other international markets for future expansion</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 57; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
            the ARF (or Research Market), our products enable thought-provoking and sophisticated simulation and
            evaluation of general human performance,
            and specifically focuses on dynamic gait and balance-focused movement research, through our industry-leading
            interactive VR platform.
            The platform is empowered by motion capture hardware, couple with advanced human body modeling software,
            that creates real time visualization
            of the active participant. The integration of this technology with advanced robotics and other smart systems
            expands imaginative research
            interests. Most of the top 50 global leading research centers in human performance and rehabilitation have
            adopted our technologies as
            the key base of their research exploration. We believe that by integrating leading products in biomechanical
            research we sourced through
            Motek (with which we have an exclusive distribution agreement) with our advanced robotics and other AI-based
            innovative products we could
            leverage clinical results with data insights to help transform protocols and processes in the industry
            related to human performance and
            movement disorders leading to solid growth potential in this important market segment in the next 5-10
            years.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
            IRFs (or Hospital Market), our products enable intensive functional training in patients with walking
            impairments, reduced balance and/or
            impaired arm and hand functions. Functional training is the backbone of rehabilitation and aims to restore
            lost abilities and enhance
            performance through learning mechanisms and neuroplasticity, and thereby increase independence in daily
            living and quality of life. Intensive
            rehabilitative therapy induces stronger and faster functional recovery. Our advanced rehabilitation robots
            enable intensive therapy,
            even in high acuity patients, by providing physical assistance and mobilization to patients as needed and
            relieving therapists from manual
            workload. Gamified exercises and feedback motivating patients during movement therapy, interactive reports
            and data integration further
            enhance the clinical value of our advanced rehabilitation solutions.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
            the vast ORFs (or Clinical Market), we enable modern specialty rehabilitation care models that differentiate
            and deliver high value with
            better and consistent outcomes due to the 3i intervention approach empowered by our technology. By blending
            technology with innovative
            care models, such modern specialty ORFs can deliver superior values to patients and their therapists by
            enabling one therapist to treat
            multiple patients with better outcomes due to the intensive, interactive, and integral approach enabled by
            our smart solutions. By leveraging
            the treatment protocol established by our advanced robots and movements platform, we are re-configuring our
            solutions through modularization
            and further acquisitions to exploit this vast and diverse market.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            Strategy</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        Physical
        disabilities and impairments represent significant global challenges, due to rapid aging, increasingly severe
        chronic diseases, and
        prevailing traumatic injuries from accidents and wars. According to the Company�s internal analysis, each year,
        approximately
        20 million people suffer from new disabilities, and it is estimated that over 300 million people are currently
        suffering from some
        form of functional impairments or disabilities globally. Those functional impairments or disabilities may
        ultimately result in
        multiple functional health problems, including cognitive, physical, emotional and spiritual issues, imposing
        severe burdens to
        health systems and significant costs to society. Adding to this, the number of people aged 60 and older globally
        is currently
        approximately 1 billion and is estimated to grow to over 2.1 billion by 2050, according to the World Health
        Organization
        (�WHO�) fact sheet dated October 1, 2024. The WHO also states that the need for rehabilitation services will
        grow due to
        the increasing aging population, as they are more prone to develop chronic diseases and disabilities (April 22,
        2024 Rehabilitation
        fact sheet). Currently, the WHO states the global need for rehabilitation is largely unmet, as approximately 2.4
        billion people are
        living with a condition that may benefit from rehabilitation services. As an example, the U.S. Bureau of Labor
        Statistics provided
        that the demand for therapists is expected to grow by 14% from 2023 to 2033, with an average demand of 13,600
        therapists per year,
        which is outpacing most other industries in job demand.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        &nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        According to an
        online industry report summary by Grandview Research, the global rehabilitation services market is estimated to
        be over $255 billion
        and is driven by an increase in individuals with physical and neurological disabilities. According to the WHO
        article published on March
        14, 2024, neurological conditions affect more than 1 in 3 individuals globally, leading to be the primary cause
        of illness and disability
        globally and the need for investments to improve treatment aimed at increasing an individual�s quality of life.
        We believe
        that such market demands create a need to support and modify a manual therapy dominated approach. The increased
        number of people suffering
        from such illnesses not only imposes a huge labor burden to therapists, but also may result in inconsistent
        outcomes due to a lack of
        consistent intensity, integration, standardization and optimization throughout the weeks or months of long
        intervention processes. According
        to Data Bridge Market Research, one of the key challenges faced by the physical therapy market is a shortage of
        skilled professionals
        driven by the increasing demand. Unlike a machine which can be calibrated thereby producing consistent therapy,
        we believe that manual
        therapy is likely to vary from therapist to therapist or even patient to patient. Measurements of progress may
        also be subjective, varying
        from therapist to therapist which may result in a patient requiring a longer period of therapy to achieve the
        desired results.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        &nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        The rapidly aging
        and increased chronic-suffering population trend will generate more demand for high quality rehabilitation care,
        while supporting the
        expected increase in the demand for therapists, thus adding increasing pressure and tension to the current
        model.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 58; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            believe the way out of such an undesirable and increasingly high pressure state is to transform the
            rehabilitation care model through
            integrated solutions empowered by our advanced technologies. The core benefits we strive to deliver to
            customers from our core products
            and solutions include:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)
            Enhancing customers� strategic positioning as leading rehabilitation facilities to attract higher paying
            patient groups by enabling
            them to attract and treat high severity and acuity patient groups, especially neurological patients;</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)
            Reducing total therapy costs by enabling the therapist to concurrently treat multiple patients, improve
            therapy outcome with the same
            time of stay or reduce time of stay without losing clinical efficacy;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)
            Providing streamlined intervention processes with data insights and potential network effects;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)
            Enabling replication and franchise established treatment protocols and best practices across chains of
            rehabilitation facilities; and</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5)
            Reducing total health system costs.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
            build on our unique position as a global robotic and VR-enabled smart technologies and solution provider to
            the rehabilitation market,
            our strategic plan is to continue to expand our leadership through sustaining innovation, selective
            acquisitions, with continued focus
            on delivering superior value to our customers, partners, patients and other stakeholders.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            strategic focus is on the following three areas:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
                        our strengths in technologies and core products to continuously expand our market leadership,
                        drive market penetration and accelerate
                        growth by building intensive market penetration capability in strategic markets in the United
                        States and Europe, enriching our product
                        offering with innovative financing solution to accelerate customers adoption, and sustain our
                        product and technology leadership with
                        continued innovation and integration efforts.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
                        our market leadership and global platform and infrastructure and consolidating the fragmented
                        marketplace to drive standardization
                        and economy of scale and scope. The breadth and depth of our business model and the scale
                        advantage enables us, not only to sustain
                        our market leadership, but also empowers us to act as active consolidators in the highly
                        fragmented rehabilitation market. By complementing
                        our organic innovation and core product leadership, DIH envisions executing 2-3 acquisition with
                        the goal to acquire proven products
                        and technologies from sub-optimal regional players to exploit global synergies and to accelerate
                        the growth of DIH�s integrated
                        solution offerings.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
                        our thought-provoking industry influence backed by leading brands and products, passionate
                        people and organizational capability;
                        DIH strives to develop transformative Total Solutions that will fundamentally enhance the
                        therapy and business model of our customers
                        and enable industry-wide transformation which is expected to eventually benefits millions of
                        people, from therapists to patients.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Core
            Product Overview</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            offers innovative, robotic-enabled devices in an augmented and interactive environment. These devices focus
            on restoring different functional
            impairment issues, while using software thereby tracking patients� progress and providing a network of
            collaboration and encouragement.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            currently offer 14 robotic rehabilitation and VR-based movement systems within three major product
            categories through the hospital,
            clinical and research markets. Our objective is to establish ourselves as a product and technology leader in
            each of the three categories,
            that correspond to three key functional impact issues, i.e., 1) upper extremity devices for arm and hand
            functional improvement; 2) lower
            extremity devices for gait and balance intervention; and 3) full body integrated intervention for strength
            and endurance enhancement.
            Through software networks, we aim not only to maximize the benefits from each of the devices itself, but
            also to deliver multi-dimensional
            clinical, economic, process and administrative benefits to therapists, patients and management by connecting
            and integrating these various
            devices into cohesive and integrated caring processes and models, enabling transformative change in
            therapies and business models.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 59; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img
            src="./prospectus_files/form424b3_002.jpg" alt="" style="width: 650px"></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upper
            Extremity Product Categories</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
            address differing clinical and economic needs, while providing consistent therapeutic interventions with
            similar treatment concepts and
            protocols, we have developed three different device models, ArmeoPower, ArmeoSpring, and ArmeoSenso. All
            follow the same modular Armeo
            Therapy Concept, that covers the �Continuum of Rehabilitation� with one software platform throughout the
            different stages
            of rehabilitation; from the early stage where the patient is very weak and needs sophisticated
            power-assisted dynamic intervention to
            help rewire the neural pattern in a safe environment which ArmeoPower provides, to self-initiated
            interactive ArmeoSpring which follows
            a similar treatment protocol of ArmeoPower for patients who have gained certain muscle power and need to
            transition from controlled patterns
            to an open environment. ArmeoSenso is for patients to apply what they learned from those self-initiated but
            still structurally controlled
            movement patterns to completely open movement environments, further expanding the patient transfer skills.
            The economic costs of devices,
            and the ratio of one therapist for multiple patients also improves dramatically, thus allowing service
            providers and health systems to
            gain significant benefits of learning curves, i.e., the learning patient picks up from early acute expensive
            interventions, which will
            be increasingly beneficial for later stages, generating a win-win, both economically and clinically.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ArmeoPower
            </b>is the backbone robot within our Upper Extremity portfolio; it has been specifically designed for arm
            and hand therapy in an early
            stage of rehabilitation. It enables patients with even severe motor impairments to perform exercises with a
            high number of repetitions.
            It assists the patient�s arm on an �as needed� basis to enable the patient to successfully reach the goal of
            the exercise.
            The robotic arm assistance can be adapted to the individual�s needs and the changing abilities of each
            patient � from full
            assistance for patients with very little activity to no assistance at all for more advanced patients. Such
            adjustable robotic assistance
            while exercising, enables and motivates patients to actively participate in their training, while providing
            weight support to enable
            extensive training. ArmeoPower supports 1D (joint-specific), 2D and 3D movements, with extensive
            game-emerged Augmented Performance Feedback
            (�APF�) exercises simulating tasks and activities essential for daily living, while enhancing strength and
            range of motion.
            Immediate performance feedback motivates patients and helps to improve their motor abilities. It improves
            efficiency of the therapy session
            by reducing the therapist�s physical effort and the need for continuous therapeutic guidance. Moreover, it
            enables therapists to
            make better use of their clinical know-how and expertise, by focusing on the optimal exercise planning,
            instead of manually delivering
            many repetitions.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 60; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ArmeoPower
            </b>precisely records how patients perform during their therapy sessions. Standardized Assessment Tools
            evaluate a patient�s motor
            functions such as joint range of motion and forces. The results can be used to analyze and document the
            patient�s state and therapy
            progress. Results can then be shared with the patient and other clinicians. ManovoPower as an add-on module
            for ArmeoPower enables hand
            opening and closing exercises.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ArmeoSpring
            </b>is targeted for less severe patients; it provides self-initiated repetitive arm and hand therapy in an
            extensive workspace. By providing
            arm weight support, it encourages the patients to achieve a higher number of arm and hand movements based on
            specific therapy goals.
            It also allows simultaneous arm and hand training in an extensive workspace. This enables patients to
            practice the movements important
            for their therapy progress. ArmeoSpring also supports 1D (joint-specific), 2D and 3D movements. An extensive
            library of motivating game-like
            APF exercises has been designed to train strength and range of motion needed for activities of daily living.
            Immediate performance feedback
            motivates patients and helps to improve their motor abilities. The ArmeoSpring enables therapists to deliver
            higher training efficiency
            (more hours per day) due to self-directed therapy. Furthermore, self-directed therapy enables patients to
            reach an even higher therapy
            intensity through extra training during after-hours and weekends.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lower
            Extremity Product Categories</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Similar
            to the Armeo Therapy Concept for arm and hand, we have also developed 3+1 Robotics + VR devices to address
            the different clinical and
            economic needs of patients across different stages of the patient journey, while providing consistent
            therapeutic interventions with
            similar treatment concepts and protocols. The Erigo Robot is designed for patients right after ICU who have
            none or very weak muscle
            power, with the goal to speed up the circulation and initiate early mobilization and prepare patients for
            intensive therapy, while preventing
            or reducing secondary further impairment. LokoMat is designed to provide maximum intensive therapy to rewire
            the broken neuro pathway
            to restricted functional capabilities through Neuroplasticity effect. Andago is designed to assist patients
            in walking in a real environment
            to maximize patient transfer skills after the patient�s functional pattern has been rewired by LokoMat.
            C-Mill is designed to enhance
            the patient�s adaptability, coordination and balancing skills in a challenging and integrative
            environment.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Erigo
            </b>is uniquely designed to provide therapy intervention to the most severe patient even at a high acute and
            critical post-ICU stage.
            It uniquely combines gradual verticalization, leg mobilization, and intensive sensorimotor stimulation
            through cyclic leg loading.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            main benefits include:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Early
                        and safe mobilization even in acute care</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cardiovascular
                        stabilization</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improved
                        orthostatic tolerance using the Erigo functional stimulation.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Helping
                        to reduce patient�s length of stay, improving efficiency and outcome</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        &nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lokomat
            </b>provides robot-assisted therapy that enables effective and intensive training to increase the strength
            of muscles and the range of
            motion of joints in order to improve walking. The physiological movement of the lower extremities is ensured
            by the individually adjustable
            patient interface. Additionally, the hip and knee joint angles can be adjusted during training to the
            patient�s specific needs.
            During rehabilitation, patients need to be challenged. Therapists can help patients reach their goals by
            setting the training parameters
            according to their performance. Lokomat motivates patients to reach their goals with various game-like
            exercises. This Augmented Performance
            Feedback, or APF, maximizes the effect of Lokomat training. Lokomat allows therapists to focus on the
            patient and the actual therapy.
            It enhances staff efficiency and safety, leading to higher training intensity, more treatments per
            therapist, and consistent, superior
            patient care.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 61; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lokomat
            </b>is available in two models, LokomatNanos and LokomatPro, and has other modules such as for pediatric use
            available. To date, we have
            installed approximately 1,219 Lokomat systems in over 650 facilities worldwide.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Andago
            </b>is designed to assist patients in walking naturally which consequently triggers continuous physiological
            afferent input, due to its
            built-in dynamic support. With its robotics smart control system, it enables patient to walk seamlessly and
            freely due to its robotic
            system. Andago bridges the gap between treadmill-based gait training and free overground walking. No
            dedicated space is needed as it
            can be used flexibly in different spaces. Its intuitive workflow allows for a quick and easy therapy start
            and simple integration into
            clinical routine. The display of key training results and export of data via USB enables training progress
            documentation for clinical
            decision-making and for health insurance providers. No infrastructure modification, meaning flexible use
            from room to room.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C-Mill
            </b>is a powerful tool that allows for more efficient rehabilitation. Besides objective assessment of
            balance and gait, the C-Mill provides
            a safe and comfortable training environment using a treadmill, augmented reality and VR. Using our
            technology, patients are able to train
            foot placement with the C-Mill, work through balance and dual-tasks with C-Mill VR or use C-Mill VR+ for
            early to late rehabilitation
            with body weight support. It is a complete, advanced gait-lab and training center on a compact space.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CAREN</b>,
            �Computer Assisted Rehabilitation Environment�, is the most advanced and sophisticated VR-enabled real time
            movement platform,
            that targets all aspects of balance and locomotion with visualization of full body participation empowered
            by Human Body Modeling. CAREN
            provides researchers with the tools to efficiently study advanced human movement by collecting objective
            human performance data in real
            time and functionally challenging environments. CAREN enables the most versatile human movement research as
            a result of its dual-belt
            instrumented treadmill mounted on a 6 degree-of-freedom movable platform, motion capture system, immersive
            and interactive environments
            and dedicated real-time and offline software packages; the CAREN is the most advanced system for your human
            movement research, training,
            and assessment. We believe CAREN will enable pioneering research in many fields of application, such as:
            motor control and learning,
            dual-tasking and feedback, balance assessment and therapy, gait analysis and adaptability, real-time human
            body modeling, virtual reality
            and integrated smart systems like robot integration. We believe CAREN is considered as the world�s most
            advanced biomechanics lab.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GRAIL</b>,
            �Gait Real-time Analysis Interactive Lab�, the total package solution for gait analysis training and
            research, employs an
            instrumented dual-belt treadmill and motion capture system combined with virtual reality and video cameras.
            GRAIL provides analysis and
            therapy in challenging conditions to improve gait, while real-time feedback enables analysis and training
            during the same session.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Total Solution</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH�s
            vision includes providing a Total Solution option for our customers and their patients. The Total Solution
            is a product package specifically
            designed for our customer and is aimed at maximizing the benefits of DIH�s products and solutions to achieve
            optimal rehabilitation
            outcomes. This offering includes DIH�s clinical integration approach, that emphasizes three key
            factors:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
            consultative sales process to guide customers in selecting advanced technologies from the company�s
            extensive product portfolio,
            enhancing their market positioning.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
            integration to align these technologies with therapeutic processes, offering comprehensive training and
            service programs to maximize
            their clinical value.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identifying
            workflow and productivity enhancement opportunities to help customers achieve operational savings.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 62; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
            Overview</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
            Market</span></p>

    <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
            to the powerfulness of our technology platform and products, and the versatile applications they enable;
            there are six major customer
            groups that are actively employing our CAREN, GRAIL and MGAIT, etc. in their leading research efforts.
            Universities purchase them to
            build modern biomedical labs and initiate systemic training, research hospitals and military purchase them
            to assess and define innovative
            interventions to restore and enhance human functions and performance, scientific and technological
            corporations purchase them to establish
            an integrated testing foundation to evaluate new concepts and accelerate new product or intervention
            modalities; and athletic institutions
            purchase them to accelerate the recovery of athletes and enhance their core performance foundations.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hospital
            Market</span></p>

    <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hospital
            Markets, or Inpatient rehabilitation facilities (IRFs), include free standing rehabilitation hospitals and
            rehabilitation units in acute
            care hospitals.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            products and solutions benefit both the rehabilitation units in acute care hospitals and free standing
            rehabilitation hospitals. Given
            our limited sales resources, our primary focused customer group are rehabilitation hospitals and acute care
            hospitals which have a high
            number of neurological patients.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
            rehabilitation hospitals, it can by further broken down by 1) academic or leading national rehabilitation
            hospitals, 2) new modern rehabilitation
            hospitals, 3) neurological patient focused rehabilitation hospitals, 4) leading regional rehabilitation
            hospital, 5) conventional or
            me-too rehabilitation hospitals. Our target markets are the first two groups. Our main objective is to
            increase our market penetration
            in those groups from an estimated 25% current penetration to 66% in focused countries.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
            Market</span></p>

    <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Clinical Market, or outpatient rehabilitation facilities (ORFs), include outpatient rehabilitation clinics,
            skilled nursing or long-term
            care facilities (SNF and LTC).</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
            there are hundreds of thousands of facilities in these massive and diverse markets and we have limited
            resources, our primary focus is
            on the modern outpatient rehabilitation clinics (M-Clinics) and top SNFs with a focus on neurological
            patients (SNF-N) in our target
            countries. Our products can provide strategic, clinical and operational value to the M-Clinics and SNF-N, as
            in the hospital market.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
            and Supply Chain</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            manufacturing and supply chain strategy is founded on a commitment to blending Swiss quality mindset with
            Dutch agility, utilizing lean
            manufacturing and supply chain practices, leveraging the Oracle ERP system implemented, ensuring efficient
            order fulfillment to global
            markets, and delivering exceptional value and commitment to our customers and patients.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            manufacture the Lokomat, Andago, Erigo, Armeo Power, Armeo Spring and Armeo Senso devices at Hocoma Medical
            GmbH in Switzerland. The
            product line we distribute for hospitals and clinics, C-Mill, is manufactured at Motek Medical B.V. in The
            Netherlands together with
            all research products (RYSEN, M-GAIT, GRAIL and CAREN).</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
            the SafeGait 360 and Active product line that we acquired from Gorbel, those two products currently are only
            sold in the United States
            and are manufactured through our manufacturing facility in Leeds, Alabama.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supply
            Chain</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
            standardized products (for hospitals and clinics) DIH conducts production planning based on the sales budget
            (yearly) and sales forecast
            (quarterly). To have the correct alignment between all stakeholders, there is a monthly standard operating
            procedures (�S&amp;OP�)
            meeting in place. In this meeting, all relevant stakeholders are involved, such as planning, procurement,
            production, order fulfillment,
            sales, finance, operational engineering, service and product management. Additionally, we have the inputs
            from regulatory and quality
            as well. In the S&amp;OP the forecast and the production/procurement planning for the quarters are set and
            the current fulfillment situation
            is monitored.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 63; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            research products are generally fairly differentiated, which makes it difficult to manage supply chain
            dynamics far in advance. Many
            of the parts are completely customized, and inputs are only known during the project phase when the order
            has been received. Basic parts
            such as treadmills, drives and motors can be planned and procured accordingly. For these research projects,
            there is also an S&amp;OP
            in place limited to the research group.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facilities</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            executive offices are located at 77 Accord Drive, Suite D-1 Norwell, MA. We do not own any properties,
            rather we lease properties to
            meet our needs. Currently, we have a research and development and operational campus that we lease for
            Hocoma operation in Switzerland
            located at Industriestrasse 2 and 4a in 8604 Volketswil.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beside
            the main campuses, we also lease five commercial offices space at the following locations to house the
            regional Sales &amp; Marketing,
            Clinical Application &amp; Training, Technical Services, Finance, Logistics, Administration and other local
            market support functions.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
                        Technology Inc. leases commercial office for the American team at 77 Accord Park Dr., Suite D-1,
                        Norwell, MA 02061, United States</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
                        Technology d.o.o leases commercial office for EMEA Indirect sales team at Letali�ka 29a, 1000
                        Ljubljana, Slovenia</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
                        GmbH leases commercial office for the Direct Sales team in DACH region, at Konrad-Adenauer
                        Strasse 13, 50996 K�ln, Germany</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
                        Pte Ltd leases commercial office for APAC team at 67 Ubi Avenue 1, #06-17 Starhub Green,
                        Singapore 408942</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
                        SpA leases commercial office for LATAM team at Pdte. Kennedy Lateral 5488, Oficina 1402;
                        Vitacura, Santiago, Chile</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Human
            Capital</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
            of September 30, 2024, we employed 200 employees, of which approximately 78 percent were outside the U.S.
            Our employees are the Company�s
            most valued asset and the driving force behind our success. For this reason, we aspire to be an employer
            that is known for cultivating
            a positive and welcoming work environment and one that fosters growth, provides a safe place to work,
            supports diversity and embraces
            inclusion.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diversity,
            Equity, and Inclusion</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are committed to fostering, cultivating and preserving a culture of diversity, equity and inclusion
            (DE&amp;I). We recognize that a diverse,
            extensive talent pool provides the best opportunity to acquire unique perspectives, experiences, ideas, and
            solutions to drive our business
            forward. We believe that diverse teams solving complex problems leads to the best business results. We
            promote diversity by developing
            policies, programs, and procedures that foster a work environment where differences are respected, and all
            employees are treated fairly.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
            Health and Safety</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
            the fiscal year ended March 31, 2024 and the six months ended September 30, 2024, there had been no
            Occupational Safety and Health Administration
            (�OSHA�) recordable or lost time injuries in the United States and zero injuries at our other global
            sites.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 64; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
            Property</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have over 19 different trademark families registered, including our most prominent product family names such
            as Lokomat, Armeo,
            and Andago. These trademarks are registered in all strategically important countries, resulting in a total
            of 419
            registrations. The latest registration was made in 2020, and the earliest in 2004.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: left; width: 16%">
                    Name/Description of Patent</td>
                <td style="text-align: center; width: 2%; padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; width: 14%; text-align: center">Status</td>
                <td style="text-align: center; width: 2%; padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; width: 16%; text-align: center">Owned or Licensed</td>
                <td style="text-align: center; width: 2%; padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; width: 12%; text-align: center">Type of patent protection
                </td>
                <td style="text-align: center; width: 2%; padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; width: 16%; text-align: center">Expiration Date (dd.mm.yy)
                </td>
                <td style="text-align: center; width: 2%; padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; width: 16%; text-align: center">Jurisdictions</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">US8834169/Method and apparatus for automating arm and grasping movement
                    training for rehabilitation of patients with motor impairment</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Licensed</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>24.11.2030</td>
                <td>&nbsp;</td>
                <td>US</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">US8192331/Device for adjusting the prestress of an elastic means around a
                    predetermined tension or position</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>10.09.2028</td>
                <td>&nbsp;</td>
                <td style="text-align: left">US, DE, FR, UK, IT, CH, CN, RU</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">US9017271/System for Arm therapy</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Licensed</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>10.02.2031</td>
                <td>&nbsp;</td>
                <td style="text-align: left">US, DE, FR</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">US8924010 /Method to Control a Robot Device and Robot Device</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>06.10.2031</td>
                <td>&nbsp;</td>
                <td style="text-align: left">US, DE, FR, NL, CH, UK</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">US9987511/Gait training apparatus</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>19.09.2034</td>
                <td>&nbsp;</td>
                <td style="text-align: left">US, DE, FR, UK, IT, CH, CN, PL, KR, NL</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">EP3095430/Gait training apparatus (Div)</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>09.11.2032</td>
                <td>&nbsp;</td>
                <td style="text-align: left">DE, FR, UK, CH</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">US10780009/Apparatus for locomotion therapy</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>06.01.2037</td>
                <td>&nbsp;</td>
                <td style="text-align: left">US, DE, FR, UK, CH, CN, RU</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">EP3100707/Apparatus for locomotion therapy (Div)</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>16.11.2032</td>
                <td>&nbsp;</td>
                <td style="text-align: left">DE, FR, UK, IT, CH TR, PL, CN</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">US9808668/Apparatus for automated walking training</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>10.08.2034</td>
                <td>&nbsp;</td>
                <td style="text-align: left">US, DE, FR, UK, IT, CH, CN, PL, TR, NL, FI, ES</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">EP3035901/ Hand motion exercising device</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>14.08.2034</td>
                <td>&nbsp;</td>
                <td style="text-align: left">DE, FR, UK, NL, SI, CH, CN</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">US10349869/Method and system for an assessment of a movement of a
                    limb-related point in a predetermined 3D space</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>16.02.2036</td>
                <td>&nbsp;</td>
                <td style="text-align: left">US, DE, FR, UK, CH, AU, IT, CN</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">US10500122/Apparatus for gait training</td>
                <td>&nbsp;</td>
                <td>Issued,</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>20.08.2037</td>
                <td>&nbsp;</td>
                <td style="text-align: left">US, DE, FR, UK, CH, CN, TR, NL, SE, ES, RU, KR</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">US10925799/ Suspension device for balancing a weight</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>27.06.2037</td>
                <td>&nbsp;</td>
                <td style="text-align: left">US, AU, CH, DE, FR, UK, IT, NL, PL, CN, KR</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">US-20230039187-A1/Leg Actuation Apparatus and Gait Rehabilitation Apparatus
                </td>
                <td>&nbsp;</td>
                <td>Pending</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">US, IN, CN, RU, EP, KR</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">US-2023-0046987-A1/User Attachment for Gait and Balance Rehabilitation
                    Apparatus</td>
                <td>&nbsp;</td>
                <td>Pending</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Utility</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">US, CN, EP, KR</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">DM/091 450/Wheeled walking frame</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Design</td>
                <td>&nbsp;</td>
                <td>08.06.2041</td>
                <td>&nbsp;</td>
                <td style="text-align: left">CH, EM, US, UK</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td>DM/221 948/ArmeoSpring Pro-Design</td>
                <td>&nbsp;</td>
                <td>Issued</td>
                <td>&nbsp;</td>
                <td>Owned</td>
                <td>&nbsp;</td>
                <td>Design</td>
                <td>&nbsp;</td>
                <td>01.07.2047</td>
                <td>&nbsp;</td>
                <td style="text-align: left">CH, EM, US, UK</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 65; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                id="D_002"></span>MANAGEMENT</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            following sets forth certain information, as of the date of this registration statement, concerning the
            persons who are serving as our
            directors and executive officers.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
            Officers and Directors</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            current executive officers and directors are as follows:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: center">Age</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid">Position</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; text-align: left">Executive Officers:</td>
                <td>&nbsp;</td>
                <td style="text-align: center">&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="width: 38%; text-align: left">Jason Chen</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 20%; text-align: center">55</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 38%; text-align: left">Chairman and Chief Executive Officer; Director</td>
            </tr>
            <tr
                style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dietmar
                            Dold</span></p>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></p>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                            Operating Officer;</span></p>
                </td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Lynden Bass</td>
                <td>&nbsp;</td>
                <td style="text-align: center">40</td>
                <td>&nbsp;</td>
                <td style="text-align: left">Chief Financial Officer; Director</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Dr. Patrick Bruno</td>
                <td>&nbsp;</td>
                <td style="text-align: center">55</td>
                <td>&nbsp;</td>
                <td style="text-align: left">Chief Marketing Officer; Director</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: center">&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; text-align: left">Class I Directors:</td>
                <td>&nbsp;</td>
                <td style="text-align: center">&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Jason Chen</td>
                <td>&nbsp;</td>
                <td style="text-align: center">55</td>
                <td>&nbsp;</td>
                <td style="text-align: left">Chairman and Chief Executive Officer; Director</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Lynden Bass</td>
                <td>&nbsp;</td>
                <td style="text-align: center">40</td>
                <td>&nbsp;</td>
                <td style="text-align: left">Chief Financial Officer; Director</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Dr. Patrick Bruno</td>
                <td>&nbsp;</td>
                <td style="text-align: center">55</td>
                <td>&nbsp;</td>
                <td style="text-align: left">Chief Marketing Officer; Director</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: center">&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; text-align: left">Class II Directors:</td>
                <td>&nbsp;</td>
                <td style="text-align: center">&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Max Baucus*</td>
                <td>&nbsp;</td>
                <td style="text-align: center">82</td>
                <td>&nbsp;</td>
                <td>Director</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">F. Samuel Eberts III**</td>
                <td>&nbsp;</td>
                <td style="text-align: center">64</td>
                <td>&nbsp;</td>
                <td>Director</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: center">&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; text-align: left">Class III Directors:</td>
                <td>&nbsp;</td>
                <td style="text-align: center">&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Ken Ludlum*</td>
                <td>&nbsp;</td>
                <td style="text-align: center">71</td>
                <td>&nbsp;</td>
                <td>Director</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Cathryn Chen*</td>
                <td>&nbsp;</td>
                <td style="text-align: center">35</td>
                <td>&nbsp;</td>
                <td>Director</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*�Independent
            Director� for purposes of the Nasdaq Listing Rules and Rule 10A-3(b)(1) under the Exchange Act.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**Lead
            Independent Director.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            following is biographical information regarding DIH executive officers and directors.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jason
                Chen.</b> Mr. Chen is the Founder, Chairman and CEO of DIH, a position he has held since September 2014.
            Before founding DIH, Mr. Chen
            served as the Senior Vice President and Managing Director of Global Sourcing of Cardinal Health, a Fortune
            50 company. At Cardinal, Mr.
            Chen led its Global-wide strategic sourcing strategy as well as its Asia-wide business and operation as its
            Asia President. Mr. Chen�s
            other international experience include serving as Chief Financial Officer of GE Healthcare N.A. Services;
            Chief Financial Officer of
            GE CSI; General Manager of GE Healthcare Greater China Sourcing and Operations; and Business Development
            Manager at GE Corporate BD Group.
            Mr. Chen earned an Executive Masters degree (EMBA) from the Kellogg School of Business, Northwestern
            University in the United States;
            an MBA in Corporate Finance from CEIBS in China, and a post-graduate fellowship at London Business School in
            Britain. We believe Mr.
            Chen�s extensive healthcare background, in particular as founder of DIH, makes him a valuable member of our
            board.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dietmar
                Dold.</b> Mr. Dold brings more than 25 years of operational experience in various
            industries to DIH and has proven his expertise in driving innovative transformations on a global scale. From
            May 2018 to October 2024,
            Mr. Dold was Chief Executive Officer of Lean Interim GmbH, which provides interim management services for
            various C-level roles and works
            closely with board members. From 2005 to 2008, Mr. Dold served as Chief Executive Officer at Videojet
            Technologies (Danaher Group) in
            Switzerland and has held several management positions throughout his career, including Partner within
            management consultancy at KPMG from
            2012 to 2016, Interim Chief Operating Officer at Condair Group and Lean Sensei at Sonova and Roche
            Diagnostics.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        &nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lynden
                Bass.</b> Ms. Bass has served as Chief Financial Officer of DIH since March 2023. Previously, she
            assisted DIH on an outside consultant
            basis from January 2023 to officially joining DIH. From September 2019 through September 2022, Ms. Bass
            served as Vice President and
            Controller for Rather Outdoors Corporation, a privately-owned wholesaler and manufacturer. From September
            2016 through May 2019, Ms.
            Bass was Chief Financial Officer of NaturChem Inc. Prior to these roles, she served as the Corporate
            Controller for Preferred Apartment
            Communities, Inc. a publicly traded real estate investment trust and began her career within the audit and
            assurance practice at Deloitte
            &amp; Touche LLP, out of Atlanta, Georgia office. Ms. Bass holds a BBA in Accounting from Harding
            University. She is a Certified Public
            Accountant, licensed in the State of Georgia.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 66; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dr.
                Patrick Bruno.</b> Dr. Bruno serves as Chief Marketing Officer for DIH in its Hospital &amp; Clinical
            Solutions Division as well as a
            Site Leader for the Production site of Hocoma in Switzerland. Dr. Bruno joined DIH in June 2017 as its
            Global Vice President of Sales
            and also served as its Chief Commercial Officer before assuming his current position in December 2020. Prior
            to joining DIH, Dr. Bruno
            was the Integration Manager, General Manager and Sales Director at Qiagen where he led global key account
            and commercialization strategies.
            Before that, he was with Siemens Healthcare where he held the position of CEO, Switzerland and has also held
            the position of Head of
            Product Management at Roche Diagnostics. Dr. Bruno holds a BBA, GSBA Z�rich (Switzerland), a Master in
            Microbiology from the University
            of Innsbruck (Austria) and a Ph.D. in Biology from the University of Bologna (Italy). We believe Dr. Bruno�s
            extensive background
            with sales for DIH and similar companies makes him a valuable member of our board.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Max
                Baucus</b>. Ambassador Baucus was nominated in 2014 by President Barack Obama to serve as Ambassador of
            the United States of America
            to the People�s Republic of China, a position he held until 2017 . Ambassador Baucus formerly served as the
            senior United States
            Senator from Montana from 1978 to 2014 and was Montana�s longest serving U.S. Senator. While in the Senate,
            Ambassador Baucus was
            Chairman and Ranking Member of the Senate Committee on Finance (the �Finance Committee�). As chairman of the
            Finance Committee,
            he was the chief architect of the Affordable Health Care Act (ACA) which was signed by President Barack
            Obama into law March 23, 2009.
            In addition, as chairman of the Finance Committee, Ambassador Baucus led the passage and enactment of the
            Free Trade Agreements with
            11 countries. While serving on the Senate Agriculture Committee, he led in securing reauthorization of
            numerous farm bills. As a member
            of the Committee on Environment and Public Works, he guided many highway bills and other infrastructure
            legislation to passage as well
            as leading the passage of The Clean Air Act of 1990. Before his election to the U.S. Senate, Ambassador
            Baucus represented Montana in
            the U.S. House of Representatives from 1975 to 1978. Ambassador Baucus earned a Bachelor�s and Juris Doctor
            degree from Stanford
            University. Ambassador Baucus currently has a consulting business, Baucus Group LLC, and advises several
            tech and bio tech companies
            as well as engaging in numerous public speaking engagements. He and his wife have also founded a public
            policy institute at the University
            of Montana School of Law, The Baucus Institute. We believe Ambassador Baucus� extensive public service
            experience along with his
            consulting work for biotech companies makes him a valuable member of our board.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.
                Samuel Eberts III</b>. Sam Eberts is an accomplished senior executive and board member with over 25
            years of success with Fortune 500
            companies in health care, consumer, and industrial services. He chairs the Daerter Group, a venture firm in
            North Carolina and New York
            providing seed investment for promising start-ups in health care and IoT technology. He recently retired as
            the Chief Legal Officer,
            Corporate Secretary and Senior Vice President of Global Corporate Affairs for Laboratory Corporation of
            America� Holdings (NYSE:
            LH ). At LabCorp, Eberts led the Global Corporate Affairs group, with enterprise-wide responsibility for the
            global Legal, Compliance,
            Corporate Secretary, Shareholder Services, Public Policy/Government Relations, Communications, Community
            Affairs/Philanthropy, Privacy
            and Security functions. Mr. Eberts serves on the Board of Trustees for Endicott College in Beverly, Mass.
            and the Alamance Community
            College Foundation in Graham, N.C. He is the past Chair of Easter Seals/UCP of North Carolina and Virginia.
            Eberts serves on the advisory
            boards for the Woodrow Wilson Center for International Scholars in Washington, D.C. and the World Policy
            Institute in New York, non-partisan
            think tanks for global policy analysis. Previously, he was a partner and served on the Board and the
            Investment Committee for MedCap
            Funds in Boston, Mass., an early-stage health care technology fund and Alpha Marketing in Raleigh, a channel
            marketing firm. Eberts has
            served on the Health Care Policy Leadership Council at Harvard University�s Kennedy School and presently
            serves on the Corporate
            Governance Forum at Harvard Law School. He is a member of the Council for Entrepreneurial Development, one
            of the largest entrepreneurial
            networks in the United States and is an active mentor working with entrepreneurs providing practical,
            day-to-day professional advice
            and coaching. Mr. Eberts is a frequent speaker on healthcare and leadership and has served as a guest
            lecturer at Harvard University�s
            Kennedy School of Government, Duke and Wake Forest University Schools of Law, Baylor University School of
            Medicine and the University
            of Minnesota�s Carlson School of Management. He has also served as an Adjunct Associate Professor at the
            University of Texas School
            of Public Health, Division of Management, Policy and Community Health. We believe Mr. Eberts� extensive
            legal experience with healthcare-related
            public companies makes him a valuable member of our board.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 67; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ken
                Ludlum</b>. </span>Mr. Ludlum has served as a director of the Company since February 2024. Mr. Ludlum is
        a professional board member
        with medical technology and biotechnology companies. He has served on the board of directors of more than a
        dozen companies. From 2002
        to 2020, Mr. Ludlum served on the board of directors and as chairman of the audit committee at Natus Medical
        Incorporated, and as chairman
        of the compensation committee from June 2018 to June 2019. Mr. Ludlum has served on the board of directors and
        as chairman of the audit
        committee of Dermavant Sciences Limited, a United Kingdom company, since 2019. Mr. Ludlum has also been on the
        board of directors and
        chairman of the audit committee of Personalis Inc., a gene sequencing company, from 2016 � 2019. From 2014 to
        2016 Mr. Ludlum served
        as Chief Financial Officer at CareDx, Inc., a molecular diagnostics company, and prior to that served as Chief
        Financial Officer for
        other publicly traded companies. Mr. Ludlum has worked for or with health care, medical device, biotechnology or
        diagnostic companies
        since 1985. Mr. Ludlum holds a B.S. degree in Business Administration from Lehigh University and a M.B.A. degree
        from Columbia University
        Graduate School of Business.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Mr. Ludlum
        is independent and his executive management experience and past board services at several public companies
        has provided him with extensive financial and accounting experience, and knowledge of accounting principles,
        financial reporting rules,
        and regulations and qualifies him as a financial expert. Mr. Ludlum also has a background in investment banking,
        which, coupled with
        his experience in finance, board service and financial leadership, provides him with the necessary skills and
        functional understanding
        to serve effectively on our Board, as Chairman of our Audit Committee and as a member of our Compensation
        Committee and Nominating and
        Governance Committee.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cathryn
                Chen</b>. Since April 2023, Cathryn Chen has served as Chief Financial Officer and Co-Vice Chairwoman of
            the Board of Directors of Aurora
            Technology Acquisition Corp. Ms. Chen served as the Chief Operating Officer and Co-Vice Chairwoman of the
            Board of Directors of Aurora
            Technology Acquisition Corp. from August 2021 until April 2023. Ms. Chen is the Managing Director of MarketX
            Ventures, a venture capital
            firm focused on growth to stage technologies investments, and the Founder &amp; CEO of MarketX Inc., a
            fintech company with the mission
            to revolutionize the private markets. Founded in March 2015, MarketX Inc. is backed by 12 technology founder
            &amp; CEOs and has completed
            over $250M in primary and secondary pre-IPO transactions. In 2020, she launched MarketX Ventures, a growth
            to late-stage focused venture
            fund, backed by technology executives such as the founders of Thrasio and Patreon. Prior to founding
            MarketX, Ms. Chen worked as an investment
            banker with prominent investment banks including Deutsche Bank, NM Rothschild, and JP Morgan in London, New
            York, and Hong Kong. During
            her investment banking career, Ms. Chen was involved with dozens of IPOs, M&amp;As, and private placements
            including Alibaba, Omada Health,
            and Twitter. Since founding MarketX Ventures, Ms. Chen has worked with and is currently advising over 200
            family offices globally. MarketX
            has invested in and transacted with a few dozen pre-IPO companies in the US, China, and Europe, with an
            aggregate market capitalization
            of over $500 billion. Previously, Ms. Chen was also an early employee with EverString Technology
            (�EverString�), an ad-tech
            company backed by Sequoia Capital &amp; Lightspeed Partners that was later sold to ZoomInfo. Ms. Chen is a
            nextgen member of the Committee
            of 100, a non-profit organization (Ma founded the Committee of 100 with I.M. Pei and several other
            distinguished Chinese Americans in
            1989 to give Chinese Americans a strong voice in U.S.-China relations and Asian American affairs). In 2008,
            Ms. Chen co-founded MoneyThink
            LA, a 501(c)3 non-profit that provides financial education to urban high school students around the nation.
            Its parent company, MoneyThink,
            received the �Champions of change� award from then-President Barrack Obama in 2012. Ms. Chen received her
            Bachelor�s
            degree from UCLA and General Course, London School of Economics and Political Science. We believe Ms. Chen�s
            extensive finance
            and investment banking background make her a valuable member of our board.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 68; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
            and Terms of Office of Officers and Directors</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            Board currently consists of seven members. The Board is classified into three classes: Class I, Class II and
            Class III. The number of
            directors in each class is as equal as possible. The Class I Directors have been elected for a term expiring
            at the 2027 annual meeting,
            the Class II Directors have been elected for a term expiring at the 2025 annual meeting and the Class III
            Directors stand appointed for
            a term expiring at the 2026 annual meeting. Directors appointed to succeed those directors whose terms
            expire are appointed for a term
            of office to expire at the third succeeding annual general meeting after their appointment. Except as
            applicable law may otherwise require,
            in the interim between annual general meetings or extraordinary general meetings called for the appointment
            of directors and/or the removal
            of one or more directors and the filling of any vacancy, additional directors and any vacancies in the board
            of directors, including
            unfilled vacancies resulting from the removal of directors for cause, may be filled by the vote of a
            majority of the remaining directors
            then in office, even though a quorum may not be present at any meeting of the directors, or by the sole
            remaining director. All directors
            hold office until the expiration of their respective terms of office and until their successors have been
            appointed. A director appointed
            to fill a vacancy resulting from the death, resignation or removal of a director serves for the remainder of
            the full term of the director
            whose death, resignation or removal has created the vacancy and until his successor has been
            appointed.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
            Independence</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Board has determined that, <span style="background-color: white">Ken Ludlum, Max Baucus, F. Samuel Eberts
                III and Cathryn Chen</span>
            are �independent directors� for purposes of the NASDAQ Stock Market (�NASDAQ�) Listing Rules and Rule
            10A-3(b)(1)
            under the Exchange Act, as the term applies to membership on the Board and the various committees of the
            Board. NASDAQ�s independence
            definition includes a series of objective tests, such as that the Director has not been an employee of the
            company within the past three
            years and has not engaged in various types of business dealings with the Company. As of June 21, 2024, the
            Board has appointed Mr. Eberts
            as Lead Independent Director (see below). In addition, as further required by NASDAQ Listing Rules, our
            Board has made an affirmative
            subjective determination as to each independent Director that no relationships exist which, in the opinion
            of the Board, would interfere
            with the exercise of independent judgment in carrying out the responsibilities of a Director. In making
            these determinations, the Board
            reviewed and discussed information provided by the Directors and us with regard to each Director�s business
            and personal activities
            as they may relate to the Company and the Company�s management.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
            of Directors, Leadership Structure, and Executive Sessions</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Board recognizes that one of its key responsibilities is to evaluate and determine its optimal leadership
            structure so as to provide
            independent oversight of management. The Board understands that there is no single, generally accepted
            approach to providing Board leadership,
            and that given the dynamic and competitive environment in which we operate, the right Board leadership
            structure may vary as circumstances
            warrant. Our Corporate Governance Guidelines currently provide that the Board may choose to appoint a single
            person to a combined Chief
            Executive Officer and Chairman role or appoint a Chairman who does not also serve as Chief Executive
            Officer. Currently, our Chief Executive
            Officer also serves as Chairman. The Board believes this leadership structure is optimal for the Company at
            the current time, as it provides
            the Company with a Chief Executive Officer and Chairman with a long history of service in a variety of
            positions and who is, therefore,
            deeply familiar with the history and operations of the Company. The Board also believes that the current
            leadership structure provides
            independent oversight and management accountability through regular executive sessions of the independent
            Directors that are mandated
            by our Corporate Governance Guidelines. The Board recognizes that when the positions of Chairman and Chief
            Executive Officer are combined,
            or when the Chairman is not an independent director, it is imperative that the Board elect a strong Lead
            Independent Director with a
            clearly defined role and robust set of responsibilities and will annually elect a non-management,
            independent director to serve in the
            Lead Independent Director role. The Lead Independent Director shall have the following responsibilities (and
            may also perform other functions,
            upon request): (i) presiding at all meetings of the Board at which the Chairman is not present; (ii)
            presiding during Executive Sessions
            of the Board; (iii) calling meetings of the independent directors or the Board, as appropriate; (iv)
            facilitating discussion and open
            dialogue among the independent directors during Board meetings, Executive Sessions and outside of Board
            meetings; (v) briefing the Chairman
            and Chief Executive Officer on issues discussed during Executive Sessions; (vi) serving as a liaison among
            the Chairman and Chief Executive
            Officer and the other directors; (vii) together with the Chairman and Chief Executive Officer, approving
            Board meeting agendas and schedules
            to assure content and sufficient time for discussion of all agenda items; (viii) authorizing the retention
            of advisors and consultants
            who report directly to the Board, when appropriate; (ix) reviewing and reporting on the results of the Board
            and Committee assessments;
            (x) discussing Board and Committee performance, effectiveness and composition, including feedback from
            individual directors, with the
            Chairman and Chief Executive Officer and meeting individually with independent directors as needed; and (x)
            being available for consultation
            and direct communication with major investors and other stakeholders upon request.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 69; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
            and Committee Membership</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            Board has three standing committees: the Audit Committee, the Compensation Committee and the Nominating and
            Corporate Governance Committee.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Committee</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
            members of the Audit Committee are Ken Ludlum (Chair), Max Baucus and Cathryn Chen. The Board has determined
            that each member is independent
            under the Nasdaq listing standards and Rule 10A-3(b)(1) of the Exchange Act. The Board has determined that
            Ken Ludlum is an �audit
            committee financial expert� within the meaning of SEC regulations. The Board has also determined that each
            member of the audit
            committee has the requisite financial expertise required under the applicable Nasdaq requirements. In
            arriving at this determination,
            the board of directors has examined each audit committee member�s scope of experience and the nature of
            their employment in the
            corporate finance sector.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
            Committee</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            members of the Compensation Committee are <span style="background-color: white">Max Baucus (Chair), Ken
                Ludlum and Cathryn Chen. The
                Board has determined that each member is a �non-employee director� as defined in Rule 16b-3 promulgated
                under the Exchange
                Act and an �outside director� as that term is defined in Section 162(m) of the Internal Revenue Code of
                1986, as amended.
                The Board has also determined that each member is independent under SEC regulations and Nasdaq listing
                standards. The primary purpose
                of the compensation committee is to discharge the responsibilities of the board of directors to oversee
                its compensation policies, plans
                and programs and to review and determine the compensation to be paid to its executive officers,
                directors and other senior management,
                as appropriate and to nominated candidates for the Board.</span></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
            and Corporate Governance Committee</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            members of the Nominating and Corporate Governance Committee are <span style="background-color: white">F.
                Samuel Eberts III (Chair),
                and Cathryn Chen</span>. <span style="background-color: white">The Board has determined each member is
                independent under the Nasdaq listing
                standards. T</span>he primary purpose of the governance committee is to evaluate the performance of the
            Board and of individual directors
            and review developments in corporate governance practices.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
            Committee Interlocks and Insider Participation</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
            of our officers currently serves, or in the past year has served, as a member of the Compensation Committee
            of any entity that has one
            or more officers serving on our Board of Directors.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code
            of Ethics</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
            of our employees, including our Chief Executive Officer and Chief Financial Officer, are required to abide
            by our Code of Ethics to ensure
            that our business is conducted in a consistently legal and ethical manner. These policies form the
            foundation of a comprehensive process
            that includes compliance with corporate policies and procedures, an open relationship among colleagues that
            contributes to good business
            conduct, and a commitment to honesty, fair dealing and full compliance with all laws and regulations
            affecting the Company�s business.
            Our policies and procedures cover all major areas of professional conduct, including employment policies,
            conflicts of interest, intellectual
            property and the protection of confidential information, as well as strict adherence to laws and regulations
            applicable to the conduct
            of our business.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
            required by the Sarbanes-Oxley Act of 2002, our Audit Committee has procedures to receive, retain and treat
            complaints received regarding
            accounting, internal accounting controls or auditing matters and to allow for the confidential and anonymous
            submission by employees
            of concerns regarding questionable accounting or auditing matters.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 70; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            full text of our Code of Ethics is posted on our website at <i>www.dih.com </i>on the �Investor Relations -
            Corporate Governance�
            page, and also included as Exhibit 14 to the Form 10-K for the fiscal year ended March 31, 2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            will disclose any future amendments to, or waivers from, provisions of these ethics policies and standards
            on our website as promptly
            as practicable, as may be required under applicable SEC and Nasdaq rules and, to the extent required, by
            filing Current Reports on Form
            8-K with the SEC disclosing such information.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
            Governance Charter</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have adopted a Nominating and Corporate Governance Committee Charter that address the composition of the
            Board, criteria for Board membership
            and other Board governance matters. These guidelines are available on our website at <span
                style="text-decoration: underline">www.dih.com</span> on the �Investor Relations
            - Corporate Governance� page.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
            Committee Charter</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have adopted an Audit Committee Charter that address the Company�s accounting and financial reporting
            processes. These guidelines
            are available on our website at <span style="text-decoration: underline">www.dih.com</span> on the �Investor
            Relations - Corporate Governance� page.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
            Committee Charter</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have adopted a Compensation Committee Charter that address the Company�s compensation structure. These
            guidelines are available
            on our website at <span style="text-decoration: underline">www.dih.com</span> on the �Investor Relations -
            Corporate Governance� page.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider
            Trading Policy</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have adopted an insider trading policy available on our website at <span
                style="text-decoration: underline">www.dih.com</span> on the �Investor Relations - Corporate Governance�
            page.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Policy
            Prohibiting Hedging or Pledging of Securities</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
            our insider trading policy, our employees, including our officers and the members of our Board, are
            prohibited from, directly or indirectly,
            among other things, (1) engaging in short sales, (2) trading in publicly-traded options, such as options,
            warrants, puts and calls, and
            other similar instruments on our securities, (3) hedging transactions (including, without limitation,
            prepaid variable forward sale contracts,
            equity swaps, collars and exchange funds), or otherwise engaging in transactions that hedge or offset, or
            are designed to hedge or offset,
            any decrease in the market value of our securities, (4) pledging any of our securities as collateral for any
            loans, (5) holding our securities
            in a margin account and (6) placing standing or limit orders on our securities.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clawback
            Policy</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have adopted Clawback Policy which is available on our website at <span
                style="text-decoration: underline">www.dih.com</span> on the �Investor Relations - Corporate Governance
            - Governance Overview� page.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conflicts
            of Interest</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
                        of our officers or directors is required to commit his or her full time to our affairs and,
                        accordingly, may have conflicts of interest
                        in allocating his or her time among various business activities.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                        the course of their other business activities, our officers and directors may become aware of
                        investment and business opportunities
                        which may be appropriate for presentation to us as well as the other entities with which they
                        are affiliated. Our management may
                        have conflicts of interest in determining to which entity a particular business opportunity
                        should be presented.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 71; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            conflicts described above may not be resolved in our favor.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
            is a table summarizing the entities to which our executive officers and directors currently have fiduciary
            duties or contractual obligations:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom; background-color: White">
                <td
                    style="border-bottom: Black 1pt solid; text-align: left; width: 32%; font-weight: bold; vertical-align: top">
                    Name of Individual</td>
                <td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td
                    style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; font-weight: bold; text-align: left">
                    Name of Affiliated Company</td>
                <td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td
                    style="border-bottom: Black 1pt solid; text-align: left; width: 32%; font-weight: bold; vertical-align: top">
                    Affiliation</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="vertical-align: top; text-align: left">Jason Chen</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">DIH Technology Ltd</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">Co-Founder<br>Chief Executive Officer</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="vertical-align: top; text-align: left">Lynden Bass</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">�</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">�</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="vertical-align: top; text-align: left">Cathryn Chen</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">ATAC Sponsor LLC</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">Co-Founder<br>Chief Financial Officer</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">ATAC Manager LLC</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">Manager<br>Member</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">MarketX Inc.</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">Founder and CEO</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">MarketX Ventures LLC</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">Managing Director</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">MarketX Securities LLC</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">Managing Director</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="vertical-align: top; text-align: left">Dr. Patrick Bruno</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">�</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">�</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="vertical-align: top; text-align: left">Dietmar Dold</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">�</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">�</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="vertical-align: top; text-align: left">Max Baucus</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">Baucus Group LLC</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">Managing Member</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="vertical-align: top; text-align: left">F. Samuel Eberts III</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">�</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">�</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="vertical-align: top; text-align: left">Ken Ludlum</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">IRIDEX Corp.</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">Director</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; vertical-align: top">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="vertical-align: top; text-align: left">Dermavant Sciences Ltd.</td>
                <td>&nbsp;</td>
                <td style="text-align: left; vertical-align: top">Director</td>
            </tr>
        </tbody>
    </table>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification
            of Directors and Officers</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
            required by our Amended and Restated Certificate of Incorporation, we indemnify our Directors and officers
            to the fullest extent permitted
            by law so that they will be free from undue concern about personal liability in connection with their
            service to the Company. We also
            have entered into agreements with our Directors and officers that contractually obligate us to provide this
            indemnification. <span style="background-color: white">We
                purchased a policy of directors� and officers� liability insurance that insures our officers and
                directors against the cost
                of defense, settlement or payment of a judgment in some circumstances and insures us against our
                obligations to indemnify our officers
                and directors. These agreements may discourage shareholders from bringing a lawsuit against our
                directors for breach of their fiduciary
                duty or have the effect of reducing the likelihood of derivative litigation against officers and
                directors, even though such an action,
                if successful, might otherwise benefit us and our shareholders. Furthermore, a shareholder�s investment
                may be adversely affected
                to the extent we pay the costs of settlement and damage awards against officers and directors pursuant
                to these indemnification provisions.</span></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            believe that these indemnity agreements and the directors� and officers� liability insurance are necessary
            to attract and
            retain talented and experienced officers and directors.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="D_003"></span>EXECUTIVE
            AND DIRECTOR COMPENSATION</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
            Compensation</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company is a �smaller reporting company� as defined by the SEC, and an �emerging growth company� as defined
            in
            the JOBS Act, and therefore is not required to provide, and does not purport to provide, all of the
            disclosures required for a �Compensation
            Discussion and Analysis� as set forth in the rules promulgated by the SEC. Therefore, the Company is
            providing a brief overview
            of its executive compensation program and has elected to comply with the scaled disclosure requirements
            applicable to emerging growth
            companies.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
            achieve our goals, we have designed, and intend to modify as necessary, our compensation and benefits
            programs to attract, retain, incentivize
            and reward deeply talented and qualified executives who share our philosophy and desire to work towards
            achieving our goals. We believe
            our compensation programs should promote the success of the Company and align executive incentives with the
            long-term interests of our
            stockholders. This section provides an overview of the material components of our executive compensation
            programs, including a narrative
            description of the material factors necessary to understand the information disclosed in the summary
            compensation table below. The following
            is a discussion and analysis of the material components of the compensation arrangements of DIH�s named
            executive officers for
            the fiscal year ended March 31, 2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 72; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
            the fiscal years ended March 31, 2024 and March 31, 2023, DIH�s �named executive officers� and their
            positions were
            as follows:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
            Chen, Chief Executive Officer</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lynden Bass, Chief Financial
            Officer</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick
            Bruno, Chief Marketing Officer</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
            discussion may contain forward-looking statements that are based on DIH�s current plans, considerations,
            expectations and determinations
            regarding future compensation programs. The actual compensation programs that DIH adopts following the
            completion of this offering may
            differ materially from the currently planned programs summarized in this discussion.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
            Philosophy</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company�s executive compensation program is designed to enable the Company to provide competitive
            compensation packages that attract,
            retain and motivate talented executives and managers while aligning management�s and stockholders� interests
            in the enhancement
            of Company performance and stockholder value.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company�s executive compensation program uses multiple elements to deliver a total package consisting of
            base salary, annual cash
            incentive awards and long-term incentive compensation in the form of equity awards, which are heavily
            weighted toward variable compensation
            tied to Company performance and stock price performance. The Compensation Committee reviews each element
            separately but also considers
            the relative mix of compensation and benefit offerings when making compensation decisions. In addition, the
            Compensation Committee retains
            discretion to make adjustments it deems advisable to balance the Company�s overall performance and the
            individual performance of
            the Company�s executive officers with our �pay for performance� philosophy.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
            Compensation Table</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal
            Years Ended March 31, 2023 and March 31, 2024 Base Salaries</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            named executive officers (�NEOs�) receive a base salary to provide a fixed component of compensation
            reflecting the executive�s
            skill set, experience, role and responsibilities.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td style="border-bottom: Black 1pt solid; font-weight: bold">Name and Principal Position</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p>
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Stock
                    Awards ($)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Nonequity
                    Incentive Plan Compensation ($)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">All Other
                    Compensation ($)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p>
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 41%; text-align: left">Jason Chen</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 6%; text-align: center">2024</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 6%; text-align: right">384,000</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 6%; text-align: right">�</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 6%; text-align: right">�</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 6%; text-align: right">(4</td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 6%; text-align: right">384,000</td>
                <td style="width: 1%; text-align: left">(4)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-style: italic; text-align: left">Chief Executive Officer</td>
                <td>&nbsp;</td>
                <td style="text-align: center">2023</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">384,000</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">384,000</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: center">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Lynden Bass</td>
                <td>&nbsp;</td>
                <td style="text-align: center">2024</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">280,000</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(5</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">280,000</td>
                <td style="text-align: left">(5)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-style: italic; text-align: left">Chief Financial Officer</td>
                <td>&nbsp;</td>
                <td style="text-align: center">2023</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">13,481</td>
                <td style="text-align: left">(1)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">13,481</td>
                <td style="text-align: left">(1)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: center">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Patrick Bruno</td>
                <td>&nbsp;</td>
                <td style="text-align: center">2024</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">370,804</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(3</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">489,083</td>
                <td style="text-align: left">(6)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">859,887</td>
                <td style="text-align: left">(6)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-style: italic; text-align: left">Chief Marketing Officer</td>
                <td>&nbsp;</td>
                <td style="text-align: center">2023</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">353,626</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(3</td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">185,230</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">538,856</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
                        Bass became our Chief Financial Officer on March 15, 2023. For the fiscal year ended March 31,
                        2023, Ms. Bass received a salary of
                        $13,481 which reflects the period of March 15, 2023 thru March 31, 2023. Ms. Bass� annual salary
                        is $280,000.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                        Bruno�s salary is denominated in Swiss Francs. At fiscal year-end, this translated into
                        US$370,804.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                        Bruno participates in a Swiss pension plan.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                        Chen is also eligible for a performance-based cash bonus of up to $190,000, the exact amount of
                        which will be determined by DIH�s
                        board of directors based on a review of his performance for the year ended March 31,
                        2024.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
                        Bass is also eligible for a performance-based cash bonus of up to $140,000, the exact amount of
                        which will be determined by DIH�s
                        board of directors based on a review of her performance for the year ended March 31,
                        2024.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                        Bruno is also eligible for a performance-based cash bonus of up to $185,401, the exact amount of
                        which will be determined by DIH�s
                        board of directors based on a review of his performance for the year ended March 31, 2024. The
                        amounts include the payout of bonuses
                        and long-term incentive plan for the years ended March 31, 2024 and 2023.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 73; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal
            Years Ended March 31, 2023 and March 31, 2024 Bonuses</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            has historically not paid discretionary annual bonuses.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
            Compensation</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
            stock options have been granted to DIH�s NEOs during fiscal years ended March 31, 2023 and March 31,
            2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
            Elements of Compensation � Employee Benefits and Perquisites</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Health/Welfare
                Plans</i>. During their employment, DIH�s named executive officers are eligible to participate in DIH�s
            employee benefit
            plans and programs, including medical and dental benefits, to the same extent as DIH�s other full-time
            employees, subject to the
            terms and eligibility requirements of those plans.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pension
            Benefits</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick
            Bruno participates in a Swiss pension plan. None of our other executive officers, including any of our other
            NEOs, participate in any
            defined benefit pension plans.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonqualified
            Deferred Compensation</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
            of our executive officers, including any of our NEOs, participate in any non-qualified deferred compensation
            plans, supplemental executive
            retirement plans or any other unfunded retirement arrangements.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
            Benefits and Perquisites</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            provide benefits to our executive officers, including our NEOs, on a similar basis as provided to all of our
            employees, including health,
            dental and vision insurance; life insurance; accidental death and dismemberment insurance; short-term and
            long-term disability insurance;
            a health savings account and flexible spending accounts. We do not maintain any executive-specific benefit
            or perquisite programs outside
            of financial planning services.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductibility
            of Executive Compensation</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
            162(m) of the Internal Revenue Code of 1986, as amended (the �Code�) limits the amount that we may deduct
            from our U.S. federal
            taxable income for compensation paid to persons who are �covered employees� for purposes of Section 162(m),
            to $1 million
            per covered employee per year. While we are mindful of the benefit of full tax deductibility of
            compensation, we also value the flexibility
            of compensating our executive officers in a manner that can best promote our corporate objectives.
            Therefore, the Compensation Committee
            and the Board may approve compensation that may not be fully deductible because of the limitation of Section
            162(m).</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 74; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
            Tax Reimbursement of Parachute Payments and Deferred Compensation</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            do not provide any executive officer, including any NEO, with a �gross-up� or other reimbursement payment
            for any tax liability
            that he or she might owe as a result of the application of Sections 280G, 4999 or 409A of the Code, and we
            have not agreed and are not
            otherwise obligated to provide any executive officer, including any NEO, with such a �gross-up� or other
            reimbursement.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
            Equity Awards at Fiscal Years-Ended March 31, 2023 and March 31, 2024.</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
            were no equity awards of any type outstanding as of March 31, 2023 and March 31, 2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
            Officer Offer Letters</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
            of the current NEOs has entered into an offer letter agreement with DIH. The employment of each officer is
            �at will� and
            the agreement may be terminated by either party, with or without cause, without the payment of any
            severance.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
            to Mr. Chen�s offer letter, Mr. Chen is entitled to an initial annual base salary of $384,000. Mr. Chen is
            also eligible for a
            performance-based cash bonus of up to $190,000, the exact amount of which will be determined by DIH�s board
            of directors based
            on a review of his performance for the year ended March 31, 2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
            to Ms. Bass�s offer letter, Ms. Bass is entitled to an initial annual base salary of $280,000. Ms. Bass is
            also eligible for a
            performance-based cash bonus of up to $140,000, the exact amount of which will be determined by DIH�s board
            of directors based
            on a review of her performance for the year ended March 31, 2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
            to Mr. Bruno�s offer letter, Mr. Bruno is entitled to an initial annual base salary of $370,804. Mr. Bruno
            is also eligible for
            a performance-based cash bonus of up to $185,401, the exact amount of which will be determined by DIH�s
            board of directors based
            on a review of his performance for the year ended March 31, 2024.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Employee
            Director Compensation</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
            the fiscal year ended March 31, 2024, DIH�s non-employee directors received the following cash and equity
            compensation for their
            service in such capacity.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
                                Earned</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or
                                Paid</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p>
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p>
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
                                Other</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span>
                    </p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p>
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p>
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 36%; text-align: left">Max Baucus</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 12%; text-align: right">0</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 12%; text-align: right">0</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 12%; text-align: right">�</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 12%; text-align: right">0</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">F. Samuel Eberts III</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">0</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">0</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">0</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Ken Ludlum</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">0</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">0</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">0</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Cathryn Chen</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">0</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">0</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">0</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
            of July 29, 2024, DIH�s non-employee directors received the following cash and equity compensation for their
            service in such capacity.
            All cash payments to directors are paid monthly on a pro-rated basis.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
                <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
                                Earned</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or
                                Paid</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
                                Other</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span>
                    </p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p>
                </td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 42%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Max
                        Baucus (1)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,333</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">�</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,333</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
                        Samuel Eberts III (2)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,667</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">�</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,667</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ken
                        Ludlum (3)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,333</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">�</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,333</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cathryn
                        Chen (4)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,667</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">�</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,667</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%">
        <tbody>
            <tr style="vertical-align: top; text-align: justify">
                <td style="vertical-align: top; width: 0.5in; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(</b>1)</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post fiscal year
                        ended March 31, 2024, Mr. Baucus is entitled to receive on an annual basis: (a) $200,000 in cash
                        fees and (b) $100,000 in shares of Common
                        Stock, as compensation for his service as director.</span></td>
            </tr>
            <tr style="vertical-align: top; text-align: justify">
                <td style="vertical-align: top; text-align: left">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top; text-align: justify">
                <td style="vertical-align: top; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post fiscal year
                        ended March 31, 2024, Mr. Eberts is entitled to receive on an annual basis: (a) $100,000 in cash
                        fees and (b) $200,000 in shares of Common
                        Stock, as compensation for his service as director.</span></td>
            </tr>
            <tr style="vertical-align: top; text-align: justify">
                <td style="vertical-align: top; text-align: left">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top; text-align: justify">
                <td style="vertical-align: top; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3<b>)</b></span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post fiscal year
                        ended March 31, 2024, Mr. Ludlum is entitled to receive on an annual basis: (a) $200,000 in cash
                        fees and (b) $100,000 in shares of Common
                        Stock, as compensation for his service as director.</span></td>
            </tr>
            <tr style="vertical-align: top; text-align: justify">
                <td style="vertical-align: top; text-align: left">&nbsp;</td>
                <td style="text-align: justify">&nbsp;</td>
            </tr>
            <tr style="vertical-align: top; text-align: justify">
                <td style="vertical-align: top; text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post fiscal year
                        ended March 31, 2024, Ms. Chen is entitled to receive on an annual basis: (a) $100,000 in cash
                        fees and (b) $200,000 in shares of Common
                        Stock, as compensation for her service as director.</span></td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 75; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="D_004"></span>CERTAIN
            RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            Related Party Transactions</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
            are considered related to DIH if the parties, directly or indirectly, through one or more intermediaries,
            control, are controlled by,
            or are under common control with DIH. Related parties also include principal owners of DIH, its management,
            members of the immediate
            families of principal owners of DIH and its management and other parties with which DIH may deal if one
            party controls or can significantly
            influence the management or operating policies of the other to an extent that one of the transacting parties
            might be prevented from
            fully pursuing its own separate interests. DIH discloses all related party transactions.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
            with DIH</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            has not historically operated as a standalone business and has had various transactional relationships with
            DIH Cayman, a company formed
            in the Cayman Islands (�DIH Cayman�). Consistent with the basis of presentation in DIH�s financial
            statements presented
            elsewhere in this registration statement, net parent company investment is primarily impacted by net funding
            provided by or distributed
            to DIH Cayman.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            and DIH International (�DIH Hong Kong�) are wholly owned subsidiaries of DIH Cayman. As of January 30, 2025,
            DIH Cayman
            remained the largest shareholder of the Company and continued to own 100% interest in DIH Hong Kong.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reorganization
            and Transaction with DIH Cayman and DIH Hong Kong</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
            the Company�s businesses have historically functioned together with the other businesses controlled by DIH
            Cayman, the Company�s
            businesses are largely isolated and not dependent on corporate or other support functions. DIH Hong Kong is
            a wholly-owned subsidiary
            of DIH Cayman and the Company was a wholly-owned subsidiary of DIH Cayman prior to closing of the Business
            Combination.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
            July 1, 2021, DIH Cayman completed a series of reorganization steps to transfer DIH US Corp and its
            subsidiaries and Hocoma Medical GmbH
            from Hocoma AG to DIH Holding US Inc., Nevada, effectively creating the Company as explained in the Hocoma
            AG and share transfers section
            below. The reorganization was accounted for as a common control transaction and the assets contributed and
            liabilities assumed were recorded
            based on their historical carrying values.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
            to the year ended March 31, 2022, the Company did not incur significant transactions with DIH Cayman or DIH
            Hong Kong. The balances recorded
            under �Due from relate party� and �Due to related party� are derived from historical transactions. The table
            below summarizes related party balances with DIH Hong Kong excluding Hocoma AG and Motek as of March 31,
            2024 and 2023.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of
                    March 31,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 60%; text-align: left">Due from related party</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">2,586</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">2,456</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Due to related party</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">1,470</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">1,311</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 76; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hocoma
            AG and share transfers</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
            July 1, 2021, Hocoma AG entered into a series of agreements with the Company and its subsidiaries to
            transfer all business aspects of
            development and production of mechanical and electronic devices in the fields of medical technology and
            biotechnology to Hocoma Medical
            GmbH.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
            July 2021 and January 2024, Hocoma AG operated as a single entity, with all business operations conducted at
            Hocoma AG while all personnel,
            except for two employees managing the MDR certification, were employed by Hocoma Medical. The EU MDR
            2017/745 came into effect in May
            2021. All medical devices certified under the previous Medical Device Directive (MDD) must certify to the
            new requirements to ensure
            that they can continue to be sold in the European market. Hocoma AG holds the MDR certification, which
            cannot legally be transferred
            to Hocoma Medical. Upon the lifting of the injunction, management performed a carve out of these entities to
            reflect the transfer from
            Hocoma AG to Hocoma Medical GmbH in July 2021.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
            ownership of DIH US Corp to DIH Nevada:</span></p>

    <p
        style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hocoma
            AG and DIH Nevada entered into a share purchase agreement effective on July 1, 2021, in which Hocoma AG
            agreed to sell all 10,000 shares
            of DIH US Corp and intercompany balances totaling $7.80 million between DIH US Corp and Hocoma AG to DIH
            Nevada. The purchase price was
            settled through a Note Agreement accruing interest at a rate of 1.25% annually (�Share Purchase Note�). The
            note has a term
            of 5 years, due on June 30, 2026, with prepayment allowed.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contribution
            net assets to Hocoma Medical:</span></p>

    <p
        style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            a Contribution Agreement effective on July 1, 2021, Hocoma AG agreed to contribute its business to Hocoma
            Medical GmbH. The contributed
            business was valued at USD 10.47 million as amended where Hocoma Medical GmbH was a wholly owned subsidiary
            of Hocoma AG at the time.
            The Contribution Agreement explicitly excluded the intellectual property rights specified in the
            Contribution Agreement. Additionally,
            the assets excluded all 10,000 shares of DIH US Corporation and certain intercompany balances. The Agreement
            specifically excludes from
            these liabilities all indebtedness of Hocoma AG related to the contributed business as of the effective
            date, as well as any liability
            for taxes relating to the contributed business as of the effective date.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
            of ownership in Hocoma Medical to DIH Nevada:</span></p>

    <p
        style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
            a separate Share Purchase Agreement effective on July 1, 2021, Hocoma AG transferred all ownership in Hocoma
            Medical GmbH in the form
            of 200 membership interests to DIH Nevada for $10.47 million, based on the final valuation. The purchase
            price was settled through a
            Note Agreement with an interest rate of 1.25% (�Membership Interest Note�). The note was agreed for a term
            of 5 years, due
            on June 30, 2026, with prepayment allowed.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
            of intellectual property to DIH US Corp:</span></p>

    <p
        style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            a business/asset, share, and IP purchase agreement on July 12, 2021, which was amended on August 3, 2021,
            Hocoma AG transferred intellectual
            property rights as listed in the Annex to the agreement to DIH Technology Inc. (a wholly owned subsidiary of
            DIH US Corp) for $1.57 million
            through a note agreement. The note payable formalized in a note agreement effective July 1, 2021, with an
            interest rate of 1.25% (�IP
            Note�). The note was agreed for a term of 5 years, due on June 30, 2026, with prepayment allowed.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Share Purchase Note, Membership Interest Note and IP Note together are referred to as �Related Party
            Notes�.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hocoma
            Medical GmbH has made periodically payments on the principal and interests of the Related Party Notes,
            resulting from the transfer of
            the business and assets above.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
            the two employees who remained at Hocoma AG provided services for the business of Hocoma Medical.
            Historically, an immaterial premium
            was charged to the cost of the employees.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 77; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
            of March 31, 2024 and 2023, the balances of Related Party Notes were $11,457 and $17,301, respectively
            included in Note payable - related
            party� on the consolidated balance sheet. The decrease resulted from the Company�s payments of principal on
            Related Party
            Notes owed to Hocoma AG.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            addition to the Related Party Notes, as of March 31, 2024 and 2023, the Company recorded a related party
            balance of $(267) and $1,992,
            respectively, representing cash balances owed by Hocoma AG. As part of the transfer discussed above, the
            Company also recorded a long-term
            related party receivable for $324 as of March 31, 2024 and 2023, included in �Other assets� on the
            consolidated balance sheet.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motek
            Group</span></p>

    <p
        style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company has entered into a distribution agreement with the Motek Group. The agreement, which has been
            historically in place, appoints
            the Company as the exclusive distributor of Motek�s advanced human movement research and rehabilitation
            products and services designed
            to support efficient functional movement therapy within specified territories. Under the distribution
            agreement, Motek supplies the products
            and services to the Company at the prices detailed in the agreement, with the Company entitled to a
            distributor margin. Motek provides
            ongoing support and assistance, including training, marketing materials, and technical documentation to the
            Company.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
            the years ended March 31, 2024 and 2023, the Company made purchases amounting to $13,599 and $11,869,
            respectively, from the Motek Group.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
            part of these transactions, the Company made advance payments to Motek, included in �Due from related
            party,� and also had
            trade payables, included in �Due to related party� on the consolidated balance sheet. The balances as of
            March 31, 2024 and
            2023 are as follows:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of
                    March 31,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 60%; text-align: left">Due from related party</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">3,367</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">1,934</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Due to related party</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">8,667</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">5,530</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in">
        &nbsp;</p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="D_005"></span>PRINCIPAL
            SECURITYHOLDERS</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
            Ownership of Certain Beneficial Owners and Management</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            following table sets forth certain information regarding beneficial ownership of our Common Stock as of
            January 7, 2025 by (i)
            each person (or group of affiliated persons) who is known by us to own more than five percent of the
            outstanding shares of our Common
            Stock, (ii) each director and executive officer, and (iii) all of our directors and executive officers as a
            group.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
            ownership is determined in accordance with SEC rules and generally includes voting or investment power with
            respect to securities. Unless
            otherwise noted, the address of each stockholder listed below is c/o D<span
                style="background-color: white">IH Holding US, Inc.,</span>
            77 Accord Park Drive, Suite D-1, Norwell, MA.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 78; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            had 41,080,368 shares of Class A Common Stock outstanding including 6,000,000 shares of common stock
            issuable in connection with the
            earn-out provisions set forth in the Business Combination Agreement as of January 30, 2025.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name and Address of
                    Beneficial Owner</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares
                    Owned</td>
                <td style="padding-bottom: 1pt; font-weight: bold"><sup>&nbsp;</sup></td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span>
                    </p>
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span><b>Ownership
                            (%)</b></p>
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; text-align: left">Directors and Executive Officers</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left"><sup>&nbsp;</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
                        Chen<sup>(1)</sup></span></td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 16%; text-align: right">14,085,241</td>
                <td style="width: 1%; text-align: left"><sup>&nbsp;</sup></td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 16%; text-align: right">34.3</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Lynden Bass</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left"><sup>&nbsp;</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Dr. Patrick Bruno</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left"><sup>&nbsp;</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Max Baucus</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">52,817</td>
                <td style="text-align: left"><sup>&nbsp;</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">*</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">F. Samuel Eberts III</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">105,634</td>
                <td style="text-align: left"><sup>&nbsp;</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">*</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Ken Ludlum</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">52,817</td>
                <td style="text-align: left"><sup>&nbsp;</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">*</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cathryn
                        Chen<sup>(2)</sup></span></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">7,725,807</td>
                <td style="text-align: left"><sup>(5)</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">17.4</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td>Dietmar Dold</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left"><sup>&nbsp;</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">All Directors and Executive Officers as a Group (8 Persons)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">21,811,048</td>
                <td style="text-align: left"><sup>(5)</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">49.2</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; text-align: left">5% or Greater Stockholders</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left"><sup>&nbsp;</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH Technology
                        Ltd.<sup>(1)(3)</sup></span></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">14,085,241</td>
                <td style="text-align: left"><sup>&nbsp;</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">34.3</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ATAC Sponsor
                        LLC<sup>(2)(4)</sup></span></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">7,725,807</td>
                <td style="text-align: left"><sup>(5)</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">17.4</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Five Narrow Lane, L.P.<sup>(7)</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">1,067,103</td>
                <td style="text-align: left"><sup>(6)</sup></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">2.5</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
            Less than 1%</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
                        Chen does not own any shares of DIH directly but may be deemed to have indirect ownership of DIH
                        through his ownership of approximately
                        42% of the outstanding shares of DIH Technology Ltd. He does not have voting or dispositive
                        power over the shares of DIH owned by
                        DIH Technology Ltd. After the completion of the Business Combination, he continues to have an
                        indirect ownership of shares of DIH
                        through his ownership of DIH Technology Ltd. but does not have voting or dispositive power over
                        such shares.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ATAC
                        Sponsor LLC (the �Former Sponsor�) is the record holder of the shares reported herein. Zachary
                        Wang, Cathryn Chen and
                        Yida Gao are managing members of the Former Sponsor. Consequently, Cathryn Chen may be deemed
                        the beneficial owner of the shares
                        held by the Former Sponsor and have voting and dispositive control over such securities. Ms.
                        Chen disclaims beneficial ownership
                        of any shares other than to the extent she may have a pecuniary interest therein, directly or
                        indirectly.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                        business address for DIH Technology Ltd is P.O. Box 61, 3rd Floor Harbour Centre, North Church
                        Street, Grand Cayman, KY1-1102, Cayman
                        Islands.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                        business address for the Former Sponsor is 4 Embarcadero Center, Suite 1449, San Francisco, CA
                        94105.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                        3,235,000 shares of Common Stock underlying the Private Placement Warrants held by the Former
                        Sponsor.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                        (i) up to 518,572 shares of Common Stock, issuable upon conversion of the remaining balance of
                        the 8% Original Issue Discount
                        Senior Secured Convertible Debenture (the �Debenture�) purchased by Five Narrow Lane, L.P.
                        pursuant to a Securities Purchase
                        Agreement dated June 7, 2024, and (ii) up to 330,000 shares of Common Stock underlying the
                        warrant issued to Five Narrow Lane L.P.,
                        in connection with the purchase of the Debenture. Pursuant to the beneficial ownership
                        limitation set forth in the Debenture and
                        the Warrant, Five Narrow Lane, L.P. is restricted from effecting any conversion of the Debenture
                        or any exercise of the Warrant which
                        would result in an excess of 9.99% of the number of shares of the Common Stock outstanding
                        immediately after giving effect to the
                        issuance of shares of Common Stock upon such conversion and/or exercise.</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                        business address for Five Narrow Lane, L.P. is 510 Madison Avenue, 14<sup>th</sup> Floor, New
                        York, NY 10022</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="D_006"></span>PLAN
            OF DISTRIBUTION</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are offering on a reasonable best efforts basis 5,937,100 Units at a public offering price of $0.7832 per
            Unit, for gross proceeds of $4,649,936.72 before deduction of placement agent fees and offering expenses.
            There is no minimum amount
            of proceeds that is a condition to closing of this offering. The actual amount of gross proceeds, if any, in
            this offering could vary
            substantially from the gross proceeds from the sale of the maximum amount of securities being offered in
            this prospectus.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
            to a placement agency agreement, we have engaged Maxim to act as our exclusive placement agent
            to solicit offers to purchase the securities offered by this prospectus. The placement agent is not
            purchasing or selling any securities,
            nor is it required to arrange for the purchase and sale of any specific number or dollar amount of
            securities, other than to use its
            �reasonable best efforts� to arrange for the sale of the securities by us. Therefore, we may not sell the
            entire amount of
            securities being offered. Investors purchasing securities offered hereby will have the option to execute a
            securities purchase agreement
            with us. In addition to the rights and remedies available to all investors in this offering under federal
            and state securities laws,
            the investors who enter into a securities purchase agreement will also be able to bring claims of breach of
            contract against us. Investors
            who do not enter into a securities purchase agreement shall rely solely on this prospectus in connection
            with the purchase of our securities
            in this offering. The placement agent may engage one or more subagents or selected dealers in connection
            with this offering.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 79; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            placement agency agreement provides that the placement agent�s obligations are subject to conditions
            contained in the placement
            agency agreement.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Units will be offered at a fixed price and are expected to be issued in a single closing. There is no
            minimum number of Units to be sold
            or minimum aggregate offering proceeds for this offering to close. We expect this offering to be completed
            not later than one trading
            day following the commencement of this offering and we will deliver all securities issued in connection with
            this offering delivery versus
            payment (�DVP�)/receipt versus payment (�RVP�) upon our receipt of investor funds. Accordingly, neither we
            nor
            the placement agent has made any arrangements to place investor funds in an escrow account or trust account
            since the placement agent
            will not receive investor funds in connection with the sale of securities offered hereunder.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            will deliver the securities being issued to the investors upon receipt of investor funds for the purchase of
            the securities offered pursuant
            to this prospectus. We expect to deliver the securities being offered pursuant to this prospectus on or
            about February 3, 2025.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement
            Agent Fees and Expenses</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
            the closing of this offering, we will pay the placement agent a cash transaction fee equal to 7.0% of the
            aggregate gross cash proceeds
            to us from the sale of the securities in the offering. The cash transaction fee will be reduced to 3.5% of
            the public offering price
            of the Units for any investors we introduce to the placement agent. In addition, we will reimburse the
            placement agent for certain of
            its out-of-pocket expenses incurred in connection with this offering, including the placement agent�s legal
            fees, and actual travel
            and reasonable out-of-pocket expenses, in an amount not to exceed $125,000 if this offering is
            completed.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            following table shows the public offering price, placement agent fees and proceeds, before expenses, to
            us.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Per
                            Unit<sup>(1)</sup></b></span></td>
                <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
                <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 60%">Public offering price</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">0.7832</p><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">4,649,936.72</p><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement agent
                        fees<sup>(2)</sup></span></td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">0.0429</p>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">254,909.67</p><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Proceeds to us, before expenses</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">0.7403</p><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">4,395,027.05</p><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            estimate that the total expenses of the offering, including registration and filing fees, printing fees and
            legal and accounting expenses,
            but excluding the placement agent fees, will be approximately $487,000, all of which are payable by us. This
            figure includes,
            among other things, the placement agent�s expenses (including the legal fees, costs and expenses for the
            placement agent�s
            legal counsel) that we have agreed to reimburse.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-Up
            Agreements</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have agreed to use our best efforts to cause each of our officers, directors and holders of five percent
            (5.0%) or more of our outstanding
            shares of common stock have agreed for a period of six (6) months after this offering is complete, subject
            to certain exceptions not
            to offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of
            any shares of our common
            stock or other securities convertible into or exercisable or exchangeable for our common stock for a period
            without the prior written
            consent of the placement agent, subject to certain exceptions.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            placement agent may in its sole discretion and at any time without notice release some or all of the shares
            subject to lock-up agreements
            prior to the expiration of the lock-up period. When determining whether or not to release shares from the
            lock-up agreements, the placement
            agent will consider, among other factors, the security holder�s reasons for requesting the release, the
            number of shares for which
            the release is being requested and market conditions at the time.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
            Issuance Standstill</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have agreed that for a period of up to 90 days from the closing of this offering that neither we nor any
            subsidiary will, without the
            prior written consent of the placement agent, (i) issue, enter into any agreement to issue or announce the
            issuance or proposed issuance
            of any shares of common stock or common stock equivalents or (ii) file any registration statement or
            prospectus, or any amendment or
            supplement thereto, subject to certain exceptions including but not limited, after thirty (30) days after
            the closing of this offering,
            filing a universal �shelf� registration statement on Form S-3. The Company has also agreed not to effect or
            enter into
            an agreement to effect any issuance of common stock or common stock equivalents involving a Variable Rate
            Transaction, as defined in
            the Securities Purchase Agreement, for a period of up to six (6) months following the closing of this
            offering.&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 80; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tail</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            there is a closing of this offering, or if our engagement agreement with the placement agent is terminated
            prior to closing of this offering,
            then if within twelve (12) months following such time, the Company completes any financing of equity,
            equity-linked, convertible or debt
            or other capital raising activity with, or receives any proceeds from, any of the investors contacted or
            introduced by the placement
            agent during the term of the engagement agreement, then we will pay the placement agent upon the closing of
            such financing or receipt
            of such proceeds a commission as described in this section, in each case only with respect to the portion of
            such financing received
            from such investors. We shall have the right to terminate this right for �cause,� for the placement agent�s
            material
            failure to provide the services contemplated in this offering, which will eliminate our obligations with
            respect to the payment of any
            fees with respect to this right.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have agreed to indemnify the placement agent against certain liabilities, including liabilities under the
            Securities Act, and to contribute
            to payments that the placement agent may be required to make for these liabilities.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulation
            M</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            placement agent may be deemed to be an underwriter within the meaning of Section 2(a)(11) of the Securities
            Act, and any commissions
            received by it and any profit realized on the resale of the securities sold by it while acting as principal
            might be deemed to be underwriting
            discounts or commissions under the Securities Act. As an underwriter, the placement agent would be required
            to comply with the requirements
            of the Securities Act and the Exchange Act, including, without limitation, Rule 10b-5 and Regulation M under
            the Exchange Act. These
            rules and regulations may limit the timing of purchases and sales of our securities by the placement agent
            acting as principal. Under
            these rules and regulations, the placement agent (i) may not engage in any stabilization activity in
            connection with our securities and
            (ii) may not bid for or purchase any of our securities or attempt to induce any person to purchase any of
            our securities, other than
            as permitted under the Exchange Act, until it has completed its participation in the distribution.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determination
            of Offering Price and Warrant Exercise Price</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            actual public offering price of the securities we are offering, and the exercise price of the Class A
            warrants
            included in the Units that we are offering, were negotiated among us, the placement agent and the investors
            in the offering based on
            the trading of our common stock prior to the offering, among other things. Other factors considered in
            determining the public offering
            price of the securities we are offering, as well as the exercise price of the warrants that we are offering,
            include our history and
            prospects, the market price of our common stock on Nasdaq, the stage of development of our business, our
            business plans for the future
            and the extent to which they have been implemented, an assessment of our management, the general conditions
            of the securities markets
            at the time of the offering and such other factors as were deemed relevant.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Electronic
            Distribution</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
            prospectus in electronic format may be made available on a website maintained by the placement agent or an
            affiliate. Other than this
            prospectus, the information on the placement agent�s website and any information contained in any other
            website maintained by the
            placement agent is not part of this prospectus or the registration statement of which this prospectus forms
            a part, has not been approved
            and/or endorsed by us or the placement agent, and should not be relied upon by investors. In connection with
            the offering, the placement
            agent or selected dealers may distribute prospectuses electronically. No forms of electronic prospectus
            other than prospectuses that
            are printable as Adobe� PDF will be used in connection with this offering.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
            than the prospectus in electronic format, the information on the placement agent�s website and any
            information contained in any
            other website maintained by the placement agent is not part of the prospectus or the registration statement
            of which this prospectus
            forms a part, has not been approved and/or endorsed by us or the placement agent in its capacity as
            placement agent and should not be
            relied upon by investors.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 81; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
            Relationships and Affiliations</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            placement agent and its affiliates are full service financial institutions engaged in various activities,
            which may include securities
            trading, commercial and investment banking, financial advisory, investment management, investment research,
            principal investment, hedging,
            financing and brokerage activities. The placement agent and its affiliates may from time to time in the
            future engage with us and perform
            services for us or in the ordinary course of their business for which they will receive customary fees and
            expenses. In the ordinary
            course of their various business activities, the placement agent and its affiliates may make or hold a broad
            array of investments and
            actively trade debt and equity securities (or related derivative securities) and financial instruments
            (including bank loans) for their
            own account and for the accounts of their customers, and such investment and securities activities may
            involve securities and/or instruments
            of us. The placement agent and its respective affiliates may also make investment recommendations and/or
            publish or express independent
            research views in respect of these securities or instruments and may at any time hold, or recommend to
            clients that they acquire, long
            and/or short positions in these securities and instruments.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listing</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Class A Common Stock trades on Nasdaq under the symbol �DHAI� and the Public Warrants trade on Nasdaq under
            the symbol �DHAIW.�</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
            Agent and Registrar</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            transfer agent and registrar for our securities is Continental Stock Transfer &amp; Trust Company.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
            Restrictions</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
            than in the United States, no action has been taken by us or the placement agent that would permit a public
            offering of the securities
            offered by this prospectus in any jurisdiction where action for that purpose is required. The securities
            offered by this prospectus may
            not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or
            advertisements in connection
            with the offer and sale of any such securities be distributed or published, in any jurisdiction, except
            under circumstances that will
            result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose
            possession this prospectus comes
            are advised to inform themselves about and to observe any restrictions relating to this offering and the
            distribution of this prospectus.
            This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities
            offered by this prospectus in
            any jurisdiction in which such an offer or a solicitation is unlawful.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Australia</i></b>.
            No placement document, prospectus, product disclosure statement or other disclosure document has been lodged
            with the Australian Securities
            and Investments Commission (ASIC), in relation to the offering.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
            prospectus does not constitute a prospectus, product disclosure statement or other disclosure document under
            the Corporations Act 2001
            (the Corporations Act) and does not purport to include the information required for a prospectus, product
            disclosure statement or other
            disclosure document under the Corporations Act.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
            offer in Australia of the securities may only be made to persons (the Exempt Investors) who are
            �sophisticated investors�
            (within the meaning of section 708(8) of the Corporations Act), �professional investors� (within the meaning
            of section 708(11)
            of the Corporations Act) or otherwise pursuant to one or more exemptions contained in section 708 of the
            Corporations Act so that it
            is lawful to offer the securities without disclosure to investors under Chapter 6D of the Corporations
            Act.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            securities applied for by Exempt Investors in Australia must not be offered for sale in Australia in the
            period of 12 months after the
            date of allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D
            of the Corporations Act
            would not be required pursuant to an exemption under section 708 of the Corporations Act or otherwise or
            where the offer is pursuant
            to a disclosure document which complies with Chapter 6D of the Corporations Act. Any person acquiring
            securities must observe such Australian
            on-sale restrictions.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 82; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
            prospectus contains general information only and does not take account of the investment objectives,
            financial situation or particular
            needs of any particular person. It does not contain any securities recommendations or financial product
            advice. Before making an investment
            decision, investors need to consider whether the information in this prospectus is appropriate to their
            needs, objectives and circumstances,
            and, if necessary, seek expert advice on those matters.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Brazil</i></b>.
            The offer of securities described in this prospectus will not be carried out by means that would constitute
            a public offering in Brazil
            under Law No. 6,385, of December 7, 1976, as amended, under the CVM Rule (Instru��o) No. 400, of December
            29, 2003. The
            offer and sale of the securities have not been and will not be registered with the Comiss�o de Valores
            M�bilearios in Brazil.
            The securities have not been offered or sold, and will not be offered or sold in Brazil, except in
            circumstances that do not constitute
            a public offering or distribution under Brazilian laws and regulations.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Canada</i></b>.
            The securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal
            that are accredited investors,
            as defined in National Instrument 45-106 <i>Prospectus Exemptions </i>or subsection 73.3(1) of the
            Securities Act (Ontario), and are
            permitted clients, as defined in National Instrument 31 103 <i>Registration Requirements, Exemptions and
                Ongoing Registrant Obligations</i>.
            Any resale of the securities must be made in accordance with an exemption from, or in a transaction not
            subject to, the prospectus requirements
            of applicable securities laws.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
            legislation in certain provinces or territories of Canada may provide a purchaser with remedies for
            rescission or damages if this prospectus
            supplement (including any amendment thereto) contains a misrepresentation, provided that the remedies for
            rescission or damages are exercised
            by the purchaser within the time limit prescribed by the securities legislation of the purchaser�s province
            or territory. The purchaser
            should refer to any applicable provisions of the securities legislation of the purchaser�s province or
            territory for particulars
            of these rights or consult with a legal advisor.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
            to section 3A.3 of National Instrument 33 105 Underwriting Conflicts (NI 33 105), the placement agent is not
            required to comply with
            the disclosure requirements of NI 33-105 regarding conflicts of interest in connection with this
            offering.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cayman
                    Islands</i></b>. No invitation, whether directly or indirectly, may be made to the public in the
            Cayman Islands to subscribe for our
            securities.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>European
                    Economic Area</i></b>. In relation to each Member State of the European Economic Area which has
            implemented the Prospectus Directive
            (each, a �Relevant Member State�) an offer to the public of any securities may not be made in that Relevant
            Member State,
            except that an offer to the public in that Relevant Member State of any securities may be made at any time
            under the following exemptions
            under the Prospectus Directive, if they have been implemented in that Relevant Member State:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                        any legal entity which is a qualified investor as defined in the Prospectus Directive;</span>
                </td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                        fewer than 100 or, if the Relevant Member State has implemented the relevant provision of
                        the 2010 PD Amending Directive, 150, natural or legal persons (other than qualified investors
                        as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject
                        to obtaining the prior consent of the representatives for any such offer; or</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                        any other circumstances falling within Article 3(2) of the Prospectus Directive, provided
                        that no such offer of securities shall result in a requirement for the publication by us
                        or any placement agent of a prospectus pursuant to Article 3 of the Prospectus Directive.</span>
                </td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
            the purposes of this provision, the expression an �offer to the public� in relation to any securities in any
            Relevant Member
            State means the communication in any form and by any means of sufficient information on the terms of the
            offer and any securities to
            be offered so as to enable an investor to decide to purchase any securities, as the same may be varied in
            that Member State by any measure
            implementing the Prospectus Directive in that Member State, the expression �Prospectus Directive� means
            Directive 2003/71/EC
            (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant
            Member State), and includes
            any relevant implementing measure in the Relevant Member State, and the expression �2010 PD Amending
            Directive� means Directive
            2010/73/EU.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 83; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Hong
                    Kong</i></b>. The contents of this prospectus have not been reviewed by any regulatory authority in
            Hong Kong. You are advised to exercise
            caution in relation to the offer. If you are in any doubt about any of the contents of this prospectus, you
            should obtain independent
            professional advice. Please note that (i) our shares may not be offered or sold in Hong Kong, by means of
            this prospectus or any document
            other than to �professional investors� within the meaning of Part I of Schedule 1 of the Securities and
            Futures Ordinance
            (Cap.571, Laws of Hong Kong) (SFO) and any rules made thereunder, or in other circumstances which do not
            result in the document being
            a �prospectus� within the meaning of the Companies Ordinance (Cap.32, Laws of Hong Kong) (CO) or which do
            not constitute
            an offer or invitation to the public for the purpose of the CO or the SFO, and (ii) no advertisement,
            invitation or document relating
            to our shares may be issued or may be in the possession of any person for the purpose of issue (in each case
            whether in Hong Kong or
            elsewhere) which is directed at, or the contents of which are likely to be accessed or read by, the public
            in Hong Kong (except if permitted
            to do so under the securities laws of Hong Kong) other than with respect to the shares which are or are
            intended to be disposed of only
            to persons outside Hong Kong or only to �professional investors� within the meaning of the SFO and any rules
            made thereunder.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Israel</i></b>.
            This document does not constitute a prospectus under the Israeli Securities Law, 5728-1968, or the
            Securities Law, and has not been filed
            with or approved by the Israel Securities Authority. In the State of Israel, this document is being
            distributed only to, and is directed
            only at, and any offer of the shares is directed only at, investors listed in the first addendum, or the
            Addendum, to the Israeli Securities
            Law, consisting primarily of joint investment in trust funds, provident funds, insurance companies, banks,
            portfolio managers, investment
            advisors, members of the Tel Aviv Stock Exchange, underwriters, venture capital funds, entities with equity
            in excess of NIS 50 million
            and �qualified individuals�, each as defined in the Addendum (as it may be amended from time to time),
            collectively referred
            to as qualified investors (in each case purchasing for their own account or, where permitted under the
            Addendum, for the accounts of
            their clients who are investors listed in the Addendum). Qualified investors will be required to submit
            written confirmation that they
            fall within the scope of the Addendum, are aware of the meaning of same and agree to it.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
                    People</i></b>�<b><i>s Republic of China</i></b>. This prospectus may not be circulated or
            distributed in the PRC and the shares
            may not be offered or sold, and will not offer or sell to any person for re-offering or resale directly or
            indirectly to any resident
            of the PRC except pursuant to applicable laws, rules and regulations of the PRC. For the purpose of this
            paragraph only, the PRC does
            not include Taiwan and the special administrative regions of Hong Kong and Macau.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Switzerland</i></b>.
            The securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange
            (the SIX) or on any other
            stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard
            to the disclosure standards
            for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure
            standards for listing prospectuses
            under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated
            trading facility in Switzerland.
            Neither this document nor any other offering or marketing material relating to the securities or the
            offering may be publicly distributed
            or otherwise made publicly available in Switzerland.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
            this document nor any other offering or marketing material relating to the offering, or the securities have
            been or will be filed with
            or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the
            offer of securities will
            not be supervised by, the Swiss Financial Market Supervisory Authority FINMA, and the offer of securities
            has not been and will not be
            authorized under the Swiss Federal Act on Collective Investment Schemes (CISA). Accordingly, no public
            distribution, offering or advertising,
            as defined in CISA, its implementing ordinances and notices, and no distribution to any non-qualified
            investor, as defined in CISA, its
            implementing ordinances and notices, shall be undertaken in or from Switzerland, and the investor protection
            afforded to acquirers of
            interests in collective investment schemes under CISA does not extend to acquirers of securities.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 84; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Taiwan</i></b>.
            The securities have not been and will not be registered with the Financial Supervisory Commission of Taiwan
            pursuant to relevant securities
            laws and regulations and may not be sold, issued or offered within Taiwan through a public offering or in
            circumstances which constitutes
            an offer within the meaning of the Securities and Exchange Act of Taiwan that requires a registration or
            approval of the Financial Supervisory
            Commission of Taiwan. No person or entity in Taiwan has been authorized to offer, sell, give advice
            regarding or otherwise intermediate
            the offering and sale of the securities in Taiwan.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>United
                    Kingdom</i></b>. This prospectus has only been communicated or caused to have been communicated and
            will only be communicated or caused
            to be communicated as an invitation or inducement to engage in investment activity (within the meaning of
            Section 21 of the Financial
            Services and Markets Act of 2000, or the FSMA) as received in connection with the issue or sale of our
            common stock in circumstances
            in which Section 21(1) of the FSMA does not apply to us. All applicable provisions of the FSMA will be
            complied with in respect to anything
            done in relation to our common stock in, from or otherwise involving the United Kingdom.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="D_007"></span>DESCRIPTION
            OF SECURITIES</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company�s capital stock is governed by the Company�s Amended and Restated Certificate of Incorporation, the
            Company�s
            Amended and Restated Bylaws and the Delaware General Corporation Law (�DGCL�). This description is a summary
            and is not complete.
            We urge you to read the Company�s Amended and Restated Certificate of Incorporation and Amended and Restated
            Bylaws, which are
            files as Exhibits 3.1 and 3.2, respectively to the registration statement of which this prospectus forms a
            part,</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            authorized capital stock of the Company consists of 100,000,000 shares of Common Stock and 10,000,000 shares
            of preferred stock.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
            Rights</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            DGCL permits a corporation to declare and pay dividends out of �surplus� or, if there is no �surplus�, out
            of
            its net profits for the fiscal year in which the dividend is declared and/or the preceding fiscal year.
            �Surplus� is defined
            as the excess of the net assets of the corporation over the amount determined to be the capital of the
            corporation by the board of directors.
            The capital of the corporation is typically calculated to be (and cannot be less than) the aggregate par
            value of all issued shares of
            capital stock. Net assets equals the fair value of the total assets minus total liabilities. The DGCL also
            provides that dividends may
            not be paid out of net profits if, after the payment of the dividend, capital is less than the capital
            represented by the outstanding
            stock of all classes having a preference upon the distribution of assets. Delaware common law also imposes a
            solvency requirement in
            connection with the payment of dividends.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
            to preferences that may apply to any shares of the Company�s preferred stock outstanding at the time, the
            holders of the Company�s
            common stock will be entitled to receive dividends out of funds legally available therefor if the Company�s
            board of directors,
            in its discretion, determines to authorize the issuance of dividends and then only at the times and in the
            amounts that the Company�s
            board of directors may determine.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
            Rights</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
            of the Common Stock are entitled to one vote for each share held as of the record date for the determination
            of the stockholders entitled
            to vote on such matters, including the election and removal of directors, except as otherwise required by
            law. Under Delaware law, the
            right to vote cumulatively does not exist unless the certificate of incorporation specifically authorizes
            cumulative voting. The Company�s
            Amended and Restated Certificate of Incorporation does not authorize cumulative voting and provides that no
            shareholder is permitted
            to cumulate votes at any election of directors.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
            to Receive Liquidation Distributions</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            the Company becomes subject to a liquidation, dissolution, or winding-up, the assets legally available for
            distribution to the Company�s
            stockholders would be distributable ratably among the holders of the Common Stock and any participating
            series of the Company�s
            preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and
            liabilities and the preferential
            rights of, and the payment of any liquidation preferences on, any outstanding shares of the Company�s
            preferred stock.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 85; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
            Matters</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
            outstanding shares of the Company�s Common Stock are fully paid and nonassessable. The Company�s common
            stock is not entitled
            to preemptive rights and is not subject to redemption or sinking fund provisions.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
            Stock</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company�s board of directors is authorized, subject to limitations prescribed by the DGCL, to issue
            preferred stock in one or more
            series, to establish from time to time the number of shares to be included in each series, and to fix the
            designation, powers, preferences,
            and rights of the shares of each series and any of its qualifications, limitations, or restrictions, in each
            case without further vote
            or action by the Company�s stockholders. The Company�s board of directors is empowered to increase or
            decrease the number
            of shares of any series of the Company�s preferred stock, but not below the number of shares of that series
            then outstanding, without
            any further vote or action by the Company�s stockholders. The Company�s board of directors is able to
            authorize the issuance
            of the Company�s preferred stock with voting or conversion rights that could adversely affect the voting
            power or other rights
            of the holders of the Company�s Common Stock. The issuance of the Company�s preferred stock, while providing
            flexibility
            in connection with possible acquisitions and other corporate purposes, could, among other things, have the
            effect of delaying, deferring,
            or preventing a change in control of the Company and might adversely affect the market price of the
            Company�s Common Stock and
            the voting and other rights of the holders of the Company�s Common Stock. There are currently no plans to
            issue any shares of the
            Company�s preferred stock.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
            of Directors</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company�s board of directors consists of seven directors. The Amended and Restated Certificate of
            Incorporation provides that the
            number of directors shall be fixed only by resolution of the board of directors. Directors are elected by a
            plurality of all of the votes
            cast in the election of directors.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Takeover
            Defense Provisions</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
            provisions of Delaware law, the Amended and Restated Certificate of Incorporation and the Amended and
            Restated Bylaws, may have the effect
            of delaying, deferring, or discouraging another person from acquiring control of the Company. They are also
            designed, in part, to encourage
            persons seeking to acquire control of the Company to negotiate first with the Company�s board of
            directors.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
            203 of the DGCL</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company is governed by the provisions of Section 203 of the DGCL. In general, Section 203 of the DGCL
            prohibits a public Delaware corporation
            from engaging in a �business combination� with an �interested stockholder� (as those terms are defined in
            Section
            203 of the DGCL) for a period of three years after the date of the transaction in which the person became an
            interested stockholder,
            unless:</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">either
                        the merger or the transaction which resulted in the stockholder becoming an interested
                        stockholder was approved by the board of directors
                        prior to the time that the stockholder became an interested stockholder;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                        consummation of the transaction which resulted in the stockholder becoming an interested
                        stockholder, the interested stockholder
                        owned at least 85% of the voting stock of the corporation outstanding at the time the
                        transaction commenced, excluding shares owned
                        by directors who are also officers of the corporation and shares owned by employee stock plans
                        in which employee participants do
                        not have the right to determine confidentially whether shares held subject to the plan will be
                        tendered in a tender or exchange offer;
                        or</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                        or subsequent to the time the stockholder became an interested stockholder, the merger was
                        approved by the Company�s board
                        of directors and authorized at an annual or special meeting of the stockholders, and not by
                        written consent, by the affirmative vote
                        of at least two-thirds of the outstanding voting stock which is not owned by the interested
                        stockholder.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 86; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            general, Section 203 defines a �business combination� to include mergers, asset sales, and other
            transactions resulting in
            financial benefit to a stockholder and an �interested stockholder� as a person who, together with affiliates
            and associates,
            owns, or, within the prior three years, did own, 15% or more of the corporation�s outstanding voting stock.
            These provisions may
            have the effect of delaying, deferring, or preventing changes in control of the Company.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classified
            Board of Directors</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Amended and Restated Certificate of Incorporation provides that the Company�s board of directors is divided
            into three classes,
            designated as Class I, Class II and Class III. Each class is an equal number of directors, as nearly as
            possible, consisting of one-third
            of the total number of directors constituting the entire board of directors. The term of the initial Class I
            directors terminates on
            the date of the 2024 annual meeting of stockholders, the term of the initial Class II directors will
            terminate on the date of the 2025
            annual meeting of stockholders and the term of the initial Class III directors will terminate on the date of
            the 2026 annual meeting
            of stockholders. At each annual meeting of stockholders, successors to the class of directors whose term
            expires at that annual meeting
            will be elected for a three-year term.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Removal
            of Directors</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Amended and Restated Certificate of Incorporation provides that stockholders may only remove a director for
            cause and only by the affirmative
            vote of the holders of a majority of the issued and outstanding capital stock of the Company entitled to
            vote in the election of directors,
            voting together as a single class.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
            of Directors Vacancies</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws authorize only a majority
            of the remaining members
            of the Company�s board of directors, although less than a quorum, to fill vacant directorships, including
            newly created directorships.
            In addition, subject to the rights of holders of any series of the Company�s preferred stock, the number of
            directors constituting
            the Company�s board of directors is permitted to be set only by a resolution of the Company�s board of
            directors. These provisions
            prevent a stockholder from increasing the size of the Company�s board of directors and then gaining control
            of the Company�s
            board of directors by filling the resulting vacancies with its own nominees. This will make it more
            difficult to change the composition
            of the Company�s board of directors and will promote continuity of management.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder
            Action; Special Meeting of Stockholders</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws provide that the Company�s
            stockholders may not
            take action by written consent but may only take action at annual or special meetings of the stockholders.
            As a result, a holder controlling
            a majority of the Company�s capital stock will not be able to amend the Amended and Restated Bylaws, amend
            the Amended and Restated
            Certificate of Incorporation or remove directors without holding a meeting of the Company�s stockholders
            called in accordance with
            the Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws. The Amended and
            Restated Certificate of Incorporation
            and Amended and Restated Bylaws further provide that special meetings of stockholders of the Company may be
            called only by the Company�s
            board of directors, the Chairperson of the Company�s board of directors, or the Chief Executive Officer or
            the President of the
            Company, thus prohibiting stockholder action to call a special meeting. These provisions might delay the
            ability of the Company�s
            stockholders to force consideration of a proposal or for stockholders controlling a majority of the
            Company�s capital stock to
            take any action, including the removal of directors.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 87; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance
            notice requirements for stockholder proposals and director nominations</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Amended and Restated Certificate of Incorporation provides that advance notice of stockholder nominations
            for the election of directors
            and of business to be brought by stockholders before any meeting of the stockholders of the Company must be
            given in the manner and to
            the extent provided in the bylaws of the Company. The Amended and Restated Bylaws provide that, with respect
            to an annual meeting of
            the Company�s stockholders, nominations of persons for election to the board of directors and the proposal
            of other business to
            be transacted by the stockholders may be made only (i) pursuant to the Company�s notice of the meeting, (ii)
            by or at the direction
            of the Company�s board of directors, (iii) as provided in the certificate of designation for any class or
            series of preferred stock
            or (iv) by any stockholder who was a stockholder of record at the time of giving the notice required by the
            Amended and Restated Amended
            and Restated Bylaws, at the record date(s) set by the board of directors for the purpose of determining
            stockholders entitled to notice
            of, and to vote at, the meeting, and at the time of the meeting, and who complies with the advance notice
            provisions of the Amended and
            Restated Bylaws.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
            respect to special meetings of stockholders, only the business specified in the Company�s notice of meeting
            may be brought before
            the meeting. Nominations of persons for election to the board of directors may be made only (i) by or at the
            direction of the Company�s
            board of directors or (ii) if the meeting has been called for the purpose of electing directors, by any
            stockholder who was a stockholder
            of record at the time of giving the notice required by the Amended and Restated Bylaws, at the record
            date(s) set by the board of directors
            for the purpose of determining stockholders entitled to notice of, and to vote at, the meeting, and at the
            time of the meeting, and who
            complies with the advance notice provisions of the Amended and Restated Bylaws.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            advance notice procedures of the Amended and Restated Bylaws provide that, to be timely, a stockholder�s
            notice with respect to
            director nominations or other proposals for an annual meeting must be delivered to the Company�s Secretary
            at the principal executive
            office of the Company not earlier than the 120th day nor later than 5:00 p.m., local time, on the 90th day
            prior to the first anniversary
            of the date of the proxy statement for the preceding year�s annual meeting. In the event that the date of
            the annual meeting is
            advanced by more than 30 days before or delayed by more than 70 days after the first anniversary of the date
            of the preceding year�s
            annual meeting, to be timely, a stockholder�s notice must be delivered not earlier than the 120th day prior
            to the date of such
            annual meeting and not later than 5:00 p.m., local time, on the later of the 90th day prior to the date of
            such annual meeting or the
            tenth day following the day on which public announcement of the date of such meeting is first made.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
            provisions might preclude stockholders of the Company from bringing matters before the annual meeting of
            stockholders or from making
            nominations for directors at the annual meeting of stockholders if the proper procedures are not followed.
            These provisions may also
            discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer�s
            own slate of directors
            or otherwise attempting to obtain control of the Company.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
            cumulative voting</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            DGCL provides that stockholders are not entitled to cumulate votes in the election of directors unless a
            corporation�s certificate
            of incorporation provides otherwise. The Amended and Restated Certificate of Incorporation does not provide
            for cumulative voting and
            provides that no stockholder is permitted to cumulate votes at any election of directors.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments
            to Certificate of Incorporation and Bylaws</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
            for those amendments permitted to be made without stockholder approval under Delaware law or the Amended and
            Restated Certificate of
            Incorporation, the Amended and Restated Certificate of Incorporation generally may be amended only if the
            amendment is first declared
            advisable by the board of directors and thereafter approved by holders of a majority of the outstanding
            stock of the Company entitled
            to vote thereon. Any amendment of certain provisions in the Amended and Restated Certificate of
            Incorporation will require approval by
            holders of at least two-thirds of the voting power of the then-outstanding voting securities of the Company
            entitled to vote thereon,
            voting together as a single class. These provisions include, among others, provisions related to the
            classified board structure, board
            composition, removal of directors, indemnification and exculpation, cumulative voting rights, preferred
            stock, exclusive forum provisions,
            provisions related to stockholder action and advance notice, corporate opportunities and amendments to the
            charter, in each case as summarized
            in this registration statement.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 88; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company�s board of directors have the power to adopt, amend or repeal any provision of the Amended and
            Restated Bylaws. In addition,
            stockholders of the Company may adopt, amend or repeal any provision of the Amended and Restated Bylaws with
            the approval by the holders
            of at least two-thirds of the voting power of the then-outstanding voting securities of the Company entitled
            to vote thereon, voting
            together as a single class.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
            but Unissued Capital Stock</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware
            law does not require stockholder approval for any issuance of authorized shares. However, the listing
            requirements of the Nasdaq Stock
            Market, which would apply if and so long as the common stock remains listed on the Nasdaq Stock Market,
            require stockholder approval
            of certain issuances equal to or exceeding 20% of the then-outstanding voting power or then-outstanding
            number of shares of common stock.
            Additional shares that may be issued in the future may be used for a variety of corporate purposes,
            including future public offerings,
            to raise additional capital or to facilitate acquisitions.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
            of the effects of the existence of unissued and unreserved common stock may be to enable the Company�s board
            of directors to issue
            shares to persons friendly to current management, which issuance could render more difficult or discourage
            an attempt to obtain control
            of the Company by means of a merger, tender offer, proxy contest or otherwise and thereby protect the
            continuity of management and possibly
            deprive stockholders of opportunities to sell their shares of common stock at prices higher than prevailing
            market prices.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusive
            Forum</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Amended and Restated Certificate of Incorporation provides that, unless otherwise consented to by the
            Company in writing, the Court of
            Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another State
            court in Delaware or the federal
            district court for the District of Delaware) will, to the fullest extent permitted by law, be the sole and
            exclusive forum for the following
            types of actions or proceedings: (i) any derivative action or proceeding brought on behalf of the Company;
            (ii) any action asserting
            a claim of breach of a duty (including any fiduciary duty) owed by any current or former director, officer,
            stockholder, employee or
            agent of the Company to the Company or the Company�s stockholders; (iii) any action asserting a claim
            against the Company or any
            current or former director, officer, stockholder, employee or agent of the Company relating to any provision
            of the DGCL or the Amended
            and Restated Certificate of Incorporation or the Amended and Restated Bylaws or as to which the DGCL confers
            jurisdiction on the Court
            of Chancery of the State of Delaware; (iv) any action asserting a claim against the Company or any current
            or former director, officer,
            stockholder, employee or agent of the Company governed by the internal affairs doctrine of the State of
            Delaware, in each such case unless
            the Court of Chancery (or such other state or federal court located within the State of Delaware, as
            applicable) has dismissed a prior
            action by the same plaintiff asserting the same claims because such court lacked personal jurisdiction over
            an indispensable party named
            as a defendant therein. The Amended and Restated Certificate of Incorporation further provides that the
            federal district courts of the
            United States will be the sole and exclusive forum for the resolution of any complaint asserting a cause of
            action arising under the
            Securities Act. Any person or entity purchasing or otherwise acquiring any interest in the Company�s
            securities will be deemed
            to have notice of and consented to this provision.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
            the Amended and Restated Certificate of Incorporation contains the choice of forum provisions described
            above, it is possible that a
            court could rule that such provisions are inapplicable for a particular claim or action or that such
            provisions are unenforceable.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Amended and Restated Certificate of Incorporation further provides that the federal district courts of the
            United States will be the
            sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the
            Securities Act. In addition,
            Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any
            duty or liability created
            by the Exchange Act or the rules and regulations thereunder, and, therefore, the exclusive forum provisions
            described above do not apply
            to any actions brought under the Exchange Act.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
            we believe these provisions benefit us by limiting costly and time-consuming litigation in multiple forums
            and by providing increased
            consistency in the application of applicable law, these exclusive forum provisions may limit the ability of
            our stockholders to bring
            a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors,
            officers or employees, which
            may discourage such lawsuits against us and our directors, officers and other employees.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 89; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limitations
            on Liability and Indemnification of Directors and Officers</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            DGCL authorizes corporations to limit or eliminate the personal liability of directors to corporations and
            their stockholders for monetary
            damages for breaches of directors� fiduciary duties, subject to certain exceptions. The Company�s Amended
            and Restated Certificate
            of Incorporation includes a provision that eliminates the personal liability of directors for monetary
            damages for any breach of fiduciary
            duty as a director to the fullest extent permitted by the DGCL as the same exists or as may hereafter be
            amended from time to time. The
            effect of these provisions is to eliminate the rights of the Company and its stockholders, through
            stockholders� derivative suits
            on the Company�s behalf, to recover monetary damages from a director for breach of fiduciary duty as a
            director, including breaches
            resulting from grossly negligent behavior. However, exculpation does not apply to any director if the
            director has acted in bad faith,
            knowingly or intentionally violated the law, authorized illegal dividends or redemptions or derived an
            improper benefit from his or her
            actions as a director.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company�s Amended and Restated Certificate of Incorporation permits and the Amended and Restated Bylaws
            obligate the Company to
            indemnify, to the fullest extent permitted by the DGCL, any director or officer of the Company who was or is
            a party or is threatened
            to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil,
            criminal, administrative or investigative
            (a �<b>Proceeding</b>�) by reason of the fact that he or she is or was a director or officer of the Company
            or is or was
            serving at the request of the Company as a director, officer, employee or agent of another corporation,
            partnership, joint venture, trust
            or other enterprise, against expenses (including attorneys� fees), judgments, fines and amounts paid in
            settlement actually and
            reasonably incurred by such person in connection with any such Proceeding. The Company will not be obligated
            to indemnify a person in
            connection with a Proceeding (or part thereof) initiated by such person unless the Proceeding (or part
            thereof) was, or is, authorized
            by the board of directors, the Company determines to provide the indemnification or is otherwise required by
            applicable law. In addition,
            the Amended and Restated Bylaws require the Company, to the fullest extent permitted by law, to pay, in
            advance of the final disposition
            of a Proceeding, expenses (including attorneys� fees) actually and reasonably incurred by an officer or
            director of the Company
            in defending any Proceeding, upon receipt of a written request therefor (together with documentation
            reasonably evidencing such expenses)
            and an undertaking by or on behalf of the person to repay such amounts if it shall ultimately be determined
            that the person is not entitled
            to be indemnified under the Amended and Restated Bylaws or the DGCL.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company entered into an indemnification agreement with each of its directors and executive officers that
            provide for indemnification
            to the maximum extent permitted by Delaware law.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Company believes that these indemnification and advancement provisions and insurance are useful to attract
            and retain qualified directors
            and executive officers. The limitation of liability and indemnification provisions in the Company�s Amended
            and Restated Certificate
            of Incorporation and Amended and Restated Bylaws may discourage stockholders from bringing a lawsuit against
            directors for breach of
            their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative
            litigation against directors
            and officers, even though such an action, if successful, might otherwise benefit the Company and its
            stockholders. In addition, your
            investment may be adversely affected to the extent the Company pays the costs of settlement and damage
            awards against directors and officers
            pursuant to these indemnification provisions. Insofar as indemnification for liabilities arising under the
            Securities Act may be permitted
            to directors or executive officers, we have been informed that in the opinion of the SEC such
            indemnification is against public policy
            and is therefore unenforceable.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
            Agent</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Transfer Agent for our securities is Continental Stock Transfer &amp; Trust Company.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listing
            of Common Stock and Warrants</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            Class A Common Stock and Public Warrants of the Company trade on Nasdaq under the symbols �DHAI� and
            �DHAIW,�
            respectively.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 90; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
                    A Warrants</i></b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Overview</i>.
            The following summary of certain terms and provisions of the Class A warrants offered hereby is not complete
            and is subject to, and qualified
            in its entirety by, the provisions of the warrant agency agreement between us the Warrant Agent, and the
            form of Class A warrant, each
            of which is filed as an exhibit to the registration statement of which this prospectus is a part.
            Prospective investors should carefully
            review the terms and provisions set forth in the warrant agency agreement, including the annexes thereto and
            the form of Class A warrant.
            Each Class A warrant issued in this offering entitles the registered holder to purchase one share of our
            Common Stock at a price
            equal to $2,92 per share, subject to adjustment as discussed below, immediately following the issuance of
            such warrant and terminating
            at 5:00 p.m., New York City time, on the fifth anniversary of the original issuance date.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercisability.
            </i>The Class A warrants are exercisable at any time after their original issuance date until the fifth
            anniversary of the original issuance
            date. The Class A warrants may be exercised upon surrender of the warrant on or prior to the expiration date
            at the offices of the Warrant
            Agent, with the exercise form included with the Class A warrant completed and executed as indicated. If we
            fail to maintain the effectiveness
            of the registration statement and current prospectus relating to the Common Stock issuable upon exercise of
            the Class A warrants, the
            holders of the Class A warrants shall have the right to exercise the Class A warrants via a cashless
            exercise feature provided for in
            the Class A warrants, until such time as there is an effective registration statement and current
            prospectus. See �� <i>Cashless
                Exercise</i>� below.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
                Limitation</i>. A holder (together with its affiliates) may not exercise any portion of the Class A
            warrants to the extent that the holder
            would own more than 4.99% (or, at the election of the holder, 9.99%) of the outstanding Common Stock
            immediately after exercise, except
            that upon at least 61 days� prior notice from the holder to us, the holder may increase the amount of
            ownership of outstanding
            stock after exercising the holder�s Class A warrants up to 9.99% of the number of shares of our Common Stock
            outstanding immediately
            after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms
            of the Class A warrants.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
                Price</i>. The exercise price per whole share of our Common Stock purchasable upon the exercise of the
            Class A warrants is $0.7832
            per share of Common Stock. The warrants will be immediately exercisable and may be exercised at any time up
            to the date that is the
            fifth anniversary of the original issuance date. The exercise price and number of shares of Common Stock
            issuable upon exercise of the
            Class A warrants may be adjusted in certain circumstances, including in the event of a stock dividend or
            recapitalization, reorganization,
            merger or consolidation. However, the Class A warrants will not be adjusted for issuances of Common Stock at
            prices below their exercise
            price.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cashless
                Exercise</i>. If, at any time after the issuance of the Class A warrants, a holder of the Class A
            warrants exercises the warrants and
            a registration statement registering the issuance of the shares of common stock underlying the warrants
            under the Securities Act is not
            then effective or available (or a prospectus is not available for the resale of shares of Common Stock
            underlying the Class A warrants),
            then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in
            payment of the aggregate exercise
            price, the holder shall instead receive upon such exercise (either in whole or in part) only the net number
            of shares of Common Stock
            determined according to a formula set forth in the Class A warrants.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fractional
                Shares</i>. No fractional shares of Common Stock will be issued upon exercise of the warrants. If, upon
            exercise of the Class A warrant,
            a holder would be entitled to receive a fractional interest in a share, we will, in our discretion and upon
            exercise, either pay a cash
            adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the exercise
            price or round up to the
            next whole share.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability</i>.
            Subject to applicable laws, the Class A warrants may be offered for sale, sold, transferred or assigned at
            the option of the holder without
            our consent.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrant
                Agent; Global Certificate</i>. The warrants will be issued in registered form under a warrant agency
            agreement between the Warrant Agent
            and us. The warrants shall initially be represented only by one or more global warrants deposited with the
            Warrant Agent, as custodian
            on behalf of The Depository Trust Company (�DTC�) and registered in the name of Cede &amp; Co., a nominee of
            DTC, or as otherwise
            directed by DTC.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 91; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fundamental
                Transactions</i>. In the event of a �fundamental transaction,� as described in the Class A warrants and
            generally including
            any reorganization, recapitalization or reclassification of our Common Stock, the sale, transfer or other
            disposition of all or substantially
            all of our properties or assets, our consolidation or merger with or into another person, the acquisition of
            more than 50% of our outstanding
            shares of Common Stock, or any person or group becoming the beneficial owner of 50% of the voting power
            represented by our outstanding
            Common Stock, the holders of the Class A warrants will be entitled to receive upon exercise of the Class A
            warrants the kind and amount
            of securities, cash or other property that the holders would have received had they exercised the Class A
            warrants immediately prior
            to such fundamental transaction.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rights
                as a Stockholder</i>. Except by virtue of such holder�s ownership of shares of our Common Stock, the
            holder of a Class A warrant
            does not have the rights or privileges of a holder of our Common Stock, including any voting rights, until
            the holder exercises the Class
            A warrant.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        &nbsp;</p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
            Warrants</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
            two Public Warrants entitles the registered holder to purchase one share of Common Stock at a price of
            $11.50 per share, subject to adjustment
            as discussed below. Because the Public Warrants may only be exercised for whole numbers of shares of Common
            Stock, only an even number
            of warrants may be exercised at any given time by a warrant holder. The Public Warrants will expire five
            years after the anniversary
            of the completion of the Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption
            or liquidation.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            are not obligated to deliver any shares of Common Stock pursuant to the exercise of a Public Warrant and
            will have no obligation to settle
            such Public Warrant exercise unless a registration statement under the Securities Act with respect to the
            Common Stock underlying the
            Public Warrants is then effective and a prospectus relating thereto is current, subject to our satisfying
            our obligations described below
            with respect to registration. No warrant is exercisable and we are not obligated to issue a share of Common
            Stock upon exercise of a
            Public Warrant unless the share of Common Stock issuable upon such Public Warrant exercise has been
            registered, qualified or deemed to
            be exempt under the securities laws of the state of residence of the registered holder of the Public
            Warrants. In the event that the
            conditions in the two immediately preceding sentences are not satisfied with respect to a Public Warrant,
            the holder of such Public Warrant
            will not be entitled to exercise such Public Warrant and such Public Warrant may have no value and expire
            worthless. In no event will
            we be required to net cash settle any Public Warrant.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            a registration statement covering the shares of Common Stock issuable upon exercise of the warrants is not
            effective within 120 days
            after the closing of the Initial Business Combination Warrants holders may, until such time as there is an
            effective registration statement
            and during any period when we will have failed to maintain an effective registration statement, exercise
            warrants on a �cashless
            basis� in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the
            above, if our Common
            Stock at the time of any exercise of a warrant is not listed on a national securities exchange such that it
            satisfies the definition
            of a �covered security� under Section 18(b)(1) of the Securities Act, we may, at our option, require holders
            of Public Warrants
            who exercise their warrants to do so on a �cashless basis� in accordance with Section 3(a)(9) of the
            Securities Act and,
            in the event we so elect, we will not be required to file or maintain in effect a registration statement,
            and in the event we do not
            so elect, we will use our best efforts to register or qualify the shares under applicable blue sky laws to
            the extent an exemption is
            not available.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 92; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
            the warrants become exercisable, we may redeem the outstanding warrants (except as described herein with
            respect to the private placement
            warrants):</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                        whole and not in part;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                        a price of $0.01 per warrant;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                        not less than 30 days� prior written notice of redemption (the �30-day redemption period�) to
                        each warrant holder;
                        and</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                        and only if, the reported last sale price of the Common Stock equals or exceeds $18.00 per share
                        (as adjusted for share sub-divisions,
                        share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within
                        a 30-trading day period ending three
                        business days before we send the notice of redemption to the warrant holders.</span></td>
            </tr>
        </tbody>
    </table>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            the foregoing conditions are satisfied and we issue a notice of redemption, each warrant holder can exercise
            his, her or its warrant
            prior to the scheduled redemption date. However, the price of our Common Stock may fall below the $18.00
            trigger price, as well as the
            $11.50 warrant exercise price after the redemption notice is issued.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            and when the Public Warrants become redeemable by us, we may not exercise our redemption right if the
            issuance of Common Stock upon exercise
            of the Public Warrants is not exempt from registration or qualification under applicable state blue sky laws
            or we are unable to effect
            such registration or qualification. We will use our best efforts to register or qualify such Common Stock
            under the blue sky laws of
            the state of residence in those states in which the Public Warrants were offered by us in this
            offering.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have established the last of the redemption criterion discussed above to prevent a redemption call unless
            there is at the time of the
            call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we
            issue a notice of redemption
            of the warrants, each warrant holder will be entitled to exercise its warrant prior to the scheduled
            redemption date. However, the price
            of the Common Stock may fall below the $18.00 redemption trigger price (as adjusted for share sub-divisions,
            share dividends, reorganizations,
            recapitalizations and the like) as well as the $11.50 warrant exercise price after the redemption notice is
            issued.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            we call the Public Warrants for redemption as described above, our management will have the option to
            require any holder that wishes
            to exercise its warrant to do so on a �cashless basis.� In determining whether to require all holders to
            exercise their Public
            Warrants on a �cashless basis,� our management will consider, among other factors, our cash position, the
            number of Public
            Warrants that are outstanding and the dilutive effect on our stockholders of issuing the maximum number of
            shares of Common Stock issuable
            upon the exercise of our Public Warrants. If our management takes advantage of this option, all holders of
            Public Warrants would pay
            the exercise price by surrendering their Public Warrants for that number of shares of Common Stock equal to
            the quotient obtained by
            dividing (x) the product of the number of shares of Common Stock underlying the Public Warrants, multiplied
            by the difference between
            the exercise price of the Public Warrants and the �fair market value� (defined below) by (y) the fair market
            value. The �fair
            market value� shall mean the average reported last sale price of the Common Stock for the 10 trading days
            ending on the third trading
            day prior to the date on which the notice of redemption is sent to the holders of warrants. If our
            management takes advantage of this
            option, the notice of redemption will contain the information necessary to calculate the number of Common
            Stock to be received upon exercise
            of the Public Warrants, including the �fair market value� in such case. Requiring a cashless exercise in
            this manner will
            reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. We
            believe this feature is an
            attractive option to us if we do not need the cash from the exercise of the warrants after our initial
            business combination. If we call
            our warrants for redemption and the holders of private placement warrants do not take advantage of this
            option, the former sponsor and
            its permitted transferees would still be entitled to exercise their private placement warrants for cash or
            on a cashless basis using
            the same formula described above that other warrant holders would have been required to use had all warrant
            holders been required to
            exercise their warrants on a cashless basis, as described in more detail below. A holder of a Public Warrant
            may notify us in writing
            in the event it elects to be subject to a requirement that such holder will not have the right to exercise
            such Public Warrant, to the
            extent that after giving effect to such exercise, such person (together with such person�s affiliates), to
            the warrant agent�s
            actual knowledge, would beneficially own in excess of 4.9% or 9.9% (or such other amount as a holder may
            specify) of the Common Stock
            outstanding immediately after giving effect to such exercise.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 93; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            the number of outstanding shares of Common Stock is increased by a share dividend payable in stock, or by a
            split-up of stock or other
            similar event, then, on the effective date of such share dividend, split-up or similar event, the number of
            shares of Common Stock issuable
            on exercise of each warrant will be increased in proportion to such increase in the outstanding shares of
            Common Stock. A rights offering
            to holders of shares of Common Stock entitling holders to purchase shares of Common Stock at a price less
            than the fair market value
            will be deemed a share dividend of a number of Common Stock equal to the product of (i) the number of shares
            of Common Stock actually
            sold in such rights offering (or issuable under any other equity securities sold in such rights offering
            that are convertible into or
            exercisable for shares of Common Stock) and (ii) one (1) minus the quotient of (x) the price per share paid
            in such rights offering divided
            by (y) the fair market value. For these purposes (i) if the rights offering is for securities convertible
            into or exercisable for shares
            of Common Stock, in determining the price payable for Common Stock, there will be taken into account any
            consideration received for such
            rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value
            means the volume weighted average
            price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior
            to the first date on which
            the Common Stock trades on the applicable exchange or in the applicable market, regular way, without the
            right to receive such rights.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a
            distribution in cash, securities
            or other assets to the holders of Common Stock on account of such Common Stock (or other shares into which
            the warrants are convertible),
            other than (a) as described above, or (b) certain Common Stock cash dividends, then the warrant exercise
            price will be decreased, effective
            immediately after the effective date of such event, by the amount of cash and/or the fair market value of
            any securities or other assets
            paid on each share of Common Stock in respect of such event.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
            the number of outstanding shares of Common Stock is decreased by a consolidation, combination or
            reclassification of Common Stock or
            other similar event, then, on the effective date of such consolidation, combination, reclassification or
            similar event, the number of
            shares of Common Stock issuable on exercise of each warrant will be decreased in proportion to such decrease
            in outstanding shares of
            Common Stock.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whenever
            the number of shares of Common Stock purchasable upon the exercise of the warrants is adjusted, as described
            above, the warrant exercise
            price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a
            fraction (x) the numerator
            of which will be the number of shares of Common Stock purchasable upon the exercise of the warrants
            immediately prior to such adjustment,
            and (y) the denominator of which will be the number of shares of Common Stock so purchasable immediately
            thereafter.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            warrants are issued in registered form under the Warrant Agreement between Continental, as warrant agent,
            and us. The Warrant Agreement
            provides that the terms of the warrants may be amended without the consent of any holder to cure any
            ambiguity or correct any defective
            provision, but requires the approval by the holders of at least 50% of the then outstanding Public Warrants
            to make any change that adversely
            affects the interests of the registered holders of Public Warrants.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at
            the offices of the warrant
            agent, with the exercise form on the reverse side of the warrant certificate completed and executed as
            indicated, accompanied by full
            payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check
            payable to us, for the number
            of warrants being exercised. The warrant holders do not have the rights or privileges of holders of Common
            Stock and any voting rights
            until they exercise their warrants and receive shares of Common Stock. After the issuance of shares of
            Common Stock upon exercise of
            the Public Warrants, each holder will be entitled to one (1) vote for each share held of record on all
            matters to be voted on by stockholders.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private
            Placement Warrants</span></p>

    <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
            as described herein, the private placement warrants have terms and provisions that are identical to those of
            the warrants being sold
            as part of the units in this offering, including as to exercise price, exercisability and exercise
            period.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 94; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have policies in place that prohibit insiders from selling our securities except during specific periods of
            time. Even during such periods
            of time when insiders will be permitted to sell our securities, an insider cannot trade in our securities if
            he or she is in possession
            of material non-public information. Accordingly, unlike public stockholders who could sell their shares of
            Common Stock issuable upon
            exercise of the warrants freely in the open market, the insiders could be significantly restricted from
            doing so. As a result, we believe
            that allowing the holders to exercise such warrants on a cashless basis is appropriate.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            addition, holders of our private placement warrants are entitled to certain registration rights.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="D_008"></span>LEGAL
            MATTERS</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            validity of the securities being offered by this registration statement will be passed upon for us by Loeb
            &amp; Loeb LLP. <span style="color: #212529; background-color: white">Ellenoff
                Grossman &amp; Schole LLP is acting as counsel to the placement agent.</span></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="D_009"></span>EXPERTS</span>
    </p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            consolidated financial statements of DIH Holding US, Inc. as of March 31, 2024 and 2023 and for each of the
            fiscal years then ended,
            included in this prospectus and in the registration statement have been so included in the reliance on the
            report of BDO AG, an independent
            registered public accounting firm, given on the authority of said firm as experts in auditing and
            accounting.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><span
                id="D_010"></span>CHANGES
            IN REGISTRANT�S CERTIFYING ACCOUNTANT</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        On March 12, 2024, the Audit Committee of the Board of Directors dismissed
        Marcum LLP (�Marcum�) as the Company�s independent registered public accounting firm. Marcum had served as
        ATAK�s independent registered public accounting firm from May 2,
        2022 through March 12, 2024.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum�s
            audit reports on ATAK�s financial statements as of and for the year ended December 31, 2023 did not contain
            an adverse opinion
            or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting
            principles, other than an
            explanatory paragraph regarding the substantial doubt about the Company�s ability to continue as a going
            concern.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
            the fiscal year ended December 31, 2023 and the subsequent interim period through March 12, 2024: (1) there
            were no �disagreements�
            (as defined in Item 304(a)(1)(iv) of Regulation S-K) with Marcum on any matter of accounting principles or
            practices, financial statement
            disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of
            Marcum, would have caused Marcum
            to make reference to the subject matter of such disagreements in connection with its reports on the
            financial statements for such periods
            and (2) there were no �reportable events� (as defined in Item 304(a)(1)(v) of Regulation S-K), except for
            the disclosure
            of the material weakness in ATAK�s internal control over financial reporting as disclosed in Part II, Item
            9A of the Company�s
            Annual Report on Form 10-K for the year ended December 31, 2023.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company
        provided Marcum
        with a copy of the Current Report on Form 8-K dated March 12, 2024 prior to its filing with the Securities and
        Exchange Commission (the
        �SEC�) and requested that Marcum furnish the Company with a letter addressed to the SEC stating whether Marcum
        agrees with
        the statements made by the Company in this report and, if not, stating the respects, if any, in which Marcum
        does not agree with such
        statements. A copy of the letter from Marcum was filed as Exhibit 16.1 to the Current Report on Form 8-K dated
        March 12, 2024.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On March 12,
        2024, the Audit
        Committee engaged BDO AG (�BDO AG�) as its new independent registered public accounting firm. The Company has
        authorized
        Marcum to respond fully to the inquiries of BDO AG, as the successor independent registered accounting firm.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">BDO AG had
        served as independent
        registered public accounting firm for Legacy DIH up through the completion of the Business Combination. During
        the two most recent fiscal
        years and the subsequent interim period through March 12, 2024, the Company did not consult with BDO AG with
        respect to (i) the application
        of accounting principles to a specified transaction, either completed or proposed, the type of audit opinion
        that might be rendered on
        the Company�s financial statements, and neither a written report nor oral advice was provided to the Company
        that BDO AG concluded
        was an important factor considered by the Company in reaching a decision as to any accounting, auditing or
        financial reporting issue,
        or (ii) any matter that was either the subject of a disagreement (as that term is defined in Item 304(a)(1)(iv)
        of Regulation S-K and
        the related instructions to Item 304 of Regulation S-K) or a reportable event (as that term is defined in Item
        304(a)(1)(v) of Regulation
        S-K).</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On September
        10, 2024, the
        Audit Committee of the Board of Directors of the Company dismissed BDO AG as the Company�s independent
        registered public accounting
        firm. BDO AG had served as the Company�s independent registered public accounting firm since March 12, 2024 and
        had served as the
        independent auditor for Legacy DIH, the Company�s wholly-owned subsidiary, since 2022.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">BDO AG�s
        audit reports
        on the Company�s financial statements as of and for the fiscal years ended March 31, 2024 and 2023 did not
        contain an adverse opinion
        or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting
        principles.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the
        fiscal year ended
        March 31, 2024 and the subsequent interim period through September 10, 2024: (1) there were no �disagreements�
        (as defined
        in Item 304(a)(1)(iv) of Regulation S-K) with BDO AG on any matter of accounting principles or practices,
        financial statement disclosure,
        or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of BDO AG, would have
        caused BDO AG to make
        reference to the subject matter of such disagreements in connection with its reports on the financial statements
        for such periods and
        (2) there were no �reportable events� (as defined in Item 304(a)(1)(v) of Regulation S-K), except for the
        disclosure of the
        material weakness in the Company�s internal control over financial reporting as disclosed in Part II, Item 9A of
        the Company�s
        Annual Report on Form 10-K for the year ended March 31, 2024.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company
        provided BDO AG
        with a copy of the Current Report on Form 8-K dated September 10, 2024 prior to its filing with the Securities
        and Exchange Commission
        (the �SEC�) and requested that BDO AG furnish the Company with a letter addressed to the SEC stating whether BDO
        AG agrees
        with the statements made by the Company in this report and, if not, stating the respects, if any, in which BDO
        AG does not agree with
        such statements. A copy of the letter from BDO AG was filed as Exhibit 16.1 to the Company�s Form 8-K dated
        September 10, 2024.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On September
        10, 2024, the
        Audit Committee appointed BDO USA, PC (�BDO USA�) as its new independent registered public accounting firm. The
        Company has
        authorized BDO AG to respond fully to the inquiries of the successor independent registered accounting firm.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the
        two most recent
        fiscal years and the subsequent interim period through September 10, 2024, the Company did not consult with BDO
        USA with respect to (i)
        the application of accounting principles to a specified transaction, either completed or proposed, the type of
        audit opinion that might
        be rendered on the Company�s financial statements, and neither a written report nor oral advice was provided to
        the Company that
        BDO USA concluded was an important factor considered by the Company in reaching a decision as to any accounting,
        auditing or financial
        reporting issue, or (ii) any matter that was either the subject of a disagreement (as that term is defined in
        Item 304(a)(1)(iv) of Regulation
        S-K and the related instructions to Item 304 of Regulation S-K) or a reportable event (as that term is defined
        in Item 304(a)(1)(v) of
        Regulation S-K).</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="SSS_001"></span>WHERE
            YOU CAN FIND MORE INFORMATION</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have filed a registration statement on Form S-1, including exhibits, under the Securities Act, with respect
            to the securities offered
            by this prospectus. This prospectus does not contain all of the information included in the registration
            statement. For further information
            pertaining to us and our securities, you should refer to the registration statement and our exhibits.</span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
            addition, we file annual, quarterly and current reports, proxy statements and other information with the
            SEC. Our SEC filings are available
            to the public on a website maintained by the SEC located at <i>www.sec.gov</i>. We also maintain a website
            at <i>https://dih.com </i>statements
            and other information as soon as reasonably practicable after they are electronically filed with, or
            furnished to, the SEC. The information
            contained on, or that may be accessed through, our website is not part of, and is not incorporated into,
            this prospectus.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 95; Value: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        <!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in">
    </p>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="aab_008"></span>INDEX
            TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0" border="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
        <tbody>
            <tr style="vertical-align: top; background-color: rgb(204,238,255)">
                <td style="padding-left: 0pt; text-indent: 0pt"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#aab_001">Report
                            of Independent Registered Public Accounting Firm</a> (<span
                            style="text-decoration: underline">BDO AG, Zurich, Switzerland, PCAOB ID #
                            5988)</span></span></td>
                <td style="text-align: center; padding-left: 0pt; width: 0.5in">F-2</td>
            </tr>

            <tr style="vertical-align: top; background-color: White">
                <td style="padding-left: 0pt; text-indent: 0pt"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#aab_002">Consolidated
                            Balance Sheets</a></span></td>
                <td style="text-align: center; padding-left: 0pt">F-3</td>
            </tr>

            <tr style="vertical-align: top; background-color: rgb(204,238,255)">
                <td style="padding-left: 0pt; text-indent: 0pt"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#aab_003">Consolidated
                            Statements of Operations</a></span></td>
                <td style="text-align: center; padding-left: 0pt">F-4</td>
            </tr>

            <tr style="vertical-align: top; background-color: White">
                <td style="padding-left: 0pt; text-indent: 0pt"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#aab_004">Consolidated
                            Statements of Comprehensive Loss</a></span></td>
                <td style="text-align: center; padding-left: 0pt">F-5</td>
            </tr>

            <tr style="vertical-align: top; background-color: rgb(204,238,255)">
                <td style="padding-left: 0pt; text-indent: 0pt"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#aab_005">Consolidated
                            Statements of Cash Flows</a></span></td>
                <td style="text-align: center; padding-left: 0pt">F-6</td>
            </tr>

            <tr style="vertical-align: top; background-color: White">
                <td style="padding-left: 0pt; text-indent: 0pt"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#aab_006">Consolidated
                            Statements of Stockholders� Deficit</a></span></td>
                <td style="text-align: center; padding-left: 0pt">F-7</td>
            </tr>

            <tr style="vertical-align: top; background-color: rgb(204,238,255)">
                <td style="padding-left: 0pt; text-indent: 0pt"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a
                            href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#aab_007">Notes
                            to Consolidated Financial Statements</a></span></td>
                <td style="text-align: center; padding-left: 0pt">F-8</td>
            </tr>
        </tbody>
    </table>



    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in">
        &nbsp;</p>

    <table cellpadding="0" cellspacing="0" border="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
        <tbody>
            <tr style="vertical-align: top; background-color: rgb(204,238,255)">
                <td><a href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#f_001">Condensed
                        Consolidated Balance Sheets as of September 30, 2024 and March 31, 2024</a></td>
                <td style="vertical-align: bottom; text-align: center">F-37</td>
            </tr>
            <tr style="background-color: White">
                <td style="vertical-align: top"><a
                        href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#f_002">Condensed
                        Consolidated Statements of Operations for the Six Months
                        Ended September 30, 2024 and 2023</a></td>
                <td style="vertical-align: bottom; text-align: center; width: 0.5in">F-38</td>
            </tr>
            <tr style="background-color: rgb(204,238,255)">
                <td style="vertical-align: top"><a
                        href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#f_003">Condensed
                        Consolidated Statements of Comprehensive Loss for the Six
                        Months Ended September 30, 2024 and 2023</a></td>
                <td style="vertical-align: bottom; text-align: center">F-39</td>
            </tr>
            <tr style="background-color: White">
                <td style="vertical-align: top"><a
                        href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#f_004">Condensed
                        Consolidated Statements of Stockholders� Deficit for the Six Months Ended September 30, 2024 and
                        2023</a></td>
                <td style="vertical-align: bottom; text-align: center">F-40</td>
            </tr>
            <tr style="background-color: rgb(204,238,255)">
                <td style="vertical-align: top"><a
                        href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#f_005">Condensed
                        Consolidated Statements of Cash Flows for the Six Months
                        Ended September 30, 2024 and 2023</a></td>
                <td style="vertical-align: bottom; text-align: center">F-42</td>
            </tr>
            <tr style="background-color: White">
                <td style="vertical-align: top"><a
                        href="https://www.sec.gov/Archives/edgar/data/1883788/000149315225004604/form424b4.htm#f_006">Notes
                        to Condensed Consolidated Financial Statements for the Six Months Ended
                        September 30, 2024 and 2023</a></td>
                <td style="vertical-align: bottom; text-align: center">F-43</td>
            </tr>
        </tbody>
    </table>



    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <!-- Field: Page; Sequence: 96; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="aab_001"></span>Report
            of Independent Registered Public Accounting Firm</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
            and Board of Directors</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            Holding US, Inc.</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norwell,
            MA</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        &nbsp;</p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
                on the Consolidated Financial Statements</b></span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        &nbsp;</p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have audited the accompanying consolidated balance sheets of DIH Holding US, Inc. (the �Company�) as of
            March 31, 2024 and
            2023, the related consolidated statements of operations, comprehensive loss, stockholders� deficit, and cash
            flows for the years
            then ended, and the related notes (collectively referred to as the �consolidated financial statements�). In
            our opinion,
            the consolidated financial statements present fairly, in all material respects, the financial position of
            the Company at March 31, 2024
            and 2023, and the results of its operations and its cash flows for each of the years then ended<b>,</b> in
            conformity with accounting
            principles generally accepted in the United States of America.</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        &nbsp;</p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
                for Opinion</b></span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        &nbsp;</p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
            consolidated financial statements are the responsibility of the Company�s management. Our responsibility is
            to express an opinion
            on the Company�s consolidated financial statements based on our audits. We are a public accounting firm
            registered with the Public
            Company Accounting Oversight Board (United States) (�PCAOB�) and are required to be independent with respect
            to the Company
            in accordance with the U.S. federal securities laws and the applicable rules and regulations of the
            Securities and Exchange Commission
            and the PCAOB.</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        &nbsp;</p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and
            perform the audit to obtain
            reasonable assurance about whether the consolidated financial statements are free of material misstatement,
            whether due to error or fraud.
            The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
            financial reporting. As part
            of our audits we are required to obtain an understanding of internal control over financial reporting but
            not for the purpose of expressing
            an opinion on the effectiveness of the Company�s internal control over financial reporting. Accordingly, we
            express no such opinion.</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        &nbsp;</p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
            audits included performing procedures to assess the risks of material misstatement of the consolidated
            financial statements, whether
            due to error or fraud, and performing procedures that respond to those risks. Such procedures included
            examining, on a test basis, evidence
            regarding the amounts and disclosures in the consolidated financial statements. Our audits also included
            evaluating the accounting principles
            used and significant estimates made by management, as well as evaluating the overall presentation of the
            consolidated financial statements.
            We believe that our audits provide a reasonable basis for our opinion.</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 45pt; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zurich,
            July 15, 2024</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BDO
            AG</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellspacing="0" cellpadding="0"
        style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
        <tbody>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
                        Christoph Tschumi</span></td>
                <td style="padding-bottom: 1pt; width: 2%">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
                        Philipp Kegele</span></td>
            </tr>
            <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christoph
                        Tschumi</span></td>
                <td>&nbsp;</td>
                <td style="font: 10pt Times New Roman, Times, Serif"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philipp
                        Kegele</span></td>
            </tr>
        </tbody>
    </table>
    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
            have served as the Company�s auditor since 2022</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 97 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            HOLDING US, INC.</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="aab_002"></span>CONSOLIDATED
            BALANCE SHEETS</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
            thousands, except share and per share data)</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0" id="xdx_302_111_pn3n3_zZA4fOT5SqT2"
        summary="xdx: Statement - Condensed Consolidated Balance Sheets"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="display: none; vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_499_20240331_zKZmnlekoyp1"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_49C_20230331_zZgLGlfDmar3"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31,
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--AssetsAbstract_iB_z6TiC6bi07Jg"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold">Assets</td>
                <td>&nbsp;</td>
                <td colspan="2">&nbsp;</td>
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td colspan="2">&nbsp;</td>
                <td>&nbsp;</td>
            </tr>
            <tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_i01B_zcp61BYobTSl"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 0.75pt">Current assets:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maACzt8d_zWERqSbxcSIh"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 64%; text-align: left; padding-left: 10pt">Cash and cash equivalents</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 14%; text-align: right">
                    <ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextref="AsOf2024-03-31"
                        id="Fact000023" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,225
                    </ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 14%; text-align: right">
                    <ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextref="AsOf2023-03-31"
                        id="Fact000024" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,175
                    </ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40F_eus-gaap--RestrictedCash_i02I_maACzt8d_zA9AAxmni591"
                style="display: none; vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Restricted cash</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_408_eus-gaap--AccountsReceivableNetCurrent_i02I_maACzt8d_z0UabNUPsT0b"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Accounts receivable, net of allowances of $<span
                        id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20240331_zrUHnG5F1qC3"
                        title="Allowance for accounts receivable">
                        <ix:nonfraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent"
                            contextref="AsOf2024-03-31" id="Fact000032" format="ixt:numdotdecimal" decimals="-3"
                            scale="3" unitref="USD">667</ix:nonfraction>
                    </span> and $<span
                        id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20230331_zvLoyzOJr2rj"
                        title="Allowance for accounts receivable">
                        <ix:nonfraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent"
                            contextref="AsOf2023-03-31" id="Fact000034" format="ixt:numdotdecimal" decimals="-3"
                            scale="3" unitref="USD">1,683</ix:nonfraction>
                    </span>, respectively</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AccountsReceivableNetCurrent" contextref="AsOf2024-03-31"
                        id="Fact000029" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,197
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AccountsReceivableNetCurrent" contextref="AsOf2023-03-31"
                        id="Fact000030" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,998
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_400_eus-gaap--InventoryNet_i02I_maACzt8d_zVJO1p6CCvM"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Inventories, net</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:InventoryNet" contextref="AsOf2024-03-31" id="Fact000036"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,830</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:InventoryNet" contextref="AsOf2023-03-31" id="Fact000037"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,850</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--OtherReceivablesNetCurrent_i02I_maACzt8d_zgOSzugPmcIg"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Due from related party</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherReceivablesNetCurrent" contextref="AsOf2024-03-31"
                        id="Fact000039" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,688
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherReceivablesNetCurrent" contextref="AsOf2023-03-31"
                        id="Fact000040" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">6,383
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_402_eus-gaap--OtherAssetsCurrent_i02I_maACzt8d_zKAp5y5bBFu1"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other current assets</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherAssetsCurrent" contextref="AsOf2024-03-31" id="Fact000042"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,116</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherAssetsCurrent" contextref="AsOf2023-03-31" id="Fact000043"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,855</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--AssetsCurrent_i02TI_mtACzt8d_maAzwer_z8ONEqEhP8V1"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 20pt">Total current assets</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AssetsCurrent" contextref="AsOf2024-03-31" id="Fact000045"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">27,056</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AssetsCurrent" contextref="AsOf2023-03-31" id="Fact000046"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">25,261</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maAzwer_zlkFI5Mo3wHd"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Property, and equipment, net</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2024-03-31"
                        id="Fact000048" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">530
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2023-03-31"
                        id="Fact000049" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">742
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--CapitalizedComputerSoftwareNet_i01I_maAzwer_zHF4zpntFRBl"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 0.75pt">Capitalized software, net</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareNet" contextref="AsOf2024-03-31"
                        id="Fact000051" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,131
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareNet" contextref="AsOf2023-03-31"
                        id="Fact000052" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,019
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--OtherIntangibleAssetsNet_i01I_maAzwer_zrHR2znDC7Rk"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Other intangible assets, net</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherIntangibleAssetsNet" contextref="AsOf2024-03-31" id="Fact000054"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">380</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherIntangibleAssetsNet" contextref="AsOf2023-03-31" id="Fact000055"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">380</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maAzwer_zAj3TWAVhJbb"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 0.75pt">Operating lease, right-of-use assets, net</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextref="AsOf2024-03-31"
                        id="Fact000057" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,466
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextref="AsOf2023-03-31"
                        id="Fact000058" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,604
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--DeferredIncomeTaxAssetsNet_i01I_maAzwer_zqDlUd1ZgfU7"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Other tax assets</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextref="AsOf2024-03-31"
                        id="Fact000060" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">267
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextref="AsOf2023-03-31"
                        id="Fact000061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_401_eus-gaap--OtherAssetsNoncurrent_i01I_maAzwer_zpO4OB1PLm4c"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Other assets</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherAssetsNoncurrent" contextref="AsOf2024-03-31" id="Fact000063"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">905</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherAssetsNoncurrent" contextref="AsOf2023-03-31" id="Fact000064"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">772</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--Assets_i01TI_mtAzwer_z4ePWLV2bO07"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Total assets</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:Assets" contextref="AsOf2024-03-31" id="Fact000066"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">35,735</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:Assets" contextref="AsOf2023-03-31" id="Fact000067"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">31,779</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40D_eus-gaap--LiabilitiesAbstract_iB_zp0fBXebWNTb"
                style="vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; text-align: left; padding-left: 0.75pt">Liabilities and Deficit</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_402_eus-gaap--LiabilitiesCurrentAbstract_i01B_zXNvlslA0a6d"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Current liabilities:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_eus-gaap--AccountsPayableCurrent_i02I_maLCza9o_zojExLV4dQHa"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Accounts payable</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AccountsPayableCurrent" contextref="AsOf2024-03-31" id="Fact000075"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,305</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AccountsPayableCurrent" contextref="AsOf2023-03-31" id="Fact000076"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,190</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40D_eus-gaap--EmployeeRelatedLiabilitiesCurrent_i02I_maLCza9o_zaAXmUdP4RHd"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Employee compensation</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextref="AsOf2024-03-31"
                        id="Fact000078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,664
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextref="AsOf2023-03-31"
                        id="Fact000079" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,163
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_402_eus-gaap--OtherLiabilitiesCurrent_i02I_maLCza9o_z41l8tN0QNa6"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Due to related party</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherLiabilitiesCurrent" contextref="AsOf2024-03-31" id="Fact000081"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">10,192</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherLiabilitiesCurrent" contextref="AsOf2023-03-31" id="Fact000082"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">6,841</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--ContractWithCustomerLiabilityCurrent_i02I_maLCza9o_znBoOl5CWRe2"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Current portion of deferred revenue</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextref="AsOf2024-03-31"
                        id="Fact000084" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,211
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextref="AsOf2023-03-31"
                        id="Fact000085" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,714
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40F_eus-gaap--StandardProductWarrantyAccrualCurrent_i02I_maLCza9o_z9cjgohW1ySb"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Manufacturing warranty obligation</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:StandardProductWarrantyAccrualCurrent" contextref="AsOf2024-03-31"
                        id="Fact000087" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">513
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:StandardProductWarrantyAccrualCurrent" contextref="AsOf2023-03-31"
                        id="Fact000088" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">973
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maLCza9o_zPJ3BjRXWch"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Current portion of long-term operating lease</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AsOf2024-03-31"
                        id="Fact000090" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,572
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AsOf2023-03-31"
                        id="Fact000091" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,005
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--ConvertibleDebtCurrent_i02I_maLCza9o_zY4y9vq2Fa8b"
                style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Current maturities of convertible debt, at fair value
                </td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_403_ecustom--AdvancePaymentsFromCustomers_i02I_maLCza9o_z84d2zx4xcpa"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Advance payments from customers</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:AdvancePaymentsFromCustomers" contextref="AsOf2024-03-31" id="Fact000096"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">10,562</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:AdvancePaymentsFromCustomers" contextref="AsOf2023-03-31" id="Fact000097"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">6,255</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_400_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_i02I_maLCza9o_zqgYgzd6Lzc7"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accrued expenses and other current
                    liabilities</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent"
                        contextref="AsOf2024-03-31" id="Fact000099" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">9,935</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent"
                        contextref="AsOf2023-03-31" id="Fact000100" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">8,631</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40D_eus-gaap--LiabilitiesCurrent_i02TI_mtLCza9o_maLz2FI_z6PKaFjwKjS5"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 0.75pt">Total current liabilities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:LiabilitiesCurrent" contextref="AsOf2024-03-31" id="Fact000102"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">44,954</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:LiabilitiesCurrent" contextref="AsOf2023-03-31" id="Fact000103"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">36,772</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--NotesPayable_i01I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLz2FI_zNpRvSbhhRRl"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Notes payable - related party</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:NotesPayable" contextref="AsOf2024-03-31_us-gaap_RelatedPartyMember"
                        id="Fact000105" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">11,457
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:NotesPayable" contextref="AsOf2023-03-31_us-gaap_RelatedPartyMember"
                        id="Fact000106" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">17,301
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40F_eus-gaap--ConvertibleDebtNoncurrent_i01I_maLz2FI_zx1dEXUs5Gok"
                style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Convertible debt, net of current maturities, at fair
                    value</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40D_eus-gaap--ContractWithCustomerLiabilityNoncurrent_i01I_maLz2FI_zbZqTVWfsVr9"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Non-current deferred revenues</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextref="AsOf2024-03-31"
                        id="Fact000111" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,670
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextref="AsOf2023-03-31"
                        id="Fact000112" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,282
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maLz2FI_zXM0DHFkBhzk"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Long-term operating lease</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AsOf2024-03-31"
                        id="Fact000114" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,917
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AsOf2023-03-31"
                        id="Fact000115" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,621
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_402_eus-gaap--DeferredIncomeTaxLiabilitiesNet_i01I_maLz2FI_zP0IUlWaL8rh"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Deferred tax liabilities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextref="AsOf2024-03-31"
                        id="Fact000117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">112
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextref="AsOf2023-03-31"
                        id="Fact000118" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">110
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_401_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLz2FI_zrzUneSncwY6"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other non-current liabilities</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherLiabilitiesNoncurrent" contextref="AsOf2024-03-31"
                        id="Fact000120" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,171
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherLiabilitiesNoncurrent" contextref="AsOf2023-03-31"
                        id="Fact000121" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,647
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_400_eus-gaap--Liabilities_i01TI_mtLz2FI_maLASEzCv0_zUrXKufcHWAl"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Total liabilities</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:Liabilities" contextref="AsOf2024-03-31" id="Fact000123"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">68,281</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:Liabilities" contextref="AsOf2023-03-31" id="Fact000124"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">60,733</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_403_eus-gaap--CommitmentsAndContingencies_iI_maLASEzCv0_zDeuqhR7Nfsd"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Commitments and contingencies (Note 16)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span
                        style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                            style="-sec-ix-hidden: xdx2ixbrl0126">-</span></span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span
                        style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                            style="-sec-ix-hidden: xdx2ixbrl0127">-</span></span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--StockholdersEquityAbstract_i01B_zrz9sPIOFCoi"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 0.75pt">Deficit:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_402_eus-gaap--PreferredStockValue_i02I_maSEzXdI_zDlFZLfj4Opa"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Preferred Stock, $<span
                        id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240331_zaJ75J7AIorj"
                        title="Preferred stock, par value"><span
                            id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20230331_zvQP6BT2cZnk"
                            title="Preferred stock, par value">
                            <ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare"
                                contextref="AsOf2024-03-31" id="Fact000135" format="ixt:numdotdecimal" decimals="INF"
                                unitref="USDPShares">
                                <ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare"
                                    contextref="AsOf2023-03-31" id="Fact000137" format="ixt:numdotdecimal"
                                    decimals="INF" unitref="USDPShares">0.00001</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> par value&#894; <span
                        id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240331_zNkPCN2ZYEy7"
                        title="Preferred stock, shares authorized"><span
                            id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20230331_zoSAk33kH3O8"
                            title="Preferred stock, shares authorized">
                            <ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" contextref="AsOf2024-03-31"
                                id="Fact000139" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                <ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized"
                                    contextref="AsOf2023-03-31" id="Fact000141" format="ixt:numdotdecimal"
                                    decimals="INF" unitref="Shares">10,000,000</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> shares authorized; <span
                        id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20240331_znP7OfX2eFg3"
                        title="Preferred stock, shares issued"><span
                            id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20240331_zze296QF95ad"
                            title="Preferred stock, shares outstanding">
                            <ix:nonfraction name="us-gaap:PreferredStockSharesIssued" contextref="AsOf2024-03-31"
                                id="Fact000143" format="ixt-sec:numwordsen" decimals="INF" unitref="Shares">
                                <ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding"
                                    contextref="AsOf2024-03-31" id="Fact000145" format="ixt-sec:numwordsen"
                                    decimals="INF" unitref="Shares">no</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> shares issued and outstanding at March 31, 2024&#894; <span
                        id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20230331_zsilIP4ZclL9"
                        title="Preferred stock, shares issued"><span
                            id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20230331_zWM6sKATCQNl"
                            title="Preferred stock, shares outstanding">
                            <ix:nonfraction name="us-gaap:PreferredStockSharesIssued" contextref="AsOf2023-03-31"
                                id="Fact000147" format="ixt-sec:numwordsen" decimals="INF" unitref="Shares">
                                <ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding"
                                    contextref="AsOf2023-03-31" id="Fact000149" format="ixt-sec:numwordsen"
                                    decimals="INF" unitref="Shares">no</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> shares authorized, issued and outstanding at March 31, 2023</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0132">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0133">�</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40E_eus-gaap--CommonStockValue_i02I_maSEzXdI_zprpurQOo9fa"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Common stock, $<span
                        id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240331_zUJrFkJEawH5"
                        title="Common stock, par value"><span
                            id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230331_z4qZdU22jPp9"
                            title="Common stock, par value">
                            <ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare"
                                contextref="AsOf2024-03-31" id="Fact000154" format="ixt:numdotdecimal" decimals="INF"
                                unitref="USDPShares">
                                <ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare"
                                    contextref="AsOf2023-03-31" id="Fact000156" format="ixt:numdotdecimal"
                                    decimals="INF" unitref="USDPShares">0.0001</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> par value&#894; <span
                        id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240331_zPGZth6MWJ3c"
                        title="Common stock, shares authorized"><span
                            id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20230331_zjztV3laEk8i"
                            title="Common stock, shares authorized">
                            <ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" contextref="AsOf2024-03-31"
                                id="Fact000158" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                <ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" contextref="AsOf2023-03-31"
                                    id="Fact000160" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                    100,000,000</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> shares authorized&#894; <span
                        id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_do_c20240331_zQ3SAhN10k9c"
                        title="Common  stock, shares issued"><span
                            id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_do_c20240331_zOfyE1d8JTi1"
                            title="Common  stock, shares outstanding">
                            <ix:nonfraction name="us-gaap:CommonStockSharesIssued" contextref="AsOf2024-03-31"
                                id="Fact000162" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                <ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" contextref="AsOf2024-03-31"
                                    id="Fact000164" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                    34,544,935</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> shares issued and outstanding at March 31, 2024&#894; <span
                        id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_pid_do_c20230331_znnCOmYwGo77"
                        title="Common  stock, shares issued"><span
                            id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_do_c20230331_zS1F1qivZJjk"
                            title="Common  stock, shares outstanding">
                            <ix:nonfraction name="us-gaap:CommonStockSharesIssued" contextref="AsOf2023-03-31"
                                id="Fact000166" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                <ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" contextref="AsOf2023-03-31"
                                    id="Fact000168" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                    25,000,000</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> shares authorized, issued and outstanding at March 31, 2023</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:CommonStockValue" contextref="AsOf2024-03-31" id="Fact000151"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:CommonStockValue" contextref="AsOf2023-03-31" id="Fact000152"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_402_eus-gaap--AdditionalPaidInCapital_i02I_maSEzXdI_zNDL4Cq5GlM3"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Additional paid-in-capital</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AdditionalPaidInCapital" contextref="AsOf2024-03-31" id="Fact000170"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,613</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:AdditionalPaidInCapital"
                        contextref="AsOf2023-03-31" id="Fact000171" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        sign="-" unitref="USD">1,898</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_405_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzXdI_zZUPf9Zuh2Uj"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Accumulated deficit</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit"
                        contextref="AsOf2024-03-31" id="Fact000173" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        sign="-" unitref="USD">35,212</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit"
                        contextref="AsOf2023-03-31" id="Fact000174" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        sign="-" unitref="USD">26,769</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_406_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maSEzXdI_z6eitrmLZPv1"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accumulated other comprehensive
                    income (loss)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax"
                        contextref="AsOf2024-03-31" id="Fact000176" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">50</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextref="AsOf2023-03-31"
                        id="Fact000177" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">289
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_40E_eus-gaap--StockholdersEquity_i01TI_mtSEzXdI_maLASEzCv0_z1k5aMTmzH34"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Total deficit</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2024-03-31" id="Fact000179"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">32,546
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2023-03-31" id="Fact000180"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">28,954
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtLASEzCv0_zkUjSbIu7fmc"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Total liabilities and deficit
                </td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextref="AsOf2024-03-31"
                        id="Fact000182" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">35,735
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextref="AsOf2023-03-31"
                        id="Fact000183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">31,779
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            accompanying notes are an integral part of these consolidated financial statements.</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 98 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            HOLDING US, INC.</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="aab_003"></span>CONSOLIDATED
            STATEMENTS OF OPERATIONS</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
            thousands, except per share data)</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0" id="xdx_30C_113_pn3n3_zeRbmo75Mbvh"
        summary="xdx: Statement - Condensed Consolidated Statements of Operations"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="display: none; vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_497_20230401__20240331_zpU9kXZbT094"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_498_20220401__20230331_zf2Mn3FWSeDd"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years
                    Ended March 31,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzhOt_zK1E3e71PDs6"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 64%; padding-left: 0.75pt">Revenue</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 14%; text-align: right">
                    <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                        contextref="From2023-04-012024-03-31" id="Fact000185" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">64,473</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 14%; text-align: right">
                    <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                        contextref="From2022-04-012023-03-31" id="Fact000186" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">54,059</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--CostOfGoodsAndServicesSold_msGPzhOt_z7EK5RTW979c"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-bottom: 1pt; padding-left: 0.75pt">Cost of sales</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:CostOfGoodsAndServicesSold" contextref="From2023-04-012024-03-31"
                        id="Fact000188" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">34,702
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:CostOfGoodsAndServicesSold" contextref="From2022-04-012023-03-31"
                        id="Fact000189" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">23,474
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40E_eus-gaap--GrossProfit_iT_mtGPzhOt_maOILzull_zvb3oQoEAkma"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Gross profit</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:GrossProfit" contextref="From2023-04-012024-03-31" id="Fact000191"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">29,771</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:GrossProfit" contextref="From2022-04-012023-03-31" id="Fact000192"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">30,585</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40D_eus-gaap--OperatingExpensesAbstract_iB_zd6ftPtYcvuf"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 0.75pt">Operating expenses:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_401_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maOEzqvZ_zGY4TUIqrork"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Selling, general, and administrative expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:SellingGeneralAndAdministrativeExpense"
                        contextref="From2023-04-012024-03-31" id="Fact000197" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">25,776</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:SellingGeneralAndAdministrativeExpense"
                        contextref="From2022-04-012023-03-31" id="Fact000198" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">22,957</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzqvZ_zfZPyQwFkuFh"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Research and development</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:ResearchAndDevelopmentExpense" contextref="From2023-04-012024-03-31"
                        id="Fact000200" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">6,609
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:ResearchAndDevelopmentExpense" contextref="From2022-04-012023-03-31"
                        id="Fact000201" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">6,919
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_404_eus-gaap--OperatingExpenses_i01T_mtOEzqvZ_msOILzull_zRiEXePtCOH5"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Total operating expenses</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingExpenses" contextref="From2023-04-012024-03-31"
                        id="Fact000203" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">32,385
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingExpenses" contextref="From2022-04-012023-03-31"
                        id="Fact000204" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">29,876
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--OperatingIncomeLoss_iT_mtOILzull_maILFCOzI9W_zBgo9hP0fWD8"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Operating income (loss)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OperatingIncomeLoss" contextref="From2023-04-012024-03-31" id="Fact000206"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">2,614</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingIncomeLoss" contextref="From2022-04-012023-03-31"
                        id="Fact000207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">709
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_402_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zPWnmdZHoaYa"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Other income (expense):</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_404_eus-gaap--InterestExpenseNonoperating_i01N_di_msNIEzDpH_zObaHWrgQL36"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Interest (expense)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:InterestExpenseNonoperating"
                        contextref="From2023-04-012024-03-31" id="Fact000212" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">693</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:InterestExpenseNonoperating"
                        contextref="From2022-04-012023-03-31" id="Fact000213" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">277</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_400_eus-gaap--OtherNonoperatingIncomeExpense_i01_maNIEzDpH_zo3gw6EOENu6"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other income (expense), net</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherNonoperatingIncomeExpense" contextref="From2023-04-012024-03-31"
                        id="Fact000215" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">3,890
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherNonoperatingIncomeExpense" contextref="From2022-04-012023-03-31"
                        id="Fact000216" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">572
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpense_i01T_maILFCOzI9W_mtNIEzDpH_zui0e2cE4DM9"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Total other income (expense)
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:NonoperatingIncomeExpense" contextref="From2023-04-012024-03-31" id="Fact000218"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">4,583</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:NonoperatingIncomeExpense" contextref="From2022-04-012023-03-31"
                        id="Fact000219" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">295
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzI9W_maNILz6Ys_zLEx3CADBoef"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Income (loss) before income taxes</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
                        contextref="From2023-04-012024-03-31" id="Fact000221" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">7,197</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction
                        name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
                        contextref="From2022-04-012023-03-31" id="Fact000222" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,004</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--IncomeTaxExpenseBenefit_msNILz6Ys_zp4j9HDpm4A1"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Income tax expense</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" contextref="From2023-04-012024-03-31"
                        id="Fact000224" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,246
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" contextref="From2022-04-012023-03-31"
                        id="Fact000225" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,018
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_402_eus-gaap--NetIncomeLoss_iT_mtNILz6Ys_zNLwcOCaSWG"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Net loss</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:NetIncomeLoss" contextref="From2023-04-012024-03-31" id="Fact000227"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">8,443</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:NetIncomeLoss" contextref="From2022-04-012023-03-31" id="Fact000228"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,014</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 0.75pt">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Net loss per share, basic and
                    diluted</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right"><span
                        id="xdx_907_eus-gaap--EarningsPerShareBasic_pid_c20230401__20240331_z5HDFiXO3zj8"
                        title="Net loss per share, basic"
                        class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span
                            id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20240331_zBjIA4E06Dih"
                            title="Net loss per share, diluted"
                            class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(
                            <ix:nonfraction name="us-gaap:EarningsPerShareBasic" contextref="From2023-04-012024-03-31"
                                id="Fact000230" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">
                                <ix:nonfraction name="us-gaap:EarningsPerShareDiluted"
                                    contextref="From2023-04-012024-03-31" id="Fact000232" format="ixt:numdotdecimal"
                                    decimals="INF" sign="-" unitref="USDPShares">0.32</ix:nonfraction>
                            </ix:nonfraction></span></span></td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right"><span
                        id="xdx_900_eus-gaap--EarningsPerShareBasic_pid_c20220401__20230331_zqfdcKaeVTpe"
                        title="Net loss per share, basic"
                        class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span
                            id="xdx_909_eus-gaap--EarningsPerShareDiluted_pid_c20220401__20230331_zXm72PasjUW9"
                            title="Net loss per share, diluted"
                            class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(
                            <ix:nonfraction name="us-gaap:EarningsPerShareBasic" contextref="From2022-04-012023-03-31"
                                id="Fact000234" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">
                                <ix:nonfraction name="us-gaap:EarningsPerShareDiluted"
                                    contextref="From2022-04-012023-03-31" id="Fact000236" format="ixt:numdotdecimal"
                                    decimals="INF" sign="-" unitref="USDPShares">0.04</ix:nonfraction>
                            </ix:nonfraction></span></span></td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Weighted-average shares
                    outstanding, basic and diluted</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right"><span
                        id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230401__20240331_zlmu6RVC47w5"
                        title="Weighted-average shares outstanding, basic"
                        class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span
                            id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230401__20240331_zUjWIq3JJfQ3"
                            title="Weighted-average shares outstanding, diluted"
                            class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">
                            <ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"
                                contextref="From2023-04-012024-03-31" id="Fact000238" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="Shares">
                                <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                    contextref="From2023-04-012024-03-31" id="Fact000240" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="Shares">26,382</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span></td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right"><span
                        id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220401__20230331_zsOcjAUKVfR8"
                        title="Weighted-average shares outstanding, basic"
                        class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span
                            id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220401__20230331_z0DharmDyX2d"
                            title="Weighted-average shares outstanding, diluted"
                            class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">
                            <ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"
                                contextref="From2022-04-012023-03-31" id="Fact000242" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="Shares">
                                <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                    contextref="From2022-04-012023-03-31" id="Fact000244" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="Shares">25,000</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span></td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            accompanying notes are an integral part of these consolidated financial statements.</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 99 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            HOLDING US, INC.</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="aab_004"></span>CONSOLIDATED
            STATEMENTS OF COMPREHENSIVE LOSS</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
            thousands)</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0" id="xdx_306_113_pn3n3_zxTMnFD2my7"
        summary="xdx: Statement - Condensed Consolidated Statements of Comprehensive Loss"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="display: none; vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_492_20230401__20240331_zSRHTvJcLdXf"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_490_20220401__20230331_zEdVDsGURiXj"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years
                    Ended March 31,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--NetIncomeLoss_maCINOTzGx1_zzr16ONcB9Hc"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 64%; text-align: left; padding-left: 0.75pt">Net loss</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 14%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2023-04-012024-03-31" id="Fact000246" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">8,443</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 14%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2022-04-012023-03-31" id="Fact000247" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">1,014</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
            </tr>
            <tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParentAbstract_iB_z3UDpfqzwJ4b"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 0.75pt">Other comprehensive (loss) income, net of tax</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_i01_maOCILNzFCU_zE7Sy4MXbB03"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Foreign currency translation adjustments, net of tax of
                    $<span
                        id="xdx_90B_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_pn3n3_c20230401__20240331_z0TQbKQ3rnBe"
                        title="Foreign currency translation adjustments, net of tax">
                        <ix:nonfraction
                            name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"
                            contextref="From2023-04-012024-03-31" id="Fact000255" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">0</ix:nonfraction>
                    </span> and $<span
                        id="xdx_90B_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_pn3n3_c20220401__20230331_zsQ8lPByz1j4"
                        title="Foreign currency translation adjustments, net of tax">
                        <ix:nonfraction
                            name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"
                            contextref="From2022-04-012023-03-31" id="Fact000257" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">0</ix:nonfraction>
                    </span></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"
                        contextref="From2023-04-012024-03-31" id="Fact000252" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,455</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"
                        contextref="From2022-04-012023-03-31" id="Fact000253" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">503</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_408_eus-gaap--OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_i01N_di_msOCILNzFCU_zdG0mq4iHUB"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Pension liability adjustments, net
                    of tax of $<span
                        id="xdx_906_eus-gaap--OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_c20230401__20240331_zpwRGPzAbt9b"
                        title="Pension liability adjustments, net of tax">
                        <ix:nonfraction
                            name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"
                            contextref="From2023-04-012024-03-31" id="Fact000262" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">0</ix:nonfraction>
                    </span> and $<span
                        id="xdx_90D_eus-gaap--OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_c20220401__20230331_zaTQ6aHNRBy3"
                        title="Pension liability adjustments, net of tax">
                        <ix:nonfraction
                            name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"
                            contextref="From2022-04-012023-03-31" id="Fact000264" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">0</ix:nonfraction>
                    </span></td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
                        contextref="From2023-04-012024-03-31" id="Fact000259" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,116</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
                        contextref="From2022-04-012023-03-31" id="Fact000260" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">421</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_405_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_i01T_maCINOTzGx1_mtOCILNzFCU_zvEhWNXe5ly8"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other comprehensive (loss) income
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"
                        contextref="From2023-04-012024-03-31" id="Fact000266" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">339</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"
                        contextref="From2022-04-012023-03-31" id="Fact000267" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">924</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--ComprehensiveIncomeNetOfTax_iT_mtCINOTzGx1_zYYRxo0J2oCg"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Comprehensive loss</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:ComprehensiveIncomeNetOfTax" contextref="From2023-04-012024-03-31" id="Fact000269"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">8,104</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:ComprehensiveIncomeNetOfTax" contextref="From2022-04-012023-03-31" id="Fact000270"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,938</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
            accompanying notes to the consolidated financial statements.</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 100 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            HOLDING US, INC.</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="aab_005"></span>CONSOLIDATED
            STATEMENTS OF CASH FLOWS</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
            thousands)</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0" id="xdx_309_112_pn3n3_zJDzVCBu1X4h"
        summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="display: none; vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_491_20230401__20240331_zXcNLEIsDvZi"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_495_20220401__20230331_zZxfp77e46G5"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years
                    Ended March 31,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zhD5IlnFJ7X1"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; text-align: left; padding-left: 0.75pt">Cash flows from operating
                    activities:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_maNCPBUzoJr_zxfFZy398ksd"
                style="vertical-align: bottom; background-color: White">
                <td style="width: 64%; text-align: left; padding-left: 0.75pt">Net loss</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 14%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2023-04-012024-03-31" id="Fact000275" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">8,443</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 14%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2022-04-012023-03-31" id="Fact000276" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">1,014</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zaP3vWTrll0c"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Adjustments to reconcile net loss to net cash
                    provided by operating activities:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--DepreciationDepletionAndAmortization_i02_maNCPBUzoJr_zSDxaCA03UXh"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Depreciation and amortization</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:DepreciationDepletionAndAmortization"
                        contextref="From2023-04-012024-03-31" id="Fact000281" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">302</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:DepreciationDepletionAndAmortization"
                        contextref="From2022-04-012023-03-31" id="Fact000282" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">66</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_404_eus-gaap--ProvisionForDoubtfulAccounts_i02_maNCPBUzoJr_zNQXMCxRqo77"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Provision for credit losses</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:ProvisionForDoubtfulAccounts"
                        contextref="From2023-04-012024-03-31" id="Fact000284" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">1,016</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ProvisionForDoubtfulAccounts" contextref="From2022-04-012023-03-31"
                        id="Fact000285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">669
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_404_ecustom--AllowanceForInventoryObsolescence_i02_maNCPBUzoJr_zB86EXxZWsej"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Allowance for inventory obsolescence</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:AllowanceForInventoryObsolescence" contextref="From2023-04-012024-03-31"
                        id="Fact000287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">617
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="DHAI:AllowanceForInventoryObsolescence"
                        contextref="From2022-04-012023-03-31" id="Fact000288" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">1,639</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_408_ecustom--NoncashBusinessCombinationExpense_i02_maNCPBUzoJr_z0HLuVFAuULd"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Noncash business combination expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:NoncashBusinessCombinationExpense" contextref="From2023-04-012024-03-31"
                        id="Fact000290" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,514
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0291">-</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_eus-gaap--PensionContributions_i02N_di_msNCPBUzoJr_zZMgo9luu7Y4"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Pension contributions</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:PensionContributions"
                        contextref="From2023-04-012024-03-31" id="Fact000293" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">530</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:PensionContributions"
                        contextref="From2022-04-012023-03-31" id="Fact000294" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">569</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_405_ecustom--PensionIncomeExpense_i02N_di_msNCPBUzoJr_zeYNyKAk7ZFi"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Pension (income) expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="DHAI:PensionIncomeExpense"
                        contextref="From2023-04-012024-03-31" id="Fact000296" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">75</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="DHAI:PensionIncomeExpense"
                        contextref="From2022-04-012023-03-31" id="Fact000297" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">400</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_40D_ecustom--ChangeInFairValueOfConvertibleDebtAndWarrantLiability_i02_maNCPBUzoJr_z7vDsCSOkpye"
                style="display: none; vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Change in fair value of convertible debt and warrant
                    liability</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40E_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i02N_di_msNCPBUzoJr_zdIzaLz0m01l"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Foreign exchange (gain) loss</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax"
                        contextref="From2023-04-012024-03-31" id="Fact000302" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">376</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextref="From2022-04-012023-03-31"
                        id="Fact000303" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">584
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_402_ecustom--NoncashLeaseExpense_i02_maNCPBUzoJr_zC8Wit59q9j4"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Noncash lease expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:NoncashLeaseExpense" contextref="From2023-04-012024-03-31"
                        id="Fact000305" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,590
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:NoncashLeaseExpense" contextref="From2022-04-012023-03-31"
                        id="Fact000306" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,423
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--OtherNoncashExpense_i02_maNCPBUzoJr_zfpQHxpxJ52j"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Noncash interest expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherNoncashExpense" contextref="From2023-04-012024-03-31"
                        id="Fact000308" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">28
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherNoncashExpense" contextref="From2022-04-012023-03-31"
                        id="Fact000309" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">19
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_ecustom--ChangeInManufacturingWarrantyObligationEstimate_i02N_di_msNCPBUzoJr_zhi6urbtNZOb"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Change in manufacturing warranty obligation estimate
                </td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="DHAI:ChangeInManufacturingWarrantyObligationEstimate"
                        contextref="From2023-04-012024-03-31" id="Fact000311" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">626</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0312">�</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_ecustom--DeferredAndOtherNoncashIncomeTaxExpenseBenefit_i02_maNCPBUzoJr_zAQ9An1iaOQg"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Deferred and other noncash income tax expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="DHAI:DeferredAndOtherNoncashIncomeTaxExpenseBenefit" contextref="From2023-04-012024-03-31"
                        id="Fact000314" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">304
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:DeferredAndOtherNoncashIncomeTaxExpenseBenefit"
                        contextref="From2022-04-012023-03-31" id="Fact000315" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">58</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zq9QRwyXRYRe"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Changes in operating assets and liabilities:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsReceivable_i02N_di_msNCPBUzoJr_zvRkPMtBYR72"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Accounts receivable</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInAccountsReceivable"
                        contextref="From2023-04-012024-03-31" id="Fact000320" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">1,853</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInAccountsReceivable"
                        contextref="From2022-04-012023-03-31" id="Fact000321" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">514</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInInventories_i02N_di_msNCPBUzoJr_z911YVNwKaE1"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt">Inventories</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInInventories"
                        contextref="From2023-04-012024-03-31" id="Fact000323" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">3,259</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInInventories" contextref="From2022-04-012023-03-31"
                        id="Fact000324" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">518
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--IncreaseDecreaseInDueFromRelatedPartiesCurrent_i02N_di_msNCPBUzoJr_zKGgtsofoUgd"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Due from related parties</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent"
                        contextref="From2023-04-012024-03-31" id="Fact000326" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">1,018</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent"
                        contextref="From2022-04-012023-03-31" id="Fact000327" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">969</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_403_ecustom--IncreaseDecreaseInDueToRelatedPartyCurrent_i02_maNCPBUzoJr_zl9jSXi87Y8j"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Due to related parties</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:IncreaseDecreaseInDueToRelatedPartyCurrent"
                        contextref="From2023-04-012024-03-31" id="Fact000329" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">3,337</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:IncreaseDecreaseInDueToRelatedPartyCurrent"
                        contextref="From2022-04-012023-03-31" id="Fact000330" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">2,471</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOtherOperatingAssets_i02N_di_msNCPBUzoJr_zOnzDozg0xEk"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Other assets</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets"
                        contextref="From2023-04-012024-03-31" id="Fact000332" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">229</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets"
                        contextref="From2022-04-012023-03-31" id="Fact000333" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,805</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_407_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i02_maNCPBUzoJr_zNeKmmkrpD5l"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Operating lease liabilities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability"
                        contextref="From2023-04-012024-03-31" id="Fact000335" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">1,782</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability"
                        contextref="From2022-04-012023-03-31" id="Fact000336" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">1,448</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayable_i02_maNCPBUzoJr_zowbnkiVUzIi"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Accounts payable</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInAccountsPayable"
                        contextref="From2023-04-012024-03-31" id="Fact000338" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">2,920</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInAccountsPayable"
                        contextref="From2022-04-012023-03-31" id="Fact000339" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">38</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInEmployeeRelatedLiabilities_i02_maNCPBUzoJr_zTQXD79qOn7d"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Employee compensation</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities"
                        contextref="From2023-04-012024-03-31" id="Fact000341" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">551</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities"
                        contextref="From2022-04-012023-03-31" id="Fact000342" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">151</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOtherNoncurrentLiabilities_i02_maNCPBUzoJr_zLM493WINrI7"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Other liabilities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities"
                        contextref="From2023-04-012024-03-31" id="Fact000344" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">970</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities"
                        contextref="From2022-04-012023-03-31" id="Fact000345" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">96</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_404_eus-gaap--IncreaseDecreaseInDeferredRevenue_i02_maNCPBUzoJr_zN32VOYdt6j9"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Deferred revenue</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInDeferredRevenue"
                        contextref="From2023-04-012024-03-31" id="Fact000347" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">90</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInDeferredRevenue"
                        contextref="From2022-04-012023-03-31" id="Fact000348" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">4,059</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_409_ecustom--IncreaseDecreaseInManufacturingWarrantyObligation_i02_maNCPBUzoJr_z3PQD1Ex2gb2"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Manufacturing warranty obligation</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:IncreaseDecreaseInManufacturingWarrantyObligation"
                        contextref="From2023-04-012024-03-31" id="Fact000350" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">163</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:IncreaseDecreaseInManufacturingWarrantyObligation"
                        contextref="From2022-04-012023-03-31" id="Fact000351" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">160</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i02_maNCPBUzoJr_zwtG7lKdDbmb"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 10pt">Advance payments from customers</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability"
                        contextref="From2023-04-012024-03-31" id="Fact000353" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">4,338</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability"
                        contextref="From2022-04-012023-03-31" id="Fact000354" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">2,083</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_ecustom--IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities_i02_maNCPBUzoJr_zw7ZMriz5R25"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accrued expense and other current
                    liabilities</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="DHAI:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities"
                        contextref="From2023-04-012024-03-31" id="Fact000356" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,071</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="DHAI:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities"
                        contextref="From2022-04-012023-03-31" id="Fact000357" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">3,126</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUzoJr_maCCERCz4Oi_zXgSAU7ayTHg"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Net cash provided by operating activities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities"
                        contextref="From2023-04-012024-03-31" id="Fact000359" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">5,192</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities"
                        contextref="From2022-04-012023-03-31" id="Fact000360" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">5,501</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zOK9K4fiPh53"
                style="vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; text-align: left; padding-left: 0.75pt">Cash flows from investing
                    activities:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUzutL_zjjUMe7RrtR9"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Purchases of property and
                    equipment</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextref="From2023-04-012024-03-31"
                        id="Fact000365" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">202
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextref="From2022-04-012023-03-31"
                        id="Fact000366" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">145
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUzutL_maCCERCz4Oi_zFRmTFHSFcQd"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 0.75pt">Net cash used in investing activities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities"
                        contextref="From2023-04-012024-03-31" id="Fact000368" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">202</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities"
                        contextref="From2022-04-012023-03-31" id="Fact000369" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">145</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zYrfqoLZ43wk"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; text-align: left; padding-left: 0.75pt">Cash flows from financing
                    activities:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_401_ecustom--ProceedsFromReverseRecapitalization_i01_maNCPBUzQEk_zzlK7xrqEBhh"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 10pt">Proceeds from reverse recapitalization</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:ProceedsFromReverseRecapitalization"
                        contextref="From2023-04-012024-03-31" id="Fact000374" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">899</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0375">�</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40A_ecustom--ProceedsFromIssuanceOfConvertibleNoteNetOfIssuanceCosts_i01N_di_msNCPBUzQEk_zqzEiILKbi25"
                style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Proceeds from issuance of
                    convertible debt, net of issuance costs</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_eus-gaap--RepaymentsOfRelatedPartyDebt_i01N_di_msNCPBUzQEk_z15RgunQGGYa"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Payments on related party notes
                    payable</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:RepaymentsOfRelatedPartyDebt" contextref="From2023-04-012024-03-31"
                        id="Fact000380" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,844
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:RepaymentsOfRelatedPartyDebt" contextref="From2022-04-012023-03-31"
                        id="Fact000381" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,053
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzQEk_maCCERCz4Oi_zykrbHpUzWb6"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Net cash used in financing
                    activities</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextref="From2023-04-012024-03-31"
                        id="Fact000383" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">4,945
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextref="From2022-04-012023-03-31"
                        id="Fact000384" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">4,053
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_maCCERCz4Oi_z1QElUVjElNh"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Effect of currency translation
                    on cash and cash equivalents</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="From2023-04-012024-03-31" id="Fact000386" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">5</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="From2022-04-012023-03-31" id="Fact000387" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">61</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCz4Oi_z84QfA5bcbqi"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 0.75pt">Net increase in cash, and cash equivalents, and
                    restricted cash</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"
                        contextref="From2023-04-012024-03-31" id="Fact000389" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">50</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"
                        contextref="From2022-04-012023-03-31" id="Fact000390" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,242</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zGo9Zm1Simr2"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Cash, and cash equivalents, and
                    restricted cash - beginning of year</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="AsOf2023-03-31" id="Fact000392" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">3,175</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="AsOf2022-03-31" id="Fact000393" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">1,933</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zkMhxWLvl73k"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Cash, and cash equivalents,
                    and restricted cash - end of year</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="AsOf2024-03-31" id="Fact000395" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">3,225</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="AsOf2023-03-31" id="Fact000396" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">3,175</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iE_zFPPS2R5eVYe"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Cash and cash equivalents - end of year</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextref="AsOf2024-03-31"
                        id="Fact000398" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,225
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextref="AsOf2023-03-31"
                        id="Fact000399" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,175
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_401_eus-gaap--RestrictedCashAndCashEquivalentsAbstract_iB_zSJXMwGNKQji"
                style="display: none; vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 0.75pt">Reconciliation of cash, cash equivalents and
                    restricted cash:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_400_eus-gaap--RestrictedCash_iE_zzTsW8w4Gdrf"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Restricted cash - end of year
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl0404">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl0405">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zSolPwID5el3"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Total cash, and cash
                    equivalents, and restricted cash - end of year</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="AsOf2024-03-31" id="Fact000407" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">3,225</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="AsOf2023-03-31" id="Fact000408" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">3,175</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zBjLyaohktbe"
                style="vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; text-align: left; padding-left: 0.75pt">Supplemental disclosure of cash
                    flow information:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40F_eus-gaap--InterestPaidNet_i01_z6v7XwnsuIy9"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 20pt">Interest paid</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:InterestPaidNet" contextref="From2023-04-012024-03-31" id="Fact000413"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">665</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:InterestPaidNet" contextref="From2022-04-012023-03-31" id="Fact000414"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">258</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--IncomeTaxesPaidNet_i01_zUqhRQDjBqo7"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 20pt">Income tax paid</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0416">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncomeTaxesPaidNet" contextref="From2022-04-012023-03-31"
                        id="Fact000417" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">210
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zJlE0XX71K2l"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; text-align: left; padding-left: 0.75pt">Supplemental disclosure of
                    non-cash investing and financing activity:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_eus-gaap--NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_i01_zgyi6BP7Rcu4"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 20pt">Accrued liability related to asset acquisition</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0422">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"
                        contextref="From2022-04-012023-03-31" id="Fact000423" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">533</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--NoncashOrPartNoncashAcquisitionPayablesAssumed1_i01_zJQHHB3E5on7"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 20pt">Accounts payable settled through escrow account upon
                    reverse recapitalization</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1"
                        contextref="From2023-04-012024-03-31" id="Fact000425" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,439</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0426">�</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            accompanying notes are an integral part of these consolidated financial statements.</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 101 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            HOLDING US, INC.</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="aab_006"></span>CONSOLIDATED
            STATEMENTS OF STOCKHOLDERS� DEFICIT</span></p>

    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
            thousands, except share data)</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0" id="xdx_303_112_pn3n3_zdwZ3GFJLUO7"
        summary="xdx: Statement - Condensed Consolidated Statements of Stockholders&#39; Deficit"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="display: none; vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2"
                    id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_ztlvg9zQyX43"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2"
                    id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_za7Ye5jbDEE8"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2"
                    id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zCbhRaCP1ck1"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2"
                    id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zYn98nurd80h"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_4BE_zhbcr5v6yf1i"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="text-align: center"><b>&nbsp;</b></td>
                <td style="font-weight: bold; padding-bottom: 1pt"><b>&nbsp;</b></td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Common
                        Stock</b></td>
                <td style="padding-bottom: 1pt; font-weight: bold"><b>&nbsp;</b></td>
                <td style="padding-bottom: 1pt"><b>&nbsp;</b></td>
                <td colspan="2" style="text-align: center"><b>Additional Paid-In</b></td>
                <td style="padding-bottom: 1pt"><b>&nbsp;</b></td>
                <td style="padding-bottom: 1pt"><b>&nbsp;</b></td>
                <td colspan="2" style="text-align: center"><b>Accumulated</b></td>
                <td style="padding-bottom: 1pt"><b>&nbsp;</b></td>
                <td style="padding-bottom: 1pt"><b>&nbsp;</b></td>
                <td colspan="2" style="text-align: center"><b>Accumulated Other Comprehensive</b></td>
                <td style="padding-bottom: 1pt"><b>&nbsp;</b></td>
                <td style="padding-bottom: 1pt"><b>&nbsp;</b></td>
                <td colspan="2" style="text-align: center"><b>Total Equity</b></td>
                <td style="padding-bottom: 1pt"><b>&nbsp;</b></td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_F24_z0y7SFaACS71"
                    style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares(1)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> Capital
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> Deficit
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> Income
                    (Loss)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> (Deficit)
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_432_c20220401__20230331_eus-gaap--StockholdersEquity_iS_z9jFpjJ0Vay7"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 40%; font-weight: bold; padding-left: 0.75pt">Balance, March 31, 2022</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_z6L5eSUjbXzh"
                    title="Balance, shares" style="width: 6%; text-align: right">&nbsp;&nbsp;<ix:nonfraction
                        name="us-gaap:SharesOutstanding" contextref="AsOf2022-03-31_us-gaap_CommonStockMember"
                        id="Fact000434" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">25,000,000
                    </ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2022-03-31_us-gaap_CommonStockMember"
                        id="Fact000428" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2
                    </ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000429"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,776</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2022-03-31_us-gaap_RetainedEarningsMember" id="Fact000430"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">25,755
                    </ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000431"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">635</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2022-03-31" id="Fact000432"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">26,894
                    </ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
            </tr>
            <tr id="xdx_404_eus-gaap--NetIncomeLoss_z8n9u28FJZNd"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 0.75pt">Net loss</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0436">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0437">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2022-04-012023-03-31_us-gaap_RetainedEarningsMember" id="Fact000438"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,014</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0439">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2022-04-012023-03-31" id="Fact000440" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">1,014</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_400_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_iN_di_zTOghehQi3g2"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Other comprehensive loss, net of tax</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0442">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0443">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0444">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                        contextref="From2022-04-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                        id="Fact000445" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">924
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                        contextref="From2022-04-012023-03-31" id="Fact000446" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">924</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_40E_ecustom--StockIssuedDuringPeriodValueNetTransactionsWithParent_zIpWfOrvp57k"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Net transactions with DIH Cayman
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">�</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl0448">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="DHAI:StockIssuedDuringPeriodValueNetTransactionsWithParent"
                        contextref="From2022-04-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000449"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">122</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl0450">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl0451">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="DHAI:StockIssuedDuringPeriodValueNetTransactionsWithParent"
                        contextref="From2022-04-012023-03-31" id="Fact000452" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">122</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_43E_c20230401__20240331_eus-gaap--StockholdersEquity_iS_zusWD8pSWVcj"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; padding-bottom: 1pt; padding-left: 0.75pt">Balance, March 31, 2023</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td id="xdx_98A_eus-gaap--SharesOutstanding_iS_pid_c20230401__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zozQDiLWpb97"
                    title="Balance, shares" style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact000460" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">25,000,000</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact000454" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">2</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000455"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,898</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
                        id="Fact000456" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">26,769
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000457"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">289</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2023-03-31" id="Fact000458"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">28,954
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_43B_c20230401__20240331_eus-gaap--StockholdersEquity_iS_zkCzpCYlKELa"
                style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; padding-bottom: 1pt; padding-left: 0.75pt">Balance</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20230401__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zawaZ7Tyg3sh"
                    title="Balance, shares" style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact000468" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">25,000,000</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact000462" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">2</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000463"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,898</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
                        id="Fact000464" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">26,769
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000465"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">289</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2023-03-31" id="Fact000466"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">28,954
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 0.75pt">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_404_eus-gaap--NetIncomeLoss_zEiFt9BOgXl8"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-left: 0.75pt">Net loss</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0470">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0471">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2023-04-012024-03-31_us-gaap_RetainedEarningsMember" id="Fact000472"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">8,443</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0473">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2023-04-012024-03-31" id="Fact000474" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">8,443</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_40D_ecustom--IssuanceOfCommonStockUponReverseRecapitalization_zHJEvcfX8o63"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-left: 0.75pt">Issuance of common stock upon reverse
                    recapitalization</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td id="xdx_985_ecustom--IssuanceOfCommonStockUponReverseRecapitalizationShares_pid_c20230401__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_z9uTq4FmLUme"
                    title="Issuance of common stock upon reverse recapitalization, shares" style="text-align: right">
                    <ix:nonfraction name="DHAI:IssuanceOfCommonStockUponReverseRecapitalizationShares"
                        contextref="From2023-04-012024-03-31_us-gaap_CommonStockMember" id="Fact000482"
                        format="ixt:numdotdecimal" decimals="INF" unitref="Shares">9,544,935</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:IssuanceOfCommonStockUponReverseRecapitalization"
                        contextref="From2023-04-012024-03-31_us-gaap_CommonStockMember" id="Fact000476"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:IssuanceOfCommonStockUponReverseRecapitalization"
                        contextref="From2023-04-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000477"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,511</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0478">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0479">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:IssuanceOfCommonStockUponReverseRecapitalization"
                        contextref="From2023-04-012024-03-31" id="Fact000480" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">4,512</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_iN_di_zloh7MmZCM16"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Other comprehensive income, net
                    of tax</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">�</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl0484">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl0485">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl0486">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                        contextref="From2023-04-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                        id="Fact000487" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">339
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                        contextref="From2023-04-012024-03-31" id="Fact000488" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">339</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_438_c20230401__20240331_eus-gaap--StockholdersEquity_iE_zLXioXj0QxK3"
                style="vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.75pt">Balance, March 31, 2024</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20230401__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zAOAIZPWARp9"
                    title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact000496" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">34,544,935</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact000490" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">3</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000491"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,613</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2024-03-31_us-gaap_RetainedEarningsMember"
                        id="Fact000492" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">35,212
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000493"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">50</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2024-03-31" id="Fact000494"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">32,546
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_430_c20230401__20240331_eus-gaap--StockholdersEquity_iE_zskORRL12etd"
                style="display: none; vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.75pt">Balance</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20230401__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zFaDX8Xd5Cn2"
                    title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact000504" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">34,544,935</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact000498" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">3</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000499"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,613</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2024-03-31_us-gaap_RetainedEarningsMember"
                        id="Fact000500" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">35,212
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000501"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">50</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2024-03-31" id="Fact000502"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">32,546
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%">
        <tbody>
            <tr style="vertical-align: top; text-align: justify">
                <td style="width: 15pt; text-align: right"><span id="xdx_F02_zoTJh3wSh1Jl"
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1).</span></td>
                <td style="text-align: justify"><span id="xdx_F13_zRPxwIWeXCS2"
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                        <ix:footnote id="Footnote000505" xml:lang="en-US">All outstanding
                            share and per-share amounts have been restated to reflect the reverse recapitalization as
                            established in the Business Combination Agreement
                            as described in Note 1.</ix:footnote>
                    </span></td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            accompanying notes are an integral part of these consolidated financial statements.</span></p>
    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 102 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p id="xdx_046_c20230401__20240331_z4eswdAYBOh3"
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
            HOLDING US, INC. AND SUBSIDIARIES</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="aab_007"></span>NOTES
            TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
            thousands, except share and per share data)</span></p>

    <p
        style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000507"
        name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
        <p id="xdx_806_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zAi0Oh1z8k6b"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_82D_z9ifDeEvbcNl">Business and Organization</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description
                of Business</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
                Holding US, Inc. and its consolidated subsidiaries (the �Company� or �DIH�) (formerly known as Aurora
                Technology
                Acquisition Corp. a Cayman Island exempted company which migrated and domesticated as a Delaware
                corporation, �ATAK�) , is
                a global solution provider in blending innovative robotic and virtual reality (�VR�) technologies with
                clinical integration
                and insights. Built through the mergers of global-leading niche technologies, DIH is positioning itself
                as a transformative total smart
                solutions provider and consolidator in a largely fragmented and manual-labor-driven industry. The
                Company�s fiscal year ends on
                March 31.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger
                / Business Combination with Aurora Tech Acquisition Corp.</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                February 7, 2024 (the �Closing Date�), ATAK, Aurora Technology Merger Sub (�Merger Sub�) and DIH Holding
                US,
                Inc., a Nevada corporation (�Legacy DIH� or �DIH Nevada�) consummated a previously announced business
                combination
                pursuant to a business agreement dated as of February 26, 2023 (as amended, supplemented or otherwise
                modified from time to time, the
                �Business Combination Agreement,� and the transactions contemplated thereby, the �Business Combination�)
                following
                the receipt of the required approval by ATAK�s and DIH (Nevada)�s stockholders and the fulfillment or
                waiver of other
                customary closing conditions. Upon closing of the Business Combination, Legacy DIH received cash held in
                trust account of $<span
                    id="xdx_906_ecustom--CashHeldInTrustAccountReceived_pn3n3_c20240207__20240207__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_ziJWegTrEVEf"
                    title="Cash held in trust account, received">
                    <ix:nonfraction name="DHAI:CashHeldInTrustAccountReceived"
                        contextref="From2024-02-072024-02-07_custom_DIHHoldingUSIncMember" id="Fact000509"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">899</ix:nonfraction>
                </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
                Legacy DIH historically existed and functioned as part of the business of DIH Technology Ltd. (�DIH
                Cayman�). At Closing
                of the Business Combination, the Company owns <span
                    id="xdx_900_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20240207__us-gaap--BusinessAcquisitionAxis__custom--DihUsCorporationMember_zCNVFji3Fxdk">
                    <ix:nonfraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired"
                        contextref="AsOf2024-02-07_custom_DihUsCorporationMember" id="Fact000510"
                        format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">100</ix:nonfraction>
                </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
                of DIH US Corp, which in turn owns the commercial entities. Additionally, the Company owns <span
                    id="xdx_90C_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20240207__us-gaap--BusinessAcquisitionAxis__custom--HocomaMedicalGmbhMember_zpvIOTYYOrYe">
                    <ix:nonfraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired"
                        contextref="AsOf2024-02-07_custom_HocomaMedicalGmbhMember" id="Fact000511"
                        format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">100</ix:nonfraction>
                </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
                ownership of Hocoma Medical GmbH, which contains the net assets transferred from Hocoma AG. Whereas,
                Hocoma AG and Motekforce Link BV
                and its subsidiaries (�Motek Group�) that remained with the DIH Cayman were excluded as discussed in
                Note 13 to the Consolidated
                Financial Statements. The Company agreed to use its best efforts to complete the reorganization as
                defined in the Business Combination
                Agreement as soon as possible thereafter. The reorganization has not been completed as of the date the
                financial statements were issued.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_906_eus-gaap--StockholdersEquityNoteStockSplit_c20230401__20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zJtVLDGH1yPh"
                    title="Stockholders&#39; equity note, stock split">
                    <ix:nonnumeric contextref="From2023-04-012024-03-31_custom_DIHHoldingUSIncMember" id="Fact000513"
                        name="us-gaap:StockholdersEquityNoteStockSplit">In
                        connection with the Closing of the Business Combination, (a) ATAK migrated and changed its
                        domestication to become a Delaware corporation
                        and changed its name to �DIH Holding US, Inc.� (b) each issued and outstanding ATAK Class A
                        Ordinary Share was converted,
                        on a one-for-one basis, into one share of DIH Class A Common Stock; (c) each issued and
                        outstanding Class B Ordinary Share was converted,
                        on a one-for-one basis, into one share of Domesticated Class B Common Stock; (d) each issued and
                        outstanding ATAK Public Warrant, ATAK
                        Private Warrant and ATAK Right was converted, on a one-for-one basis, into a DIH Public Warrant,
                        DIH Private Warrant and DIH Right, respectively;
                        and (e) the governing documents of ATAK were replaced by governing documents for the Delaware
                        corporation. The Amended and Restated Certificate
                        of Incorporation authorizes one class of common stock as Class A Common Stock (�Common Stock�)
                    </ix:nonnumeric>
                </span>.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                the Closing date, (a) Stockholders of Legacy DIH received $<span
                    id="xdx_900_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20240207__20240207__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zVaVcNg1lsVg"
                    title="Aggregate consideration amount">
                    <ix:nonfraction name="us-gaap:BusinessCombinationConsiderationTransferred1"
                        contextref="From2024-02-072024-02-07_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember"
                        id="Fact000515" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">250,000,000
                    </ix:nonfraction>
                </span> in aggregate consideration (the �Aggregate Base Consideration�)
                in the form of newly-issued shares of DIH Common Stock, calculated based on a price of $<span
                    id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20240207__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_ztVEZTEpzVmi"
                    title="Issued price per share">
                    <ix:nonfraction name="us-gaap:SharesIssuedPricePerShare"
                        contextref="AsOf2024-02-07_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember"
                        id="Fact000517" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">10.00
                    </ix:nonfraction>
                </span> per share; (b) DIH�s financial advisor
                received <span
                    id="xdx_90B_ecustom--FinancialAdvisoryPaymentShares_c20240207__20240207__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zdS7jPaFTMu9"
                    title="Financial advisory payment, shares">
                    <ix:nonfraction name="DHAI:FinancialAdvisoryPaymentShares"
                        contextref="From2024-02-072024-02-07_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember"
                        id="Fact000519" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">700,000
                    </ix:nonfraction>
                </span> shares of DIH Common Stock valued at the closing price of $<span
                    id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_c20240207__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zPixkTA9V8s6"
                    title="Shares price">
                    <ix:nonfraction name="us-gaap:SaleOfStockPricePerShare"
                        contextref="AsOf2024-02-07_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember"
                        id="Fact000521" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">5.02
                    </ix:nonfraction>
                </span> as payment for the financial advisory fee due to it;
                (c) the <span
                    id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240207__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zaRZN8UPFQO3"
                    title="Number of warrants or rights outstanding">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightOutstanding"
                        contextref="AsOf2024-02-07_custom_DIHHoldingUSIncMember" id="Fact000523"
                        format="ixt:numdotdecimal" decimals="INF" unitref="Shares">20,200,000</ix:nonfraction>
                </span> outstanding DIH Rights were converted into <span
                    id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240207__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zTAu5T6h8Nq7"
                    title="Number of warrants or rights converted into shares">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"
                        contextref="AsOf2024-02-07_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember"
                        id="Fact000525" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">2,020,000
                    </ix:nonfraction>
                </span> shares of DIH Common Stock; (d) each outstanding share of DIH
                Class B Common Stock was converted into a share of DIH Common Stock. (e) in connection with the closing
                of the Business combination,
                additional <span
                    id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240207__20240207__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zjzGFpgWenM5"
                    title="Stock issued during period shares issued for services">
                    <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices"
                        contextref="From2024-02-072024-02-07_custom_DIHHoldingUSIncMember" id="Fact000527"
                        format="ixt:numdotdecimal" decimals="INF" unitref="Shares">532,796</ix:nonfraction>
                </span> shares were issued to various ATAK service providers, including ATAK�s underwriter, for services
                rendered in
                related to the transaction. The shares were issued as partial payments to those providers, whereas
                certain service providers forewent
                all or partial receipt of Common Stock.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 103 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                addition to the Aggregate Base Consideration, Legacy DIH stockholders as of the effective date of the
                merger may be entitled to receive
                up to <span
                    id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230226__20230226__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember__srt--TitleOfIndividualAxis__custom--StockholdersMember_zc2EG2LXHk1h"
                    title="Shares issued">
                    <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues"
                        contextref="From2023-02-262023-02-26_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember_custom_StockholdersMember"
                        id="Fact000529" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">6,000,000
                    </ix:nonfraction>
                </span> Earnout Shares, as additional consideration upon satisfaction of the following milestones,
                during the period beginning
                on the Closing Date and expiring on the fifth anniversary of the closing date (the �Earnout
                Period�):</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                                id="xdx_905_ecustom--EarnoutShares_iI_pid_c20230226__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zarAvWjs72f2"
                                title="Earnout shares">
                                <ix:nonfraction name="DHAI:EarnoutShares"
                                    contextref="AsOf2023-02-26_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember"
                                    id="Fact000531" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,000,000
                                </ix:nonfraction>
                            </span>
                            Earnout Shares if the volume-weighted average price (�VWAP�) of DIH Common Stock
                            is equal to or exceeds $<span
                                id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230226__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zDOsucmHDIn7"
                                title="Shares Price">
                                <ix:nonfraction name="us-gaap:SaleOfStockPricePerShare"
                                    contextref="AsOf2023-02-26_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember"
                                    id="Fact000533" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">12.00
                                </ix:nonfraction>
                            </span> for any <span
                                id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_pid_uTradingDays_c20230226__20230226__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zoozRQElHdO5"
                                title="Trading days">
                                <ix:nonfraction name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays"
                                    contextref="From2023-02-262023-02-26_us-gaap_CommonClassAMember_custom_DIHHoldingUSIncMember"
                                    id="Fact000535" format="ixt:numdotdecimal" decimals="INF" unitref="TradingDays">20
                                </ix:nonfraction>
                            </span> trading days during the Earnout Period;</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                                id="xdx_90D_ecustom--EarnoutShares_iI_pid_c20230226__us-gaap--StatementClassOfStockAxis__custom--CommonClassAOneMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zaBsIr9mlL37"
                                title="Earnout shares">
                                <ix:nonfraction name="DHAI:EarnoutShares"
                                    contextref="AsOf2023-02-26_custom_CommonClassAOneMember_custom_DIHHoldingUSIncMember"
                                    id="Fact000537" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,333,333
                                </ix:nonfraction>
                            </span>
                            Earnout Shares if the VWAP of DIH Common Stock is equal to or exceeds $<span
                                id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230226__us-gaap--StatementClassOfStockAxis__custom--CommonClassAOneMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zFHB6u8u8NKg"
                                title="Shares Price">
                                <ix:nonfraction name="us-gaap:SaleOfStockPricePerShare"
                                    contextref="AsOf2023-02-26_custom_CommonClassAOneMember_custom_DIHHoldingUSIncMember"
                                    id="Fact000539" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">13.50
                                </ix:nonfraction>
                            </span> for any <span
                                id="xdx_909_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_pid_uTradingDays_c20230226__20230226__us-gaap--StatementClassOfStockAxis__custom--CommonClassAOneMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zpSVvFEUPAc2"
                                title="Trading days">
                                <ix:nonfraction name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays"
                                    contextref="From2023-02-262023-02-26_custom_CommonClassAOneMember_custom_DIHHoldingUSIncMember"
                                    id="Fact000541" format="ixt:numdotdecimal" decimals="INF" unitref="TradingDays">20
                                </ix:nonfraction>
                            </span> trading
                            days during the Earnout Period;</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                                id="xdx_90B_ecustom--EarnoutShares_iI_pid_c20230226__us-gaap--StatementClassOfStockAxis__custom--CommonClassATwoMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zra5QHKCgAAg"
                                title="Earnout shares">
                                <ix:nonfraction name="DHAI:EarnoutShares"
                                    contextref="AsOf2023-02-26_custom_CommonClassATwoMember_custom_DIHHoldingUSIncMember"
                                    id="Fact000543" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,666,667
                                </ix:nonfraction>
                            </span>
                            Earnout Shares if the VWAP of DIH Common Stock is equal to or exceeds $<span
                                id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230226__us-gaap--StatementClassOfStockAxis__custom--CommonClassATwoMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_z2R3GN9hkUM8"
                                title="Shares Price">
                                <ix:nonfraction name="us-gaap:SaleOfStockPricePerShare"
                                    contextref="AsOf2023-02-26_custom_CommonClassATwoMember_custom_DIHHoldingUSIncMember"
                                    id="Fact000545" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">15.00
                                </ix:nonfraction>
                            </span> for any <span
                                id="xdx_907_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_pid_uTradingDays_c20230226__20230226__us-gaap--StatementClassOfStockAxis__custom--CommonClassATwoMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zsQxdCf8VYpi"
                                title="Trading days">
                                <ix:nonfraction name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays"
                                    contextref="From2023-02-262023-02-26_custom_CommonClassATwoMember_custom_DIHHoldingUSIncMember"
                                    id="Fact000547" format="ixt:numdotdecimal" decimals="INF" unitref="TradingDays">20
                                </ix:nonfraction>
                            </span> trading
                            days during the Earnout Period; and</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                                id="xdx_907_ecustom--EarnoutShares_iI_pid_c20230226__us-gaap--StatementClassOfStockAxis__custom--CommonClassAThreeMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_z7flCIvaFe8b"
                                title="Earnout shares">
                                <ix:nonfraction name="DHAI:EarnoutShares"
                                    contextref="AsOf2023-02-26_custom_CommonClassAThreeMember_custom_DIHHoldingUSIncMember"
                                    id="Fact000549" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">2,000,000
                                </ix:nonfraction>
                            </span>
                            Earnout Shares if the VWAP of DIH Common Stock is equal to or exceeds $<span
                                id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230226__us-gaap--StatementClassOfStockAxis__custom--CommonClassAThreeMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_z0l1luu6wpB7"
                                title="Shares Price">
                                <ix:nonfraction name="us-gaap:SaleOfStockPricePerShare"
                                    contextref="AsOf2023-02-26_custom_CommonClassAThreeMember_custom_DIHHoldingUSIncMember"
                                    id="Fact000551" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">16.50
                                </ix:nonfraction>
                            </span> for any <span
                                id="xdx_90C_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_pid_uTradingDays_c20230226__20230226__us-gaap--StatementClassOfStockAxis__custom--CommonClassAThreeMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zBnwa6eoR781"
                                title="Trading days">
                                <ix:nonfraction name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays"
                                    contextref="From2023-02-262023-02-26_custom_CommonClassAThreeMember_custom_DIHHoldingUSIncMember"
                                    id="Fact000553" format="ixt:numdotdecimal" decimals="INF" unitref="TradingDays">20
                                </ix:nonfraction>
                            </span> trading
                            days during the Earnout Period.</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                            Earnout Founder Shares are accounted for as equity-classified equity instruments and
                            recorded
                            in additional paid-in capital as part of the Business Combination.</span></td>
                </tr>
            </tbody>
        </table>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                February 8, 2024, the Company entered into a subscription agreement with OrbiMed Asia GP II, L.P., an
                existing shareholder of DIH Cayman. Pursuant
                to the agreement, the Company will issue <span
                    id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240208__20240208__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__srt--TitleOfIndividualAxis__custom--OrbiMedMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_z98pfdMg8bLk">
                    <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues"
                        contextref="From2024-02-082024-02-08_us-gaap_CommonClassAMember_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember"
                        id="Fact000554" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">150,000
                    </ix:nonfraction>
                </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Common
                Stock at a purchase price of
                $<span
                    id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20240208__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__srt--TitleOfIndividualAxis__custom--OrbiMedMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zkfy2wo9v1dc">
                    <ix:nonfraction name="us-gaap:SaleOfStockPricePerShare"
                        contextref="AsOf2024-02-08_us-gaap_CommonClassAMember_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember"
                        id="Fact000555" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">10.00
                    </ix:nonfraction>
                </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share for
                aggregate purchase price of $<span
                    id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20240208__20240208__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__srt--TitleOfIndividualAxis__custom--OrbiMedMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zwnYnTa3EBGl">
                    <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues"
                        contextref="From2024-02-082024-02-08_us-gaap_CommonClassAMember_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember"
                        id="Fact000556" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">1.5
                    </ix:nonfraction>
                </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million together
                with warrants to purchase an
                additional <span
                    id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240208__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__srt--TitleOfIndividualAxis__custom--OrbiMedMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_z0gnYM0FWNyk">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"
                        contextref="AsOf2024-02-08_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember"
                        id="Fact000557" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">300,000
                    </ix:nonfraction>
                </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of DIH
                Common Stock with an exercise price
                of $<span
                    id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240208__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__srt--TitleOfIndividualAxis__custom--OrbiMedMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zpWX4TbiJCi2">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"
                        contextref="AsOf2024-02-08_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember"
                        id="Fact000558" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">10.00
                    </ix:nonfraction>
                </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
                The transaction is not closed as of the date the financial statements were issued.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Business Combination was accounted for as a reverse recapitalization, in accordance with accounting
                principles generally accepted in
                the United States of America (�U.S. GAAP�). Under this method of accounting, ATAK was treated as the
                acquired company and
                Legacy DIH was treated as the acquirer for financial reporting purposes. The net assets of ATAK were
                stated at carrying value, with no
                goodwill or other intangible assets recorded. The consolidated and combined assets, liabilities and
                results of operations prior to the
                Business Combination are those of Legacy DIH and the assets, liabilities and results of operations of
                ATAK were consolidated with Legacy
                DIH beginning on the Closing Date. The shares and net loss per common share prior to the Business
                Combination have been retrospectively
                restated as shares reflecting the <span
                    id="xdx_90F_eus-gaap--SharesIssued_iI_pn5n6_c20240207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LegacyDihMember_zbrGpMRDyBi4"
                    title="Shares issued">
                    <ix:nonfraction name="us-gaap:SharesIssued" contextref="AsOf2024-02-07_custom_LegacyDihMember"
                        id="Fact000560" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="Shares">25.0
                    </ix:nonfraction>
                </span> million shares issued to the Legacy DIH shareholders pursuant to the Business Combination
                Agreement.
                Legacy DIH was determined to be the accounting acquirer based on evaluation of the following facts and
                circumstance:</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
                            DIH�s existing stockholders have the largest voting interest in the Company;</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
                            DIH�s executive management makes up the management of the Company;</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
                            DIH nominated a majority of the initial members of the Company�s board of Directors;</span>
                    </td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                            post-combination company assumed the name �DIH Holding US, Inc.�&#894; and</span></td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                </tr>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
                            DIH is the larger entity based on historical operating activity and employee base.</span>
                    </td>
                </tr>
            </tbody>
        </table>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
                and Capital Resources</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                of March 31, 2024, the Company had $<span
                    id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zMcKgSUjzch7"
                    title="Cash and cash equivalents">
                    <ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue"
                        contextref="AsOf2024-03-31_custom_DIHHoldingUSIncMember" id="Fact000562"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,225</ix:nonfraction>
                </span> in cash and cash equivalents. The Company�s sources of liquidity have been predominantly
                from proceeds received from product sales and services provided. The Company�s sources of liquidity have
                enabled the Company to
                expand the installation base and grow its market share.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 104 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company�s net losses began in 2020 and continued through the twelve months ended March 31, 2024. The
                Company�s historical
                operating losses resulted in an accumulated deficit of $<span
                    id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pn5n6_c20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zVfhCR8uE3R5"
                    title="Accumulated deficit">
                    <ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit"
                        contextref="AsOf2024-03-31_custom_DIHHoldingUSIncMember" id="Fact000564"
                        format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">35.2</ix:nonfraction>
                </span> million as of March 31, 2024. Operating losses were mainly driven by decreased
                sales during the COVID-19 pandemic due to social distancing measures that affected demand for
                rehabilitation services, increased expenditures
                in connection with its implementation of a new financial system (Oracle) and increased compliance costs
                associated with the European
                Union Medical Device Regulation (EU MDR). Additionally, DIH had elevated costs related to efforts of
                adopting to public company standards.
                During the year ended March 31, 2024, the Company had positive cash flows from operating activities and
                negative operating results. The
                Company continues to take steps to streamline its organization and cost structure as well as improve
                future revenue growth.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company�s gross revenue has increased by <span
                    id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_dp_uPure_c20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zYcsHD9tQc4k"
                    title="Gross rerevenue increased percentage">
                    <ix:nonfraction name="us-gaap:RevenueRemainingPerformanceObligationPercentage"
                        contextref="AsOf2024-03-31_custom_DIHHoldingUSIncMember" id="Fact000566"
                        format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">19.3</ix:nonfraction>
                </span>%, from $<span
                    id="xdx_901_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220401__20230331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zwfusHBxqYng"
                    title="Gross revenue">
                    <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax"
                        contextref="From2022-04-012023-03-31_custom_DIHHoldingUSIncMember" id="Fact000568"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">54,059</ix:nonfraction>
                </span> to $<span
                    id="xdx_90F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230401__20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_z8xyjSfRbB2h"
                    title="Gross revenue">
                    <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax"
                        contextref="From2023-04-012024-03-31_custom_DIHHoldingUSIncMember" id="Fact000570"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">64,473</ix:nonfraction>
                </span>, for the year ended March 31, 2023 and 2024, respectively.
                The Company plans to continue to fund its growth through cash flows from operations and future debt and
                equity financing. The Company
                believes that its current cash and cash equivalents, together with cash provided by operating activities
                will provide adequate liquidity
                through one year from the date that these consolidated financial statements are issued.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company has <span
                    id="xdx_905_ecustom--NumberOfNotesPayableToRelatedParty_dc_uNotePayable_c20230401__20240331_zlqczs2zHWEc"
                    title="Number of notes payable to related party">
                    <ix:nonfraction name="DHAI:NumberOfNotesPayableToRelatedParty" contextref="From2023-04-012024-03-31"
                        id="Fact000572" format="ixt-sec:numwordsen" decimals="INF" unitref="NotePayable">three
                    </ix:nonfraction>
                </span> notes payable to a related party which are included in �Notes payable - related party�. Each
                note is due
                on <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20230401__20240331_zAYQzXcjMMG1"
                    title="Debt instrument, maturity date">
                    <ix:nonnumeric contextref="From2023-04-012024-03-31" format="ixt:datemonthdayyearen" id="Fact000574"
                        name="us-gaap:DebtInstrumentMaturityDate">June 30, 2026</ix:nonnumeric>
                </span> with an interest rate of <span
                    id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240331_zuiYcWGv44ic"
                    title="Debt instrument interest rate">
                    <ix:nonfraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage"
                        contextref="AsOf2024-03-31" id="Fact000576" format="ixt:numdotdecimal" decimals="INF" scale="-2"
                        unitref="Pure">1.25</ix:nonfraction>
                </span>% as further discussed in Note 13 to the Consolidated Financial Statements. The Company
                has made periodic payments on the principal and interests on the notes payable historically.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company�s future liquidity needs may vary materially from those currently planned and will depend on
                many factors, including the
                more aggressive and expansive growth plan, or for any unforeseen reductions in demand.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000578"
        name="us-gaap:SignificantAccountingPoliciesTextBlock">
        <p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zUJV8YnsBYMc"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_829_zZnuCHUKdcW2">Summary of Significant Accounting Policies</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000580"
            name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock">
            <p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zgUfG27Y9kdh"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
                    of Presentation</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                    February 7, 2024, the Company consummated the Business Combination and became a publicly-traded
                    company and its financial statements
                    are now presented on a consolidated basis. Prior to the Business Combination, the Company�s
                    historical financial statements were
                    prepared on a combined basis derived from DIH Cayman in the registration statement.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                    connection with the Closing of the Business Combination and in accordance with the terms of the
                    Business Combination Agreement, ATAK
                    agreed to waive the closing condition that the reorganization be completed prior to Closing. The
                    Company has recast historical financial
                    statements filed in the registration statements to exclude assets, liabilities and results of
                    operations of entities that are not controlled
                    by the Company as of March 31, 2024. Control exists when the Company has the power, directly and
                    indirectly, to govern the financial
                    and operating policies of an entity and be exposed to the variable returns from its activities. The
                    financial statements for all periods
                    presented, including historical periods prior to February 7, 2024, are now referred to as
                    �Consolidated financial statements�
                    and have been prepared in conformity with U.S. GAAP.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
                    the Company�s businesses have historically functioned together with the other businesses controlled
                    by DIH Cayman, the Company�s
                    businesses are largely isolated and not dependent on corporate or other support functions. DIH
                    Cayman did not have significant corporate
                    or operational activity and does not have shared services that it provides to its subsidiaries. The
                    Company considered allocations from
                    the DIH Cayman and its subsidiaries but they are insignificant because of the organizational
                    structure such that the Company has been
                    operating on a standalone basis historically.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                    of March 31, 2023, legacy DIH and DIH International (�DIH Hong Kong�) were wholly owned subsidiaries
                    of DIH Cayman. As of
                    March 31, 2024, DIH Cayman remains the largest shareholder of the Company and continues to own <span
                        id="xdx_90F_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHongKongMember_zWZaDwAqQbp1"
                        title="Percentage of Interest own by wholly owned subsidiaries">
                        <ix:nonfraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired"
                            contextref="AsOf2024-03-31_custom_DIHHongKongMember" id="Fact000582"
                            format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">100</ix:nonfraction>
                    </span>% interest in DIH Hong Kong. Transactions
                    with DIH Cayman, DIH Hong Kong and its subsidiaries are disclosed as related party transactions in
                    Note 13.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                    intercompany balances, transactions and profits are eliminated in consolidation.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


            <ix:exclude><!-- Field: Page; Sequence: 105 -->
                <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                    <table cellpadding="0" cellspacing="0"
                        style="border-collapse: collapse; width: 100%; font-size: 10pt">
                        <tbody>
                            <tr style="vertical-align: top; text-align: left">
                                <td style="text-align: center; width: 100%">
                                    F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div style="break-before: page; margin-top: 6pt">
                    <p style="margin: 0pt">&nbsp;</p>
                </div>
                <!-- Field: /Page -->
            </ix:exclude>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span>
            </p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000584"
            name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
            <p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zAMgaAWg2n5j"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
                    Currency Reporting</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    functional currency for the Company�s non-U.S. subsidiaries is their local currency. The assets and
                    liabilities of foreign subsidiaries
                    are translated into U.S. dollars using the exchange rate in effect as of the balance sheet date.
                    Revenues and expenses are translated
                    at the average exchange rates for each respective reporting period. Adjustments resulting from
                    translating local currency financial statements
                    into U.S. dollars are reflected in accumulated other comprehensive loss in equity (deficit).</span>
            </p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
                    denominated in currencies other than the functional currency are remeasured based on the exchange
                    rates at the time of the transaction.
                    Foreign currency gains and losses arising primarily from changes in exchange rates on foreign
                    currency denominated intercompany transactions
                    and balances between foreign locations are recorded in the consolidated statements of operations.
                    Realized and unrealized gains (losses)
                    resulting from transactions conducted in foreign currencies for the years ended March 31, 2024 and
                    2023 were $<span
                        id="xdx_908_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pn3n3_c20230401__20240331_zJ0eVbNn326k"
                        title="Foreign exchange (gain) loss">(<ix:nonfraction
                            name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax"
                            contextref="From2023-04-012024-03-31" id="Fact000586" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" sign="-" unitref="USD">376</ix:nonfraction>)</span> and $<span
                        id="xdx_902_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pn3n3_c20220401__20230331_zDMvDwMDWyPl"
                        title="Foreign exchange (gain) loss">
                        <ix:nonfraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax"
                            contextref="From2022-04-012023-03-31" id="Fact000588" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">584</ix:nonfraction>
                    </span>, respectively.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000590"
            name="us-gaap:UseOfEstimates">
            <p id="xdx_846_eus-gaap--UseOfEstimates_zV3X8ciDZf2d"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
                    of Estimates</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    preparation of financial statements in conformity with U.S. GAAP requires management to make
                    estimates and assumptions that affect the
                    reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the
                    date of the consolidated financial
                    statements, and the reported amounts of revenue and expenses during the reporting period.
                    Significant estimates made by management in
                    connection with the preparation of the accompanying consolidated financial statements include the
                    useful lives of long-lived assets,
                    inventory valuations, the allocation of transaction price among various performance obligations,
                    valuation of securities, the allowance
                    for credit losses, the fair value of financial assets, liabilities, actuarial valuation of pensions
                    and realizability of deferred income
                    tax asset or liabilities. Actual results could differ from those estimates.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000592"
            name="us-gaap:ConcentrationRiskCreditRisk">
            <p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zzTZ8i6c6V32"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentration
                    of Credit Risk</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                    instruments that potentially subject the Company to credit risk primarily consists of cash and cash
                    equivalents and accounts receivable.
                    The Company maintains its cash and cash equivalents with highly-rated financial institutions and
                    limits the amount of credit exposure
                    to any one entity. We believe we do not have any significant credit risk on our cash and cash
                    equivalents. For accounts receivable, the
                    Company is exposed to credit risk in the event of nonpayment by customers which is limited to the
                    amounts recorded on the consolidated
                    balance sheets. The risk associated with this concentration is mitigated by prepayment arrangement
                    and our ongoing credit-review procedures
                    and letters of credit or payment prior to shipment.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major
                    customers are defined as those individually comprising more than <span
                        id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230401__20240331__srt--MajorCustomersAxis__custom--MajorCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zq3wzPLZYws4"
                        title="Concentration risk percent"><span
                            id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230401__20240331__srt--MajorCustomersAxis__custom--MajorCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--TradeAndAccountsReceivableMember_zg09B1puwC85"
                            title="Concentration risk percent">
                            <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                                contextref="From2023-04-012024-03-31_custom_MajorCustomersMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
                                id="Fact000594" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                                    contextref="From2023-04-012024-03-31_custom_MajorCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember"
                                    id="Fact000596" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                    10</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span>% of our trade accounts receivable or revenues. As of March 31, 2024,
                    no customer represented more than <span
                        id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230401__20240331__srt--MajorCustomersAxis__custom--NoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--TradeAndAccountsReceivableMember_zfxCnBMVdNZ5"
                        title="Concentration risk percent">
                        <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                            contextref="From2023-04-012024-03-31_custom_NoCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember"
                            id="Fact000598" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">10
                        </ix:nonfraction>
                    </span>% of total trade accounts receivables. As of March 31, 2023, one customer comprised <span
                        id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220401__20230331__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--TradeAndAccountsReceivableMember_znMhDeRSkiRh"
                        title="Concentration risk percent">
                        <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                            contextref="From2022-04-012023-03-31_custom_OneCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember"
                            id="Fact000600" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">13.9
                        </ix:nonfraction>
                    </span>% of total
                    trade accounts receivables. For the year ended March 31, 2024, no customer comprised <span
                        id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230401__20240331__srt--MajorCustomersAxis__custom--NoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zlw3xGjEx3Fh"
                        title="Concentration risk percent">
                        <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                            contextref="From2023-04-012024-03-31_custom_NoCustomersMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
                            id="Fact000602" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">10
                        </ix:nonfraction>
                    </span>% of total revenue. For the year ended March 31,
                    2023, one customer comprised <span
                        id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220401__20230331__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zOfUEYeO6D2i"
                        title="Concentration risk percent">
                        <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                            contextref="From2022-04-012023-03-31_custom_OneCustomersMember_us-gaap_CustomerConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
                            id="Fact000604" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">12.0
                        </ix:nonfraction>
                    </span>% of total revenue.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000606"
            name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock">
            <p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zKK7sMoIDpTj"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
                    Recognition</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
                    are recognized as the performance obligations to deliver products or services are satisfied and are
                    recorded based on the amount of consideration
                    the Company expects to receive in exchange for satisfying the performance obligations. The Company�s
                    sales are recognized primarily
                    when it transfers control to the customer, which can be on the date of shipment of the product, the
                    date of receipt of the product by
                    the customer or upon completion of any required product installation service depending on the terms
                    of the sales contracts and product
                    shipping terms. If a contract contains more than one performance obligation, the transaction price
                    is allocated to each performance obligation
                    based upon a relative standalone selling price and recognizes the related revenue when or as control
                    of each individual performance obligation
                    is transferred to customers. The Company does not assess whether promised goods or services are
                    performance obligations if they are immaterial
                    in the context of the contract with the customer. Sales represent the amount of consideration the
                    Company expects to receive from customers
                    in exchange for transferring products and services. Net sales exclude sales tax, value added and
                    other taxes the Company collects from
                    customers. Sales for extended warranties are deferred and recognized as revenue on a straight-line
                    basis over the warranty period. The
                    Company extends terms of payment to its customers based on commercially reasonable terms for the
                    markets of its customers, while also
                    considering their credit quality. Shipping and handling costs charged to customers are included in
                    net sales.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


            <ix:exclude><!-- Field: Page; Sequence: 106 -->
                <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                    <table cellpadding="0" cellspacing="0"
                        style="border-collapse: collapse; width: 100%; font-size: 10pt">
                        <tbody>
                            <tr style="vertical-align: top; text-align: left">
                                <td style="text-align: center; width: 100%">
                                    F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div style="break-before: page; margin-top: 6pt">
                    <p style="margin: 0pt">&nbsp;</p>
                </div>
                <!-- Field: /Page -->
            </ix:exclude>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
                    of the Company�s products are sold through distributors and third-party sales representatives under
                    standard agreements whereby
                    distributors purchase products from the Company and resell them to customers. These arrangements do
                    not provide stock rotation or price
                    protection rights and do not contain extended payment terms. Rights of return are limited to repair
                    or replacement of delivered products
                    that are defective or fail to meet the Company�s published specifications. Provisions for these
                    warranty costs are recognized in
                    the same period that the related revenue is recorded similar to other assurance-type
                    warranties.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
                    revenue primarily represents service contracts and equipment maintenance, for which consideration is
                    received in advance of when service
                    for the device or equipment is provided. Revenue related to services contracts and equipment
                    maintenance is recognized over the service
                    period as time elapses. Revenues related to products containing an installation clause, are
                    recognized once the item is confirmed installed.
                    See Note 3 for further information on the Company�s deferred revenue balances and remaining
                    performance obligations.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
                    exclude any taxes that the Company collects from customers and remits to tax authorities. Amounts
                    billed to the customer for shipping
                    and handling are included in revenue, while the related shipping and handling costs are reflected in
                    cost of sales in the period in which
                    revenue is recognized. The Company has elected a practical expedient under ASC 606 that allows for
                    shipping and handling activities that
                    occur after the customer has obtained control of a good to be accounted for as a fulfillment cost.
                    The Company does not adjust the promised
                    amount of consideration for the effects of a significant financing component, if, at contract
                    inception, the Company expects the period
                    between the time when the Company transfers a promised good or service to the customer and the time
                    when the customer pays for that good
                    or service will be one year or less.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company exercises judgment in determining the timing of revenue by analyzing the point in time or
                    the period over which the customer
                    has the ability to direct the use of and obtain substantially all of the remaining benefits of the
                    performance obligation. The Company
                    primarily recognizes revenue from sales of products at the point in time that the customer obtains
                    control, which is typically based
                    upon the terms of delivery. The billing terms for these point-in time product contracts generally
                    coincide with delivery to the customer
                    and customer acceptance. When the Company receives customer advances, these are recognized as
                    advance payments from customers in the
                    consolidated balance sheet. The Company recognizes revenue from the sale of certain service
                    contracts over time on a ratable basis consistent
                    with the nature, timing and extent of services, which primarily relate to extended warranties. Our
                    billing terms for these contracts
                    vary and can occur in advance of or following the service period of service. The differences between
                    the timing of our revenue recognized
                    and customer billings (based on contractual terms) result in changes to our contract asset or
                    contract liability positions.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000608"
            name="us-gaap:ExtendedProductWarrantyPolicy">
            <p id="xdx_847_eus-gaap--ExtendedProductWarrantyPolicy_z8OLHjSYcQOk"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranties</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company generally provides warranties for its products from manufacturing defects on a limited basis
                    for a period of one year after purchase,
                    but also has extended warranties that are separately priced for periods of up to four years. During
                    the term of the warranty, if the
                    device fails to operate properly from defects in materials and workmanship, the Company will fix or
                    replace the defective product. If
                    the customer does not allow the required scheduled maintenance of the product during the extended
                    warranty contract terms, the contract
                    is canceled.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    company estimates the costs that it may incur under its warranty programs based on the number of
                    units sold, historical and anticipated
                    rates of warranty claims, and cost per claim, and records a liability equal to these estimated costs
                    in cost of sales. The company assesses
                    the adequacy of its recorded warranty liabilities on a quarterly basis and adjusts these amounts as
                    necessary.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


            <ix:exclude><!-- Field: Page; Sequence: 107 -->
                <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                    <table cellpadding="0" cellspacing="0"
                        style="border-collapse: collapse; width: 100%; font-size: 10pt">
                        <tbody>
                            <tr style="vertical-align: top; text-align: left">
                                <td style="text-align: center; width: 100%">
                                    F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div style="break-before: page; margin-top: 6pt">
                    <p style="margin: 0pt">&nbsp;</p>
                </div>
                <!-- Field: /Page -->
            </ix:exclude>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000610"
                name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock">
                <p id="xdx_897_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zyQCXhz3WVWb"
                    style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                        reconciliation of the changes in manufacturing warranty obligation is as follows:</span></p>

                <p
                    style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

                <p
                    style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                    <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                            id="xdx_8B6_zoOYQ92MTC0a">Reconciliation
                            of Changes in Manufacturing Warranty Obligation</span></span></p>

                <p
                    style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                </p>

                <table cellpadding="0" cellspacing="0"
                    style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                    <tbody>
                        <tr style="display: none; vertical-align: bottom">
                            <td style="display: none">&nbsp;</td>
                            <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="2" id="xdx_492_20230401__20240331_zwhMob8XIAhb"
                                style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                                2024</td>
                            <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                            <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="2" id="xdx_497_20220401__20230331_zLoyfF5l3ps7"
                                style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                                2023</td>
                            <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        </tr>
                        <tr style="vertical-align: bottom">
                            <td>&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="6"
                                style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years
                                Ended March 31,</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        </tr>
                        <tr style="vertical-align: bottom">
                            <td>&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="2"
                                style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="2"
                                style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        </tr>
                        <tr id="xdx_408_eus-gaap--StandardProductWarrantyAccrual_iS_pn3n3_z9EzLYhk1oSh"
                            style="vertical-align: bottom; background-color: rgb(204,238,255)">
                            <td style="width: 64%; padding-left: 0.75pt">Balance as of beginning of period</td>
                            <td style="width: 2%">&nbsp;</td>
                            <td style="width: 1%; text-align: left">$</td>
                            <td style="width: 14%; text-align: right">
                                <ix:nonfraction name="us-gaap:StandardProductWarrantyAccrual"
                                    contextref="AsOf2023-03-31" id="Fact000612" format="ixt:numdotdecimal" decimals="-3"
                                    scale="3" unitref="USD">973</ix:nonfraction>
                            </td>
                            <td style="width: 1%; text-align: left">&nbsp;</td>
                            <td style="width: 2%">&nbsp;</td>
                            <td style="width: 1%; text-align: left">$</td>
                            <td style="width: 14%; text-align: right">
                                <ix:nonfraction name="us-gaap:StandardProductWarrantyAccrual"
                                    contextref="AsOf2022-03-31" id="Fact000613" format="ixt:numdotdecimal" decimals="-3"
                                    scale="3" unitref="USD">836</ix:nonfraction>
                            </td>
                            <td style="width: 1%; text-align: left">&nbsp;</td>
                        </tr>
                        <tr id="xdx_402_eus-gaap--StandardProductWarrantyAccrualWarrantiesIssued_pn3n3_zX5oPVDbIFO6"
                            style="vertical-align: bottom; background-color: White">
                            <td style="text-align: left; padding-left: 10pt">Current-year provisions</td>
                            <td>&nbsp;</td>
                            <td style="text-align: left">&nbsp;</td>
                            <td style="text-align: right">
                                <ix:nonfraction name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued"
                                    contextref="From2023-04-012024-03-31" id="Fact000615" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">1,139</ix:nonfraction>
                            </td>
                            <td style="text-align: left">&nbsp;</td>
                            <td>&nbsp;</td>
                            <td style="text-align: left">&nbsp;</td>
                            <td style="text-align: right">
                                <ix:nonfraction name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued"
                                    contextref="From2022-04-012023-03-31" id="Fact000616" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">973</ix:nonfraction>
                            </td>
                            <td style="text-align: left">&nbsp;</td>
                        </tr>
                        <tr id="xdx_40C_eus-gaap--StandardProductWarrantyAccrualPayments_iN_pn3n3_di_z8jSQ216ebyi"
                            style="vertical-align: bottom; background-color: rgb(204,238,255)">
                            <td style="text-align: left; padding-left: 10pt">Reductions for settlements</td>
                            <td>&nbsp;</td>
                            <td style="text-align: left">&nbsp;</td>
                            <td style="text-align: right">(<ix:nonfraction
                                    name="us-gaap:StandardProductWarrantyAccrualPayments"
                                    contextref="From2023-04-012024-03-31" id="Fact000618" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">973</ix:nonfraction>
                            </td>
                            <td style="text-align: left">)</td>
                            <td>&nbsp;</td>
                            <td style="text-align: left">&nbsp;</td>
                            <td style="text-align: right">(<ix:nonfraction
                                    name="us-gaap:StandardProductWarrantyAccrualPayments"
                                    contextref="From2022-04-012023-03-31" id="Fact000619" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">836</ix:nonfraction>
                            </td>
                            <td style="text-align: left">)</td>
                        </tr>
                        <tr id="xdx_405_eus-gaap--StandardProductWarrantyAccrualPeriodIncreaseDecrease_pn3n3_z4c51ERYjHlj"
                            style="vertical-align: bottom; background-color: White">
                            <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Adjustments related to
                                changes in estimates</td>
                            <td style="padding-bottom: 1pt">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                    name="us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease"
                                    contextref="From2023-04-012024-03-31" id="Fact000621" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" sign="-" unitref="USD">626</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 1pt; text-align: left">)</td>
                            <td style="padding-bottom: 1pt">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                    style="-sec-ix-hidden: xdx2ixbrl0622">-</span></td>
                            <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        </tr>
                        <tr id="xdx_406_eus-gaap--StandardProductWarrantyAccrual_iE_pn3n3_zBegY5kp4sTi"
                            style="vertical-align: bottom; background-color: rgb(204,238,255)">
                            <td style="padding-bottom: 2.5pt; padding-left: 0.75pt">Balance as of end of period</td>
                            <td style="padding-bottom: 2.5pt">&nbsp;</td>
                            <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                            <td style="border-bottom: Black 2.5pt double; text-align: right">
                                <ix:nonfraction name="us-gaap:StandardProductWarrantyAccrual"
                                    contextref="AsOf2024-03-31" id="Fact000624" format="ixt:numdotdecimal" decimals="-3"
                                    scale="3" unitref="USD">513</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                            <td style="padding-bottom: 2.5pt">&nbsp;</td>
                            <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                            <td style="border-bottom: Black 2.5pt double; text-align: right">
                                <ix:nonfraction name="us-gaap:StandardProductWarrantyAccrual"
                                    contextref="AsOf2023-03-31" id="Fact000625" format="ixt:numdotdecimal" decimals="-3"
                                    scale="3" unitref="USD">973</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        </tr>
                    </tbody>
                </table>

            </ix:nonnumeric>
            <p id="xdx_8A3_zCND93f8rwK3"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000627"
            name="us-gaap:CostOfSalesPolicyTextBlock">
            <p id="xdx_844_eus-gaap--CostOfSalesPolicyTextBlock_zTSxpS9NxSDf"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
                    of Sales</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
                    of sales is comprised of direct materials and supplies consumed in the manufacture of products, as
                    well as manufacturing labor, depreciation
                    expense and direct overhead expense necessary to acquire and convert the purchased materials and
                    supplies into finished product. Cost
                    of sales also includes the cost to distribute products to customers, inbound freight costs,
                    warehousing costs and other shipping and
                    handling activity, excluding shipping and handling to customers.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
                    of service is comprised primarily of employee wages, benefits and related personnel expenses of our
                    technical support team, our professional
                    consulting personnel, and our training teams. It also includes costs related to travel and other
                    associated expenses, as well as material
                    and supplies consumed in providing services.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000629"
            name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
            <p id="xdx_84F_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zBrLzAMo3ww9"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling,
                    General and Administrative Expenses</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling,
                    general and administrative expense is comprised personnel related expenses for DIH�s sales and
                    corporate functions and expenses
                    for outside professional services as well as expenses for facilities, overhead, depreciation,
                    amortization, and marketing costs.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000631"
            name="us-gaap:ResearchAndDevelopmentExpensePolicy">
            <p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_zyD3YPGLe4Za"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
                    and Development</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
                    and development costs are expensed when incurred except for production stage software research and
                    development costs. Research and development
                    costs include costs of research, engineering, and technical activities to develop a new product or
                    service or make significant improvement
                    to an existing product or manufacturing process. Research and development costs also include
                    pre-approval regulatory and clinical trial
                    expenses.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000633"
            name="us-gaap:TradeAndOtherAccountsReceivablePolicy">
            <p id="xdx_849_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zt49SSuAyzL3"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
                    Receivable, net</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
                    receivable, net in the accompanying consolidated balance sheets are presented net of allowances for
                    credit losses. The Company performs
                    evaluations of its customers� financial condition and, generally, requires no collateral from its
                    customers. The standard terms
                    and conditions include provisions of prepayments of up to 100% of the contract value prior to
                    shipping the product to the customer. The
                    Company evaluates the collectability of its accounts receivable based upon several factors,
                    including historical experience, the likelihood
                    of payment from its customers, and any other known specific factors associated with its customers.
                    Allowances are made based upon a specific
                    review of aged invoices as well as a review of the overall quality and age of those invoices not
                    specifically reviewed. Each period,
                    the allowance for credit losses is adjusted through earnings to reflect expected credit losses over
                    the remaining lives of the assets.
                    Uncollectible accounts are written-off against the allowance when it is deemed that a customer
                    account is uncollectible.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    decrease in Accounts Receivable related to the application of the Current Expected Credit Loss
                    (CECL) methodology is primarily due to
                    the more forward-looking and comprehensive approach to estimating credit losses under CECL compared
                    to the previous incurred loss model.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


            <ix:exclude><!-- Field: Page; Sequence: 108 -->
                <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                    <table cellpadding="0" cellspacing="0"
                        style="border-collapse: collapse; width: 100%; font-size: 10pt">
                        <tbody>
                            <tr style="vertical-align: top; text-align: left">
                                <td style="text-align: center; width: 100%">
                                    F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div style="break-before: page; margin-top: 6pt">
                    <p style="margin: 0pt">&nbsp;</p>
                </div>
                <!-- Field: /Page -->
            </ix:exclude>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000635"
                name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock">
                <p id="xdx_894_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_znK6gqI84O02"
                    style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                        following table presents the allowance for credit loss and the changes therein:</span></p>

                <p
                    style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                    &nbsp;</p>

                <p
                    style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                            id="xdx_8BC_zHhNwwiUX946" style="display: none">Summary
                            of Allowance for Credit Loss and Changes</span>&nbsp;</span>&nbsp;</p>

                <table cellpadding="0" cellspacing="0"
                    style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                    <tbody>
                        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                            <td style="width: 82%; padding-left: 0.75pt">Balance as of March 31, 2023</td>
                            <td style="width: 2%">&nbsp;</td>
                            <td style="width: 1%; text-align: left">$</td>
                            <td id="xdx_98F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pn3n3_c20230401__20240331_zC18xHO5sF95"
                                title="Balance as of March 31, 2023" style="width: 14%; text-align: right">
                                <ix:nonfraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable"
                                    contextref="AsOf2023-03-31" id="Fact000637" format="ixt:numdotdecimal" decimals="-3"
                                    scale="3" unitref="USD">1,683</ix:nonfraction>
                            </td>
                            <td style="width: 1%; text-align: left">&nbsp;</td>
                        </tr>
                        <tr style="vertical-align: bottom; background-color: White">
                            <td style="text-align: left; padding-left: 10pt">CECL implementation</td>
                            <td>&nbsp;</td>
                            <td style="text-align: left">&nbsp;</td>
                            <td id="xdx_98B_ecustom--CurrentExpectedCreditLossImplementation_pn3n3_c20230401__20240331_zrMqvYvDkWr1"
                                title="CECL implementation" style="text-align: right">(<ix:nonfraction
                                    name="DHAI:CurrentExpectedCreditLossImplementation"
                                    contextref="From2023-04-012024-03-31" id="Fact000639" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" sign="-" unitref="USD">547</ix:nonfraction>
                            </td>
                            <td style="text-align: left">)</td>
                        </tr>
                        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                            <td style="padding-left: 10pt">Recoveries</td>
                            <td>&nbsp;</td>
                            <td style="text-align: left">&nbsp;</td>
                            <td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_iN_pn3n3_di_c20230401__20240331_zU7mb1QfyXR2"
                                title="Recoveries" style="text-align: right">(<ix:nonfraction
                                    name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries"
                                    contextref="From2023-04-012024-03-31" id="Fact000641" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">704</ix:nonfraction>
                            </td>
                            <td style="text-align: left">)</td>
                        </tr>
                        <tr style="vertical-align: bottom; background-color: White">
                            <td style="text-align: left; padding-left: 10pt">Credit loss expense</td>
                            <td>&nbsp;</td>
                            <td style="text-align: left">&nbsp;</td>
                            <td id="xdx_982_eus-gaap--AccountsReceivableChangeInMethodCreditLossExpenseReversal_pn3n3_c20230401__20240331_zmaF7dbh0pq8"
                                title="Credit loss expense" style="text-align: right">
                                <ix:nonfraction name="us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal"
                                    contextref="From2023-04-012024-03-31" id="Fact000643" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">279</ix:nonfraction>
                            </td>
                            <td style="text-align: left">&nbsp;</td>
                        </tr>
                        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                            <td style="padding-bottom: 1pt; padding-left: 10pt">Write-offs</td>
                            <td style="padding-bottom: 1pt">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                            <td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pn3n3_di_c20230401__20240331_zrjUuhPTirkj"
                                title="Write-offs" style="border-bottom: Black 1pt solid; text-align: right">(
                                <ix:nonfraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs"
                                    contextref="From2023-04-012024-03-31" id="Fact000645" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">44</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 1pt; text-align: left">)</td>
                        </tr>
                        <tr style="vertical-align: bottom; background-color: White">
                            <td style="padding-bottom: 1pt; padding-left: 0.75pt">Balance as of March 31, 2024</td>
                            <td style="padding-bottom: 1pt">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                            <td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pn3n3_c20230401__20240331_zNGhjEhkPN85"
                                title="Balance as of March 31, 2024"
                                style="border-bottom: Black 1pt solid; text-align: right">
                                <ix:nonfraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable"
                                    contextref="AsOf2024-03-31" id="Fact000647" format="ixt:numdotdecimal" decimals="-3"
                                    scale="3" unitref="USD">667</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        </tr>
                    </tbody>
                </table>

            </ix:nonnumeric>
            <p id="xdx_8A9_zKgfzzqWD54d"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000649"
            name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock">
            <p id="xdx_840_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zlqYGs8Pep44"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
                    Value Measurements</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company uses any of three valuation approaches to measure fair value: the market approach, the
                    income approach, and the cost approach
                    in determining the appropriate valuation methodologies based on the nature of the asset or liability
                    being measured and the reliability
                    of the inputs used in arriving at fair value.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company�s financial instruments consist primarily of cash and cash equivalents, accounts receivable,
                    accounts payable, long-term
                    related party notes payable, accrued expenses and other current liabilities, and accrued employee
                    benefits. The carrying amounts of cash
                    and cash equivalents, accounts receivable, accounts payable, accrued expenses and other current
                    liabilities, and accrued employee benefits
                    are representative of their respective fair values due to the short-term maturity of these
                    instruments. The Company�s related party
                    notes payable are due within two years and is classified as noncurrent in the consolidated balance
                    sheet and the Company makes regular
                    prepayments historically prior to the due date. Therefore the Company�s related party notes
                    payable�s carrying value approximate
                    the fair value due to the remaining duration.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
                    value is defined as the price that would be received to sell an asset or paid to transfer a
                    liability in an orderly transaction between
                    market participants at the measurement date. These fair value measurements incorporate
                    nonperformance risk (i.e., the risk that an obligation
                    will not be fulfilled). In measuring fair value, the Company reflects the impact of credit risk on
                    liabilities, as well as any collateral.
                    The Company also considers the credit standing of counterparties in measuring the fair value of
                    assets.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company follows the provisions of ASC 820, Fair Value Measurements (�ASC 820�) for non-financial
                    assets and liabilities measured
                    on a non-recurring basis such as on a potential impairment loss related to long-lived assets and
                    assets and liabilities acquired in a
                    business combination.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    framework for measuring fair value provides a fair value hierarchy that prioritizes the inputs to
                    valuation techniques used to measure
                    fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets
                    for identical assets or liabilities
                    (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).</span>
            </p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    three levels of the valuation hierarchy are defined as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
                <tbody>
                    <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                        <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                        <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                1 � Observable inputs such as quoted prices in active markets at the measurement date
                                for identical, unrestricted assets or liabilities.</span></td>
                    </tr>
                    <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                        <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                        <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                    </tr>
                    <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                        <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                        <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                2 � Other inputs that are observable directly or indirectly such as quoted prices in
                                markets that are not active, or inputs which are observable, either directly or
                                indirectly,
                                for substantially the full term of the asset or liability.</span></td>
                    </tr>
                    <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                        <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                        <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
                        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</td>
                    </tr>
                    <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                        <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                        <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                3 � Unobservable inputs for which there is little or no market data and which the
                                Company
                                makes its own assumptions about how market participants would price the assets and
                                liabilities.</span></td>
                    </tr>
                </tbody>
            </table>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                    financial instrument�s categorization within the valuation hierarchy is based upon the lowest level
                    of input that is significant
                    to the fair value measurement. The Company�s assessment of the significance of a particular input to
                    the fair value measurement
                    in its entirety requires judgment and considers factors specific to the asset or liability.</span>
            </p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


            <ix:exclude><!-- Field: Page; Sequence: 109 -->
                <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                    <table cellpadding="0" cellspacing="0"
                        style="border-collapse: collapse; width: 100%; font-size: 10pt">
                        <tbody>
                            <tr style="vertical-align: top; text-align: left">
                                <td style="text-align: center; width: 100%">
                                    F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div style="break-before: page; margin-top: 6pt">
                    <p style="margin: 0pt">&nbsp;</p>
                </div>
                <!-- Field: /Page -->
            </ix:exclude>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span>
            </p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000651"
            name="us-gaap:CashAndCashEquivalentsPolicyTextBlock">
            <p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zdTRFCMI4gg"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
                    and Cash Equivalents</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company considers all highly liquid investments that are readily convertible into cash and have an
                    original maturity of three months
                    or less at the time of purchase to be cash equivalents.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000653"
            name="us-gaap:InventoryPolicyTextBlock">
            <p id="xdx_847_eus-gaap--InventoryPolicyTextBlock_zx5K4vRdAcId"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories,
                    net</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
                    are stated at the lower of cost or net realizable value, with cost determined on a weighted average
                    cost basis. The Company reduces the
                    carrying value of inventories for items that are potentially excess, obsolete, or slow-moving based
                    on changes in customer demand, technology
                    developments, or other economic factors. These reserves are included within the raw materials and
                    spare parts, work in process, and finished
                    and semi-finished goods accounts.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
                    costs for manufactured products consist primarily of direct labor and materials (including salary
                    and fringe benefits, raw materials,
                    and supplies) and indirect costs (including allocations of costs from departments that support
                    manufacturing activities and facility
                    allocations). The allocation of fixed production overhead costs is based on actual production
                    levels, to the extent that they are within
                    the range of the facility�s normal capacity. Inventory costs for products purchased for resale or
                    manufactured under contract consist
                    primarily of the purchase cost, freight-in charges, and indirect costs as appropriate.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company regularly evaluates its inventory to determine if the costs are appropriately recorded at
                    the lower of cost or market value.
                    Lower of cost or market value write-downs are recorded if the book value exceeds the estimated net
                    realizable value of the inventory,
                    based on recent sales prices at the time of the evaluation.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000655"
            name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock">
            <p id="xdx_847_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zl8TozPwdj98"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
                    and Equipment, Net</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
                    and equipment are stated at cost and depreciated over the useful lives of the assets using the
                    straight- line method except for leasehold
                    improvements which are depreciated over the shorter of the useful life or the lease term. Useful
                    lives by asset category are as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000657"
                name="DHAI:PropertyAndEquipmentTextBlock">
                <p id="xdx_896_ecustom--PropertyAndEquipmentTextBlock_zuQPEEakX4e8"
                    style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                    <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                            id="xdx_8B5_zLkTqvp69rHf">Schedule
                            of Property and Equipment, Useful Life</span></span></p>

                <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
                    <tbody>
                        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                            <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 50%"><span
                                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span>
                            </td>
                            <td
                                style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 50%">
                                <span
                                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years</b></span>
                            </td>
                        </tr>
                        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
                                    software and hardware</span></td>
                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span
                                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                                        id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zGDbpreiSk4i"
                                        title="Computer software and hardware">
                                        <ix:nonnumeric contextref="AsOf2024-03-31_us-gaap_ComputerEquipmentMember"
                                            format="ixt-sec:duryear" id="Fact000659"
                                            name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonnumeric>
                                    </span>
                                    years</span></td>
                        </tr>
                        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery
                                    and equipment</span></td>
                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span
                                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                                        id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_z3SBkdL9Paaa"
                                        title="Computer software and hardware">
                                        <ix:nonnumeric
                                            contextref="AsOf2024-03-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember"
                                            format="ixt-sec:duryear" id="Fact000661"
                                            name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonnumeric>
                                    </span>-<span
                                        id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zbpKGIB54Yx9"
                                        title="Computer software and hardware">
                                        <ix:nonnumeric
                                            contextref="AsOf2024-03-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember"
                                            format="ixt-sec:duryear" id="Fact000663"
                                            name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonnumeric>
                                    </span>
                                    years</span></td>
                        </tr>
                        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span>
                            </td>
                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span
                                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                                        id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zJPcqW0YtAKk"
                                        title="Vehicles">
                                        <ix:nonnumeric contextref="AsOf2024-03-31_us-gaap_VehiclesMember"
                                            format="ixt-sec:duryear" id="Fact000665"
                                            name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonnumeric>
                                    </span>
                                    years</span></td>
                        </tr>
                        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
                                    and fixtures</span></td>
                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span
                                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                                        id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_z7xhn7tPv679"
                                        title="Furniture and fixtures">
                                        <ix:nonnumeric
                                            contextref="AsOf2024-03-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember"
                                            format="ixt-sec:duryear" id="Fact000667"
                                            name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonnumeric>
                                    </span>-<span
                                        id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zL4zOdcZdnSf"
                                        title="Furniture and fixtures">
                                        <ix:nonnumeric
                                            contextref="AsOf2024-03-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember"
                                            format="ixt-sec:duryear" id="Fact000669"
                                            name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonnumeric>
                                    </span>
                                    years</span></td>
                        </tr>
                        <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
                            <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify">
                                Property plant and equipment useful life</td>
                            <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: center">
                                <span
                                    style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                                        id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zbTzY60cFUaj"
                                        title="Property plant and equipment useful life" style="display: none">
                                        <ix:nonnumeric
                                            contextref="AsOf2024-03-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember"
                                            format="ixt-sec:duryear" id="Fact000671"
                                            name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonnumeric>
                                    </span>-<span
                                        id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zFDNyCz0tLsb"
                                        title="Property plant and equipment useful life" style="display: none">
                                        <ix:nonnumeric
                                            contextref="AsOf2024-03-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember"
                                            format="ixt-sec:duryear" id="Fact000673"
                                            name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonnumeric>
                                    </span>
                                    years</span></td>
                        </tr>
                        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
                                    improvements</span></td>
                            <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span
                                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                                        id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_iI_dxL_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zgW71XoTugc4"
                                        title="::XDX::http%3A%2F%2Ffasb.org%2Fus-gaap%2F2024%23LeaseholdImprovementsMember"><span
                                            style="-sec-ix-hidden: xdx2ixbrl0674">Shorter
                                            of remaining lease term or estimated useful life</span></span></span></td>
                        </tr>
                    </tbody>
                </table>
            </ix:nonnumeric>
            <p id="xdx_8A3_z6XLTFSOoJ57"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions
                    and improvements that extend the lives of the assets are capitalized, while expenditures for repairs
                    and maintenance are expensed as
                    incurred. When assets are retired or otherwise disposed of, the cost and related accumulated
                    depreciation are removed from the accounts,
                    and any resulting gain or loss are reflected in the accompanying consolidated statements of
                    operations for the period.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000676"
            name="us-gaap:InternalUseSoftwarePolicy">
            <p id="xdx_840_eus-gaap--InternalUseSoftwarePolicy_z62cTiTkqHi4"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
                    software, net</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
                    development costs are capitalized in accordance with ASC 350-40, Internal Use Software Accounting
                    and Capitalization. Software development
                    costs related to preliminary project activities and post-implementation and maintenance activities
                    are expensed as incurred. Direct costs
                    related to application development activities that are probable to result in additional
                    functionality are capitalized. Capitalized software
                    development costs are amortized using the straight-line amortization method over the estimated
                    useful life of the applicable software,
                    <span
                        id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SoftwareMember_zS5qlrdL6OWk"
                        title="Estimated useful life">
                        <ix:nonnumeric contextref="AsOf2024-03-31_custom_SoftwareMember" format="ixt-sec:duryear"
                            id="Fact000678" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonnumeric>
                    </span> years, from which the expected benefit will be derived.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


            <ix:exclude><!-- Field: Page; Sequence: 110 -->
                <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                    <table cellpadding="0" cellspacing="0"
                        style="border-collapse: collapse; width: 100%; font-size: 10pt">
                        <tbody>
                            <tr style="vertical-align: top; text-align: left">
                                <td style="text-align: center; width: 100%">
                                    F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div style="break-before: page; margin-top: 6pt">
                    <p style="margin: 0pt">&nbsp;</p>
                </div>
                <!-- Field: /Page -->
            </ix:exclude>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span>
            </p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000680"
            name="us-gaap:IntangibleAssetsFiniteLivedPolicy">
            <p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z9hyzeKe5TX3"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                    intangible assets, net</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
                    associated with the acquisition of patent and technology related intangibles are capitalized and
                    amortized using the straight-line method
                    over the estimated useful life of <span
                        id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentAndTechnologyMember_zXSR6072t23k"
                        title="Estimated useful life intangible assets">
                        <ix:nonnumeric contextref="AsOf2024-03-31_custom_PatentAndTechnologyMember"
                            format="ixt-sec:durwordsen" id="Fact000682"
                            name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10 years</ix:nonnumeric>
                    </span>, from which the expected benefit will be derived.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000684"
            name="DHAI:DemonstrationUnitsPolicy">
            <p id="xdx_842_ecustom--DemonstrationUnitsPolicy_zjl631yTFzRc"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Demonstration
                    Units</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company utilizes product demonstration units that are used to display the product�s capabilities and
                    demonstrate how it works to
                    potential customers or for other appropriate applications. The Company records and carries the cost
                    of these demonstration units as either
                    inventory or property and equipment depending on several factors including the nature of the
                    product, length of time the units are in
                    the field prior to being sold, and whether management�s intent is to sell the units. If the product
                    demonstration units are classified
                    as property and equipment, the balance will be carried net of accumulated depreciation.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000686"
            name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
            <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_z7Ucec1N9ty"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impairment
                    of Long-Lived Assets, including intangible assets</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
                    assets include acquired property and equipment, subject to amortization. The Company evaluates the
                    recoverability of long-lived assets
                    for possible impairment whenever events or changes in circumstances indicate that the related
                    carrying amount may not be recoverable.
                    Such events and changes may include significant changes in performance relative to expected
                    operating results, significant changes in
                    asset use, significant negative industry or economic trends, and changes in the Company�s business
                    strategy. Recoverability is
                    measured by a comparison of the carrying amount of an asset or asset group to the undiscounted
                    future cash flows expected to be generated
                    by the asset or asset group. When required, impairment losses on assets to be held and used are
                    recognized based on the excess of the
                    asset�s carrying amount over the fair value of the asset, while long-lived assets to be disposed of
                    are reported at the lower of
                    carrying amount or fair value less cost to sell.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
                    software costs and other intangible assets are tested for impairment whenever events or changes in
                    circumstances that could impact recoverability
                    occur.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                    the years ended March 31, 2024 and 2023, the Company did not record any impairment losses.</span>
            </p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000688"
            name="us-gaap:LesseeLeasesPolicyTextBlock">
            <p id="xdx_84C_eus-gaap--LesseeLeasesPolicyTextBlock_zirv34n97jZj"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company adopted the provisions of the Financial Accounting Standards Board (�FASB�) Accounting
                    Standards Codification (�ASC�)
                    842 on April 1, 2021 using the modified retrospective approach and, as a result, did not restate
                    prior periods. At the commencement of
                    a contract, the Company determines if a contract meets the definition of a lease. A lease is a
                    contract, or part of a contract, that
                    conveys the right to control the use of identified property or equipment (an identified asset) for a
                    period of time in exchange for consideration.
                    The Company determines if the contract conveys the right to control the use of an identified asset
                    for a period of time. The Company
                    assesses throughout the period of use whether the Company has the following: (1) the right to obtain
                    substantially all the economic benefits
                    from use of the identified asset, and (2) the right to direct the use of the identified asset. This
                    determination is reassessed if the
                    terms of the contract are changed. Leases are classified as operating leases based on the terms of
                    the lease agreement and certain characteristics
                    of the identified asset. Right-of-use assets and lease liabilities are recognized at lease
                    commencement date based on the present value
                    of the minimum future lease payments. If the interest rate implicit in the Company�s leases is not
                    readily determinable, in determining
                    the weighted-average discount rate used to calculate the net present value of lease payments, the
                    Company utilizes an estimate of its
                    incremental borrowing rate.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company leases office space, vehicles and office equipment under operating leases. <span
                        id="xdx_908_eus-gaap--LessorOperatingLeaseDescription_c20230401__20240331_zUXH2i2KV6V2"
                        title="Lessor, operating lease description">
                        <ix:nonnumeric contextref="From2023-04-012024-03-31" id="Fact000690"
                            name="us-gaap:LessorOperatingLeaseDescription">The Company has elected several practical
                            expedients
                            permitted under ASC 842. The Company has elected not to recognize right-of-use assets and
                            liability for leases with a term of 12 months
                            or less unless the lease includes an option to renew or purchase the underlying asset that
                            are reasonably certain to be exercised</ix:nonnumeric>
                    </span>. The
                    Company has elected to account for lease and non-lease components as a single lease component for
                    all of the Company�s leases.
                    The Company has elected to use hindsight relief in determining the lease term and assessing
                    impairment of right-of-use assets when transitioning
                    to ASC 842. The Company has elected to not re-evaluate existing or expired contracts containing a
                    lease, the classification of leases,
                    or the initial direct costs for any existing leases previously accounted for under ASC 840.</span>
            </p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


            <ix:exclude><!-- Field: Page; Sequence: 111 -->
                <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                    <table cellpadding="0" cellspacing="0"
                        style="border-collapse: collapse; width: 100%; font-size: 10pt">
                        <tbody>
                            <tr style="vertical-align: top; text-align: left">
                                <td style="text-align: center; width: 100%">
                                    F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div style="break-before: page; margin-top: 6pt">
                    <p style="margin: 0pt">&nbsp;</p>
                </div>
                <!-- Field: /Page -->
            </ix:exclude>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
                    real estate leases contain clauses for renewal at the Company�s option with renewal terms that
                    generally extend the lease term
                    from six months to five years. Certain lease agreements contain options to purchase the leased
                    property and options to terminate the
                    lease. Payments to be made in option periods are recognized as part of the right-of-use lease assets
                    and lease liabilities when it is
                    reasonably certain that the option to extend the lease will be exercised or the option to terminate
                    the lease will not be exercised or
                    is not at the Company�s option. The Company determines whether the reasonably certain threshold is
                    met by considering all relevant
                    factors, including company-specific plans and economic outlook.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000692"
            name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock">
            <p id="xdx_841_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_z4YazJuAWND1"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingencies</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company records a liability in the consolidated financial statements for loss contingencies when a
                    loss is known or considered probable,
                    and the amount may be reasonably estimated. If the reasonable estimate of a known or probable loss
                    is a range, and no amount within the
                    range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is
                    reasonably possible but not known
                    or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed.
                    Legal costs incurred in connection with
                    loss contingencies are expensed as incurred.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000694"
            name="DHAI:PublicAndPrivatePlacementWarrantsPolicyTextBlock">
            <p id="xdx_84B_ecustom--PublicAndPrivatePlacementWarrantsPolicyTextBlock_zik7tGkmA65d"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
                    and Private Placement Warrants</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company assumed <span
                        id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zOsdjDjHSgO"
                        title="Class of warrants or rights warrants issued during the period units">
                        <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"
                            contextref="AsOf2024-03-31_custom_PublicWarrantsMember_us-gaap_IPOMember" id="Fact000696"
                            format="ixt:numdotdecimal" decimals="INF" unitref="Shares">20,200,000</ix:nonfraction>
                    </span> warrants originally issued in ATAK�s initial public offering (the �Public Warrants�) and
                    <span
                        id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zuZbiUwEVIJa"
                        title="Class of warrants or rights warrants issued during the period units">
                        <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"
                            contextref="AsOf2024-03-31_custom_PrivatePlacementWarrantMember_us-gaap_IPOMember"
                            id="Fact000698" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">6,470,000
                        </ix:nonfraction>
                    </span> ATAK Private Placement Warrants. Each <span
                        id="xdx_903_ecustom--NumberOfWarrantsOrRightsConvertedIntoShares_iI_pid_dc_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zMYlqtMvtLmf"
                        title="Number of warrants or rights converted into shares"><span
                            id="xdx_908_ecustom--NumberOfWarrantsOrRightsConvertedIntoShares_iI_pid_dc_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zX1DihGKMYzb"
                            title="Number of warrants or rights converted into shares">
                            <ix:nonfraction name="DHAI:NumberOfWarrantsOrRightsConvertedIntoShares"
                                contextref="AsOf2024-03-31_custom_PrivatePlacementWarrantMember_us-gaap_CommonClassAMember"
                                id="Fact000700" format="ixt-sec:numwordsen" decimals="INF" unitref="Shares">
                                <ix:nonfraction name="DHAI:NumberOfWarrantsOrRightsConvertedIntoShares"
                                    contextref="AsOf2024-03-31_custom_PublicWarrantsMember_us-gaap_CommonClassAMember"
                                    id="Fact000702" format="ixt-sec:numwordsen" decimals="INF" unitref="Shares">two
                                </ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> warrants entitles the registered holder to purchase <span
                        id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_dc_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zj6qaUE1c941"
                        title="Class of warrant or right, number of securities called by each warrant or right"><span
                            id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_dc_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zrpZpdMjx3Zh"
                            title="Class of warrant or right, number of securities called by each warrant or right">
                            <ix:nonfraction
                                name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"
                                contextref="AsOf2024-03-31_custom_PublicWarrantsMember_us-gaap_CommonClassAMember"
                                id="Fact000704" format="ixt-sec:numwordsen" decimals="INF" unitref="Shares">
                                <ix:nonfraction
                                    name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"
                                    contextref="AsOf2024-03-31_custom_PrivatePlacementWarrantMember_us-gaap_CommonClassAMember"
                                    id="Fact000706" format="ixt-sec:numwordsen" decimals="INF" unitref="Shares">one
                                </ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> share of Common Stock at
                    a price of $<span
                        id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zC4n5HLCi804"
                        title="Class of warrant or right, exercise price of warrants or rights"><span
                            id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zywSjuu94pL6"
                            title="Class of warrant or right, exercise price of warrants or rights">
                            <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"
                                contextref="AsOf2024-03-31_custom_PublicWarrantsMember_us-gaap_CommonClassAMember"
                                id="Fact000708" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">
                                <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"
                                    contextref="AsOf2024-03-31_custom_PrivatePlacementWarrantMember_us-gaap_CommonClassAMember"
                                    id="Fact000710" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">11.50
                                </ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> per share, subject to adjustment.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Public Warrants are publicly traded and are exercisable for cash unless certain conditions occur,
                    such as the failure to have an effective
                    registration statement related to the shares issuable upon exercise or redemption by the Company
                    under certain conditions, at which time
                    the warrants may be cashless exercised at the option of the Company. The Private Placement Warrants
                    have terms and provisions that are
                    identical to the Public Warrants except that the Private Placement Warrants holder can exercise
                    their Private Placement Warrants for
                    cash or on a cashless basis when the Company call the warrants for redemption at the option of
                    private placement warrant holders and
                    that the Private Placement Warrants were not transferable, assignable or salable until 30 days after
                    the completion of the Business Combination.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company evaluated the Public and Private Placement Warrants under ASC 815-40, Derivatives and
                    Hedging-Contracts in Entity�s Own
                    Equity (�ASC 815-40�), and concluded they meet the criteria for equity classification as they are
                    considered to be indexed
                    to the Company�s own stock. Since the Public and Private Placement Warrants met the criteria for
                    equity classification upon the
                    consummation of the Business Combination, the Company recorded these warrants in additional paid-in
                    capital as part of the Business Combination.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000712"
            name="us-gaap:SegmentReportingPolicyPolicyTextBlock">
            <p id="xdx_84D_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zR59COv8ga47"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Segment
                    Information</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company operates in one operating and reportable segment. Operating segments are defined as
                    components of an enterprise for which separate
                    financial information is evaluated regularly by the chief operating decision maker (�CODM�), in
                    deciding how to allocate
                    resources and assess performance. The Company�s Chief Executive Officer is the Company�s CODM. The
                    CODM reviews revenue at
                    the geographic region level, and gross profit, operating income and expenses, and net income at the
                    Company wide level to allocate resources
                    and assess the Company�s overall performance. Accordingly, decision-making regarding the Company�s
                    overall operating performance
                    and allocation of Company resources is assessed on an aggregate basis.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


            <ix:exclude><!-- Field: Page; Sequence: 112 -->
                <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                    <table cellpadding="0" cellspacing="0"
                        style="border-collapse: collapse; width: 100%; font-size: 10pt">
                        <tbody>
                            <tr style="vertical-align: top; text-align: left">
                                <td style="text-align: center; width: 100%">
                                    F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div style="break-before: page; margin-top: 6pt">
                    <p style="margin: 0pt">&nbsp;</p>
                </div>
                <!-- Field: /Page -->
            </ix:exclude>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span>
            </p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000714"
            name="us-gaap:DefinedBenefitPlanAccountingPolicyElectionMeasurementDatePolicyTextBlock">
            <p id="xdx_840_eus-gaap--DefinedBenefitPlanAccountingPolicyElectionMeasurementDatePolicyTextBlock_zbL7ST7NLFq7"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defined
                    Benefit Plan</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company sponsors defined a benefit pension plan (�pension plan�) for certain employees and retirees.
                    The Company recognizes
                    the funded status of its pension plan on the consolidated balance sheets based on the year-end
                    measurements of plan assets and benefit
                    obligations. When the fair value of plan assets is in excess of the plan benefit obligations, the
                    amounts are reported in other current
                    assets and other assets. When the fair value of plan benefit obligations is in excess of plan
                    assets, the amounts are reported in accrued
                    expenses and other long-term liabilities based on the amount by which the actuarial present value of
                    benefits payable in the next twelve
                    months included in the benefit obligation exceeds the fair value of plan assets.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                    periodic pension benefit cost/(income) is recorded in the consolidated statements of operations and
                    includes service cost, interest cost,
                    expected return on plan assets, amortization of prior service costs/(credits) and (gains) losses
                    previously recognized as a component
                    of other comprehensive income (loss) and amortization of the net transition asset remaining in
                    accumulated other comprehensive income
                    (loss). The service cost component of net benefit cost is recorded in selling, general and
                    administrative in the consolidated statements
                    of operations. The other components of net benefit cost are presented separately from service cost
                    within other income (expense) in the
                    consolidated statements of operations.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Gains)
                    losses and prior service costs/(credits) are recognized as a component of other comprehensive income
                    (loss) in the consolidated statements
                    of comprehensive loss as they arise. Those (gains) losses and prior service costs (credits) are
                    subsequently recognized as a component
                    of net periodic cost (income) pursuant to the recognition and amortization provisions of applicable
                    accounting guidance. (Gains) losses
                    arise as a result of differences between actual experience and assumptions or as a result of changes
                    in actuarial assumptions. Prior
                    service costs (credits) represent the cost of benefit changes attributable to prior service granted
                    in plan amendments.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    measurement of benefit obligations and net periodic cost/(income) is based on estimates and
                    assumptions approved by the company�s
                    management. These valuations reflect the terms of the plans and use participant-specific information
                    such as compensation, age, and years
                    of service, as well as certain assumptions, including estimates of discount rates, expected return
                    on plan assets, rate of compensation
                    increases, interest crediting rates and mortality rates. See Note 14 for further information.</span>
            </p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000716"
            name="us-gaap:BusinessCombinationsPolicy">
            <p id="xdx_841_eus-gaap--BusinessCombinationsPolicy_zOTBqtgeHa7d"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisitions</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                    conjunction with each acquisition transaction, the Company determines if the acquisition meets the
                    criteria to be accounted for as a
                    business combination set forth in ASC 805, Business Combinations (�ASC 805�). The Company evaluates
                    the acquisition to assess
                    whether or not the transaction should be accounted for as a business combination or asset
                    acquisition by first applying a screen test
                    to determine if substantially all of the fair value of the gross assets acquired is concentrated in
                    a single identifiable asset or group
                    of similar identifiable assets. If the screen is met, the transaction is accounted for as an asset
                    acquisition. If the screen is not
                    met, further determination is required as to whether or not the Company has acquired inputs and
                    processes that have the ability to create
                    outputs which would meet the definition of a business.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                    the transaction is determined not to be a business combination, it is accounted for as an asset
                    acquisition. For asset acquisitions,
                    the Company allocates the purchase price and other related costs incurred to the assets acquired and
                    liabilities assumed based on recent
                    independent appraisals and management judgment.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                    the acquisition is determined to be a business combination, the Company records the fair value of
                    acquired tangible assets and identified
                    intangible assets and as well as any noncontrolling interest in accordance ASC 805. Any
                    consideration paid in excess of the net fair
                    value of the identifiable assets and liabilities acquired in a business combination is recorded to
                    goodwill and acquisition-related costs
                    are expensed as incurred.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                    October 2022, DIH acquired the SafeGait 360 and SafeGait Active smart mobility trainer systems from
                    Gorbel, an innovative United States-based
                    developer and manufacturer of smart material handling and fall protection equipment. The SafeGait
                    acquisition was accounted for as an
                    asset acquisition based on an evaluation of the U.S. GAAP guidance for business combinations. The
                    total cost of the asset acquisition
                    was $<span
                        id="xdx_90B_eus-gaap--BusinessCombinationConsiderationTransferred1_pn5n6_c20221001__20221031__us-gaap--BusinessAcquisitionAxis__custom--SafeGaitAcquisitionMember_zmPbELzS3C22"
                        title="Total cost of asset acquisition">
                        <ix:nonfraction name="us-gaap:BusinessCombinationConsiderationTransferred1"
                            contextref="From2022-10-012022-10-31_custom_SafeGaitAcquisitionMember" id="Fact000718"
                            format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">0.8</ix:nonfraction>
                    </span> million, of which $<span
                        id="xdx_906_eus-gaap--PaymentsToAcquireBusinessesGross_pn5n6_c20221001__20221031__us-gaap--BusinessAcquisitionAxis__custom--SafeGaitAcquisitionMember_zkdMHh5jLdOk"
                        title="Amount paid upon acquisition">
                        <ix:nonfraction name="us-gaap:PaymentsToAcquireBusinessesGross"
                            contextref="From2022-10-012022-10-31_custom_SafeGaitAcquisitionMember" id="Fact000720"
                            format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">0.1</ix:nonfraction>
                    </span> million was paid upon closing. The Company made subsequent payments of $<span
                        id="xdx_903_eus-gaap--PaymentsToAcquireBusinessesGross_pn5n6_c20230401__20230630__us-gaap--BusinessAcquisitionAxis__custom--SafeGaitAcquisitionMember_zQwmnDmyMMVa"
                        title="Amount paid upon acquisition">
                        <ix:nonfraction name="us-gaap:PaymentsToAcquireBusinessesGross"
                            contextref="From2023-04-012023-06-30_custom_SafeGaitAcquisitionMember" id="Fact000722"
                            format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">0.2</ix:nonfraction>
                    </span> million in the first quarter
                    of the year ending March 31, 2024. These subsequent payments and the $<span
                        id="xdx_90E_eus-gaap--BusinessCombinationContingentConsiderationLiabilityCurrent_iI_pn5n6_c20240331__us-gaap--BusinessAcquisitionAxis__custom--SafeGaitAcquisitionMember_zPlLb3hUOhEa"
                        title="Asset acquisition contingent consideration liability">
                        <ix:nonfraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent"
                            contextref="AsOf2024-03-31_custom_SafeGaitAcquisitionMember" id="Fact000724"
                            format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">0.5</ix:nonfraction>
                    </span> million contingent consideration liability is presented within
                    accrued expenses and other current liabilities in the consolidated balance sheet as of March 31,
                    2024. The Company determined that the
                    contingent consideration was not subject to derivative accounting.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


            <ix:exclude><!-- Field: Page; Sequence: 113 -->
                <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                    <table cellpadding="0" cellspacing="0"
                        style="border-collapse: collapse; width: 100%; font-size: 10pt">
                        <tbody>
                            <tr style="vertical-align: top; text-align: left">
                                <td style="text-align: center; width: 100%">
                                    F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div style="break-before: page; margin-top: 6pt">
                    <p style="margin: 0pt">&nbsp;</p>
                </div>
                <!-- Field: /Page -->
            </ix:exclude>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span>
            </p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000726"
            name="us-gaap:IncomeTaxPolicyTextBlock">
            <p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_z4CMwgvU5BHc"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
                    Taxes</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
                    taxes are accounted for under the asset-and-liability method. Under this method, deferred tax assets
                    and liabilities are recognized for
                    the future tax consequences attributable to temporary differences between the financial statement
                    carrying amounts of existing assets
                    and liabilities, as well as loss and tax credit carryforwards and their respective tax bases
                    measured using enacted tax rates expected
                    to apply to taxable income in the years in which those temporary differences are expected to be
                    recovered or settled. The effect on deferred
                    tax assets and liabilities of a change in tax rates is recognized in income in the period that
                    includes the enactment date.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                    valuation allowance is established if, based upon the available evidence, it is more likely than not
                    that some or all the deferred tax
                    assets will not be realized. The Company considers all available evidence, both positive and
                    negative, including historical levels of
                    income, expectations and risks associated with estimates of future taxable income in assessing the
                    need for a valuation allowance.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
                    tax assets and deferred tax liabilities are presented as noncurrent in a classified balance
                    sheet.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company�s tax positions are subject to income tax audits by multiple tax jurisdictions throughout
                    the world. The Company recognizes
                    the tax benefit of an uncertain tax position only if it is more likely than not the position will be
                    sustainable upon examination by
                    the taxing authority, including resolution of any related appeals or litigation processes. This
                    evaluation is based on all available
                    evidence and assumes that the tax authorities have full knowledge of all relevant information
                    concerning the tax position. The tax benefit
                    recognized is measured as the largest amount of benefit which is more likely than not (greater than
                    50% likely) to be realized upon ultimate
                    settlement with the taxing authority. The Company recognizes interest accrued and penalties related
                    to unrecognized tax benefits in income
                    tax expense (benefit). The Company adjusts these reserves in accordance with the income tax guidance
                    when facts and circumstances change,
                    such as the closing of a tax audit or the refinement of an estimate. To the extent that the final
                    tax outcome of these matters is different
                    from the amounts recorded, such differences will affect the provision for income taxes in the period
                    in which such determination is made
                    and could have a material impact on the Company�s financial condition and operating results.</span>
            </p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                    the Tax Cuts and Jobs Act, the Global Intangible Low-Taxed Income (�GILTI�) provisions impose a tax
                    on foreign income in
                    excess of a deemed return on tangible assets of foreign corporations. Under GAAP, companies are
                    allowed to make an accounting policy
                    election to either (i) account for GILTI as a period cost within income tax expense in the period in
                    which it is incurred or (ii) account
                    for GILTI in a company�s measurement of deferred taxes. The Company elected to account for GILTI as
                    a period cost.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000728"
            name="us-gaap:EarningsPerSharePolicyTextBlock">
            <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zHVcwy7B2wTl"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
                    per share</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
                    earnings (loss) per share is calculated by dividing net income (loss) by the weighted-average number
                    of common shares outstanding during
                    the period. Diluted earnings (loss) per share is computed based on the sum of the weighted average
                    number of common shares and potentially
                    dilutive common shares outstanding during the period.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                    periods prior to the closing of the Business Combination, basic and diluted income (loss) per share
                    was calculated based on the <span
                        id="xdx_904_eus-gaap--SharesIssued_iI_pn5n6_c20240207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DihNevadaMember_ziG09ZbrtFAc"
                        title="Shares issued">
                        <ix:nonfraction name="us-gaap:SharesIssued"
                            contextref="AsOf2024-02-07_custom_DihNevadaMember22260578" id="Fact000730"
                            format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="Shares">25.0</ix:nonfraction>
                    </span>
                    million shares issued to DIH Nevada�s shareholders at the Closing Date.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000732"
            name="DHAI:EmergingGrowthCompanyPolicyTextBlock">
            <p id="xdx_842_ecustom--EmergingGrowthCompanyPolicyTextBlock_zZ5KchaU6PC7"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
                    Growth Company</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company is an �emerging growth company,� as defined in Section 2(a) of the Securities Act, as
                    modified by the JOBS Act, and
                    it may take advantage of certain exemptions from various reporting requirements that are applicable
                    to other public companies that are
                    not emerging growth companies including, but not limited to, not being required to comply with the
                    independent registered public accounting
                    firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
                    obligations regarding executive compensation
                    in its periodic reports and proxy statements, and exemptions from the requirements of holding a
                    nonbinding advisory vote on executive
                    compensation and shareholder approval of any golden parachute payments not previously
                    approved.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


            <ix:exclude><!-- Field: Page; Sequence: 114 -->
                <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                    <table cellpadding="0" cellspacing="0"
                        style="border-collapse: collapse; width: 100%; font-size: 10pt">
                        <tbody>
                            <tr style="vertical-align: top; text-align: left">
                                <td style="text-align: center; width: 100%">
                                    F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div style="break-before: page; margin-top: 6pt">
                    <p style="margin: 0pt">&nbsp;</p>
                </div>
                <!-- Field: /Page -->
            </ix:exclude>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
                    Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply
                    with new or revised financial accounting
                    standards until private companies (that is, those that have not had a Securities Act registration
                    statement declared effective or do
                    not have a class of securities registered under the Exchange Act) are required to comply with the
                    new or revised financial accounting
                    standards. The JOBS Act provides that a company can elect to opt out of the extended transition
                    period and comply with the requirements
                    that apply to non-emerging growth companies but any such election to opt out is irrevocable. The
                    Company has elected not to opt out of
                    such extended transition period which means that when a standard is issued or revised and it has
                    different application dates for public
                    or private companies, the Company, as an emerging growth company, can adopt the new or revised
                    standard at the time private companies
                    adopt the new or revised standard. This may make comparison of the Company�s financial statements
                    with another public company which
                    is either not an emerging growth company or an emerging growth company which has opted out of using
                    the extended transition period difficult
                    or impossible because of the potential differences in accounting standards used.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000734"
            name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock">
            <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z6WRLqdz2mh9"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span id="xdx_867_zpt4av3BsrTb"
                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
                    Pronouncements Recently Adopted</span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                    June 2016, the FASB issued ASU No. 2016-13, <i>Financial Instruments-Credit Losses (Topic 326):
                        Measurement of Credit Losses on Financial
                        Instruments</i> (�ASC 326�). ASC 326 provides more decision-useful information about the
                    expected credit losses on financial
                    instruments, other commitments to extend credit held by a reporting entity at each reporting date,
                    and requires the entity to estimate
                    its credit losses as far as it can reasonably estimate. This update became effective for the Company
                    on April 1, 2023. The adoption of
                    this guidance did not have a material impact on the Company�s consolidated financial
                    statements.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000736"
            name="DHAI:RecentAccountingPronouncementsNotYetAdoptedPolicyTextBlock">
            <p id="xdx_84C_ecustom--RecentAccountingPronouncementsNotYetAdoptedPolicyTextBlock_zgnueXukkMmb"
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_86C_zd3KofuCUrLd">Recent
                        Accounting Pronouncements Not Yet Adopted</span></span></p>

            <p
                style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                    August 2020, the FASB issued ASU No. 2020-06, Debt � Debt with Conversion and Other Options
                    (Subtopic 470- 20) and Derivatives
                    and Hedging � Contracts in Entity�s Own Equity (Subtopic 815-40): Accounting for Convertible
                    Instruments and Contracts in
                    an Entity�s Own Equity (�ASU 2020-06�), which simplifies accounting for convertible instruments by
                    removing major separation
                    models required under current U.S. GAAP and simplifies the diluted earnings per share (�EPS�)
                    calculation in certain areas.
                    Under the new guidance there will be no separate accounting for embedded conversion features. It
                    removes certain settlement conditions
                    that are required for equity contracts to qualify for the derivative scope exception. The amendments
                    in this update are effective for
                    the Company on April 1, 2024. Early adoption is permitted. We do not expect the adoption to have a
                    material impact on our financial position
                    or results of operations.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                    November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to
                    Reportable Segment Disclosures. Update
                    No. 2023-07 requires disclosure, on an annual and interim basis, of significant segment expenses
                    that are regularly provided to the CODM
                    and included within each reported measure of segment profit or loss in addition to disclosure of
                    amounts for other segment items and
                    a description of its composition. Update No. 2023-07 is effective for fiscal years beginning after
                    December 15, 2023, and interim periods
                    within fiscal years beginning after December 15, 2024. We are currently evaluating the impact of
                    adopting ASU 2023-07.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                    December 2023, the FASB issued ASU No. 2023-09 (�ASU 2023-09�), Income Taxes (Topic 740):
                    Improvements to Income Tax Disclosures.
                    ASU 2023-09addresses investor requests for more transparency about income tax information through
                    improvements to income tax disclosures
                    primarily related to the rate reconciliation and income taxes paid information. This update also
                    includes certain other amendments to
                    improve the effectiveness of income tax disclosures. The provisions of ASU 2023-09 are effective for
                    annual periods beginning after December
                    15, 2024, with early adoption permitted. We are currently evaluating the impact of adopting ASU
                    2023-09.</span></p>

        </ix:nonnumeric>
        <p id="xdx_858_zhljC6iArSza"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000738"
        name="us-gaap:RevenueFromContractWithCustomerTextBlock">
        <p id="xdx_808_eus-gaap--RevenueFromContractWithCustomerTextBlock_z3eJjMMUQDm9"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_82B_zEqiqyUklD93">Revenue Recognition</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company�s revenues are derived from the sales of medical rehabilitation devices and technology services.
                The Company�s primary
                customers include healthcare systems, clinics, third-party healthcare providers, distributors, and other
                institutions, including governmental
                healthcare programs and group purchasing organizations.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 115 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregation
                of Revenue</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000740"
            name="us-gaap:DisaggregationOfRevenueTableTextBlock">
            <p id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_zy0lmyGnhES9"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company disaggregates its revenue with customers by category and by geographic region based on
                    customer location, see Note 4 for further
                    information. The following represents the net revenue for the years ended March 31, 2024 and 2023,
                    based on revenue category:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B7_zmmmxWKH4yT8">Schedule
                        of Disaggregation of Revenue</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="display: none">&nbsp;</td>
                        <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_491_20230401__20240331_zbO9DmDx5344"
                            style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_495_20220401__20230331_zF8q2RIryeLc"
                            style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Years Ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DevicesMember_zG6pL4f1val9"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; padding-left: 0.75pt">Devices</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012024-03-31_custom_DevicesMember" id="Fact000742"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">51,125</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2022-04-012023-03-31_custom_DevicesMember" id="Fact000743"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">43,452</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__us-gaap--ServiceMember_z8RprjKaEbqi"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 0.75pt">Services</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012024-03-31_us-gaap_ServiceMember" id="Fact000745"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">11,105</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2022-04-012023-03-31_us-gaap_ServiceMember" id="Fact000746"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">9,292</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--OtherMember_zrisNlvn0S6d"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-bottom: 1pt; padding-left: 0.75pt">Other</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012024-03-31_custom_OtherMember" id="Fact000748"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,243</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2022-04-012023-03-31_custom_OtherMember" id="Fact000749"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,315</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_zHhVo3UNv4g5"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total revenue, net</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012024-03-31" id="Fact000751" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">64,473</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2022-04-012023-03-31" id="Fact000752" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">54,059</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A8_zvcvFXz6orNe"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                revenue that is recognized at a point in time was primarily related to the revenues from devices and the
                revenue that is recognized over
                time was related to revenue from services. Other revenue primarily relates to freight and packaging on
                devices and recognized at a point
                in time.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
                Revenue and Remaining Performance Obligations</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
                revenue as of March 31, 2024 and 2023 was $<span
                    id="xdx_905_eus-gaap--DeferredRevenue_iI_pn3n3_c20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_z1XQj2vg0Tc4"
                    title="Deferred revenue">
                    <ix:nonfraction name="us-gaap:DeferredRevenue"
                        contextref="AsOf2024-03-31_custom_DIHHoldingUSIncMember" id="Fact000754"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">9,881</ix:nonfraction>
                </span> and $<span
                    id="xdx_905_eus-gaap--DeferredRevenue_iI_pn3n3_c20230331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_z8oRN2qHRgRg"
                    title="Deferred revenue">
                    <ix:nonfraction name="us-gaap:DeferredRevenue"
                        contextref="AsOf2023-03-31_custom_DIHHoldingUSIncMember" id="Fact000756"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">9,996</ix:nonfraction>
                </span>, respectively. During the years ended March 31, 2024 and 2023, the Company
                recognized $<span
                    id="xdx_905_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pn3n3_c20230401__20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zHgT3J6iAdX1"
                    title="Deferred revenue, revenue recognized">
                    <ix:nonfraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized"
                        contextref="From2023-04-012024-03-31_custom_DIHHoldingUSIncMember" id="Fact000758"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,405</ix:nonfraction>
                </span> and $<span
                    id="xdx_905_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pn3n3_c20220401__20230331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_ziZZo298f5Q"
                    title="Deferred revenue, revenue recognized">
                    <ix:nonfraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized"
                        contextref="From2022-04-012023-03-31_custom_DIHHoldingUSIncMember" id="Fact000760"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,358</ix:nonfraction>
                </span> of revenue that was included in deferred revenue as of March 31, 2023 and March 31, 2022,
                respectively.
                Remaining performance obligations include goods and services that have not yet been delivered or
                provided under existing, noncancelable
                contracts with minimum purchase commitments. As of March 31, 2024 and 2023, the aggregate amount of the
                contracted revenue allocated
                to unsatisfied performance obligations with an original duration of one year or more was approximately
                $<span
                    id="xdx_90C_eus-gaap--RevenueRemainingPerformanceObligation_iI_pn3n3_c20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zai4YshGnsOc"
                    title="Revenue, remaining performance obligation, amount">
                    <ix:nonfraction name="us-gaap:RevenueRemainingPerformanceObligation"
                        contextref="AsOf2024-03-31_custom_DIHHoldingUSIncMember" id="Fact000762"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,670</ix:nonfraction>
                </span> and $<span
                    id="xdx_909_eus-gaap--RevenueRemainingPerformanceObligation_iI_pn3n3_c20230331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_z7UFAhqBiOc7"
                    title="Revenue, remaining performance obligation, amount">
                    <ix:nonfraction name="us-gaap:RevenueRemainingPerformanceObligation"
                        contextref="AsOf2023-03-31_custom_DIHHoldingUSIncMember" id="Fact000764"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,698</ix:nonfraction>
                </span>, respectively.
                As of March 31, 2024, the Company expects to recognize revenue on the majority of these remaining
                performance obligations over the next
                <span
                    id="xdx_909_ecustom--RevenueRemainingPerformanceObligationsExpectedTimingOfSatisfactionPeriod1_dtY_c20230401__20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zA0cmtlOsJl2"
                    title="Deferred revenue recognized">
                    <ix:nonnumeric contextref="From2023-04-012024-03-31_custom_DIHHoldingUSIncMember"
                        format="ixt-sec:duryear" id="Fact000766"
                        name="DHAI:RevenueRemainingPerformanceObligationsExpectedTimingOfSatisfactionPeriod1">2
                    </ix:nonnumeric>
                </span> years.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance
                Payments From Customers</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company receives advance payments related to customers from their orders to support the operation of the
                company in the production of
                the goods. The Company recognizes these prepayments as a liability under �Advance payments from
                customers� on the consolidated
                balance sheets when they are received. Revenue associated with the advance payments is recognized when
                performance obligation is fulfilled.
                Advance payments from customers was $<span
                    id="xdx_902_ecustom--AdvancePaymentsFromCustomers_iI_pn5n6_c20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zExNceLaaS6b"
                    title="Advance payments from customers">
                    <ix:nonfraction name="DHAI:AdvancePaymentsFromCustomers"
                        contextref="AsOf2024-03-31_custom_DIHHoldingUSIncMember" id="Fact000768"
                        format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">10.6</ix:nonfraction>
                </span> million and $<span
                    id="xdx_909_ecustom--AdvancePaymentsFromCustomers_iI_pn5n6_c20230331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zNJQ0rosZlt"
                    title="Advance payments from customers">
                    <ix:nonfraction name="DHAI:AdvancePaymentsFromCustomers"
                        contextref="AsOf2023-03-31_custom_DIHHoldingUSIncMember" id="Fact000770"
                        format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">6.3</ix:nonfraction>
                </span> million as of March 31, 2024 and 2023, respectively.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000772"
        name="us-gaap:SegmentReportingDisclosureTextBlock">
        <p id="xdx_800_eus-gaap--SegmentReportingDisclosureTextBlock_zLofsHxtrlec"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_826_z6s35va1wa61">Geographical Information</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000774"
            name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
            <p id="xdx_892_eus-gaap--RevenueFromExternalCustomersByGeographicAreasTableTextBlock_z26VETR3Z2yj"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    following represents revenue attributed to geographic regions based on customer location:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8BA_zlsIS7xSX4O1">Schedule
                        of Revenue Attributed to Geographic Regions Based on Customer Location</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="display: none; text-align: center">&nbsp;</td>
                        <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_494_20230401__20240331_z839sFvpoaU4"
                            style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49D_20220401__20230331_zTx31jvzm5cc"
                            style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Years Ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__us-gaap--EMEAMember_zTFonQiLbon2"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Europe, Middle East and Africa
                            (�EMEA�)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012024-03-31_us-gaap_EMEAMember" id="Fact000776"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">36,002</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2022-04-012023-03-31_us-gaap_EMEAMember" id="Fact000777"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">31,454</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__srt--AmericasMember_znntPdY3LNhk"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 0.75pt">Americas</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012024-03-31_srt_AmericasMember" id="Fact000779"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">16,716</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2022-04-012023-03-31_srt_AmericasMember" id="Fact000780"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">14,264</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__srt--AsiaPacificMember_zl2c5LTsmBF4"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Asia Pacific (�APAC�)
                        </td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012024-03-31_srt_AsiaPacificMember" id="Fact000782"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">11,755</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2022-04-012023-03-31_srt_AsiaPacificMember" id="Fact000783"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">8,341</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_zKEkPJSjEoR8"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total revenue</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012024-03-31" id="Fact000785" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">64,473</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2022-04-012023-03-31" id="Fact000786" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">54,059</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AB_z5SzRLfh5Sa2"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            &nbsp;</p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            For
            the three months ended September 30, 2024 and 2023, the United States represented <span
                id="xdx_903_ecustom--RevenuePercentage_dp_uPure_c20240701__20240930__srt--StatementGeographicalAxis__country--US_zGym6cVQiFK2"
                title="Revenue percentage"
                class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                <ix:nonfraction name="DHAI:RevenuePercentage" contextref="From2024-07-012024-09-30_country_US"
                    id="Fact000788" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">23
                </ix:nonfraction>
            </span>% and <span
                id="xdx_90E_ecustom--RevenuePercentage_dp_uPure_c20230701__20230930__srt--StatementGeographicalAxis__country--US_zNwUaNYlNIol"
                title="Revenue percentage"
                class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                <ix:nonfraction name="DHAI:RevenuePercentage" contextref="From2023-07-012023-09-30_country_US"
                    id="Fact000790" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">20
                </ix:nonfraction>
            </span>% of total revenue, respectively. Russia
            represented <span
                id="xdx_902_ecustom--RevenuePercentage_dp_uPure_c20230701__20230930__srt--StatementGeographicalAxis__country--RU_zPl3f8kGylPk"
                title="Revenue percentage"
                class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                <ix:nonfraction name="DHAI:RevenuePercentage" contextref="From2023-07-012023-09-30_country_RU"
                    id="Fact000792" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">20
                </ix:nonfraction>
            </span>% of total revenue for the three months ended September 30, 2023. For the six months ended September
            30, 2024 and 2023,
            the United States represented <span
                id="xdx_90F_ecustom--RevenuePercentage_dp_uPure_c20240401__20240930__srt--StatementGeographicalAxis__country--US_zhfZWrX8zQY"
                title="Revenue percentage"
                class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                <ix:nonfraction name="DHAI:RevenuePercentage" contextref="From2024-04-012024-09-30_country_US"
                    id="Fact000794" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">19
                </ix:nonfraction>
            </span>% and <span
                id="xdx_904_ecustom--RevenuePercentage_dp_uPure_c20230401__20230930__srt--StatementGeographicalAxis__country--US_zIxVWBakSEdg"
                title="Revenue percentage"
                class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                <ix:nonfraction name="DHAI:RevenuePercentage" contextref="From2023-04-012023-09-30_country_US"
                    id="Fact000796" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">20
                </ix:nonfraction>
            </span>% of total revenue, respectively. Russia represented <span
                id="xdx_90D_ecustom--RevenuePercentage_dp_uPure_c20230401__20230930__srt--StatementGeographicalAxis__country--RU_zwD6ZACohfG9"
                title="Revenue percentage"
                class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                <ix:nonfraction name="DHAI:RevenuePercentage" contextref="From2023-04-012023-09-30_country_RU"
                    id="Fact000798" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">20
                </ix:nonfraction>
            </span>% of total revenue for the six months
            ended September 30, 2023. No other countries represented greater than <span
                id="xdx_901_ecustom--RevenuePercentage_dp_uPure_c20230701__20230930__srt--StatementGeographicalAxis__custom--OtherMember_zULDVhjgCdcl"
                title="Revenue percentage"
                class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><span
                    id="xdx_907_ecustom--RevenuePercentage_dp_uPure_c20230401__20230930__srt--StatementGeographicalAxis__custom--OtherMember_zhxTpBWc3m87"
                    title="Revenue percentage"
                    class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><span
                        id="xdx_90B_ecustom--RevenuePercentage_dp_uPure_c20240401__20240930__srt--StatementGeographicalAxis__custom--OtherMember_zqGjq40GsYid"
                        title="Revenue percentage"
                        class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><span
                            id="xdx_90F_ecustom--RevenuePercentage_dp_uPure_c20240701__20240930__srt--StatementGeographicalAxis__custom--OtherMember_zo054UhiaRC3"
                            title="Revenue percentage"
                            class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                            <ix:nonfraction name="DHAI:RevenuePercentage"
                                contextref="From2023-07-012023-09-30_custom_OtherMember22262187" id="Fact000800"
                                format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                <ix:nonfraction name="DHAI:RevenuePercentage"
                                    contextref="From2023-04-012023-09-30_custom_OtherMember22262187" id="Fact000802"
                                    format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                    <ix:nonfraction name="DHAI:RevenuePercentage"
                                        contextref="From2024-04-012024-09-30_custom_OtherMember22262187" id="Fact000804"
                                        format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                        <ix:nonfraction name="DHAI:RevenuePercentage"
                                            contextref="From2024-07-012024-09-30_custom_OtherMember22262203"
                                            id="Fact000806" format="ixt:numdotdecimal" decimals="INF" scale="-2"
                                            unitref="Pure">10</ix:nonfraction>
                                    </ix:nonfraction>
                                </ix:nonfraction>
                            </ix:nonfraction>
                        </span></span></span></span>% of revenue during the three and six months ended September
            30, 2024 and 2023.</p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000808"
            name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock">
            <p id="xdx_895_eus-gaap--LongLivedAssetsByGeographicAreasTableTextBlock_zZUYQmlhasf2"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
                    assets shown below include property and equipment, net. The following represents long-lived assets
                    where they are physically located:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B1_zIcCmmvsMyie">Schedule
                        of Long-lived Assets</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_496_20240331_zeloDyilIara"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_494_20230331_zlq93RgRsGic"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_hsrt--StatementGeographicalAxis__us-gaap--EMEAMember_zZjMFxLmWDfi"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; padding-left: 0.75pt">EMEA</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet"
                                contextref="AsOf2024-03-31_us-gaap_EMEAMember" id="Fact000810"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">276</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet"
                                contextref="AsOf2023-03-31_us-gaap_EMEAMember" id="Fact000811"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">236</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_hsrt--StatementGeographicalAxis__srt--AmericasMember_z17PPlajInH2"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 0.75pt">Americas</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet"
                                contextref="AsOf2024-03-31_srt_AmericasMember" id="Fact000813"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">206</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet"
                                contextref="AsOf2023-03-31_srt_AmericasMember" id="Fact000814"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">390</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_hsrt--StatementGeographicalAxis__srt--AsiaPacificMember_zP4EqO99iP4"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-bottom: 1pt; padding-left: 0.75pt">APAC</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet"
                                contextref="AsOf2024-03-31_srt_AsiaPacificMember" id="Fact000816"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">48</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet"
                                contextref="AsOf2023-03-31_srt_AsiaPacificMember" id="Fact000817"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">116</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_zMyEu4n4hHo"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total property and
                            equipment, net</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2024-03-31"
                                id="Fact000819" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">530
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2023-03-31"
                                id="Fact000820" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">742
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A9_zs5PAFOeZz6l"
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 116 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000822"
        name="us-gaap:EarningsPerShareTextBlock">
        <p id="xdx_808_eus-gaap--EarningsPerShareTextBlock_zvGOPZJLmr3f"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_825_zgLwHtrs1Lw1">Net
                    Loss Per Share</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
                income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of
                common shares outstanding during
                the period. Diluted income (loss) per share is computed based on the sum of the weighted average number
                of common shares and dilutive
                common shares outstanding during the period. As described in Note 1 - Business and Organization earnout
                shares issued in connection with
                the Business Combination are subject to vesting based on the volume weighted average trading prices
                (�VWAP�) of common shares
                during the earnout period. The earnout shares are excluded from the calculation of basic and diluted
                weighted-average number of common
                shares outstanding until vested. For periods prior to the Business Combination, basic and diluted loss
                per share was calculated based
                on the <span
                    id="xdx_90B_eus-gaap--SharesIssued_iI_pn5n6_c20240207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LegacyDihMember_zuA7Nfg6sbVh"
                    title="Shares issued">
                    <ix:nonfraction name="us-gaap:SharesIssued" contextref="AsOf2024-02-07_custom_LegacyDihMember"
                        id="Fact000824" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="Shares">25.0
                    </ix:nonfraction>
                </span> million shares issued to Legacy DIH shareholders at the Closing Date. Potential shares of common
                stock are excluded from
                the computation of diluted net loss per share if their effect would have been anti-dilutive for the
                periods presented or if the issuance
                of shares is contingent upon events that did not occur by the end of the period.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                of March 31, 2024, there were <span
                    id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20240331_z3eUKc2cvVM6"
                    title="Common stock, shares, issued"><span
                        id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240331_zVesg1CUeXhf"
                        title="Common stock shares outstanding">
                        <ix:nonfraction name="us-gaap:CommonStockSharesIssued" contextref="AsOf2024-03-31"
                            id="Fact000826" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                            <ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" contextref="AsOf2024-03-31"
                                id="Fact000828" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">34,544,935
                            </ix:nonfraction>
                        </ix:nonfraction>
                    </span></span> shares of Common Stock issued and outstanding, excluding earnout shares.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000830"
            name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
            <p id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zzYh5tweMJo5"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computation
                    of basic and diluted net loss per share for the years ended March 31, 2024 and 2023, is as follows
                    (in thousands, except share and per
                    share amounts):</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B3_zBJtiLcHxyD8">Schedule
                        of Computation of Basic and Diluted Net Loss Per Share</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="display: none">&nbsp;</td>
                        <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49B_20230401__20240331_zX9GG8D2hrO7"
                            style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_498_20220401__20230331_zPLxCNWXtGhg"
                            style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Years Ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--NetIncomeLoss_pn3n3_zaYgz8zkuZi4"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Net loss</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                                contextref="From2023-04-012024-03-31" id="Fact000832" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">8,443</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                                contextref="From2022-04-012023-03-31" id="Fact000833" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">1,014</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Weighted-average shares
                            outstanding, basic and diluted</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230401__20240331_zz7Qqfp6vpH8"
                                title="Weighted-average shares outstanding, basic"><span
                                    id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230401__20240331_zr80L8n4r7Lh"
                                    title="Weighted-average shares outstanding, diluted">
                                    <ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"
                                        contextref="From2023-04-012024-03-31" id="Fact000835" format="ixt:numdotdecimal"
                                        decimals="INF" unitref="Shares">
                                        <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                            contextref="From2023-04-012024-03-31" id="Fact000837"
                                            format="ixt:numdotdecimal" decimals="INF" unitref="Shares">26,382,190
                                        </ix:nonfraction>
                                    </ix:nonfraction>
                                </span></span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220401__20230331_zZZzh9o7TYo5"
                                title="Weighted-average shares outstanding, basic"><span
                                    id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220401__20230331_zy3IpGlQIW4a"
                                    title="Weighted-average shares outstanding, diluted">
                                    <ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"
                                        contextref="From2022-04-012023-03-31" id="Fact000839" format="ixt:numdotdecimal"
                                        decimals="INF" unitref="Shares">
                                        <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                            contextref="From2022-04-012023-03-31" id="Fact000841"
                                            format="ixt:numdotdecimal" decimals="INF" unitref="Shares">25,000,000
                                        </ix:nonfraction>
                                    </ix:nonfraction>
                                </span></span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Net loss per
                            share&#8201;�&#8201;basic and diluted</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right"><span
                                id="xdx_906_eus-gaap--EarningsPerShareBasic_pid_c20230401__20240331_z8HAJ7KOVrr1"
                                title="Net loss per share - basic"><span
                                    id="xdx_900_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20240331_z6oMjyvoM069"
                                    title="Net loss per share - diluted">(<ix:nonfraction
                                        name="us-gaap:EarningsPerShareBasic" contextref="From2023-04-012024-03-31"
                                        id="Fact000843" format="ixt:numdotdecimal" decimals="INF" sign="-"
                                        unitref="USDPShares">
                                        <ix:nonfraction name="us-gaap:EarningsPerShareDiluted"
                                            contextref="From2023-04-012024-03-31" id="Fact000845"
                                            format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">0.32
                                        </ix:nonfraction>
                                    </ix:nonfraction></span></span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right"><span
                                id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20220401__20230331_zlNJhkgVOcMc"
                                title="Net loss per share - basic"><span
                                    id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20220401__20230331_zNPBA9AElKM9"
                                    title="Net loss per share - diluted">(<ix:nonfraction
                                        name="us-gaap:EarningsPerShareBasic" contextref="From2022-04-012023-03-31"
                                        id="Fact000847" format="ixt:numdotdecimal" decimals="INF" sign="-"
                                        unitref="USDPShares">
                                        <ix:nonfraction name="us-gaap:EarningsPerShareDiluted"
                                            contextref="From2022-04-012023-03-31" id="Fact000849"
                                            format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">0.04
                                        </ix:nonfraction>
                                    </ix:nonfraction></span></span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A9_zeER5M5djmff"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000851"
            name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
            <p id="xdx_890_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zjuj8JSgGLQg"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    following table outlines dilutive common share equivalents outstanding, which are excluded in the
                    above diluted net loss per share calculation,
                    as the effect of their inclusion would be anti-dilutive or the share equivalents were contingently
                    issuable as of each period presented:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8BF_zuJ5hevKHwQ6">Schedule
                        of Antidilutive Securities Excluded From Computation of Net Loss Per Share</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="display: none; text-align: center">&nbsp;</td>
                        <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49B_20230401__20240331_zvVS71fv5hI2"
                            style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_498_20220401__20230331_zmv57t6Wt6Nc"
                            style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EarnoutSharesMember_zbpk2c5UhMOa"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; padding-left: 0.75pt">Earnout shares</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                                contextref="From2023-04-012024-03-31_custom_EarnoutSharesMember" id="Fact000853"
                                format="ixt:numdotdecimal" decimals="INF" unitref="Shares">6,000,000</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0854">�</span>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublicWarrantsMember_zPvV6OCBAza8"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Common Stock underlying Public Warrants</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                                contextref="From2023-04-012024-03-31_custom_PublicWarrantsMember" id="Fact000856"
                                format="ixt:numdotdecimal" decimals="INF" unitref="Shares">10,100,000</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0857">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PrivatePlacementWarrantMember_zsxJ5tQChp5e"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Common Stock underlying
                            Private Placement Warrants</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                                contextref="From2023-04-012024-03-31_custom_PrivatePlacementWarrantMember"
                                id="Fact000859" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">3,235,000
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl0860">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_zuGe9IaYh0q7"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-bottom: 2.5pt; padding-left: 10pt">Total</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                                contextref="From2023-04-012024-03-31" id="Fact000862" format="ixt:numdotdecimal"
                                decimals="INF" unitref="Shares">19,335,000</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl0863">�</span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A5_zB0SORJrmQWf"
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            &nbsp;</p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
        </p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000865"
        name="us-gaap:InventoryDisclosureTextBlock">
        <p id="xdx_804_eus-gaap--InventoryDisclosureTextBlock_zRqAip9ewMTl"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span
                        id="xdx_829_zDa8MP8ukZu9">Inventories, Net</span></span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000867"
            name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock">
            <p id="xdx_89B_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zFlFkE20ZZb8"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                    of March 31, 2024 and 2023, inventories, net, consisted of the following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
                <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8BD_zxy73rJVnxnl">Schedule
                        of Inventories, Net</span>&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="display: none">&nbsp;</td>
                        <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49C_20240331_zPHi4f6uKaLb"
                            style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20230331_zcywuh0X0Zjl"
                            style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--InventoryRawMaterials_iI_pn3n3_maINznvn_zH2bE0Qz0Grb"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Raw materials and spare parts
                        </td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryRawMaterials" contextref="AsOf2024-03-31"
                                id="Fact000869" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,882
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryRawMaterials" contextref="AsOf2023-03-31"
                                id="Fact000870" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,619
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maINznvn_zXo1uU4pz06l"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Work in process</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryWorkInProcess" contextref="AsOf2024-03-31"
                                id="Fact000872" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,769
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryWorkInProcess" contextref="AsOf2023-03-31"
                                id="Fact000873" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,105
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_403_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINznvn_zS8ejyTLEZJ2"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Finished goods</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryFinishedGoods" contextref="AsOf2024-03-31"
                                id="Fact000875" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,283
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryFinishedGoods" contextref="AsOf2023-03-31"
                                id="Fact000876" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">613
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_403_eus-gaap--InventoryAdjustments_iNI_pn3n3_di_msINznvn_z5YWRGA1XRec"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Less: reserves</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:InventoryAdjustments" contextref="AsOf2024-03-31" id="Fact000878"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,104</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:InventoryAdjustments" contextref="AsOf2023-03-31" id="Fact000879"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,487</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--InventoryNet_iTI_pn3n3_mtINznvn_zuPr2UPy2wH9"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Total inventories, net
                        </td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryNet" contextref="AsOf2024-03-31" id="Fact000881"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,830</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryNet" contextref="AsOf2023-03-31" id="Fact000882"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,850</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AA_zK1WVhtJYeDj"
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 117 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000884"
        name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock">
        <p id="xdx_80C_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zmQfosw1L2De"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_82B_zShkRl4rfCHj">Property and Equipment, Net</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000886"
            name="us-gaap:PropertyPlantAndEquipmentTextBlock">
            <p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zi542r7kDkEa"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
                    and equipment, net as of March 31, 2024 and 2023 consisted of the following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                &nbsp;</p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B3_z5e1g136ltai">Schedule
                        of Property and Equipment, Net</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="display: none; text-align: center">&nbsp;</td>
                        <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49C_20240331_zyOXlvUV3k73"
                            style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="display: none; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20230331_zBOGEbLsHVcj"
                            style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="display: none; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zHwyYCFc4mpi"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Computer software and hardware
                        </td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-03-31_us-gaap_ComputerEquipmentMember" id="Fact000888"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">849</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2023-03-31_us-gaap_ComputerEquipmentMember" id="Fact000889"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">802</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zDObi84zPHx"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Machinery and equipment</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-03-31_us-gaap_MachineryAndEquipmentMember" id="Fact000891"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">807</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2023-03-31_us-gaap_MachineryAndEquipmentMember" id="Fact000892"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">661</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zcnyrfCxCiah"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Leasehold improvements</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-03-31_us-gaap_LeaseholdImprovementsMember" id="Fact000894"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,357</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2023-03-31_us-gaap_LeaseholdImprovementsMember" id="Fact000895"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,249</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zRnFDv9Apso1"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Furniture and fixtures</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-03-31_us-gaap_FurnitureAndFixturesMember" id="Fact000897"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">871</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2023-03-31_us-gaap_FurnitureAndFixturesMember" id="Fact000898"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">818</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_ztjtVbJ7wWl1"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 0.75pt">Vehicles</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-03-31_us-gaap_VehiclesMember" id="Fact000900"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">70</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2023-03-31_us-gaap_VehiclesMember" id="Fact000901"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">55</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DemonstrationUnitsMember_zIN7sVwTxD9b"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Demonstration units</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-03-31_custom_DemonstrationUnitsMember" id="Fact000903"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">222</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2023-03-31_custom_DemonstrationUnitsMember" id="Fact000904"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">466</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzCTh_zplj5hx5GzX3"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 10pt">Property and equipment</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AsOf2024-03-31"
                                id="Fact000906" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,176
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AsOf2023-03-31"
                                id="Fact000907" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,051
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzCTh_z6lBpwQA9Iz4"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Less: accumulated
                            depreciation</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"
                                contextref="AsOf2024-03-31" id="Fact000909" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">3,646</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"
                                contextref="AsOf2023-03-31" id="Fact000910" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">3,309</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzCTh_z3lWyQiS0KR3"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Property and equipment,
                            net</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2024-03-31"
                                id="Fact000912" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">530
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2023-03-31"
                                id="Fact000913" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">742
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A2_z0kpNYIF7fP9"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
                expense totaled $<span id="xdx_909_eus-gaap--Depreciation_pn3n3_c20230401__20240331_zggMi2WDhUhl"
                    title="Depreciation expense">
                    <ix:nonfraction name="us-gaap:Depreciation" contextref="From2023-04-012024-03-31" id="Fact000915"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">302</ix:nonfraction>
                </span> and $<span id="xdx_903_eus-gaap--Depreciation_pn3n3_c20220401__20230331_zbITRBwoYdfl"
                    title="Depreciation expense">
                    <ix:nonfraction name="us-gaap:Depreciation" contextref="From2022-04-012023-03-31" id="Fact000917"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">66</ix:nonfraction>
                </span> for the years ended March 31, 2024 and 2023, respectively.</span></p>
        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000919"
        name="DHAI:CapitalizedSoftwareNetAndOtherIntangibleAssetsNetDisclosureTextBlock">
        <p id="xdx_80B_ecustom--CapitalizedSoftwareNetAndOtherIntangibleAssetsNetDisclosureTextBlock_znXM1cCyGh4i"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_82A_zXVqdHdM0lQa">Capitalized software, net and other intangible assets, net</span></span>
        </p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000921"
            name="DHAI:SummaryOfCapitalizedSoftwareNetAndOtherIntangibleAssetsNetTableTextBlock">
            <p id="xdx_89E_ecustom--SummaryOfCapitalizedSoftwareNetAndOtherIntangibleAssetsNetTableTextBlock_z87RJoZ3pVah"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
                    software, net and other intangible assets, net as of March 31, 2024 and 2023 consisted of the
                    following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B8_zFdITgbrcvea" style="display: none">Schedule
                        of Capitalized Software and Other Intangible Assets</span>&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Gross Carrying Amount</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Accumulated Amortization</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Net Carrying Amount</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Gross Carrying Amount</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Accumulated Amortization</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Net Carrying Amount</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 40%; text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">
                            Capitalized software</td>
                        <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                        <td id="xdx_98C_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20240331_zslOv0lbijId"
                            title="Gross Carrying Amount, Capitalized software"
                            style="border-bottom: Black 2.5pt double; width: 6%; text-align: right">
                            <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareGross" contextref="AsOf2024-03-31"
                                id="Fact000923" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,131
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                        <td id="xdx_986_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_iI_pn3n3_c20240331_zKmFivixQxEa"
                            title="Accumulated Amortization, Capitalized software"
                            style="border-bottom: Black 2.5pt double; width: 6%; text-align: right">
                            &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<span
                                style="-sec-ix-hidden: xdx2ixbrl0925">�</span></td>
                        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                        <td id="xdx_989_eus-gaap--CapitalizedComputerSoftwareNet_iI_pn3n3_c20240331_zrZus8F7jpKf"
                            title="Net Carrying Amount, Capitalized software"
                            style="border-bottom: Black 2.5pt double; width: 6%; text-align: right">
                            <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareNet" contextref="AsOf2024-03-31"
                                id="Fact000927" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,131
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                        <td id="xdx_98D_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20230331_zT57hAU0zpqb"
                            title="Gross Carrying Amount, Capitalized software"
                            style="border-bottom: Black 2.5pt double; width: 6%; text-align: right">
                            <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareGross" contextref="AsOf2023-03-31"
                                id="Fact000929" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,019
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                        <td id="xdx_984_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_iI_pn3n3_c20230331_z5OlaEp0lo4c"
                            title="Accumulated Amortization, Capitalized software"
                            style="border-bottom: Black 2.5pt double; width: 6%; text-align: right">
                            &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<span
                                style="-sec-ix-hidden: xdx2ixbrl0931">�</span></td>
                        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                        <td id="xdx_98F_eus-gaap--CapitalizedComputerSoftwareNet_iI_pn3n3_c20230331_zeVlGeWMC0Th"
                            title="Net Carrying Amount, Capitalized software"
                            style="border-bottom: Black 2.5pt double; width: 6%; text-align: right">
                            <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareNet" contextref="AsOf2023-03-31"
                                id="Fact000933" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,019
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Other intangible
                            assets</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_982_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240331_zQXP3V0EXzse"
                            title="Gross Carrying Amount, Other intangible assets"
                            style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross"
                                contextref="AsOf2024-03-31" id="Fact000935" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">380</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240331_zTkDnXmAaZOg"
                            title="Accumulated Amortization, Other intangible assets"
                            style="border-bottom: Black 2.5pt double; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl0937">�</span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_iI_pn3n3_c20240331_zWy3anuTk2k7"
                            title="Net Carrying Amount, Other intangible assets"
                            style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherIntangibleAssetsNet" contextref="AsOf2024-03-31"
                                id="Fact000939" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">380
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_iI_pn3n3_c20230331_zshxMrQYBaq5"
                            title="Gross Carrying Amount, Other intangible assets"
                            style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross"
                                contextref="AsOf2023-03-31" id="Fact000941" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">380</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20230331_z3RqegBZHslc"
                            title="Accumulated Amortization, Other intangible assets"
                            style="border-bottom: Black 2.5pt double; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl0943">�</span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_iI_pn3n3_c20230331_z5IdE28FpeNk"
                            title="Net Carrying Amount, Other intangible assets"
                            style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherIntangibleAssetsNet" contextref="AsOf2023-03-31"
                                id="Fact000945" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">380
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A0_zoqbIGTg67bd"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                intangible assets include patent and technology related intangible assets of $<span
                    id="xdx_903_eus-gaap--OtherIntangibleAssetsNet_iI_pn3n3_c20230331_zbxdxaI9VKMj"
                    title="Other intangible assets, net">
                    <ix:nonfraction name="us-gaap:OtherIntangibleAssetsNet" contextref="AsOf2023-03-31" id="Fact000947"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">380</ix:nonfraction>
                </span> acquired from the SafeGait asset acquisition discussed
                in Note 2, which represented non-cash investing activities for the year ended March 31, 2023. The
                weighted-average useful lives of these
                intangible assets are <span
                    id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220401__20230331_z9C94zNBCVNc"
                    title="Weighted average useful lives of intangible assets">
                    <ix:nonnumeric contextref="From2022-04-012023-03-31" format="ixt-sec:duryear" id="Fact000949"
                        name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">10</ix:nonnumeric>
                </span> years.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
                software, net and other intangible assets, net are subject to amortization when they are available for
                their intended use. For the years
                ended March 31, 2024 and 2023, the Capitalized software, net and other intangible assets are not
                available for intended use and thus
                not amortized. The weighted-average useful life of capitalized software is <span
                    id="xdx_907_ecustom--CapitalizedSoftwareWeightedAverageUsefulLife_dtY_c20230401__20240331_zfcJN6TajsX1"
                    title="Capitalized software, weighted-average useful life">
                    <ix:nonnumeric contextref="From2023-04-012024-03-31" format="ixt-sec:duryear" id="Fact000951"
                        name="DHAI:CapitalizedSoftwareWeightedAverageUsefulLife">5</ix:nonnumeric>
                </span> years.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000953"
            name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
            <p id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zaJQ4w4DQhRd"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
                    annual amortization for intangible assets over the next five years are as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span id="xdx_8B2_z2Cy0TTIm4Qe" style="display: none">Schedule of Estimated Annual Amortization for
                    Intangible Assets</span><span
                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2025</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2026</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2027</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2028</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2029</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 35%; text-align: left; padding-left: 0.75pt">Estimated annual amortization
                        </td>
                        <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_uUSD_c20240331_zUytIkup7oU3"
                            title="2025" style="width: 2%">&nbsp;<span
                                style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                                    style="-sec-ix-hidden: xdx2ixbrl0955">-</span></span></td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_uUSD_c20240331_zYknchmCWD0e"
                            title="2025" style="width: 9%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"
                                contextref="AsOf2024-03-31" id="Fact000957" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">90</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_uUSD_c20240331_zoWmu1xodMrf"
                            title="2026" style="width: 9%; text-align: right">
                            <ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"
                                contextref="AsOf2024-03-31" id="Fact000959" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">464</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_uUSD_c20240331_z324qOjuVDT4"
                            title="2027" style="width: 9%; text-align: right">
                            <ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"
                                contextref="AsOf2024-03-31" id="Fact000961" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">464</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_uUSD_c20240331_zrs3mKe2wsm4"
                            title="2028" style="width: 9%; text-align: right">
                            <ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"
                                contextref="AsOf2024-03-31" id="Fact000963" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">464</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pn3n3_uUSD_c20240331_zc8KIpU3Xo5e"
                            title="Estimated annual amortization, Year 5" style="width: 9%; text-align: right">
                            <ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"
                                contextref="AsOf2024-03-31" id="Fact000965" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">464</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>


        </ix:nonnumeric>
        <p id="xdx_8AE_zQRrq0RTHKxc"
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 118 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000967"
        name="us-gaap:OtherCurrentAssetsTextBlock">
        <p id="xdx_80C_eus-gaap--OtherCurrentAssetsTextBlock_zNPrbHsdxN8e"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_82A_zywApYRoZ0P5">Other current assets</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000969"
            name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock">
            <p id="xdx_891_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zYwDymsWqGkh"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                    current assets as of March 31, 2024 and 2023 consisted of the following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B5_zMDnutRvbkrl" style="display: none">Schedule
                        of Other Current Assets</span>&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49A_20240331_zR1tOZqwNGFh"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_491_20230331_zeAQgaxTH9Ue"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_ecustom--DeferredCostOfSales_iI_pn3n3_maOACz0AP_zrNunDVK5d2i"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Deferred cost of sales</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="DHAI:DeferredCostOfSales" contextref="AsOf2024-03-31" id="Fact000971"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,754</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="DHAI:DeferredCostOfSales" contextref="AsOf2023-03-31" id="Fact000972"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,505</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_402_eus-gaap--ValueAddedTaxReceivable_iI_pn3n3_maOACz0AP_zKKJySSLhXic"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Value added tax (�VAT�) receivable</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:ValueAddedTaxReceivable" contextref="AsOf2024-03-31"
                                id="Fact000974" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">635
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:ValueAddedTaxReceivable" contextref="AsOf2023-03-31"
                                id="Fact000975" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">361
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_ecustom--AdvancePayments_iI_pn3n3_maOACz0AP_z4zBnjjJX354"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Advance payments</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:AdvancePayments" contextref="AsOf2024-03-31" id="Fact000977"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">414</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:AdvancePayments" contextref="AsOf2023-03-31" id="Fact000978"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">726</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--OtherAssetsMiscellaneousCurrent_iI_pn3n3_maOACz0AP_zf3XEDMo4bKe"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Other current assets
                        </td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherAssetsMiscellaneousCurrent" contextref="AsOf2024-03-31"
                                id="Fact000980" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">313
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherAssetsMiscellaneousCurrent" contextref="AsOf2023-03-31"
                                id="Fact000981" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">263
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--OtherAssetsCurrent_iTI_pn3n3_mtOACz0AP_zsDrpW561bsf"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Total other current
                            assets</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherAssetsCurrent" contextref="AsOf2024-03-31"
                                id="Fact000983" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,116
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherAssetsCurrent" contextref="AsOf2023-03-31"
                                id="Fact000984" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,855
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A8_zhFRdfU6gYIj"
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            &nbsp;</p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000986"
        name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
        <p id="xdx_802_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zzPVeACCwpzb"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_820_zTEAH3zSjTQb">Accrued Expenses and Other Current Liabilities</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000988"
            name="DHAI:DisclosureOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock">
            <p id="xdx_899_ecustom--DisclosureOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock_zt8LTV1gx8ee"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
                    expenses and other current liabilities as of March 31, 2024 and 2023 consisted of the
                    following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span id="xdx_8B1_z6TVo41W2mcg" style="display: none">Schedule of Accrued Expenses and Other Current
                    Liabilities</span><span
                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49D_20240331_zkaTyCCETAG3"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49A_20230331_zHEdGoCEvHF7"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--TaxesPayableCurrent_iI_pn3n3_maALAOLzwtl_zpQlVaMCrSr5"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Taxes payable</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:TaxesPayableCurrent" contextref="AsOf2024-03-31"
                                id="Fact000990" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,554
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:TaxesPayableCurrent" contextref="AsOf2023-03-31"
                                id="Fact000991" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,114
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_ecustom--OtherPayablesAndCurrentLiabilities_iI_pn3n3_maALAOLzwtl_zsO9kLjSTzTc"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Other payables and
                            current liabilities</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="DHAI:OtherPayablesAndCurrentLiabilities" contextref="AsOf2024-03-31"
                                id="Fact000993" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,381
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="DHAI:OtherPayablesAndCurrentLiabilities" contextref="AsOf2023-03-31"
                                id="Fact000994" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">6,517
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iTI_pn3n3_mtALAOLzwtl_zyEbGB736YEa"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total accrued expenses
                            and other current liabilities</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities"
                                contextref="AsOf2024-03-31" id="Fact000996" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">9,935</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities"
                                contextref="AsOf2023-03-31" id="Fact000997" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">8,631</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A4_zSUn10DBuuA4"
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact000999"
        name="us-gaap:OtherLiabilitiesDisclosureTextBlock">
        <p id="xdx_807_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zp5KJOeVk4yj"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_822_z7uhjy3M0oea">Other Non-Current Liabilities</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001001"
            name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock">
            <p id="xdx_899_eus-gaap--OtherNoncurrentLiabilitiesTableTextBlock_zGM0cRXYeBoc"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                    non-current liabilities as of March 31, 2024 and 2023 consisted of the following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B7_zmHGm0og03ti" style="display: none">Summary of Other Non-Current
                        Liabilities</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49A_20240331_z8r4YdMqvSwg"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_499_20230331_zAHlc8tGpH42"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40E_ecustom--Provisions_pn3n3_maOLNzlkT_zbhSPjoDrb3h"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; padding-left: 0.75pt">Provisions</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="DHAI:Provisions" contextref="AsOf2024-03-31" id="Fact001003"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,977</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="DHAI:Provisions" contextref="AsOf2023-03-31" id="Fact001004"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,576</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_ecustom--PensionLiabilities_pn3n3_maOLNzlkT_zRPbZqpZxo6c"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Pension liabilities</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="DHAI:PensionLiabilities" contextref="AsOf2024-03-31" id="Fact001006"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,194</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="DHAI:PensionLiabilities" contextref="AsOf2023-03-31" id="Fact001007"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,071</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_eus-gaap--OtherLiabilitiesNoncurrent_iTI_pn3n3_mtOLNzlkT_zG9MSiKhW1v7"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total other non-current
                            liabilities</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherLiabilitiesNoncurrent" contextref="AsOf2024-03-31"
                                id="Fact001009" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,171
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherLiabilitiesNoncurrent" contextref="AsOf2023-03-31"
                                id="Fact001010" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,647
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AC_zBZc87XpQ9Gk"
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001012"
        name="us-gaap:StockholdersEquityNoteDisclosureTextBlock">
        <p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_ze4zr9q2Vwc3"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_82C_ziMxn9PlUCK2">Stockholders� Equity</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
                and Outstanding Capital Stock</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                authorized capital stock of the Company consists of <span
                    id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20240331_z13gWwFHz91b"
                    title="Common stock, shares authorized">
                    <ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" contextref="AsOf2024-03-31"
                        id="Fact001014" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">100,000,000
                    </ix:nonfraction>
                </span> shares of Common Stock and <span
                    id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20240331_zxsyGKC5bKVc"
                    title="Preferred stock, shares authorized">
                    <ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" contextref="AsOf2024-03-31"
                        id="Fact001016" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">10,000,000
                    </ix:nonfraction>
                </span> shares of preferred stock.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                Stock</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Amended and Restated Certificate of Incorporation authorizes one class of common stock.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_90A_eus-gaap--CommonStockVotingRights_c20230401__20240331_zbGWmrtWwo99"
                    title="Common stock voting rights description">
                    <ix:nonnumeric contextref="From2023-04-012024-03-31" id="Fact001018"
                        name="us-gaap:CommonStockVotingRights">Holders
                        of the Company�s common stock are entitled to one vote for each share held as of the record date
                        for the determination of the shareholders
                        entitled to vote on such matters, including the election and removal of directors, except as
                        otherwise required by law. Under Delaware
                        law, the right to vote cumulatively does not exist unless the certificate of incorporation
                        specifically authorizes cumulative voting.
                        The Company�s Amended and Restated Certificate of Incorporation does not authorize cumulative
                        voting and provides that no shareholder
                        is permitted to cumulate votes at any election of directors. Consequently, the holders of a
                        majority of the outstanding shares of the
                        Company�s common stock can elect all of the directors then standing for election, and the
                        holders of the remaining shares are not
                        able to elect any directors.</ix:nonnumeric>
                </span></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 119 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                to preferences that may apply to any shares of the Company�s preferred stock outstanding at the time,
                the holders of the Company�s
                common stock will be entitled to receive dividends out of funds legally available therefor if the
                Company�s board of directors,
                in its discretion, determines to authorize the issuance of dividends and then only at the times and in
                the amounts that the Company�s
                board of directors may determine. If the Company becomes subject to a liquidation, dissolution, or
                winding-up, the assets legally available
                for distribution to the Company�s shareholders would be distributable ratably among the holders of the
                Company�s common stock
                and any participating series of the Company�s preferred stock outstanding at that time, subject to prior
                satisfaction of all outstanding
                debt and liabilities and the preferential rights of, and the payment of any liquidation preferences on,
                any outstanding shares of the
                Company�s preferred stock.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
                Stock</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                the terms of our certificate of incorporation, our Board has the authority, without further action by
                our stockholders, to issue up to
                <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20240331_zpXQdi2TjOxi"
                    title="Preferred stock, shares authorized">
                    <ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" contextref="AsOf2024-03-31"
                        id="Fact001020" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">10,000,000
                    </ix:nonfraction>
                </span> shares of preferred stock in one or more series, to establish from time to time the number of
                shares to be included in each
                such series, to fix the dividend, voting and other rights, preferences and privileges of the shares of
                each wholly unissued series and
                any qualifications, limitations or restrictions thereon, and to increase or decrease the number of
                shares of any such series, but not
                below the number of shares of such series then outstanding.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_900_eus-gaap--PreferredStockVotingRights_c20230401__20240331_z1EZg7N297Qk"
                    title="Preferred stock voting rights description">
                    <ix:nonnumeric contextref="From2023-04-012024-03-31" id="Fact001022"
                        name="us-gaap:PreferredStockVotingRights">The
                        Company�s board of directors is able to authorize the issuance of the Company�s preferred stock
                        with voting or conversion
                        rights that could adversely affect the voting power or other rights of the holders of the
                        Company�s common stock. The issuance
                        of the Company�s preferred stock, while providing flexibility in connection with possible
                        acquisitions and other corporate purposes,
                        could, among other things, have the effect of delaying, deferring, or preventing a change in
                        control of the Company and might adversely
                        affect the market price of the Company�s common stock and the voting and other rights of the
                        holders of the Company�s common
                        stock. There are currently no plans to issue any shares of the Company�s preferred stock
                    </ix:nonnumeric>
                </span>.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
                Shares</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                described in Note 1 - Business and Organization earnout shares issued in connection with the Business
                Combination are subject to vesting
                based on the volume weighted average trading prices (�VWAP�) of common shares during the earnout period.
                If, upon the expiration
                of the Earnout Period, the vesting of any of the Earnout Shares has not occurred, then the applicable
                Earnout Shares that failed to vest
                shall terminate and no longer apply and the Company shall instruct the escrow agent to deliver the
                Earnout Shares applicable to such
                unachieved earnout triggers to the Company for cancellation.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                <span
                    id="xdx_904_ecustom--NumberOfWarrantsOrRightsConvertedIntoShares_iI_dc_c20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEi3fx7Qq2P1"
                    title="Number of warrants or rights converted into shares">
                    <ix:nonfraction name="DHAI:NumberOfWarrantsOrRightsConvertedIntoShares"
                        contextref="AsOf2024-03-31_us-gaap_WarrantMember" id="Fact001024" format="ixt-sec:numwordsen"
                        decimals="INF" unitref="Shares">two</ix:nonfraction>
                </span> warrants entitles the registered holder to purchase <span
                    id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_dc_c20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zWVZcSFdDJog"
                    title="Number of warrants or rights converted into shares">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"
                        contextref="AsOf2024-03-31_us-gaap_WarrantMember_us-gaap_CommonStockMember" id="Fact001026"
                        format="ixt-sec:numwordsen" decimals="INF" unitref="Shares">one</ix:nonfraction>
                </span> share of Common Stock at a price of $<span
                    id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7362zwkJMjd"
                    title="Share price">
                    <ix:nonfraction name="us-gaap:SharePrice"
                        contextref="AsOf2024-03-31_us-gaap_WarrantMember_us-gaap_CommonStockMember" id="Fact001028"
                        format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">11.50</ix:nonfraction>
                </span> per share, subject to adjustment
                as discussed below. Because the warrants may only be exercised for whole numbers of Common Stock, only
                an even number of warrants may
                be exercised at any given time by a warrant holder. The warrants will expire five years after the
                completion of our initial business
                combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
                once the Public Warrants become exercisable, the Company can redeem the outstanding Public
                Warrants:</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                            whole and not in part;</span></td>
                </tr>
            </tbody>
        </table>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                            a price of $<span
                                id="xdx_90D_ecustom--ClassOfWarrantsRedemptionPricePerUnit_pid_c20230401__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_zENGxNBg13tb"
                                title="Class of warrants redemption price per unit">
                                <ix:nonfraction name="DHAI:ClassOfWarrantsRedemptionPricePerUnit"
                                    contextref="From2023-04-012024-03-31_custom_RedemptionOfWarrantsMember_us-gaap_CommonStockMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember"
                                    id="Fact001030" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">0.01
                                </ix:nonfraction>
                            </span> per warrant;</span></td>
                </tr>
            </tbody>
        </table>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                            not less than <span
                                id="xdx_905_ecustom--ClassOfWarrantsRedemptionNoticePeriod_dc_c20230401__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_zoKl6fPy2KR1"
                                title="Class of warrants, redemption notice period">
                                <ix:nonfraction name="DHAI:ClassOfWarrantsRedemptionNoticePeriod"
                                    contextref="From2023-04-012024-03-31_custom_RedemptionOfWarrantsMember_us-gaap_CommonStockMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember"
                                    id="Fact001032" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">30
                                </ix:nonfraction>
                            </span> days� prior written notice of redemption (the �30-day redemption
                            period�) to each warrant holder; and</span></td>
                </tr>
            </tbody>
        </table>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <table cellpadding="0" cellspacing="0"
            style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
            <tbody>
                <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
                    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span
                            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                            and only if, the reported last sale price of the Common Stock equals or exceeds $<span
                                id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_zTbEHSlwogs3"
                                title="Share price">
                                <ix:nonfraction name="us-gaap:SharePrice"
                                    contextref="AsOf2024-03-31_custom_RedemptionOfWarrantsMember_us-gaap_CommonStockMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember"
                                    id="Fact001034" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">18.00
                                </ix:nonfraction>
                            </span> per
                            share (as adjusted for share sub-divisions, share dividends, reorganizations,
                            recapitalizations
                            and the like) for any <span
                                id="xdx_90F_ecustom--NumberOfConsecutiveTradingDaysForDeterminingSharePrice_dtD_c20230401__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_zlrlVcQmXOui"
                                title="Number of consecutive trading days for determining share price">
                                <ix:nonnumeric
                                    contextref="From2023-04-012024-03-31_custom_RedemptionOfWarrantsMember_us-gaap_CommonStockMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember"
                                    format="ixt-sec:durday" id="Fact001036"
                                    name="DHAI:NumberOfConsecutiveTradingDaysForDeterminingSharePrice">20
                                </ix:nonnumeric>
                            </span> trading days within a <span
                                id="xdx_909_ecustom--NumberOfTradingDaysForDeterminingSharePrice_dtD_c20230401__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--RedemptionOfWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__custom--ShareRedemptionTriggerPriceAxis__custom--SharePriceEqualOrExceedsEighteenRupeesPerDollarMember_zcrmkQuzEeXk"
                                title="Number of trading days for determining share price">
                                <ix:nonnumeric
                                    contextref="From2023-04-012024-03-31_custom_RedemptionOfWarrantsMember_us-gaap_CommonStockMember_custom_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember"
                                    format="ixt-sec:durday" id="Fact001038"
                                    name="DHAI:NumberOfTradingDaysForDeterminingSharePrice">30</ix:nonnumeric>
                            </span>-trading day period ending three business
                            days before we send the notice of redemption to the warrant holders.</span></td>
                </tr>
            </tbody>
        </table>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 120 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                the Company calls the Public Warrants for redemption as previously described, the Company has the option
                to require all holders that
                wish to exercise the Public Warrants to do so on a cashless basis.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
                with ATAK�s initial public offering, ATAK consummated a private placement of <span
                    id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zQUGodnZkcs1"
                    title="Class of Warrant or Right, Number of Securities Called by Warrants or Rights">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"
                        contextref="AsOf2024-03-31_custom_PrivatePlacementWarrantsMember" id="Fact001040"
                        format="ixt:numdotdecimal" decimals="INF" unitref="Shares">6,470,000</ix:nonfraction>
                </span> Private Placement Warrants with ATAK�s
                sponsor. Each <span
                    id="xdx_90F_ecustom--NumberOfWarrantsOrRightsConvertedIntoShares_iI_dc_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_z78oy3UdFOra"
                    title="Number of warrants or rights converted into shares">
                    <ix:nonfraction name="DHAI:NumberOfWarrantsOrRightsConvertedIntoShares"
                        contextref="AsOf2024-03-31_custom_PrivatePlacementWarrantsMember" id="Fact001042"
                        format="ixt-sec:numwordsen" decimals="INF" unitref="Shares">two</ix:nonfraction>
                </span> Private Placement Warrants is exercisable for <span
                    id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_dc_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zOzQmOoh47y7"
                    title="Class of warrant or right, number of securities called by each warrant or right">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"
                        contextref="AsOf2024-03-31_custom_PrivatePlacementWarrantsMember" id="Fact001044"
                        format="ixt-sec:numwordsen" decimals="INF" unitref="Shares">one</ix:nonfraction>
                </span> share of common stock at a price of $<span
                    id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zIkMOGNQx9Gh"
                    title="Share price">
                    <ix:nonfraction name="us-gaap:SharePrice"
                        contextref="AsOf2024-03-31_custom_PrivatePlacementWarrantsMember" id="Fact001046"
                        format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">11.50</ix:nonfraction>
                </span> per share, subject to
                adjustment. The Private Placement Warrants have terms and provisions that are identical to those of the
                Public Warrants except that the
                Private Placement Warrants holder can exercise their Private Placement Warrants for cash or on a
                cashless basis when the Company call
                the warrants for redemption at the option of private placement warrant holders the Private Placement
                Warrants were not transferable,
                assignable or salable until <span
                    id="xdx_90D_ecustom--WarrantsTransferableAssignableOrSalableTermAfterDateOfCompletionOfBusinessCombination_dtD_c20230401__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zQbdLeF9P93j"
                    title="Warrants transferable, assignable or salable term after date of completion of business combination">
                    <ix:nonnumeric contextref="From2023-04-012024-03-31_custom_PrivatePlacementWarrantsMember"
                        format="ixt-sec:durday" id="Fact001048"
                        name="DHAI:WarrantsTransferableAssignableOrSalableTermAfterDateOfCompletionOfBusinessCombination">
                        30</ix:nonnumeric>
                </span> days after the completion of the Business Combination.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001050"
        name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock">
        <p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zg04Y69c8pR1"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_824_zBrlcrmq2Qig">Related Party Transactions</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
                are considered related to the Company if the parties, directly or indirectly, through one or more
                intermediaries, control, are controlled
                by, or are under common control with the Company. Related parties also include principal owners of the
                Company, its management, members
                of the immediate families of principal owners of the Company and its management and other parties with
                which the Company may deal with
                if one party controls or can significantly influence the management or operating policies of the other
                to an extent that one of the transacting
                parties might be prevented from fully pursuing its own separate interests. The Company discloses all
                related party transactions.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reorganization
                and Transaction with DIH Cayman and DIH Hong Kong</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
                the Company�s businesses have historically functioned together with the other businesses controlled by
                DIH Cayman, the Company�s
                businesses are largely isolated and not dependent on corporate or other support functions. DIH Hong Kong
                is a wholly-owned subsidiary
                of DIH Cayman and the Company was a wholly-owned subsidiary of DIH Cayman prior to closing of the
                Business Combination.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                July 1, 2021, DIH Cayman completed a series of reorganization steps to transfer DIH US Corp and its
                subsidiaries and Hocoma Medical GmbH
                from Hocoma AG to DIH Holding US Inc., Nevada, effectively creating the Company as explained in the
                Hocoma AG and share transfers section
                below. The reorganization was accounted for as a common control transaction and the assets contributed
                and liabilities assumed were recorded
                based on their historical carrying values.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
                to the year ended March 31, 2022, the Company did not incur significant transactions with DIH Cayman or
                DIH Hong Kong. The balances recorded
                under �Due from relate party� and �Due to related party� are derived from historical transactions. The
                table
                below summarizes related party balances with DIH Hong Kong excluding Hocoma AG and Motek as of March 31,
                2024 and 2023.</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31_custom_DihCaymanAndDihHongKongMember" escape="true"
            id="Fact001052" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock">
            <p id="xdx_891_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DihCaymanAndDihHongKongMember_z3Q8MdmaKV1c"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zcbpIOlkG6N"
                        style="display: none">Schedule
                        of Related Party Balances with Related Party</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49C_20240331_znJoBiMMwFp8"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_491_20230331_znESYUL5R4qf"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--OtherReceivables_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DIHHongKongMember_zcy6iQV0nh48"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Due from related party</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherReceivables"
                                contextref="AsOf2024-03-31_custom_DIHHongKongMember22266921" id="Fact001054"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,586</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherReceivables"
                                contextref="AsOf2023-03-31_custom_DIHHongKongMember" id="Fact001055"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,456</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--OtherLiabilities_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DIHHongKongMember_zV5VHKF1BT76"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Due to related party</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherLiabilities"
                                contextref="AsOf2024-03-31_custom_DIHHongKongMember22266921" id="Fact001057"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,470</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherLiabilities"
                                contextref="AsOf2023-03-31_custom_DIHHongKongMember" id="Fact001058"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,311</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A9_zAcB83RqbrQc"
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hocoma
                AG and share transfers</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                <span
                    id="xdx_90C_ecustom--OriginalContributionAgreementDate_c20210701__20210701__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zpaAAWdd9Npg"
                    title="Original contribution agreement date">
                    <ix:nonnumeric contextref="From2021-07-012021-07-01_custom_HocomaAgMember"
                        format="ixt:datemonthdayyearen" id="Fact001060" name="DHAI:OriginalContributionAgreementDate">
                        July 1, 2021</ix:nonnumeric>
                </span>, Hocoma AG entered into a series of agreements with the Company and its subsidiaries to transfer
                all business aspects of
                development and production of mechanical and electronic devices in the fields of medical technology and
                biotechnology to Hocoma Medical
                GmbH.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
                July 2021 and January 2024, Hocoma AG operated as a single entity, with all business operations
                conducted at Hocoma AG while all personnel, except for <span
                    id="xdx_906_ecustom--NumberOfWarrantsOrRightsConvertedIntoShares_iI_pid_dc_c20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zQx2BjW2z6il"
                    title="Number of warrants or rights converted into shares">
                    <ix:nonfraction name="DHAI:NumberOfWarrantsOrRightsConvertedIntoShares"
                        contextref="AsOf2024-03-31_custom_PrivatePlacementWarrantsMember" id="Fact001062"
                        format="ixt-sec:numwordsen" decimals="INF" unitref="Shares">two</ix:nonfraction>
                </span> employees managing the MDR certification, were employed by Hocoma Medical. The EU MDR 2017/745
                came into effect in May
                2021. All medical devices certified under the previous Medical Device Directive (MDD) must certify to
                the new requirements to ensure that they can continue to be sold in the European market. Hocoma AG holds
                the MDR certification, which cannot legally be transferred
                to Hocoma Medical. Upon the lifting of the injunction, management performed a retrospective separation
                of these entities to account for
                the original transactions reinstated by the court.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 121 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
                ownership of DIH US Corp to DIH Nevada:</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hocoma
                AG and DIH Nevada entered into a share purchase agreement effective on July 1, 2021, in which Hocoma AG
                agreed to sell all <span
                    id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210701__20210701__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DihNevadaMember_zJSUBqHsqSj"
                    title="Number of shares issued in transaction">
                    <ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction"
                        contextref="From2021-07-012021-07-01_custom_SharePurchaseAgreementMember_custom_DihNevadaMember"
                        id="Fact001064" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">10,000
                    </ix:nonfraction>
                </span> shares
                of DIH US Corp and intercompany balances totaling $<span
                    id="xdx_907_ecustom--OriginalContributionAgreementAmount_pn4n6_c20210701__20210701__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DihNevadaMember_zpDwq8NpfYQc"
                    title="Original contribution agreement amount">
                    <ix:nonfraction name="DHAI:OriginalContributionAgreementAmount"
                        contextref="From2021-07-012021-07-01_custom_SharePurchaseAgreementMember_custom_DihNevadaMember"
                        id="Fact001066" format="ixt:numdotdecimal" decimals="-4" scale="6" unitref="USD">7.80
                    </ix:nonfraction>
                </span> million between DIH US Corp and Hocoma AG to DIH Nevada. The purchase price was
                settled through a Note Agreement accruing interest at a rate of <span
                    id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210701__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DihNevadaMember_zsUpByKQEsul"
                    title="Debt instrument interest rate">
                    <ix:nonfraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage"
                        contextref="AsOf2021-07-01_custom_SharePurchaseAgreementMember_custom_DihNevadaMember"
                        id="Fact001068" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">1.25
                    </ix:nonfraction>
                </span>% annually (�Share Purchase Note�). The note has a term
                of <span
                    id="xdx_900_eus-gaap--DebtInstrumentTerm_dtY_c20210701__20210701__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DihNevadaMember_zy7H99x8cmAg"
                    title="Debt instrument term">
                    <ix:nonnumeric
                        contextref="From2021-07-012021-07-01_custom_SharePurchaseAgreementMember_custom_DihNevadaMember"
                        format="ixt-sec:duryear" id="Fact001070" name="us-gaap:DebtInstrumentTerm">5</ix:nonnumeric>
                </span> years, due on <span
                    id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_c20210701__20210701__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DihNevadaMember_zAjKfSyyoUe"
                    title="Debt instrument maturity date">
                    <ix:nonnumeric
                        contextref="From2021-07-012021-07-01_custom_SharePurchaseAgreementMember_custom_DihNevadaMember"
                        format="ixt:datemonthdayyearen" id="Fact001072" name="us-gaap:DebtInstrumentMaturityDate">June
                        30, 2026</ix:nonnumeric>
                </span>, with prepayment allowed.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contribution
                net assets to Hocoma Medical:</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                a Contribution Agreement effective on <span
                    id="xdx_907_ecustom--OriginalContributionAgreementDate_c20210701__20210701__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember__us-gaap--TypeOfArrangementAxis__custom--ContributionAgreementMember_z4d7V8EBEtmh"
                    title="Original contribution agreement date">
                    <ix:nonnumeric
                        contextref="From2021-07-012021-07-01_custom_HocomaAgMember_custom_ContributionAgreementMember"
                        format="ixt:datemonthdayyearen" id="Fact001074" name="DHAI:OriginalContributionAgreementDate">
                        July 1, 2021</ix:nonnumeric>
                </span>, Hocoma AG agreed to contribute its business to Hocoma Medical GmbH. The contributed
                business was valued at USD <span
                    id="xdx_904_ecustom--OriginalContributionAgreementAmount_pn4n6_c20210701__20210701__us-gaap--TypeOfArrangementAxis__custom--ContributionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaMedicalGmbhMember_zUQbTRSDB0q5"
                    title="Original contribution agreement amount">
                    <ix:nonfraction name="DHAI:OriginalContributionAgreementAmount"
                        contextref="From2021-07-012021-07-01_custom_ContributionAgreementMember_custom_HocomaMedicalGmbhMember"
                        id="Fact001076" format="ixt:numdotdecimal" decimals="-4" scale="6" unitref="USD">10.47
                    </ix:nonfraction>
                </span> million as amended where Hocoma Medical GmbH was a wholly owned subsidiary of Hocoma AG at the
                time.
                The Contribution Agreement explicitly excluded the intellectual property rights specified in the
                Contribution Agreement. Additionally,
                the assets excluded all <span
                    id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210701__20210701__us-gaap--TypeOfArrangementAxis__custom--ContributionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DihUsCorporationMember_zWCFZRorNYWg"
                    title="Number of shares issued in transaction">
                    <ix:nonfraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction"
                        contextref="From2021-07-012021-07-01_custom_ContributionAgreementMember_custom_DihUsCorporationMember"
                        id="Fact001078" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">10,000
                    </ix:nonfraction>
                </span> shares of DIH US Corporation and certain intercompany balances. The Agreement specifically
                excludes from
                these liabilities all indebtedness of Hocoma AG related to the contributed business as of the effective
                date, as well as any liability
                for taxes relating to the contributed business as of the effective date.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
                of ownership in Hocoma Medical to DIH Nevada:</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                a separate Share Purchase Agreement effective on July 1, 2021, Hocoma AG transferred all ownership in
                Hocoma Medical GmbH in the form
                of <span
                    id="xdx_902_ecustom--NumberOfMembershipInterestsInSubsidiary_uInteger_c20210701__20210701__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DIHHoldingUSIncMember__us-gaap--TypeOfArrangementAxis__custom--TransferOfMembershipInterestsAgreementMember_z6tufH9mHqR9"
                    title="Number of employees managing MDR certification">
                    <ix:nonfraction name="DHAI:NumberOfMembershipInterestsInSubsidiary"
                        contextref="From2021-07-012021-07-01_custom_DIHHoldingUSIncMember_custom_TransferOfMembershipInterestsAgreementMember"
                        id="Fact001080" format="ixt:numdotdecimal" decimals="INF" unitref="Integer">200</ix:nonfraction>
                </span> membership interests to DIH Nevada for $<span
                    id="xdx_90E_ecustom--OriginalContributionAgreementAmount_pn4n6_c20210701__20210701__us-gaap--TypeOfArrangementAxis__custom--TransferOfMembershipInterestsAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DIHHoldingUSIncMember_zubN7R1AJqW5"
                    title="Original contribution agreement amount">
                    <ix:nonfraction name="DHAI:OriginalContributionAgreementAmount"
                        contextref="From2021-07-012021-07-01_custom_DIHHoldingUSIncMember_custom_TransferOfMembershipInterestsAgreementMember"
                        id="Fact001082" format="ixt:numdotdecimal" decimals="-4" scale="6" unitref="USD">10.47
                    </ix:nonfraction>
                </span> million, based on the final valuation. The purchase price was settled through a
                Note Agreement with an interest rate of <span
                    id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210701__us-gaap--TypeOfArrangementAxis__custom--TransferOfMembershipInterestsAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DIHHoldingUSIncMember_zAITJmfnuvdb"
                    title="Debt instrument interest rate">
                    <ix:nonfraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage"
                        contextref="AsOf2021-07-01_custom_TransferOfMembershipInterestsAgreementMember_custom_DIHHoldingUSIncMember"
                        id="Fact001084" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">1.25
                    </ix:nonfraction>
                </span>% (�Membership Interest Note�). The note was agreed for a term of <span
                    id="xdx_90A_eus-gaap--DebtInstrumentTerm_dtY_c20210701__20210701__us-gaap--TypeOfArrangementAxis__custom--TransferOfMembershipInterestsAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DIHHoldingUSIncMember_zKDQTAWMdfT2"
                    title="Debt instrument term">
                    <ix:nonnumeric
                        contextref="From2021-07-012021-07-01_custom_DIHHoldingUSIncMember_custom_TransferOfMembershipInterestsAgreementMember"
                        format="ixt-sec:duryear" id="Fact001086" name="us-gaap:DebtInstrumentTerm">5</ix:nonnumeric>
                </span> years, due
                on <span
                    id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_c20210701__20210701__us-gaap--TypeOfArrangementAxis__custom--TransferOfMembershipInterestsAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DIHHoldingUSIncMember_zhGOAQ6g6ZXc"
                    title="Debt instrument maturity date">
                    <ix:nonnumeric
                        contextref="From2021-07-012021-07-01_custom_DIHHoldingUSIncMember_custom_TransferOfMembershipInterestsAgreementMember"
                        format="ixt:datemonthdayyearen" id="Fact001088" name="us-gaap:DebtInstrumentMaturityDate">June
                        30, 2026</ix:nonnumeric>
                </span>, with prepayment allowed.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
                of intellectual property to DIH US Corp:</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                a business/asset, share, and IP purchase agreement on July 12, 2021, which was amended on August 3, 2021
                Hocoma AG transferred intellectual
                property rights as listed in the Annex to the agreement to DIH Technology Inc. (a wholly owned
                subsidiary of DIH US Corp) for $<span
                    id="xdx_906_ecustom--IpRightsAndTrademarks_iI_pn4n6_c20210712__us-gaap--TypeOfArrangementAxis__custom--BusinessAssetShareAndIpPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zSgwxrOxTYHe"
                    title="IP rights and trademarks">
                    <ix:nonfraction name="DHAI:IpRightsAndTrademarks"
                        contextref="AsOf2021-07-12_custom_BusinessAssetShareAndIpPurchaseAgreementMember_custom_HocomaAgMember"
                        id="Fact001090" format="ixt:numdotdecimal" decimals="-4" scale="6" unitref="USD">1.57
                    </ix:nonfraction>
                </span> million
                through a note agreement. The note payable formalized in a note agreement effective July 1, 2021, with
                an interest rate of <span
                    id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210712__us-gaap--TypeOfArrangementAxis__custom--BusinessAssetShareAndIpPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zL3sxAQE1zy9"
                    title="Debt instrument interest rate">
                    <ix:nonfraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage"
                        contextref="AsOf2021-07-12_custom_BusinessAssetShareAndIpPurchaseAgreementMember_custom_HocomaAgMember"
                        id="Fact001092" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">1.25
                    </ix:nonfraction>
                </span>% (�IP
                Note�). The note was agreed for a term of <span
                    id="xdx_906_eus-gaap--DebtInstrumentTerm_dtY_c20210712__20210712__us-gaap--TypeOfArrangementAxis__custom--BusinessAssetShareAndIpPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zy9f0mc9YKK4"
                    title="Debt instrument term">
                    <ix:nonnumeric
                        contextref="From2021-07-122021-07-12_custom_BusinessAssetShareAndIpPurchaseAgreementMember_custom_HocomaAgMember"
                        format="ixt-sec:duryear" id="Fact001094" name="us-gaap:DebtInstrumentTerm">5</ix:nonnumeric>
                </span> years, due on <span
                    id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_c20210712__20210712__us-gaap--TypeOfArrangementAxis__custom--BusinessAssetShareAndIpPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_z5khRIkneFea"
                    title="Debt instrument maturity date">
                    <ix:nonnumeric
                        contextref="From2021-07-122021-07-12_custom_BusinessAssetShareAndIpPurchaseAgreementMember_custom_HocomaAgMember"
                        format="ixt:datemonthdayyearen" id="Fact001096" name="us-gaap:DebtInstrumentMaturityDate">June
                        30, 2026</ix:nonnumeric>
                </span>, with prepayment allowed.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Share Purchase Note, Membership Interest Note and IP Note together are referred to as �Related Party
                Notes�.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hocoma
                Medical GmbH has made periodically payments on the principal and interests of the Related Party Notes,
                resulting from the transfer of
                the business and assets above.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, the <span
                    id="xdx_901_ecustom--NumberOfEmployeesManagingMdrCertification_dc_uInteger_c20230401__20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zX2WHDOtfNs9"
                    title="Number of employees managing MDR certification">
                    <ix:nonfraction name="DHAI:NumberOfEmployeesManagingMdrCertification"
                        contextref="From2023-04-012024-03-31_custom_HocomaAgMember" id="Fact001098"
                        format="ixt-sec:numwordsen" decimals="INF" unitref="Integer">two</ix:nonfraction>
                </span> employees who remained at Hocoma AG provided services for the business of Hocoma Medical.
                Historically, an immaterial premium
                was charged to the cost of the employees.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                of March 31, 2024 and 2023, the balances of Related Party Notes were $<span
                    id="xdx_901_eus-gaap--NotesPayable_iI_pn3n3_c20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zTylC7xApDS1"
                    title="Notes Payable">
                    <ix:nonfraction name="us-gaap:NotesPayable" contextref="AsOf2024-03-31_us-gaap_RelatedPartyMember"
                        id="Fact001100" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">11,457
                    </ix:nonfraction>
                </span> and $<span
                    id="xdx_902_eus-gaap--NotesPayable_iI_pn3n3_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z5mYGumid5d6"
                    title="Notes Payable">
                    <ix:nonfraction name="us-gaap:NotesPayable" contextref="AsOf2023-03-31_us-gaap_RelatedPartyMember"
                        id="Fact001102" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">17,301
                    </ix:nonfraction>
                </span>, respectively included in Note payable - related
                party�. The decrease resulted from the Company�s payments of principal on Related Party Notes owed to
                Hocoma AG.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                addition to the Related Party Notes, as of March 31, 2024 and 2023, the Company recorded a related party
                balance of $<span
                    id="xdx_905_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pn3n3_c20230401__20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_ziTvbu0p2AJi"
                    title="Net settlement amount">(<ix:nonfraction
                        name="us-gaap:RelatedPartyTransactionAmountsOfTransaction"
                        contextref="From2023-04-012024-03-31_custom_HocomaAgMember" id="Fact001104"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">267</ix:nonfraction>
                    </span>) and $<span
                    id="xdx_90E_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pn3n3_c20220401__20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zEPVTDEMVdn9"
                    title="Net settlement amount">
                    <ix:nonfraction name="us-gaap:RelatedPartyTransactionAmountsOfTransaction"
                        contextref="From2022-04-012023-03-31_custom_HocomaAgMember" id="Fact001106"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,992</ix:nonfraction>
                </span>,
                respectively, representing cash balances owed by Hocoma AG. As part of the transfer discussed above, the
                Company also recorded a long-term
                related party receivable for $<span
                    id="xdx_90F_ecustom--LongTermRelatedPartyReceivable_iI_pn3n3_c20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zrAgIqQqZqaj"
                    title="Long term related party receivable"><span
                        id="xdx_90E_ecustom--LongTermRelatedPartyReceivable_iI_pn3n3_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zYtprQHNC5s6"
                        title="Long term related party receivable">
                        <ix:nonfraction name="DHAI:LongTermRelatedPartyReceivable"
                            contextref="AsOf2024-03-31_custom_HocomaAgMember" id="Fact001108" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">
                            <ix:nonfraction name="DHAI:LongTermRelatedPartyReceivable"
                                contextref="AsOf2023-03-31_custom_HocomaAgMember" id="Fact001110"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">324</ix:nonfraction>
                        </ix:nonfraction>
                    </span></span> as of March 31, 2024 and 2023, included in �Other assets�.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 122 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motek
                Group</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 24.5pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company has entered into a distribution agreement with the Motek Group. The agreement, which has been
                historically in place, appoints
                the Company as the exclusive distributor of Motek�s advanced human movement research and rehabilitation
                products and services designed
                to support efficient functional movement therapy within specified territories. Under the distribution
                agreement, Motek supplies the products
                and services to the Company at the prices detailed in the agreement, with the Company entitled to a
                distributor margin. Motek provides
                ongoing support and assistance, including training, marketing materials, and technical documentation to
                the Company.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                the years ended March 31, 2024 and 2023, the Company made purchases amounting to $<span
                    id="xdx_90D_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pn3n3_c20230401__20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MotekGroupMember_zZEbigIT6XE4"
                    title="Purchases amount to related party">
                    <ix:nonfraction name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty"
                        contextref="From2023-04-012024-03-31_custom_MotekGroupMember" id="Fact001112"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">13,599</ix:nonfraction>
                </span> and $<span
                    id="xdx_901_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pn3n3_c20220401__20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MotekGroupMember_zsjX7KARyI1d"
                    title="Purchases amount to related party">
                    <ix:nonfraction name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty"
                        contextref="From2022-04-012023-03-31_custom_MotekGroupMember" id="Fact001114"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">11,869</ix:nonfraction>
                </span>, respectively, from the Motek Group.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                part of these transactions, the Company made advance payments to Motek, included in �Due from related
                party,� and also had
                trade payables, included in �Due to related party.� The balances as of March 31, 2024 and 2023 are as
                follows:</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31_custom_MotekGroupMember" escape="true" id="Fact001116"
            name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock">
            <p id="xdx_891_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MotekGroupMember_zghnD7U2CTFi"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span id="xdx_8B6_zO2niDfx2tzk" style="display: none">Schedule
                    of Related Party Balances with Related Party</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49D_20240331_z3vQu4r3XFCl"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_494_20230331_zKAJqS6S6Akh"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_403_eus-gaap--OtherReceivables_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MotekGroupMember_zTDjJl6WhBSl"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Due from related party</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherReceivables"
                                contextref="AsOf2024-03-31_custom_MotekGroupMember" id="Fact001118"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,367</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherReceivables"
                                contextref="AsOf2023-03-31_custom_MotekGroupMember" id="Fact001119"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,934</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_eus-gaap--OtherLiabilities_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MotekGroupMember_zqvPLwKUy5m7"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Due to related party</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherLiabilities"
                                contextref="AsOf2024-03-31_custom_MotekGroupMember" id="Fact001121"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">8,667</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherLiabilities"
                                contextref="AsOf2023-03-31_custom_MotekGroupMember" id="Fact001122"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,530</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AE_zJBoWbBLPKue"
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001124"
        name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock">
        <p id="xdx_801_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zz53YJ1kC2sj"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_821_zZviM6SJzYX">Employee Benefit Plans</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defined
                Contribution Plans</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company sponsors a defined contribution plan in the United States. The Company�s obligation is limited
                to its contributions made
                in accordance with each plan document. Employer contributions to defined contribution plans are
                recognized as expense. Expenses related
                to the Company�s plans for the years ended March 31, 2024 and 2023 were $<span
                    id="xdx_90C_eus-gaap--DefinedContributionPlanCostRecognized_pn3n3_c20230401__20240331_zLe2apQDUYL2"
                    title="Defined contribution plan expenses">
                    <ix:nonfraction name="us-gaap:DefinedContributionPlanCostRecognized"
                        contextref="From2023-04-012024-03-31" id="Fact001126" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">119</ix:nonfraction>
                </span> and $<span
                    id="xdx_90C_eus-gaap--DefinedContributionPlanCostRecognized_pn3n3_c20220401__20230331_zfk4YPilu0af"
                    title="Defined contribution plan expenses"><span
                        id="xdx_904_eus-gaap--DefinedContributionPlanCostRecognized_pn3n3_c20220401__20230331_zLc5iIbbVnGc"
                        title="Defined contribution plan expenses">
                        <ix:nonfraction name="us-gaap:DefinedContributionPlanCostRecognized"
                            contextref="From2022-04-012023-03-31" id="Fact001128" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">
                            <ix:nonfraction name="us-gaap:DefinedContributionPlanCostRecognized"
                                contextref="From2022-04-012023-03-31" id="Fact001130" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">105</ix:nonfraction>
                        </ix:nonfraction>
                    </span></span>, respectively.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defined
                Benefit Plans</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company has a Swiss defined benefit plans (the �Pension Plan�) covering substantially all the employees
                of Hocoma Medical
                GmbH in Switzerland. The Pension Plan exceed the minimum benefit requirements under Swiss pension law.
                The Swiss plans offer retirement,
                disability and survivor benefits and is governed by a Pension Foundation Board. The responsibilities of
                this board are defined by Swiss
                pension law and the plan rules.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_905_eus-gaap--DefinedBenefitPlansGeneralInformation_c20230401__20240331_z4Ab1N2WULdh"
                    title="Defined benefit plans description">
                    <ix:nonnumeric contextref="From2023-04-012024-03-31" id="Fact001132"
                        name="us-gaap:DefinedBenefitPlansGeneralInformation">The
                        plans offer to members at the normal retirement age of 65 a choice between a lifetime pension
                        and a partial or full lump sum payment.
                        Participants can choose to draw early retirement benefits starting from the age of 58 but can
                        also continue employment and remain active
                        members of the plan until the age of 70. Employees can make additional purchases of benefits to
                        fund early retirement benefits. The pension
                        amount payable to a participant is calculated by applying a conversion rate to the accumulated
                        balance of the participant�s retirement
                        savings account at the retirement date. The balance is based on credited vested benefits
                        transferred from previous employers, purchases
                        of benefits, and the employee and employer contributions that have been made to the
                        participant�s retirement savings account, as
                        well as the interest accrued. The annual interest rate credited to participants is determined by
                        the Pension Foundation Board at the
                        end of each year</ix:nonnumeric>
                </span>.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
                the Swiss plans are based on a defined contribution promise under Swiss pension law, it is accounted for
                as a defined benefit plan under
                GAAP, primarily because of the obligation to accrue interest on the participants� retirement savings
                accounts and the payment of
                lifetime pension benefits.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                actuarial valuation in accordance with Swiss pension law is performed regularly. Should an underfunded
                situation on this basis occur,
                the Pension Foundation Board is required to take the necessary measures to ensure that full funding can
                be expected to be restored within
                a maximum period of 10 years. If a Swiss plan were to become significantly underfunded on a Swiss
                pension law basis, additional employer
                and employee contributions could be required.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 123 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                investment strategy of the Swiss plan complies with Swiss pension law, including the rules and
                regulations relating to diversification
                of plan assets, and is derived from the risk budget defined by the Pension Foundation Board on the basis
                of regularly performed asset
                and liability management analyses. The Pension Foundation Board strives for a medium- and long-term
                balance between assets and liabilities.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001134"
            name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
            <p id="xdx_89F_eus-gaap--ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_zUIhfHWXgsr7"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
                    recognized in the consolidated statements of operations for the years ended March 31, 2024 and 2023,
                    in respect of the Pension Plan were
                    as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8BB_zLJq0G9xYCbl" style="display: none">Schedule
                        of Pension Plans</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_493_20230401__20240331_zb2wnSDOUMig"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49A_20220401__20230331_zUPn5GcTJa99"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Years Ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_eus-gaap--DefinedBenefitPlanServiceCost_pn3n3_msPIEz5mf_z11H7NaTcd76"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Current service cost</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanServiceCost"
                                contextref="From2023-04-012024-03-31" id="Fact001136" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">655</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanServiceCost"
                                contextref="From2022-04-012023-03-31" id="Fact001137" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">678</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--DefinedBenefitPlanInterestCost_pn3n3_msPIEz5mf_z0DXLuRcxBe"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Interest cost</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanInterestCost"
                                contextref="From2023-04-012024-03-31" id="Fact001139" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">213</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanInterestCost"
                                contextref="From2022-04-012023-03-31" id="Fact001140" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">129</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_400_eus-gaap--DefinedBenefitPlanExpectedReturnOnPlanAssets_iN_pn3n3_di_maPIEz5mf_zRKEFPRHGLQh"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Expected return on plan assets</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets"
                                contextref="From2023-04-012024-03-31" id="Fact001142" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">296</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets"
                                contextref="From2022-04-012023-03-31" id="Fact001143" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">194</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_400_eus-gaap--DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_iN_pn3n3_di_maPIEz5mf_zBmGOhPRepSc"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Actuarial loss / (gain) recognized</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"
                                contextref="From2023-04-012024-03-31" id="Fact001145" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">161</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"
                                contextref="From2022-04-012023-03-31" id="Fact001146" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">179</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_iN_pn3n3_di_maPIEz5mf_z2ABLCrCb4Cl"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Actuarial loss / (gain) recognized because of
                            settlement</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"
                                contextref="From2023-04-012024-03-31" id="Fact001148" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">341</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"
                                contextref="From2022-04-012023-03-31" id="Fact001149" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">699</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_pn3n3_msPIEz5mf_zdfd0SehLBli"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Amortization of prior
                            service credit</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"
                                contextref="From2023-04-012024-03-31" id="Fact001151" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">145</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"
                                contextref="From2022-04-012023-03-31" id="Fact001152" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">135</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_404_ecustom--PensionIncomeExpense_iNT_pn3n3_di_mtPIEz5mf_zbTl9jmzQVTb"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Net charge to statement
                            of operations</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                                name="DHAI:PensionIncomeExpense" contextref="From2023-04-012024-03-31" id="Fact001154"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">75</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                                name="DHAI:PensionIncomeExpense" contextref="From2022-04-012023-03-31" id="Fact001155"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">400</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A0_zP6BbUZj5m7"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001157"
            name="us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock">
            <p id="xdx_898_eus-gaap--ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_zo2DLV2W61t"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
                    of the employee defined benefits obligations and plan assets in respect of the Pension Plan are as
                    follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8BD_zfREvJ9JqOr2" style="display: none">Schedule
                        of Employee Defined Benefits Obligation and plan Assets</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_495_20230401__20240331_zyROD7Slsi65"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_491_20220401__20230331_zj8pTRXwhkfj"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Years Ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="font-weight: bold">Change in present value of defined benefit obligation:</td>
                        <td>&nbsp;</td>
                        <td colspan="2">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td>&nbsp;</td>
                        <td colspan="2">&nbsp;</td>
                        <td>&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--DefinedBenefitPlanBenefitObligation_iS_pn3n3_znPnBu3w6SI4"
                        style="vertical-align: bottom; background-color: White">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Defined benefit obligation at the
                            beginning of the year</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanBenefitObligation"
                                contextref="AsOf2023-03-31" id="Fact001159" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">9,337</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanBenefitObligation"
                                contextref="AsOf2022-03-31" id="Fact001160" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">9,500</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_407_eus-gaap--DefinedBenefitPlanInterestCost_pn3n3_zyraPL4SiXc5"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Interest on defined obligation</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanInterestCost"
                                contextref="From2023-04-012024-03-31" id="Fact001162" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">213</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanInterestCost"
                                contextref="From2022-04-012023-03-31" id="Fact001163" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">129</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40E_eus-gaap--DefinedBenefitPlanServiceCost_pn3n3_zzZAapKvpYjc"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Current service cost</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanServiceCost"
                                contextref="From2023-04-012024-03-31" id="Fact001165" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">655</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanServiceCost"
                                contextref="From2022-04-012023-03-31" id="Fact001166" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">678</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_pn3n3_zFiQXPySoboc"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Contributions by plan participants</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"
                                contextref="From2023-04-012024-03-31" id="Fact001168" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">444</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"
                                contextref="From2022-04-012023-03-31" id="Fact001169" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">476</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_pn3n3_zO5j6ftHdTD9"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Translation (gain) loss</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"
                                contextref="From2023-04-012024-03-31" id="Fact001171" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">534</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"
                                contextref="From2022-04-012023-03-31" id="Fact001172" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">20</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_40F_eus-gaap--DefinedBenefitPlanBenefitObligationBenefitsPaid_iN_pn3n3_di_zVL1BLVtHiQ5"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Benefits paid</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid"
                                contextref="From2023-04-012024-03-31" id="Fact001174" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">289</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid"
                                contextref="From2022-04-012023-03-31" id="Fact001175" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">1,095</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_403_eus-gaap--DefinedBenefitPlanActuarialGainLoss_pn3n3_zWeehNtlBpia"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Actuarial loss arising
                            on projected benefit obligation</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanActuarialGainLoss"
                                contextref="From2023-04-012024-03-31" id="Fact001177" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">118</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanActuarialGainLoss" contextref="From2022-04-012023-03-31"
                                id="Fact001178" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">331</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_400_eus-gaap--DefinedBenefitPlanBenefitObligation_iE_pn3n3_zuMzujKSFbG9"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Defined benefit obligation
                            at the end of the year</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanBenefitObligation"
                                contextref="AsOf2024-03-31" id="Fact001180" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">11,012</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanBenefitObligation"
                                contextref="AsOf2023-03-31" id="Fact001181" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">9,337</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="font-weight: bold; text-align: left; padding-left: 0.75pt">Change in plan assets:
                        </td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iS_pn3n3_zD0rQjbFMR97"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Fair value of plan assets at the beginning of
                            the year</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31" id="Fact001183" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">7,761</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2022-03-31" id="Fact001184" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">7,353</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40E_eus-gaap--DefinedBenefitPlanActualReturnOnPlanAssets_pn3n3_zdt5dmP0ahAi"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Actual return on plan assets</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets"
                                contextref="From2023-04-012024-03-31" id="Fact001186" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">68</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets"
                                contextref="From2022-04-012023-03-31" id="Fact001187" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">457</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--DefinedBenefitPlanContributionsByEmployer_pn3n3_zLRaydlv9qEb"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Contributions by the employer</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanContributionsByEmployer"
                                contextref="From2023-04-012024-03-31" id="Fact001189" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">530</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanContributionsByEmployer"
                                contextref="From2022-04-012023-03-31" id="Fact001190" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">569</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_400_eus-gaap--DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_pn3n3_zaXckLVvzJ4b"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Contributions by plan participants</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"
                                contextref="From2023-04-012024-03-31" id="Fact001192" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">444</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"
                                contextref="From2022-04-012023-03-31" id="Fact001193" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">476</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--DefinedBenefitPlanPlanAssetsBenefitsPaid_iN_pn3n3_di_zqYFolMOTrPd"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Benefits paid</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid"
                                contextref="From2023-04-012024-03-31" id="Fact001195" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">289</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid"
                                contextref="From2022-04-012023-03-31" id="Fact001196" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">1,095</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_pn3n3_zJvo7Wy7qyhj"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Translation loss</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"
                                contextref="From2023-04-012024-03-31" id="Fact001198" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">440</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"
                                contextref="From2022-04-012023-03-31" id="Fact001199" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">1</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iE_pn3n3_zdYhkz5RANYi"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Fair value of plan assets
                            - at the end of the year</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31" id="Fact001201" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">8,818</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31" id="Fact001202" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">7,761</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--DefinedBenefitPlanFundedStatusOfPlan_iE_pn3n3_zXGv0JHceTZ2"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Funded status at end of
                            the year</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" contextref="AsOf2024-03-31"
                                id="Fact001204" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">2,194</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" contextref="AsOf2023-03-31"
                                id="Fact001205" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">1,576</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A4_zxHA97h4H7dl"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 124 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001207"
            name="us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
            <p id="xdx_897_eus-gaap--ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_zcyUdJRMvCr8"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
                    relating to these defined benefit plans with accumulated benefit obligations in excess of plan
                    assets were as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8BC_zSdPgaKdbBBg" style="display: none">Schedule
                        of Defined Benefit Plans with Accumulated Benefit Obligations in Excess of Plan
                        Assets</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20240331_zcHL7bvGS0M"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_498_20230331_z1GqOg8a8qC3"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_402_eus-gaap--DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_iI_pn3n3_zkkRQe9OuGl7"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Accumulated benefit obligation
                        </td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"
                                contextref="AsOf2024-03-31" id="Fact001209" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">10,686</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"
                                contextref="AsOf2023-03-31" id="Fact001210" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">9,049</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_eus-gaap--DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_iI_pn3n3_zPkSkRiaBZn4"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 0.75pt">Fair value of plan assets</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31" id="Fact001212" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">8,818</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31" id="Fact001213" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">7,761</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A8_zdQsmnON19kb"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001215"
            name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
            <p id="xdx_89A_eus-gaap--ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_zRbETRKFd6hf"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
                    recognized in the Company�s consolidated balance sheet related to the present value of defined
                    benefit obligations consist of the
                    following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B6_z3WdGftPqZs3" style="display: none">Schedule
                        of Amounts Recognized in Balance Sheet</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20240331_zw2bxG41zTL7"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_498_20230331_z9sFzdRgSVke"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40D_eus-gaap--PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_iI_pn3n3_maPAOPDzH6h_zMTXf1KQOoxk"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Current liabilities</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1217">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1218">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_iI_pn3n3_maPAOPDzH6h_zbKhoAWT4i49"
                        style="vertical-align: bottom; background-color: White">
                        <td style="width: 64%; text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Non-current
                            liabilities</td>
                        <td style="width: 2%; padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"
                                contextref="AsOf2024-03-31" id="Fact001220" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">2,194</ix:nonfraction>
                        </td>
                        <td style="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="width: 2%; padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"
                                contextref="AsOf2023-03-31" id="Fact001221" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">1,576</ix:nonfraction>
                        </td>
                        <td style="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_iTI_pn3n3_mtPAOPDzH6h_zt8cBsVLNVNf"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Total recognized in
                            the consolidated balance sheet</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"
                                contextref="AsOf2024-03-31" id="Fact001223" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">2,194</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"
                                contextref="AsOf2023-03-31" id="Fact001224" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">1,576</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AD_zQo9Uif9lCFk"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001226"
            name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
            <p id="xdx_892_eus-gaap--ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_zhT4Qt1szNif"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
                    recorded in accumulated other comprehensive income (loss) in respect of the pension plan consist of
                    the following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8BC_z9xzVYtX7OJd" style="display: none">Schedule
                        of Amounts Recognized in Other Comprehensive Income (Loss)</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49E_20230401__20240331_zydoU68fQgV1"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20220401__20230331_zOICk608GDdf"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Years Ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_iN_pn3n3_di_msOCIDBzx5c_zTvRWN4UaIia"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Net gain (loss)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"
                                contextref="From2023-04-012024-03-31" id="Fact001228" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">1,633</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"
                                contextref="From2022-04-012023-03-31" id="Fact001229" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">2,610</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_pn3n3_maOCIDBzx5c_zQKgXWt3tEHa"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Prior service (cost)
                            credit</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"
                                contextref="From2023-04-012024-03-31" id="Fact001231" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">837</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"
                                contextref="From2022-04-012023-03-31" id="Fact001232" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">976</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_iT_pn3n3_mtOCIDBzx5c_z8mPYCitNWZd"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total recorded in
                            accumulated other comprehensive income</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"
                                contextref="From2023-04-012024-03-31" id="Fact001234" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">2,470</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"
                                contextref="From2022-04-012023-03-31" id="Fact001235" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">3,586</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AF_zg2xMLcw1Zyc"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
                of prior service (cost) credit is recorded in selling, general and administrative in the consolidated
                statements of operations.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001237"
            name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock">
            <p id="xdx_890_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_zPOf18fGHAF5"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    principal assumptions used for the purpose of actuarial valuation of the pension plan are as
                    follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B4_zvYOVnRIlXX9" style="display: none">Schedule
                        of Principal Assumptions Used for the Purpose of Actuarial Valuation</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Discount rate</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right"><span
                                id="xdx_906_eus-gaap--DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_pid_dp_uPure_c20230401__20240331_z6uLrwJSXhs1"
                                title="Discount rate">
                                <ix:nonfraction
                                    name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"
                                    contextref="From2023-04-012024-03-31" id="Fact001239" format="ixt:numdotdecimal"
                                    decimals="INF" scale="-2" unitref="Pure">1.50</ix:nonfraction>
                            </span></td>
                        <td style="width: 1%; text-align: left">%</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right"><span
                                id="xdx_905_eus-gaap--DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_pid_dp_uPure_c20220401__20230331_zcKja2gyDXS1"
                                title="Discount rate">
                                <ix:nonfraction
                                    name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"
                                    contextref="From2022-04-012023-03-31" id="Fact001241" format="ixt:numdotdecimal"
                                    decimals="INF" scale="-2" unitref="Pure">2.10</ix:nonfraction>
                            </span></td>
                        <td style="width: 1%; text-align: left">%</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Expected return on plan assets</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_90B_eus-gaap--DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_pid_dp_uPure_c20230401__20240331_ziBZT170iklh"
                                title="Expected return on plan assets">
                                <ix:nonfraction
                                    name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"
                                    contextref="From2023-04-012024-03-31" id="Fact001243" format="ixt:numdotdecimal"
                                    decimals="INF" scale="-2" unitref="Pure">3.50</ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_904_eus-gaap--DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_pid_dp_uPure_c20220401__20230331_zCluafLMtFgc"
                                title="Expected return on plan assets">
                                <ix:nonfraction
                                    name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"
                                    contextref="From2022-04-012023-03-31" id="Fact001245" format="ixt:numdotdecimal"
                                    decimals="INF" scale="-2" unitref="Pure">3.50</ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Expected rate of salary increase</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_900_eus-gaap--DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_pid_dp_uPure_c20230401__20240331_z74cjHtcd3A7"
                                title="Expected rate of salary increase">
                                <ix:nonfraction
                                    name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"
                                    contextref="From2023-04-012024-03-31" id="Fact001247" format="ixt:numdotdecimal"
                                    decimals="INF" scale="-2" unitref="Pure">1.00</ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_90F_eus-gaap--DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_pid_dp_uPure_c20220401__20230331_zUzNMwNXAzJ3"
                                title="Expected rate of salary increase">
                                <ix:nonfraction
                                    name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"
                                    contextref="From2022-04-012023-03-31" id="Fact001249" format="ixt:numdotdecimal"
                                    decimals="INF" scale="-2" unitref="Pure">1.00</ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AF_zUUh71cISJij"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                actuarial assumptions used for the defined benefit plans are based on the economic conditions prevailing
                in the jurisdiction in which
                they are offered. Changes in the defined benefit obligation are most sensitive to changes in the
                discount rate. The discount rate is
                based on the yield of high-quality corporate bonds quoted in an active market in the currency of the
                respective plan. A decrease in the
                discount rate increases the defined benefit obligation. The Company regularly reviews the actuarial
                assumptions used in calculating the
                defined benefit obligation to determine their continuing relevance.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
                Policy</span></p>

        <p
            style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                is the objective of the plan sponsor to maintain an adequate level of diversification to balance market
                risk, to prudently invest to
                preserve capital and to provide sufficient liquidity while maximizing earnings for near-term payments of
                benefits accrued under the plan
                and to pay plan administrative expenses. The assumption used for the expected long-term rate of return
                on plan assets is based on the
                long-term expected returns for the investment mix of assets currently in the portfolio. Historical
                return trends for the various asset
                classes in the class portfolio are combined with current and anticipated future market conditions to
                estimate the rate of return for
                each class. These rates are then adjusted for anticipated future inflation to determine estimated
                nominal rates of return for each class.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 125 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001251"
            name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock">
            <p id="xdx_891_eus-gaap--ScheduleOfAllocationOfPlanAssetsTableTextBlock_ztcCYzkAJOKg"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    table below represents the Company�s pension plan� weighted-average asset allocation as of March 31,
                    2024 and 2023 by asset
                    category:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B7_z2dq8TB5044c" style="display: none">Schedule
                        of Weighted Average Asset Allocation</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Equity securities</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right"><span
                                id="xdx_90D_eus-gaap--DefinedBenefitPlanWeightedAverageAssetAllocations_iI_pid_dp_uPure_c20240331__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember_zbcfoUUPlnS9"
                                title="Equity securities">
                                <ix:nonfraction name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations"
                                    contextref="AsOf2024-03-31_us-gaap_EquitySecuritiesMember" id="Fact001253"
                                    format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">36.58
                                </ix:nonfraction>
                            </span></td>
                        <td style="width: 1%; text-align: left">%</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right"><span
                                id="xdx_908_eus-gaap--DefinedBenefitPlanWeightedAverageAssetAllocations_iI_pid_dp_uPure_c20230331__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember_zYgExlUhYXJ2"
                                title="Equity securities">
                                <ix:nonfraction name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations"
                                    contextref="AsOf2023-03-31_us-gaap_EquitySecuritiesMember" id="Fact001255"
                                    format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">33.99
                                </ix:nonfraction>
                            </span></td>
                        <td style="width: 1%; text-align: left">%</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Debt securities</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_904_eus-gaap--DefinedBenefitPlanWeightedAverageAssetAllocations_iI_pid_dp_uPure_c20240331__us-gaap--FairValueByAssetClassAxis__us-gaap--DebtSecuritiesMember_zP6zIX3LstRg"
                                title="Debt securities">
                                <ix:nonfraction name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations"
                                    contextref="AsOf2024-03-31_us-gaap_DebtSecuritiesMember" id="Fact001257"
                                    format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">28.16
                                </ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_903_eus-gaap--DefinedBenefitPlanWeightedAverageAssetAllocations_iI_pid_dp_uPure_c20230331__us-gaap--FairValueByAssetClassAxis__us-gaap--DebtSecuritiesMember_zhz07DR5wUE9"
                                title="Debt securities">
                                <ix:nonfraction name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations"
                                    contextref="AsOf2023-03-31_us-gaap_DebtSecuritiesMember" id="Fact001259"
                                    format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">26.43
                                </ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Other, primarily cash and cash equivalents,
                            senior loans and mutual funds</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_909_eus-gaap--DefinedBenefitPlanWeightedAverageAssetAllocations_iI_pid_dp_uPure_c20240331__us-gaap--FairValueByAssetClassAxis__custom--CashAndCashEquivalentsAndHedgeFundsMember_ztHAaaX4wGqc"
                                title="Pension plan, Asset allocation">
                                <ix:nonfraction name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations"
                                    contextref="AsOf2024-03-31_custom_CashAndCashEquivalentsAndHedgeFundsMember"
                                    id="Fact001261" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                    35.26</ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_903_eus-gaap--DefinedBenefitPlanWeightedAverageAssetAllocations_iI_pid_dp_uPure_c20230331__us-gaap--FairValueByAssetClassAxis__custom--CashAndCashEquivalentsAndHedgeFundsMember_zUthK9KR1fab"
                                title="Pension plan, Asset allocation">
                                <ix:nonfraction name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations"
                                    contextref="AsOf2023-03-31_custom_CashAndCashEquivalentsAndHedgeFundsMember"
                                    id="Fact001263" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                    39.58</ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                    </tr>
                </tbody>
            </table>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    table below presents the target allocation for each major asset category for the Company�s pension
                    plan for the years ended March
                    31, 2024 and 2023:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Years Ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Equity securities</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right"><span
                                id="xdx_90E_eus-gaap--DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_iI_pid_dp_uPure_c20240331__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember_zbfmNR3Mapuk"
                                title="Equity securities">
                                <ix:nonfraction name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"
                                    contextref="AsOf2024-03-31_us-gaap_EquitySecuritiesMember" id="Fact001265"
                                    format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">34.00
                                </ix:nonfraction>
                            </span></td>
                        <td style="width: 1%; text-align: left">%</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right"><span
                                id="xdx_905_eus-gaap--DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_iI_pid_dp_uPure_c20230331__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember_z08SfJqor48a"
                                title="Equity securities">
                                <ix:nonfraction name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"
                                    contextref="AsOf2023-03-31_us-gaap_EquitySecuritiesMember" id="Fact001267"
                                    format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">34.00
                                </ix:nonfraction>
                            </span></td>
                        <td style="width: 1%; text-align: left">%</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Debt securities</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_90A_eus-gaap--DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_iI_pid_dp_uPure_c20240331__us-gaap--FairValueByAssetClassAxis__us-gaap--DebtSecuritiesMember_zsMLs6JNHTw5"
                                title="Debt securities">
                                <ix:nonfraction name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"
                                    contextref="AsOf2024-03-31_us-gaap_DebtSecuritiesMember" id="Fact001269"
                                    format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">28.50
                                </ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_90E_eus-gaap--DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_iI_pid_dp_uPure_c20230331__us-gaap--FairValueByAssetClassAxis__us-gaap--DebtSecuritiesMember_zrvtZBuphNDf"
                                title="Debt securities">
                                <ix:nonfraction name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"
                                    contextref="AsOf2023-03-31_us-gaap_DebtSecuritiesMember" id="Fact001271"
                                    format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">28.00
                                </ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Other, primarily cash and cash equivalents,
                            senior loans and mutual funds</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_90C_eus-gaap--DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_iI_pid_dp_uPure_c20240331__us-gaap--FairValueByAssetClassAxis__custom--CashAndCashEquivalentsAndHedgeFundsMember_zTWlM8Xb7JSl"
                                title="Pension plan, Target allocation">
                                <ix:nonfraction name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"
                                    contextref="AsOf2024-03-31_custom_CashAndCashEquivalentsAndHedgeFundsMember"
                                    id="Fact001273" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                    37.50</ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_90A_eus-gaap--DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_iI_pid_dp_uPure_c20230331__us-gaap--FairValueByAssetClassAxis__custom--CashAndCashEquivalentsAndHedgeFundsMember_zWx3tlwFwrmc"
                                title="Pension plan, Target allocation">
                                <ix:nonfraction name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"
                                    contextref="AsOf2023-03-31_custom_CashAndCashEquivalentsAndHedgeFundsMember"
                                    id="Fact001275" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                    38.00</ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AE_zWXYFjHBE5Cd"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001277"
            name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
            <p id="xdx_892_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_zEFRuLY0Pxhf"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    following tables provides the fair value of plan assets held by the Company�s pension plan by asset
                    category and by fair value
                    hierarchy level:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8BE_zzsWJ4Z7NFh6" style="display: none">Schedule
                        of Fair Value of Plan Assets</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: justify">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            As of March 31, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: justify">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">
                            Level 1</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Level 2</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Level 3</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Total</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 44%; text-align: justify; padding-left: 0.75pt">Cash and cash equivalents</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_98D_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanCashAndCashEquivalentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zCNmoImF8Yw7"
                            title="Cash and cash equivalents" style="width: 10%; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member"
                                id="Fact001279" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">106
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_981_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanCashAndCashEquivalentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGPGHH5lnI4e"
                            title="Cash and cash equivalents" style="width: 10%; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1281">�</span></td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_98C_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanCashAndCashEquivalentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcJI5zU5RVQ9"
                            title="Cash and cash equivalents" style="width: 10%; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1283">�</span></td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_985_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanCashAndCashEquivalentsMember_z0FaEWmjoQ9e"
                            title="Cash and cash equivalents" style="width: 10%; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"
                                id="Fact001285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">106
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: justify; padding-left: 0.75pt">Equity securities</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_98B_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanEquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQSEYpnbxId7"
                            title="Equity securities" style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member"
                                id="Fact001287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,316
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_988_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanEquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z2Dih7j30V9a"
                            title="Equity securities" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1289">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_98B_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanEquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBQWF6RJ3Tl3"
                            title="Equity securities" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1291">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_98C_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanEquitySecuritiesMember_z8O97cfCI4c6"
                            title="Equity securities" style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember"
                                id="Fact001293" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,316
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: justify; padding-left: 0.75pt">Debt securities</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_98D_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanDebtSecurityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZmMrr4zsfz3"
                            title="Debt securities" style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember_us-gaap_FairValueInputsLevel1Member"
                                id="Fact001295" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,310
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_988_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanDebtSecurityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1hFcsX57Idi"
                            title="Debt securities" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1297">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_98E_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanDebtSecurityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zvoXyYUg2QEc"
                            title="Debt securities" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1299">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_988_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanDebtSecurityMember_zH2FF9XBIFub"
                            title="Debt securities" style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember"
                                id="Fact001301" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,310
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: justify; padding-left: 0.75pt">Real estate</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_98B_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanRealEstateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zGxbk3aSiAu3"
                            title="Real estate" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1303">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_985_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanRealEstateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zEqxoRmM18t7"
                            title="Real estate" style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember_us-gaap_FairValueInputsLevel2Member"
                                id="Fact001305" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,851
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_989_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanRealEstateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfMp94MHAUD8"
                            title="Real estate" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1307">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_987_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanRealEstateMember_zccTxXBdacB5"
                            title="Real estate" style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember"
                                id="Fact001309" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,851
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.75pt">Non-traditional
                            assets</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td id="xdx_987_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__custom--DefinedBenefitPlanNonTraditionalAssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQXShUZce6Md"
                            title="Non-traditional assets" style="border-bottom: Black 1pt solid; text-align: right">
                            <span style="-sec-ix-hidden: xdx2ixbrl1311">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td id="xdx_981_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__custom--DefinedBenefitPlanNonTraditionalAssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zYC3wYT4OnW7"
                            title="Non-traditional assets" style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember_us-gaap_FairValueInputsLevel2Member"
                                id="Fact001313" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,235
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td id="xdx_98C_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__custom--DefinedBenefitPlanNonTraditionalAssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z2VQ6tmDbd66"
                            title="Non-traditional assets" style="border-bottom: Black 1pt solid; text-align: right">
                            <span style="-sec-ix-hidden: xdx2ixbrl1315">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td id="xdx_982_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__custom--DefinedBenefitPlanNonTraditionalAssetsMember_zljLPlq9xLLi"
                            title="Non-traditional assets" style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember"
                                id="Fact001317" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,235
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="padding-bottom: 2.5pt; padding-left: 10pt">Total</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_983_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZ1sXnad4jrj"
                            title="Total" style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_FairValueInputsLevel1Member"
                                id="Fact001319" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,732
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_988_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhZcMkwHaYml"
                            title="Total" style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_FairValueInputsLevel2Member"
                                id="Fact001321" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,086
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_98F_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zTBEesN476Ql"
                            title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1323">�</span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_98E_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember_zGw8vo0S25tb"
                            title="Total" style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember" id="Fact001325"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">8,818</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.75pt">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: justify">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            As of March 31, 2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: justify">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Level 1</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Level 2</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Level 3</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Total</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 44%; text-align: justify; padding-left: 0.75pt">Cash and cash equivalents</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_98C_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanCashAndCashEquivalentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6bcLxevRxfj"
                            title="Cash and cash equivalents" style="width: 10%; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member"
                                id="Fact001327" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">186
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td id="xdx_98E_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanCashAndCashEquivalentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSmyVJry66Ll"
                            title="Cash and cash equivalents" style="width: 10%; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1329">�</span></td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_986_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanCashAndCashEquivalentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgy9rL5eLCei"
                            title="Cash and cash equivalents" style="width: 10%; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1331">�</span></td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td id="xdx_985_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanCashAndCashEquivalentsMember_zKupAAUspm4j"
                            title="Cash and cash equivalents" style="width: 10%; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"
                                id="Fact001333" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">186
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: justify; padding-left: 0.75pt">Equity securities</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_987_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanEquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zNOc4fC57Gck"
                            title="Equity securities" style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member"
                                id="Fact001335" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,763
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_98D_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanEquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zu9jidTCHSzi"
                            title="Equity securities" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1337">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_989_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanEquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zljSAz1Vm3jj"
                            title="Equity securities" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1339">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_985_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanEquitySecuritiesMember_zHabyB0JiOWh"
                            title="Equity securities" style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanEquitySecuritiesMember"
                                id="Fact001341" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,763
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: justify; padding-left: 0.75pt">Debt securities</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_986_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanDebtSecurityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zJF68YCYmjA1"
                            title="Debt securities" style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember_us-gaap_FairValueInputsLevel1Member"
                                id="Fact001343" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,987
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_981_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanDebtSecurityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zYL5VPgjLP94"
                            title="Debt securities" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1345">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_98E_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanDebtSecurityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCn36PKPfiV2"
                            title="Debt securities" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1347">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_98C_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanDebtSecurityMember_zAvrmNnRn9Z1"
                            title="Debt securities" style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanDebtSecurityMember"
                                id="Fact001349" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,987
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: justify; padding-left: 0.75pt">Real estate</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_98C_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanRealEstateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zuJfXttX7xyh"
                            title="Real estate" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1351">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_988_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanRealEstateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zH9EmoSo6YA9"
                            title="Real estate" style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember_us-gaap_FairValueInputsLevel2Member"
                                id="Fact001353" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,855
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_986_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanRealEstateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBFfXzsh4rmf"
                            title="Real estate" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1355">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_980_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__us-gaap--DefinedBenefitPlanRealEstateMember_zvxVjVnkyN0a"
                            title="Real estate" style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_DefinedBenefitPlanRealEstateMember"
                                id="Fact001357" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,855
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.75pt">Non-traditional
                            assets</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td id="xdx_987_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__custom--DefinedBenefitPlanNonTraditionalAssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6xc9xvRFU74"
                            title="Non-traditional assets" style="border-bottom: Black 1pt solid; text-align: right">
                            <span style="-sec-ix-hidden: xdx2ixbrl1359">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td id="xdx_980_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__custom--DefinedBenefitPlanNonTraditionalAssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9m0OCBH39Aj"
                            title="Non-traditional assets" style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember_us-gaap_FairValueInputsLevel2Member"
                                id="Fact001361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">970
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td id="xdx_989_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__custom--DefinedBenefitPlanNonTraditionalAssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zQ9TU6nl2I4j"
                            title="Non-traditional assets" style="border-bottom: Black 1pt solid; text-align: right">
                            <span style="-sec-ix-hidden: xdx2ixbrl1363">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td id="xdx_989_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--DefinedBenefitPlanByPlanAssetCategoriesAxis__custom--DefinedBenefitPlanNonTraditionalAssetsMember_zOQ0wP0mUFb"
                            title="Non-traditional assets" style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_custom_DefinedBenefitPlanNonTraditionalAssetsMember"
                                id="Fact001365" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">970
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.75pt">Total</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_98A_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zS83Qmrm3cbg"
                            title="Total" style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_FairValueInputsLevel1Member"
                                id="Fact001367" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,936
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_983_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zALeZtFVo9a5"
                            title="Total" style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember_us-gaap_FairValueInputsLevel2Member"
                                id="Fact001369" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,825
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_983_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zRYeuYX6QtJ"
                            title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1371">�</span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_98D_eus-gaap--DefinedBenefitPlanFairValueOfPlanAssets_iI_pn3n3_c20230331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember_zblkqEpg4d95"
                            title="Total" style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets"
                                contextref="AsOf2023-03-31_us-gaap_PensionPlansDefinedBenefitMember" id="Fact001373"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,761</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A4_zEyPO54cnwTb"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                the year ending March 31, 2025, the Company expects to contribute $<span
                    id="xdx_90B_eus-gaap--DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_iI_pn3n3_c20240331__us-gaap--RetirementPlanTypeAxis__us-gaap--PensionPlansDefinedBenefitMember_zMZB0fRbcV03"
                    title="Expected contribution">
                    <ix:nonfraction name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"
                        contextref="AsOf2024-03-31_us-gaap_PensionPlansDefinedBenefitMember" id="Fact001375"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">652</ix:nonfraction>
                </span> to its pension plan.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001377"
            name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock">
            <p id="xdx_89C_eus-gaap--ScheduleOfExpectedBenefitPaymentsTableTextBlock_zeP7DFgyQ2F"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    following table presents expected pension plan payments over the next 10 years:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B1_zna6YTHxidLb" style="display: none">Schedule
                        of Expected Pension Plan Payments</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: left">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49F_20240331_zohtEzqreHug"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="font-weight: bold; text-align: center; padding-left: 0.75pt">Year Ending March 31,
                        </td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_iI_pn3n3_zOHqmm50CBie"
                        style="vertical-align: bottom; background-color: White">
                        <td style="width: 82%; text-align: left; padding-left: 0.75pt">2025</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"
                                contextref="AsOf2024-03-31" id="Fact001379" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">43</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_iI_pn3n3_zWjHKEBOXtX"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">2026</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"
                                contextref="AsOf2024-03-31" id="Fact001381" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">252</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_402_eus-gaap--DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_iI_pn3n3_zlOtiuh2VmTj"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">2027</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"
                                contextref="AsOf2024-03-31" id="Fact001383" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">81</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_iI_pn3n3_zPrCmzILd2P"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">2028</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"
                                contextref="AsOf2024-03-31" id="Fact001385" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">88</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_407_eus-gaap--DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_iI_pn3n3_z3BmoaCdcJY5"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">2029</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"
                                contextref="AsOf2024-03-31" id="Fact001387" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">95</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_iI_pn3n3_zAhnyzw568q4"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">2030-2034</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"
                                contextref="AsOf2024-03-31" id="Fact001389" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">1,059</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>
        </ix:nonnumeric>
        <p id="xdx_8A0_z4aDiAACHGD1"
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 126 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001391"
        name="us-gaap:IncomeTaxDisclosureTextBlock">
        <p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_z6DRnToj9ZVl"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_82B_zZ8COCeNbWW2">Income Taxes</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001393"
            name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
            <p id="xdx_89B_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zuYnc1EfwZw5"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    components of loss before income tax for the years ended March 31, 2024 and 2023 were as
                    follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8BE_zyoNsGDkdVo2" style="display: none">Schedule
                        of Components of Loss Before Income Tax</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="padding-left: -10pt; text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49F_20230401__20240331_zD8P2GRSCgQf"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49A_20220401__20230331_zxQl5umWOZ68"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="padding-left: -10pt; text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Year ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="padding-left: -10pt; text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pn3n3_maILFCOzZ95_zBc8k62UXdLh"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0pt">U.S. operations</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">(<ix:nonfraction
                                name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"
                                contextref="From2023-04-012024-03-31" id="Fact001395" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">11,652</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">(<ix:nonfraction
                                name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"
                                contextref="From2022-04-012023-03-31" id="Fact001396" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">4,806</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pn3n3_maILFCOzZ95_zsbj19VsePC"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Non-U.S. operations</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"
                                contextref="From2023-04-012024-03-31" id="Fact001398" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">4,455</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"
                                contextref="From2022-04-012023-03-31" id="Fact001399" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">5,810</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pn3n3_mtILFCOzZ95_zKwhwd3pSdV9"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total loss before income
                            taxes</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                                name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
                                contextref="From2023-04-012024-03-31" id="Fact001401" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">7,197</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
                                contextref="From2022-04-012023-03-31" id="Fact001402" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">1,004</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A3_zpi4yGNHB3T"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001404"
            name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
            <p id="xdx_894_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zN3EQ4mA7iD7"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    provision for income taxes during the years ended March 31, 2024 and 2023 consists of the
                    following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B4_zKCb1RcusLXa" style="display: none">Schedule of Provision for Income
                        Taxes</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49B_20230401__20240331_zLHvT3UvfBAa"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49A_20220401__20230331_zE4bGqA3bloc"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Year ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zDeYKuoCrFl4"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 0.75pt">Current:</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40D_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pn3n3_maITEBz94a_zbCPYqbf2cz8"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 10pt">State</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1409">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1410">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_402_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_maITEBz94a_zHIsqD1HVSoj"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt">Federal</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1412">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1413">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--CurrentForeignTaxExpenseBenefit_pn3n3_maITEBz94a_ztpX2GyP8Ba"
                        style="vertical-align: bottom; background-color: White">
                        <td style="width: 64%; padding-left: 10pt">Foreign</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:CurrentForeignTaxExpenseBenefit"
                                contextref="From2023-04-012024-03-31" id="Fact001415" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">347</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:CurrentForeignTaxExpenseBenefit"
                                contextref="From2022-04-012023-03-31" id="Fact001416" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">1,435</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_z4TLCcslQEvh"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt">Deferred:</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">�</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">�</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_pn3n3_maITEBz94a_zBW9ul7AyGQ3"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 10pt">State</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1421">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1422">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_maITEBz94a_zBEend4eis7j"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt">Federal</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit"
                                contextref="From2023-04-012024-03-31" id="Fact001424" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">1</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit"
                                contextref="From2022-04-012023-03-31" id="Fact001425" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">58</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_pn3n3_maITEBz94a_zMJQSXZoIIPe"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 10pt">Foreign</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_ecustom--NoncurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zRtPkrRBsTbc"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 0.75pt">Noncurrent:</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_ecustom--NonCurrentStateAndLocalTaxExpenseBenefit_pn3n3_maITEBz94a_z99Tgq09mzCg"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt">State</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1433">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1434">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_ecustom--NonCurrentFederalTaxExpenseBenefit_pn3n3_maITEBz94a_zC4xedWDY6Sd"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 10pt">Federal</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:NonCurrentFederalTaxExpenseBenefit"
                                contextref="From2023-04-012024-03-31" id="Fact001436" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">200</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:NonCurrentFederalTaxExpenseBenefit"
                                contextref="From2022-04-012023-03-31" id="Fact001437" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">525</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_401_ecustom--NonCurrentForeignTaxExpenseBenefit_pn3n3_maITEBz94a_zS6KYY8DxUyl"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-bottom: 1pt; padding-left: 10pt">Foreign</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="DHAI:NonCurrentForeignTaxExpenseBenefit"
                                contextref="From2023-04-012024-03-31" id="Fact001439" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">698</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1440">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_iT_pn3n3_mtITEBz94a_zQRHR122RPR7"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-bottom: 2.5pt; padding-left: 0.75pt">Total</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" contextref="From2023-04-012024-03-31"
                                id="Fact001442" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,246
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" contextref="From2022-04-012023-03-31"
                                id="Fact001443" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,018
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AF_zlW69cbS7Wj"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001445"
            name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
            <p id="xdx_899_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zFryIAJKW8q8"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                    reconciliation of income tax expense computed at the statutory corporate income tax rate to the
                    effective income tax rate for the years
                    ended March 31, 2024 and 2023 is as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8BC_z4zV006Qkow5" style="display: none">Schedule of Reconciliation of Income Tax Expense
                        Computed at Statutory Corporate Income Tax Rate to Effective Income Tax Rate</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_493_20230401__20240331_zX3TNGpFgJz7"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49B_20220401__20230331_zxo4POi2TtAl"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Year ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maCal_zRqNPJkwbSk9"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Tax expense computed at federal
                            statutory rate</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"
                                contextref="From2023-04-012024-03-31" id="Fact001447" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">21.0</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">%</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"
                                contextref="From2022-04-012023-03-31" id="Fact001448" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">21.0</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">%</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maCal_zfVNymu1dTu2"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">State tax</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"
                                contextref="From2023-04-012024-03-31" id="Fact001450" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">6.4</ix:nonfraction>
                        </td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"
                                contextref="From2022-04-012023-03-31" id="Fact001451" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" sign="-" unitref="Pure">12.7</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)%</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maCal_zG3GDsYeEvS8"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Change in valuation allowance</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"
                                contextref="From2023-04-012024-03-31" id="Fact001453" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">11.6</ix:nonfraction>
                        </td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"
                                contextref="From2022-04-012023-03-31" id="Fact001454" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">80.0</ix:nonfraction>
                        </td>
                        <td style="text-align: left">%</td>
                    </tr>
                    <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_maCal_zg0VVSXQ6qL8"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Foreign rate differential</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"
                                contextref="From2023-04-012024-03-31" id="Fact001456" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">9.2</ix:nonfraction>
                        </td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"
                                contextref="From2022-04-012023-03-31" id="Fact001457" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" sign="-" unitref="Pure">7.7</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)%</td>
                    </tr>
                    <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_maCal_zkxkrMLmmoSa"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Non-deductible expenses</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense"
                                contextref="From2023-04-012024-03-31" id="Fact001459" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" sign="-" unitref="Pure">15.2</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense"
                                contextref="From2022-04-012023-03-31" id="Fact001460" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">62.6</ix:nonfraction>
                        </td>
                        <td style="text-align: left">%</td>
                    </tr>
                    <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxContingencies_pid_dp_uPure_maCal_zToRy3qyK6i"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Uncertain Tax Positions</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies"
                                contextref="From2023-04-012024-03-31" id="Fact001462" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" sign="-" unitref="Pure">53.5</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies"
                                contextref="From2022-04-012023-03-31" id="Fact001463" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">52.3</ix:nonfraction>
                        </td>
                        <td style="text-align: left">%</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maCal_z5zpL73pLqy4"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-bottom: 1pt; padding-left: 0.75pt">Other</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments"
                                contextref="From2023-04-012024-03-31" id="Fact001465" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">3.2</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">%</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments"
                                contextref="From2022-04-012023-03-31" id="Fact001466" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">5.5</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">%</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_maCal_z0n9GKSqt4x3"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total income tax expense
                        </td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                                name="us-gaap:EffectiveIncomeTaxRateContinuingOperations"
                                contextref="From2023-04-012024-03-31" id="Fact001468" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" sign="-" unitref="Pure">17.3</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)%</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations"
                                contextref="From2022-04-012023-03-31" id="Fact001469" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">201.0</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">%</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A4_ztoZveDYDGa2"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 127 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001471"
            name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
            <p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zbmOl40H4pvj"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company�s deferred tax position reflects the net tax effects of the temporary differences between
                    the carrying amounts of assets
                    and liabilities for financial reporting purposes and the amounts used for income tax reporting.
                    Significant components of the deferred
                    tax assets and liabilities are as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                &nbsp;</p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B1_zLDfoH0bu8O9" style="display: none">Schedule
                        of&nbsp;Significant Components of Deferred Tax Assets and Liabilities</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="padding-bottom: 1pt; text-align: center">&nbsp;</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td colspan="2" id="xdx_497_20240331_zhUTPPQ3ggQ7"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td colspan="2" id="xdx_49F_20230331_z2wMQYxD3tNb"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Year ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="padding-bottom: 1pt; text-align: center">&nbsp;</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="font-weight: bold; text-align: justify; padding-left: 0.75pt">Deferred tax assets:
                        </td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGz07t_zFMNSkXkXVm3"
                        style="vertical-align: bottom; background-color: White">
                        <td style="width: 64%; text-align: left; padding-left: 10pt">Net operating loss carryforwards
                        </td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards"
                                contextref="AsOf2024-03-31" id="Fact001473" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">6,793</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards"
                                contextref="AsOf2023-03-31" id="Fact001474" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">6,483</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_iI_pn3n3_maDTAGz07t_z5H1EAUUfqza"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt">Pension</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions"
                                contextref="AsOf2024-03-31" id="Fact001476" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">422</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions"
                                contextref="AsOf2023-03-31" id="Fact001477" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">323</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_iI_pn3n3_maDTAGz07t_z4U7fKuUXre4"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 10pt">Accrued expenses</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"
                                contextref="AsOf2024-03-31" id="Fact001479" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">35</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"
                                contextref="AsOf2023-03-31" id="Fact001480" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">138</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pn3n3_maDTAGz07t_zV2JK2WtvHo1"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 10pt">Section 163(j) interest expense carryforward
                        </td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxAssetInterestCarryforward"
                                contextref="AsOf2024-03-31" id="Fact001482" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">84</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxAssetInterestCarryforward"
                                contextref="AsOf2023-03-31" id="Fact001483" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">165</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_pn3n3_maDTAGz07t_zHLr8uji6AHf"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 10pt">Capitalized R&amp;D</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment"
                                contextref="AsOf2024-03-31" id="Fact001485" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">332</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment"
                                contextref="AsOf2023-03-31" id="Fact001486" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">689</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40C_ecustom--DeferredTaxAssetsGaapToStatutoryAdjustments_iI_pn3n3_maDTAGz07t_zfYlO5cnjbR8"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 10pt">GAAP to statutory adjustments</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:DeferredTaxAssetsGaapToStatutoryAdjustments"
                                contextref="AsOf2024-03-31" id="Fact001488" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">741</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:DeferredTaxAssetsGaapToStatutoryAdjustments"
                                contextref="AsOf2023-03-31" id="Fact001489" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">686</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGz07t_zYBSzAxDII3l"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-bottom: 1pt; padding-left: 10pt">Other</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxAssetsOther" contextref="AsOf2024-03-31"
                                id="Fact001491" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">217
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxAssetsOther" contextref="AsOf2023-03-31"
                                id="Fact001492" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">152
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGz07t_maDTANzL6A_zXKnSknDDdAj"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 10pt">Total gross deferred tax assets</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxAssetsGross" contextref="AsOf2024-03-31"
                                id="Fact001494" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">8,624
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxAssetsGross" contextref="AsOf2023-03-31"
                                id="Fact001495" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">8,636
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzL6A_zwrLdAhrMub8"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Less: valuation allowance
                        </td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:DeferredTaxAssetsValuationAllowance" contextref="AsOf2024-03-31"
                                id="Fact001497" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">8,139
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:DeferredTaxAssetsValuationAllowance" contextref="AsOf2023-03-31"
                                id="Fact001498" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">8,264
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_407_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzL6A_msDTLz0oI_zbETile30741"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Total deferred tax
                            assets, net of valuation allowance</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxAssetsNet" contextref="AsOf2024-03-31"
                                id="Fact001500" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">485
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxAssetsNet" contextref="AsOf2023-03-31"
                                id="Fact001501" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">372
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="font-weight: bold; text-align: left; padding-left: 0.75pt">Deferred tax liabilities:
                        </td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_ecustom--DeferredTaxLiabilitiesDepreciation_iI_pn3n3_maDITLzQdi_zdyXUtOUiJH5"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt">Depreciation</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:DeferredTaxLiabilitiesDepreciation" contextref="AsOf2024-03-31"
                                id="Fact001503" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">6
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:DeferredTaxLiabilitiesDepreciation" contextref="AsOf2023-03-31"
                                id="Fact001504" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_ecustom--DeferredTaxLiabilitiesGaapToStatutoryAdjustments_iI_pn3n3_maDITLzQdi_z9pLXapnBcnf"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 10pt">GAAP to statutory adjustments</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:DeferredTaxLiabilitiesGaapToStatutoryAdjustments"
                                contextref="AsOf2024-03-31" id="Fact001506" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">418</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:DeferredTaxLiabilitiesGaapToStatutoryAdjustments"
                                contextref="AsOf2023-03-31" id="Fact001507" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">424</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesOther_iI_pn3n3_maDITLzQdi_ztTINPlhohK5"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-bottom: 1pt; padding-left: 10pt">Other</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxLiabilitiesOther" contextref="AsOf2024-03-31"
                                id="Fact001509" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">173
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxLiabilitiesOther" contextref="AsOf2023-03-31"
                                id="Fact001510" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">51
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_407_eus-gaap--DeferredIncomeTaxLiabilities_iTI_pn3n3_mtDITLzQdi_maDTLz0oI_z9DPdETpaV5g"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Total gross deferred tax
                            liabilities</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredIncomeTaxLiabilities" contextref="AsOf2024-03-31"
                                id="Fact001512" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">597
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredIncomeTaxLiabilities" contextref="AsOf2023-03-31"
                                id="Fact001513" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">482
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_403_eus-gaap--DeferredTaxLiabilities_iTI_pn3n3_mtDTLz0oI_zLEEWrKM5HEd"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Net deferred tax
                            liabilities</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxLiabilities" contextref="AsOf2024-03-31"
                                id="Fact001515" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">112
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:DeferredTaxLiabilities" contextref="AsOf2023-03-31"
                                id="Fact001516" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">110
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A9_zZRLg6h7qjog"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                valuation allowance for deferred tax assets as of March 31, 2024 and 2023 primarily relates to net
                operating loss and interest deduction
                limitation carryforwards that, in the judgment of the Company, are not more-likely-than-not to be
                realized.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                assessing the realizability of deferred tax assets, the Company considers whether it is
                more-likely-than-not that some portion or all
                the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is
                dependent upon the generation of future
                taxable income during the periods in which those temporary differences become deductible. The Company
                considers the scheduled reversal
                of deferred tax liabilities (including the impact of available carryback and carryforward periods),
                projected future taxable income,
                and tax-planning strategies in making this assessment. Based upon the level of historical taxable income
                and projections for future taxable
                income over the periods in which the deferred tax assets are deductible, the Company believes it is
                more-likely-than-not that it will
                realize the benefits of these deductible differences, net of the existing valuation allowances as of
                March 31, 2024 and 2023.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                of March 31, 2024 and 2023, the Company has tax effected net operating loss carryforwards in U.S. of
                $<span
                    id="xdx_906_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pn3n3_c20240331_zQqfpTQDAMk8"
                    title="Net operating loss carryforwards in U.S">
                    <ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic"
                        contextref="AsOf2024-03-31" id="Fact001518" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">5,000</ix:nonfraction>
                </span> and $<span
                    id="xdx_902_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pn3n3_c20230331_zAK0Q0XfRHe5"
                    title="Net operating loss carryforwards in U.S">
                    <ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic"
                        contextref="AsOf2023-03-31" id="Fact001520" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">2,453</ix:nonfraction>
                </span>, respectively,
                of which $<span
                    id="xdx_902_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pn3n3_c20240331_zUlQRRKMXvE2"
                    title="Net operating loss carryforwards expire starting in 2035">
                    <ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"
                        contextref="AsOf2024-03-31" id="Fact001522" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">761</ix:nonfraction>
                </span> will expire starting in <span
                    id="xdx_90F_ecustom--OperatingLossCarryforwardsDomesticExpirationYear_c20230401__20240331_zQRiUmEllzak"
                    title="Operating loss carryforwards domestic expiration year">
                    <ix:nonnumeric contextref="From2023-04-012024-03-31" id="Fact001524"
                        name="DHAI:OperatingLossCarryforwardsDomesticExpirationYear">2035</ix:nonnumeric>
                </span> and the remainder which can be carried forward indefinitely. As of March 31, 2024 and 2023,
                the Company has U.S. state tax effected net operating loss carryforwards of approximately $<span
                    id="xdx_90B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_pn3n3_c20240331_zIH7WkH9xbga"
                    title="Operating loss carryforwards, state and local">
                    <ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"
                        contextref="AsOf2024-03-31" id="Fact001526" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">1,169</ix:nonfraction>
                </span> and $<span
                    id="xdx_90E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_pn3n3_c20230331_zJ41GoJH4mAb"
                    title="Operating loss carryforwards, state and local">
                    <ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"
                        contextref="AsOf2023-03-31" id="Fact001528" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">464</ix:nonfraction>
                </span> that, if unused, will expire
                starting in <span
                    id="xdx_90F_ecustom--OperatingLossCarryforwardsStateAndLocalExpirationYear_c20230401__20240331_zS4V9hHNfHyc"
                    title="Operating loss carryforwards expiration year">
                    <ix:nonnumeric contextref="From2023-04-012024-03-31" id="Fact001530"
                        name="DHAI:OperatingLossCarryforwardsStateAndLocalExpirationYear">2035</ix:nonnumeric>
                </span>. As of March 31, 2024 and 2023, the Company has other foreign tax effected net operating loss
                carryforwards of $<span
                    id="xdx_90E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pn3n3_c20240331_zLRK7n1gsKt8"
                    title="Foreign tax effected net operating loss carryforwards">
                    <ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign"
                        contextref="AsOf2024-03-31" id="Fact001532" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">912</ix:nonfraction>
                </span>
                and $<span
                    id="xdx_904_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pn3n3_c20230331_zf9TgzwAjpv8"
                    title="Foreign tax effected net operating loss carryforwards">
                    <ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign"
                        contextref="AsOf2023-03-31" id="Fact001534" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">4,946</ix:nonfraction>
                </span> of which the majority can be carried forward <span
                    id="xdx_90A_ecustom--OperatingLossCarryforwardsForeignPeriod_dc_c20230401__20240331_zaH5RV9UFT96"
                    title="Foreign tax effected net operating loss carryforwards, period">
                    <ix:nonnumeric contextref="From2023-04-012024-03-31" format="ixt-sec:durwordsen" id="Fact001536"
                        name="DHAI:OperatingLossCarryforwardsForeignPeriod">seven years</ix:nonnumeric>
                </span>.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company prepares its financial statements on a consolidated basis. Income tax expense is calculated in
                accordance with the local tax
                laws of each entity in its relevant jurisdiction on a separate company basis.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 128 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001538"
            name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
            <p id="xdx_89B_eus-gaap--ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_zp3kcoqOV7uc"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                    reconciliation of beginning and ending amount of unrecognized tax liability is presented
                    below:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B7_ztP0tgaB57c9" style="display: none">Schedule of Reconciliation of Beginning and
                        Ending Amount of Unrecognized Tax Liability</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Year ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Unrecognized Tax Liability � beginning
                            balance</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td id="xdx_98E_eus-gaap--UnrecognizedTaxBenefits_iS_pn3n3_c20230401__20240331_zO4UJd1TdzM1"
                            title="Unrecognized Tax Liability beginning balance" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1540">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td id="xdx_98A_eus-gaap--UnrecognizedTaxBenefits_iS_pn3n3_c20220401__20230331_zItRa1SzDzl"
                            title="Unrecognized Tax Liability  beginning balance" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1542">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Net Increases � tax positions in current year
                        </td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_988_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_pn3n3_c20230401__20240331_z8joulOGgTdf"
                            title="Net Increases  tax positions in current year" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1544">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_98A_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_pn3n3_c20220401__20230331_zcP8lilg4DSb"
                            title="Net Increases  tax positions in current year" style="text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1546">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Net
                            Increases � tax positions in prior year</td>
                        <td style="width: 2%; padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&nbsp;</td>
                        <td id="xdx_985_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_pn3n3_c20230401__20240331_zvvuWAjOBQwf"
                            title="Net Increases  tax positions in prior year"
                            style="border-bottom: Black 1pt solid; width: 14%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"
                                contextref="From2023-04-012024-03-31" id="Fact001548" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">3,499</ix:nonfraction>
                        </td>
                        <td style="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="width: 2%; padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&nbsp;</td>
                        <td id="xdx_98B_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_pn3n3_c20220401__20230331_z1kN1tPkc8H1"
                            title="Net Increases  tax positions in prior year"
                            style="border-bottom: Black 1pt solid; width: 14%; text-align: right"><span
                                style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                                    style="-sec-ix-hidden: xdx2ixbrl1550">-</span></span></td>
                        <td style="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5pt">Total income tax expense
                        </td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_980_eus-gaap--UnrecognizedTaxBenefits_iE_pn3n3_c20230401__20240331_zePHPu2QhMGj"
                            title="Total income tax expense"
                            style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefits" contextref="AsOf2024-03-31"
                                id="Fact001552" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,499
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                        <td id="xdx_986_eus-gaap--UnrecognizedTaxBenefits_iE_pn3n3_c20220401__20230331_zWwmfc53hzu"
                            title="Total income tax expense"
                            style="border-bottom: Black 2.5pt double; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1554">�</span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A3_zBv4I9e7KRc1"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                of March 31, 2024 and March 31, 2023, the company had unrecognized tax benefits of $<span
                    id="xdx_906_eus-gaap--UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_iI_pn3n3_c20240331_z0yByE4r3iMd"
                    title="Unrecognized tax benefits would affect annual effective tax rate">
                    <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"
                        contextref="AsOf2024-03-31" id="Fact001556" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">3,499</ix:nonfraction>
                </span>, and $<span
                    id="xdx_908_eus-gaap--UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_iI_pn3n3_c20230331_zd0XnbgTxMjc"
                    title="Unrecognized tax benefits would affect annual effective tax rate">
                    <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"
                        contextref="AsOf2023-03-31" id="Fact001558" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">0</ix:nonfraction>
                </span>, respectively, which related to tax
                positions that, if recognized, would affect the annual effective tax rate. The company recognized
                accrued interest and penalties in income
                tax expense. As of March 31, 2024 and March 31, 2023 accrued interest and penalties totaling to $<span
                    id="xdx_901_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pn3n3_c20240331_zfyaP5QSZH8f"
                    title="Income tax expense, accrued interest and penalties">
                    <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"
                        contextref="AsOf2024-03-31" id="Fact001560" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">159</ix:nonfraction>
                </span> thousand, and $<span
                    id="xdx_909_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pn3n3_c20230331_zmj6fZceMKqi"
                    title="Income tax expense, accrued interest and penalties">
                    <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"
                        contextref="AsOf2023-03-31" id="Fact001562" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">0</ix:nonfraction>
                </span>, respectively,
                is included in other long-term liabilities. The Company has identified potential penalty exposure in
                relation to specific information
                reporting requirements in the United States. Although the Company is trying to address these issues and
                pursue penalty abatement, it
                has recorded a long-term payable for the penalties, until potential relief is granted. As of March 31,
                2024 and 2023, the recorded accrual
                balances stand at $<span id="xdx_903_eus-gaap--AccruedIncomeTaxes_iI_pn3n3_c20240331_zHrU0o61weEd"
                    title="Accrued income taxes">
                    <ix:nonfraction name="us-gaap:AccruedIncomeTaxes" contextref="AsOf2024-03-31" id="Fact001564"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,200</ix:nonfraction>
                </span> and $<span id="xdx_901_eus-gaap--AccruedIncomeTaxes_iI_pn3n3_c20230331_zWpSxX5nFS22"
                    title="Accrued income taxes">
                    <ix:nonfraction name="us-gaap:AccruedIncomeTaxes" contextref="AsOf2023-03-31" id="Fact001566"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,000</ix:nonfraction>
                </span>, respectively.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_900_eus-gaap--IncomeTaxExaminationDescription_c20230401__20240331_zNuoIoCyPRqi"
                    title="Income tax examination, description">
                    <ix:nonnumeric contextref="From2023-04-012024-03-31" id="Fact001568"
                        name="us-gaap:IncomeTaxExaminationDescription">The
                        Company is subject to taxation in Switzerland, the U.S., and other jurisdictions of its foreign
                        subsidiaries. As of March 31, 2024, tax
                        years 2020, 2021, and 2022 are subject to examination by the tax authorities in the U.S. The
                        Company is not currently under examination
                        by tax authorities in any jurisdiction.</ix:nonnumeric>
                </span></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001570"
        name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock">
        <p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_ztvICKxLqhJ2"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_82B_zHpZHn8H7ON1">Commitments and Contingencies</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
                time to time, the Company may be involved in lawsuits, claims, investigations, and proceedings,
                consisting of intellectual property,
                commercial, employment, and other matters, which arise in the ordinary course of business. In accordance
                with ASC 450, <i>Contingencies</i>,
                the Company makes a provision for a liability when it is both probable that a liability has been
                incurred and the amount of the loss
                can be reasonably estimated.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company is not presently a party to any litigation the outcome of which, it believes, if determined
                adversely to the Company, would individually
                or taken together, have a material adverse effect on the Company�s business, operating results, cash
                flows or financial condition.
                The Company has determined that the existence of a material loss is neither probable nor reasonably
                possible.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001572"
        name="us-gaap:LesseeOperatingLeasesTextBlock">
        <p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_z15P68RbuaVe"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_825_zdm5KG3uP2uh">Leases</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company leases office space (real estate), vehicles and office equipment under operating leases. The
                Company did not have any finance
                leases as of March 31, 2024 and 2023.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001574"
            name="DHAI:ScheduleOfRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock">
            <p id="xdx_899_ecustom--ScheduleOfRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_zFJlon2snjg4"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
                    lease assets and lease liabilities that are reported in the Company�s consolidated balance sheet as
                    of March 31, 2024 and 2023
                    are as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B1_zIw2TiO08AK7" style="display: none">Schedule of Right-of-use Lease Assets and Lease
                        Liabilities</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20240331_zqfR02x7etFk"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_490_20230331_zQuk5NW5Ojti"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_zv65saplGzTd"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Operating lease, right-of-use
                            assets, net</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextref="AsOf2024-03-31"
                                id="Fact001576" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,466
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextref="AsOf2023-03-31"
                                id="Fact001577" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,604
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 0.75pt">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_maOLLz7z6_zJylND6SoDEf"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Current portion of long-term operating lease
                        </td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AsOf2024-03-31"
                                id="Fact001579" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,572
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AsOf2023-03-31"
                                id="Fact001580" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,005
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_maOLLz7z6_zt0pFOHGv0Qf"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Long-term operating
                            lease</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AsOf2024-03-31"
                                id="Fact001582" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,917
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AsOf2023-03-31"
                                id="Fact001583" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,621
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--OperatingLeaseLiability_iTI_pn3n3_mtOLLz7z6_zgz4X5uInz8l"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total operating lease
                            liabilities</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiability" contextref="AsOf2024-03-31"
                                id="Fact001585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,489
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiability" contextref="AsOf2023-03-31"
                                id="Fact001586" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,626
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AA_zaY4yoUlsPr6"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 129 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001588"
            name="us-gaap:LeaseCostTableTextBlock">
            <p id="xdx_89C_eus-gaap--LeaseCostTableTextBlock_zFZMt5Zl09d9"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
                    expense for lease payments is recognized on a straight-line basis over the lease term. The expense
                    is presented within Selling, general,
                    and administrative expense. The components of lease expense related to the Company�s lease for the
                    years ended March 31, 2024 and
                    2023 were:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B3_ze52S1nCLYJd" style="display: none">Schedule of Lease Expense</span>&nbsp;</span>
            </p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_491_20230401__20240331_zRxYH5F4fr5c"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49A_20220401__20230331_zXRobrd2PyQa"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Years Ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--OperatingLeaseCost_pn3n3_maLCzjz6_zM9BOD4ECHEe"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Fixed operating lease costs</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseCost" contextref="From2023-04-012024-03-31"
                                id="Fact001590" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,766
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseCost" contextref="From2022-04-012023-03-31"
                                id="Fact001591" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,604
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--ShortTermLeaseCost_pn3n3_maLCzjz6_z7CtYx1PzyC9"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Short-term lease costs
                        </td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:ShortTermLeaseCost" contextref="From2023-04-012024-03-31"
                                id="Fact001593" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">13
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1594">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--LeaseCost_iT_pn3n3_mtLCzjz6_zE98oCqbec31"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Total lease cost</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:LeaseCost" contextref="From2023-04-012024-03-31"
                                id="Fact001596" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,779
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:LeaseCost" contextref="From2022-04-012023-03-31"
                                id="Fact001597" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,604
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A7_zxRpuQ2ngLL3"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001599"
            name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
            <p id="xdx_890_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zvUe9rUH9Rg3"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
                    cash flow information related to leases was as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B5_zUBQ1pEz02y7" style="display: none">Schedule of Supplemental Cash Flow Information
                        Related to Leases</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_491_20230401__20240331_zM8hYRDGeY2j"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49A_20220401__20230331_zhZkf1LN0Agj"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Years Ended March 31,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_ecustom--OperatingCashFlowsIncludedInMeasurementOfLeaseLiabilities_iN_pn3n3_di_z8JV4OQ29c6d"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Operating cash flows included in
                            the measurement of lease liabilities</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">(<ix:nonfraction
                                name="DHAI:OperatingCashFlowsIncludedInMeasurementOfLeaseLiabilities"
                                contextref="From2023-04-012024-03-31" id="Fact001601" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">1,786</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">(<ix:nonfraction
                                name="DHAI:OperatingCashFlowsIncludedInMeasurementOfLeaseLiabilities"
                                contextref="From2022-04-012023-03-31" id="Fact001602" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">1,659</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_407_ecustom--NoncashLeaseActivityRelatedToRightofuseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities_pn3n3_zfQ7IeIgSmGa"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Non-cash lease activity related to
                            right-of-use assets obtained in exchange for new operating lease liabilities</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="DHAI:NoncashLeaseActivityRelatedToRightofuseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities"
                                contextref="From2023-04-012024-03-31" id="Fact001604" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">406</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="DHAI:NoncashLeaseActivityRelatedToRightofuseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities"
                                contextref="From2022-04-012023-03-31" id="Fact001605" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">128</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40C_ecustom--OtherNoncashChangesToRouAssetsDueToReassessmentOfLeaseTerm_pn3n3_zlE3hYISXDY3"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Other non-cash changes to ROU assets due to
                            reassessment of the lease term</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:OtherNoncashChangesToRouAssetsDueToReassessmentOfLeaseTerm"
                                contextref="From2023-04-012024-03-31" id="Fact001607" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">2,946</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1608">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AD_zB742mzjJSM9"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001610"
            name="DHAI:WeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock">
            <p id="xdx_89E_ecustom--WeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_znViVsDROe8d"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    weighted average remaining lease term and discount rate for the Company�s operating leases as of
                    March 31, 2024 and 2023 were:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span id="xdx_8B6_zhfqKxJMZfZa" style="display: none">Schedule of Weighted Average Remaining Lease Term
                    and Discount Rate</span><span
                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 64%; text-align: left; padding-left: 0.75pt">Weighted-average remaining lease
                            term (in years)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right"><span
                                id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240331_zMstcguKGHO9"
                                title="Weighted-average remaining lease term">
                                <ix:nonnumeric contextref="AsOf2024-03-31" format="ixt-sec:duryear" id="Fact001612"
                                    name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">2.63</ix:nonnumeric>
                            </span></td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 14%; text-align: right"><span
                                id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230331_zevZHeJLvFhd"
                                title="Weighted-average remaining lease term">
                                <ix:nonnumeric contextref="AsOf2023-03-31" format="ixt-sec:duryear" id="Fact001614"
                                    name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">2.77</ix:nonnumeric>
                            </span></td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">Weighted-average discount rate</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20240331_zBewfwxBNAt2"
                                title="Weighted-average discount rate">
                                <ix:nonfraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent"
                                    contextref="AsOf2024-03-31" id="Fact001616" format="ixt:numdotdecimal"
                                    decimals="INF" scale="-2" unitref="Pure">4.00</ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230331_zJunq5l2mf04"
                                title="Weighted-average discount rate">
                                <ix:nonfraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent"
                                    contextref="AsOf2023-03-31" id="Fact001618" format="ixt:numdotdecimal"
                                    decimals="INF" scale="-2" unitref="Pure">4.00</ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A4_zMw8xVy9iHS"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
                duration was determined utilizing renewal options that the Company is reasonably certain to
                execute.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001620"
            name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
            <p id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zFaWIcRoigCj"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                    of March 31, 2024, maturities of operating lease liabilities for each of the following five years
                    ending March 31 and a total thereafter
                    were as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B0_zLNDKPvfHVUh" style="display: none">Schedule of Maturities of Operating Lease
                        Liabilities</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_490_20240331_z0Q8xuVF1Vyb"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating
                            Leases</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_maLOLLPz1Eb_zWzEs8Bht0yi"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 80%; text-align: left; padding-left: 0.75pt">2025</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"
                                contextref="AsOf2024-03-31" id="Fact001622" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">1,717</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPz1Eb_z4lor8f8I99h"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">2026</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"
                                contextref="AsOf2024-03-31" id="Fact001624" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">1,181</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPz1Eb_zzLu8tco1Seh"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">2027</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree"
                                contextref="AsOf2024-03-31" id="Fact001626" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">899</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPz1Eb_zdQqe6qzli6g"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-left: 0.75pt">2028</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour"
                                contextref="AsOf2024-03-31" id="Fact001628" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">893</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_maLOLLPz1Eb_zaOnxJMH86h"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">2029</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive"
                                contextref="AsOf2024-03-31" id="Fact001630" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">111</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_ecustom--LesseeOperatingLeaseLiabilityPaymentDueYearSix_iI_pn3n3_maLOLLPz1Eb_zM0K04y8IZS8"
                        style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">2030</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_maLOLLPz1Eb_zsckD0aIkwp3"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-bottom: 1pt; padding-left: 0.75pt">Thereafter</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1634">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPz1Eb_zuz6kqtprTX6"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 10pt">Total lease payments</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue"
                                contextref="AsOf2024-03-31" id="Fact001636" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">4,801</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zhH0b67ug0bc"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Less: imputed interest
                        </td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"
                                contextref="AsOf2024-03-31" id="Fact001638" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">312</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zzZK69jr0oKl"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Total lease liability
                        </td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiability" contextref="AsOf2024-03-31"
                                id="Fact001640" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,489
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>


        </ix:nonnumeric>
        <p id="xdx_8AC_zMS7DwBWLDR6"
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 130 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001642"
        name="us-gaap:ComprehensiveIncomeNoteTextBlock">
        <p id="xdx_80D_eus-gaap--ComprehensiveIncomeNoteTextBlock_zF8qG8emfep"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_82C_zYXBCvTjd0Sd">Accumulated Other Comprehensive Income</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001644"
            name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
            <p id="xdx_896_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z28O6V6lZ2ve"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    changes in accumulated other comprehensive income (loss) by component are summarized below:</span>
            </p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B2_zZ48YpiRDvxc" style="display: none">Schedule of Changes in Accumulated Other
                        Comprehensive Income (Loss)</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2"
                            id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_z8zAGBGdAloa"
                            style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Foreign
                            Currency Translation</td>
                        <td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2"
                            id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_zVsrUF0OBFmj"
                            style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Defined
                            Benefit Plan Items</td>
                        <td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2"
                            id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zljSia5xXLQ5"
                            style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Total
                            Accumulated Other Comprehensive (Loss) Income</td>
                        <td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_437_c20220401__20230331_eus-gaap--StockholdersEquity_iS_pn3n3_zcrF5ZN0E1Z5"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 46%; font-weight: bold; padding-left: 0.75pt">Balance at March 31, 2022</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2022-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001646" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">3,372</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2022-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001647" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,007
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact001648" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">635
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="font-weight: bold; padding-left: 0.75pt">Transfer of defined benefit plan</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_pn3n3_zWqqNOkO8CTi"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Other comprehensive income (loss) before
                            reclassifications</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2022-04-012023-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001650" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">503</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2022-04-012023-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001651" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">592
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2022-04-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact001652" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">89
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_pn3n3_zLBUxzfGSU7"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Reclassifications to
                            statements of earnings</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1654">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                                contextref="From2022-04-012023-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001655" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">1,013</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                                contextref="From2022-04-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact001656" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">1,013</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_iN_pn3n3_di_z1eRI835lbmj"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Total other
                            comprehensive loss</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2022-04-012023-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001658" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">503
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2022-04-012023-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001659" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">421
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2022-04-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact001660" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">924
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_43F_c20230401__20240331_eus-gaap--StockholdersEquity_iS_pn3n3_z0N4UzQZTud1"
                        style="vertical-align: bottom; background-color: White">
                        <td style="font-weight: bold; padding-bottom: 1pt; padding-left: 0.75pt">Balance, March 31, 2023
                        </td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001662" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">3,875</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001663" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,586
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact001664" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">289</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_431_c20230401__20240331_eus-gaap--StockholdersEquity_iS_pn3n3_zygdhmDrFwH"
                        style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="font-weight: bold; padding-bottom: 1pt; padding-left: 0.75pt">Balance, value</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001666" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">3,875</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001667" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,586
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact001668" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">289</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_pn3n3_zWoAsNWPAYB9"
                        style="display: none; vertical-align: bottom; background-color: White">
                        <td style="font-weight: bold; padding-bottom: 1pt; padding-left: 0.75pt">Transfer of defined
                            benefit plan</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_pn3n3_zxVxqMRAH5ci"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-left: 0.75pt">Other comprehensive income (loss) before
                            reclassifications</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2023-04-012024-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001674" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,455
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2023-04-012024-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001675" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">469</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2023-04-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact001676" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">986
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_pn3n3_zDUBD6S46whb"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Reclassifications to
                            statements of earnings</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl1678">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                                contextref="From2023-04-012024-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001679" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">647</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                                contextref="From2023-04-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact001680" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">647</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_iN_pn3n3_di_zaf7rb7IQdKg"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Total other
                            comprehensive income (loss)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2023-04-012024-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001682" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">1,455</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2023-04-012024-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001683" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,116
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2023-04-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact001684" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">339</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_43D_c20230401__20240331_eus-gaap--StockholdersEquity_iE_pn3n3_zN98uiDnipUj"
                        style="vertical-align: bottom; background-color: White">
                        <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.75pt">Balance, March 31,
                            2024</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001686" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">2,420</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001687" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,470
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact001688" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">50
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_432_c20230401__20240331_eus-gaap--StockholdersEquity_iE_pn3n3_z2j96GEvcEPf"
                        style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.75pt">Balance, value</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001690" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">2,420</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact001691" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,470
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact001692" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">50
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AA_zhMtnjGJpuEh"
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2023-04-012024-03-31" escape="true" id="Fact001694"
        name="us-gaap:SubsequentEventsTextBlock">
        <p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zugRNwxpVi24"
            style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.
                <span id="xdx_825_zwX0h40baxf3">Subsequent Events</span></span></p>




        <p
            style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                June 6, 2024, the Company entered into a Securities Purchase Agreement, pursuant to which the Company
                issued $<span
                    id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20240606__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zASfWz3kJMeh"
                    title="Aggregate principal amount">
                    <ix:nonfraction name="us-gaap:DebtInstrumentFaceAmount"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember"
                        id="Fact001696" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">3.3
                    </ix:nonfraction>
                </span> million in principal
                amount of <span
                    id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240606__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUQaiNRiewZc"
                    title="Original issue discount percentage">
                    <ix:nonfraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember"
                        id="Fact001698" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">8
                    </ix:nonfraction>
                </span>% Original Issue Discount Senior Secured Convertible Debentures (the �Debentures�). The
                Debentures were issued
                with an original issue discount of $<span
                    id="xdx_900_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20240606__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdk6hWL8O25"
                    title="Debentures issued with original issue discount">
                    <ix:nonfraction name="us-gaap:DebtInstrumentCarryingAmount"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember"
                        id="Fact001700" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">300
                    </ix:nonfraction>
                </span> thousand, resulting in gross proceeds of approximately $<span
                    id="xdx_906_eus-gaap--ProceedsFromIssuanceOfDebt_pn6n6_c20240606__20240606__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztb1sd6RT6Q6"
                    title="Gross proceeds from issuance of debt">
                    <ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfDebt"
                        contextref="From2024-06-062024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember"
                        id="Fact001702" format="ixt:numdotdecimal" decimals="-6" scale="6" unitref="USD">3
                    </ix:nonfraction>
                </span> million and net proceeds of approximately
                $<span
                    id="xdx_904_ecustom--NetProceedsFromIssuanceOfDebt_pn5n6_c20240606__20240606__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmsiB1qWEl2e"
                    title="Net proceeds from issuance of debt">
                    <ix:nonfraction name="DHAI:NetProceedsFromIssuanceOfDebt"
                        contextref="From2024-06-062024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember"
                        id="Fact001704" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">2.5
                    </ix:nonfraction>
                </span> million after deducting estimated offering expenses.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Debentures are convertible into an aggregate of <span
                    id="xdx_90A_eus-gaap--DebtInstrumentConvertibleNumberOfEquityInstruments_pid_uShares_c20240606__20240606__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zZycELTl0Wn4"
                    title="Debentures convertible into common shares">
                    <ix:nonfraction name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments"
                        contextref="From2024-06-062024-06-06_us-gaap_CommonStockMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
                        id="Fact001706" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">660,000
                    </ix:nonfraction>
                </span> shares of the Company�s Common Stock at a conversion price of $<span
                    id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240606__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zv7JcyU8Ytr9"
                    title="Debt instrument conversion price">
                    <ix:nonfraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1"
                        contextref="AsOf2024-06-06_us-gaap_CommonStockMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
                        id="Fact001708" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">5.00
                    </ix:nonfraction>
                </span> per
                share, subject to adjustment. The Debentures mature on <span
                    id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_dd_c20240606__20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zHbNoQTohvN1"
                    title="Debt instrument, maturity date">
                    <ix:nonnumeric
                        contextref="From2024-06-062024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember"
                        format="ixt:datemonthdayyearen" id="Fact001710" name="us-gaap:DebtInstrumentMaturityDate">
                        December 7, 2025</ix:nonnumeric>
                </span>, and bear interest at a rate of <span
                    id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zsDOmiiYY5p8"
                    title="Debt instrument interest rate">
                    <ix:nonfraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember"
                        id="Fact001712" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">8
                    </ix:nonfraction>
                </span>% per annum, <span
                    id="xdx_903_eus-gaap--DebtInstrumentPaymentTerms_c20240606__20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zBZiDaEb46Lh"
                    title="Debt instrument, payment terms">
                    <ix:nonnumeric
                        contextref="From2024-06-062024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember"
                        id="Fact001714" name="us-gaap:DebtInstrumentPaymentTerms">payable monthly
                        beginning one year from the issuance date.</ix:nonnumeric>
                </span></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_90B_eus-gaap--LongTermDebtMaturitiesRepaymentTerms_c20240606__20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6FObVNOJbFc"
                    title="Debt instruments, maturities, repayment terms">
                    <ix:nonnumeric
                        contextref="From2024-06-062024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember"
                        id="Fact001716" name="us-gaap:LongTermDebtMaturitiesRepaymentTerms">Provided
                        that no event of default has occurred or is continuing, and at least 33% of the principal amount
                        of the Debentures has either previously
                        been repaid or converted in accordance with the terms of the Debenture, the Company may elect,
                        by notice to the holder of the Debentures,
                        to extend the Maturity Date by six months upon the payment of six months� interest on the
                        then-outstanding principal amount.</ix:nonnumeric>
                </span></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Debentures are secured by substantially all of the assets of the Company and its domestic subsidiaries,
                excluding certain specified assets.
                Additionally, the Company�s domestic subsidiaries have provided an unconditional guarantee of the
                Debentures. In connection with
                the issuance of the Debentures, the Company also issued warrants to purchase an aggregate of <span
                    id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240606__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zc4lxqiFHAsc"
                    title="Number of warrants or rights converted into shares">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember"
                        id="Fact001718" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">330,000
                    </ix:nonfraction>
                </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common
                stock at an exercise price of
                $<span
                    id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240606__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0qE1BOeQlP8"
                    title="Number of warrant or right, exercise price">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_SubsequentEventMember"
                        id="Fact001720" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">5.00
                    </ix:nonfraction>
                </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, with
                a <span
                    id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20240606__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXqLaxE4SqEf"
                    title="Term of warrants::XDX::P5Y"><span
                        style="-sec-ix-hidden: xdx2ixbrl1722">five</span></span></span><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-year
                term.&nbsp;</span></p>

    </ix:nonnumeric>
    <p id="xdx_816_zE6MbG3WXSZ7"
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 131 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_001"></span>DIH
                HOLDING US, INC.</b></span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
                CONSOLIDATED BALANCE SHEETS</b></span></p>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)
                (in thousands, except share and per share data)</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <table cellpadding="0" cellspacing="0" id="xdx_303_111_pn3n3_zohzCGh2L3H8"
        summary="xdx: Statement - Condensed Consolidated Balance Sheets"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_490_20240930_zTh8XUEXVRb4"
                    style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of September 30,
                    2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_499_20240331_zg7DB8A2JtHf"
                    style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March 31, 2024
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--AssetsAbstract_iB_zYy3wB9q9via"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold">Assets</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_i01B_zhh10SsX2wV3"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Current assets:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_400_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_zCFm9sNdJj62"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; width: 60%; text-align: left">Cash and cash equivalents</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">
                    <ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextref="AsOf2024-09-30"
                        id="Fact001730" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,759
                    </ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">
                    <ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextref="AsOf2024-03-31"
                        id="Fact001731" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,225
                    </ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40E_eus-gaap--RestrictedCash_i02I_zosvJBnBqGLa"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Restricted cash</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:RestrictedCash" contextref="AsOf2024-09-30" id="Fact001733"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">300</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1734">�</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--AccountsReceivableNetCurrent_i02I_z7jduaU6Shhk"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Accounts receivable, net of allowances of $<span
                        id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20240930_zF8up9WdfTI2"
                        title="Allowance for accounts receivable">
                        <ix:nonfraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent"
                            contextref="AsOf2024-09-30" id="Fact001739" format="ixt:numdotdecimal" decimals="-3"
                            scale="3" unitref="USD">233</ix:nonfraction>
                    </span> and $<span
                        id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20240331_zj5XthZoEhl"
                        title="Allowance for accounts receivable">
                        <ix:nonfraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent"
                            contextref="AsOf2024-03-31" id="Fact001741" format="ixt:numdotdecimal" decimals="-3"
                            scale="3" unitref="USD">667</ix:nonfraction>
                    </span>, respectively</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AccountsReceivableNetCurrent" contextref="AsOf2024-09-30"
                        id="Fact001736" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">6,383
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AccountsReceivableNetCurrent" contextref="AsOf2024-03-31"
                        id="Fact001737" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,197
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--InventoryNet_i02I_z7dJNj2gjCc5"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Inventories, net</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:InventoryNet" contextref="AsOf2024-09-30" id="Fact001743"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">9,591</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:InventoryNet" contextref="AsOf2024-03-31" id="Fact001744"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,830</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--OtherReceivablesNetCurrent_i02I_znRUyRwbaHue"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Due from related party</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherReceivablesNetCurrent" contextref="AsOf2024-09-30"
                        id="Fact001746" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">6,133
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherReceivablesNetCurrent" contextref="AsOf2024-03-31"
                        id="Fact001747" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,688
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--OtherAssetsCurrent_i02I_zqjLQNsy2CR2"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other current assets</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherAssetsCurrent" contextref="AsOf2024-09-30" id="Fact001749"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,608</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherAssetsCurrent" contextref="AsOf2024-03-31" id="Fact001750"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,116</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40F_eus-gaap--AssetsCurrent_i02TI_ztTFBpp112Ub"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 20pt; text-align: left">Total current assets</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AssetsCurrent" contextref="AsOf2024-09-30" id="Fact001752"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">29,774</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AssetsCurrent" contextref="AsOf2024-03-31" id="Fact001753"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">27,056</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentNet_i01I_zw332AYkeIOk"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Property, and equipment, net</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2024-09-30"
                        id="Fact001755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">790
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2024-03-31"
                        id="Fact001756" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">530
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_401_eus-gaap--CapitalizedComputerSoftwareNet_i01I_ziGq2zVn69fe"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Capitalized software, net</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareNet" contextref="AsOf2024-09-30"
                        id="Fact001758" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,992
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareNet" contextref="AsOf2024-03-31"
                        id="Fact001759" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,131
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_404_eus-gaap--OtherIntangibleAssetsNet_i01I_zOKqUzpa4YR4"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Other intangible assets, net</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherIntangibleAssetsNet" contextref="AsOf2024-09-30" id="Fact001761"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">380</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherIntangibleAssetsNet" contextref="AsOf2024-03-31" id="Fact001762"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">380</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_402_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_zv2fUVrZeSNa"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Operating lease, right-of-use assets, net</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextref="AsOf2024-09-30"
                        id="Fact001764" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,182
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextref="AsOf2024-03-31"
                        id="Fact001765" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,466
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40A_eus-gaap--DeferredIncomeTaxAssetsNet_i01I_zfKjOkWw7Ejk"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Other tax assets</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextref="AsOf2024-09-30"
                        id="Fact001767" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">128
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextref="AsOf2024-03-31"
                        id="Fact001768" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">267
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_408_eus-gaap--OtherAssetsNoncurrent_i01I_ziIj5YVoR7X1"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt">Other assets</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherAssetsNoncurrent" contextref="AsOf2024-09-30" id="Fact001770"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">948</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherAssetsNoncurrent" contextref="AsOf2024-03-31" id="Fact001771"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">905</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--Assets_i01TI_z8SSk7OLcQTa"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 2.5pt">Total assets</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:Assets" contextref="AsOf2024-09-30" id="Fact001773"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">38,194</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:Assets" contextref="AsOf2024-03-31" id="Fact001774"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">35,735</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40D_eus-gaap--LiabilitiesAbstract_iB_zScIT2uJlex9"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; text-align: left">Liabilities and Deficit</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_402_eus-gaap--LiabilitiesCurrentAbstract_i01B_zweaEg09p2H2"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Current liabilities:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--AccountsPayableCurrent_i02I_zAMewEJc3Ni"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Accounts payable</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AccountsPayableCurrent" contextref="AsOf2024-09-30" id="Fact001782"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,231</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AccountsPayableCurrent" contextref="AsOf2024-03-31" id="Fact001783"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,305</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_i02I_zzQY4JlO6DGf"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Employee compensation</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextref="AsOf2024-09-30"
                        id="Fact001785" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,813
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextref="AsOf2024-03-31"
                        id="Fact001786" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,664
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40D_eus-gaap--OtherLiabilitiesCurrent_i02I_zJ1fDYhYy8wa"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Due to related party</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherLiabilitiesCurrent" contextref="AsOf2024-09-30" id="Fact001788"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">10,322</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherLiabilitiesCurrent" contextref="AsOf2024-03-31" id="Fact001789"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">10,192</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--ContractWithCustomerLiabilityCurrent_i02I_zd6BPBHWQEO9"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Current portion of deferred revenue</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextref="AsOf2024-09-30"
                        id="Fact001791" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,900
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextref="AsOf2024-03-31"
                        id="Fact001792" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,211
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_402_eus-gaap--StandardProductWarrantyAccrualCurrent_i02I_z2NobPRL3H14"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Manufacturing warranty obligation</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:StandardProductWarrantyAccrualCurrent" contextref="AsOf2024-09-30"
                        id="Fact001794" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">621
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:StandardProductWarrantyAccrualCurrent" contextref="AsOf2024-03-31"
                        id="Fact001795" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">513
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_zHZlLdkVK775"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Current portion of long-term operating lease</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AsOf2024-09-30"
                        id="Fact001797" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,494
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AsOf2024-03-31"
                        id="Fact001798" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,572
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--ConvertibleDebtCurrent_i02I_zdg0g63JGR81"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Current maturities of convertible debt, at fair value
                </td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ConvertibleDebtCurrent" contextref="AsOf2024-09-30" id="Fact001800"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,991</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1801">�</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40F_ecustom--AdvancePaymentsFromCustomers_i02I_zjBKWdkAWZwk"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Advance payments from customers</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:AdvancePaymentsFromCustomers" contextref="AsOf2024-09-30" id="Fact001803"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">8,945</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:AdvancePaymentsFromCustomers" contextref="AsOf2024-03-31" id="Fact001804"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">10,562</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_i02I_zTHlJqLAf7I"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accrued expenses and other current
                    liabilities ($<span
                        id="xdx_908_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_c20240930_zO3EnltjlOMj"
                        title="Other accrued liabilities"><span
                            id="xdx_90A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_c20240331_zOCDmW7a2rWl"
                            title="Other accrued liabilities">
                            <ix:nonfraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextref="AsOf2024-09-30"
                                id="Fact001809" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">
                                <ix:nonfraction name="us-gaap:OtherAccruedLiabilitiesCurrent"
                                    contextref="AsOf2024-03-31" id="Fact001811" format="ixt:numdotdecimal" decimals="-3"
                                    scale="3" unitref="USD">480</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> measured
                    at fair value)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent"
                        contextref="AsOf2024-09-30" id="Fact001806" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">11,046</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent"
                        contextref="AsOf2024-03-31" id="Fact001807" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">9,935</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_eus-gaap--LiabilitiesCurrent_i02TI_zeoFGqGWJ6jj"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Total current liabilities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:LiabilitiesCurrent" contextref="AsOf2024-09-30" id="Fact001813"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">49,363</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:LiabilitiesCurrent" contextref="AsOf2024-03-31" id="Fact001814"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">44,954</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_eus-gaap--ConvertibleDebtNoncurrent_i01I_z04Dz4M3XnU5"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Convertible debt, net of current maturities, at fair
                    value</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ConvertibleDebtNoncurrent" contextref="AsOf2024-09-30" id="Fact001816"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">928</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1817">�</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40E_eus-gaap--NotesPayable_i01I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1buFQ4o2J0a"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Notes payable - related party</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:NotesPayable" contextref="AsOf2024-09-30_us-gaap_RelatedPartyMember"
                        id="Fact001819" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">9,404
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:NotesPayable" contextref="AsOf2024-03-31_us-gaap_RelatedPartyMember"
                        id="Fact001820" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">11,457
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40A_eus-gaap--ContractWithCustomerLiabilityNoncurrent_i01I_zsjbtctd5i4b"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Non-current deferred revenues</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextref="AsOf2024-09-30"
                        id="Fact001822" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,943
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextref="AsOf2024-03-31"
                        id="Fact001823" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,670
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_zdKvHJIxqV01"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Long-term operating lease</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AsOf2024-09-30"
                        id="Fact001825" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,731
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AsOf2024-03-31"
                        id="Fact001826" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,917
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_eus-gaap--DeferredIncomeTaxLiabilitiesNet_i01I_zBw9odU22pJg"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Deferred tax liabilities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextref="AsOf2024-09-30"
                        id="Fact001828" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">86
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextref="AsOf2024-03-31"
                        id="Fact001829" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">112
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_eus-gaap--OtherLiabilitiesNoncurrent_i01I_zugEI4YKoiDk"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other non-current liabilities</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherLiabilitiesNoncurrent" contextref="AsOf2024-09-30"
                        id="Fact001831" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,134
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherLiabilitiesNoncurrent" contextref="AsOf2024-03-31"
                        id="Fact001832" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,171
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--Liabilities_i01TI_zcwhBZf5S3Qb"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt">Total liabilities</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:Liabilities" contextref="AsOf2024-09-30" id="Fact001834"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">72,589</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:Liabilities" contextref="AsOf2024-03-31" id="Fact001835"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">68,281</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_404_eus-gaap--CommitmentsAndContingencies_iI_zthyc0ck4ED4"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Commitments and contingencies (Note 16)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span
                        style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                            style="-sec-ix-hidden: xdx2ixbrl1837">-</span></span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span
                        style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                            style="-sec-ix-hidden: xdx2ixbrl1838">-</span></span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--StockholdersEquityAbstract_i01B_z2OGn98MK9b2"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td>Deficit:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--PreferredStockValue_i02I_z8FXTCR09xui"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Preferred stock, $<span
                        id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240930_zLqW3kXWuUrj"
                        title="Preferred stock, par value"><span
                            id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240331_zlV5gfEzWnA4"
                            title="Preferred stock, par value">
                            <ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare"
                                contextref="AsOf2024-09-30" id="Fact001846" format="ixt:numdotdecimal" decimals="INF"
                                unitref="USDPShares">
                                <ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare"
                                    contextref="AsOf2024-03-31" id="Fact001848" format="ixt:numdotdecimal"
                                    decimals="INF" unitref="USDPShares">0.00001</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> par value&#894; <span
                        id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240930_zFax9cC6Hue2"
                        title="Preferred stock, shares authorized"><span
                            id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240331_zYBDejlcSdF3"
                            title="Preferred stock, shares authorized">
                            <ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" contextref="AsOf2024-09-30"
                                id="Fact001850" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                <ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized"
                                    contextref="AsOf2024-03-31" id="Fact001852" format="ixt:numdotdecimal"
                                    decimals="INF" unitref="Shares">10,000,000</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> shares authorized; <span
                        id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20240930_zrvGHYl4QEA9"
                        title="Preferred stock, shares issued"><span
                            id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20240930_zU328DPLsPni"
                            title="Preferred stock, shares outstanding"><span
                                id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20240331_zPnF0cEKM43g"
                                title="Preferred stock, shares issued"><span
                                    id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20240331_z6lavM9y7Jzc"
                                    title="Preferred stock, shares outstanding">
                                    <ix:nonfraction name="us-gaap:PreferredStockSharesIssued"
                                        contextref="AsOf2024-09-30" id="Fact001854" format="ixt-sec:numwordsen"
                                        decimals="INF" unitref="Shares">
                                        <ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding"
                                            contextref="AsOf2024-09-30" id="Fact001856" format="ixt-sec:numwordsen"
                                            decimals="INF" unitref="Shares">
                                            <ix:nonfraction name="us-gaap:PreferredStockSharesIssued"
                                                contextref="AsOf2024-03-31" id="Fact001858" format="ixt-sec:numwordsen"
                                                decimals="INF" unitref="Shares">
                                                <ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding"
                                                    contextref="AsOf2024-03-31" id="Fact001860"
                                                    format="ixt-sec:numwordsen" decimals="INF" unitref="Shares">no
                                                </ix:nonfraction>
                                            </ix:nonfraction>
                                        </ix:nonfraction>
                                    </ix:nonfraction>
                                </span></span></span></span> shares
                    issued and outstanding at September 30, 2024 and March 31, 2024</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1843">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1844">�</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_400_eus-gaap--CommonStockValue_i02I_zQcSCUUM22i1"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Common stock, $<span
                        id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240930_zF8DngwcHi4a"
                        title="Common stock, par value"><span
                            id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240331_zAYb69SDcFb8"
                            title="Common stock, par value">
                            <ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare"
                                contextref="AsOf2024-09-30" id="Fact001865" format="ixt:numdotdecimal" decimals="INF"
                                unitref="USDPShares">
                                <ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare"
                                    contextref="AsOf2024-03-31" id="Fact001867" format="ixt:numdotdecimal"
                                    decimals="INF" unitref="USDPShares">0.0001</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> par value&#894; <span
                        id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240930_z1ITSqLjRQ28"
                        title="Common stock, shares authorized"><span
                            id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240331_zH404Ftuzu26"
                            title="Common stock, shares authorized">
                            <ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" contextref="AsOf2024-09-30"
                                id="Fact001869" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                <ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" contextref="AsOf2024-03-31"
                                    id="Fact001871" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                    100,000,000</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span> shares authorized&#894; <span
                        id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20240930_zA48xVrhw23g"
                        title="Common stock, shares issued"><span
                            id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240930_zhqtEx1Ol1h3"
                            title="Common stock, shares outstanding"><span
                                id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_pid_c20240331_zE1Tdc1s5jdi"
                                title="Common stock, shares issued"><span
                                    id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240331_zFRU1FrAaWsj"
                                    title="Common stock, shares outstanding">
                                    <ix:nonfraction name="us-gaap:CommonStockSharesIssued" contextref="AsOf2024-09-30"
                                        id="Fact001873" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                        <ix:nonfraction name="us-gaap:CommonStockSharesOutstanding"
                                            contextref="AsOf2024-09-30" id="Fact001875" format="ixt:numdotdecimal"
                                            decimals="INF" unitref="Shares">
                                            <ix:nonfraction name="us-gaap:CommonStockSharesIssued"
                                                contextref="AsOf2024-03-31" id="Fact001877" format="ixt:numdotdecimal"
                                                decimals="INF" unitref="Shares">
                                                <ix:nonfraction name="us-gaap:CommonStockSharesOutstanding"
                                                    contextref="AsOf2024-03-31" id="Fact001879"
                                                    format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                                    34,544,935</ix:nonfraction>
                                            </ix:nonfraction>
                                        </ix:nonfraction>
                                    </ix:nonfraction>
                                </span></span></span></span>
                    shares issued and outstanding at September 30, 2024 and March 31, 2024</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:CommonStockValue" contextref="AsOf2024-09-30" id="Fact001862"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:CommonStockValue" contextref="AsOf2024-03-31" id="Fact001863"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_i02I_zzH0Cccac11l"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Additional paid-in-capital</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AdditionalPaidInCapital" contextref="AsOf2024-09-30" id="Fact001881"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,323</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AdditionalPaidInCapital" contextref="AsOf2024-03-31" id="Fact001882"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,613</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_400_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_zB83XarpojAe"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Accumulated deficit</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit"
                        contextref="AsOf2024-09-30" id="Fact001884" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        sign="-" unitref="USD">35,756</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit"
                        contextref="AsOf2024-03-31" id="Fact001885" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        sign="-" unitref="USD">35,212</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_407_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_zmgTNxHjdRPg"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated other comprehensive
                    income (loss)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextref="AsOf2024-09-30"
                        id="Fact001887" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,965
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax"
                        contextref="AsOf2024-03-31" id="Fact001888" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">50</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40A_eus-gaap--StockholdersEquity_i01TI_zPdYPS20aQg4"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt">Total deficit</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2024-09-30" id="Fact001890"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">34,395
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2024-03-31" id="Fact001891"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">32,546
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_zt0ZfYrrBygf"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities and deficit</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextref="AsOf2024-09-30"
                        id="Fact001893" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">38,194
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextref="AsOf2024-03-31"
                        id="Fact001894" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">35,735
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 132 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_002"></span>DIH
                HOLDING US, INC.</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
                CONSOLIDATED STATEMENTS OF OPERATIONS</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)
                (in thousands, except per share data)</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <table cellpadding="0" cellspacing="0" id="xdx_303_113_pn3n3_zWoCu9jfOY4e"
        summary="xdx: Statement - Condensed Consolidated Statements of Operations"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="display: none; vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_499_20240701__20240930_zgBpZeloIIk3"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_490_20230701__20230930_zIrgUCKaVUya"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_497_20240401__20240930_zBXW9PetiMs9"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_49C_20230401__20230930_zzFvwFLC3cbb"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the
                    Three Months Ended September
                    30,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the
                    Six Months Ended September
                    30,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zUhSVY33qtu5"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 40%">Revenue</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 11%; text-align: right">
                    <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                        contextref="From2024-07-012024-09-30" id="Fact001896" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">18,162</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 11%; text-align: right">
                    <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                        contextref="From2023-07-012023-09-30" id="Fact001897" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">13,060</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 11%; text-align: right">
                    <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                        contextref="From2024-04-01to2024-09-30" id="Fact001898" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">35,122</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 11%; text-align: right">
                    <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                        contextref="From2023-04-012023-09-30" id="Fact001899" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">26,105</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--CostOfGoodsAndServicesSold_zehcsOpxuDY1"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-bottom: 1pt">Cost of sales</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:CostOfGoodsAndServicesSold" contextref="From2024-07-012024-09-30"
                        id="Fact001901" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">8,605
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:CostOfGoodsAndServicesSold" contextref="From2023-07-012023-09-30"
                        id="Fact001902" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,652
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:CostOfGoodsAndServicesSold" contextref="From2024-04-01to2024-09-30"
                        id="Fact001903" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">16,110
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:CostOfGoodsAndServicesSold" contextref="From2023-04-012023-09-30"
                        id="Fact001904" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">15,300
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_403_eus-gaap--GrossProfit_iT_zG9UcOFvAsn8"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Gross profit</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:GrossProfit" contextref="From2024-07-012024-09-30" id="Fact001906"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">9,557</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:GrossProfit" contextref="From2023-07-012023-09-30" id="Fact001907"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,408</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:GrossProfit" contextref="From2024-04-01to2024-09-30" id="Fact001908"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">19,012</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:GrossProfit" contextref="From2023-04-012023-09-30" id="Fact001909"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">10,805</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40D_eus-gaap--OperatingExpensesAbstract_iB_z39kW94v8uAa"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Operating expenses:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_zQdH6bQ8sXs3"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Selling, general, and administrative expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:SellingGeneralAndAdministrativeExpense"
                        contextref="From2024-07-012024-09-30" id="Fact001916" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">5,758</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:SellingGeneralAndAdministrativeExpense"
                        contextref="From2023-07-012023-09-30" id="Fact001917" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">6,372</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:SellingGeneralAndAdministrativeExpense"
                        contextref="From2024-04-01to2024-09-30" id="Fact001918" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">14,368</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:SellingGeneralAndAdministrativeExpense"
                        contextref="From2023-04-012023-09-30" id="Fact001919" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">12,209</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_403_eus-gaap--ResearchAndDevelopmentExpense_i01_zw0xj79sv1E7"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Research and development</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:ResearchAndDevelopmentExpense" contextref="From2024-07-012024-09-30"
                        id="Fact001921" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,911
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:ResearchAndDevelopmentExpense" contextref="From2023-07-012023-09-30"
                        id="Fact001922" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,584
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:ResearchAndDevelopmentExpense" contextref="From2024-04-01to2024-09-30"
                        id="Fact001923" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,555
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:ResearchAndDevelopmentExpense" contextref="From2023-04-012023-09-30"
                        id="Fact001924" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,022
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_404_eus-gaap--OperatingExpenses_i01T_zWAMNyzQe3Mj"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt">Total operating expenses</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingExpenses" contextref="From2024-07-012024-09-30"
                        id="Fact001926" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,669
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingExpenses" contextref="From2023-07-012023-09-30"
                        id="Fact001927" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,956
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingExpenses" contextref="From2024-04-01to2024-09-30"
                        id="Fact001928" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">17,923
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingExpenses" contextref="From2023-04-012023-09-30"
                        id="Fact001929" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">15,231
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--OperatingIncomeLoss_iT_zylBsTdfKEH7"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Operating income (loss)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingIncomeLoss" contextref="From2024-07-012024-09-30"
                        id="Fact001931" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,888
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OperatingIncomeLoss" contextref="From2023-07-012023-09-30" id="Fact001932"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">2,548</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OperatingIncomeLoss" contextref="From2024-04-01to2024-09-30"
                        id="Fact001933" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,089
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OperatingIncomeLoss" contextref="From2023-04-012023-09-30" id="Fact001934"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">4,426</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_402_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zhS0UdphjKu1"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Other income (expense):</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40D_eus-gaap--InterestExpenseNonoperating_i01N_di_zEnYb4pgsyw2"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Interest expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:InterestExpenseNonoperating"
                        contextref="From2024-07-012024-09-30" id="Fact001941" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">26</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:InterestExpenseNonoperating"
                        contextref="From2023-07-012023-09-30" id="Fact001942" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">155</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:InterestExpenseNonoperating"
                        contextref="From2024-04-01to2024-09-30" id="Fact001943" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">161</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:InterestExpenseNonoperating"
                        contextref="From2023-04-012023-09-30" id="Fact001944" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">275</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_406_eus-gaap--OtherNonoperatingIncomeExpense_i01_zSHewFnKjKv"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other income (expense), net</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherNonoperatingIncomeExpense" contextref="From2024-07-012024-09-30"
                        id="Fact001946" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,761
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:OtherNonoperatingIncomeExpense" contextref="From2023-07-012023-09-30"
                        id="Fact001947" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">271
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherNonoperatingIncomeExpense" contextref="From2024-04-01to2024-09-30"
                        id="Fact001948" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">414
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherNonoperatingIncomeExpense" contextref="From2023-04-012023-09-30"
                        id="Fact001949" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">418
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_409_eus-gaap--NonoperatingIncomeExpense_i01T_zMrv1lXpex9c"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Total other income (expense)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:NonoperatingIncomeExpense" contextref="From2024-07-012024-09-30" id="Fact001951"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,787</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:NonoperatingIncomeExpense" contextref="From2023-07-012023-09-30"
                        id="Fact001952" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">116
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:NonoperatingIncomeExpense" contextref="From2024-04-01to2024-09-30" id="Fact001953"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">575</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:NonoperatingIncomeExpense" contextref="From2023-04-012023-09-30" id="Fact001954"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">693</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_zgN4lxn0nF9l"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Income (loss) before income taxes</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction
                        name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
                        contextref="From2024-07-012024-09-30" id="Fact001956" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">101</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
                        contextref="From2023-07-012023-09-30" id="Fact001957" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">2,432</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction
                        name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
                        contextref="From2024-04-01to2024-09-30" id="Fact001958" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">514</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
                        contextref="From2023-04-012023-09-30" id="Fact001959" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">5,119</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_409_eus-gaap--IncomeTaxExpenseBenefit_ziL35GxjJWS6"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" contextref="From2024-07-012024-09-30"
                        id="Fact001961" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">335
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" contextref="From2023-07-012023-09-30"
                        id="Fact001962" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">52
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" contextref="From2024-04-01to2024-09-30"
                        id="Fact001963" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,058
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" contextref="From2023-04-012023-09-30"
                        id="Fact001964" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">278
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_404_eus-gaap--NetIncomeLoss_iT_zRrqCrYkvoV"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:NetIncomeLoss" contextref="From2024-07-012024-09-30" id="Fact001966"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">234</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:NetIncomeLoss" contextref="From2023-07-012023-09-30" id="Fact001967"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">2,484</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:NetIncomeLoss" contextref="From2024-04-01to2024-09-30" id="Fact001968"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">544</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:NetIncomeLoss" contextref="From2023-04-012023-09-30" id="Fact001969"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">5,397</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td>&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Net loss per share, basic and diluted</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right"><span
                        id="xdx_90D_eus-gaap--EarningsPerShareBasic_pid_c20240701__20240930_zs0mguiyGVk6"
                        title="Net loss per share, basic"
                        class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span
                            id="xdx_906_eus-gaap--EarningsPerShareDiluted_pid_c20240701__20240930_z6xwdLQfD9G1"
                            title="Net loss per share, diluted"
                            class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(
                            <ix:nonfraction name="us-gaap:EarningsPerShareBasic" contextref="From2024-07-012024-09-30"
                                id="Fact001971" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">
                                <ix:nonfraction name="us-gaap:EarningsPerShareDiluted"
                                    contextref="From2024-07-012024-09-30" id="Fact001973" format="ixt:numdotdecimal"
                                    decimals="INF" sign="-" unitref="USDPShares">0.01</ix:nonfraction>
                            </ix:nonfraction></span></span></td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right"><span
                        id="xdx_904_eus-gaap--EarningsPerShareBasic_pid_c20230701__20230930_zlnqKkqw5RA4"
                        title="Net loss per share, basic"
                        class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span
                            id="xdx_906_eus-gaap--EarningsPerShareDiluted_pid_c20230701__20230930_zIscl7EqzSj2"
                            title="Net loss per share, diluted"
                            class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(
                            <ix:nonfraction name="us-gaap:EarningsPerShareBasic" contextref="From2023-07-012023-09-30"
                                id="Fact001975" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">
                                <ix:nonfraction name="us-gaap:EarningsPerShareDiluted"
                                    contextref="From2023-07-012023-09-30" id="Fact001977" format="ixt:numdotdecimal"
                                    decimals="INF" sign="-" unitref="USDPShares">0.10</ix:nonfraction>
                            </ix:nonfraction></span></span></td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right"><span
                        id="xdx_90D_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240930_zUCq2WkRUKGk"
                        title="Net loss per share, basic"
                        class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span
                            id="xdx_905_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240930_zp89h3byaDdc"
                            title="Net loss per share, diluted"
                            class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(
                            <ix:nonfraction name="us-gaap:EarningsPerShareBasic" contextref="From2024-04-01to2024-09-30"
                                id="Fact001979" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">
                                <ix:nonfraction name="us-gaap:EarningsPerShareDiluted"
                                    contextref="From2024-04-01to2024-09-30" id="Fact001981" format="ixt:numdotdecimal"
                                    decimals="INF" sign="-" unitref="USDPShares">0.02</ix:nonfraction>
                            </ix:nonfraction></span></span></td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right"><span
                        id="xdx_90F_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230930_zxgMhsMRGKub"
                        title="Net loss per share, basic"
                        class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span
                            id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230930_za3CVvDUEvqd"
                            title="Net loss per share, diluted"
                            class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(
                            <ix:nonfraction name="us-gaap:EarningsPerShareBasic" contextref="From2023-04-012023-09-30"
                                id="Fact001983" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">
                                <ix:nonfraction name="us-gaap:EarningsPerShareDiluted"
                                    contextref="From2023-04-012023-09-30" id="Fact001985" format="ixt:numdotdecimal"
                                    decimals="INF" sign="-" unitref="USDPShares">0.22</ix:nonfraction>
                            </ix:nonfraction></span></span></td>
                <td style="text-align: left">)</td>
            </tr>
            <tr style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Weighted average common shares outstanding, basic and
                    diluted</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span
                        id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20240930_zr15BKBhIOIi"
                        title="Weighted-average shares outstanding, basic"
                        class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span
                            id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240701__20240930_zS2a4R99oqY4"
                            title="Weighted-average shares outstanding, diluted"
                            class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">
                            <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                contextref="From2024-07-012024-09-30" id="Fact001987" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="Shares">
                                <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                    contextref="From2024-07-012024-09-30" id="Fact001989" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="Shares">34,545</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span
                        id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930_zYWjn5BfsHri"
                        title="Weighted-average shares outstanding, basic"
                        class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span
                            id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930_zpM8q3qdXRI4"
                            title="Weighted-average shares outstanding, diluted"
                            class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">
                            <ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"
                                contextref="From2023-07-012023-09-30" id="Fact001991" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="Shares">
                                <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                    contextref="From2023-07-012023-09-30" id="Fact001993" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="Shares">25,000</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span
                        id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20240401__20240930_zSIRPWew3ss6"
                        title="Weighted-average shares outstanding, basic"
                        class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span
                            id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20240401__20240930_z3wS3DiKOg9h"
                            title="Weighted-average shares outstanding, diluted"
                            class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">
                            <ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"
                                contextref="From2024-04-01to2024-09-30" id="Fact001995" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="Shares">
                                <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                    contextref="From2024-04-01to2024-09-30" id="Fact001997" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="Shares">34,545</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span
                        id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230401__20230930_zQXoq2igOaT4"
                        title="Weighted-average shares outstanding, basic"
                        class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span
                            id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230401__20230930_zjqRkxYscRvc"
                            title="Weighted-average shares outstanding, diluted"
                            class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">
                            <ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"
                                contextref="From2023-04-012023-09-30" id="Fact001999" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="Shares">
                                <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                    contextref="From2023-04-012023-09-30" id="Fact002001" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="Shares">25,000</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 133 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_003"></span>DIH
                HOLDING US, INC.</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
                CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)
                (in thousands)</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <table cellpadding="0" cellspacing="0" id="xdx_30F_113_pn3n3_zVCAmmLwMgA6"
        summary="xdx: Statement - Condensed Consolidated Statements of Comprehensive Loss"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="display: none; vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_493_20240701__20240930_zIiFADHKH468"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_49B_20230701__20230930_zf9YTuTjyoFi"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_490_20240401__20240930_zIrYDSvPZvF1"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_499_20230401__20230930_zS4QrEOWyfrb"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the
                    Three Months Ended September
                    30,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the
                    Six Months Ended September
                    30,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_404_eus-gaap--NetIncomeLoss_zWosHvtZfNea"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 40%; text-align: left">Net loss</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 11%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2024-07-012024-09-30" id="Fact002003" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">234</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 11%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2023-07-012023-09-30" id="Fact002004" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">2,484</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 11%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2024-04-01to2024-09-30" id="Fact002005" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">544</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 11%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2023-04-012023-09-30" id="Fact002006" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">5,397</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
            </tr>
            <tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParentAbstract_iB_zSGt6xNS2IZg"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Other comprehensive (loss) income, net of tax</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40A_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_i01_zwWkdTAX1dh6"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Foreign currency translation adjustments, net of tax of
                    $<span
                        id="xdx_90D_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_pn3n3_c20240401__20240930_zWG4rkJlVbWh"
                        title="Foreign currency translation adjustments, net of tax"><span
                            id="xdx_903_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_pn3n3_c20230401__20230930_z50893GpOinj"
                            title="Foreign currency translation adjustments, net of tax">
                            <ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"
                                contextref="From2024-04-01to2024-09-30" id="Fact002018" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">
                                <ix:nonfraction
                                    name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"
                                    contextref="From2023-04-012023-09-30" id="Fact002020" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">0</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span></td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"
                        contextref="From2024-07-012024-09-30" id="Fact002013" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">454</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"
                        contextref="From2023-07-012023-09-30" id="Fact002014" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">601</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"
                        contextref="From2024-04-01to2024-09-30" id="Fact002015" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">934</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"
                        contextref="From2023-04-012023-09-30" id="Fact002016" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">240</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40E_eus-gaap--OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_i01N_di_zNcn3UF62Td6"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Pension liability adjustments, net
                    of tax of $<span
                        id="xdx_908_eus-gaap--OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_pn3n3_c20240401__20240930_z1Ozoa5qAsP4"
                        title="Pension liability adjustments, net of tax"><span
                            id="xdx_90D_eus-gaap--OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_pn3n3_c20230401__20230930_zuo2rhMcmfJ4"
                            title="Pension liability adjustments, net of tax">
                            <ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"
                                contextref="From2024-04-01to2024-09-30" id="Fact002027" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">
                                <ix:nonfraction
                                    name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"
                                    contextref="From2023-04-012023-09-30" id="Fact002029" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">0</ix:nonfraction>
                            </ix:nonfraction>
                        </span></span></td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
                        contextref="From2024-07-012024-09-30" id="Fact002022" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">562</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
                        contextref="From2023-07-012023-09-30" id="Fact002023" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">60</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
                        contextref="From2024-04-01to2024-09-30" id="Fact002024" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,081</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
                        contextref="From2023-04-012023-09-30" id="Fact002025" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">360</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_400_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_i01T_zSjN4DshFXMb"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other comprehensive (loss) income
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"
                        contextref="From2024-07-012024-09-30" id="Fact002031" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">108</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"
                        contextref="From2023-07-012023-09-30" id="Fact002032" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">541</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"
                        contextref="From2024-04-01to2024-09-30" id="Fact002033" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">2,015</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"
                        contextref="From2023-04-012023-09-30" id="Fact002034" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">120</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_40F_eus-gaap--ComprehensiveIncomeNetOfTax_iT_zEXcPr5oY292"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 2.5pt">Comprehensive loss</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:ComprehensiveIncomeNetOfTax" contextref="From2024-07-012024-09-30" id="Fact002036"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">342</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:ComprehensiveIncomeNetOfTax" contextref="From2023-07-012023-09-30" id="Fact002037"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">3,025</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:ComprehensiveIncomeNetOfTax" contextref="From2024-04-01to2024-09-30"
                        id="Fact002038" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">2,559
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:ComprehensiveIncomeNetOfTax" contextref="From2023-04-012023-09-30" id="Fact002039"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">5,517</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&nbsp;</i></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
            accompanying notes to the condensed consolidated financial statements.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 134 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_004"></span>DIH
                HOLDING US, INC.</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
                <span style="background-color: white">CONSOLIDATED STATEMENTS OF STOCKHOLDERS� DEFICIT</span></b></span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)
                (in thousands, except share data)</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <table cellpadding="0" cellspacing="0" id="xdx_30E_114_pn3n3_zhtS88mNobb7"
        summary="xdx: Statement - Condensed Consolidated Statements of Stockholders&#39; Deficit"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="display: none; vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Shares</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2"
                    id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zPwkgGiYQdE6"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">Amount</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2"
                    id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zYqnNmpQMkbb"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">Additional Paid-In Capital</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2"
                    id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zJ9u98MB8Vyb"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated Deficit</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2"
                    id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zTxT9FFTUZGd"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated Other Comprehensive
                    Income (Loss)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_4BE_zXeak7OYW3tf"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">Total Equity (Deficit)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the
                    Three Months Ended September
                    30,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common
                    Stock</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Additional
                    Paid-In Capital</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    Accumulated Deficit</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    Accumulated Other Comprehensive
                    Income (Loss)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total
                    Equity (Deficit)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_432_c20240701__20240930_eus-gaap--StockholdersEquity_iS_zfBE5UN8rFD2"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 40%; font-weight: bold">Balance, June 30, 2024</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYxbVwQnJgMj"
                    title="Balance, shares" style="width: 6%; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact002047" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">34,544,935</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact002041" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">3</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002042"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,323</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact002043"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">35,522
                    </ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002044"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,857</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-06-30" id="Fact002045" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        sign="-" unitref="USD">34,053</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
            </tr>
            <tr id="xdx_404_eus-gaap--NetIncomeLoss_zVImXKrvFlW5"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Net loss</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2049">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2050">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="Fact002051"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">234</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2052">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2024-07-012024-09-30" id="Fact002053" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">234</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_400_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_iN_di_zgzBOfpokbHl"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt">Other comprehensive loss, net of tax</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">�</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2055">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2056">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2057">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                        contextref="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                        id="Fact002058" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">108
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextref="From2024-07-012024-09-30"
                        id="Fact002059" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">108
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_43F_c20240701__20240930_eus-gaap--StockholdersEquity_iE_zU3OrbMgkAT3"
                style="vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; padding-bottom: 1pt">Balance, September 30, 2024</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td id="xdx_981_eus-gaap--SharesOutstanding_iE_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOhwUJFHzBlk"
                    title="Balance, shares" style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact002067" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">34,544,935</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact002061" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">3</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002062"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,323</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2024-09-30_us-gaap_RetainedEarningsMember"
                        id="Fact002063" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">35,756
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002064"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,965</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2024-09-30" id="Fact002065"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">34,395
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
        </tbody>
    </table>


    <p style="margin: 0">&nbsp;</p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b><sup>(1)</sup></span>
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Additional
                    Paid-In Capital</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    Accumulated Deficit</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    Accumulated Other Comprehensive
                    Income (Loss)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total
                    Equity (Deficit)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_435_c20230701__20230930_eus-gaap--StockholdersEquity_iS_zjdHJzQT4FR2"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 40%; font-weight: bold">Balance, June 30, 2023</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td id="xdx_988_eus-gaap--SharesOutstanding_iS_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zVwh9ZUzzg81"
                    title="Balance, shares" style="width: 6%; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact002075" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">25,000,000</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact002069" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">2</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002070"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,898</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact002071"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">29,682
                    </ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002072"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">132</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-06-30" id="Fact002073" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        sign="-" unitref="USD">31,446</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
            </tr>
            <tr id="xdx_404_eus-gaap--NetIncomeLoss_zt8K78LESjW5"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Net loss</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2077">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2078">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="Fact002079"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">2,484</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2080">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2023-07-012023-09-30" id="Fact002081" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">2,484</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_400_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_iN_di_zhdWlunSsDhd"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt">Other comprehensive loss, net of tax</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">�</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2083">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2084">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2085">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                        contextref="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                        id="Fact002086" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">541
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextref="From2023-07-012023-09-30"
                        id="Fact002087" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">541
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_435_c20230701__20230930_eus-gaap--StockholdersEquity_iE_zgqcjPwIGBL1"
                style="vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; padding-bottom: 1pt">Balance, September 30, 2023</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zT8jcutfZEQe"
                    title="Balance, shares" style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact002095" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">25,000,000</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact002089" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">2</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002090"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,898</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
                        id="Fact002091" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">32,166
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002092"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">409</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2023-09-30" id="Fact002093"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">34,471
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
        </tbody>
    </table>

    <p
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%">
        <tbody>
            <tr style="vertical-align: top; text-align: justify">
                <td style="width: 15pt; text-align: right"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
                <td style="width: 5pt"></td>
                <td style="text-align: justify"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All outstanding
                        share and per-share amounts have been restated to reflect the reverse recapitalization as
                        established in the Business Combination Agreement
                        as described in Note 1.</span></td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 135 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIH
                HOLDING US, INC.</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
                <span style="background-color: white">CONSOLIDATED STATEMENTS OF STOCKHOLDERS� DEFICIT</span></b></span>
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)
                (in thousands, except share data)</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the
                    Six Months Ended September
                    30,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common
                    Stock</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="text-align: center">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td>&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Additional
                    Paid-In Capital</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    Accumulated Deficit</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    Accumulated Other Comprehensive
                    Income (Loss)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total
                    Equity (Deficit)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_436_c20240401__20240930_eus-gaap--StockholdersEquity_iS_zjxHFELyyrE2"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 40%; font-weight: bold">Balance, March 31, 2024</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20240401__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcwktMDNRlM3"
                    title="Balance, shares" style="width: 6%; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact002103" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">34,544,935</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact002097" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">3</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002098"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,613</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-03-31_us-gaap_RetainedEarningsMember" id="Fact002099"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">35,212
                    </ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002100"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">50</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-03-31" id="Fact002101" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        sign="-" unitref="USD">32,546</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
            </tr>
            <tr id="xdx_404_eus-gaap--NetIncomeLoss_zgIhxeikaxc2"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Net loss</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2105">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2106">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2024-04-012024-09-30_us-gaap_RetainedEarningsMember" id="Fact002107"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">544</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2108">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2024-04-01to2024-09-30" id="Fact002109" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">544</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_402_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_zeHQrtI912hj"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Out of period adjustment related to reverse recapitalization (Note 2)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2111">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"
                        contextref="From2024-04-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002112"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">710</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2113">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2114">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"
                        contextref="From2024-04-01to2024-09-30" id="Fact002115" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">710</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_iN_di_zRbo8NjUEIZf"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Other comprehensive loss, net of tax</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">�</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2117">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2118">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2119">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                        contextref="From2024-04-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                        id="Fact002120" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,015
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextref="From2024-04-01to2024-09-30"
                        id="Fact002121" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,015
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_438_c20240401__20240930_eus-gaap--StockholdersEquity_iE_zUR2B9IVHMWd"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, September 30, 2024</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20240401__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLlhtoYna272"
                    title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact002129" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">34,544,935</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact002123" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">3</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002124"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,323</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2024-09-30_us-gaap_RetainedEarningsMember"
                        id="Fact002125" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">35,756
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002126"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,965</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2024-09-30" id="Fact002127"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">34,395
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
            </tr>
        </tbody>
    </table>


    <p style="margin: 0">&nbsp;</p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b><sup>(1)</sup></span>
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount
                </td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Additional
                    Paid-In Capital</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    Accumulated Deficit</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                    Accumulated Other Comprehensive
                    Income (Loss)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total
                    Equity (Deficit)</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_43D_c20230401__20230930_eus-gaap--StockholdersEquity_iS_zCTbeLnxDMlh"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="width: 40%; font-weight: bold">Balance, March 31, 2023</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20230401__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zYblwgzioQue"
                    title="Balance, shares" style="width: 6%; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact002137" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">25,000,000</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact002131" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">2</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">&nbsp;</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002132"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,898</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_RetainedEarningsMember" id="Fact002133"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">26,769
                    </ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002134"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">289</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 6%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31" id="Fact002135" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        sign="-" unitref="USD">28,954</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
            </tr>
            <tr id="xdx_43C_c20230401__20230930_eus-gaap--StockholdersEquity_iS_zBOSl8oNSXTc"
                style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold">Balance</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20230401__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zQ6biN6I9Eo9"
                    title="Balance, shares" style="text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact002145" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">25,000,000</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact002139" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">2</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact002140"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,898</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_RetainedEarningsMember" id="Fact002141"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">26,769
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002142"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">289</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-03-31" id="Fact002143" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        sign="-" unitref="USD">28,954</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_404_eus-gaap--NetIncomeLoss_zbbJqUOKaqJk"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Net loss</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">�</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2147">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2148">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2023-04-012023-09-30_us-gaap_RetainedEarningsMember" id="Fact002149"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">5,397</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2150">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2023-04-012023-09-30" id="Fact002151" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">5,397</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_iN_di_z5QmJ44UNRvc"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt">Other comprehensive loss, net of tax</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">�</td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2153">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2154">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2155">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                        contextref="From2023-04-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                        id="Fact002156" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">120
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextref="From2023-04-012023-09-30"
                        id="Fact002157" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">120
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_43B_c20230401__20230930_eus-gaap--StockholdersEquity_iE_zLl1rW3hxbXh"
                style="vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, September 30, 2023</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td id="xdx_982_eus-gaap--SharesOutstanding_iE_pid_c20230401__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_zRAPIN2cu3Nk"
                    title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact002165" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">25,000,000</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact002159" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">2</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002160"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,898</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
                        id="Fact002161" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">32,166
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002162"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">409</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2023-09-30" id="Fact002163"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">34,471
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_43C_c20230401__20230930_eus-gaap--StockholdersEquity_iE_zMcOzI8GTr89"
                style="display: none; vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; padding-bottom: 2.5pt">Balance</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                <td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20230401__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKDEp_ztMwdv4WzEyk"
                    title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:SharesOutstanding"
                        contextref="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact002173" format="ixt:numdotdecimal"
                        decimals="INF" unitref="Shares">25,000,000</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact002167" format="ixt:numdotdecimal"
                        decimals="-3" scale="3" unitref="USD">2</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002168"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">1,898</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
                        id="Fact002169" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">32,166
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity"
                        contextref="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002170"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">409</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                        name="us-gaap:StockholdersEquity" contextref="AsOf2023-09-30" id="Fact002171"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">34,471
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">)</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <table cellpadding="0" cellspacing="0"
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%">
        <tbody>
            <tr style="vertical-align: top; text-align: justify">
                <td style="width: 15pt; text-align: right"><span id="xdx_F0E_zhLfSwT9Gfkf"
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1).</span></td>
                <td style="width: 5pt"></td>
                <td style="text-align: justify"><span id="xdx_F1E_zdw5QOf5Ojt2"
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                        <ix:footnote id="Footnote002174" xml:lang="en-US">All outstanding
                            share and per-share amounts have been restated to reflect the reverse recapitalization as
                            established in the Business Combination Agreement
                            as described in Note 1.</ix:footnote>
                    </span></td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 136 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_005"></span>DIH
                HOLDING US, INC.</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
                CONSOLIDATED STATEMENTS OF CASH FLOWS</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)
                (in thousands)</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <table cellpadding="0" cellspacing="0" id="xdx_307_112_pn3n3_zPXbGBpX1jC6"
        summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows"
        style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
        <tbody>
            <tr style="display: none; vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_494_20240401__20240930_zDw3eraN4kY9"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" id="xdx_49A_20230401__20230930_z1WsVz9MKntg"
                    style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the
                    Six Months Ended September
                    30,</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr style="vertical-align: bottom">
                <td style="text-align: center">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_z0eOFWocKolb"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_405_eus-gaap--NetIncomeLoss_zpFhIoaX0oj1"
                style="vertical-align: bottom; background-color: White">
                <td style="width: 60%; text-align: left">Net loss</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2024-04-01to2024-09-30" id="Fact002179" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">544</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
                <td style="width: 2%">&nbsp;</td>
                <td style="width: 1%; text-align: left">$</td>
                <td style="width: 16%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                        contextref="From2023-04-012023-09-30" id="Fact002180" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">5,397</ix:nonfraction>
                </td>
                <td style="width: 1%; text-align: left">)</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zOSdxzUfEOIb"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Adjustments to reconcile net loss to net cash provided by operating
                    activities:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40A_eus-gaap--DepreciationDepletionAndAmortization_i02_zPEdobQRIze2"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:DepreciationDepletionAndAmortization"
                        contextref="From2024-04-01to2024-09-30" id="Fact002185" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">351</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:DepreciationDepletionAndAmortization"
                        contextref="From2023-04-012023-09-30" id="Fact002186" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">147</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40F_eus-gaap--ProvisionForDoubtfulAccounts_i02_z6YmIVwuEM6h"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Provision for credit losses</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:ProvisionForDoubtfulAccounts"
                        contextref="From2024-04-01to2024-09-30" id="Fact002188" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">434</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:ProvisionForDoubtfulAccounts"
                        contextref="From2023-04-012023-09-30" id="Fact002189" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">869</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_401_ecustom--AllowanceForInventoryObsolescence_i02_z8T83YEfNdT4"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Allowance for inventory obsolescence</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="DHAI:AllowanceForInventoryObsolescence"
                        contextref="From2024-04-01to2024-09-30" id="Fact002191" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">108</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:AllowanceForInventoryObsolescence" contextref="From2023-04-012023-09-30"
                        id="Fact002192" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">739
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--PensionContributions_i02N_di_zlOdW2v7STLj"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Pension contributions</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:PensionContributions"
                        contextref="From2024-04-01to2024-09-30" id="Fact002194" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">309</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:PensionContributions"
                        contextref="From2023-04-012023-09-30" id="Fact002195" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">309</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_407_ecustom--PensionIncomeExpense_i02N_di_zSDCs6FO6TDa"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Pension expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:PensionIncomeExpense" contextref="From2024-04-01to2024-09-30"
                        id="Fact002197" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">155
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:PensionIncomeExpense" contextref="From2023-04-012023-09-30"
                        id="Fact002198" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">136
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_402_ecustom--ChangeInFairValueOfConvertibleDebtAndWarrantLiability_i02_zZFRBafb5yTk"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible debt and warrant
                    liability</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:ChangeInFairValueOfConvertibleDebtAndWarrantLiability"
                        contextref="From2024-04-01to2024-09-30" id="Fact002200" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">400</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2201">�</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_403_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i02N_di_zaKcAvsNUyLb"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Foreign exchange (gain) loss</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax"
                        contextref="From2024-04-01to2024-09-30" id="Fact002203" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">38</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax"
                        contextref="From2023-04-012023-09-30" id="Fact002204" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">418</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_408_ecustom--NoncashLeaseExpense_i02_zrhGX07Rt21h"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Noncash lease expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:NoncashLeaseExpense" contextref="From2024-04-01to2024-09-30"
                        id="Fact002206" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">828
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:NoncashLeaseExpense" contextref="From2023-04-012023-09-30"
                        id="Fact002207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">770
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_408_eus-gaap--OtherNoncashExpense_i02_z1EArlz5BnCa"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Noncash interest expense</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2209">�</span></td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:OtherNoncashExpense" contextref="From2023-04-012023-09-30"
                        id="Fact002210" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">14
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_408_ecustom--DeferredAndOtherNoncashIncomeTaxExpenseBenefit_i02_zU6wt1zLyvEa"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Deferred and other noncash income tax (income) expense
                </td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:DeferredAndOtherNoncashIncomeTaxExpenseBenefit"
                        contextref="From2024-04-01to2024-09-30" id="Fact002212" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">112</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:DeferredAndOtherNoncashIncomeTaxExpenseBenefit"
                        contextref="From2023-04-012023-09-30" id="Fact002213" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">12</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zmlyqJfgU4Dl"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left">Changes in operating assets and liabilities:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_eus-gaap--IncreaseDecreaseInAccountsReceivable_i02N_di_zvbzPlWPVR15"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Accounts receivable</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInAccountsReceivable"
                        contextref="From2024-04-01to2024-09-30" id="Fact002218" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">694</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInAccountsReceivable"
                        contextref="From2023-04-012023-09-30" id="Fact002219" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">2,149</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--IncreaseDecreaseInInventories_i02N_di_zqgB0J9ywc88"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt">Inventories</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInInventories"
                        contextref="From2024-04-01to2024-09-30" id="Fact002221" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,527</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInInventories"
                        contextref="From2023-04-012023-09-30" id="Fact002222" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,528</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInDueFromRelatedPartiesCurrent_i02N_di_zDX9m9XElTeb"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Due from related parties</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent"
                        contextref="From2024-04-01to2024-09-30" id="Fact002224" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">548</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent"
                        contextref="From2023-04-012023-09-30" id="Fact002225" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">343</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_ecustom--IncreaseDecreaseInDueToRelatedPartyCurrent_i02_zYAvt5z2wOB9"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Due to related parties</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="DHAI:IncreaseDecreaseInDueToRelatedPartyCurrent"
                        contextref="From2024-04-01to2024-09-30" id="Fact002227" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">98</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:IncreaseDecreaseInDueToRelatedPartyCurrent"
                        contextref="From2023-04-012023-09-30" id="Fact002228" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">988</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_eus-gaap--IncreaseDecreaseInOtherOperatingAssets_i02N_di_z7kMVhY2iyzh"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Other assets</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets"
                        contextref="From2024-04-01to2024-09-30" id="Fact002230" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">481</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets"
                        contextref="From2023-04-012023-09-30" id="Fact002231" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,350</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_402_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i02_zxoaDEByhyfh"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Operating lease liabilities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability"
                        contextref="From2024-04-01to2024-09-30" id="Fact002233" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">820</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability"
                        contextref="From2023-04-012023-09-30" id="Fact002234" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">957</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInAccountsPayable_i02_zumzHd6Xu6Y8"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Accounts payable</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInAccountsPayable"
                        contextref="From2024-04-01to2024-09-30" id="Fact002236" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">813</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInAccountsPayable"
                        contextref="From2023-04-012023-09-30" id="Fact002237" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,764</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_401_eus-gaap--IncreaseDecreaseInEmployeeRelatedLiabilities_i02_zRKVB0S8dJU3"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Employee compensation</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities"
                        contextref="From2024-04-01to2024-09-30" id="Fact002239" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,070</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities"
                        contextref="From2023-04-012023-09-30" id="Fact002240" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">59</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_408_eus-gaap--IncreaseDecreaseInOtherNoncurrentLiabilities_i02_zF1qds5w3yi2"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Other liabilities</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities"
                        contextref="From2024-04-01to2024-09-30" id="Fact002242" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">247</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities"
                        contextref="From2023-04-012023-09-30" id="Fact002243" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">197</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_401_eus-gaap--IncreaseDecreaseInDeferredRevenue_i02_zaf8pcADP7y"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Deferred revenue</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInDeferredRevenue"
                        contextref="From2024-04-01to2024-09-30" id="Fact002245" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">846</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInDeferredRevenue"
                        contextref="From2023-04-012023-09-30" id="Fact002246" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,265</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40B_ecustom--IncreaseDecreaseInManufacturingWarrantyObligation_i02_zSycW1nUa0x9"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Manufacturing warranty obligation</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:IncreaseDecreaseInManufacturingWarrantyObligation"
                        contextref="From2024-04-01to2024-09-30" id="Fact002248" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">100</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:IncreaseDecreaseInManufacturingWarrantyObligation"
                        contextref="From2023-04-012023-09-30" id="Fact002249" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">180</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i02_zVN8mgfKSmW"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left">Advance payments from customers</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability"
                        contextref="From2024-04-01to2024-09-30" id="Fact002251" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">1,737</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability"
                        contextref="From2023-04-012023-09-30" id="Fact002252" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">2,591</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_ecustom--IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities_i02_zGW9KkFQ2Lp2"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accrued expense and other current
                    liabilities</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="DHAI:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities"
                        contextref="From2024-04-01to2024-09-30" id="Fact002254" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,376</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="DHAI:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities"
                        contextref="From2023-04-012023-09-30" id="Fact002255" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">519</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_zUHbIqWMS4C"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Net cash provided by (used in) operating activities
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:NetCashProvidedByUsedInOperatingActivities"
                        contextref="From2024-04-01to2024-09-30" id="Fact002257" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">1,534</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities"
                        contextref="From2023-04-012023-09-30" id="Fact002258" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">1,763</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zNc00vi0I0rg"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_403_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_zkOOvHD6FNw4"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Purchases of property and
                    equipment</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"
                        contextref="From2024-04-01to2024-09-30" id="Fact002263" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">423</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextref="From2023-04-012023-09-30"
                        id="Fact002264" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">73
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_zgR4rM9TLFpb"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:NetCashProvidedByUsedInInvestingActivities"
                        contextref="From2024-04-01to2024-09-30" id="Fact002266" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">423</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextref="From2023-04-012023-09-30"
                        id="Fact002267" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">73
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zcbk0olvx2v7"
                style="vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40A_ecustom--ProceedsFromIssuanceOfConvertibleNoteNetOfIssuanceCosts_i01N_di_zXwwLwRx3mf5"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 10pt; text-align: left">Proceeds from issuance of convertible debt, net of
                    issuance costs</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">
                    <ix:nonfraction name="DHAI:ProceedsFromIssuanceOfConvertibleNoteNetOfIssuanceCosts"
                        contextref="From2024-04-01to2024-09-30" id="Fact002272" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">2,809</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2273">�</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40F_eus-gaap--RepaymentsOfRelatedPartyDebt_i01N_di_zUlJ3d124Cp"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Payments on related party notes
                    payable</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:RepaymentsOfRelatedPartyDebt" contextref="From2024-04-01to2024-09-30"
                        id="Fact002275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,053
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:RepaymentsOfRelatedPartyDebt" contextref="From2023-04-012023-09-30"
                        id="Fact002276" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,744
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_zUv4OpoCmcN2"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 1pt">Net cash provided by (used in) financing activities
                </td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities"
                        contextref="From2024-04-01to2024-09-30" id="Fact002278" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">756</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                        name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextref="From2023-04-012023-09-30"
                        id="Fact002279" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">3,744
                    </ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">)</td>
            </tr>
            <tr id="xdx_40E_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_zSbwQ8pXBQfc"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Effect of currency translation on cash and cash
                    equivalents</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="From2024-04-01to2024-09-30" id="Fact002281" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">35</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="From2023-04-012023-09-30" id="Fact002282" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">15</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_zkbwfLjjduh8"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Net decrease in cash, and cash equivalents, and restricted cash</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"
                        contextref="From2024-04-01to2024-09-30" id="Fact002284" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">1,166</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">(<ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"
                        contextref="From2023-04-012023-09-30" id="Fact002285" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" sign="-" unitref="USD">2,039</ix:nonfraction>
                </td>
                <td style="text-align: left">)</td>
            </tr>
            <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_ziZRckgBGUVl"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Cash, cash equivalents and restricted cash - beginning
                    of period</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="AsOf2024-03-31" id="Fact002287" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">3,225</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="AsOf2023-03-31" id="Fact002288" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">3,175</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zwKg5i9L6r9e"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt">Cash, cash equivalents and restricted cash- end of
                    period</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="AsOf2024-09-30" id="Fact002290" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">2,059</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="AsOf2023-09-30" id="Fact002291" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">1,136</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_401_eus-gaap--RestrictedCashAndCashEquivalentsAbstract_iB_zOZk92ZD7ACb"
                style="vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; text-align: left">Reconciliation of cash, cash equivalents and restricted
                    cash:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iE_z5metl9sulMd"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left">Cash and cash equivalents</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextref="AsOf2024-09-30"
                        id="Fact002296" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,759
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextref="AsOf2023-09-30"
                        id="Fact002297" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,136
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_400_eus-gaap--RestrictedCash_iE_zaRUhLDQh4wj"
                style="vertical-align: bottom; background-color: White">
                <td style="text-align: left; padding-bottom: 1pt">Restricted cash</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right">
                    <ix:nonfraction name="us-gaap:RestrictedCash" contextref="AsOf2024-09-30" id="Fact002299"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">300</ix:nonfraction>
                </td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 1pt">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                <td style="border-bottom: Black 1pt solid; text-align: right"><span
                        style="-sec-ix-hidden: xdx2ixbrl2300">�</span></td>
                <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_z85cJUIrRon9"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="text-align: left; padding-bottom: 2.5pt">Total cash, cash equivalents and restricted cash
                </td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="AsOf2024-09-30" id="Fact002302" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">2,059</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                <td style="padding-bottom: 2.5pt">&nbsp;</td>
                <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                <td style="border-bottom: Black 2.5pt double; text-align: right">
                    <ix:nonfraction
                        name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"
                        contextref="AsOf2023-09-30" id="Fact002303" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">1,136</ix:nonfraction>
                </td>
                <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--SupplementalCashFlowInformationAbstract_iB_z6NzPZFYT50c"
                style="vertical-align: bottom; background-color: White">
                <td style="font-weight: bold; text-align: left">Supplemental disclosure of cash flow information:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40F_eus-gaap--InterestPaidNet_i01_zgQKh8udPSw"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="padding-left: 20pt; text-align: left">Interest paid</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:InterestPaidNet" contextref="From2024-04-01to2024-09-30"
                        id="Fact002308" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">162
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:InterestPaidNet" contextref="From2023-04-012023-09-30" id="Fact002309"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">262</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_406_eus-gaap--IncomeTaxesPaidNet_i01_z41dvJXvpGr3"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 20pt; text-align: left">Income tax paid</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:IncomeTaxesPaidNet" contextref="From2024-04-01to2024-09-30"
                        id="Fact002311" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">15
                    </ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2312">�</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_409_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zWwhucjO77a6"
                style="vertical-align: bottom; background-color: rgb(204,238,255)">
                <td style="font-weight: bold; text-align: left">Supplemental disclosure of non-cash investing and
                    financing activity:</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
                <td style="text-align: right">&nbsp;</td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
            <tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_i01_zhBDafzVQcJj"
                style="vertical-align: bottom; background-color: White">
                <td style="padding-left: 20pt; text-align: left">Out of period adjustment related to reverse
                    recapitalization (Note 2)</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right">
                    <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"
                        contextref="From2024-04-01to2024-09-30" id="Fact002317" format="ixt:numdotdecimal" decimals="-3"
                        scale="3" unitref="USD">710</ix:nonfraction>
                </td>
                <td style="text-align: left">&nbsp;</td>
                <td>&nbsp;</td>
                <td style="text-align: left">$</td>
                <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2318">�</span></td>
                <td style="text-align: left">&nbsp;</td>
            </tr>
        </tbody>
    </table>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
            accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 137 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p id="xdx_040_c20240401__20240930_z1XxokkdBVZa"
        style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_006"></span>DIH
                HOLDING US, INC. AND SUBSIDIARIES</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
                TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)
                (in thousands, except share and per share data)</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002320"
        name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
        <p id="xdx_806_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zttLkMqxkTY3"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_827_zfpfOcCuiVi5">Business and Organization</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Description
                        of Business</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIH
                Holding US, Inc., a Delaware corporation and its consolidated subsidiaries are referred to in this Form
                10-Q as �we,� �our,�
                �us,� the �Company,� or �DIH.� DIH is a global provider of advanced robotic devices used in physical
                rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical
                research and intensive functional rehabilitation
                and training in patients with walking impairments, reduced balance and/or impaired arm and hand
                functions. The Company�s fiscal
                year ends on March 31.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merger/Business
                        Combination with Aurora Technology Acquisition Corp.</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                February 7, 2024 (the �Closing Date�), ATAK, Aurora Technology Merger Sub (�Merger Sub�) and DIH Holding
                US,
                Inc., a Nevada corporation (�Legacy DIH� or �DIH Nevada�) consummated a previously announced business
                combination
                pursuant to a business agreement dated as of February 26, 2023 (as amended, supplemented or otherwise
                modified from time to time, the
                �Business Combination Agreement,� and the transactions contemplated thereby, the �Business Combination�)
                following
                the receipt of the required approval by ATAK�s and DIH Nevada�s shareholders and the fulfillment or
                waiver of other customary
                closing conditions. Legacy DIH historically existed and functioned as part of the business of DIH
                Technology Ltd. (�DIH Cayman�).
                Upon the closing of the Business Combination, <span style="background-color: white">the Company owns
                    <span
                        id="xdx_90C_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20240207__us-gaap--BusinessAcquisitionAxis__custom--DihNevadaMember_zOYN0OSKTFlh">
                        <ix:nonfraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired"
                            contextref="AsOf2024-02-07_custom_DihNevadaMember" id="Fact002321"
                            format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">100</ix:nonfraction>
                    </span>% of DIH Nevada, which owns <span
                        id="xdx_90B_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20240207__us-gaap--BusinessAcquisitionAxis__custom--DihUsCorporationMember_zf1JavRKnF2b">
                        <ix:nonfraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired"
                            contextref="AsOf2024-02-07_custom_DihUsCorporationMember" id="Fact002322"
                            format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">100</ix:nonfraction>%
                    </span>
                    of DIH US Corp. DIH US Corp owns five commercial entities located in the USA, Chile, Slovenia,
                    Germany, and Singapore. Additionally,
                    the Company owns <span
                        id="xdx_901_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20240207__us-gaap--BusinessAcquisitionAxis__custom--HocomaMedicalGmbhMember_zyqydaKYflB4">
                        <ix:nonfraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired"
                            contextref="AsOf2024-02-07_custom_HocomaMedicalGmbhMember" id="Fact002323"
                            format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">100</ix:nonfraction>
                    </span>% of Hocoma Medical GmbH, which contains the net operating assets used in the manufacturing
                    process of the company�s
                    products. These assets were transferred from Hocoma AG, as of July 1, 2021. The intellectual
                    property (�IP�) of Hocoma AG
                    was transferred to the commercial entity located in the USA. The legal entities of </span>Hocom<span
                    style="background-color: white">a
                    AG and Motekforce Link BV and its subsidiaries (�Motek Group�) remained with DIH Cayman and were
                    excluded from the condensed
                    Consolidated Financial Statements. The Company agreed to use its best efforts to complete the
                    reorganization as defined in the Business
                    Combination Agreement as soon as possible thereafter. The reorganization has not been completed as
                    of the date these financial statements
                    were issued. </span></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                February 8, 2024, the Company entered into a subscription agreement with OrbiMed Asia GP II, L.P., an
                existing shareholder of DIH Cayman. Pursuant
                to the agreement, the Company will issue <span
                    id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240208__20240208__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__srt--TitleOfIndividualAxis__custom--OrbiMedMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zWKql8HhXAKc">
                    <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues"
                        contextref="From2024-02-082024-02-08_us-gaap_CommonClassAMember_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember"
                        id="Fact002324" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">150,000
                    </ix:nonfraction>
                </span></span><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">shares of
                Common Stock
                at a purchase price of $<span
                    id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20240208__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__srt--TitleOfIndividualAxis__custom--OrbiMedMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zvXp38EZBORh">
                    <ix:nonfraction name="us-gaap:SaleOfStockPricePerShare"
                        contextref="AsOf2024-02-08_us-gaap_CommonClassAMember_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember"
                        id="Fact002325" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">10.00
                    </ix:nonfraction>
                </span></span><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">per share
                for aggregate
                purchase price of $<span
                    id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20240208__20240208__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__srt--TitleOfIndividualAxis__custom--OrbiMedMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_z1Mf3jAlYbjl">
                    <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues"
                        contextref="From2024-02-082024-02-08_us-gaap_CommonClassAMember_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember"
                        id="Fact002326" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">1.5
                    </ix:nonfraction>
                </span></span><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">million
                together with
                warrants to purchase an additional <span
                    id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240208__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__srt--TitleOfIndividualAxis__custom--OrbiMedMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zlxv9DGepYtc">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"
                        contextref="AsOf2024-02-08_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember"
                        id="Fact002327" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">300,000
                    </ix:nonfraction>
                </span></span><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">shares of
                DIH Common
                Stock with an exercise price of $<span
                    id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240208__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__srt--TitleOfIndividualAxis__custom--OrbiMedMember__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zfc2r40fph66">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"
                        contextref="AsOf2024-02-08_custom_SubscriptionAgreementMember_custom_OrbiMedMember_custom_DIHHoldingUSIncMember"
                        id="Fact002328" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">10.00
                    </ix:nonfraction>
                </span></span><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">.
                The transaction has not closed as of the date the financial statements were issued. </span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
                        and Going Concern</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                Accounting Standards Codification (�ASC�) 205-40, Going Concern, the Company is required each reporting
                period, to evaluate
                whether there is substantial doubt regarding its ability to continue as a going concern. The
                accompanying condensed consolidated financial
                statements are prepared in accordance with U.S. GAAP applicable to a going concern. This presentation
                contemplates the realization of
                assets and the satisfaction of liabilities in the normal course of business and does not include any
                adjustments that might be necessary
                if it is unable to continue as a going concern.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                of September 30, 2024, the Company had $<span
                    id="xdx_90C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn5n6_c20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zlWKCCTYKZM3"
                    title="Cash and cash equivalents">
                    <ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue"
                        contextref="AsOf2024-09-30_custom_DIHHoldingUSIncMember" id="Fact002330"
                        format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">1.8</ix:nonfraction>
                </span> million in cash and cash equivalents and $<span
                    id="xdx_904_eus-gaap--RestrictedCashCurrent_iI_pn5n6_c20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zxAeyMiOtqIa"
                    title="Restricted cash">
                    <ix:nonfraction name="us-gaap:RestrictedCashCurrent"
                        contextref="AsOf2024-09-30_custom_DIHHoldingUSIncMember" id="Fact002332"
                        format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">0.3</ix:nonfraction>
                </span> million restricted cash. The Company�s
                net losses began in 2020 and continued through the six months ended September 30, 2024. The Company�s
                historical operating losses
                resulted in an accumulated deficit of $<span
                    id="xdx_902_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pn5n6_c20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zbqDP5bTirAi"
                    title="Accumulated deficit">
                    <ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit"
                        contextref="AsOf2024-09-30_custom_DIHHoldingUSIncMember" id="Fact002334"
                        format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">35.8</ix:nonfraction>
                </span> million as of September 30, 2024. Operating losses were mainly driven by decreased sales
                during the COVID-19 pandemic due to social distancing measures that affected demand for rehabilitation
                services, increased expenditures
                in connection with its implementation of a new financial system (Oracle) and increased comp<span
                    style="background-color: white">liance
                    costs associated with the European Union Medical Device Regulation (EU MDR). Additionally, DIH had
                    elevated costs related to efforts
                    of adopting to public company standards. During the six months ended September 30, 2024, the Company
                </span>had negative cash flows from
                operating activities, negative operating results and negative working capital.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                June 6, 2024, the Company issued $<span
                    id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20240606__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_z2twaYQ80dJb"
                    title="Aggregate principal amount">
                    <ix:nonfraction name="us-gaap:DebtInstrumentFaceAmount"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember"
                        id="Fact002336" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">3.3
                    </ix:nonfraction>
                </span>million in principal amount of convertible debt that matures on December 7, 2025. Beginning on
                the November 1, 2024, the Company will be required to redeem a portion of the total amount in cash or in
                shares of Common Stock with
                the election to extend the maturity date by six months as further discussed in Note 12 to the Condensed
                Consolidated Financial Statements.
                The first redemption payment was made in cash on November 1, 2024.</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 138 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company has <span
                    id="xdx_905_ecustom--NumberOfNotesPayableToRelatedParty_dc_uNotePayable_c20240401__20240930_zLeGAiN4XzJl"
                    title="Number of notes payable to related party">
                    <ix:nonfraction name="DHAI:NumberOfNotesPayableToRelatedParty"
                        contextref="From2024-04-01to2024-09-30" id="Fact002338" format="ixt-sec:numwordsen"
                        decimals="INF" unitref="NotePayable">three</ix:nonfraction>
                </span> notes payable to a related party which are included in �Notes payable - related party�. Each
                note is due
                on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20240401__20240930_zfx8k2nnGFUg"
                    title="Debt instrument, maturity date">
                    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" format="ixt:datemonthdayyearen"
                        id="Fact002340" name="us-gaap:DebtInstrumentMaturityDate">June 30, 2026</ix:nonnumeric>
                </span> with an interest rate of <span
                    id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930_zGKESd9L11q6"
                    title="Debt instrument interest rate">
                    <ix:nonfraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage"
                        contextref="AsOf2024-09-30" id="Fact002342" format="ixt:numdotdecimal" decimals="INF" scale="-2"
                        unitref="Pure">1.25</ix:nonfraction>
                </span>% as further discussed in Note 13 to the Condensed Consolidated Financial Statements. The
                Company has made periodic payments on the principal and interests on the notes payable
                historically.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                above conditions raise substantial doubt about the Company�s ability to continue as a going concern
                within one year after the date
                of this filing.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company�s revenue has increased by<span
                    id="xdx_90F_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_dp_uPure_c20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zAwBAFS71R3a"
                    title="Gross rerevenue increased percentage">
                    <ix:nonfraction name="us-gaap:RevenueRemainingPerformanceObligationPercentage"
                        contextref="AsOf2024-09-30_custom_DIHHoldingUSIncMember" id="Fact002344"
                        format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">34.5</ix:nonfraction>
                </span>% to $<span
                    id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240401__20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_z6BUSfs6RjJ5"
                    title="Revenue">
                    <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                        contextref="From2024-04-012024-09-30_custom_DIHHoldingUSIncMember" id="Fact002346"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">35,122</ix:nonfraction>
                </span> from $<span
                    id="xdx_908_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230401__20230930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zHE1r6p1swBk"
                    title="Revenue">
                    <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                        contextref="From2023-04-012023-09-30_custom_DIHHoldingUSIncMember" id="Fact002348"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">26,105</ix:nonfraction>
                </span> for the six months ended September 30, 2024 and 2023, respectively.
                Historically, the Company�s sources of liquidity have been predominantly from proceeds received from
                product sales and services
                provided. The Company anticipates sources of liquidity to include cash on hand and cash flow from
                operations. The Company continues to
                explore financing alternatives in debt or equity to fund its ongoing operations and to fulfill current
                obligations. The Company continues
                to take steps to streamline its organization and cost structure as well as improve future revenue
                growth.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company�s future liquidity needs may vary materially from those currently planned and will depend on
                many factors, including the
                more aggressive and expansive growth plan, or for any unforeseen reductions in demand, and the
                availability of debt or equity funding
                upon terms and conditions acceptable to the Company.</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002350"
        name="us-gaap:SignificantAccountingPoliciesTextBlock">
        <p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zQmqvyLEkMJe"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_82D_zqkZ3O6zZOnl">Summary of Significant Accounting Policies</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002352"
            name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock">
            <p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zQEPP2zFRP1h"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span
                                id="xdx_865_zulCnUrlBOrh">Basis
                                of Presentation</span></i></b></span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                    February 7, 2024, the Company consummated the Business Combination and became a publicly-traded
                    company and its financial statements
                    are now presented on a consolidated basis. Prior to the Business Combination, the Company�s
                    historical financial statements were
                    prepared on a combined basis derived from DIH Cayman.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                    connection with the Closing of the Business Combination and in accordance with the terms of the
                    Business Combination Agreement, ATAK
                    agreed to waive the closing condition that the reorganization be completed prior to Closing. The
                    Company has recast historical financial
                    statements filed in the registration statements to exclud<span style="background-color: white">e
                        assets, liabilities and results of operations
                        of entities that are not controlled by the Company as of </span>September 30, 2024<span
                        style="background-color: white">. </span>Control
                    exists when the Company has the power, directly and indirectly, to govern the financial and
                    operating policies of an entity and be exposed
                    to the variable returns from its activities. The financial statements for all periods presented,
                    including historical periods prior to
                    February 7, 2024, are now referred to as �Consolidated financial statements� and have been prepared
                    in conformity with U.S.
                    GAAP. During the three months ended June 30, 2024, the Company recorded an out of period adjustment
                    to reduce accounts payable and increase
                    additional paid in capital related to payments made as part of the reverse recapitalization that
                    were not previously recorded.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">While
                    the Company�s businesses have historically functioned together with the other businesses</span>
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">controlled
                    by DIH Cayman, the Company�s businesses are largely isolated and not dependent on corporate or other
                    support functions. DIH Cayman
                    did not have significant corporate or operational activity and does not have shared services that it
                    provides to its subsidiaries. The
                    Company considered allocations from the DIH Cayman and its subsidiaries but they are insignificant
                    because of the organizational structure
                    such that the Company has been operating on a standalone basis historically.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                    of September 30, 2024 and March 31, 2024, DIH Cayman remains the largest shareholder of the Company
                    and continues to own <span
                        id="xdx_900_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHongKongMember_zs0Yr6G4qsde"
                        title="Percentage of Interest own by wholly owned subsidiaries">
                        <ix:nonfraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired"
                            contextref="AsOf2024-09-30_custom_DIHHongKongMember" id="Fact002354"
                            format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">100</ix:nonfraction>
                    </span>% interest
                    in DIH International (�DIH Hong Kong�). In the three and six months ended September 30, 2023, legacy
                    DIH and DIH Hong Kong
                    were wholly owned subsidiaries of DIH Cayman. Transactions with DIH Cayman, DIH Hong Kong and its
                    subsidiaries are disclosed as related
                    party transactions in <span style="background-color: white">Note 13.</span></span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    condensed consolidated financial statements (the �financial statements�) have been prepared in
                    accordance with United States
                    (�U.S.�) generally accepted accounting principles (�U.S. GAAP�) for interim financial information
                    and in accordance
                    with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the financial
                    statements do not include all of the
                    information and notes required by U.S. GAAP for complete financial statements. In the opinion of
                    management, all adjustments, including
                    normal recurring adjustments, considered necessary for a fair statement of the Company�s financial
                    position and operating results
                    have been included. All intercompany balances and transactions within the Company have been
                    eliminated in the financial statements. Operating
                    results for the three and six months ended September 30, 2024 and 2023 are not necessarily
                    indicative of the results that may be expected
                    for the fiscal year as a whole. The March 31, 2024 period presented on the Condensed Consolidated
                    Balance Sheet was derived from audited
                    financial statements, but does not include all disclosures required by U.S. GAAP. The following
                    tables and footnotes are presented in
                    thousands of U.S. dollars unless otherwise stated. These condensed consolidated financial statements
                    should be read in conjunction with
                    the Company�s Annual Report on Form 10-K for the year ended March 31, 2024.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span>
            </p>


            <ix:exclude><!-- Field: Page; Sequence: 139 -->
                <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                    <table cellpadding="0" cellspacing="0"
                        style="border-collapse: collapse; width: 100%; font-size: 10pt">
                        <tbody>
                            <tr style="vertical-align: top; text-align: left">
                                <td style="text-align: center; width: 100%">
                                    F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div style="break-before: page; margin-top: 6pt">
                    <p style="margin: 0pt">&nbsp;</p>
                </div>
                <!-- Field: /Page -->
            </ix:exclude>

            <p
                style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span>
            </p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002356"
            name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
            <p id="xdx_84E_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zw0yCUm6brr1"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span
                                id="xdx_86F_zJwKBa8g0Fwf">Foreign
                                Currency Reporting</span></i></b></span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    functional currency for the Company�s non-U.S. subsidiaries is their local currency. The assets and
                    liabilities of foreign subsidiaries
                    are translated into U.S. dollars using the exchange rate in effect as of the balance sheet date.
                    Revenues and expenses are translated
                    at the average exchange rates for each respective reporting period. Adjustments resulting from
                    translating local currency financial statements
                    into U.S. dollars are reflected in accumulated other comprehensive income (loss).</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
                    denominated in currencies other than the functional currency are remeasured based on the exchange
                    rates at the time of the transaction.
                    Foreign currency gains and losses arising primarily from changes in exchange rates on foreign
                    currency denominated intercompany transactions
                    and balances between foreign locations are recorded in the condensed consolidated statements of
                    operations. Realized and unrealized gains
                    (losses) resulting <span style="background-color: white">from transactions conducted in foreign
                        currencies for the </span>three months
                    ended September 30, 2024 and 2023 were $<span
                        id="xdx_900_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pn3n3_c20240701__20240930_zLAhRgv56CCf"
                        title="Foreign exchange (gain) loss">(<ix:nonfraction
                            name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax"
                            contextref="From2024-07-012024-09-30" id="Fact002358" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" sign="-" unitref="USD">1,415</ix:nonfraction>)</span> and $<span
                        id="xdx_905_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pn3n3_c20230701__20230930_zhhLp6sKtw5j"
                        title="Foreign exchange (gain) loss">
                        <ix:nonfraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax"
                            contextref="From2023-07-012023-09-30" id="Fact002360" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">271</ix:nonfraction>
                    </span>, respectively, and <span style="background-color: white">$<span
                            id="xdx_904_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pn3n3_c20240401__20240930_zqOLFUHXilff"
                            title="Foreign exchange (gain) loss">
                            <ix:nonfraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax"
                                contextref="From2024-04-01to2024-09-30" id="Fact002362" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">38</ix:nonfraction>
                        </span> and $<span
                            id="xdx_904_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pn3n3_c20230401__20230930_zpYkkOceS2b5"
                            title="Foreign exchange (gain) loss">(<ix:nonfraction
                                name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax"
                                contextref="From2023-04-012023-09-30" id="Fact002364" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">418</ix:nonfraction>)</span> for
                        the six months ended September 30, 2024 and 2023, respectively.</span></span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span>
            </p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002366"
            name="us-gaap:UseOfEstimates">
            <p id="xdx_84A_eus-gaap--UseOfEstimates_zJrGu3vSg2Al"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span
                                id="xdx_869_zUnKRXGojYsj">Use
                                of Estimates</span></i></b></span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    preparation of financial statements in conformity with U.S. GAAP requires management to make
                    estimates and assumptions that affect the
                    reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the
                    date of the condensed consolidated
                    financial statements, and the reported amounts of revenue and expenses during the reporting period.
                    Significant estimates made by management
                    in connection with the preparation of the accompanying condensed consolidated financial statements
                    include the useful lives of long-lived
                    assets, inventory valuations, the allocation of transaction price among various performance
                    obligations, valuation of securities, the
                    allowance for credit losses, the fair value of financial assets, liabilities, actuarial valuation of
                    pensions and realizability of deferred
                    income tax asset or liabilities. Actual results could differ from those estimates.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span>
            </p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002368"
            name="us-gaap:ConcentrationRiskCreditRisk">
            <p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zGEyRNQNs0k6"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span
                                id="xdx_86E_z8yA9Tpr0BZd">Concentration
                                of Credit Risk</span></i></b></span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                    instruments that potentially subject the Company to credit risk primarily consists of cash and cash
                    equivalents and accounts receivable.
                    The Company maintains its cash and cash equivalents with highly-rated financial institutions and
                    limits the amount of credit exposure
                    to any one entity. We believe we do not have any significant credit risk on our cash and cash
                    equivalents. For accounts receivable, the
                    Company is exposed to credit risk in the event of nonpayment by customers which is limited to the
                    amounts recorded on the condensed consolidated
                    balance sheets. The risk associated with this concentration is mitigated by prepayment arrangements
                    and our ongoing credit-review procedures
                    and letters of credit or payment prior to shipment.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">M<span
                        style="background-color: white">ajor
                        customers are defined as those individually comprising more than <span
                            id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240401__20240930__srt--MajorCustomersAxis__custom--MajorCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--TradeAndAccountsReceivableMember_zemKxI35r8R7"
                            title="Concentration risk percent">
                            <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                                contextref="From2024-04-012024-09-30_custom_MajorCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember"
                                id="Fact002370" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">10
                            </ix:nonfraction>
                        </span>% of our trade accounts receivable or revenues. As of September 30,
                        2024 and March 31, 2024, no customer comprised more than <span
                            id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240401__20240930__srt--MajorCustomersAxis__custom--NoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--TradeAndAccountsReceivableMember_zVtyx7XsIGT2"
                            title="Concentration risk percent"><span
                                id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230401__20240331__srt--MajorCustomersAxis__custom--NoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--TradeAndAccountsReceivableMember_zHyzUEbDmfod"
                                title="Concentration risk percent">
                                <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                                    contextref="From2024-04-012024-09-30_custom_NoCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember"
                                    id="Fact002372" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                    <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                                        contextref="From2023-04-012024-03-31_custom_NoCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember"
                                        id="Fact002374" format="ixt:numdotdecimal" decimals="INF" scale="-2"
                                        unitref="Pure">10</ix:nonfraction>
                                </ix:nonfraction>
                            </span></span>% of total trade accounts receivables. </span>For the three and six months
                    ended September 30, 2024, no custome<span style="background-color: white">r comprised more than
                        <span
                            id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240701__20240930__srt--MajorCustomersAxis__custom--NoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--TradeAndAccountsReceivableMember_zmp5CRpg3Pd4"
                            title="Concentration risk percent"><span
                                id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240401__20240930__srt--MajorCustomersAxis__custom--NoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--TradeAndAccountsReceivableMember_zuUaWDblNtWk"
                                title="Concentration risk percent">
                                <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                                    contextref="From2024-07-012024-09-30_custom_NoCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember"
                                    id="Fact002376" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                    <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                                        contextref="From2024-04-012024-09-30_custom_NoCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_TradeAndAccountsReceivableMember"
                                        id="Fact002378" format="ixt:numdotdecimal" decimals="INF" scale="-2"
                                        unitref="Pure">10</ix:nonfraction>
                                </ix:nonfraction>
                            </span></span>% of total revenue. For the three and
                        six months ended September 30, 2023, one customer comprised <span
                            id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20230930__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenuesMember_zgIEYotBYG35"
                            title="Concentration risk percent">
                            <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                                contextref="From2023-07-012023-09-30_custom_OneCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_RevenuesMember"
                                id="Fact002380" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">15.9
                            </ix:nonfraction>
                        </span>% and <span
                            id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230401__20230930__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenuesMember_zxNJuuhFi0V5"
                            title="Concentration risk percent">
                            <ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1"
                                contextref="From2023-04-012023-09-30_custom_OneCustomersMember_us-gaap_CustomerConcentrationRiskMember_custom_RevenuesMember"
                                id="Fact002382" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">16.6
                            </ix:nonfraction>
                        </span>% of total revenue, respectively.</span></span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span>
            </p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002384"
            name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock">
            <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zvEIQbipdkX1"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span
                                id="xdx_864_zHEcI8AVJbih">Accounting
                                Pronouncements Recently Adopted</span> </i></b></span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
                    August 2020, the FASB issued ASU No. 2020-06, <i>Debt � Debt with Conversion and Other Options
                        (Subtopic 470- 20) and Derivatives
                        and Hedging � Contracts in Entity�s Own Equity (Subtopic 815-40): Accounting for Convertible
                        Instruments and Contracts in
                        an Entity�s Own Equity</i> (�ASU 2020-06�), which simplifies accounting for convertible
                    instruments by removing major
                    separation models required under current U.S. GAAP and simplifies the diluted earnings per share
                    (�EPS�) calculation in certain
                    areas. Under the new guidance there will be no separate accounting for embedded conversion features.
                    It removes certain settlement conditions
                    that are required for equity contracts to qualify for the derivative scope exception. The amendments
                    in this update are effective for
                    the Company on April 1, 2024. </span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span>
            </p>

        </ix:nonnumeric>
        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002386"
            name="DHAI:RecentAccountingPronouncementsNotYetAdoptedPolicyTextBlock">
            <p id="xdx_846_ecustom--RecentAccountingPronouncementsNotYetAdoptedPolicyTextBlock_zxrEOzPWqIDk"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span
                                id="xdx_86E_zmvkQcFxFxf">Recent
                                Accounting Pronouncements Not Yet Adopted</span></i></b></span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
                    November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to
                    Reportable Segment Disclosures. Update
                    No. 2023-07 requires disclosure, on an annual and interim basis, of significant segment expenses
                    that are regularly provided to the Chief
                    operating decision maker (�CODM�) and included within each reported measure of segment profit or
                    loss in addition to disclosure
                    of amounts for other segment items and a description of its composition. Update No. 2023-07 is
                    effective for fiscal years beginning after
                    December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We are
                    currently evaluating the impact
                    of adopting ASU 2023-07.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


            <ix:exclude><!-- Field: Page; Sequence: 140 -->
                <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                    <table cellpadding="0" cellspacing="0"
                        style="border-collapse: collapse; width: 100%; font-size: 10pt">
                        <tbody>
                            <tr style="vertical-align: top; text-align: left">
                                <td style="text-align: center; width: 100%">
                                    F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div style="break-before: page; margin-top: 6pt">
                    <p style="margin: 0pt">&nbsp;</p>
                </div>
                <!-- Field: /Page -->
            </ix:exclude>

            <p
                style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
                    December 2023, the FASB issued ASU No. 2023-09 (�ASU 2023-09�), Income Taxes (Topic 740):
                    Improvements to Income Tax Disclosures.
                    ASU 2023-09 addresses investor requests for more transparency about income tax information through
                    improvements to income tax disclosures
                    primarily related to the rate reconciliation and income taxes paid information. This update also
                    includes certain other amendments to
                    improve the effectiveness of income tax disclosures. The provisions of ASU 2023-09 are effective for
                    annual periods beginning after December
                    15, 2024, with early adoption permitted. We are currently evaluating the impact of adopting ASU
                    2023-09.</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        </ix:nonnumeric>
        <p id="xdx_857_z1BoPchUTRk7"
            style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
                November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense
                Disaggregation Disclosures (Subtopic
                220-40): Disaggregation of Income Statement Expenses, which requires more detailed disclosures of
                certain categories of expenses such
                as employee compensation, depreciation, and intangible asset amortization that are components of
                existing expense captions presented
                on the face of the income statement. This ASU is effective for annual reporting periods beginning after
                December 15, 2026, and interim
                reporting periods beginning after December 15, 2027. Early adoption is permitted. Companies have the
                option to apply the guidance either
                on a retrospective or prospective basis, and early adoption is permitted. The Company is currently
                evaluating the impact this standard
                will have on its financial statement presentation and disclosures. </span><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br>
                <br></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002388"
        name="us-gaap:RevenueFromContractWithCustomerTextBlock">
        <p id="xdx_80E_eus-gaap--RevenueFromContractWithCustomerTextBlock_za0Vxn0c67Bh"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_82B_zgSFO4ql00g5">Revenue Recognition</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company�s revenues are derived from the sales of medical rehabilitation devices and technology services.
                The Company�s primary
                customers include healthcare systems, clinics, third-party healthcare providers, distributors, and other
                institutions, including governmental
                healthcare programs and group purchasing organizations.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Disaggregation
                        of Revenue</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" continuedat="ConU002393-01" escape="true" id="Fact002393"
            name="us-gaap:DisaggregationOfRevenueTableTextBlock">
            <p id="xdx_89E_eus-gaap--DisaggregationOfRevenueTableTextBlock_gL3DORTTB-STRXYE_zZHkd7lW6OB1"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    Company disaggregates its revenue with customers by category and by geographic region based on
                    customer location, see Note 4 for further
                    information. The following represents the revenue for the three and six months ended September 30,
                    2024 and 2023, based on revenue category:</span></p>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span><span
                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span><span
                    id="xdx_8BE_zY7PyJIqMDu1" style="display: none">Schedule
                    of Disaggregation of Revenue</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_498_20240701__20240930_zfaO4oKLIqcf"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20230701__20230930_zurGc7AwIc83"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49F_20240401__20240930_z1CBzTkvKd1h"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20230401__20230930_zPkWBim2Ob92"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Three Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Six Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DevicesMember_zQAX8zUzHQP"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 40%">Devices</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-07-012024-09-30_custom_DevicesMember" id="Fact002395"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">15,045</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-07-012023-09-30_custom_DevicesMember" id="Fact002396"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">10,112</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-04-012024-09-30_custom_DevicesMember" id="Fact002397"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">28,573</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012023-09-30_custom_DevicesMember" id="Fact002398"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">20,555</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__us-gaap--ServiceMember_zlT48ncIbEEh"
                        style="vertical-align: bottom; background-color: White">
                        <td>Services</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-07-012024-09-30_us-gaap_ServiceMember" id="Fact002400"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,695</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-07-012023-09-30_us-gaap_ServiceMember" id="Fact002401"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,710</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-04-012024-09-30_us-gaap_ServiceMember" id="Fact002402"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,995</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012023-09-30_us-gaap_ServiceMember" id="Fact002403"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,085</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--OtherMember_ztXZO71fakOd"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-bottom: 1pt">Other</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-07-012024-09-30_custom_OtherMember" id="Fact002405"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">422</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-07-012023-09-30_custom_OtherMember" id="Fact002406"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">238</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-04-012024-09-30_custom_OtherMember" id="Fact002407"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">554</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012023-09-30_custom_OtherMember" id="Fact002408"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">465</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_zVh0hAu4LQkf"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total revenue, net</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-07-012024-09-30" id="Fact002410" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">18,162</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-07-012023-09-30" id="Fact002411" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">13,060</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-04-01to2024-09-30" id="Fact002412" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">35,122</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012023-09-30" id="Fact002413" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">26,105</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A7_zhDOwF0XX56i"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                revenue that is recognized at a point in time was related to the revenues from devices and from service
                on demand. The revenue that is
                recognized over time was related to revenue from service contracts. Other revenue primarily relates to
                freight and packaging on devices
                and recognized at a point in time. The following represents the revenue for the three and six months
                ended September 30, 2024 and 2023,
                based on timing of recognition:</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span id="xdx_C02_gL3DORTTB-STRXYE_zk4MwCrYgfW7">
                <ix:continuation continuedat="ConU002393-02" id="ConU002393-01"><span
                        style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span>
                </ix:continuation>
            </span></p>

        <div id="xdx_C04_gL3DORTTB-STRXYE_zgFK3yiiW9rl">
            <ix:continuation continuedat="ConU002393-03" id="ConU002393-02">
                <table cellpadding="0" cellspacing="0" id="xdx_30B_134_pn3n3_zAbH42ky5sFe"
                    summary="xdx: Disclosure - Schedule of Disaggregation of Revenue (Details)"
                    style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                    <tbody>
                        <tr style="display: none; vertical-align: bottom">
                            <td style="text-align: center">&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="2" id="xdx_498_20240701__20240930_zZXFNMLzWAY"
                                style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="2" id="xdx_492_20230701__20230930_zUWck2uM5Nw9"
                                style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="2" id="xdx_49F_20240401__20240930_z25lb6fY4Rv"
                                style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="2" id="xdx_492_20230401__20230930_zuIZkNi6gbk2"
                                style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        </tr>
                        <tr style="vertical-align: bottom">
                            <td style="text-align: center">&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="6"
                                style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the
                                Three Months Ended September
                                30,</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="6"
                                style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the
                                Six Months Ended September
                                30,</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        </tr>
                        <tr style="vertical-align: bottom">
                            <td style="text-align: center">&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="2"
                                style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="2"
                                style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="2"
                                style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                            <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                            <td colspan="2"
                                style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td>
                            <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        </tr>
                        <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_zLECiR4FCgn8"
                            style="vertical-align: bottom; background-color: rgb(204,238,255)">
                            <td style="width: 40%; text-align: left">Point in time</td>
                            <td style="width: 2%">&nbsp;</td>
                            <td style="width: 1%; text-align: left">$</td>
                            <td style="width: 11%; text-align: right">
                                <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                    contextref="From2024-07-012024-09-30_us-gaap_TransferredAtPointInTimeMember"
                                    id="Fact002415" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">
                                    16,175</ix:nonfraction>
                            </td>
                            <td style="width: 1%; text-align: left">&nbsp;</td>
                            <td style="width: 2%">&nbsp;</td>
                            <td style="width: 1%; text-align: left">$</td>
                            <td style="width: 11%; text-align: right">
                                <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                    contextref="From2023-07-012023-09-30_us-gaap_TransferredAtPointInTimeMember"
                                    id="Fact002416" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">
                                    11,386</ix:nonfraction>
                            </td>
                            <td style="width: 1%; text-align: left">&nbsp;</td>
                            <td style="width: 2%">&nbsp;</td>
                            <td style="width: 1%; text-align: left">$</td>
                            <td style="width: 11%; text-align: right">
                                <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                    contextref="From2024-04-012024-09-30_us-gaap_TransferredAtPointInTimeMember"
                                    id="Fact002417" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">
                                    31,170</ix:nonfraction>
                            </td>
                            <td style="width: 1%; text-align: left">&nbsp;</td>
                            <td style="width: 2%">&nbsp;</td>
                            <td style="width: 1%; text-align: left">$</td>
                            <td style="width: 11%; text-align: right">
                                <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                    contextref="From2023-04-012023-09-30_us-gaap_TransferredAtPointInTimeMember"
                                    id="Fact002418" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">
                                    22,892</ix:nonfraction>
                            </td>
                            <td style="width: 1%; text-align: left">&nbsp;</td>
                        </tr>
                        <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zMfXO1kmedi8"
                            style="vertical-align: bottom; background-color: White">
                            <td style="text-align: left; padding-bottom: 1pt">Over time</td>
                            <td style="padding-bottom: 1pt">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: right">
                                <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                    contextref="From2024-07-012024-09-30_us-gaap_TransferredOverTimeMember"
                                    id="Fact002420" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">
                                    1,987</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                            <td style="padding-bottom: 1pt">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: right">
                                <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                    contextref="From2023-07-012023-09-30_us-gaap_TransferredOverTimeMember"
                                    id="Fact002421" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">
                                    1,674</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                            <td style="padding-bottom: 1pt">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: right">
                                <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                    contextref="From2024-04-012024-09-30_us-gaap_TransferredOverTimeMember"
                                    id="Fact002422" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">
                                    3,952</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                            <td style="padding-bottom: 1pt">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: right">
                                <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                    contextref="From2023-04-012023-09-30_us-gaap_TransferredOverTimeMember"
                                    id="Fact002423" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">
                                    3,213</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        </tr>
                        <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_zmI204FvBT63"
                            style="vertical-align: bottom; background-color: rgb(204,238,255)">
                            <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Total revenue</td>
                            <td style="padding-bottom: 1pt">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                            <td style="border-bottom: Black 1pt solid; text-align: right">
                                <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                    contextref="From2024-07-012024-09-30" id="Fact002425" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">18,162</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                            <td style="padding-bottom: 1pt">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                            <td style="border-bottom: Black 1pt solid; text-align: right">
                                <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                    contextref="From2023-07-012023-09-30" id="Fact002426" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">13,060</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                            <td style="padding-bottom: 1pt">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                            <td style="border-bottom: Black 1pt solid; text-align: right">
                                <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                    contextref="From2024-04-01to2024-09-30" id="Fact002427" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">35,122</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                            <td style="padding-bottom: 1pt">&nbsp;</td>
                            <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                            <td style="border-bottom: Black 1pt solid; text-align: right">
                                <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                    contextref="From2023-04-012023-09-30" id="Fact002428" format="ixt:numdotdecimal"
                                    decimals="-3" scale="3" unitref="USD">26,105</ix:nonfraction>
                            </td>
                            <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        </tr>
                    </tbody>
                </table>

            </ix:continuation>
        </div>
        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span
                            id="xdx_C0E_gL3DORTTB-STRXYE_z5nHLrTWOCgj">
                            <ix:continuation id="ConU002393-03">&nbsp;</ix:continuation>
                        </span></i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Deferred
                        Revenue and Remaining Performance Obligations</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defe<span
                    style="background-color: white">rred
                    revenue as of September 30, 2024 and March 31, 2024 was $<span
                        id="xdx_90A_eus-gaap--DeferredRevenue_iI_pn3n3_c20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zSTEtK6Dkft5"
                        title="Deferred revenue">
                        <ix:nonfraction name="us-gaap:DeferredRevenue"
                            contextref="AsOf2024-09-30_custom_DIHHoldingUSIncMember" id="Fact002430"
                            format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">10,843</ix:nonfraction>
                    </span> and $<span
                        id="xdx_905_eus-gaap--DeferredRevenue_iI_pn3n3_c20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zNHmO2DiHdGi"
                        title="Deferred revenue">
                        <ix:nonfraction name="us-gaap:DeferredRevenue"
                            contextref="AsOf2024-03-31_custom_DIHHoldingUSIncMember" id="Fact002432"
                            format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">9,881</ix:nonfraction>
                    </span>, respectively. </span>Defe<span style="background-color: white">rred
                    revenue as of September 30, 2023 and March 31, 2023 was $<span
                        id="xdx_90B_eus-gaap--DeferredRevenue_iI_pn3n3_c20230930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zGVS0kJiTLJ"
                        title="Deferred revenue">
                        <ix:nonfraction name="us-gaap:DeferredRevenue"
                            contextref="AsOf2023-09-30_custom_DIHHoldingUSIncMember" id="Fact002434"
                            format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">11,300</ix:nonfraction>
                    </span> and $<span
                        id="xdx_90D_eus-gaap--DeferredRevenue_iI_pn3n3_c20230331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zdJk2H1n7bD7"
                        title="Deferred revenue">
                        <ix:nonfraction name="us-gaap:DeferredRevenue"
                            contextref="AsOf2023-03-31_custom_DIHHoldingUSIncMember" id="Fact002436"
                            format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">9,996</ix:nonfraction>
                    </span>, respectively. The Company recognized revenue of $<span
                        id="xdx_905_eus-gaap--Revenues_pn3n3_c20240701__20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zDgSgQdeF3L2"
                        title="Revenue">
                        <ix:nonfraction name="us-gaap:Revenues"
                            contextref="From2024-07-012024-09-30_custom_DIHHoldingUSIncMember" id="Fact002438"
                            format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,147</ix:nonfraction>
                    </span> and
                    $<span
                        id="xdx_90F_eus-gaap--Revenues_pn3n3_c20240401__20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_z8pi1f8Cwg9k"
                        title="Revenue">
                        <ix:nonfraction name="us-gaap:Revenues"
                            contextref="From2024-04-012024-09-30_custom_DIHHoldingUSIncMember" id="Fact002440"
                            format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,033</ix:nonfraction>
                    </span>, respectively during the three and six months ended September 30, 2024 that was included in
                    deferred revenue as of March 31, 2024,
                    and $<span
                        id="xdx_908_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zj4NOVWQuOqi"
                        title="Revenue">
                        <ix:nonfraction name="us-gaap:Revenues"
                            contextref="From2023-07-012023-09-30_custom_DIHHoldingUSIncMember" id="Fact002442"
                            format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,013</ix:nonfraction>
                    </span> and $<span
                        id="xdx_906_eus-gaap--Revenues_pn3n3_c20230401__20230930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zTCx263uplrc"
                        title="Revenue">
                        <ix:nonfraction name="us-gaap:Revenues"
                            contextref="From2023-04-012023-09-30_custom_DIHHoldingUSIncMember" id="Fact002444"
                            format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,953</ix:nonfraction>
                    </span> respectively, during the three and six months ended September 30, 2023, that was included in
                    deferred revenue as
                    of March 31, 2023. Remaining performance obligations include goods and services that have not yet
                    been delivered or provided under existing,
                    noncancelable contracts. As of September 30, </span>2024 and March 31, 2024, the aggregate amount of
                the contracted revenue allocated
                to unsatisfied performance obligations with an original duration of one year or more was approximately
                $<span
                    id="xdx_903_eus-gaap--RevenueRemainingPerformanceObligation_iI_pn3n3_c20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zBtD1NwDwu0l"
                    title="Revenue, remaining performance obligation, amount">
                    <ix:nonfraction name="us-gaap:RevenueRemainingPerformanceObligation"
                        contextref="AsOf2024-09-30_custom_DIHHoldingUSIncMember" id="Fact002446"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,943</ix:nonfraction>
                </span> and $<span
                    id="xdx_90C_eus-gaap--RevenueRemainingPerformanceObligation_iI_pn3n3_c20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zLtVjCo7zDId"
                    title="Revenue, remaining performance obligation, amount">
                    <ix:nonfraction name="us-gaap:RevenueRemainingPerformanceObligation"
                        contextref="AsOf2024-03-31_custom_DIHHoldingUSIncMember" id="Fact002448"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,670</ix:nonfraction>
                </span>, respectively.
                As of September 30, 2024, the Company expects to recognize revenue on the majority of these remaining
                performance obligations over the
                next<span
                    id="xdx_90C_ecustom--RevenueRemainingPerformanceObligationsExpectedTimingOfSatisfactionPeriod1_dtY_c20240401__20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zaGTAOPV7v0h"
                    title="Deferred revenue recognized">
                    <ix:nonnumeric contextref="From2024-04-012024-09-30_custom_DIHHoldingUSIncMember"
                        format="ixt-sec:duryear" id="Fact002450"
                        name="DHAI:RevenueRemainingPerformanceObligationsExpectedTimingOfSatisfactionPeriod1">2
                    </ix:nonnumeric>
                </span> years.</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        </p>

        <ix:exclude><!-- Field: Page; Sequence: 141 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advance
                        Payments From Customers</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company receives advance payments related to customers from their orders to support the operation of the
                company in the production of
                the goods. The Company recognizes these prepayments as a liability under �Advance payments from
                customers� on the condensed
                consolidated balance sheets when they are received. Balances associated with the advance payments are
                reclassed to deferred revenue upon
                invoicing and revenue is recognized when performance obligations are fulfilled. Advance payments from
                customers was $<span
                    id="xdx_904_ecustom--AdvancePaymentsFromCustomers_iI_pn5n6_c20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zTDEuOn7BrJg"
                    title="Advance payments from customers">
                    <ix:nonfraction name="DHAI:AdvancePaymentsFromCustomers"
                        contextref="AsOf2024-09-30_custom_DIHHoldingUSIncMember" id="Fact002452"
                        format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">8.9</ix:nonfraction>
                </span> million and
                $<span
                    id="xdx_903_ecustom--AdvancePaymentsFromCustomers_iI_pn5n6_c20240331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zKNWlK5gRV65"
                    title="Advance payments from customers">
                    <ix:nonfraction name="DHAI:AdvancePaymentsFromCustomers"
                        contextref="AsOf2024-03-31_custom_DIHHoldingUSIncMember" id="Fact002454"
                        format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">10.6</ix:nonfraction>
                </span> million as of September 30, 2024 and March 31, 2024, respectively. Advance payments from
                customers <span style="background-color: white">as
                    of September 30, 2023 and March 31, 2023 was $<span
                        id="xdx_903_eus-gaap--ReceivablesFromCustomers_iI_pn3n3_c20230930__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zuM89TDBliWd"
                        title="Advance payments from customers">
                        <ix:nonfraction name="us-gaap:ReceivablesFromCustomers"
                            contextref="AsOf2023-09-30_custom_DIHHoldingUSIncMember" id="Fact002456"
                            format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">8,865</ix:nonfraction>
                    </span> and $<span
                        id="xdx_90B_eus-gaap--ReceivablesFromCustomers_iI_c20230331__us-gaap--BusinessAcquisitionAxis__custom--DIHHoldingUSIncMember_zJw2DJr340Ef"
                        title="Advance payments from customers">
                        <ix:nonfraction name="us-gaap:ReceivablesFromCustomers"
                            contextref="AsOf2023-03-31_custom_DIHHoldingUSIncMember" id="Fact002458"
                            format="ixt:numdotdecimal" decimals="0" unitref="USD">6,225</ix:nonfraction>
                    </span>, respectively.</span></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002460"
        name="us-gaap:SegmentReportingDisclosureTextBlock">
        <p id="xdx_800_eus-gaap--SegmentReportingDisclosureTextBlock_zeysp5Y4BNTi"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_826_ze2M8jvV5bp2">Geographical Information</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002462"
            name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
            <p id="xdx_892_eus-gaap--RevenueFromExternalCustomersByGeographicAreasTableTextBlock_zwEgGIka0kn8"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    following represents revenue attributed to geographic regions based on customer location:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span><span
                    id="xdx_8B4_zJ9APrMHx8Jj" style="display: none">Schedule
                    of Revenue Attributed to Geographic Regions Based on Customer Location</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20240701__20240930_zoAZQc5B8lh2"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20230701__20230930_z8epG9uKwRNd"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_494_20240401__20240930_zpFhQS66gol5"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_493_20230401__20230930_zaMPb1OYpMnh"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Three Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Six Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__us-gaap--EMEAMember_zdxxqhaPj3bd"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 40%; text-align: left">Europe, Middle East and Africa (�EMEA�)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-07-012024-09-30_us-gaap_EMEAMember" id="Fact002464"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">10,696</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-07-012023-09-30_us-gaap_EMEAMember" id="Fact002465"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">6,234</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-04-012024-09-30_us-gaap_EMEAMember" id="Fact002466"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">21,748</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012023-09-30_us-gaap_EMEAMember" id="Fact002467"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">12,867</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__srt--AmericasMember_zXsVNJ5N3T7f"
                        style="vertical-align: bottom; background-color: White">
                        <td>Americas</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-07-012024-09-30_srt_AmericasMember" id="Fact002469"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,601</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-07-012023-09-30_srt_AmericasMember" id="Fact002470"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,835</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-04-012024-09-30_srt_AmericasMember" id="Fact002471"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">9,139</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012023-09-30_srt_AmericasMember" id="Fact002472"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">6,819</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__srt--AsiaPacificMember_zyCIknXoX412"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt">Asia Pacific (�APAC�)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-07-012024-09-30_srt_AsiaPacificMember" id="Fact002474"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,865</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-07-012023-09-30_srt_AsiaPacificMember" id="Fact002475"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,991</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-04-012024-09-30_srt_AsiaPacificMember" id="Fact002476"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,235</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012023-09-30_srt_AsiaPacificMember" id="Fact002477"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">6,419</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_z8YyhS8OYbYj"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total revenue</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-07-012024-09-30" id="Fact002479" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">18,162</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-07-012023-09-30" id="Fact002480" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">13,060</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2024-04-01to2024-09-30" id="Fact002481" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">35,122</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
                                contextref="From2023-04-012023-09-30" id="Fact002482" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">26,105</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A4_z7qTc9fgKDM9"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                the three months ended September 30, 2024 and 2023, the United States represented <span
                    id="xdx_904_ecustom--RevenuePercentage_dp_uPure_c20240701__20240930__srt--StatementGeographicalAxis__country--US_z7mV7DDapAJg"
                    title="Revenue percentage"
                    class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                    <ix:nonfraction name="DHAI:RevenuePercentage" contextref="From2024-07-012024-09-30_country_US"
                        id="Fact002484" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">23
                    </ix:nonfraction>
                </span>% and <span
                    id="xdx_900_ecustom--RevenuePercentage_dp_uPure_c20230701__20230930__srt--StatementGeographicalAxis__country--US_zWRa6SLU7wF1"
                    title="Revenue percentage"
                    class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                    <ix:nonfraction name="DHAI:RevenuePercentage" contextref="From2023-07-012023-09-30_country_US"
                        id="Fact002486" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">20
                    </ix:nonfraction>
                </span>% of total revenue, respectively. Russia
                represented <span
                    id="xdx_909_ecustom--RevenuePercentage_dp_uPure_c20230701__20230930__srt--StatementGeographicalAxis__country--RU_zHd82kTiDdk4"
                    title="Revenue percentage"
                    class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                    <ix:nonfraction name="DHAI:RevenuePercentage" contextref="From2023-07-012023-09-30_country_RU"
                        id="Fact002488" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">20
                    </ix:nonfraction>
                </span>% of total revenue for the three months ended September 30, 2023. For the six months ended
                September 30, 2024 and 2023,
                the United States represented <span
                    id="xdx_90E_ecustom--RevenuePercentage_dp_uPure_c20240401__20240930__srt--StatementGeographicalAxis__country--US_zenxEyf0pEL3"
                    title="Revenue percentage"
                    class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                    <ix:nonfraction name="DHAI:RevenuePercentage" contextref="From2024-04-012024-09-30_country_US"
                        id="Fact002490" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">19
                    </ix:nonfraction>
                </span>% and <span
                    id="xdx_909_ecustom--RevenuePercentage_dp_uPure_c20230401__20230930__srt--StatementGeographicalAxis__country--US_zaVaKokxKDUe"
                    title="Revenue percentage"
                    class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                    <ix:nonfraction name="DHAI:RevenuePercentage" contextref="From2023-04-012023-09-30_country_US"
                        id="Fact002492" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">20
                    </ix:nonfraction>
                </span>% of total revenue, respectively. Russia represented <span
                    id="xdx_908_ecustom--RevenuePercentage_dp_uPure_c20230401__20230930__srt--StatementGeographicalAxis__country--RU_zHesaT7w7Di1"
                    title="Revenue percentage"
                    class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                    <ix:nonfraction name="DHAI:RevenuePercentage" contextref="From2023-04-012023-09-30_country_RU"
                        id="Fact002494" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">20
                    </ix:nonfraction>
                </span>% of total revenue for the six months
                ended September 30, 2023. No other countries represented greater than <span
                    id="xdx_909_ecustom--RevenuePercentage_dp_uPure_c20230701__20230930__srt--StatementGeographicalAxis__custom--OtherMember_zqadbNwggje3"
                    title="Revenue percentage"
                    class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><span
                        id="xdx_90A_ecustom--RevenuePercentage_dp_uPure_c20230401__20230930__srt--StatementGeographicalAxis__custom--OtherMember_zZHC9Ai6VQEj"
                        title="Revenue percentage"
                        class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><span
                            id="xdx_907_ecustom--RevenuePercentage_dp_uPure_c20240401__20240930__srt--StatementGeographicalAxis__custom--OtherMember_z5UiierZQmji"
                            title="Revenue percentage"
                            class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__"><span
                                id="xdx_902_ecustom--RevenuePercentage_dp_uPure_c20240701__20240930__srt--StatementGeographicalAxis__custom--OtherMember_zUEMiNmIsbye"
                                title="Revenue percentage"
                                class="xdx_phnt_RGlzY2xvc3VyZSAtIEdlb2dyYXBoaWNhbCBJbmZvcm1hdGlvbiAoRGV0YWlscyBOYXJyYXRpdmUpAA__">
                                <ix:nonfraction name="DHAI:RevenuePercentage"
                                    contextref="From2023-07-012023-09-30_custom_OtherMember22262187" id="Fact002496"
                                    format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                    <ix:nonfraction name="DHAI:RevenuePercentage"
                                        contextref="From2023-04-012023-09-30_custom_OtherMember22262187" id="Fact002498"
                                        format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">
                                        <ix:nonfraction name="DHAI:RevenuePercentage"
                                            contextref="From2024-04-012024-09-30_custom_OtherMember22262187"
                                            id="Fact002500" format="ixt:numdotdecimal" decimals="INF" scale="-2"
                                            unitref="Pure">
                                            <ix:nonfraction name="DHAI:RevenuePercentage"
                                                contextref="From2024-07-012024-09-30_custom_OtherMember22262203"
                                                id="Fact002502" format="ixt:numdotdecimal" decimals="INF" scale="-2"
                                                unitref="Pure">10</ix:nonfraction>
                                        </ix:nonfraction>
                                    </ix:nonfraction>
                                </ix:nonfraction>
                            </span></span></span></span>% of revenue during the three and six months ended September
                30, 2024 and 2023.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002504"
            name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock">
            <p id="xdx_895_eus-gaap--LongLivedAssetsByGeographicAreasTableTextBlock_zKxXd58bgYZ3"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
                    assets shown below include property and equipment, net. The following represents long-lived assets
                    where they are physically located:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span><span
                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span><span
                    id="xdx_8BB_zSFKqrp4Sig6" style="display: none">Schedule
                    of Long-lived Assets</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49E_20240930_z6IZ1UltXA1h"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of
                            September 30, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49D_20240331_zdgWaBwkJJG1"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March
                            31, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_hsrt--StatementGeographicalAxis__us-gaap--EMEAMember_zM5yor9EfeEf"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 60%">EMEA</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet"
                                contextref="AsOf2024-09-30_us-gaap_EMEAMember" id="Fact002506"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">495</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet"
                                contextref="AsOf2024-03-31_us-gaap_EMEAMember" id="Fact002507"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">276</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_hsrt--StatementGeographicalAxis__srt--AmericasMember_zhVxUx3AYWkh"
                        style="vertical-align: bottom; background-color: White">
                        <td>Americas</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet"
                                contextref="AsOf2024-09-30_srt_AmericasMember" id="Fact002509"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">240</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet"
                                contextref="AsOf2024-03-31_srt_AmericasMember" id="Fact002510"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">206</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_hsrt--StatementGeographicalAxis__srt--AsiaPacificMember_znYZKsDMeBUa"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-bottom: 1pt">APAC</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet"
                                contextref="AsOf2024-09-30_srt_AsiaPacificMember" id="Fact002512"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">55</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet"
                                contextref="AsOf2024-03-31_srt_AsiaPacificMember" id="Fact002513"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">48</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_zxVMuJH3M6Y1"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total property and
                            equipment, net</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2024-09-30"
                                id="Fact002515" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">790
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2024-03-31"
                                id="Fact002516" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">530
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A2_zkPXBEN0ph06"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
            &nbsp;</p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
        </p>

        <ix:exclude><!-- Field: Page; Sequence: 142 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002518"
        name="us-gaap:EarningsPerShareTextBlock">
        <p id="xdx_808_eus-gaap--EarningsPerShareTextBlock_zpg31JRBR05g"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span
                        id="xdx_820_z9bIAKWzJZu9">Net Loss Per Share</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
                loss per share is calculated by dividing net loss by the weighted-average number of common shares
                outstanding during the period. Diluted
                loss per share is computed based on the sum of the weighted average number of common shares and dilutive
                common shares outstanding during
                the period. In connection with the Business Combination as described in Note 1 - Business and
                Organization, the Company issued earnout
                shares which are held in escrow until they are earned. The targets for the release of earnout shares are
                based on the volume weighted
                average trading prices (�VWAP�) of common shares during the earnout period. The earnout shares are
                excluded from the calculation
                of basic and diluted weighted-average number of common shares outstanding until vested. For periods
                prior to the Business Combination,
                basic and diluted loss per share was calculated based on the <span
                    id="xdx_904_eus-gaap--SharesIssued_iI_pn5n6_c20240207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LegacyDihMember_zmEtUtI3D2Xf"
                    title="Shares issued">
                    <ix:nonfraction name="us-gaap:SharesIssued" contextref="AsOf2024-02-07_custom_LegacyDihMember"
                        id="Fact002520" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="Shares">25.0
                    </ix:nonfraction>
                </span> million shares issued to Legacy DIH shareholders at the Closing Date.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
                shares of common stock are excluded from the computation of diluted net loss per share if their effect
                would have been anti-dilutive
                for the periods presented or if the issuance of shares is contingent upon events that did not occur by
                the end of the period. Diluted
                loss per share for the public warrants, private placement warrants and warrants issued in connection
                with the convertible debt is calculated
                under the treasury method. Diluted loss per share for the convertible debt and earn-out shares is
                calculated under the if-converted method.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                of September 30, 2024, there were <span
                    id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_pid_c20240930_zYoAtqck0HZc"
                    title="Common stock shares issued"><span
                        id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240930_zylD3fHHDH51"
                        title="Common stock shares outstanding">
                        <ix:nonfraction name="us-gaap:CommonStockSharesIssued" contextref="AsOf2024-09-30"
                            id="Fact002522" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                            <ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" contextref="AsOf2024-09-30"
                                id="Fact002524" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">34,544,935
                            </ix:nonfraction>
                        </ix:nonfraction>
                    </span></span> shares of Common Stock issued and outstanding, excluding earnout shares.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002526"
            name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
            <p id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zbJUSALpYJr7"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computation
                    of basic and diluted net loss per share for the three and six months ended September 30, 2024 and
                    2023, is as follows (in thousands,
                    except share and per share amounts):</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span><span
                    id="xdx_8B0_zNHPUbvJN074" style="display: none">Schedule
                    of Computation of Basic and Diluted Net Loss Per Share</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_490_20240701__20240930_zwcZCGF6huZi"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49A_20230701__20230930_zlHXh8qh8Fhh"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_499_20240401__20240930_zobdvCAxk2pe"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49B_20230401__20230930_zRdMRDk4yzd5"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Three Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Six Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--NetIncomeLoss_pn3n3_zDYHQnzbPOv8"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 40%; text-align: left">Net loss</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                                contextref="From2024-07-012024-09-30" id="Fact002528" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">234</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                                contextref="From2023-07-012023-09-30" id="Fact002529" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">2,484</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                                contextref="From2024-04-01to2024-09-30" id="Fact002530" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">544</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss"
                                contextref="From2023-04-012023-09-30" id="Fact002531" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">5,397</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Weighted-average shares outstanding - basic
                            and diluted</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240701__20240930_zkcIjNbqViga"
                                title="Weighted-average shares outstanding, basic"><span
                                    id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240701__20240930_zk8NmohY0sY8"
                                    title="Weighted-average shares outstanding, diluted">
                                    <ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"
                                        contextref="From2024-07-012024-09-30" id="Fact002533" format="ixt:numdotdecimal"
                                        decimals="INF" unitref="Shares">
                                        <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                            contextref="From2024-07-012024-09-30" id="Fact002535"
                                            format="ixt:numdotdecimal" decimals="INF" unitref="Shares">34,544,935
                                        </ix:nonfraction>
                                    </ix:nonfraction>
                                </span></span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230701__20230930_zl8zib8rEIgj"
                                title="Weighted-average shares outstanding, basic"><span
                                    id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230701__20230930_zXHFK1zB6Xef"
                                    title="Weighted-average shares outstanding, diluted">
                                    <ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"
                                        contextref="From2023-07-012023-09-30" id="Fact002537" format="ixt:numdotdecimal"
                                        decimals="INF" unitref="Shares">
                                        <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                            contextref="From2023-07-012023-09-30" id="Fact002539"
                                            format="ixt:numdotdecimal" decimals="INF" unitref="Shares">25,000,000
                                        </ix:nonfraction>
                                    </ix:nonfraction>
                                </span></span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240401__20240930_zFHx2OQmEI5g"
                                title="Weighted-average shares outstanding, basic"><span
                                    id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240401__20240930_zbKbKpLTe7Ci"
                                    title="Weighted-average shares outstanding, diluted">
                                    <ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"
                                        contextref="From2024-04-01to2024-09-30" id="Fact002541"
                                        format="ixt:numdotdecimal" decimals="INF" unitref="Shares">
                                        <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                            contextref="From2024-04-01to2024-09-30" id="Fact002543"
                                            format="ixt:numdotdecimal" decimals="INF" unitref="Shares">34,544,935
                                        </ix:nonfraction>
                                    </ix:nonfraction>
                                </span></span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230401__20230930_zoQMm4NonFN8"
                                title="Weighted-average shares outstanding, basic"><span
                                    id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230401__20230930_zTUdgYsjVb46"
                                    title="Weighted-average shares outstanding, diluted">
                                    <ix:nonfraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic"
                                        contextref="From2023-04-012023-09-30" id="Fact002545" format="ixt:numdotdecimal"
                                        decimals="INF" unitref="Shares">
                                        <ix:nonfraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"
                                            contextref="From2023-04-012023-09-30" id="Fact002547"
                                            format="ixt:numdotdecimal" decimals="INF" unitref="Shares">25,000,000
                                        </ix:nonfraction>
                                    </ix:nonfraction>
                                </span></span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share&#8201;�&#8201;basic and
                            diluted</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right"><span
                                id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20240701__20240930_z9cOHHsaSGF2"
                                title="Net loss per share - basic"><span
                                    id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pid_c20240701__20240930_ztIlcNsvu8T9"
                                    title="Net loss per share - diluted">(<ix:nonfraction
                                        name="us-gaap:EarningsPerShareBasic" contextref="From2024-07-012024-09-30"
                                        id="Fact002549" format="ixt:numdotdecimal" decimals="INF" sign="-"
                                        unitref="USDPShares">
                                        <ix:nonfraction name="us-gaap:EarningsPerShareDiluted"
                                            contextref="From2024-07-012024-09-30" id="Fact002551"
                                            format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">0.01
                                        </ix:nonfraction>
                                    </ix:nonfraction></span></span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right"><span
                                id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20230701__20230930_zSueKUCH0CPj"
                                title="Net loss per share - basic"><span
                                    id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20230701__20230930_z3G0XHbTLqni"
                                    title="Net loss per share - diluted">(<ix:nonfraction
                                        name="us-gaap:EarningsPerShareBasic" contextref="From2023-07-012023-09-30"
                                        id="Fact002553" format="ixt:numdotdecimal" decimals="INF" sign="-"
                                        unitref="USDPShares">
                                        <ix:nonfraction name="us-gaap:EarningsPerShareDiluted"
                                            contextref="From2023-07-012023-09-30" id="Fact002555"
                                            format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">0.10
                                        </ix:nonfraction>
                                    </ix:nonfraction></span></span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right"><span
                                id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20240401__20240930_zaCqitjZpC4b"
                                title="Net loss per share - basic"><span
                                    id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20240401__20240930_zyyoArkiCDx8"
                                    title="Net loss per share - diluted">(<ix:nonfraction
                                        name="us-gaap:EarningsPerShareBasic" contextref="From2024-04-01to2024-09-30"
                                        id="Fact002557" format="ixt:numdotdecimal" decimals="INF" sign="-"
                                        unitref="USDPShares">
                                        <ix:nonfraction name="us-gaap:EarningsPerShareDiluted"
                                            contextref="From2024-04-01to2024-09-30" id="Fact002559"
                                            format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">0.02
                                        </ix:nonfraction>
                                    </ix:nonfraction></span></span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right"><span
                                id="xdx_90D_eus-gaap--EarningsPerShareBasic_pid_c20230401__20230930_zq4QzqF5W1zg"
                                title="Net loss per share - basic"><span
                                    id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pid_c20230401__20230930_zLrZa5tomcZj"
                                    title="Net loss per share - diluted">(<ix:nonfraction
                                        name="us-gaap:EarningsPerShareBasic" contextref="From2023-04-012023-09-30"
                                        id="Fact002561" format="ixt:numdotdecimal" decimals="INF" sign="-"
                                        unitref="USDPShares">
                                        <ix:nonfraction name="us-gaap:EarningsPerShareDiluted"
                                            contextref="From2023-04-012023-09-30" id="Fact002563"
                                            format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">0.22
                                        </ix:nonfraction>
                                    </ix:nonfraction></span></span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A6_znUOQ3awk1n7"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                following table outlines dilutive common share equivalents outstanding, which were excluded in the above
                diluted net loss per share calculation
                because they are anti-dilutive. Beginning on the November 1, 2024, the Company will be required to
                redeem each month at an amount of
                $<span
                    id="xdx_901_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn2n3_c20240606__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zqmcGvEvv8i4"
                    title="Redeemable convertible debt">
                    <ix:nonfraction name="us-gaap:ConvertibleNotesPayableCurrent"
                        contextref="AsOf2024-06-06_us-gaap_ConvertibleDebtMember" id="Fact002565"
                        format="ixt:numdotdecimal" decimals="-2" scale="3" unitref="USD">235.7</ix:nonfraction>
                </span> thousand in cash or in shares of Common Stock at the lower of (i) $<span
                    id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240606__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ztFlpbT4axmi"
                    title="Debt instrument convertible price">
                    <ix:nonfraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1"
                        contextref="AsOf2024-06-06_us-gaap_ConvertibleDebtMember" id="Fact002567"
                        format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">5.00</ix:nonfraction>
                </span> per share or (ii) <span
                    id="xdx_90F_ecustom--DebtInstrumentRedemptionThresholdPercentageOfVolumeWeightedAveragePrice_dp_uPure_c20240606__20240606__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zhB79x7sa6w8"
                    title="Debt instrument redemption, threshold percentage of VWAP">
                    <ix:nonfraction name="DHAI:DebtInstrumentRedemptionThresholdPercentageOfVolumeWeightedAveragePrice"
                        contextref="From2024-06-062024-06-06_us-gaap_ConvertibleDebtMember" id="Fact002569"
                        format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">90</ix:nonfraction>
                </span>% of the average of the five lowest
                VWAPs for the <span
                    id="xdx_90F_ecustom--DebtInstrumentRedemptionThresholdConsecutiveTradingDays_dtD_c20240606__20240606__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zcnSEs9ED9Fl"
                    title="Number of consecutive trading days">
                    <ix:nonnumeric contextref="From2024-06-062024-06-06_us-gaap_ConvertibleDebtMember"
                        format="ixt-sec:durday" id="Fact002571"
                        name="DHAI:DebtInstrumentRedemptionThresholdConsecutiveTradingDays">10</ix:nonnumeric>
                </span> consecutive Trading Days ending on the trading day immediately prior to redemption date. The
                table below assumes the
                conversion and redemption price of $<span
                    id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zXkZNrRWzZ"
                    title="Debt instrument convertible price">
                    <ix:nonfraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1"
                        contextref="AsOf2024-06-30_us-gaap_ConvertibleDebtMember" id="Fact002573"
                        format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">5.00</ix:nonfraction>
                </span> per share. See Note 12 for details.</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002575"
            name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
            <p id="xdx_890_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zNNc3DGNiiHj"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span><span
                    style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8BA_z1TVkwOU8tj4">Schedule
                        of Antidilutive Securities Excluded From Computation of Net Loss Per Share</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49D_20240401__20240930_zrcTtIp1dbOl"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49F_20230401__20230930_zdeCmkp5iJy5"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            September 30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EarnoutSharesMember_zbiWMcGHl9I4"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 60%">Earnout shares</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                                contextref="From2024-04-012024-09-30_custom_EarnoutSharesMember" id="Fact002577"
                                format="ixt:numdotdecimal" decimals="INF" unitref="Shares">6,000,000</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2578">�</span>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublicWarrantsMember_ziEDwQEhFTr3"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Common Stock underlying Public Warrants</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                                contextref="From2024-04-012024-09-30_custom_PublicWarrantsMember" id="Fact002580"
                                format="ixt:numdotdecimal" decimals="INF" unitref="Shares">10,100,000</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2581">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PrivatePlacementWarrantMember_z4g3G1e4BF9d"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left">Common Stock underlying Private Placement Warrants</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                                contextref="From2024-04-012024-09-30_custom_PrivatePlacementWarrantMember"
                                id="Fact002583" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">3,235,000
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2584">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zOtRxJ3bhcn4"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Convertible debt (see Note 12)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                                contextref="From2024-04-012024-09-30_us-gaap_ConvertibleDebtSecuritiesMember"
                                id="Fact002586" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">660,000
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2587">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsIssuedWithConvertibleDebtMember_zoOPbGTTyoG6"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt">Warrants issued with convertible debt (see
                            Note 12)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                                contextref="From2024-04-012024-09-30_custom_WarrantsIssuedWithConvertibleDebtMember"
                                id="Fact002589" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">330,000
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl2590">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_zqXNcf6785Ng"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"
                                contextref="From2024-04-01to2024-09-30" id="Fact002592" format="ixt:numdotdecimal"
                                decimals="INF" unitref="Shares">20,325,000</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl2593">�</span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>
            <!-- Field: Split-Segment; Name: 001 -->
        </ix:nonnumeric>
        <p id="xdx_8A0_zZbDRoZ969tk"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002595"
        name="us-gaap:InventoryDisclosureTextBlock">
        <p id="xdx_80B_eus-gaap--InventoryDisclosureTextBlock_zoxLWgYknR51"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_829_z5q300rIIk83">Inventories, Net</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002597"
            name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock">
            <p id="xdx_89B_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJHJACc9vJwl"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                    of September 30, 2024 and March 31, 2024, inventories, net, consisted of the following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span><span
                    style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B0_zrcmREpTaVUb">Schedule
                        of Inventories, Net</span>&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49B_20240930_zpvfJMyk2CXf"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of
                            September 30, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49C_20240331_za2sVqgZcgV2"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March
                            31, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--InventoryRawMaterials_iI_pn3n3_maINznvn_zN3rXubQG572"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 60%; text-align: left">Raw materials and spare parts</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryRawMaterials" contextref="AsOf2024-09-30"
                                id="Fact002599" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,346
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryRawMaterials" contextref="AsOf2024-03-31"
                                id="Fact002600" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,882
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maINznvn_zhOgPdse6wDk"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Work in process</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryWorkInProcess" contextref="AsOf2024-09-30"
                                id="Fact002602" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,661
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryWorkInProcess" contextref="AsOf2024-03-31"
                                id="Fact002603" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,769
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_403_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINznvn_z9WpXQbCRVL5"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left">Finished goods</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryFinishedGoods" contextref="AsOf2024-09-30"
                                id="Fact002605" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,580
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryFinishedGoods" contextref="AsOf2024-03-31"
                                id="Fact002606" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,283
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_403_eus-gaap--InventoryAdjustments_iNI_pn3n3_di_msINznvn_zvNRBiExrxk8"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Less: reserves</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:InventoryAdjustments" contextref="AsOf2024-09-30" id="Fact002608"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,996</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:InventoryAdjustments" contextref="AsOf2024-03-31" id="Fact002609"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,104</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--InventoryNet_iTI_pn3n3_mtINznvn_zmGXK0tpAwOd"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt">Total inventories, net</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryNet" contextref="AsOf2024-09-30" id="Fact002611"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">9,591</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:InventoryNet" contextref="AsOf2024-03-31" id="Fact002612"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,830</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AD_zgv1h1fLykz2"
            style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 143 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002614"
        name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock">
        <p id="xdx_80C_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zYmTPB9G9saj"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_822_zexWiLYm1wVl">Property and Equipment, Net</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002616"
            name="us-gaap:PropertyPlantAndEquipmentTextBlock">
            <p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zLvBOH5UnEU7"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
                    and equipment, net as of September 30, 2024 and March 31, 2024 consisted of the following:</span>
            </p>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span><span
                    style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<span
                        id="xdx_8B5_zFor6Ffd1u05">Schedule
                        of Property and Equipment, Net</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_499_20240930_zjJtM0HzYfP1"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of
                            September 30, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49C_20240331_zDsy71BEpW86"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March
                            31, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_z4ZebcQrkyQk"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 60%; text-align: left">Computer software and hardware</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-09-30_us-gaap_ComputerEquipmentMember" id="Fact002618"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">915</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-03-31_us-gaap_ComputerEquipmentMember" id="Fact002619"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">849</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zn1Z9GMhRS4d"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Machinery and equipment</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember" id="Fact002621"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">832</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-03-31_us-gaap_MachineryAndEquipmentMember" id="Fact002622"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">807</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z9SKo6PyaB98"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left">Leasehold improvements</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-09-30_us-gaap_LeaseholdImprovementsMember" id="Fact002624"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,406</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-03-31_us-gaap_LeaseholdImprovementsMember" id="Fact002625"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,357</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zC2grF3yTbY2"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Furniture and fixtures</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-09-30_us-gaap_FurnitureAndFixturesMember" id="Fact002627"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">888</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-03-31_us-gaap_FurnitureAndFixturesMember" id="Fact002628"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">871</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zuP41ELYedq9"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td>Vehicles</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-09-30_us-gaap_VehiclesMember" id="Fact002630"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">71</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-03-31_us-gaap_VehiclesMember" id="Fact002631"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">70</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DemonstrationUnitsMember_zYgryGW4JRA3"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Demonstration units</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-09-30_custom_DemonstrationUnitsMember" id="Fact002633"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">370</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross"
                                contextref="AsOf2024-03-31_custom_DemonstrationUnitsMember" id="Fact002634"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">222</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzCTh_zBAfNudLz082"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt; text-align: left">Property and equipment</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AsOf2024-09-30"
                                id="Fact002636" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,482
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AsOf2024-03-31"
                                id="Fact002637" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,176
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzCTh_zQ55nUTTpQ1l"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"
                                contextref="AsOf2024-09-30" id="Fact002639" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">3,692</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"
                                contextref="AsOf2024-03-31" id="Fact002640" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">3,646</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzCTh_zFop0k0idYC3"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Property and equipment,
                            net</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2024-09-30"
                                id="Fact002642" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">790
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2024-03-31"
                                id="Fact002643" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">530
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A9_zBLWdzSBkHHg"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
                expense totaled $<span id="xdx_906_eus-gaap--Depreciation_pn3n3_c20240701__20240930_zDkRVHzsI7pd"
                    title="Depreciation expense">
                    <ix:nonfraction name="us-gaap:Depreciation" contextref="From2024-07-012024-09-30" id="Fact002645"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">79</ix:nonfraction>
                </span> and $<span id="xdx_907_eus-gaap--Depreciation_pn3n3_c20230701__20230930_zoV2tgGVzI83"
                    title="Depreciation expense">
                    <ix:nonfraction name="us-gaap:Depreciation" contextref="From2023-07-012023-09-30" id="Fact002647"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">68</ix:nonfraction>
                </span> for the three months ended September 30, 2024 and 2023, respectively, and $<span
                    id="xdx_909_eus-gaap--Depreciation_pn3n3_c20240401__20240930_z3QCQnvvbSQd"
                    title="Depreciation expense">
                    <ix:nonfraction name="us-gaap:Depreciation" contextref="From2024-04-01to2024-09-30" id="Fact002649"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">170</ix:nonfraction>
                </span> and $<span id="xdx_90C_eus-gaap--Depreciation_pn3n3_c20230401__20230930_z8tXhIeZKDQi"
                    title="Depreciation expense">
                    <ix:nonfraction name="us-gaap:Depreciation" contextref="From2023-04-012023-09-30" id="Fact002651"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">147</ix:nonfraction>
                </span> for the six months
                ended September 30, 2024 and 2023, respectively.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 24.5pt; text-align: justify; text-indent: -24.5pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002653"
        name="DHAI:CapitalizedSoftwareNetAndOtherIntangibleAssetsNetDisclosureTextBlock">
        <p id="xdx_80C_ecustom--CapitalizedSoftwareNetAndOtherIntangibleAssetsNetDisclosureTextBlock_zvnV0R07IUne"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span
                        id="xdx_826_zAj7c3q8ixYc">Capitalized software, net and other intangible assets,
                        net</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002655"
            name="DHAI:SummaryOfCapitalizedSoftwareNetAndOtherIntangibleAssetsNetTableTextBlock">
            <p id="xdx_890_ecustom--SummaryOfCapitalizedSoftwareNetAndOtherIntangibleAssetsNetTableTextBlock_z8WmihP4ZSE6"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
                    software, net and other intangible assets, net as of September 30, 2024 and March 31, 2024 consisted
                    of the following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B9_zj8SxnBPCcR6" style="display: none">Schedule
                        of Capitalized Software and Other Intangible Assets</span>&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            As of September 30, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            As of March 31, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Gross Carrying Amount</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Accumulated Amortization</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Net Carrying Amount</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Gross Carrying Amount</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Accumulated Amortization</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Net Carrying Amount</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 40%; text-align: left; padding-bottom: 2.5pt">Capitalized software</td>
                        <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                        <td id="xdx_98F_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20240930_zSZrCrpt3KK9"
                            title="Gross Carrying Amount, Capitalized software"
                            style="border-bottom: Black 2.5pt double; width: 6%; text-align: right">
                            <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareGross" contextref="AsOf2024-09-30"
                                id="Fact002657" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,173
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                        <td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_iNI_pn3n3_di_c20240930_zAXQPhcDNic4"
                            title="Accumulated Amortization, Capitalized software"
                            style="border-bottom: Black 2.5pt double; width: 6%; text-align: right">(<ix:nonfraction
                                name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization"
                                contextref="AsOf2024-09-30" id="Fact002659" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">181</ix:nonfraction>
                        </td>
                        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td>
                        <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                        <td id="xdx_980_eus-gaap--CapitalizedComputerSoftwareNet_iI_pn3n3_c20240930_zBTBqbaK84u6"
                            title="Net Carrying Amount, Capitalized software"
                            style="border-bottom: Black 2.5pt double; width: 6%; text-align: right">
                            <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareNet" contextref="AsOf2024-09-30"
                                id="Fact002661" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,992
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                        <td id="xdx_98B_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20240331_zCxq7xw9Fkhj"
                            title="Gross Carrying Amount, Capitalized software"
                            style="border-bottom: Black 2.5pt double; width: 6%; text-align: right">
                            <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareGross" contextref="AsOf2024-03-31"
                                id="Fact002663" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,131
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                        <td id="xdx_986_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_iNI_pn3n3_di_c20240331_znI7WTEj1tr1"
                            title="Accumulated Amortization, Capitalized software"
                            style="border-bottom: Black 2.5pt double; width: 6%; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl2665">�</span></td>
                        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="width: 2%; padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
                        <td id="xdx_988_eus-gaap--CapitalizedComputerSoftwareNet_iI_pn3n3_c20240331_zMScouTJfO68"
                            title="Net Carrying Amount, Capitalized software"
                            style="border-bottom: Black 2.5pt double; width: 6%; text-align: right">
                            <ix:nonfraction name="us-gaap:CapitalizedComputerSoftwareNet" contextref="AsOf2024-03-31"
                                id="Fact002667" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,131
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 2.5pt">Other intangible assets</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240930_zE8l7hBUyht5"
                            title="Gross Carrying Amount, Other intangible assets"
                            style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross"
                                contextref="AsOf2024-09-30" id="Fact002669" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">380</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240930_ztBy4ETubici"
                            title="Accumulated Amortization, Other intangible assets"
                            style="border-bottom: Black 2.5pt double; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl2671">�</span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_98E_eus-gaap--OtherIntangibleAssetsNet_iI_pn3n3_c20240930_zkwggC6z3SZf"
                            title="Net Carrying Amount, Other intangible assets"
                            style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherIntangibleAssetsNet" contextref="AsOf2024-09-30"
                                id="Fact002673" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">380
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_98F_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240331_zAFxW51qj0t9"
                            title="Gross Carrying Amount, Other intangible assets"
                            style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross"
                                contextref="AsOf2024-03-31" id="Fact002675" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">380</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240331_zCskUNOybF15"
                            title="Accumulated Amortization, Other intangible assets"
                            style="border-bottom: Black 2.5pt double; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl2677">�</span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_iI_pn3n3_c20240331_zI24rXOXWU6b"
                            title="Net Carrying Amount, Other intangible assets"
                            style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherIntangibleAssetsNet" contextref="AsOf2024-03-31"
                                id="Fact002679" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">380
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AC_zM7KW1ERTt3"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                intangible assets include patent and technology related intangible assets of $<span
                    id="xdx_902_eus-gaap--OtherIntangibleAssetsNet_iI_pn3n3_c20240930_zASI743EIG46"
                    title="Other intangible assets, net">
                    <ix:nonfraction name="us-gaap:OtherIntangibleAssetsNet" contextref="AsOf2024-09-30" id="Fact002681"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">380</ix:nonfraction>
                </span> acquired from the SafeGait asset acquisition. The weighted-average
                useful lives of these intangible assets are <span
                    id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240401__20240930_z9H7FVvvx0P1"
                    title="Weighted average useful lives of intangible assets">
                    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" format="ixt-sec:duryear" id="Fact002683"
                        name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">10</ix:nonnumeric>
                </span> years. For the three and six months ended September 30, 2024 and 2023, <span
                    style="background-color: white">other
                    intangible assets were not amortized because they were not ready for intended use.</span></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
                software, net and other intangible assets, net are subject to amortization when they are available for
                their intended use. Amortization
                expense totaled <span style="background-color: white">$<span
                        id="xdx_906_eus-gaap--AdjustmentForAmortization_pn3n3_c20240701__20240930_zb6hxpu5yM9l"
                        title="Amortization expense">
                        <ix:nonfraction name="us-gaap:AdjustmentForAmortization" contextref="From2024-07-012024-09-30"
                            id="Fact002685" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">181
                        </ix:nonfraction>
                    </span>and $<span
                        id="xdx_90E_eus-gaap--AdjustmentForAmortization_pn3n3_c20240401__20240930_zod4g1LXuk76"
                        title="Amortization expense">
                        <ix:nonfraction name="us-gaap:AdjustmentForAmortization" contextref="From2024-04-01to2024-09-30"
                            id="Fact002687" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">181
                        </ix:nonfraction>
                    </span> for the three and six months ended September 30, 2024, respectively
                    because it was ready for intended use. For the three and six months ended September 30, 2023, the
                    Capitalized software, net were not
                    amortized. T</span>he weighted-average useful life of capitalized software is<span
                    id="xdx_905_ecustom--CapitalizedSoftwareWeightedAverageUsefulLife_dtY_c20230701__20230930_zjspS0BuvCH4"
                    title="Capitalized software, weighted-average useful life"> <span
                        id="xdx_901_ecustom--CapitalizedSoftwareWeightedAverageUsefulLife_dtY_c20230401__20230930_zkJRRqYz7eva"
                        title="Capitalized software, weighted-average useful life">
                        <ix:nonnumeric contextref="From2023-07-012023-09-30" format="ixt-sec:duryear" id="Fact002689"
                            name="DHAI:CapitalizedSoftwareWeightedAverageUsefulLife">
                            <ix:nonnumeric contextref="From2023-04-012023-09-30" format="ixt-sec:duryear"
                                id="Fact002691" name="DHAI:CapitalizedSoftwareWeightedAverageUsefulLife">5
                            </ix:nonnumeric>
                        </ix:nonnumeric>
                    </span></span> years.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002693"
            name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
            <p id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zRwsV7yx4awk"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
                    annual amortization for intangible assets over the next five years are as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">
                <span id="xdx_8B0_zwAfuJaAL2a4" style="display: none">Schedule of Estimated Annual Amortization for
                    Intangible Assets</span><span
                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2025</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2026</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2027</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2028</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2029</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 35%; text-align: left">Estimated annual amortization</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_uUSD_c20240930_zoulHvrbzq2"
                            title="Estimated annual amortization, Remainder of fiscal year"
                            style="width: 9%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"
                                contextref="AsOf2024-09-30" id="Fact002695" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">236</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_uUSD_c20240930_zy77ku6g0DHa"
                            title="Estimated annual amortization, Year 1" style="width: 9%; text-align: right">
                            <ix:nonfraction
                                name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"
                                contextref="AsOf2024-09-30" id="Fact002697" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">473</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_uUSD_c20240930_zxXTgvmUiycc"
                            title="Estimated annual amortization, Year 2" style="width: 9%; text-align: right">
                            <ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"
                                contextref="AsOf2024-09-30" id="Fact002699" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">473</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_uUSD_c20240930_z5yxLCkFPl77"
                            title="Estimated annual amortization, Year 3" style="width: 9%; text-align: right">
                            <ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"
                                contextref="AsOf2024-09-30" id="Fact002701" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">473</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_uUSD_c20240930_zfQM8HNuMfIj"
                            title="Estimated annual amortization, Year 4" style="width: 9%; text-align: right">
                            <ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"
                                contextref="AsOf2024-09-30" id="Fact002703" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">473</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AA_zSF954MALqh5"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002705"
        name="us-gaap:OtherCurrentAssetsTextBlock">
        <p id="xdx_805_eus-gaap--OtherCurrentAssetsTextBlock_zT6doASUWEg7"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_82C_zSbXqmpraqab">Other current assets</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002707"
            name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock">
            <p id="xdx_89D_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zcXsClbnGDcd"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                    current assets as of September 30, 2024 and March 31, 2024 consisted of the following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span><span
                    style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zOTdy68UrqGa"
                        style="display: none">Schedule
                        of Other Current Assets</span>&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49B_20240930_zQ9SRzlydEXk"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of
                            September 30, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49A_20240331_zdfrHNucXfOb"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March
                            31, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_400_ecustom--DeferredCostOfSales_iI_pn3n3_maOACztdh_zROmXXAGVdj4"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 60%; text-align: left">Deferred cost of sales</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="DHAI:DeferredCostOfSales" contextref="AsOf2024-09-30" id="Fact002709"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,783</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="DHAI:DeferredCostOfSales" contextref="AsOf2024-03-31" id="Fact002710"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,754</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--ValueAddedTaxReceivable_iI_pn3n3_maOACztdh_zwBizes8KVdj"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Value added tax (�VAT�) receivable</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:ValueAddedTaxReceivable" contextref="AsOf2024-09-30"
                                id="Fact002712" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">873
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:ValueAddedTaxReceivable" contextref="AsOf2024-03-31"
                                id="Fact002713" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">635
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_402_ecustom--AdvancePayments_iI_pn3n3_maOACztdh_zFFF1KMe4LX7"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left">Advance payments</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:AdvancePayments" contextref="AsOf2024-09-30" id="Fact002715"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">696</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:AdvancePayments" contextref="AsOf2024-03-31" id="Fact002716"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">414</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--OtherAssetsMiscellaneousCurrent_iI_pn3n3_maOACztdh_zmWMH9fTX2Yk"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Other current assets</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherAssetsMiscellaneousCurrent" contextref="AsOf2024-09-30"
                                id="Fact002718" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">256
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherAssetsMiscellaneousCurrent" contextref="AsOf2024-03-31"
                                id="Fact002719" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">313
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_eus-gaap--OtherAssetsCurrent_iTI_pn3n3_mtOACztdh_zE4ogeGVFNNh"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt">Total other current assets</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherAssetsCurrent" contextref="AsOf2024-09-30"
                                id="Fact002721" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,608
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherAssetsCurrent" contextref="AsOf2024-03-31"
                                id="Fact002722" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,116
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AB_zGuuVhyyV0qe"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 144 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
                cost of sales represents products in transit or delivered to customers prior to the Company recognizing
                the associated revenue and deferred
                extended warranty contract costs in connection with the products the Company purchases from Motek Group,
                where Motek provides the warranty
                service and the associated revenue has not yet been recognized. As of September 30, 2024, deferred
                product cost and deferred warranty
                cost was $<span id="xdx_906_ecustom--DeferredProductCost_iI_pn3n3_c20240930_zx4iTj3j4Tu1"
                    title="Deferred product cost">
                    <ix:nonfraction name="DHAI:DeferredProductCost" contextref="AsOf2024-09-30" id="Fact002724"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,915</ix:nonfraction>
                </span> and $<span id="xdx_901_ecustom--DeferredWarrantyCost_iI_pn3n3_c20240930_z0AvJpLr8FWb"
                    title="Deferred warranty cost">
                    <ix:nonfraction name="DHAI:DeferredWarrantyCost" contextref="AsOf2024-09-30" id="Fact002726"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,868</ix:nonfraction>
                </span> respectively. As of March 31, 2024, deferred product cost and deferred warranty cost was $<span
                    id="xdx_90F_ecustom--DeferredProductCost_iI_pn3n3_c20240331_zHnyMH7IHVue"
                    title="Deferred product cost">
                    <ix:nonfraction name="DHAI:DeferredProductCost" contextref="AsOf2024-03-31" id="Fact002728"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,172</ix:nonfraction>
                </span> and $<span id="xdx_90B_ecustom--DeferredWarrantyCost_iI_pn3n3_c20240331_zPa572EUCdm5"
                    title="Deferred warranty cost">
                    <ix:nonfraction name="DHAI:DeferredWarrantyCost" contextref="AsOf2024-03-31" id="Fact002730"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,582</ix:nonfraction>
                </span>,
                respectively.</span></p>
        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002732"
        name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
        <p id="xdx_802_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zDwLlZMjrxDe"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_823_zZnny3U1tgWe">Accrued Expenses and Other Current Liabilities</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002734"
            name="DHAI:DisclosureOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock">
            <p id="xdx_89B_ecustom--DisclosureOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock_zeQeeZ3cp6d"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
                    expenses and other current liabilities as of September 30, 2024 and March 31, 2024 consisted of the
                    following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8BD_zzBvSNBs6aBi" style="display: none">Schedule of Accrued Expenses and Other Current
                        Liabilities</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49B_20240930_zCe2ymr8lh56"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of
                            September 30, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_490_20240331_zx3Z7WQkJEna"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March
                            31, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--TaxesPayableCurrent_iI_pn3n3_maALAOLzwtl_zICrspjKLoIl"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 60%; text-align: left">Taxes payable</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:TaxesPayableCurrent" contextref="AsOf2024-09-30"
                                id="Fact002736" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,309
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:TaxesPayableCurrent" contextref="AsOf2024-03-31"
                                id="Fact002737" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,554
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_ecustom--OtherPayablesAndCurrentLiabilities_iI_pn3n3_zvWk2VdMJ5T"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Other payables and current liabilities</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="DHAI:OtherPayablesAndCurrentLiabilities" contextref="AsOf2024-09-30"
                                id="Fact002739" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,737
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="DHAI:OtherPayablesAndCurrentLiabilities" contextref="AsOf2024-03-31"
                                id="Fact002740" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">7,381
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40E_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iTIC_pn3n3"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total accrued expenses
                            and other current liabilities</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities"
                                contextref="AsOf2024-09-30" id="Fact002742" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">11,046</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities"
                                contextref="AsOf2024-03-31" id="Fact002743" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">9,935</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AB_zISvnXypU1Fk"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002745"
        name="us-gaap:OtherLiabilitiesDisclosureTextBlock">
        <p id="xdx_801_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zFfvj0mOdURl"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_828_zkvu9I6VtH8a">Other Non-Current Liabilities</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002747"
            name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock">
            <p id="xdx_89E_eus-gaap--OtherNoncurrentLiabilitiesTableTextBlock_zKBcev6uB7B5"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                    non-current liabilities as of September 30, 2024 and March 31, 2024 consisted of the
                    following:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B5_zbWxIVnc57cc" style="display: none">Summary of Other Non-Current
                        Liabilities</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_490_20240930_znl31s2Pg4E6"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of
                            September 30, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_490_20240331"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March
                            31, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40E_ecustom--Provisions_iI_pn3n3_zJIMeAhGqXS7"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 60%">Provisions</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="DHAI:Provisions" contextref="AsOf2024-09-30" id="Fact002749"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,909</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="DHAI:Provisions" contextref="AsOf2024-03-31" id="Fact002750"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,977</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40D_ecustom--PensionLiabilities_iI_pn3n3_zyfHqpZwLpC5"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Pension liabilities</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="DHAI:PensionLiabilities" contextref="AsOf2024-09-30" id="Fact002752"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,225</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="DHAI:PensionLiabilities" contextref="AsOf2024-03-31" id="Fact002753"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,194</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--OtherLiabilitiesNoncurrent_iTI_pn3n3_zqLc6kjhfcCe"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total other non-current
                            liabilities</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherLiabilitiesNoncurrent" contextref="AsOf2024-09-30"
                                id="Fact002755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,134
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherLiabilitiesNoncurrent" contextref="AsOf2024-03-31"
                                id="Fact002756" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,171
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A5_zhB5gdnsKO9e"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                company has recorded non-current liabilities related to tax positions in certain jurisdictions in which,
                upon examination, may require
                additional tax payments to be made. In addition, the company has recorded potential interest and
                penalties related to these uncertain
                tax positions.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002758"
        name="us-gaap:DebtDisclosureTextBlock">
        <p id="xdx_804_eus-gaap--DebtDisclosureTextBlock_zNTSySmD1iFi"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_824_zG98ZOyWLPf8">Convertible Debt and Warrant</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                June 6, 2024, the Company entered into a Securities Purchase Agreement (the �Purchase Agreement�) with
                the purchasers named
                therein (the �Purchasers�), pursuant to which the Company issued $<span
                    id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMBlRpUduJdi"
                    title="Aggregate principal amount">
                    <ix:nonfraction name="us-gaap:DebtInstrumentFaceAmount"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember"
                        id="Fact002760" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">3.3
                    </ix:nonfraction>
                </span> million in principal amount of <span
                    id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zBoiOQRAFO4i"
                    title="Original issue discount percentage">
                    <ix:nonfraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember"
                        id="Fact002762" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">8
                    </ix:nonfraction>
                </span>% Original Issue Discount
                Senior Secured Convertible Debentures (the �Debentures� or �Convertible Debt�). The Debentures were
                issued with
                an original issue discount of $<span
                    id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_pn5n6_c20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_ziwi015FWX2j"
                    title="Debentures issued with original issue discount">
                    <ix:nonfraction name="us-gaap:DebtInstrumentCarryingAmount"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember"
                        id="Fact002764" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">0.3
                    </ix:nonfraction>
                </span> million, resulting in gross proceeds of $<span
                    id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_pn6n6_c20240606__20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zrWJ4Yil2pB6"
                    title="Gross proceeds from issuance of debt">
                    <ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfDebt"
                        contextref="From2024-06-062024-06-06_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_custom_SecuritiesPurchaseAgreementMember"
                        id="Fact002766" format="ixt:numdotdecimal" decimals="-6" scale="6" unitref="USD">3
                    </ix:nonfraction>
                </span> million and net proceeds of approximately $<span
                    id="xdx_904_ecustom--NetProceedsFromIssuanceOfDebt_pn5n6_c20240606__20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zjGHoiJMYS9k"
                    title="Net proceeds from issuance of debt">
                    <ix:nonfraction name="DHAI:NetProceedsFromIssuanceOfDebt"
                        contextref="From2024-06-062024-06-06_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_custom_SecuritiesPurchaseAgreementMember"
                        id="Fact002768" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">2.8
                    </ix:nonfraction>
                </span> million
                including $<span
                    id="xdx_907_eus-gaap--DebtInstrumentCollateralAmount_iI_pn5n6_c20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zcAWvMBIhUNl"
                    title="Bank deposit for additional security for debentures">
                    <ix:nonfraction name="us-gaap:DebtInstrumentCollateralAmount"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember"
                        id="Fact002770" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">0.3
                    </ix:nonfraction>
                </span> million deposited into a bank account as additional security for the Debentures after deducting
                offering expenses. At
                election of the holder, the Debentures are convertible into an aggregate of <span
                    id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20240606__20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zp5BNCO86y2b"
                    title="Debentures convertible into common shares">
                    <ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1"
                        contextref="From2024-06-062024-06-06_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember"
                        id="Fact002772" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">660,000
                    </ix:nonfraction>
                </span> shares of the Company�s Common Stock at a conversion
                price of $<span
                    id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zS0r0IvbNfpg"
                    title="Convertible into common shares per share">
                    <ix:nonfraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1"
                        contextref="AsOf2024-06-06_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember"
                        id="Fact002774" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">5.00
                    </ix:nonfraction>
                </span> per share, subject to adjustment in whole or in part from the issuance date. The Debentures
                mature on <span
                    id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20240606__20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqGBcW30bjha"
                    title="Debt instrument, maturity date">
                    <ix:nonnumeric
                        contextref="From2024-06-062024-06-06_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_custom_SecuritiesPurchaseAgreementMember"
                        format="ixt:datemonthdayyearen" id="Fact002776" name="us-gaap:DebtInstrumentMaturityDate">
                        December 7, 2025</ix:nonnumeric>
                </span>
                (the �Maturity Date�), and bear interest at a rate of <span
                    id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zIhywd9Zpkx2"
                    title="Debt instrument interest rate">
                    <ix:nonfraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember"
                        id="Fact002778" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">8
                    </ix:nonfraction>
                </span>% per annum, payable monthly beginning one year from the issuance
                date.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company may provide an irrevocable election to redeem some or all of the then outstanding principal
                amount of the Debenture (in minimum
                increments of $<span
                    id="xdx_902_eus-gaap--DebtInstrumentIncreaseDecreaseForPeriodNet_pn5n6_c20240606__20240606__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zbqGpDCMs2qi"
                    title="Minimum increments of outstanding principal amount">
                    <ix:nonfraction name="us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet"
                        contextref="From2024-06-062024-06-06_us-gaap_ConvertibleDebtMember" id="Fact002780"
                        format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">0.3</ix:nonfraction>
                </span> million unless the outstanding principal amount is less than $<span
                    id="xdx_90E_eus-gaap--ShorttermDebtMaximumAmountOutstandingDuringPeriod_pn5n6_c20240606__20240606__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zqwLERTsLCj3"
                    title="Outstanding principal amount">
                    <ix:nonfraction name="us-gaap:ShorttermDebtMaximumAmountOutstandingDuringPeriod"
                        contextref="From2024-06-062024-06-06_us-gaap_ConvertibleDebtMember" id="Fact002782"
                        format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">0.3</ix:nonfraction>
                </span> million) for cash. Beginning on the November 1,
                2024, the Company will be required to redeem an amount of the Debentures equal to $<span
                    id="xdx_908_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn2n3_c20240606__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zUlZ1HHxGWD1"
                    title="Redeemable convertible debt">
                    <ix:nonfraction name="us-gaap:ConvertibleNotesPayableCurrent"
                        contextref="AsOf2024-06-06_us-gaap_ConvertibleDebtMember" id="Fact002784"
                        format="ixt:numdotdecimal" decimals="-2" scale="3" unitref="USD">235.7</ix:nonfraction>
                </span> thousand, together with all other amounts owed
                to the Purchaser. Such amount shall be payable in cash or in shares of Common Stock based on a
                conversion price equal to the lesser of
                (i) the then Conversion Price and (ii) <span
                    id="xdx_90C_eus-gaap--DebtWeightedAverageInterestRate_iI_pid_dp_uPure_c20240606__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z1y2NjpeV0x8"
                    title="Percentage of five lowest VWAPs">
                    <ix:nonfraction name="us-gaap:DebtWeightedAverageInterestRate"
                        contextref="AsOf2024-06-06_us-gaap_ConvertibleDebtMember" id="Fact002786"
                        format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">90</ix:nonfraction>
                </span>% of the average of the five lowest VWAPs for the <span
                    id="xdx_905_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_uTradingDays_c20240606__20240606__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z7kSrehFwuZc"
                    title="Trading days">
                    <ix:nonfraction name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays"
                        contextref="From2024-06-062024-06-06_us-gaap_ConvertibleDebtMember" id="Fact002788"
                        format="ixt:numdotdecimal" decimals="INF" unitref="TradingDays">10</ix:nonfraction>
                </span> consecutive Trading Days ending on the
                trading day immediately prior to redemption date.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                    id="xdx_909_eus-gaap--LongTermDebtMaturitiesRepaymentTerms_c20240606__20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zxbAjZgdGeO1"
                    title="Debt instruments, maturities, repayment terms">
                    <ix:nonnumeric
                        contextref="From2024-06-062024-06-06_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember_us-gaap_ConvertibleDebtMember"
                        id="Fact002790" name="us-gaap:LongTermDebtMaturitiesRepaymentTerms">Provided
                        that no event of default has occurred or is continuing, and at least <span
                            id="xdx_900_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20240606__20240606__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zxaCSNUZ9BP6"
                            title="Minimum percentage of principle amount of debentures repaid or converted">
                            <ix:nonfraction
                                name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"
                                contextref="From2024-06-062024-06-06_us-gaap_ConvertibleDebtMember" id="Fact002792"
                                format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">33</ix:nonfraction>
                        </span>% of the principal amount of the Debentures has either previously
                        been repaid or converted in accordance with the terms of the Debenture, the Company may elect,
                        by notice to the holder of the Debentures,
                        to extend the Maturity Date by six months upon the payment of six months� interest on the
                        then-outstanding principal amount.</ix:nonnumeric>
                </span> The
                monthly redemption amount is then adjusted to correspond to the extended maturity date.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Debentures are secured by substantially all of the assets of the Company and its domestic subsidiaries,
                excluding certain specified assets.
                Additionally, the Company�s domestic subsidiaries have provided an unconditional guarantee of the
                Debentures.</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 145 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                connection with the issuance of the Debentures, the Company also issued warrants to purchase an
                aggregate of <span
                    id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zSzpB9ImnH14"
                    title="Class of warrants or rights warrants issued during the period units">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember"
                        id="Fact002794" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">330,000
                    </ix:nonfraction>
                </span> shares of common
                stock at an exercise price of $<span
                    id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zoLnCRlodEOk"
                    title="Number of warrant or right, exercise price">
                    <ix:nonfraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"
                        contextref="AsOf2024-06-06_custom_SecuritiesPurchaseAgreementMember_custom_OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember"
                        id="Fact002796" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">5.00
                    </ix:nonfraction>
                </span> per share, with a <span
                    id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20240606__us-gaap--LongtermDebtTypeAxis__custom--OriginalIssueDiscountSeniorSecuredConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z26hBsNLFUz5"
                    title="Term of warrants::XDX::P5Y"><span
                        style="-sec-ix-hidden: xdx2ixbrl2798">five-year</span></span> term.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                adoption of ASU 2020-06, the Company accounted for the convertible debt along with the associated
                conversion feature as a single liability
                measured at fair value to simplify the accounting for the convertible instrument. The fair value of the
                convertible debt was measured
                using a Monte Carlo simulation model. The change in fair value is presented in other comprehensive
                income to the extent that it is attributable
                to credit risk. The remaining portion of the change in fair value is recognized in other income
                (expense), net in the condensed consolidated
                results of operations.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company evaluated the freestanding warrants issued in connection with issuance of the convertible debt
                under ASC 815 and determined that
                they were classified as liability on the condensed consolidated balance sheets. The fair value of the
                warrant on the issuance date calculated
                using a Monte Carlo simulation model. The proceeds from the issuance of the convertible debt were
                allocated to the warrants and convertible
                note under the relative fair value method<span style="background-color: white">.</span></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Monte Carlo simulation model required certain assumptions, including a risk-free rate of <span
                    id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zCJ8MEFPcsd8"
                    title="Warrants and rights outstanding, measurement input">
                    <ix:nonfraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput"
                        contextref="AsOf2024-09-30_custom_PublicWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
                        id="Fact002800" format="ixt:numdotdecimal" decimals="INF" unitref="Pure">3.78</ix:nonfraction>
                </span>%, a credit spread of <span
                    id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember_zDtpQGHQu0s2"
                    title="Warrants and rights outstanding, measurement input">
                    <ix:nonfraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput"
                        contextref="AsOf2024-09-30_custom_PublicWarrantsMember_us-gaap_MeasurementInputCreditSpreadMember"
                        id="Fact002802" format="ixt:numdotdecimal" decimals="INF" unitref="Pure">27.4</ix:nonfraction>
                </span>% and an estimated
                volatility of <span
                    id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zho8XvFfdw29"
                    title="Warrants and rights outstanding, measurement input">
                    <ix:nonfraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput"
                        contextref="AsOf2024-09-30_custom_PublicWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember"
                        id="Fact002804" format="ixt:numdotdecimal" decimals="INF" unitref="Pure">62.5</ix:nonfraction>
                </span>%, respectively as of September 30, 2024. The risk-free interest rate assumption was based on
                U.S. treasury constant
                maturity yields on the issuance date with a term corresponding to the expected length of the remaining
                term. The credit spread was derived
                based on the terms and economics of the instruments and to reconcile the model values of the basket
                (consisting of convertible notes
                and warrants) with the proceeds generated from the issuance and sale of the basket in an arm�s-length
                transaction on the inception
                date. Due to the Company�s limited trading history, the estimated volatility assumption was based upon
                the observed historical
                volatilities of the designated peer group and consideration of volatility haircut concepts, typical in
                practice in the valuation of convertible
                instruments. There was no dividend yield utilized in the Monte Carlo simulation model as the Company has
                not paid any cash dividends.
                Such assumptions were applied to both the convertible debt and warrant liability as unobservable inputs.
                The convertible debt and warrant
                were considered Level 3 in the fair value hierarchy. The Company assesses the credit spread at each
                reporting date in valuation to determine
                the amount that should be recorded to other comprehensive income.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                of the issuance date, the debenture was measured at $<span
                    id="xdx_90A_eus-gaap--DebtInstrumentFairValue_iI_pn3n3_c20240606_zs8mgNkeFvRd"
                    title="Measurement of debt instrument fair value">
                    <ix:nonfraction name="us-gaap:DebtInstrumentFairValue" contextref="AsOf2024-06-06" id="Fact002806"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,638</ix:nonfraction>
                </span>and the warrant was measured at $<span
                    id="xdx_901_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_c20240606_zTeaJnFNdgZ5"
                    title="Measurement of warrant liability">
                    <ix:nonfraction name="us-gaap:WarrantsAndRightsOutstanding" contextref="AsOf2024-06-06"
                        id="Fact002808" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">362
                    </ix:nonfraction>
                </span>. A total of $<span
                    id="xdx_909_eus-gaap--PaymentsOfDebtIssuanceCosts_pn3n3_c20240401__20240930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_z17bIXCvv7J2"
                    title="Debt issuance costs">
                    <ix:nonfraction name="us-gaap:PaymentsOfDebtIssuanceCosts"
                        contextref="From2024-04-012024-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
                        id="Fact002810" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">191
                    </ix:nonfraction>
                </span> debt issuance costs
                was recorded in �Selling, general, and administrative expense� in the condensed consolidated statements
                of operations.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                of September 30, 2024, the fair value of the debenture was measured at $<span
                    id="xdx_907_eus-gaap--EquitySecuritiesFvNiCurrentAndNoncurrent_iI_pn3n3_c20240930_zeoD9Dh5uKX9"
                    title="Fair value of debenture">
                    <ix:nonfraction name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" contextref="AsOf2024-09-30"
                        id="Fact002812" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,920
                    </ix:nonfraction>
                </span> recorded to �<span style="background-color: white">Current
                    maturities of convertible debt� and �Convertible debt, net of current maturities�</span> in <span
                    style="background-color: white">the
                    condensed consolidated balance sheets</span>. The warrant was measured at $<span
                    id="xdx_90D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_c20240930_zBylo40dnXb3"
                    title="Accrued expenses and other liabilities">
                    <ix:nonfraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextref="AsOf2024-09-30"
                        id="Fact002814" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">480
                    </ix:nonfraction>
                </span> recorded to �<span style="background-color: white">Accrued
                    expenses and other current liabilities� in the condensed consolidated balance sheets</span>. The
                Company recorded $<span
                    id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20240930_zXRSEQ9PJpFg"
                    title="Fair value of debenture and warrants">
                    <ix:nonfraction name="us-gaap:FairValueAdjustmentOfWarrants" contextref="From2024-07-012024-09-30"
                        id="Fact002816" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">295
                    </ix:nonfraction>
                </span> and $<span
                    id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240401__20240930_zO89jV5xY4A9"
                    title="Fair value of debenture and warrants">
                    <ix:nonfraction name="us-gaap:FairValueAdjustmentOfWarrants" contextref="From2024-04-01to2024-09-30"
                        id="Fact002818" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">400
                    </ix:nonfraction>
                </span>
                change in the fair value of the debenture and the warrant to the �Other income (expense), net� in the
                condensed consolidated
                statements of operations for the three and six months ended September 30, 2024.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002820"
        name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock">
        <p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zfdlCZBnxQ1c"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span
                        id="xdx_829_z6nkTeuxeITl">Related Party Transactions</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
                are considered related to the Company if the parties, directly or indirectly, through one or more
                intermediaries, control, are controlled
                by, or are under common control with the Company. Related parties also include principal owners of the
                Company, its management, members
                of the immediate families of principal owners of the Company and its management and other parties with
                which the Company may deal with
                if one party controls or can significantly influence the management or operating policies of the other
                to an extent that one of the transacting
                parties might be prevented from fully pursuing its own separate interests. The Company discloses all
                related party transactions.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reorganization
                        and Transaction with DIH Cayman and DIH Hong Kong</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company�s businesses have historically functioned together with the other businesses controlled by DIH
                Cayman. DIH Cayman remains
                the largest shareholder of the Company and continues to own <span
                    id="xdx_90B_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20240930__us-gaap--BusinessAcquisitionAxis__custom--DIHHongKongMember_zzVAFpe6F7Ud"
                    title="Percentage of Interest own by wholly owned subsidiaries">
                    <ix:nonfraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired"
                        contextref="AsOf2024-09-30_custom_DIHHongKongMember" id="Fact002822" format="ixt:numdotdecimal"
                        decimals="INF" scale="-2" unitref="Pure">100</ix:nonfraction>
                </span>% interest in DIH International (�DIH Hong Kong�) as of September
                30, 2024<span style="background-color: white">. </span></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
                to the year ended March 31, 2022, the Company did not incur significant transactions with DIH Cayman or
                DIH Hong Kong. The balances recorded
                under �Due from related party� and �Due to related party� are derived from historical transactions. The
                table
                below summarizes related party balances with DIH Hong Kong excluding Hocoma AG and Motek as of September
                30, 2024 and March 31, 2024</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 146 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
            &nbsp;</p>

        <ix:nonnumeric contextref="From2024-04-012024-09-30_custom_DihCaymanAndDihHongKongMember" escape="true"
            id="Fact002824" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock">
            <p id="xdx_899_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DihCaymanAndDihHongKongMember_ze3Zoy47YT75"
                style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B6_zYwMZhJlWsQd" style="display: none">Schedule of Related Party Balances with Related
                        Party</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49E_20240930_zm3GOkV49th1"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30,
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49C_20240331_zC5YcGPQmrp1"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2024
                        </td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--OtherReceivables_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DIHHongKongMember_zmJpG3D6uJD1"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 60%; text-align: left">Due from related party</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherReceivables"
                                contextref="AsOf2024-09-30_custom_DIHHongKongMember22266953" id="Fact002826"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,641</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherReceivables"
                                contextref="AsOf2024-03-31_custom_DIHHongKongMember22266921" id="Fact002827"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,586</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--OtherLiabilities_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DIHHongKongMember_z2Qqgz0TN7pl"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Due to related party</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherLiabilities"
                                contextref="AsOf2024-09-30_custom_DIHHongKongMember22266953" id="Fact002829"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,504</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherLiabilities"
                                contextref="AsOf2024-03-31_custom_DIHHongKongMember22266921" id="Fact002830"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,470</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A4_zoz2b4ye4HQh"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Hocoma
                        AG and share transfers</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                <span
                    id="xdx_908_ecustom--OriginalContributionAgreementDate_c20210701__20210701__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zQOosJaQoHU6"
                    title="Original contribution agreement date">
                    <ix:nonnumeric contextref="From2021-07-012021-07-01_custom_HocomaAgMember"
                        format="ixt:datemonthdayyearen" id="Fact002832" name="DHAI:OriginalContributionAgreementDate">
                        July 1, 2021</ix:nonnumeric>
                </span>, Hocoma AG entered into a series of agreements with the Company and its subsidiaries to transfer
                all business aspects of
                development and production of mechanical and electronic devices in the fields of medical technology and
                biotechnology to Hocoma Medical
                GmbH as disclosed in the Company�s Annual Report on Form 10-K for the year ended March 31, 2024. In
                connection with the transactions,
                the Company incurred three related party notes payable to Hocoma AG amounting to $<span
                    id="xdx_908_eus-gaap--NotesPayable_iI_pn4n6_c20240930__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyOneMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zaENWUvIlaYj"
                    title="Notes payable - related party">
                    <ix:nonfraction name="us-gaap:NotesPayable"
                        contextref="AsOf2024-09-30_custom_RelatedPartyOneMember_custom_HocomaAgMember" id="Fact002834"
                        format="ixt:numdotdecimal" decimals="-4" scale="6" unitref="USD">10.47</ix:nonfraction>
                </span> million, $<span
                    id="xdx_909_eus-gaap--NotesPayable_iI_pn4n6_c20240930__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zNWzgOo97k31"
                    title="Notes payable - related party">
                    <ix:nonfraction name="us-gaap:NotesPayable"
                        contextref="AsOf2024-09-30_custom_RelatedPartyTwoMember_custom_HocomaAgMember" id="Fact002836"
                        format="ixt:numdotdecimal" decimals="-4" scale="6" unitref="USD">7.80</ix:nonfraction>
                </span> million and $<span
                    id="xdx_901_eus-gaap--NotesPayable_iI_pn4n6_c20240930__us-gaap--RelatedPartyTransactionAxis__custom--RelatedPartyThreeMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zas2yPwsUQJ5"
                    title="Notes payable - related party">
                    <ix:nonfraction name="us-gaap:NotesPayable"
                        contextref="AsOf2024-09-30_custom_RelatedPartyThreeMember_custom_HocomaAgMember" id="Fact002838"
                        format="ixt:numdotdecimal" decimals="-4" scale="6" unitref="USD">1.57</ix:nonfraction>
                </span> million, respectively.
                The <span
                    id="xdx_907_ecustom--NumberOfNotesPayableToRelatedParty_dc_uNotePayable_c20240401__20240930_zuVUecQd0iZ"
                    title="Number of notes payable to related party">
                    <ix:nonfraction name="DHAI:NumberOfNotesPayableToRelatedParty"
                        contextref="From2024-04-01to2024-09-30" id="Fact002840" format="ixt-sec:numwordsen"
                        decimals="INF" unitref="NotePayable">three</ix:nonfraction>
                </span> related party notes payable are referred to as �Related Party Notes�. Each of the Related Party
                Notes Payable is
                due on <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20240401__20240930_zoTK9pJqY0yk"
                    title="Debt instrument, maturity date">
                    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" format="ixt:datemonthdayyearen"
                        id="Fact002842" name="us-gaap:DebtInstrumentMaturityDate">June 30, 2026</ix:nonnumeric>
                </span> with interest rate of <span
                    id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240930_zVVuZfVBcJta"
                    title="Debt instrument interest rate">
                    <ix:nonfraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage"
                        contextref="AsOf2024-09-30" id="Fact002844" format="ixt:numdotdecimal" decimals="INF" scale="-2"
                        unitref="Pure">1.25</ix:nonfraction>
                </span>%. The Company has made periodic payments on Related Party Notes payable with proceeds
                from its operations.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                of September 30, 2024 and March 31, 2024, the balances of Related Party Notes were $<span
                    id="xdx_909_eus-gaap--NotesPayable_iI_pn5n6_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z2iTlwUAm744"
                    title="Notes payable - related party">
                    <ix:nonfraction name="us-gaap:NotesPayable" contextref="AsOf2024-09-30_us-gaap_RelatedPartyMember"
                        id="Fact002846" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">9.4
                    </ix:nonfraction>
                </span> million and $<span
                    id="xdx_909_eus-gaap--NotesPayable_iI_pn5n6_c20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zD6yra2FZPQk"
                    title="Notes payable - related party">
                    <ix:nonfraction name="us-gaap:NotesPayable" contextref="AsOf2024-03-31_us-gaap_RelatedPartyMember"
                        id="Fact002848" format="ixt:numdotdecimal" decimals="-5" scale="6" unitref="USD">11.5
                    </ix:nonfraction>
                </span> million, respectively included
                in �Note payable - related party�. The decrease resulted from the Company�s payments of principal on
                Related Party
                Notes owed to Hocoma AG.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                addition to the Related Party Notes, as of September 30, 2024 and March 31, 2024, the Company recorded a
                related party balance of $<span
                    id="xdx_90E_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pn3n3_c20240401__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_ziX5kRqrfIma"
                    title="Net settlement amount">
                    <ix:nonfraction name="us-gaap:RelatedPartyTransactionAmountsOfTransaction"
                        contextref="From2024-04-012024-09-30_custom_HocomaAgMember" id="Fact002850"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">321</ix:nonfraction>
                </span>
                and $<span
                    id="xdx_905_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pn3n3_c20230401__20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zNySNkWa8Awf"
                    title="Net settlement amount">(<ix:nonfraction
                        name="us-gaap:RelatedPartyTransactionAmountsOfTransaction"
                        contextref="From2023-04-012024-03-31_custom_HocomaAgMember" id="Fact002852"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitref="USD">267</ix:nonfraction>
                    )</span>, respectively, representing cash balances owed by and owed to Hocoma AG. As part of the
                transfer discussed above, the Company
                also recorded a long-term related party receivable for $<span
                    id="xdx_90D_ecustom--LongTermRelatedPartyReceivable_iI_pn3n3_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_zpjWjBF4Ev78"
                    title="Long-term related party receivable"><span
                        id="xdx_905_ecustom--LongTermRelatedPartyReceivable_iI_pn3n3_c20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HocomaAgMember_z7l9f6ZDXKti"
                        title="Long-term related party receivable">
                        <ix:nonfraction name="DHAI:LongTermRelatedPartyReceivable"
                            contextref="AsOf2024-09-30_custom_HocomaAgMember" id="Fact002854" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">
                            <ix:nonfraction name="DHAI:LongTermRelatedPartyReceivable"
                                contextref="AsOf2024-03-31_custom_HocomaAgMember" id="Fact002856"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">324</ix:nonfraction>
                        </ix:nonfraction>
                    </span></span> as of September 30, 2024 and March 31, 2024, included in �Other assets�.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Motek
                        Group</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company has entered into a distribution agreement with the Motek Group. The agreement, which has been
                historically in place, appoints
                the Company as the exclusive distributor of Motek�s advanced human movement research and rehabilitation
                products and services designed
                to support efficient functional movement therapy within specified territories. Under the distribution
                agreement, Motek supplies the products
                and services to the Company at the prices detailed in the agreement. Motek provides ongoing support and
                assistance, including training,
                marketing materials, and technical documentation to the Company. In connection with the products the
                Company purchased from Motek Group,
                the Company purchased warranty associated with the products. Upon distribution of Motek products, the
                cost of warranty are recorded to
                deferred cost of sales in �Other current assets� prior to the Company recognizing warranty
                revenue.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                the three months ended September 30, 2024 and 2023, the Company made purchases amounti<span
                    style="background-color: white">ng to $<span
                        id="xdx_90E_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pn3n3_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MotekGroupMember_zN2JszgclhGi"
                        title="Purchases amount to related party">
                        <ix:nonfraction name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty"
                            contextref="From2024-07-012024-09-30_custom_MotekGroupMember" id="Fact002858"
                            format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,978</ix:nonfraction>
                    </span>
                    a</span>nd $<span
                    id="xdx_90B_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pn3n3_c20230701__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MotekGroupMember_zhO5C8gBaq03"
                    title="Purchases amount to related party">
                    <ix:nonfraction name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty"
                        contextref="From2023-07-012023-09-30_custom_MotekGroupMember" id="Fact002860"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,189</ix:nonfraction>
                </span>, respectively, from the Motek Group. For the six months ended September 30, 2024 and 2023, the
                Company made purchases
                amounti<span style="background-color: white">ng to $<span
                        id="xdx_905_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pn3n3_c20240401__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MotekGroupMember_zCrC31H13Msk"
                        title="Purchases amount to related party">
                        <ix:nonfraction name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty"
                            contextref="From2024-04-012024-09-30_custom_MotekGroupMember" id="Fact002862"
                            format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,973</ix:nonfraction>
                    </span> a</span>nd $<span
                    id="xdx_90F_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pn3n3_c20230401__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MotekGroupMember_ztuQQkTLUKSd"
                    title="Purchases amount to related party">
                    <ix:nonfraction name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty"
                        contextref="From2023-04-012023-09-30_custom_MotekGroupMember" id="Fact002864"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">5,958</ix:nonfraction>
                </span>, respectively, from the Motek Group.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-012024-09-30_custom_MotekGroupMember" escape="true" id="Fact002866"
            name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock">
            <p id="xdx_894_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MotekGroupMember_zwWIGckiDV19"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                    part of these transactions, the Company made advance payments to Motek, included in �Due from
                    related party,� and also had
                    trade payables, included in �Due to related party.� The balances as of September 30, 2024 and March
                    31, 2024 are as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B5_zPTuoSb3XKkb" style="display: none">Schedule of Related Party Balances with Related
                        Party</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_494_20240930_zzxdhlgHsmg7"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30,
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49D_20240331_zQRcDotqEEKb"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2024
                        </td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--OtherReceivables_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MotekGroupMember_zTUHqkU5scY4"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 60%; text-align: left">Due from related party</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherReceivables"
                                contextref="AsOf2024-09-30_custom_MotekGroupMember" id="Fact002868"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,169</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherReceivables"
                                contextref="AsOf2024-03-31_custom_MotekGroupMember" id="Fact002869"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,367</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_eus-gaap--OtherLiabilities_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MotekGroupMember_zpviohRd3Wml"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Due to related party</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherLiabilities"
                                contextref="AsOf2024-09-30_custom_MotekGroupMember" id="Fact002871"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">8,762</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherLiabilities"
                                contextref="AsOf2024-03-31_custom_MotekGroupMember" id="Fact002872"
                                format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">8,667</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A1_zUtXmKF15dU7"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002874"
        name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock">
        <p id="xdx_801_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zYjpCylyksdd"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_829_za8jW8oRxBo">Employee Benefit Plans</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Defined
                        Contribution Plans</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company sponsors a defined contribution plan in the United States. The Company�s obligation is limited
                to its contributions made
                in accordance with each plan document. Employer contributions to defined contribution plans are re<span
                    style="background-color: white">cognized
                    as expense recorded in the �</span>Selling, general, and administrative expense�<span
                    style="background-color: white">. Expenses
                    related to the Company�s plans were $<span
                        id="xdx_905_eus-gaap--DefinedContributionPlanCostRecognized_pn3n3_c20240701__20240930_z3Z4A0Cn7Z6l"
                        title="Defined contribution plan expenses">
                        <ix:nonfraction name="us-gaap:DefinedContributionPlanCostRecognized"
                            contextref="From2024-07-012024-09-30" id="Fact002876" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">26</ix:nonfraction>
                    </span> and $<span
                        id="xdx_908_eus-gaap--DefinedContributionPlanCostRecognized_pn3n3_c20230701__20230930_zFS9nX73cejk"
                        title="Defined contribution plan expenses">
                        <ix:nonfraction name="us-gaap:DefinedContributionPlanCostRecognized"
                            contextref="From2023-07-012023-09-30" id="Fact002878" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">46</ix:nonfraction>
                    </span> for </span>the three months ended September 30, 2024 and 2023, respectively, <span
                    style="background-color: white">and
                    $<span
                        id="xdx_904_eus-gaap--DefinedContributionPlanCostRecognized_pn3n3_c20240401__20240930_zchXlQVgmbX8"
                        title="Defined contribution plan expenses">
                        <ix:nonfraction name="us-gaap:DefinedContributionPlanCostRecognized"
                            contextref="From2024-04-01to2024-09-30" id="Fact002880" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">66</ix:nonfraction>
                    </span> and $<span
                        id="xdx_904_eus-gaap--DefinedContributionPlanCostRecognized_pn3n3_c20230401__20230930_zyRoAB3Sv16g"
                        title="Defined contribution plan expenses">
                        <ix:nonfraction name="us-gaap:DefinedContributionPlanCostRecognized"
                            contextref="From2023-04-012023-09-30" id="Fact002882" format="ixt:numdotdecimal"
                            decimals="-3" scale="3" unitref="USD">78</ix:nonfraction>
                    </span> for the six months ended September 30, 2024 and 2023, respectively.</span></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 147 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&nbsp;</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Defined
                        Benefit Plans</i></b></span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company has a Swis<span style="background-color: white">s defined benefit plans (the �Pension Plan�)
                    covering substantially
                    all the employees of Hocoma Medical GmbH in Switzerland. The Pension Plan meets the benefit
                    requirements under Swiss pension law. The
                    Swiss plans offer retirement, disability and surv</span>ivor benefits and is governed by a Pension
                Foundation Board. The responsibilities
                of this board are defined by Swiss pension law and the plan rules. Expenses from defined benefit plan
                are allocated to Cost of Sales,
                Selling, general, and administrative expense and Research and development.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002884"
            name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
            <p id="xdx_89F_eus-gaap--ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_z03N2EPIKr67"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
                    recognized in the condensed consolidated statements of operations for the three and six months ended
                    September 30, 2024 and 2023, in
                    respect of the Pension Plan were as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8BD_zqNS0pIGnlC8" style="display: none">Schedule of Pension Plans</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49A_20240701__20240930_z6P60NrQfTK4"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_493_20230701__20230930_zjH9xaQF0Tfb"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49D_20240401__20240930_zODYv78X91hg"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49C_20230401__20230930_zD4Z6YOX6F53"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Three Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Six Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_403_eus-gaap--DefinedBenefitPlanServiceCost_pn3n3_msPIEz5ma_zwKUA425US5h"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 40%; text-align: left">Current service cost</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanServiceCost"
                                contextref="From2024-07-012024-09-30" id="Fact002886" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">180</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanServiceCost"
                                contextref="From2023-07-012023-09-30" id="Fact002887" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">171</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanServiceCost"
                                contextref="From2024-04-01to2024-09-30" id="Fact002888" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">353</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanServiceCost"
                                contextref="From2023-04-012023-09-30" id="Fact002889" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">330</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40E_eus-gaap--DefinedBenefitPlanInterestCost_pn3n3_msPIEz5ma_z0cyw2YdCFPf"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Interest cost</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanInterestCost"
                                contextref="From2024-07-012024-09-30" id="Fact002891" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">50</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanInterestCost"
                                contextref="From2023-07-012023-09-30" id="Fact002892" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">52</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanInterestCost"
                                contextref="From2024-04-01to2024-09-30" id="Fact002893" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">101</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:DefinedBenefitPlanInterestCost"
                                contextref="From2023-04-012023-09-30" id="Fact002894" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">102</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--DefinedBenefitPlanExpectedReturnOnPlanAssets_iN_pn3n3_di_maPIEz5ma_zXyoNe2s5k41"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left">Expected return on plan assets</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets"
                                contextref="From2024-07-012024-09-30" id="Fact002896" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">97</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets"
                                contextref="From2023-07-012023-09-30" id="Fact002897" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">73</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets"
                                contextref="From2024-04-01to2024-09-30" id="Fact002898" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">195</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets"
                                contextref="From2023-04-012023-09-30" id="Fact002899" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">142</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_iN_pn3n3_di_maPIEz5ma_zJnaKQjfiNn6"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Actuarial loss / (gain) recognized</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"
                                contextref="From2024-07-012024-09-30" id="Fact002901" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">14</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"
                                contextref="From2023-07-012023-09-30" id="Fact002902" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">42</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"
                                contextref="From2024-04-01to2024-09-30" id="Fact002903" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">27</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"
                                contextref="From2023-04-012023-09-30" id="Fact002904" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">81</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_iN_pn3n3_di_maPIEz5ma_zbECetjqnVpj"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left">Actuarial loss / (gain) recognized because of settlement</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"
                                contextref="From2024-07-012024-09-30" id="Fact002906" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">4</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2907">-</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"
                                contextref="From2024-04-01to2024-09-30" id="Fact002908" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">4</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2909">-</span></td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_pn3n3_msPIEz5ma_zb3sannPF6n2"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Amortization of prior service credit</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"
                                contextref="From2024-07-012024-09-30" id="Fact002911" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">37</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"
                                contextref="From2023-07-012023-09-30" id="Fact002912" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">38</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"
                                contextref="From2024-04-01to2024-09-30" id="Fact002913" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">73</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"
                                contextref="From2023-04-012023-09-30" id="Fact002914" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">73</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_40E_ecustom--PensionIncomeExpense_iNT_pn3n3_di_mtPIEz5ma_zYwMtwHN2Tc8"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Net charge to statement
                            of operations</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="DHAI:PensionIncomeExpense" contextref="From2024-07-012024-09-30"
                                id="Fact002916" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">78</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="DHAI:PensionIncomeExpense" contextref="From2023-07-012023-09-30"
                                id="Fact002917" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">70</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="DHAI:PensionIncomeExpense" contextref="From2024-04-01to2024-09-30"
                                id="Fact002918" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">155</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="DHAI:PensionIncomeExpense" contextref="From2023-04-012023-09-30"
                                id="Fact002919" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">136</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A8_zdhCsaILcyuh"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002921"
        name="us-gaap:IncomeTaxDisclosureTextBlock">
        <p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zJUXkjd8tA91"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_828_z1e4E03XEral">Income Taxes</span></b></span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>&nbsp;</span></b></span>
        </p>



        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002923"
            name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
            <p id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zV8esuP3MIg3"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B4_zzz1mkynA6F1" style="display: none">Schedule
                        of Reconciliation of Income Tax Expense and Effective Income Tax Rate</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49F_20240701__20240930_zDs5wGbw5iGl"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_497_20230701__20230930_zB5okkW8AOI2"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_494_20240401__20240930_zcRavgodyDig"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_491_20230401__20230930_zuH8jcaFQ1Vk"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Three Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Six Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_i01_zH9JIdr5xXR"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 40%; text-align: left">Income tax expense/(benefit)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" contextref="From2024-07-012024-09-30"
                                id="Fact002925" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">335
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" contextref="From2023-07-012023-09-30"
                                id="Fact002926" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">52
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit"
                                contextref="From2024-04-01to2024-09-30" id="Fact002927" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">1,058</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:IncomeTaxExpenseBenefit" contextref="From2023-04-012023-09-30"
                                id="Fact002928" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">278
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Effective tax rate</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_985_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20240701__20240930_zluPF3yStpqi"
                            title="Effective tax rate" style="text-align: right">
                            <ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations"
                                contextref="From2024-07-012024-09-30" id="Fact002930" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">332</ix:nonfraction>
                        </td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_988_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230701__20230930_zyw3NKqAqtM2"
                            title="Effective tax rate" style="text-align: right">(<ix:nonfraction
                                name="us-gaap:EffectiveIncomeTaxRateContinuingOperations"
                                contextref="From2023-07-012023-09-30" id="Fact002932" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" sign="-" unitref="Pure">2</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_980_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20240401__20240930_zGZSOd4ZTNJ2"
                            title="Effective tax rate" style="text-align: right">
                            <ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations"
                                contextref="From2024-04-01to2024-09-30" id="Fact002934" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" unitref="Pure">206</ix:nonfraction>
                        </td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td id="xdx_989_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230401__20230930_zpvJvaFKxPO6"
                            title="Effective tax rate" style="text-align: right">(<ix:nonfraction
                                name="us-gaap:EffectiveIncomeTaxRateContinuingOperations"
                                contextref="From2023-04-012023-09-30" id="Fact002936" format="ixt:numdotdecimal"
                                decimals="INF" scale="-2" sign="-" unitref="Pure">5</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)%</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A7_zw6I5rOQ8Aaf"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                effective rate for the three and six month period ended September 30, 2024 is higher than the statutory
                rate due to losses in certain
                jurisdictions that did not create a benefit, combined with income in others creating tax expense. The
                effective tax rate for the three
                month and six month period ended September 30, 2024 isn�t comparable to the three month and six month
                period ended September 30,
                2023 due to the pre-tax book income for three month and six month period ended September 30 2024 being
                close to break even.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company prepares its financial statements on a consolidated basis. Income tax expense is calculated in
                accordance with the local tax
                laws of each entity in its relevant jurisdiction on a separate company basis.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                of September 30, 2024 and September 30, 2023, the Company had unrecognized tax benefits of $<span
                    id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_pn3n3_c20240930_z812p7q5wGoi"
                    title="Unrecognized tax benefits">
                    <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefits" contextref="AsOf2024-09-30" id="Fact002938"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,250</ix:nonfraction>
                </span> and $<span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_pn3n3_c20230930_zVD1iLx48m8e"
                    title="Unrecognized tax benefits">
                    <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefits" contextref="AsOf2023-09-30" id="Fact002940"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">0</ix:nonfraction>
                </span>, respectively, which related
                to tax positions that, if recognized, would affect the annual effective tax rate. The company recognized
                accrued interest and penalties
                in income tax expense. As of September 30, 2024 and September 30, 2023 accrued interest and penalties
                totaling to $<span
                    id="xdx_902_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pn3n3_c20240930_zGDCALgedhXg"
                    title="Income tax expense, accrued interest and penalties">
                    <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"
                        contextref="AsOf2024-09-30" id="Fact002942" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">76</ix:nonfraction>
                </span> and $<span
                    id="xdx_90E_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pn3n3_c20230930_zXR0eiRTuLB1"
                    title="Income tax expense, accrued interest and penalties">
                    <ix:nonfraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"
                        contextref="AsOf2023-09-30" id="Fact002944" format="ixt:numdotdecimal" decimals="-3" scale="3"
                        unitref="USD">0</ix:nonfraction>
                </span> respectively
                is included in long-term liabilities. The Company has identified potential penalty exposure in relation
                to specific information reporting
                requirements in the United States. Although the Company is trying to address these issues and pursue
                penalty abatement, it has recorded
                a long-term payable for the penalties, until potential relief is granted. As of September 30, 2024 and
                September 30, 2023, the recorded
                accrual balances stand at $<span
                    id="xdx_906_eus-gaap--AccruedIncomeTaxes_iI_pn3n3_c20240930_zi3MMrDmOxW2"
                    title="Accrued income taxes">
                    <ix:nonfraction name="us-gaap:AccruedIncomeTaxes" contextref="AsOf2024-09-30" id="Fact002946"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,200</ix:nonfraction>
                </span> and $<span id="xdx_90C_eus-gaap--AccruedIncomeTaxes_iI_pn3n3_c20230930_zYieszKadGdi"
                    title="Accrued income taxes">
                    <ix:nonfraction name="us-gaap:AccruedIncomeTaxes" contextref="AsOf2023-09-30" id="Fact002948"
                        format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,200</ix:nonfraction>
                </span>, respectively.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002950"
        name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock">
        <p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z24kB1YBaZr2"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_82A_zuRgkkFO7kf4">Commitments and Contingencies</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
                time to time, the Company may be involved in lawsuits, claims, investigations, and proceedings,
                consisting of intellectual property,
                commercial, employment, and other matters, which arise in the ordinary course of business. In accordance
                with ASC 450, <i>Contingencies</i>,
                the Company makes a provision for a liability when it is both probable that a liability has been
                incurred and the amount of the loss
                can be reasonably estimated.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company is not presently a party to any litigation the outcome of which, it believes, if determined
                adversely to the Company, would individually
                or taken together, have a material adverse effect on the Company�s business, operating results, cash
                flows or financial condition.
                The Company has determined that the existence of a material loss is neither probable nor reasonably
                possible.</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>


        <ix:exclude><!-- Field: Page; Sequence: 148 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002952"
        name="us-gaap:LesseeOperatingLeasesTextBlock">
        <p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_z1CcjGJYVhId"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span
                        id="xdx_82F_zizWSuHOr6xd">Leases</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                Company leases office space (real estate), vehicles and office equipment under operating leases. The
                Company did not have any finance
                leases as of September 30, 2024 and March 31, 2024.</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002954"
            name="DHAI:ScheduleOfRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock">
            <p id="xdx_890_ecustom--ScheduleOfRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_zYGKHgE4dZN2"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
                    lease assets and lease liabilities that are reported in the Company�s condensed consolidated balance
                    sheet as of September 30,
                    2024 and March 31, 2024 are as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B3_zIAUKCC3kOU9" style="display: none">Schedule of Right-of-use Lease Assets and Lease
                        Liabilities</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49D_20240930_zMf2B5XC80q8"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of
                            September 30, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20240331_zOKMUvS20WM3"
                            style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March
                            31, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_zOq4gaRNIa1i"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 60%; text-align: left">Operating lease, right-of-use assets, net</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextref="AsOf2024-09-30"
                                id="Fact002956" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,182
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextref="AsOf2024-03-31"
                                id="Fact002957" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,466
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td>&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_maOLLz7z6_zNRugsWkWAT3"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left">Current portion of long-term operating lease</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AsOf2024-09-30"
                                id="Fact002959" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,494
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AsOf2024-03-31"
                                id="Fact002960" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,572
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_maOLLz7z6_zhQnNktLvVAg"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Long-term operating lease</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AsOf2024-09-30"
                                id="Fact002962" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,731
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AsOf2024-03-31"
                                id="Fact002963" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,917
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--OperatingLeaseLiability_iTI_pn3n3_mtOLLz7z6_zTgqtMCcI4s4"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total operating lease
                            liabilities</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiability" contextref="AsOf2024-09-30"
                                id="Fact002965" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,225
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiability" contextref="AsOf2024-03-31"
                                id="Fact002966" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,489
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AF_zWUWLcOcZu1"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002968"
            name="us-gaap:LeaseCostTableTextBlock">
            <p id="xdx_89E_eus-gaap--LeaseCostTableTextBlock_zMHqB5MPM016"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
                    expense for lease payments is recognized on a straight-line basis over the lease term. The expense
                    is presented within Selling, general,
                    and administrative expense. The components of lease expense related to the Company�s lease for the
                    three and six months ended September
                    30, 2024 and 2023 were:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zW7dN8m48Kq"
                        style="display: none">Schedule of Lease Expense</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_491_20240701__20240930_zSErYG0J4ugb"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_490_20230701__20230930_zuJUx8UZK9Fk"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_496_20240401__20240930_zXaB7KkvIZna"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_491_20230401__20230930_z9N4jJwWaQGe"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Three Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Six Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--OperatingLeaseCost_pn3n3_maLCzjz6_zFhur3fbM8K7"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 40%; text-align: left">Fixed operating lease costs</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseCost" contextref="From2024-07-012024-09-30"
                                id="Fact002970" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">449
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseCost" contextref="From2023-07-012023-09-30"
                                id="Fact002971" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">436
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseCost" contextref="From2024-04-01to2024-09-30"
                                id="Fact002972" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">950
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 11%; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseCost" contextref="From2023-04-012023-09-30"
                                id="Fact002973" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">861
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--ShortTermLeaseCost_pn3n3_maLCzjz6_zr6XNktyGlZ5"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Short-term lease costs</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:ShortTermLeaseCost" contextref="From2024-07-012024-09-30"
                                id="Fact002975" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">11
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:ShortTermLeaseCost" contextref="From2023-07-012023-09-30"
                                id="Fact002976" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">14
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:ShortTermLeaseCost" contextref="From2024-04-01to2024-09-30"
                                id="Fact002977" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">24
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:ShortTermLeaseCost" contextref="From2023-04-012023-09-30"
                                id="Fact002978" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">27
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_40A_eus-gaap--LeaseCost_iT_pn3n3_mtLCzjz6_zynvpgy1Xe35"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 2.5pt">Total lease cost</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:LeaseCost" contextref="From2024-07-012024-09-30"
                                id="Fact002980" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">460
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:LeaseCost" contextref="From2023-07-012023-09-30"
                                id="Fact002981" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">450
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:LeaseCost" contextref="From2024-04-01to2024-09-30"
                                id="Fact002982" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">974
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:LeaseCost" contextref="From2023-04-012023-09-30"
                                id="Fact002983" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">888
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A2_zvlm1KDMADd3"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002985"
            name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
            <p id="xdx_893_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zEMFUlC4D7Gc"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
                    cash flow information related to leases was as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B2_zaHPM7Qm2WRk" style="display: none">Schedule of Supplemental Cash Flow Information
                        Related to Leases</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20240401__20240930_z9maqSuB1WTk"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_492_20230401__20230930_zjr2JoDXMtR3"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Six Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            2023</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_ecustom--OperatingCashFlowsIncludedInMeasurementOfLeaseLiabilities_iN_pn3n3_di_zmj6rJzCt3d2"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 60%; text-align: left">Operating cash flows included in the measurement of
                            lease liabilities</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">(<ix:nonfraction
                                name="DHAI:OperatingCashFlowsIncludedInMeasurementOfLeaseLiabilities"
                                contextref="From2024-04-01to2024-09-30" id="Fact002987" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">967</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 16%; text-align: right">(<ix:nonfraction
                                name="DHAI:OperatingCashFlowsIncludedInMeasurementOfLeaseLiabilities"
                                contextref="From2023-04-012023-09-30" id="Fact002988" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">874</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_403_ecustom--NoncashLeaseActivityRelatedToRightofuseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities_pn3n3_ztUHsn6IZ1P5"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Non-cash lease activity related to right-of-use assets obtained in
                            exchange for new operating lease
                            liabilities</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="DHAI:NoncashLeaseActivityRelatedToRightofuseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities"
                                contextref="From2024-04-01to2024-09-30" id="Fact002990" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">123</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction
                                name="DHAI:NoncashLeaseActivityRelatedToRightofuseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities"
                                contextref="From2023-04-012023-09-30" id="Fact002991" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">169</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_ecustom--OtherNoncashChangesToRouAssetsDueToReassessmentOfLeaseTerm_pn3n3_z5WLDneDpau3"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left">Other non-cash changes to ROU assets due to reassessment of the
                            lease term</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="DHAI:OtherNoncashChangesToRouAssetsDueToReassessmentOfLeaseTerm"
                                contextref="From2024-04-01to2024-09-30" id="Fact002993" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" sign="-" unitref="USD">130</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:OtherNoncashChangesToRouAssetsDueToReassessmentOfLeaseTerm"
                                contextref="From2023-04-012023-09-30" id="Fact002994" format="ixt:numdotdecimal"
                                decimals="-3" scale="3" unitref="USD">2,305</ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A9_zL6WFLym8JS8"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact002996"
            name="DHAI:WeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock">
            <p id="xdx_89A_ecustom--WeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_zAAu4G6aHFYi"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    weighted average remaining lease term and discount rate for the Company�s operating leases as of
                    September 30, 2024 and March 31,
                    2024 were:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B6_zoW9VLaCTYb8" style="display: none">Schedule of Weighted Average Remaining Lease
                        Term and Discount Rate</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of September 30, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As
                            of March 31, 2024</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 60%; text-align: left">Weighted-average remaining lease term (in years)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 16%; text-align: right"><span
                                id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240930_zJBz4bkIPmq2"
                                title="Weighted-average remaining lease term">
                                <ix:nonnumeric contextref="AsOf2024-09-30" format="ixt-sec:duryear" id="Fact002998"
                                    name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">2.37</ix:nonnumeric>
                            </span></td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 16%; text-align: right"><span
                                id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240331_zndr8ZIS01P4"
                                title="Weighted-average remaining lease term">
                                <ix:nonnumeric contextref="AsOf2024-03-31" format="ixt-sec:duryear" id="Fact003000"
                                    name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">2.63</ix:nonnumeric>
                            </span></td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Weighted-average discount rate</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20240930_zKV3GIDyErwd"
                                title="Weighted-average discount rate">
                                <ix:nonfraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent"
                                    contextref="AsOf2024-09-30" id="Fact003002" format="ixt:numdotdecimal"
                                    decimals="INF" scale="-2" unitref="Pure">4.00</ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span
                                id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20240331_zwjgpZOaXUA3"
                                title="Weighted-average discount rate">
                                <ix:nonfraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent"
                                    contextref="AsOf2024-03-31" id="Fact003004" format="ixt:numdotdecimal"
                                    decimals="INF" scale="-2" unitref="Pure">4.00</ix:nonfraction>
                            </span></td>
                        <td style="text-align: left">%</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AA_z9j4iXv4RYO4"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
                duration was determined utilizing renewal options that the Company is reasonably certain to
                execute.</span></p>

        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


        <ix:exclude><!-- Field: Page; Sequence: 149 -->
            <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
                <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
                    <tbody>
                        <tr style="vertical-align: top; text-align: left">
                            <td style="text-align: center; width: 100%">
                                F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div style="break-before: page; margin-top: 6pt">
                <p style="margin: 0pt">&nbsp;</p>
            </div>
            <!-- Field: /Page -->
        </ix:exclude>

        <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact003006"
            name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
            <p id="xdx_89C_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z8jxRJiFUBwc"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                    of September 30, 2024, maturities of operating lease liabilities for each of the following five
                    years ending March 31 and a total thereafter
                    were as follows:</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8B7_z2fwkTIJwmYf" style="display: none">Schedule of Maturities of Operating Lease
                        Liabilities</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="vertical-align: bottom">
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" id="xdx_49B_20240930_zfppvSsORnC7"
                            style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Operating
                            Leases</td>
                        <td>&nbsp;</td>
                    </tr>
                    <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_maLOLLPz1Eb_zZXiIkWdjPMg"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 78%; text-align: left">2025</td>
                        <td style="width: 2%; text-align: left">&nbsp;</td>
                        <td style="width: 1%">$</td>
                        <td style="text-align: right; width: 18%">
                            <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"
                                contextref="AsOf2024-09-30" id="Fact003008" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">894</ix:nonfraction>
                        </td>
                        <td style="width: 1%">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPz1Eb_zXrLRb5iy8cg"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">2026</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"
                                contextref="AsOf2024-09-30" id="Fact003010" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">1,276</ix:nonfraction>
                        </td>
                        <td>&nbsp;</td>
                    </tr>
                    <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPz1Eb_zZTPKPlNelSl"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left">2027</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree"
                                contextref="AsOf2024-09-30" id="Fact003012" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">1,049</ix:nonfraction>
                        </td>
                        <td>&nbsp;</td>
                    </tr>
                    <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPz1Eb_z5EDTaEbVlik"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">2028</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour"
                                contextref="AsOf2024-09-30" id="Fact003014" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">1,045</ix:nonfraction>
                        </td>
                        <td>&nbsp;</td>
                    </tr>
                    <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_maLOLLPz1Eb_z3qJVUYRvAK8"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left">2029</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive"
                                contextref="AsOf2024-09-30" id="Fact003016" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">223</ix:nonfraction>
                        </td>
                        <td>&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_ecustom--LesseeOperatingLeaseLiabilityPaymentDueYearSix_iI_pn3n3_maLOLLPz1Eb_zoEvleTr7ili"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">2030</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="DHAI:LesseeOperatingLeaseLiabilityPaymentDueYearSix"
                                contextref="AsOf2024-09-30" id="Fact003018" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">22</ix:nonfraction>
                        </td>
                        <td>&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_maLOLLPz1Eb_zcsYmgATmFj3"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-bottom: 1pt; text-align: left"><span
                                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl3020">�</span></td>
                        <td>&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPz1Eb_z8D5dE0QLRt9"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-left: 10pt; text-align: left"><span
                                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                lease payments</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue"
                                contextref="AsOf2024-09-30" id="Fact003022" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">4,509</ix:nonfraction>
                        </td>
                        <td>&nbsp;</td>
                    </tr>
                    <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zcznjpuTWZVj"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="padding-bottom: 1pt; text-align: left"><span
                                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
                                imputed interest</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"
                                contextref="AsOf2024-09-30" id="Fact003024" format="ixt:numdotdecimal" decimals="-3"
                                scale="3" unitref="USD">284</ix:nonfraction>
                        </td>
                        <td>)</td>
                    </tr>
                    <tr id="xdx_401_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zqHyVIyEHhi3"
                        style="vertical-align: bottom; background-color: White">
                        <td style="padding-bottom: 2.5pt; text-align: left"><span
                                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                lease liability</span></td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:OperatingLeaseLiability" contextref="AsOf2024-09-30"
                                id="Fact003026" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">4,225
                            </ix:nonfraction>
                        </td>
                        <td>&nbsp;</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8A9_zus25NdmEZf6"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact003028"
        name="us-gaap:ComprehensiveIncomeNoteTextBlock">
        <p id="xdx_809_eus-gaap--ComprehensiveIncomeNoteTextBlock_zuEbSptgOtna"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18.</b></span> <span
                style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span
                        id="xdx_829_zlIFC6ICPZXk">Accumulated Other Comprehensive Income</span></b></span></p>



        <p
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

        <ix:nonnumeric contextref="From2024-04-01to2024-09-30" escape="true" id="Fact003030"
            name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
            <p id="xdx_897_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zlHSiNhMdVPh"
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                    changes in accumulated other comprehensive income (loss) by component are summarized below:</span>
            </p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.3in">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span
                        id="xdx_8BF_zJmwWGf3rLNh" style="display: none">Schedule of Changes in Accumulated Other
                        Comprehensive Income (Loss)</span></span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2"
                            id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_zVvEUQ6ubaT9"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2"
                            id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_zJKoma79Ptoc"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2"
                            id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_z2MdqRYUtoF"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Three Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Foreign Currency<br>
                            Translation</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Defined Benefit<br>
                            Plan Items</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Total Accumulated Other<br>
                            Comprehensive
                            (Loss) Income</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_432_c20240701__20240930_eus-gaap--StockholdersEquity_iS_pn3n3_zjKqm9PUi27e"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 46%; font-weight: bold">Balance, June 30, 2024</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-06-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003032" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">3,808</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003033" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,951
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003034" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">1,857</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_pn3n3_zpQiON22wzGi"
                        style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="font-weight: bold">Transfer of defined benefit plan</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_pn3n3_zXyTRgi2gqAi"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Other comprehensive income (loss) before reclassifications</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2024-07-012024-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003040" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">454
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2024-07-012024-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003041" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">362</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003042" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">92
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_pn3n3_zN2AC3VdUVya"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt">Reclassifications to statements of earnings
                        </td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl3044">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                                contextref="From2024-07-012024-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003045" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">200</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                                contextref="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003046" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">200</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_iN_pn3n3_di_zBiyFsYSL9fj"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Total other comprehensive loss</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2024-07-012024-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003048" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">454</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2024-07-012024-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003049" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">562
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003050" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">108
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_43F_c20240701__20240930_eus-gaap--StockholdersEquity_iE_pn3n3_zjdHw4kAYYt8"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="font-weight: bold; padding-bottom: 1pt">Balance, September 30, 2024</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003052" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">3,354</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003053" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,389
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003054" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">1,965</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: White">
                        <td>&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_437_c20230701__20230930_eus-gaap--StockholdersEquity_iS_pn3n3_zEJ8AjazwLMj"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="font-weight: bold">Balance, June 30, 2023</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-06-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003056" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">3,034</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003057" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,166
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003058" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">132
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_pn3n3_zgnifD7qaRy"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Other comprehensive income (loss) before reclassifications</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2023-07-012023-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003060" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">601</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2023-07-012023-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">139
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003062" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">462</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_pn3n3_z9dJoSpszt9d"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt">Reclassifications to statements of earnings
                        </td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl3064">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                                contextref="From2023-07-012023-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003065" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">79</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                                contextref="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003066" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">79</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_iN_pn3n3_di_zZdQgMaZ43Jc"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Total other comprehensive loss</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2023-07-012023-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003068" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">601
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2023-07-012023-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003069" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">60</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003070" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">541
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_43B_c20230701__20230930_eus-gaap--StockholdersEquity_iE_pn3n3_zZjqDEnUfDO5"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="font-weight: bold; padding-bottom: 1pt">Balance, September 30, 2023</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003072" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">3,635</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003073" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,226
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003074" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">409</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                </tbody>
            </table>

            <p
                style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">
                <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

            <table cellpadding="0" cellspacing="0"
                style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
                <tbody>
                    <tr style="display: none; vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2"
                            id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_zktI6nposKmb"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2"
                            id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_zIoGnd7anB1f"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2"
                            id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zYPkFKyH0cM7"
                            style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td>&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            For the Six Months Ended September
                            30,</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr style="vertical-align: bottom">
                        <td style="text-align: center">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Foreign Currency<br>
                            Translation</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Defined Benefit<br>
                            Plan Items</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                        <td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
                        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">
                            Total Accumulated Other<br>
                            Comprehensive
                            (Loss) Income</td>
                        <td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
                    </tr>
                    <tr id="xdx_438_c20240401__20240930_eus-gaap--StockholdersEquity_iS_pn3n3_zgnYS4T7WNbi"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="width: 46%; font-weight: bold">Balance, March 31, 2024</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003076" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">2,420</ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">)</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003077" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,470
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                        <td style="width: 2%">&nbsp;</td>
                        <td style="width: 1%; text-align: left">$</td>
                        <td style="width: 14%; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">50
                            </ix:nonfraction>
                        </td>
                        <td style="width: 1%; text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_405_eus-gaap--OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_pn3n3_zwusYyoAj4Dd"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left">Transfer of defined benefit plan</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3080">�</span></td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
                                contextref="From2024-04-012024-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003081" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">228</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
                                contextref="From2024-04-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003082" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">228</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_pn3n3_zzj9wPOHVZej"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left">Other comprehensive income (loss) before reclassifications</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2024-04-012024-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003084" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">934</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2024-04-012024-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003085" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">604</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2024-04-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003086" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">1,538</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_pn3n3_zUiWtgWs1mI4"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Reclassifications to statements of earnings
                        </td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl3088">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                                contextref="From2024-04-012024-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003089" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">249</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                                contextref="From2024-04-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003090" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">249</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_iN_pn3n3_di_z8SMvPhixMH5"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt">Total other comprehensive loss</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2024-04-012024-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003092" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">934
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2024-04-012024-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,081
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2024-04-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003094" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">2,015
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_439_c20240401__20240930_eus-gaap--StockholdersEquity_iE_pn3n3_zYMARDfm5MD2"
                        style="vertical-align: bottom; background-color: White">
                        <td style="font-weight: bold; padding-bottom: 1pt">Balance, September 30, 2024</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003096" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">3,354</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003097" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">1,389
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003098" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">1,965</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td>&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_43A_c20230401__20230930_eus-gaap--StockholdersEquity_iS_pn3n3_zLlww386JtH2"
                        style="vertical-align: bottom; background-color: White">
                        <td style="font-weight: bold">Balance, March 31, 2023</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003100" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">3,875</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003101" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,586
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003102" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">289</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_43F_c20230401__20230930_eus-gaap--StockholdersEquity_iS_pn3n3_zKok1zudiFPf"
                        style="display: none; vertical-align: bottom; background-color: White">
                        <td style="font-weight: bold">Beginning balance, value</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-03-31_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003104" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">3,875</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-03-31_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003105" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,586
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">$</td>
                        <td style="text-align: right">(<ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003106" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">289</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                    </tr>
                    <tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_pn3n3_zn9ZIwyrVWsb"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left">Other comprehensive income (loss) before reclassifications</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2023-04-012023-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003108" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">240
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2023-04-012023-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003109" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">205</ix:nonfraction>
                        </td>
                        <td style="text-align: left">)</td>
                        <td>&nbsp;</td>
                        <td style="text-align: left">&nbsp;</td>
                        <td style="text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"
                                contextref="From2023-04-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003110" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">35
                            </ix:nonfraction>
                        </td>
                        <td style="text-align: left">&nbsp;</td>
                    </tr>
                    <tr id="xdx_404_eus-gaap--ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_pn3n3_zLUPYg1d4c6e"
                        style="vertical-align: bottom; background-color: White">
                        <td style="text-align: left; padding-bottom: 1pt">Reclassifications to statements of earnings
                        </td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right"><span
                                style="-sec-ix-hidden: xdx2ixbrl3112">�</span></td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                                contextref="From2023-04-012023-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003113" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">155</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"
                                contextref="From2023-04-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003114" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">155</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_408_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_iN_pn3n3_di_zhdxJbXyIlE5"
                        style="vertical-align: bottom; background-color: rgb(204,238,255)">
                        <td style="text-align: left; padding-bottom: 1pt">Total other comprehensive loss</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">
                            <ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2023-04-012023-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003116" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">240</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2023-04-012023-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">360
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                        <td style="padding-bottom: 1pt">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td>
                        <td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction
                                name="us-gaap:OtherComprehensiveIncomeLossNetOfTax"
                                contextref="From2023-04-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003118" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">120
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 1pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_43C_c20230401__20230930_eus-gaap--StockholdersEquity_iE_pn3n3_zxf0eS9095ic"
                        style="vertical-align: bottom; background-color: White">
                        <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, September 30, 2023</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003120" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">3,635</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003121" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,226
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003122" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">409</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                    </tr>
                    <tr id="xdx_43F_c20230401__20230930_eus-gaap--StockholdersEquity_iE_pn3n3_zwK5sK1t8fmk"
                        style="display: none; vertical-align: bottom; background-color: White">
                        <td style="font-weight: bold; padding-bottom: 2.5pt">Ending balance, value</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-09-30_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003124" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">3,635</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">
                            <ix:nonfraction name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
                                id="Fact003125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitref="USD">3,226
                            </ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td>
                        <td style="padding-bottom: 2.5pt">&nbsp;</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
                        <td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction
                                name="us-gaap:StockholdersEquity"
                                contextref="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
                                id="Fact003126" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-"
                                unitref="USD">409</ix:nonfraction>
                        </td>
                        <td style="padding-bottom: 2.5pt; text-align: left">)</td>
                    </tr>
                </tbody>
            </table>

        </ix:nonnumeric>
        <p id="xdx_8AD_zH35oPHBRQQf"
            style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
            <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>

    </ix:nonnumeric>
    <p id="xdx_81B_zA97xFZ8IR92"
        style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</span></p>


    <!-- Field: Page; Sequence: 150 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="text-align: center; width: 100%">
                        F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td>
                </tr>
            </tbody>
        </table>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt">
        <p style="margin: 0pt">&nbsp;</p>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span
            style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></span></p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">5,937,100 Units, each consisting
        of</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">One Share of Common Stock to
        purchase One Share
        of Common Stock and One Class A Warrants to purchase One Share of Common Stock</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">5,937,100 Shares of Common Stock
        Underlying
        the Class A Warrants</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">DIH HOLDING US, INC.</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">PROSPECTUS</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Sole Placement Agent</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Maxim Group LLC</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">January 31, 2025</p>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;
    </p>

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

    <!-- Field: Page; Sequence: 151; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
            <tbody>
                <tr style="vertical-align: top; text-align: left">
                    <td style="width: 100%">&nbsp;</td>
                </tr>
            </tbody>
        </table>
    </div>
    <!-- Field: /Page -->

    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>






















</body>

</html>